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Plenary Session 1: Standardizations
Chairs: Andrew Hill; Hidetoshi Tahara
Location: Level 3, Hall B
NanoCosmos: extracellular vesicles as nanosized extracellular
organelles delivering the complex messages between cells and
organisms
Yong Song Gho
Department of Life Sciences, POSTECH, Pohang, Republic of Korea
The secretion of nanosized lipid bilayered extracellular
vesicles is a universal cellular process occurring from
simple organisms to complex multicellular organisms.
Recent progress in this area has revealed that extracel-
lular vesicles play multifaceted pathophysiological
functions by delivering the complex messages between
cells and organisms, suggesting that extracellular vesi-
cles are NanoCosmos, i.e., extracellular organelles that
play diverse roles in intercellular and interkingdom
communication. This presentation briefly introduces
our last 20 year’s comprehensive research on
extracellular vesicles derived from host, bacteria, diet
and environments including their physical, biochem-
ical and biological complex properties (http://evpedia.
info). Then, this presentation focuses on our recent
progress in novel extracellular vesicle-mimetic technol-
ogies for targeted drug delivery, theranostics and epi-
genetic reprogramming as well as for adjuvant-free,
non-toxic vaccine delivery system against bacterial
infection. Furthermore, bacterial extracellular vesicle-
based cancer immunotherapy will be introduced. Based
on the concept of emergent properties of heteroge-
neous extracellular vesicles, future research directions
to decode the complexity of extracellular vesicle-
mediated intercellular communication network, either
at the single vesicle level or at a systems level as a
whole, and the secret of life will be briefly introduced.
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Symposium Session 1: Cardiovascular Disease
Thursday 25 April 2019
Chairs: J. Brian Byrd; Pia Siljander
Location: Level B1, Hall B
11:00–12:30
OT01.01
Extracellular vesicles mediate neutrophil cell deployment from the
spleen following acute myocardial infarction
Naveed Akbar and Robin Choudhury
University of Oxford, Oxford, UK
Introduction: Acute myocardial infarction (AMI) mobi-
lizes monocytes from the splenic reserve and induces
transcriptional activation en route to the injured myo-
cardium, possibly through interactions involving plasma
liberated extracellular vesicles (EVs). Neutrophils also
reside in the spleen and are the first cells to arrive at
sites of injury and mediate further damage. Here, we
describe neutrophil deployment from the spleen in AMI
and by endothelial cell (EC)-derived EVs.
Methods: Patients provided informed consent as part of
the Oxford Acute Myocardial Infarction Study. EV were
isolated using ultra centrifugation (120,000g 2 h) and
characterized for size and concentration by Nanoparticle
Tracking Analysis, EV markers (TSG101, ALIX, CD63/
CD69) by western blot, and microRNAs (miRNAs) by
RT-qPCR. Mouse and human EC were used in vitro to
derive EC-EV.
Results: Patients presenting with AMI (n = 15) have 2.2-
fold more plasma EV at time of injury vs. a 6-month
follow-up measurement (P = 0.008). Plasma EVs at the
time of presentation correlate significantly with the extent
of ischemic injury (R = 0.046, P = 0.006) and plasma
neutrophils (R = 0.37, P = 0.017). Experimental AMI in
wild type, naïve (C57B6/J) mice induces splenic-neutro-
phil deployment (P = 0.004). Human plasma EV-
miRNAs are significantly altered post-AMI. AMI plasma
EV-miRNA-mRNA targets (IPA, Qiagen) are signifi-
cantly over represented when compared to neutrophil
Gene Ontology terms for degranulation (P < 0.001), acti-
vation (P < 0.001), chemotaxis (P = 0.008) and migration
(P = 0.008). Human EC releases more EV after inflam-
matory stimulation (control 2.4 × 108 ± 4.9 x 107 EVs/
mL vs. tumour necrosis factor-alpha stimulated,
1.4 × 109 ± 3.0 × 108 EVs/mL, P = 0.003) and contains
many of the miRNAs enriched in human plasma-EV
following AMI. Mouse EC-EV tail vein injected into
otherwise wild-type, naïve mice mobilize splenic neutro-
phils to peripheral blood (P < 0.001).
Summary/Conclusion: Neutrophils appear at sites of
injury in the immediate hours after ischemic injury.
Neutrophil interactions with EC-EV may mediate their
splenic liberation and transcriptional programming fol-
lowing AMI, en route to the injured myocardium. The
splenic neutrophil reserve may be a novel therapeutic
target in AMI.
Funding: British Heart Foundation.
OT01.02
In vivo characterization of endogenous cardiovascular extracellular
vesicles and their response to ischaemic injury
Aaron Scotta, Costanza Emanuelib and Rebecca Richardsonc
aUniversity of Bristol, Uffculme, UK; bImperial College London, London, UK;
cUniversity of Bristol, Bristol, UK
Introduction: Cardiomyocytes and endothelial cells are
counted among the cell types that secrete extracellular
vesicles (EVs). EVs mediate the targeted transfer of
lipids, proteins and nucleic acids by traversing the
extracellular milieu. Recent studies suggest that EVs
play a functional role in cardiovascular disease and
cardiac repair. For example, a population of exosomes
carrying proangiogenic miRNAs was found in the peri-
cardial fluid of patients undergoing heart surgery.
Further investigation will be required to determine
which cardiac cells are producing these EVs, the cell
type receiving them and the functional relevance of
this.
Methods: A complete understanding of this process
requires a comprehensive in vivo model. The zebrafish
is an amenable vertebrate model with genetic tractabil-
ity and optical transparency allowing for subcellular
observation in a living organism. The use of stable
transgenic lines with cell-type-specific promoters driv-
ing the expression of membrane tethered fluorophores
allows labelling of the cell membrane and the EVs
produced by individual cell types. Light sheet micro-
scopy permits cardiovascular-specific EVs to be tracked
in vivo and an established ischaemic injury model
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allows EV profiles from uninjured, injured and repair-
ing/regenerating cardiac tissue to be determined and
compared.
Results: Live imaging of transgenic zebrafish with
endothelial cell-derived EVs labelled with mCherry
reveals large numbers of EVs in the peripheral circula-
tion, interactions with downstream endothelial cells
and release in to the blood flow from filopodia-like
protrusions. Cardiomyocyte-derived EVs are observed
in the pericardial fluid surrounding the heart and are
often seen interacting with cells of the pericardial wall.
Additionally, a modified FACS protocol reveals how
cardiomyocyte-derived EV numbers fluctuate in
response to cardiac injury.
Summary/Conclusion: This data present exciting
opportunities to further dissect the cargo being carried
by these EVs in a vertebrate model of human disease.
Funding: British Heart Foundation.
OT01.03
Enhanced fibrinolysis and altered extracellular vesicles after remote
ischaemic preconditioning in non-diabetic coronary artery disease
patients
Caroline J. Reddela, Jerrett Laub, Gabrielle Penningc, Vivien Chend and
Leonard Kritharidese
aANZAC Research Institute, University of Sydney, Concord Repatriation
General Hospital, Concord, Australia; bDepartment of Cardiology, Concord
Repatriation General Hospital, Concord, Australia; cANZAC Research
Institute, University of Sydney, Concord Repatriation General Hospital,
Concord, Australia; dANZAC Research Institute and Department of
Haematology, Concord Repatriation General Hospital, Concord, Australia;
eANZAC Research Institute and Department of Cardiology, Concord
Repatriation General Hospital, Concord, Australia
Introduction: Brief non-harmful ischaemia, remote
ischaemic preconditioning (RIPC) has been shown to
confer benefit to patients with coronary artery disease
(CAD). Some studies indicate lesser benefit in patients
with diabetes. RIPC may enhance fibrinolysis.
Hypothesis: RIPC causes an increase in fibrinolytic
potential through release of fibrinolytic factors from
the endothelium or fibrinolysis-supporting extracellu-
lar vesicles (EVs) and this effect is less evident in
patients with diabetes.
Methods: Patients at Concord Hospital with suspected
CAD gave written informed consent and were admi-
nistered RIPC (sphygmomanometer on the arm, 3 × 5
min cycles, n = 31) or sham (n = 29) before angiogra-
phy, with recruitment ongoing. Blood was collected
pre- and immediately post-RIPC/sham and platelet-
free plasma generated. Global coagulation/fibrinolytic
potential was measured by overall haemostatic poten-
tial assay (Reddel et al. Thromb Res. 2013; 131(5): 457–
462) and various fibrinolytic factors by ELISA. EV were
assessed by flow cytometry (Reddel et al. Thromb
Haemost. 2018; 118(4): 723–733) using fluorescent sur-
face markers for phosphatidylserine and cell origin
including platelets (CD41a), leukocytes (CD45) and
MAC-1 (CD11b). Positive events were defined with
supernatant of ultracentrifuged pooled normal plasma
as negative control. Changes pre–post RIPC were
assessed by paired t-test. The study was approved by
the local ethics committee.
Results: In the whole population, there was no effect of
RIPC on fibrinolytic factors but a decrease in platelet-
derived EV. However, in non-diabetic patients and not
in diabetic patients, RIPC increased overall fibrinolytic
potential and CD45+ and CD11b+ EV. These effects
were not seen after sham treatment.
Summary/Conclusion: There is a global increase in
fibrinolytic potential after RIPC treatment in CAD
patients without diabetes mellitus, which may be con-
tributed to by increased leukocyte-derived EV and/or
decreased platelet-derived EV. Ongoing work aims to
directly identify this contribution in patients who
undergo RIPC.
OTO1.04
Urinary extracellular vesicle concentration, microRNA-155 expression
and inflammatory surface marker expression are altered in patients
with symptomatic coronary artery disease
Stephen Fitzsimonsa, Silvia Oggerob, Niall Mahonc, Nicola Ryanc, Mauro
Perrettid and Orina Beltona
aUniversity College Dublin, Dublin, Ireland; bQueen Mary University of
London, London, UK; cThe Mater Misericordiae University Hospital,
Dublin, Ireland; dWilliam Harvey Research institute, Queen Mary
University of London, London, UK
Introduction: Urinary extracellular vesicles (uEVs)
(exosomes, microvesicles and apoptotic bodies) have
potential as diagnostic and prognostic biomarkers. In
atherosclerosis, the underlying cause of heart attack
and stroke, EV release can be dysregulated and their
contents can mediate pro-inflammatory effects. Several
markers have been previously identified on uEV
including exosome markers CD63 and CD9, CD45
(leukocyte marker), CD61 (platelet marker), CD14
(monocyte/macrophage marker) and α/β integrins.
The selectively packaged cargo of these membrane
bound carriers include microRNAs (miRs). miR-21
and miR-155 are key regulatory miRs that are upregu-
lated in immune cells and are released in EVs following
exposure to pro-inflammatory stimuli. miR-155 has
been reported to have pro-atherogenic effects and
miR-155 deficiency in murine models results in
reduced atherosclerotic lesion burden.
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Methods: Urine was collected from patients diagnosed
with coronary artery disease (CAD), classified as symp-
tomatic (non-ST-elevation myocardial infarction, ST-
elevation myocardial infarction or unstable angina) or
asymptomatic (stable angina). uEVs from symptomatic
and asymptomatic patients were isolated via benchtop
centrifugation. The concentration and size of uEVs
were analysed via the NanoSight NS300 (n = 15 per
group). The expression of miR-155 and miR-21 was
investigated by RT-qPCR (n = 10 per group). uEV
surface marker expression was analysed by
ImageStreamX MK2 Imaging Flow Cytometer (12 per
group).
Results: uEV concentration in symptomatic patients
(median; 6.46E+9 particles/mL) was significantly
decreased (p < 0.05) compared to asymptomatic
patients (median; 1.25E+10 particles/mL). CD11B+
uEVs were increased and CD16+ uEVs were decreased
in the symptomatic patients (p < 0.01). In addition, the
concentration of CD45+ EVs were increased in symp-
tomatic patients (p < 0.001). Although uEV miR-21
was unchanged, miR-155 expression was significantly
increased in the symptomatic group (p < 0.05).
Summary/Conclusion: uEV concentration, miR-155
expression and surface marker expression have diag-
nostic and prognostic potential. As CAD severity
increases, uEV concentration is reduced, surface mar-
ker expression is altered and uEV miR-155 expression
is increased.
Funding: The Irish Research Council.
OT01.05
Circulating extracellular vesicle-associated microRNAs as predictive
biomarkers of cardiovascular complications in end-stage renal
disease
Dakota D. Gustafsona, Jessica Fitzpatrickb, Jason Fishc and Rulan Parekhb
aDepartment of Laboratory Medicine and Pathobiology, University of
Toronto, Toronto, ON, Canada; bChild Health Evaluative Sciences,
Research Institute, The Hospital for Sick Children, Toronto, ON, Canada;
cToronto General Hospital Research Institute, University Health Network,
Toronto, ON, Canada
Introduction: Chronic kidney disease affects roughly
three million Canadians and is accompanied by con-
siderable human suffering, premature death and costly
medical care. The incidence of ESRD and its associated
cardiovascular (CV) complications continues to rise
despite improved treatments for the primary etiologies
of diabetes and hypertension.
Methods: We are using multiple biological approaches
to better understand the organ-level effects of extracel-
lular vesicle (EV)/miRNA dysregulation and gather the
detailed mechanistic insight necessary for the
development of an integrative CV risk prediction
model for diabetic ESRD patients. The foundation of
this study is the Predictors of Arrhythmic and
Cardiovascular Risk in End Stage Renal Disease
(PACE) cohort (n = 571); a cohort of ESRD patients
followed over four years, with a repository of clinical
data with matched biological samples. ExoQuick was
used for the isolation of EVs from plasma, and their
properties characterized through NanoSight analysis,
western blotting and electron microscopy. A high-
throughput microfluidics RT-qPCR platform
(n = 420) was used to examine potential associations
between miRNA and clinical outcomes. We then vali-
dated functionality on human coronary endothelial
cells (n = 12, coronary artery disease vs. control)
using mRNA-Seq.
Results: EV analysis revealed diabetic ESRD patients
have increased circulating vesicle concentrations; in
addition to having vesicles of a larger mean size. Data
from our clinically translatable microfluidics-based RT-
qPCR methodology identified numerous potential
microRNA biomarkers for CV complications of
ESRD. Following miRNA identification, we utilized
penalized regression models to generate a panel of
miRNAs which may serve as CV-risk predictors for
diabetic ESRD patients. In particular, miR-23b-3p
appears to be significantly associated with coronary
artery disease severity.
Summary/Conclusion: This data will be weighted with
the novel biomarker data and fully integrated to build a
clinical risk prediction model for the development of
CV complications in ESRD and reassessed in a new
cohort (D4 Cohort) replicate the findings and validate
the risk prediction model.
Funding: This work was funded by AstraZeneca and
the Canadian Vascular Network.
OT01.06
Live tracking system for endogenous exosomes
Weijia Luoa, Yuan Daia, Kelsey Andradea, Megha Chandnab, Pamela Ulloa-
Francoc and Jiang Changa
aTexas A&M University College of Medicine, Houston, USA; bUniversity of
Texas-Austin, Houston, USA; cTrinity College, Hartford, USA
Introduction: Exosomes are emerging new category of
messengers that communicating among cells, tissues
and organs. Understanding the kinetic of exosome
communication in vivo is a critical foundation for
studying exosome functions and developing exosome-
based drug-delivery models. Current studies of exo-
some in vivo trafficking largely rely on the administra-
tion of exogenous exosomes labelled by fluorescent
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dyes or proteins. These methods may not fully repre-
sent endogenous exosome kinetics due to ex vivo exo-
some manipulation. Here, we established the first
inducible endogenous exosome tracking mouse model
that tracks endogenous exosome released by cardio-
myocytes in vivo.
Methods: We generated a transgenic mouse expressing
the bioluminescent reporter Nano-luciferase (NanoLuc)-
fusion protein. The ultrasensitive and stable NanoLuc
reporter has a 150-fold stronger signal compared to the
traditional Firefly and Renilla luciferases and the longest
luminescent half-life amongst all known luciferases. We
fused NanoLuc reporter with exosome surface marker
CD63 for specific labelling of exosomes. Then, the cardi-
omyocyte-specific αMHC promoter followed by a loxP-
STOP-loxP cassette was engineered for precise spatial
labelling of exosomes originating from cardiomyocytes.
We then crossed the cardiomyocyte-specific mouse with a
tamoxifen-inducible Cre mouse (R26CreERT2) to achieve
an inducible system. The exosome labelling and distribu-
tion were assessed by luciferase assay and noninvasive
bioluminescent live imaging.
Results: CD63NanoLuc expression was tightly con-
trolled and only detected in cardiomyocytes upon
induction. The endogenous exosomes released from
cardiomyocytes were labelled and detected in vitro in
cell culture supernatant, and in vivo in animal plasma.
A signature distribution profile of the endogenous car-
diomyocyte-releasing exosomes was achieved.
Summary/Conclusion: This exosome tracking model
enables elucidating the endogenous exosome traffick-
ing pattern, and allows the study of exosome behaviour
under different conditions. It will provide a powerful
tool for the exploration of the biological functions,
mechanisms and clinical applications of exosomes in
a broad spectrum of research.
Funding: AHA Innovative Project Award: 18IPA341
80012.
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Symposium Session 2: Nucleic Acid Biomarkers in Human Disease
Chairs: Robert Kitchen; Louise Laurent
Location: Level B1, Lecture Room
11:00–12:30
OT02.01
miRNA exosomal biomarkers in brain derived and serum exosomes
associated with neurodegenerative diseases
Lesley Chenga, Xia Lib, James Doeckec, Laura Vellad, Natasha Vassileffe,
Mitch C. Shambrooka, Robyn Sharplesf, Saima Zafarg, Inga Zerrh, Catriona
McLeani, Malcolm Horned, Colin Mastersd, Kevin Barnhamd and Andrew
Hillj
aDepartment of Biochemistry and Genetics, La Trobe Institute for
Molecular Science, La Trobe University, VIC, Australia, Melbourne,
Australia; bDepartment of Mathematics and Statistics, La Trobe Institute
for Molecular Science, La Trobe University, VIC, Australia, Melbourne,
Australia; cCSIRO Digital Productivity Flagship/The Australian E-Health
Research Centre, Herston, Queensland, Australia, Brisbane, Australia;
dThe Florey Institute of Neuroscience and Mental Health, The University of
Melbourne, Parkville, Victoria, Australia; eThe Department of Biochemistry and
Genetics, La Trobe Institute for Molecular Science, La Trobe University,
Bundoora, Victoria, Australia; fThe Department of Biochemistry and Genetics,
La Trobe Institute for Molecular Science, La Trobe University, Bundoora,
Victoria, Australia; gDepartment of Neurology, Clinical Dementia Centre,
University Hospital Göttingen, Göttingen, Germany; hThe Florey Institute of
Neuroscience and Mental Health, The University of Melbourne, Parkville,
Victoria, Australia., Melbourne, Australia; iThe Department of Biochemistry
and Genetics, La Trobe Institute for Molecular Science, La Trobe University,
Bundoora, Victoria, Australia
Introduction: Several blood-based tests have been
explored to detect Alzheimer’s disease (AD) and other
neurogenerative diseases; however, evidence is required
to determine whether blood sampling is an appropriate
specimen to diagnose brain diseases. Exosomes are
small extracellular membrane vesicles packaged with
RNA and protein cargo. Previously we isolated serum
exosomes from AD patients which displayed an abnor-
mal composition of 16 specific microRNA (miRNA)
biomarkers compared to controls.
Methods: To provide evidence that our serum exoso-
mal miRNA biomarkers are suitable for the detection
of a brain condition, we also profiled exosomes isolated
from post-mortem human AD (n = 8), PD (n = 8), ALS
(n = 7) and control (n = 5–8 per group) brain tissues
using next-generation sequencing.
Results: Brain-derived exosomes (BDEs) were found to
contain a unique profile of small RNA, including
miRNA, compared to whole tissue. Furthermore, all
16 AD serum biomarkers, identified in our previous
study, were detected in BDEs, together with differen-
tiators for PD, ALS and CJD diagnosis in serum and in
some cases neural-derived exosomes.
Summary/Conclusion: This work has identified highly
specific panels of miRNA that is both present in the
brain and blood of AD, PD, ALS and CJD patients. The
miRNA candidates can be used to develop a blood-
based diagnostic test highly relevant to a brain disease,
equivalent to noninvasive brain biopsy.
Funding: National Health and Medical Research
Council, Australia MND, Australia Creutzfeldt-Jakob
disease Support Group Network, Australia Dementia
Centre for Research Collaboration, Australia
OT02.02
Brain-derived extracellular vesicle microRNA signatures associated
with in utero and postnatal oxycodone exposure: Implications for
altered synaptogenesis
Victoria Schaala, Dalia Mooreb, Peng Xiaoa, Sowmya V. Yelamanchilib,
Gurudutt Pendyalaa
aUniversity of Nebraska Medical Center, Omaha, USA; bDepartment of
Pharmacology and Experimental Neuroscience, University of Nebraska
Medical Center, Omaha, USA
Introduction: Oxycodone (oxy) is a semi-synthetic
opioid commonly used as a pain medication which
also is a widely abused prescription drug. While very
limited studies have examined the effect of in utero oxy
(IUO) exposure on neurodevelopment, a significant
gap in knowledge is the effect of IUO compared with
postnatal oxy (PNO) exposure on synaptogenesis – a
key process in the formation of synapses during brain
development in the exposed offspring. In the present
study, we isolated and characterized brain-derived
extracellular vesicle (BDE)-associated microRNA
cargo from the brains of IUO and PNO offspring
using RNA seq. Several key miRNAs unique to both
the IUO and PNO groups were identified and validated
using RT-PCR. To further gain mechanistic insights,
we characterized the miRNA cargo effects on changes
in synaptic architecture using in vitro primary neurons
during a key stage of brain development.
Methods: Density gradient EV isolations from brain
tissue, transmission electron microscopy, RT-PCR, in
vitro primary neuronal cultures and spine density
analysis.
Results: Transmission electron microscopy revealed an
increase in BDE sizes in both the PNO and IUO groups
suggesting that oxy exposure can affect BDE size thus
indicating differential expression of molecular cargo.
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Next, RNA-Seq identified novel and distinct BDE
miRNAs unique to IUO and PNO which were further
validated by RT-PCR. Bioinformatics analysis on these
differentially expressed BDEs, revealed key Gene
Ontology terms involved in neurodevelopment such
as neuron projection development, neuronal morpho-
genesis, pallium/cerebellum development in the IUO
offspring. To determine, if BDEs impacted the synap-
todendritic architecture, we treated 14 days in vitro rat
cortical primary neurons with equal amounts of P14
BDEs from the three groups. Confocal imaging of
dendritic spines showed a significant reduction on
treatment with PNO BDEs and which was further
exacerbated on treatment with the IUO BDEs.
Summary/Conclusion: We conclude that BDEs from
PNO and IUO offspring carry potentially distinct BDE
miRNA cargo that subsequently damage the synapto-
dendritic architecture and could further lead to neuro-
nal dysfunction at a key stage of neurodevelopment.
Funding: Start-up funds and NIH/NIDA.
OT02.03
Development of a high-performance urine exosomal-mRNA signature
for identification of bladder cancer
Sudipto Chakraborttya, Robert Kitchena, James Hurleya, Georg Stollb, Xuan
Zhangc, Mikkel Noerholmd, Seth Yua and Johan Skoge
aExosome Diagnostics, Inc, Waltham, USA; bExosome Diagnostics, GmbH,
Martinsried, Germany; cNeuology and Radiology Services and program in
Neuroscience, Harvard Medical School, Massachusetts General Hospital,
Boston, USA; dExosome Diagnostics, GmbH, Martinsried, Germany;
eExosome Diagnostics, Inc., Waltham, Massachusetts, USA
Introduction: Blood in the urine is a common symp-
tom of bladder cancer but of individuals who present
with haematuria on average only 8% will have cancer.
Moreover, up to 70% of patients with a prior bladder
tumour will experience a relapse. The majority of these
individuals will therefore undergo invasive and expen-
sive testing (cystoscopy & CT scan) to confirm the
presence of a tumour, either for first diagnosis or active
surveillance of recurrence. A low-cost, noninvasive
urine test capable of preventing unnecessary biopsies
is a challenging but attractive proposition.
Methods: Here, we present results from a clinical study
in which exosomal mRNAs were profiled from voided
urine, collected prior to diagnosis, from individuals
suspected of having either newly diagnosed or relapsed
bladder cancer. We selected 81 individuals for the
clinical study, 44 of whom were diagnosed with mostly
early stage bladder cancer. The remaining individuals
were healthy or diagnosed with a non-cancerous urin-
ary disease.
Results: We identified a 16-mRNA signature by
mining over 25,000 public and proprietary RNA-seq
datasets, using a machine learning approach to rank
genes based on dysregulation in bladder cancer, pre-
sence in urine exosomes and stability to haematuria.
Using this signature, we trained a classifier to differ-
entiate samples based on presence/absence of bladder
cancer, optimized for negative predictive value (NPV).
The model performs well in both newly diagnosed and
recurrent cases, even in low-grade disease, with an
overall performance of 100% NPV at 46% specificity.
As the model is based solely on exosomal mRNA
abundance, the score provides entirely new informa-
tion that would enable a clinician to further improve
specificity by considering standard of care parameters.
Summary/Conclusion: Exosomal mRNAs have been
used to diagnose other malignancies but this represents
the first application of this form of liquid biopsy to
bladder cancer. While performance must be validated
in a larger clinical trial, this signature could prevent
~50% of unnecessary biopsies, provide a noninvasive
means of monitoring relapse and reduce the financial
burden of early stage bladder cancer care.
OT02.04
Genome-wide methylation profiling of extracellular vesicle DNA
allows brain tumour classification
Franz Lennard. Ricklefsa, Cecile Maireb, Katharina Kolbeb, Mareike Holzb,
Manfred Westphalb, Ullrich Schüllerb and Katrin Lamszusb
aUniversity medical center Hamburg-Eppendorf, Hamburg, Germany;
bUniversity Medical Center Hamburg-Eppendorf, Hamburg, Germany
Introduction: Genome-wide methylation profiling has
recently been developed into a tool that allows subtype
tumour classification in central nervous system (CNS)
tumours. Extracellular vesicles (EVs) are released by
CNS tumour cells protecting their cargo, including
DNA, from degradation rendering EVs as optimal bio-
markers to define subgroups, stratify patients and
monitor therapy by liquid biopsy. It is unclear, how-
ever, if DNA derived from glioma EVs reflects gen-
ome-wide methylation profiles and mutational statuses
that would allow tumour classification.
Methods: DNA was isolated from glioma cell cultures
(GSC) EVs, GSCs and matched tumour samples
(n = 3). EVs were isolated through differential ultra-
centrifugation and classified by nanoparticle tracking
analysis (NTA), immunoblotting, imaging flow cyto-
metry (IFCM), multiplex EV assay and electron micro-
scopy. Genome-wide DNA methylation profiling was
performed using a 850-k Illumina EPIC array and
classified by the DKFZ brain tumour classifier.
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Results: GSCs secrete diverse EVs as measures by IFCM
and multiplex EV assay that are high for common EV
markers (a.e. CD9, CD63 and CD81). The range of EVs
was 120–150 nm measured by NTA. Genome-wide
methylation profiles of GSC EVs in addition to copy
number alterations and mutations matched their paren-
tal GSC and original tumour sample, being
Glioblastoma, IDH wildtype or mutant, with additional
subclass analyses. Specifically, MGMT methylation sta-
tuses could be obtained through EV DNA.
Summary/Conclusion: Here we report, that EV DNA
reflects the tumour methylation class as well as most
copy number variations and mutations present in the
parental cells and the original tumour. DNA EV
methylation profiles may therefore be used to detect
and classify CNS tumours.
Funding: FLR received a scholarship of the German
Academic Foundation.
OT02.05
Methamphetamine use disorder alters plasma extracellular vesicle
characteristics and microRNA expression
Ursula Sandaua, John Nolanb, Xiao Shic, Tracy Swansonc, Marilyn Huckansd,
William Schutzerd, Kylie Sagee, Jodi Lapidusf, Jennifer Loftisd, Aaron
Janowskyg and Julie A. Saugstada
aDepartment of Anesthesiology & Perioperative Medicine, Oregon Health &
Science University, Portland, USA; bScintillon Institute, San Diego, USA; cVA
Portland Health Care System, and Department of Psychiatry, Oregon Health
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Introduction: Methamphetamine’s (MA) rewarding
properties and addictive potential are correlated with
increased synaptic dopamine availability following
alterations in dopamine and vesicular monoamine trans-
porter function. We examined plasma extracellular vesi-
cle (EV) number, size, protein markers and miRNA
content in human subjects who are actively using MA.
Methods: Plasma samples from 10 adults with active MA
dependence (MA-ACT), and 10 non-dependent controls
(CTL) were obtained from the Methamphetamine Abuse
Research Center Biorepository at Oregon Health &
Science University and the VA Portland Health Care
System. We used single Vesicle Flow Cytometry to
directly measure plasma EV concentration and size. We
used size-exclusion chromatography (iZON Science) to
isolate plasma EVs. EV total RNA isolated by mirVana™
PARIS™ RNA Kit (ThermoFisher) was analysed on
TaqMan® Array Human MicroRNA A + B Cards Set
v3.0 (ThermoFisher). MiRNA expression was compared
between MA-ACT and CTL using two-sample t-tests for
miRNA expressed in at least 50% of samples in at least
one of the two groups. Tobacco use was controlled for.
Results: The data show that in MA-ACT (n = 5) vs. CTL
(n = 5), four of the five MA-ACT have an increase in
total plasma EVs relative to all five CTL. The average EV
concentration in MA users (2 × 108 ± 4.5 × 107 EV/μL)
is trending to increased levels, relative to CTL
(7.5 × 107 ± 0.9 × 107 EV/μL). EV counts relative to
size show a range of EVs with a mode of ~110 nm in
both MA-ACT and CTL plasma, and equivalent median
EV size. Of 226 miRNA in the EVs, there are 30 miRNAs
that meet have area under the curve (AUC) >0.65 and
median difference >1, and 47 miRNAs with AUC >0.65
and mean difference >1. Twenty-three of these miRNAs
overlap and are the current focus of target prediction.
Summary/Conclusion: EV miRNA expression in sub-
jects with MA use disorder was significantly different
than in control participants, suggesting that MA may
affect EV communication among cells. The differential
miRNA expression also implicates a role for EVs in
behavioural and physiological effects specific to MA
and suggests that there may be changes in expression
of miRNAs that are relevant to specific drugs of addic-
tion, as well as to a spectrum of drug-mediated addic-
tion disorders.
OT02.06
Use of extracellular vesicles purified from lymphatic exudative
seroma as surrogate markers of melanoma residual disease
Susana Garcia-Silvaa, Alberto Benito-Martínb, Sara Sanchez-Redondoc,
Alberto hernandez-Barrancoa, Pilar Ximénez-Embúnd, Laura Noguésa, Ana
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Ortiz-Romeroj, José Luis Rodríguez-Peraltok, Piotr Rutkowskil and Héctor
Peinadoa
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Universidad Complutense, Instituto i + 12, Hospital Universitario 12 de
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Introduction: Liquid biopsies in melanoma patients
have the potential to improve prognosis. Exudative
seroma obtained in the drainage implanted post-lym-
phadenectomy has never been explored as a source of
biomarkers. The use of circulating extracellular vesicles
(EVs) as surrogate markers of residual disease could be
a novel and powerful non-invasive tool.
Methods: Exosomes were purified by ultracentrifuga-
tion from exudative seroma obtained after lymphade-
nectomy from stage III melanoma patients, were
analysed by nanosight analysis and electron micro-
scopy, and compared to plasma in a total of 92 sam-
ples. We profiled the proteomic profiles of exudative
seroma- and plasma-derived exosomes by mass spec-
trometry. Extracellular vesicle-associated nucleic acids
(EV-NAs) and analysed BRAFV600E by an allele-spe-
cific PCR in exudative seroma samples as a novel
parameter to detect residual disease
Results: We found that exudative seroma is a novel
biofluid highly enriched in EVs, higher size and
increased DNA cargo in comparison to plasma.
Proteomic analysis of seroma-derived exosomes
demonstrated that they are enriched in melanoma
oncogenic pathways together with immune-related
pathways; however, proteomic analysis did not allow
identify biomarkers of relapse or progression.
Importantly, detection of BRAFV600E mutation in ser-
oma-derived EVs obtained 24–48 hours post-lympha-
denectomy identified patients at risk of relapse
significantly (Log rank p = .0067) in a cohort of 17
stage III melanoma patients followed up for 700 days.
Summary/conclusion: Our data show for the first time
that exudative seroma obtained post-lymphadenectomy
is a novel biofluid enriched on EVs and DNA that can
be interrogated for melanoma markers and BRAF
mutation. Analysis of BRAFV600 mutation identified
patients at risk of relapse with high significance. These
data support that our approach could be a novel factor
to detect residual disease right after surgery in stage III
melanoma patients. Our analysis could be a novel
approach to aid oncologists to identify high-risk groups
of patients post-lymphadenectomy and improve
patient outcome.
Funding: MINECO, NIH, Starr Foundation, Ramon y
Cajal Programme, AECC, FERO foundation, and
MINECO-REDiEX.
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Stem cell-derived extracellular vesicles increase cancer stem cell
sensitivity to tyrosine kinase inhibitors through Akt/mTOR/PTEN-
combined modulation
Benedetta Bussolatia, Valentina Fonsatob, Michela De Lenac, Stefania Trittad,
Alessia Brossab, Ruggero Calvettie, Ciro Tettaf and Giovanni Camussig
aDepartment of Molecular Biotechnology and Health Sciences, University of
Turin, Turin, Italy; bMolecular Biotechnology Center, University of Torino,
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Introduction: Cancer Stem Cells (CSCs) are a small
cell population able to sustain the maintenance and
recurrence of tumours. In consideration of the high
drug resistance and tumour initiating capability, target-
ing CSCs represents an important approach to eradi-
cate tumours. We previously showed a pro-apoptotic
effect of extracellular vesicles (EVs) derived from
human liver stem cells. In this study, we evaluated
whether HLSC-EVs could act in synergy with tyrosine
kinase inhibitor drugs (TKIs) on apoptosis of CSCs
isolated from renal carcinomas.
Methods: We administered HLSC-EVs and TKIs to
renal CSCs, as co-incubation or sequential administra-
tion. TKIs were also loaded in EVs. Intracellular phos-
phoproteins were evaluated in the CSC lysates by the
magnetic bead-based immunoassays Bio-Plex Pro cell-
signalling assay and confirmed by Western Blot
analysis.
Results: We found that HLSC-EVs in combination
with Sunitinb or Sorafenib significantly increased
renal CSCs apoptosis induced by low TKI dose. At
variance, no synergistic effect was observed when
bone marrow mesenchymal stem cell-derived EVs
were used. CSC apoptosis was also enhanced when
TKIs were loaded in HLSC-EVs. In particular, renal
CSCs chemosensitivity to TKIs was enhanced when
HLSC-EVs were either co-administered with TKIs or
added after, but not before. By a mechanistic point of
view, Akt/mTOR and Erk and Creb intracellular path-
ways, known to be pivotal in the induction of tumour
growth and survival, appeared modulated as conse-
quence of TKIs/HLSC-EVs co-administration as well
as by EV post-administration.
Summary/Conclusion: Our results indicated that
HLSC-EVs and TKIs have a synergistic anti-tumour
effect on renal CSCs inducing an enhancement of
apoptosis by a combined effect on intracellular path-
ways pivotal in the induction of tumour growth and
survival. This effect appear to be due to an EV-depen-
dent enhancement of TKI induced mechanisms and
not to epigenetic changes induced by EV leading to
increased TKI sensitivity. This study provides a rational
for a combined use in tumour treatment.
Funding: This study was supported by Associazione
Italiana per la Ricerca sul Cancro (A.I.R.C.), project
IG2012 and by grant no. 071215 from Unicyte.
OT03.02
Exosomal nidogen 1 drives liver cancer metastasis by inducing
secretion of tumour necrosis factor receptor 1 from activated lung
fibroblasts
Xiaowen Mao, Sze Keong Tey and Judy Yam
The University of Hong Kong, Hong Kong, Hong Kong
Introduction: Hepatocellular carcinoma (HCC) is an
aggressive tumour with metastasis as a signature in the
advanced stage. Acquisition of migratory and invasive
behaviours is fundamental to cancer cells to metasta-
size. A supportive microenvironment for the coloniza-
tion of incoming disseminated cancer cells during
metastasis is also indispensable. Exosome shedding
has emerged as an important channel for intercellular
communication in tumour microenvironment during
metastasis.
Methods: Exosomes derived from HCC cell lines were
functionally characterized by in vitro and in vivo
assays. Proteomic profiling and expression level of
exosomal proteins were analysed by mass spectrometry
and enzyme-linked immunosorbent assay (ELISA),
respectively. The study of interplay between exosomes,
HCC cells and lung fibroblasts were carried out using
functional assays, immunofluorescent staining and
ELISA.
Results: Exosomes derived from metastatic HCC cells
augmented cell migration and invasiveness. In animal
model, metastatic-exosomes promoted liver tumour
formation, increased incidence of distant metastasis to
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lungs as well as facilitated colonization of hepatoma
cells in lungs and enhanced the permeability of pul-
monary vasculature. Proteomic profiling of exosomes
identified nidogen 1 (NID1) as a functional component
responsible for the promoting effect of metastatic-exo-
somes. Our data showed that suppression of exosomal
NID1 (exo-NID1) significantly diminished the biologi-
cal activities of metastatic-exosomes. Apart from HCC
cells, exo-NID1 enhanced the growth and induced
activation of lung fibroblasts. Tumour necrosis factor
receptor 1 (TNFR1), found to be released by lung
fibroblast pretreated with metastatic-exosomes, showed
potent effect in promoting HCC cell motility. Notably,
the level of exo-NID1 was well correlated with the
metastatic potential of parental HCC cells.
Encouragingly, the level of NID1 in circulating exo-
somes of HCC late stage patients was higher than those
at early stage.
Summary/Conclusion: Our study reveals the novel
role of NID1, in the form of exosomes, in HCC metas-
tasis and illuminates the expression profile of exosomal
NID1 with clinical significance. Our study implicates
that targeting signalling pathway mediated by exo-
somes of metastatic HCC as a therapeutic strategy
for HCC.
Funding: RGC GRF (17,113,116) and SKLLR IRF 2017.
OT03.03
Cancer extracellular vesicles create functional heterogeneity of
cancer-associated fibroblasts in gastric cancer
Yutaka Naitoa, Yusuke Yamamotob, Akiko Kogurec, Iwao Shimomurad,
Minami Kumazakic and Takahiro Ochiyad
aDivision of Molecular and Cellular Medicine, National Cancer Center
Research Institute, London, UK; bDivision of Molecular and Cellular
Medicine, National Cancer Center Research Institute, Tokyo, USA;
cDivision of Molecular and Cellular Medicine, National Cancer Center
Research Institute, Tokyo, Japan; dDepartment of Molecular and Cellular
Medicine, Institute of Medical Science, Tokyo Medical University,
Shinjyuku-ku, Japan
Introduction: Cancer-associated fibroblasts (CAFs) are
the major stromal components in the various types of
malignancies. It has been recognized that the func-
tional heterogeneity of CAFs provide an appropriate
microenvironment for tumour progression. However,
it is still largely unknown how functional heterogeneity
of CAF is governed by tumour cells. In this study, we
investigated the role of extracellular vesicles (EVs) on
the formation of CAF functional heterogeneity.
Methods: We treated EVs derived from high-meta-
static diffuse-type gastric cancer (DGC) cells or low-
metastatic DGC cells to the fibroblasts. By comparing
transcriptome profiles of fibroblasts with the EVs, we
sought to understand how high-metastatic DGC cells
created an appropriate microenvironment for the
metastasis.
Results: Our whole-transcriptome analysis of fibro-
blasts revealed that high metastatic DGC cell-derived
EVs strongly induced the expression of inflammatory
chemokines such as CXCL1 and CXCL8. However, it is
not observed in the fibroblast treated with EVs from
low-metastatic DGC. Interestingly, both cancer-derived
EVs did not affect the expression of alpha-smooth
muscle actin (α-SMA), a typical marker of myofibro-
blast phenotype. When fibroblasts were treated with
TGFβ, α-SMA was clearly induced but suppressed
inflammatory chemokine expression in the fibroblasts.
Immunocytochemical analysis of CXCL8 and α-SMA
showed distinct populations of activated fibroblasts in
the co-culture with high-metastatic DGC, suggesting
that functional heterogeneity was generated by EVs.
We also identified that various miRNAs including
miR-193b were enriched in high metastatic DGC cell-
derived EVs to induce chemokine expression in
fibroblasts.
Summary/Conclusion: Our findings suggest that the
intercellular crosstalk of high-metastatic DGC and fibro-
blasts via EVs contributes to forming the appropriate
tumour microenvironment toward the metastasis.
OT03.04
Extracellular vesicles from obese human adipose tissue alter the
invasive and proliferative properties of prostate cancer cells
Anca D. Dobriana, Ryan Huyck, Bronson Haynes, Vanessa Correll, Avennette
Pinto, James Reed, Matthew Freedman, William McPheat, Julius O.
Nyalwidheb, O. John Semmesb
aEastern Virginia Medical School, Norfolk, USA; bLeroy T. Canoles Jr. Cancer
Research Center, Eastern Virginia Medical School, Norfolk, USA
Introduction: Obesity increases the risk and aggres-
siveness of multiple cancers including prostate cancer.
Adipose tissue (AT) is a rich source of extracellular
vesicles (EVs) that were shown to contribute to vascu-
lar and metabolic pathologies. Here we characterized
the miRNA and proteome of EV isolated from human
visceral (V) and subcutaneous (S) fat of bariatric sub-
jects and explored their mechanistic effects on mole-
cular and functional phenotypes of metastatic prostate
cancer cells.
Methods: Paired S and V AT collected intraoperatively
were used to isolate EVs by ultracentrifugation
(n = 27). DIO-labelled EV-S or EV-V was incubated
overnight with PC3-ML metastatic prostate cancer
cells. EV uptake, proliferation, migration and invasion
were quantified by fluorescence microscopy, BrdU
incorporation, wound healing and invasion assays,
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respectively. The miRNA and proteome cargo of EVs
were measured using the Nanostring platform and LC/
MS/MS. Changes in gene expression in recipient PC3-
ML cells were determined using Nanostring.
Results: EV-S and EV-V produced similar effects on
recipient PC3-ML cells. EVs increased cell proliferation
by ~1.8-fold (p < 0.05); had no effect on cell migration
but dramatically decreased cell invasion by 2.5-fold
(p < 0.01) compared to untreated controls. Gene
expression in recipient PC3-ML cells showed signifi-
cant two to three fold decrease in expression of 8
MMPs without changes in TIMP expression.
Mesenchymal markers Snail and Zeb were also signifi-
cantly decreased and seven glycolytic and PPP enzymes
were 1.5- to 2.5-fold increased. Consistent with these
changes, the miRNA cargo of EVs was shown to target
all the above pathways and the top pathways detected
in the EV proteome were metabolism and energy
production.
Summary/Conclusion: AT EVs appear to induce a
mesenchymal to epithelial transition in prostate cancer
cells. This study reveals a novel role of EVs from
human AT on metastasis and suggests a new mechan-
istic link between obesity and prostate cancer.
Funding: Commonwealth of Virginia Health Research
Board.
OT03.05
Novel vesicular mediators of peritoneal metastases
Shelly Loewensteina, Fabian Gerstenhaberb, Nir Lubezkyb, Eran Nizrib, Joseph
Klausnerb, Noam Shomronc, Guy Lahatb
aTel Aviv Sourasky Medical Center, Tel Aviv, Israel; bSurgery Division, Tel
Aviv Sourasky Medical Center, Tel-Aviv, Israel; cTel Aviv university, Tel
Aviv, Israel
Introduction: Malignant progression results from a
dynamic crosstalk between stromal and cancer cells.
Recent data suggest that this crosstalk is mediated by
exosomes, nanovesicles secreted by various cell types
which allow the transfer of proteins, and nucleic acids
between cells. We investigated the potential role of
omental fat exosomes in gastric cancer peritoneal
metastasis.
Methods: Omental fat exosomes were produced from
fresh human omental fat specimens. Proliferation,
migration, invasion and chemoresistance were used to
evaluate the phenotypic behaviour of omental-exo-
somes treated gastric cancer cells. Using a comprehen-
sive cytokine array, we identified the proteome of
omental-exosomes. Exosomal miRNAs were profiled
using NanoString technology. A xenograft model was
used to evaluate in vivo effects of omental-exosomes on
gastric cancer tumour growth.
Results: Initially, we demonstrate a robust uptake of
omental fat exosomes by gastric cancer cells. We show
that these exosomes enhance gastric cancer cell prolif-
eration, migration and invasion. We also revealed that
the number of exosomes is directly related to their
effect on gastric cancer cells. We further show that
omental fat exosomes induce gastric cancer cellular
chemoresistance to platinum-based therapy, and that
omental exosomes augment gastric cancer xenograft
tumour growth in-vivo. Using a cytokine array, we
characterized the proteome of omental fat exosomes
compared to SC exosomes. miRNA profiling identified
several established oncomiRs. These vesicles carry
numerous proteins and miRNAs implicated in cellular
adhesion and chemotaxis, tumour growth and motility
as well as chemoresistance; some of these molecules
have been reported as pro-tumourigenic factors in gas-
tric cancer. Finally, we demonstrate that omental fat-
exosomes increase the expression of transcription fac-
tors, mRNA of extracellular matrix proteins and adhe-
sion molecules within gastric cancer cells.
Summary/Conclusion: These observations demon-
strate for the first time the uptake of omental fat exo-
somes by cancer cells; these vesicles carry different
molecules which promote gastric cancer cellular
aggressiveness in vitro and in vivo. Taken together,
our data imply that omental fat exosomes might play
a role in gastric cancer peritoneal spread.
OT03.06
Non-SUMOylated Cx43 changes the recruitment of cellular
components into exosomes switching the role of these vesicles in
metastatic melanoma
Adrián Varela-Vázqueaa, María D. Mayán Santosb, Amanda Guitián-
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Introduction: Connexin43 (Cx43), a transmembrane
protein involved in cell communication and signalling,
has been described as a tumour suppressor factor in
melanoma, however its role in disease progression
remains under debate. Extracellular vesicles (EVs)
released by melanoma cells provide signals and “edu-
cate” distant cells. The presence of Cx43 in EVs pro-
vides these particles with an additional capacity to
exchange small molecules such as RNAs, metabolites
or ions with target cells via gap junction channels
(GJs).In this study, we have investigated the role of
exosomal Cx43 in metastatic melanoma.
Methods: Protein levels and activity were studied by
western-blot, immunofluorescence, colony formation
and proliferation and migration assays. GJIC by
Scrape loading. EVs were isolated by ultracentrifuga-
tion and analysed using the NanoSight and electron
microscopy. Their content was analysed by mass spec-
trometry (MS) and by RNA-seq.
Results: Low levels and SUMOylated Cx43 in BRAF-
mutant human melanoma cells was associated with
cytoplasmic distribution and low incidence of dye cou-
pling (GJIC). Ectopic Cx43 gene expression using
vectors restored Cx43 membrane localization, raised
GJIC and increased Cx43 in the EVs. EVs isolated
from BRAF-mutant melanoma cells overexpressing
Cx43 only contains the non-SUMOylated Cx43.
When different melanoma cell lines were exposed to
exosomes containing Cx43, these EVs significantly
decreased cell proliferation and blocked colonies
growth. The effect of exosomal Cx43 was compared
to the overexpression of the protein. The presence of
Cx43 in EVs significantly increased the sensitivity of
BRAF-mutant metastatic melanoma to drugs such as
BRAF/MEK inhibitors. The RNA and proteomic com-
ponent identified by RNA-Seq and MS revealed that
exosomal Cx43 through its scaffolding function could
be involved in the recruitment of proteins and small
RNAs to the EVs switching the messages and therefore
the role of these EVs in melanoma.
Summary/Conclusion: Our results indicate that exo-
somal particles containing Cx43 are potent vehicles to
combat metastatic melanoma. Further understanding
of the role of Cx43 in EVs will have implications for
the development of new therapeutic strategies. For
instance, we demonstrated their ability as drug carriers
to combat metastasic melanoma when these vesicles
contain Cx43.
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OT04.01
Linking the trafficking of CD63 and CD9 to their secretion
mechanisms into extracellular vesicles
Mathilde Mathieua, José Ignacio Valenzuelab, Mathieu Maurina, Mabel
Jouvea, Nathalie Nevoa, Gaëlle Boncompaina, Franck Perezb and Clotilde
Theryc
aInstitut Curie, INSERM U932, Paris, France; bInstitut Curie, umr144, Paris,
France; 3Institue Curie, Paris, France
Introduction: A major challenge in the study of extra-
cellular vesicles is to characterize and separate the
different extracellular vesicle (EV) subtypes of a differ-
ent origin. Indeed, small EVs from the plasma mem-
brane or from endosomes cannot be separated with the
classical EV isolation methods. Moreover, even if some
of their molecular mechanisms of secretion are known,
it is challenging to find specific mechanisms for one
particular subtype (see perspective article: Mathieu et
al. Nat cell Biol 2019, in press). Understanding how
markers of subtypes of EVs are directed to similar or
different EVs could help to differentiate them, even-
tually to describe their specific functions. At least two
different populations of small EVs were previously
described, one carrying the three tetraspanins CD63,
CD9 and CD81, and one with CD9 only (Kowal et al.
PNAS 2016).
Methods: We chose to study in HeLa cells the traffick-
ing of CD63 and CD9 and its link with their secretion
in EVs, using the RUSH system to synchronize and
follow their post-Golgi trafficking (Boncompain et al.
Nat Methods 2012). We used the RUSH system to
perform live-cell imaging, electron microscopy, immu-
nofluorescence and flow cytometry analyses at different
steps of trafficking, and to analyse EVs secreted after a
specific time of trafficking.
Results: Despite their presence in the same EVs, CD63
and CD9 do not traffic to the same final compartments.
While CD63 is endosomal, CD9 is located on the
plasma membrane. We showed that CD9 could be
found transiently with CD63 in intracellular compart-
ments before reaching the plasma membrane (PM),
while CD63 goes to the PM before being internalized.
By forcing stable expression of CD63 at the PM, or
impairing post-Golgi and endosomal trafficking, we
observed increased secretion of CD63+ but not CD9
+ EVs.
Summary/Conclusion: Our results demonstrate that
small EVs can form both at the PM and inside multi-
vesicular endosomes. Our tools can be used to deter-
mine the respective effects of drugs and gene silencing
on secretion of each of these EVs
OT04.02
Interdependency of the multiple endosomal sorting mechanisms
influencing exosome biogenesis
Roberta Palmullia, Guillaume van Nielb, Frederik Verweijb, Xavier
Heilingensteina, Eric Rubinsteinc and Graça Raposoa
aInstitut Curie, PSL Research University, CNRS UMR144, Paris, France;
bCPN, Centre for Psychiatry and Neuroscience, Hôpital Saint-Anne,
Universite´ Descartes, INSERM U894, Paris, France; cInserm U935 (ex.
U1004) – Paul Brousse Hospital – André Lwoff Institute, Villejuif, France
Introduction: Exosomes are generated as intraluminal
vesicles (ILVs) in the multivesicular endosome (MVE).
In the endosomal system, protein cargoes either are
sequestered to ILVs by inward budding or exit the
system by outward budding. Sorting to ILVs is
mediated by various machineries, whose interdepen-
dency is poorly understood, and is likely counterba-
lanced by recycling mechanisms that retrieve protein
from MVEs. We have taken profit of the particular role
of CD63 in the balance between ESCRT-dependent and
-independent biogenesis of ILVs and in the sorting of
ApoE in melanoma cells to elucidate the interdepen-
dency of different sorting mechanisms influencing exo-
some composition.
Methods: After siRNA depletion of reported key actors
of exosome production, EVs released by melanoma cells
were isolated by differential ultracentrifugation and floa-
tation on density gradient and characterized using bio-
chemistry and electron microscopy. ILV biogenesis and
sorting of specific cargoes throughout the endosomal
system was assessed by immunofluorescence or electron
microscopy after high-pressure freezing.
Results: Our data show that melanoma cells secrete
subpopulations of exosomes with different density
and composition. Investigation of known key regula-
tors of in- or outward budding in MVEs differently
affected exosome subpopulations. In particular, CD63
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modulates ApoE secretion on exosomes and its cellular
localization, suggesting that CD63 is a master regulator
of cargo trafficking in the endosomal system.
Summary/Conclusion: Our data highlight that exo-
somes biogenesis is not only dependent on ILV bud-
ding but also on a global regulation of endosomal
homeostasis. Our study provides a better perception
of the interconnections existing between sorting of
cargoes to ILVs and their retrieval from the endosomal
system. This broader view is crucial to understand the
precise roles of reported regulators of exosomes bio-
genesis that are broadly used by the community.
OT04.03
A bright, versatile live cell reporter of exosome secretion and uptake
Bong Hwan Sunga and Alissa Weaverb
aVanderbilt University, Nashville, USA; bDepartment of Cell and
Developmental Biology, Vanderbilt University School of Medicine,
Nashville, USA
Introduction: Small extracellular vesicles (EVs) called
exosomes affect a variety of autocrine and paracrine
cellular phenotypes. Understanding the function of
exosomes in these processes requires a variety of
tools. We previously constructed a live-cell reporter,
pHLuorin-CD63 that allowed dynamic monitoring of
exosome secretion in migrating and spreading cells.
However, there were some caveats to its use, including
relatively low fluorescent expression in cells and the
inability to make cell lines that stably express the
protein.
Methods: By incorporating a stabilizing mutation in
the pHLuorin moiety, M153R, pHLuorin-CD63 now
exhibits higher and stable expression in cells and super-
ior monitoring of exosome secretion. Cancer cells sta-
bly expressing pHLuorin_M153R-CD63 were imaged
using a variety of microscopy techniques including a
confocal and wide-field microscopy and a correlative
light-electron microscopy.
Results: pHLuorin_M153R-CD63 was exclusively
detected in exosome-enriched small EV preparations.
Live-cell imaging revealed pHLuorin_M153R-CD63-
positive puncta left behind migrating cells suggesting
the deposition consists of exosomes. Those puncta and
trails were not only positive for other exosome markers
such as Alix and TSG101 but also correspond to small
EVs observed by a scanning electron microscope. In
addition, follower cells exhibited pathfinding behaviour
over pHLuorin_M153R-CD63 deposits. Incorporation
of mScarlet, a non-pH-sensitive red fluorescent tag, to
pHLuorin_M153R-CD63 further improves the ability
to track trafficking and secretion of multivesicular
bodies (MVBs) in cells allowing visualization of traf-
ficking to the leading edge of migrating cells and
uptake of external exosome deposits.
Summary/Conclusion: Using pHLuorin_M153R-
CD63 construct, we demonstrate superior visualization
of exosome secretion in multiple contexts and identify
a role for exosomes in promoting leader-follower beha-
viour in collective migration. By incorporating a
further non-pH-sensitive red fluorescent tag, this
reporter allows visualization of the entire exosome life-
cycle, including MVB trafficking, exosome secretion,
exosome uptake and endosome acidification. This
new reporter will be a useful tool for understanding
both autocrine and paracrine roles of exosomes.
OT04.04
An explanation for “PS-negative” extracellular vesicles: endogenous
annexin-a5 from the cytosol cover externalized phosphatidylserines
on plasma membranes
Anis Khiat, Dominique Charue, Sihem Sadoudi, Sylvain Le Jeune, Marie Lê-
Hoang, Chantal Boulanger, Olivier P. Blanc-brude
INSERM ‘ParCC’ Paris-Cariovascular Research Center, Hôpital Européen
Georges Pompidou, Assistance Publique-Hôpitaux de Paris, and Université
Sorbonne, Paris, France
Introduction: Stressed cells shed extracellular vesicles
(EVs) thought to bear externalized phosphatidylserine
(PS) at their surface and promote inflammation, coa-
gulation and tissue injury. Conversely, endogenous
cytosolic annexins, such as annexin-A5, orchestrate
vesicle trafficking and membrane repair within multi-
ple cell types, via Ca2+-dependent binding to intracel-
lular PS. We hypothesized that endogenous annexin-
A5 binds to PS during vesiculation and gets externa-
lized with PS at the surface of EVs.
Methods: We purified healthy plasma and red blood
cells and induced Ca2+-mediated vesiculation. We
assessed annexin-A5 and EV distribution in superna-
tants by Western blots, FACS, ELISA, cryo-TEM.
Results: (1) About 20% cytosolic annexin-A5 leaked
out during vesiculation, but cytoskeletal proteins were
not released. (2) We separated supernatant EVs from
“free” proteins by size-exclusion chromatography and
quantified EV-bound vs. “free” annexin-A5. All
annexin-A5 remained bound to EVs. Other cytosolic
proteins (haemoglobin) bound to EVs only partly.
FACS with anti-annexin-A5 antibodies revealed the
presence of annexin-A5 at the EV surface. (3) We
measured EV-bound and “free” annexin-A5 in plasma,
vs PS-, PS+, CD235a+ and annexin-A5+ EVs, and
made similar observations. Our study suggests that
endogenous annexin-A5 can cover externalized PSs
on EVs in the presence of Ca2+.
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Summary/Conclusion: This new mechanism of PS-
neutralization may explain previous reports of appar-
ently “PS-negative” EVs. Conventional detection of
EVs with EXOgenous fluorescent annexin-A5 (FACS)
may thus depend on PS not being engaged by endo-
genous annexin-A5 prior to detection. The physio-
pathological relevance of endogenous PS
neutralization may complement enzyme- and ATP-
mediated internalization of PS in healthy cells. PS
neutralization may become critical when internaliza-
tion mechanisms are overwhelmed, and serve to
restrain PS-mediated reactions and enforce anti-
inflammatory and anti-thrombotic control when the
integrity of a few cells only is compromised. On the
other hand, dysfunctional annexin-A5 or calcium
metabolism may contribute to the release of pro-
inflammatory and pro-thrombotic PS+ EVs.
Funding: Funded by Fondation pour la Recherche
Médicale and Sorbonne University.
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Identification of EV secretion-associated gene involved in melanoma
progression by microRNA-based screening
Nobuyoshi Kosakaa, Fumihiko Urabeb, Tomofumi Yamamotoc, Yurika Sawad
and Takahiro Ochiyaa
aDepartment of Molecular and Cellular Medicine, Institute of Medical
Science, Tokyo Medical University, Shinjyuku-ku, Japan; bDivision of
Molecular and Cellular Medicine, National Cancer Center Research
Institute, Tokyo, Japan; cDepartment of Molecular and Cellular Medicine,
Institute of Medical Science, Tokyo Medical University, Tokyo, Japan;
dDepartment of Molecular and Cellular Medicine, Institute of Medical
Science, Tokyo Medical University, Tokyo, Japan
Introduction:It has been shown that extracellular vesi-
cles (EVs) derived from cancer cells dictate their sur-
rounding microenvironmental cells or distant cells in
the future metastatic organs for the benefit of cancer
cells. Thus, revealing the molecular mechanisms under-
lying the production of EVs would prove to be a valu-
able contribution for establishing EV-targeted therapy
against cancer. However, the precise mechanism of EV
production, especially in cancer cells, remains unclear.
Here, we established a microRNA-based screening sys-
tem to identify the molecules involved in EV produc-
tion from melanoma cells.
Methods: Melanoma cell lines, A375 cells, were used in
this study. Combined with the ultra-sensitive EV detec-
tion method (Yoshioka), ExoScreen, we have screened
nearly 2000 miRNAs in melanoma cells. To confirm
the results of ExoScreen, we employed the nanoparticle
tracking analysis. Target genes of miRNAs were iden-
tified by the combination of gene expression analysis
and target prediction bioinformatics.
Results: miRNAs which suppressed the secretion of
EVs from melanoma cells were identified after the
screening of nearly 2000 miRNAs. To understand the
molecular mechanisms mediated by these miRNAs, the
target genes of these miRNAs were identified and eval-
uated for their contribution to EV production in cancer
cells. Indeed, attenuation of these target genes declined
the secretion of EVs from melanoma cells, suggesting
the contribution of these genes in EV production/
secretion. Furthermore, the expression of these genes
was higher in melanoma tumour tissues compared with
that in normal tissues.
Summary/Conclusion: These findings suggest that the
miRNAs and their target genes were involved in EV
production/secretion, resulting in the promotion of
cancer progression.
OT04.06
Distinct mechanisms of microRNA sorting into cancer cell-derived
extracellular vesicle subtypes
Morayma Temoche-Diaza, Matthew Shurtleffa, Ryan Nottinghamb, Jun Yaob,
Alan Lambowitzb, Randy Schekmana
aUniversity of California, Berkeley, Berkeley, USA; bUniversity of Texas,
Austin, Austin, USA
Introduction: Extracellular vesicles (EVs) encompass a
variety of vesicles secreted to the extracellular space.
EVs have been implicated in promoting tumour metas-
tasis but the molecular compositions of tumour-
derived EV sub-types and the mechanisms by which
molecules are sorted into EVs remain mostly unknown.
As such dissecting different EV sub-populations and
analysing the molecular mechanisms behind active
cargo sorting is needed.
Methods: The highly metastatic breast cancer cell line,
MDA-MB-231, was used as the model cell line for this
study. Iodixanol linear gradient allowed for the separation
of EV sub-populations. miRNA profiling and TGIRT-
sequencing was used to study the miRNA content of
the distinct EV sub-populations. Cell fractionation and
cell-free miRNA packaging reconstitutions, coupled with
in vivo confirmation, in cultured cells, were used to study
the molecular mechanisms of miRNA sorting.
Results: We found that at least two distinct EV sub-
populations are released by MDA-MB-231 cells. Their
differential biochemical properties suggest different sub-
cellular origins (endosomes vs. direct budding from the
plasma membrane). Moreover, they are governed by dis-
tinct mechanisms of miRNA sorting (active vs. passive).
By using biochemical and genetic tools, we found that the
Lupus La protein is responsible for mir122 sorting into
EVs in vitro and in vivo. Moreover, in vitro studies
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showed that the Lupus La protein interacts with mir122
with very high affinity. Finally, we uncovered the mir122
motifs required for mir122-La high affinity interaction,
and therefore mir122 sorting into EVs.
Summary/Conclusion: Two EV sub-populations with
distinct sub-cellular origins, are released by MDA-MB-
231 cells. Their differential sub-cellular origin is
coupled with two distinct mechanisms of miRNA sort-
ing. The Lupus La protein is responsible for the active
sorting of mir122 into EVs in vitro and in vivo.
Funding: Howard Hughes Medical Institute (HHMI).
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miR-1227 alters extracellular vesicle shedding
Andrew R. China, Minyung Kima, Valentina R. Minciacchib, Tatyana
Vagnera, Javier Mariscala, Cristiana Spinellia, Mandana Zandiana, Paolo
Gandellinic, Nadia Zaffaronic, Shivani Sharmad, Sungyong Youa and
Dolores Di Vizioa
aCedars Sinai Medical Center, West Hollywood, USA; bCedars Sinai Medical
Center, Frankfurt, Germany; cFondazione IRCCS Istituto Nazionale Tumori,
Milan, USA; dUniversity of California, Los Angeles, Los Angeles, USA
Introduction: Extracellular vesicles (EVs) play a key
role in cancer development and metastasis by influen-
cing the behaviour of the primary tumour and by
aiding the establishment of a pre-metastatic niche in
distant organs. This process is due to the EV-mediated
functional transfer of biologically active molecules
including microRNA (miRNA). miR-1227 is a poorly
characterized miRNA that is enriched in EV secreted
by prostate cancer (PC) cells in comparison to non-
tumorigenic prostate epithelial cells. However, the role
of miR-1227 in cancer is poorly understood. Our
objective is to determine the role of miR-1227 in PC.
Methods: RNA sequencing from miR-1227 stably
expressing PC cells, RISCTRAP Immunoprecipitation
of miR-1227 bound mRNA and five different in silico
miRNA target prediction methods were used to iden-
tify putative miR-1227 targets. Exosomes and large
oncosomes (LO) were isolated by differential ultracen-
trifugation followed by density gradient purification.
Atomic force microscopy and TRPS were used to
quantify exosomes and LO secreted by PC cells stably
expressing miR-1227 or vector control.
Results: A comparative analysis between different EV
subtypes indicates that miR-1227 is enriched in LO, a
class of EV that are secreted by highly invasive and
metastatic amoeboid-migrating cells. LO carry more
RNA than the more widely studied exosomes indicat-
ing that LO may be a more robust source of EV-
encapsulated miRNA. Gene ontology analysis from
miR-1227 targets identified by RNA sequencing from
miR-1227 stably expressing PC cells, RISCTRAP
Immunoprecipitation of miR-1227 bound mRNA, and
in silico miRNA target prediction highlighted several
genes related to EV secretion. miR-1227 alters the
localization of exosome and LO markers in multiple
cancer cell lines, and induces the shedding of LO while
inhibiting the shedding of exosomes. Furthermore,
miR-1227 induces the migration of poorly migratory
cancer cells and increases the expression of tumour
supportive cytokines.
Summary/Conclusion: Together these data hint that
miR-1227 may promote prostate cancer progression
through several mechanisms including alteration of
EV shedding.
Funding: 2017–2022 R01CA218526.
2018–2020 Chesapeake Urology Associates Sanford
J. Siegel, MD Prostate Cancer Research Scholarship
2018–2020 Luke Wu-Jei Chang Discovery Fund
2016–2019 PI DoD PCRP Award PC150836
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MSC exosome works through a multi-faceted mechanism of action in
joint repair
Shipin Zhanga, Yedan Wangb, Francis Keng Lin Wongc, Ming Wangb, Ruenn
Chai Laid, James Hoi Po Huib, Sai Kiang Limd and Wei Seong Toha
aFaculty of Dentistry, National University of Singapore, Singapore, Singapore;
bDepartment of Orthopaedic Surgery, Yong Loo Lin School of Medicine,
National University of Singapore, Singapore, Singapore; cDepartment of
Orthopaedic Surgery, Sengkang General Hospital, Singhealth, Singapore,
Singapore; dInstitute of Medical Biology, Agency for Science, Technology
and Research, Singapore, Singapore
Introduction: MSC exosome is increasingly accepted
as the principal agent that underpins the therapeutic
efficacy of mesenchymal stem cell (MSC) in tissue
repair. Here, we aim to elucidate the mechanism of
action (MoA) of MSC exosome in immunocompetent
rat models of osteochondral defect and osteoarthri-
tis (OA).
Methods: Exosomes were purified from conditioned
medium of human MSCs by size fractionation.
Osteochondral defect creation or anterior cruciate liga-
ment transection to induce OA were performed in 72
adult rats. Thereafter, weekly 100-µl intra-articular
injections of 100-µg exosome or PBS vehicle were
given. Analysis included weight distribution, histology,
immunohistochemistry and cytokine assay. Cellular
assays using chondrocytes were performed to deter-
mine the exosome-activated cellular processes and sig-
nalling pathways.
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Results: We observed that exosome-mediated repair of
osteochondral defects was characterized by increased
cellular infiltration and proliferation, enhanced matrix
synthesis, together with a regenerative M2 macrophage
phenotype and a reduction in pro-inflammatory cyto-
kines IL-1β and TNF-α. In OA joints, MSC exosome
mediated an early suppression of pain and degenera-
tion with reduced inflammation, followed by sustained
proliferation and matrix restoration that led to cartilage
and subchondral bone regeneration. Using chondro-
cyte cultures, we could attribute some of these cellular
activities during exosome-mediated joint repair to exo-
somal CD73-mediated adenosine activation of AKT
and ERK signalling. These effects were partially abro-
gated by wortmannin or U0126, which inhibited AKT
and ERK phosphorylation, respectively. The role of
exosomal CD73 was confirmed using CD73 inhibitor
and theophylline that showed inhibition of exosome-
induced AKT and ERK phosphorylation.
Summary/Conclusion: Our observations suggest that
MSC exosome works through a multi-faceted MoA
that involved multiple cellular processes to restore
joint homeostasis and promote regeneration.
Funding: National Medical Research Council Singapore
(NMRC/CNIG/1168/2017 and NMRC/CIRG/1480/2017).
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Identification of extracellular vesicles as biomarkers for myocardial
infraction by flow cytometry and automated data processing
Aleksandra Gaseckaa, Edwin van der Polb, Frank Coumansc, Kinga Plutad,
Grzegorz Opolskid, Krzysztof J. Filipiake, Rienk Nieuwlandc
a1st Chair and Department of Cardiology, Medical University of Warsaw,
Warsaw, Poland; bAmsterdam UMC, University of Amsterdam, Department
of Biomedical Engineering and Physics, Amsterdam, Netherlands;
cAmsterdam UMC, University of Amsterdam, Laboratory of Experimental
Clinical Chemistry, Amsterdam, Netherlands; d1st Chair and Department of
Cardiology, Medical University of Warsaw, Warsaw, Poland; e1st Chair and
Department of Cardiology, Medical University of Warsaw, Warsaw, Poland
Introduction: Acute myocardial infarction (AMI) is a
major cause of death. To diagnose AMI, measuring
troponin concentration is the gold standard. Since tro-
ponin is unspecific for AMI, novel biomarkers for AMI
are urgently needed. After the onset of AMI, platelets,
endothelial cells and blood cells release specific extra-
cellular vesicles (EVs). Our aim is to identify these EVs
as biomarkers for AMI diagnosis and treatment
monitoring.
Methods: The study was approved by the medical
ethics committee. Venous blood was collected 24 h,
72 h and 6 months after AMI from fasting patients
(n = 60, 64.5 ± 10.8 years, 68% male) and healthy
controls (n = 30, 57.7 ± 6.6 years, 62% male). Flow
cytometry (Apogee A60 Micro) was used to determine
plasma concentrations of EVs labelled with antibodies
for activated platelets (CD61, CD62p; PEVs), endothe-
lial cells (CD146; EEVs) and red blood cells (CD235a;
RBC-EVs). Processing of 1,224 flow cytometry data
files was performed using in-house developed, auto-
mated software (MATLAB R2018a), enabling flow
rate stabilization, diameter and refractive index deter-
mination, MESF calibration, fluorescent gate determi-
nation and statistics reporting.
Results: Between AMI patients and controls, PEV con-
centrations in plasma were comparable (p = ns), EEV
concentrations increased (p < 0.0001) and RBC-EV
concentrations decreased (p < 0.0001). Antiplatelet
drug ticagrelor decreased concentrations of PEVs
(p = 0.03), compared to less potent clopidogrel but
did not affect EEVs and RBC-EVs. In turn, concentra-
tions of EEVs, but not PEVs and RBC-EVs, positively
correlated with the dose of atorvastatin (p < 0.001). The
antioxidative β-blocker carvedilol increased concentra-
tions of RBC-EVs, compared to nebivolol (p = 0.05)
but did not affect PEVs and EEVs.
Summary/Conclusion: Flow cytometry and automated
data processing were used to find biomarkers for AMI
based on EVs in plasma. During treatment, ticagrelor
decreased PEV concentrations, atorvastatin increased
EEV concentrations and carvedilol increased RBC-EV
concentrations, suggesting that EVs might be used to
monitor AMI treatment. AMI patients differed from
controls regarding EEV and RBC-EV concentrations,
but not PEVs, likely because blood was collected 24 h
after the start of antiplatelet therapy. In follow-up
studies, it is crucial to collect blood prior to treatment.
OWP1.04=PF11.15
Exosome mediated enhancement of cellular therapy in acute
myelogenous leukemia (AML)
Theo Borgovana, Peter Quesenberryb, Mike Deltatto; Sicheng Wenc, Mark
Doonerb
aBrown University Department of Hematology Oncology; Rhode Island
Hospital, Pawtucket, USA; bBrown University Department of Hematology
Oncology; Rhode Island Hospital, providence, USA; cBrown University/
Rhode Island Hospital, Providence, USA
Introduction: Of the AML patients able to tolerate
curative therapy with chemotherapy and stem cell
transplant many are challenged by treatment related
toxicities as well as graft vs. host disease. There is
novel work exploring the utility of haploidentical cel-
lular therapy infusion in order to incite purposeful
recipient immune response and subsequent cytokine
storm to treat refractory AML. Our group has demon-
strated the healing potential of bone marrow derived
mesenchymal stem cell extracellular vesicles (MSC-
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EVs) across multiple disease states, most recently
demonstrating the pro-apoptoic signalling imparted
by these nanoparticles on nascent leukemic cells in
vivo; as well as the potentiating effects of MSC-EVs
when used as an adjunct to standard cytarabine che-
motherapy. We have also shown the protective role of
hMSC EV on radiated BM and stem cell recovery.
Methods: Kasumi AML cells lines were seeded with
MSC-derived EVs. Vesicles were isolated using an
established differential centrifugation technique, and
were co-cultured with Kasumi cells for various time
points. To study cellular viability, we used a fluores-
cence-based method for quantifying viable cells.
We also explored various modes of death EVs may
illicit via a tri-dye Abcam assay designed to simulta-
neously monitor apoptotic, necrotic and healthy cells.
Both assays were used to measure viability and apop-
tosis in similar experiments employing cytarabine
Results: AML cell Proliferation Decreased after 1–
6 days of co-culture with hMSC-derived EVs.
Apoptosis is the primary mode of death induced.
AML cell proliferation decreased synergistic after 1–
6 days of co-culture with hMSC-derived EVs ±
Cytarabine.
Summary/Conclusion: MSCs inhibits the proliferation
of the AML cell line in vitro and work synergistically
with cytarabine chemotherapy to promote apoptotic
death in AML cell lines. Our prior work has shown
that MSC-EVs can abate the effects of toxic chemo/
radiation and serve to protect stem cell allowing for
quicker recover in cell blood counts.
Based on the innate ability of MSC-EV to directly
alter the cellular machinery of abnormal leukemic cell
and of nascent immune cells our corollary hypothesis is
that BM-derived MSC-EVs may serve as suitable alter-
native to conditioning chemo/radiation in the AML
setting and will enhance the effects seen by cellular
therapy infusion.
Funding: t32.
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Extracellular vesicles derived from amniotic fluid stem cells rescue
impaired foetal lung development via the release of microRNAs
Lina Antounians, Vincenzo Catania, Benjamin Liu, Areti Tzanetakis, Louise
Montalva and Augusto Zani
The Hospital for Sick Children, Toronto, Canada
Introduction: Incomplete lung development, also known
as pulmonary hypoplasia (PH), is a recognized cause of
neonatal death. To date, there is no effective treatment that
promotes foetal lung growth and maturation. Herein, we
describe a stem cell-based approach that enhances foetal
lung development via the administration of extracellular
vesicles (EVs) derived from amniotic fluid stem cells
(AFSCs) in rat models of PH. Moreover, we report the
microRNAs present in AFSC-EVs that are responsible for
these beneficial effects.
Methods: AFSC-EVs were isolated by ultracentrifuga-
tion from conditioned medium (CM) of c-Kit+ rat
AFSC that were grown in exosome-depleted FBS for
18h. AFSC-EVs were assessed for size (nanoparticle
tracking analysis), morphology (TEM), and expression
of CD63, Hsp70, Flo-1 and TSG101 (Western).
Ex vivo: Pregnant dams were gavaged nitrofen at E9.5
to induce foetal PH. At E14.5, foetal lungs were har-
vested, and incubated with culture medium alone,
AFSC-CM, or AFSC-EVs. Foetal lungs from untreated
dams served as control. Lungs were compared for
terminal bud density and surface area at 72 h, by two
independent investigators.
In vitro: Foetal rat lung organoids were generated with
epithelial cells from normal and hypoplastic lungs.
Organoids were cultured for 10 days in either medium
alone or medium supplemented with AFSC-EVs. Lung
organoids from untreated normal pups served as con-
trol. Organoids were assessed for proliferation (Ki67)
and markers of epithelial cell differentiation via
immunofluorescence.
RNA-sequencing: RNA was isolated using SeraMir,
constructed into libraries (CleanTag Small RNA) and
sequenced onNextSeqHighOutput single-end sequencing
run.
Results: Administration of AFSC-EVs increased term-
inal bud density and surface area of lung explants back
to control levels and promoted lung epithelial cell
differentiation in lung organoids (increased SPC and
CC10 expression). AFSC-EVs contain 901 microRNAs,
some of which are crucial for foetal lung development,
such as miR17 ~ 92 cluster.
Summary/Conclusion: Administration of AFSC-EVs
rescues impaired foetal lung development in experi-
mental models of PH. AFSC-EV regenerative ability is
exerted via the release of miRNAs some of which
regulate genes involved in foetal lung development.
AFSC-EVs represent a promising therapeutic strategy
for PH in foetuses.
Funding: CIHR-SickKids Foundation.
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Extracellular vesicles from Fat-laden hypoxic hepatocytes activates
pro-fibrogenic signals in Hepatic Stellate Cells
Alejandra Hernandeza, Yana Gengb, Daniel Cabrerac, Nancy Solisd, Han
Moshagee and Marco Arresed
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aPontificia Universidad Católica de Chile; University Medical Center of
Groningen, Groningen, Netherlands; bUMCG, Groningen, Netherlands;
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Chile; eUniversity Medical Center Groningen, Groningen, Netherlands
Introduction/Background: Transition from isolated
steatosis to non-alcoholic steatohepatitis is a key issue
in non-alcoholic fatty liver disease (NAFLD). Recent
observations in patients with obstructive sleep apnoea
syndrome (OSAS), suggest that hypoxia may contri-
bute to disease progression mainly through activation
of hypoxia inducible factor 1α (HIF-1α)-related path-
ways. Release of extracellular vesicles (EV) by injured
hepatocytes may be involved in NAFLD progression.
Aim: to explore whether hypoxia modulates the release
of EV from free fatty acid (FFA)-exposed hepatocytes
and assess cellular crosstalk between hepatocytes and
LX-2 cells (human hepatic stellate cell line).
Methods: HepG2 cells were treated with FFAs (250 μM
palmitic acid + 500 μM oleic acid) and chemical
hypoxia (CH) was induced with Cobalt (II) Chloride,
which is an inducer of HIF-1α. Induction of CH was
confirmed by Western blot (WB) of HIF-1α. EV isola-
tion and quantification was performed by ultracentri-
fugation and nanoparticle tracking analysis
respectively. EV characterization was performed by
electron microscopy and WB of CD-81 marker. LX-2
cells were treated with 15 μg/ml of EV from hepato-
cytes obtained from different groups and markers of
pro-fibrogenic signalling were determined by quantita-
tive PCR (qPCR), WB and immunofluorescence (IF).
Results: FFA and CH-treatment of HepG2 cells
increased gene expression of IL-1β and TGF-β1 in
HepG2 cells and increased the release of EV compared
to non-treated HepG2 cells. Treatment of LX-2 cells
with EV from FFA-treated hypoxic HepG2 cells
increased gene expression of TGF-β1, CTGF, α-SMA
and Collagen1A1 compared to LX-2 cells treated with
EV from non-treated hepatocytes or LX-2 cells exposed
to EV-free supernatant from FFA-treated hypoxic
HepG2 cells. Moreover, EV from FFA-treated hypoxic
HepG2 cells increased Collagen1A1 and α-SMA pro-
tein levels.
Summary/Conclusion: CH promotes EV release from
HepG2 cells. EV from hypoxic FFA-treated HepG2 cells
evoke pro-fibrotic responses in LX-2 cells. Further geno-
mic and proteomic characterization of EV released by
steatotic cells under hypoxia are necessary to further
delineate their role in the crosstalk between hepatocytes
and stellate cells in the setting of NAFLD and OSAS.
Funding: FONDECYT 1150327–1150311.
OWP1.07=PS08.07
Exploration of the surface modification of outer membrane vesicles
Maximilian Richtera, Eleonora Diamantib, Anna Hirschb, Gregor Fuhrmannc
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Saarland, BION, Saarbruecken, Germany
Introduction: Introducing bacteria-binding small mole-
cules to the surface of outer membrane vesicles (OMVs)
could greatly improve their potential for antimicrobial
drug delivery too difficult to treat bacteria. Among the
small number of studies on surface modification of
OMVs, very few deal with small molecules. The aim of
the present study is to evaluate different methods of intro-
ducing bacteria specific targeting moieties to OMVs. We
assessed the modification of surface proteins using N-
hydroxysuccinimide (NHS) esters, well established for
mammalian extracellular vesicles (EVs), cholesterol inser-
tion, mainly applied for liposomes, and the novel applica-
tion of diazo-transfer followed by click-chemistry.
Methods: OMVs were obtained from model myxo-
bacteria by differential ultracentrifugation (UC) fol-
lowed by size-exclusion chromatography (SEC). For
cholesterol insertion and NHS ester-modification,
purified OMVs were incubated with either cholesteryl
PEG 2,000 FITC or sulfo cyanine7 NHS ester. For
diazo transfer the pellet after UC was incubated with
a diazo transfer agent and the OMVs subsequently
conjugated with DBCO-AF594. Unincorporated dye
was removed by SEC. Liposomes were composed of
DMPC and DPPC in 2:3 molar ratio. Results repre-
sent correlated fluorescence intensity and particle
number.
Results: Treatment with sulfo cyanine7 NHS ester led
to the modification with 547 ± 163 molecules per
OMVs, compared to 18 ± 1 for the control using
sulfo cyanine7 acid. Cholesterol insertion introduced
4 ± 1 molecules per OMV, compared to 101 ± 23 for
liposomes. First results for the diazo-transfer showed
71 dye-molecules per OMV, with 32 for the control.
Summary/Conclusion: Of the three methods, NHS
ester-modification displayed the highest efficiency,
similar to published results for mammalian EVs. In
comparison, diazo transfer only yielded ~13% of the
dye-molecules per particle. However, there are still
many parameters to be optimized for this method,
including OMV concentration and incubation period.
Cholesterol insertion was unsuccessful for OMVs,
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probably owing to their membrane structure. In this
study, we aim to get important insights into the mod-
ification of OMVs for bacterial targeting and EV-sur-
face engineering in general.
Funding: This project was funded by Studienstiftung
des Deutschen Volkes and Bundesministerium fuer
Bildung und Forschung.
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Isolation of neuron-specific extracellular vesicles
Dmitry Ter-Ovanesyana, Maia Kipmanb, Emma Kowalc, Ju Hyun Leeb,
Wendy Trieub, Aviv Regevd, David Waltb and George Churchb
aHarvard, Cambridge, USA; bWyss Institute, Boston, USA; cMIT, Cambridge,
USA; dBroad Institute, Cambridge, USA
Introduction: Human biological fluids contain extra-
cellular vesicles (EVs) from different cell types. It
would be incredibly useful to be able to isolate EVs
that originated from specific cell types for diagnostic
purposes as a way to gain molecular information
(RNA, protein) from inaccessible cell types non-
invasively.
Methods: We have developed a general framework for
identifying EV surface markers that can be used for
immuno-isolation of cell type specific EVs. As a proof
of principle, we have applied this framework to the
isolation of neuron-derived EVs from human cere-
brospinal fluid or plasma. In addition to the computa-
tional analysis, we have developed an in-vitro system of
human neurons differentiated from human induced
pluripotent (iPS) cells. We performed mass spectro-
metry on EVs isolated from these neurons to identify
neuron-specific proteins. We also used this system to
develop a robust immune-isolation method for neuron
EV markers.
Results: We have characterized the proteins present in
neuron exosomes by mass spectrometry and then used
computational analysis of published gene expression
and proteomics data to come up with a list of candidate
neuron-specific EV markers. After developing methods
for immuno-isolation of neuron EVs with these mar-
kers, we applied our methods to human cerebrospinal
fluid and plasma.
Summary/conclusion: We have developed a frame-
work for the isolation of cell type specific EVs through
the combination of an experimental in vitro system and
computational analysis of gene expression and proteo-
mics data. We have applied this framework to the
isolation of neuron-specific EVs in human biological
fluids. We envision these methods being broadly
applicable to the development of novel diagnostic bio-
markers for a variety of diseases.
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Coagulation influences properties of extracellular vesicles isolated
from autologous blood derived products
Andrea De Lunaa, Alexander Otahala, Olga Kutenb, Zsombor Laczac and
Stefan Nehrera
aDanube University Krems, Krems, Austria; bOrthoSera GmbH, Krems,
Austria; cOrthosera GmbH, Krems, Austria
Introduction: Platelet rich plasma (PRP) is the most
commonly used blood derivative in clinics due to its
high concentration of platelets and perceived high
growth factor levels. Drawbacks of using PRP are dis-
crepancies among preparation protocols and the pre-
sence of cells (platelets, leucocytes) which can evoke
cellular processes (e.g. inflammation) when injected
into the host. One possibility is to isolate only the
active components of blood derivatives which may
overcome this problem. In the current study, we
focused on extracellular vesicles (EVs) isolated from
two autologous blood derivatives, PRP and hyperacute
serum and investigated whether the clotting cascade
influences EV properties.
Methods: EVs were isolated from citrate-anticoagu-
lated PRP (CPRP) and hyperacute serum using differ-
ential ultracentrifugation followed by a size exclusion
chromatography. Particle concentration and size were
determined by nanoparticle tracking analysis (NTA).
Cryo-electronmicrosopy was performed to visualize
isolated EVs. Expression of miRNAs transported
within EVs as well as in their respective input material
was analysed by qPCR.
Results: NTA revealed higher particle concentrations
and bigger sized EVs within CPRP compared to hyper-
acute serum. These findings were confirmed by cryo-
electronmicroscopy. Profound differences were
detected regarding miRNA expression between the
two blood derivatives. In total, 126 miRNAs were
identified which were expressed both in input material
as well as in the corresponding EVs. The correlation
between miRNAs in EVs and input material was higher
in CPRP compared to hyperacute serum meaning that
in hyperacute serum miRNAs were identified which
were higher expressed in EVs than in the correspond-
ing input material.
Summary/conclusion: EVs from autologous blood
products represent a novel and cell-free regeneration
approach. We observed that the clotting cascade
(plasma versus serum) has an influence on concentra-
tion, size and miRNA expression patterns of EVs.
These differences might have an impact on the biolo-
gical mode of action of blood-derived products used in
clinics.
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expression analysis was performed by TAmiRNA
GmbH. Cryo-electronmicroscopy was conducted at
the Core Facility of the Vienna Bio-Center.
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Type-2 transglutaminase affects calcium homeostasis in neurons and
is released in association with astrocytes-derived exosomes
Elisa Tonolia, Ilaria Pradab, Claudia Verderioc and Elisabetta Verderioa
aNottingham Trent University, Nottingham, United Kingdom; bCNR
Institute of Neuroscience, Milan, Italy., Milan, Italy; cCNR Institute of
Neuroscience, Milan, Italy, Milan, Italy
Introduction: Type-2 transglutaminase (TG2) has been
linked to calcium (Ca2+) dysregulation in conditions
such as neurodegeneration. Recent evidences suggest
that extracellular vesicles (EVs) contribute to the onset
and progression of neurological diseases, and we have
recently shown that TG2 is a cargo of EVs in biological
fluids (Furini et al., 2018). Here, we hypothesise that
TG2 could be released by EVs, interact with neurons
and affect neuronal Ca2+ homeostasis.
Methods: Primary hippocampal neurons were estab-
lished from E18 rat embryos. Extracellular TG2 was
modulated in neurons either by lipofectamine transfec-
tion of a TG2-EGFP construct or by addition of pur-
ified TG2. Intracellular Ca2+ concentration ([Ca2+]i)
was assessed by live imaging in fura-2/AM-loaded neu-
rons. EVs were isolated from primary astrocytes (60
DIV) by serial centrifugation, characterised by western
blotting (flotillin-2 and alix) and nanoparticle tracking
analysis (ZetaView). Experiments to assess TG2 influ-
ence on exosomes-to-neural cells interactions, using a
Renilla sensor based on miR-146a-5p-transfer, are still
ongoing.
Results: Increase of extracellular TG2 levels in neurons
induced an influx of extracellular Ca2+ ions, leading to
a significant raise in basal [Ca2+]i both in normal
conditions (ΔF340/380 = 0.126 ± 0.014; N = 23;
p < 10–5) and with inhibited synaptic transmission
(tetrodotoxin) (ΔF340/380 = 0.058 ± 0.005; N = 33;
p < 10–5). Nifedipine, a blocker of L-type voltage-
operated Ca2+ channels (VOCCs), partially prevented
TG2-dependent Ca2+ response (average inhibition
36%; N = 21; p < 10–5), suggesting that Ca2+ influx
may occur through L-type VOCCs. To identify the
source of extracellular TG2, we analysed EVs isolated
from rat primary astrocytes, previously reported to
release TG2 into the matrix especially in inflammatory
conditions. TG2 was detected in astrocytic exosomes
(but not in ectosomes) only upon LPS stimulus, and
not in the EVs-free medium, suggesting that TG2 is a
cargo of exosomes during neuroinflammation.
Summary/conclusion: TG2 is externalised through
astrocyte-derived exosomes upon neuroinflammatory
stimuli. Extracellular TG2 mediates the opening of L-
type VOCCs in neurons and sets basal [Ca2+]i at
higher levels, which could have a significant impact
on neuronal activity in neuroinflammation.
Funding: John Turland PhD bursary (NTU) and IBRO
travel fund.
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Ev-avogadro project: towards a liposomal concentration standard for
extracellular vesicle research
Gergo Bartaa, Diana Kitkaa, Andras Wachaa, Judith Mihalya, Attila Botaa,
Krisztina Nemetha, Pal Szaboa, Jean-Luc Fraikinb and Zoltan Vargac
aResearch Centre for Natural Sciences HAS, Budapest, Hungary;
bSpectradyne LLC, Torrance, USA; cResearch Centre for Natural Sciences,
Hungarian Academy of Sciences, Budapest, Hungary
Introduction: There is an unmet need for standardiza-
tion of concentration measurements in the field of
extracellular vesicles (EVs). Liposomes may serve an
ideal reference system for EVs, but the determination
of the number concentration of liposomes from first
principles was not attempted so far. Inspired by the
International Avogadro project, we aimed to determine
the concentration of liposomes with well-defined size
and composition via counting the number of phospho-
lipid molecules in these “nanospheres”.
Methods: Liposomes composed of phosphocholine and
phosphoglycerol were prepared by the extrusion
method. Wide-angle X-ray scattering (WAXS) was
used to determine the area-per-lipid value. The size
distribution of the liposomes was determined by
microfluidic resistive pulse sensing (MRPS) and
freeze-fracture combined TEM. Small-angle X-ray scat-
tering (SAXS), differential scanning calorimetry (DSC)
and infrared spectroscopy (IR) were used to prove the
unilamellarity, the ideal miscibility of the lipids and the
ordered packing of the hydrocarbon chains of the
lipids, respectively. Concentration of the lipids was
determined by liquid chromatography–mass spectro-
metry (LC-MS).
Results: The prepared liposomes proved to be unila-
mellar with narrow size distribution (83 nm avg.), as
obtained by MRPS and TEM. DSC and IR measure-
ments confirmed that the phospholipid bilayer of these
liposomes is in the liquid-ordered phase, hence the
area-per-lipid of 0.41 nm2 was determined from
WAXS measurements. Using the concentration of
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phospholipids from LC-MS measurements, the number
concentration of liposomes was determined (8E+13
1/mL).
Summary/conclusion: Liposomes containing saturated
phospholipids are in the liquid-ordered phase, which
can be utilized to determine the area-per-lipid using
WAXS. This value, together with the independently
determined size, and lipid concentration can be used
to calculate the number concentration of liposomes. As
the light scattering properties of liposomes matches
that of EVs, liposome-based standards for optical mea-
surements of EVs can be obtained with the presented
techniques.
Funding: This work was supported under grant num-
bers PD 121326 and NVKP_16-1-2016-0007 by NKFIH
(Hungary). ZV was supported by the János Bolyai
Research Fellowship.
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Plasma exosomes regulate proliferation and migration of vascular
smooth muscle cells
Kosuke Otania, Mai Yokoyab, Muneyoshi Okadac and Hideyuki Yamawakib
aLaboratory of Veterinary Pharmacology, School of Veterinary Medicine,
Kitasato University, Towada, Japan; bKitasato University, Towada, Japan;
cKitasato University, School of Veterinary Medicine, Laboratory of
Veterinary Pharmacology, Towada, Japan
Introduction: We previously reported that systolic
blood pressure in spontaneously hypertensive rats, an
animal model of essential hypertension, was partly
modulated by circulating exosomes (BBRC 2018).
Vascular wall remodelling regulated by proliferation
and migration of vascular smooth muscle cells
(VSMCs) mediates development of hypertension. We
aimed to clarify the effects of plasma exosomes derived
from SHR and control Wistar Kyoto Rats (WKY) on
proliferation and migration of VSMCs.
Methods: Exosomes were isolated from rat plasma by
an ultracentrifuge method, and identified through
measurement of particle size distribution by a tunable
resistance pulse sensing. For exploring exosome inter-
nalization in VSMCs, the isolated exosomes were
labelled with PKH67 dye and observed by a fluores-
cence microscopy. Proliferation and migration of
SMCs were determined by a bromodeoxyuridine incor-
poration and Boyden chamber assay, respectively.
Actin cytoskeleton was visualized by a rhodamine-
phalloidin staining. Expression of protein and
microRNA in exosomes was determined by Western
blotting and microarray, respectively.
Results: There was no difference in size and concen-
tration of plasma exosomes between WKY and SHR.
Exosomes were incorporated into VSMCs, while the
internalization of SHR exosomes was significantly
lower than WKY exosomes. Both WKY and SHR exo-
somes similarly stimulated proliferation, migration and
cytoskeletal changes such as formation of filopodia and
lamellipodia in VSMCs. Heparin, an inhibitor of exo-
some internalization, completely blocked the migration
and proliferation. Protein expression of CD9 and
CD63, an exosomal marker, was significantly higher
in exosomes from WKY than SHR. The expression of
several microRNAs in SHR exosomes changed com-
pared with WKY exosomes.
Summary/conclusion: These results suggest that
plasma exosomes play physiological, but not patholo-
gical, role on VSMCs irrespective of their origin (nor-
motensive or hypertensive rats). Further research is
required for determining whether the changes in mole-
cular profiles of circulating exosomes mediate the
development of high blood pressure in SHR.
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Colorectal cancer cell-derived exosome enhances microenvironmental
angiogenesis through modulation of intracellular metabolism
Atsushi Ikedaa, Satoshi Nagayamab and Koji Uedac
aCancer proteomics group, Cancer Precision Medicine Center, Japanese
Foundation for Cancer Research, Tokyo, Japan; bDepartment of
Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation
for Cancer Research, Tokyo, Japan; cCancer Proteomics Group, Cancer
Precision Medicine Center, Japanese Foundation for Cancer Research,
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Introduction: For improvement of prognosis of color-
ectal cancer (CRC), detection at an earlier stage of CRC
is essential. Exosomes are nanovesicles secreted from
plasma membrane, and have potential to be served as
biomarker carriers. In this study, we performed pro-
teomic profiling of exosomes secreted from viable CRC
tissues.
Methods: To identify early detection biomarkers for
CRC, we performed comprehensive proteome analysis
of tissue-exudative extracellular vesicles (Te-EVs),
which were obtained from culture media of freshly
resected viable CRC tissue or adjacent normal mucosa
(n = 17). Among the identified Te-EV proteins, we
narrowed down the biomarker candidate by selecting
proteins which are statistically upregulated (p < .05,
fold change > 5.0) in Te-EVs from CRC tissues than
those from adjacent normal tissues. Then we per-
formed functional analysis of the biomarker candidate
specifically.
Results: Comprehensive LC/MS analysis identified
6,149 Te-EV proteins, in which 641 proteins showed
significant upregulation in Te-EVs from CRC tissues
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(p < .05, fold change > 5. 0) compared to those from
adjacent normal mucosa. We focused especially on
GAM (p = 7.0 × 10–5, fold change = 7.4) as a novel
biomarker candidate. GAM protein was significantly
overexpressed in CRC tissues compared with adjacent
normal mucosa. In EV-sandwich ELISA assay, the
expression level of GAM on plasma EVs from CRC
patients was significantly higher than that from healthy
donors in EV-sandwich ELISA assay (n = 133,
p = 4.0 × 10–7). In addition, the uptake of GAM-over-
expressing EVs enhanced vascular endothelial cell
growth and angiogenesis through modulation of nitric
oxide metabolism.
Summary/conclusion: EV-GAM might have great
potential as a target for both CRC diagnosis and ther-
apy. Our strategy for identification of exosomal bio-
marker by proteomic profiling of Te-EV proteins can
be applied to other cancers.
OWP1.14=LBS02.01
Annexin V binding modulates the response of macrophages to
mesenchymal stromal cell-derived extracellular vesicles
Michele Grassia, Michela Pozzobonb, Melania Scarpac, Damiana Incendid,
Alessia Giarraputoe, Anna Maria Tolomeoa, Marcin Jurgaf, Andrea
Porzionatog and Maurizio Muracah
aDepartment of Women’s and Children’s Health – University of Padova,
Padova, Italy; bUniversity of Padova, Padova, Italy; cIstituto Oncologico
Veneto IOV-IRCCS, Padova, Italy; dUniversity di Padova Department DNS,
Padova, Italy; eUniversity of Padova, Padova, Italy; fThe Cell Factory, Niel,
Belgium; gDepartment of Neuroscience, University of Padua, Padova, Italy;
hUniversity of Padova, Padova, Italy
Introduction: We have previously shown that Annexin
a5 (An5) binding to mesenchymal stromal cell-derived
extracellular vesicles (MSC-EVs) enhances the anti-
inflammatory properties of these nanoparticles in an
animal model of colitis. However, the mechanisms
underlying these effects are unknown. Here, we inves-
tigated the immunoregulatory effect of MSC-EVs with
and without An5 binding on activated macrophages in
vitro.
Methods: Macrophages were isolated from mouse bone
marrow and activated by INFgamma and LPS. Clinical
grade Wharton Jelly-derived MSC-EVs were obtained
from The Cell Factory (Esperite NV, Niel, Belgium)
and quantified by Resistive Pulse Sensing analysis. 5,0E
+05 macrophages were incubated with PBS (vehicle
only, control, group 1) 5,0E+08 MSC-EVs (group 2),
5,0E+08 MSC-EVs added with 2 ug An5 (group 3) or
with 2 ug free An5 (group 4). After 24 h, the cells were
analysed by flow cytometry and RNA was extracted for
RT-PCR analysis.
Results: Incubation with MSC-EVs significantly
increased only the expression of IL-10 in IFN-
gamma/LPS-activated macrophages. Incubation with
An5-MSC-EVs resulted in a significant induction in
the expression of both pro- and anti-inflammatory
cytokines, including TNF-alfa, IL-1Beta, IL-6, IL-10
and TGFbeta1. Incubation with free An5 induced
only pro-inflammatory cytokines without affecting IL-
10 and TGFbeta1 expression. The iNOS2/Arg1 ratio
was reduced in both EV-treated groups, indicating a
shift from M1 to M2 polarization.
Summary/conclusion: In conclusion, both MSC-EVs
and An5-MSC-EVs shift the macrophage phenotype
from M1 to M2. The combined induction of
TGFbeta1 and IL-10, observed only in An5-MSC-EV-
stimulated macrophages, might be related to the
immune-modulating characteristics of these modified
EVs that contribute to the therapeutic effects observed
in vivo.
Funding: The BROAD MEDICAL RESEARCH
PROGRAM AT CCFA supported this work
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Membrane-radiolabelled exosomes for comparative biodistribution
analysis in immunocompetent and immunodeficient mice – A novel
and universal approach
Farid N. Faruqua, Julie Wanga, Lizhou Xub, Luke McNicklea, Ming-Yiu
Chonga, Mark Gurneyc, Aled Claytonc, Lesley A. Smythd, Robert Hidera,
Jane Sosabowskie and Khuloud Al-Jamala
aKing‘s College London, London, United Kingdom; bSchool of Cancer and
Pharmaceutical Sciences, King‘s College London, London, United Kingdom;
cCardiff University, Cardiff, United Kingdom; dUniversity of East London,
London, United Kingdom; eQueen Mary University of London, London,
United Kingdom
Introduction: Exosomes have gained interest as novel
drug nanocarriers due to their biological origin and
role in intercellular biomolecule delivery. In-depth
knowledge of their in vivo biodistribution is therefore
essential. This work aimed to develop a reliable and
universal method to radiolabel exosomes to study in
vivo biodistribution in mice.
Methods: Melanoma (B16F10 cells)-derived exosomes
(ExoB16) were isolated and characterised for size, yield,
purity, exosomal markers and morphology using
Nanoparticle Tracking Analysis (NTA), protein mea-
surements, flow cytometry and electron microscopy.
Two radiolabelling approaches were explored – intra-
luminal labelling (111Indium entrapment via tropolone
shuttling); and membrane labelling (111Indium chela-
tion by covalently attached bifunctional chelator).
Labelling efficiency and stability was assessed by gel
filtration and thin layer chromatography. Melanoma-
bearing immunocompetent (C57BL/6) and immunode-
ficient (NSG) mice were injected intravenously with
radiolabelled ExoB16 (1x1011 particles) followed by
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metabolic cages study, whole body SPECT-CT imaging
and ex vivo gamma counting at 1, 4 and 24 h post-
injection.
Results: Membrane-labelled ExoB16 (ML-ExoB16)
showed superior radiolabelling efficiency and radioche-
mical stability compared to intraluminal-labelled
ExoB16 (IL-ExoB16). Both IL- and ML-ExoB16
showed prominent accumulation in liver and spleen.
IL-ExoB16 showed higher tumour accumulation than
ML- ExoB16 (6.7% and 0.6% ID/g tissue, respectively),
with the former showing similar value as its free tracer
([111]Trop). The superior stability of the membrane-
labelling approach rendered its result more reliable and
was used to compare ExoB16 biodistribution in mela-
noma-bearing immunocompromised (NSG) mice.
Similar biodistribution profile was observed in both
C57BL/6 and NSG mice, where prominent accumula-
tion was seen in liver and spleen, apart from the lower
tumour accumulation observed in the NSG mice.
Summary/conclusion: Membrane radiolabelling of
exosomes is a reliable approach that allows for both
live imaging and quantitative biodistribution studies to
be performed on potentially all exosome types without
engineering parent cells.
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Identification of common EV markers in plasma using high-resolution
flow cytometry
Anders Askelanda, Jaco Bothab, Rikke Wehner Rasmussenb and Aase
Handbergb
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Introduction: Recent advancements in flow cytometry
(FCM) have led to the development of high-resolution
FCMs dedicated to the analysis of small particles
(hFCM). hFCM studies have predominantly focused
on the analysis of EVs expressing phosphatidylserine
(PS). PS is enriched in microvesicles (MVs), wherein it
is involved in lipid rearrangements responsible for MV
budding. While PS also is expressed on exosomes, it is
unknown whether it can be used as a universal marker
for smaller EVs. In this study, we attempted to char-
acterize proteins enriched in smaller EVs (CD9, CD63,
CD81 and ADAM 10) and the relative co-expression of
PS with each of these markers.
Methods: FCM analysis was performed on an Apogee
A60 Micro-PLUS. In brief, platelet-poor plasma (PPP)
from healthy individuals was stained with lactadherin-
FITC (PS+) and one of several EV surface markers
enriched in smaller EVs. To evaluate the precise differ-
ences in PS and specific EV marker expression, the
analysis was performed twice, (1) triggering on lactad-
herin and (2) each EV marker (CD9-PE, CD81-PE,
CD63-PE, ADAM10-PE), separately. All antibodies
were matched with appropriate isotope controls and
centrifuged at 17,000g for 10 min prior to antibody
labelling. EVs were defined as lactadherin or EV sur-
face marker positive events ≤1000 nm.
Results: Initial results indicate that CD9 is highly
expressed on EVs and is not universally associated to
PS. Triggering on PS revealed that 34.7% of all events
were CD9 positive (CD9+|PS+). Conversely, triggering
on CD9 resulted in a 2.1-fold increase in total events,
where 17.0% of events were PS+ (CD9+|PS+). Inferring
size from silica nanospheres, it appeared that popula-
tions containing CD9 (CD9+|PS+ and CD9+|PS-) were
smaller (94.4–99.7% <180 nm) compared to popula-
tions that did not (PS+|CD9-; 85.6% <180 nm & 95.2%
<300 nm). Interestingly, we did not detect CD81, CD63
or ADAM10 on EVs. We hypothesize that this is due to
a low abundance of these markers in PPP from healthy
individuals.
Summary/Conclusion: Our findings demonstrate that
hFCM can be used for the characterization of smaller
EVs in PPP. Furthermore, we find that CD9+EVs do
not universally express PS. From this point on, we plan
to study enrichment of these EV phenotypes following
a number of EV purification protocols, and determine
whether EV isolation enable a more extensive charac-
terization of smaller EVs.
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Software to automate calibration and processing of flow cytometry
data in clinical studies
Edwin van der Pols, Frank Coumansb, Leonie de Rondc, Aleksandra
Gaseckad, Najat Hajjie, Rienk Nieuwlandb and Ton van Leeuwenf
aAmsterdam UMC, University of Amsterdam, Department of Biomedical
Engineering and Physics, Amsterdam, Netherlands; bAmsterdam UMC,
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Amsterdam, Netherlands; cAmsterdam University Medical Centers,
Amsterdam, USA; d1st Chair and Department of Cardiology, Medical
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Introduction: In search of new biomarkers, flow cyt-
ometers are used in clinical studies to measure the
concentration of specific extracellular vesicles (EVs).
Flow cytometers measure light scattering and fluores-
cence of single EVs in a fluid stream. However, to
realize data interpretation and comparison, light scat-
tering and fluorescence signals and the flow rate
require calibration. Moreover, flow cytometers gener-
ate large datasets. For example, a clinical study invol-
ving 60 patients, 30 controls, and 8 antibody labels
covers 1224 data files, >33 gigabytes of data and >0.3
billion events. To manually calibrate and analyse such a
dataset would take days if not weeks and is prone to
human mistakes. Therefore, an urgent need exists for
software to automate calibration and processing of flow
cytometry data.
Methods: We have developed software (MATLAB
R2018a) to automatically process multiple .fcs files
and (1) relate two scatter signals to the diameter in
nm and refractive index (RI) of EVs, (2) express
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fluorescence signals in terms of molecules of equivalent
soluble fluorochrome, (3) export calibrated channels to
new .fcs files, (4) recognize unstable flow rates, (5)
determine fluorescence thresholds, (6) apply gates, (7)
create PDFs with scatter plots and (8) report statistics.
We are using clinical studies to validate and apply the
software.
Results: Compared to manual thresholding, automatic
thresholding results in a systematic decrease in counts
of 10% and a maximum difference of 14% (n = 5).
Using a high-end laptop, data processing takes typically
a minute or several seconds per .fcs file with or without
PDF reporting, respectively. Flow rate monitoring is
useful for 61% of the data. The platelet marker CD61
stains 7% of the events with an RI >1.42, which are
lipoproteins, and the concentration of these lipopro-
teins differed 4000-fold between individuals.
Summary/Conclusion: We have developed software to
automate calibration and processing of flow cytometry
data in clinical studies, thereby reducing analyses time,
preventing human mistakes and providing new
insights. For example, non-specific labelling of antibo-
dies to lipoproteins together with variations in lipopro-
tein concentrations emphasize the relevance of fasting
before venipuncture. Our next step is to extend the
software with machine learning.
Funding: NWO-TTW VENI 15924.
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Conventional, high-resolution and imaging flow cytometry:
potentials, pitfalls and solutions for EV characterization
Jaco Botha, Rikke Wehner Rasmussen, Mathilde Sanden and Aase Handberg
Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg,
Denmark
Introduction: Flow cytometry (FCM) has long been a
preferred method for characterizing EVs, however their
small size have limited the applicability of conventional
FCM to some extent. Thus, high-resolution and ima-
ging FCMs have been developed but not yet system-
atically evaluated. The aim of this presentation is to
describe the applicability of high-resolution and ima-
ging FCM in the context of EV characterization and
the most significant pitfalls potentially influencing data
interpretation.
Methods: (1) First, we present a side-by-side compar-
ison of three different cytometry platforms on charac-
terising EVs from blood plasma regarding sensitivity,
resolution and reproducibility: a conventional FCM, a
high-resolution FCM and an imaging FCM. (2) Next,
we demonstrate how different pitfalls can influence the
interpretation of results on the different cytometry
platforms. (3) Finally, we propose controls, solutions
or workarounds for understanding and limiting the
influence of each of these pitfalls.
Results: (1) High-resolution FCM and imaging FCM
displayed greater sensitivity and resolution compared
to conventional FCM when measuring a mixture of
nanospheres. Equally, both methods could detect larger
concentrations of specific EV phenotypes than conven-
tional FCM, where imaging FCM outperformed high-
resolution FCM. Within day variability (n = 20 ali-
quots) was similar for conventional and high-resolu-
tion FCM, while imaging FCM had a markedly larger
variability. Between day variability (n = 5 × 5 aliquots)
was similar for all three platforms. (2) The three most
substantial pitfalls variably influencing interpretation
of results on the three platforms are non-specific bind-
ing of labels, antibody aggregates, and entities in the
sample (i.e. lipoproteins) binding EV-defining dyes. (3)
The most important strategies for circumventing these
pitfalls are stringent matching, gating and comparison
of antibodies and isotype controls, high-speed centri-
fugation of antibodies and labels prior to staining, and
the use and interpretation of stained buffer controls
and detergent treated samples.
Summary/Conclusion: High-resolution and imaging
FCM hold great potential for EV characterization.
However, increased sensitivity also leads to new arte-
facts and pitfalls. The solutions proposed in this pre-
sentation provide useful strategies for circumventing
these.
OWP2.04=PS08.11
Convolutional neural networks for classification of tumour derived
extracellular vesicles
Wooje Leea, Aufried Lenferinka, Cees Ottob and Herman Offerhausa
aUniversity of Twente, Enschede, Netherlands; bMedical Cell Biophysics,
University of Twente, Enschede, Netherlands
Introduction: Raman spectroscopy probes molecular
vibration and thus reveals chemical information of a
sample without labelling. This optical technique can be
used to study the chemical composition of diverse
extracellular vesicles (EVs) subtypes. EVs have a com-
plex chemical structure and heterogeneous nature so
that we need a smart way to analyse/classify the
obtained Raman spectra. Machine learning (ML) can
be a solution for this problem. ML is a widely used
strategy in the field of computer vision. It is used for
recognizing patterns and images as well as classifying
data. In this research, we applied ML to classify the
EVs’ Raman spectra.
30 ISEV2019 ABSTRACT BOOK
Methods: With Raman optical tweezers, we obtained
Raman spectra from four EV subtypes – red blood cell,
platelet PC3 and LNCaP – derived EVs. To classify
them by their origin, we used a convolutional neural
network (CNN). We adapted the CNN to one-dimen-
sional spectral data for this application.
The ML algorithm is a data hungry model. The
model requires a lot of training data for accurate pre-
diction. To further increase our substantial dataset, we
performed data augmentation by adding randomly
generated Gaussian white noise.
The model has three convolutional layers and fully
connected layers with five hidden layers. The Leaky
rectified linear unit and the hyperbolic tangent are
used as activation functions for the convolutional
layer and fully connected layer, respectively.
Results: In previous research, we classified EV Raman
spectra using principal component analysis (PCA).
PCA was not able to classify raw Raman data, but it
can classify preprocessed data. CNN can classify both
raw and preprocessed data with an accuracy of 93% or
higher. It allows to skip the data preprocessing and
avoids artefacts and (unintentional) data biasing by
data processing.
Summary/Conclusion: We performed Raman experi-
ments on four different EV subtypes. Because of its
complexity, we applied a ML technique to classify EV
spectra by their cellular origin. As a result of this
approach, we were able to classify EVs by cellular
origin with a classification accuracy of 93%.
Funding: This work is part of the research programme
[Cancer-ID] with project number [14197] which is
financed by the Netherlands Organization for
Scientific Research (NWO).
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Microfluidic electrochemical aptasensor for detection of breast
cancer-derived exosomes in biofluids
Leila Kashefi-Kheyrabadi, Sudesna Chakravarty, Junmoo Kim, Kyung-A
Hyun, Seung-Il Kim and Hyo-Il Jung
Yonsei University, Seoul, Republic of Korea
Introduction: Exosomes are nano-sized extracellular
vesicles, which are emerging as potential noninvasive
biomarkers for early diagnosis of cancer. However, the
small size and heterogeneity of the exosomes remain
significant challenges to their quantification in the bio-
fluids. In the present research, a microfluidic electro-
chemical biosensing system (MEBS) is introduced to
detect ultra-low levels of breast cancer cell-derived
exosomes (BCE).
Methods: Fabrication procedure of MEBS comprises
three main steps: first, biosensing surface was prepared
by immobilizing EPCAM binding aptamer (EBA) on a
nanostructured carbon electrode. The nanostructured
surface (NS) consists of 2-D nanomaterials including
MoS2 nano-sheets, graphene nano-platelets, and a
well-ordered layer of electrodeposited gold nanoparti-
cles. The NS was well characterized with FESEM and
EDX. FESEM analysis showed a well-ordered gold
nano-structuring for 50 nM of gold solution.
Furthermore, EDAX analysis confirmed >60% coverage
of gold nanoparticles on NS compared to bare carbon
electrode. At the second step, a herringbone structured
microfluidic channel, which is able to enrich BCE was
designed and fabricated. Finally, microfluidic channel
was integrated to biosensing surface. Different concen-
trations of exosome solutions was introduced and
enriched to biosensing surface (SPCE/NS/GNP/EBA)
using microchannel. After capturing BCEs on the sen-
sing surface a secondary aptamer labelled with silver
nanoparticles (SNPs) as redox reporter was introduced
to the sensing surface.
Results: Direct electro-oxidation of SNPs was moni-
tored as analytical signal. The unique design of micro-
channel in combining with high specific interaction
between BCE and EBA provided a high sensitive detec-
tion of BCE as low as ~100 exosomes/μL.
Summary/Conclusion: The unique design of MEBS
provides a highly sensitive accurate platform for detec-
tion of ultra-low levels of cancer-derived exosomes.
This tool holds great potential for early cancer diagno-
sis in clinical applications.
OWP2.06=PS08.13
A software suite allowing standardized analysis and reporting of
fluorescent and scatter measurements from flow cytometers
Joshua Welsh and Jennifer C. Jones
Translational Nanobiology Section, Laboratory of Pathology, National Cancer
Institute, National Institutes of Health, Bethesda, USA
Introduction: Single vesicle analysis using flow cyto-
metry is an extremely powerful technique to allow
identification of unique proteins in biological samples,
as well as enumerating the changes in concentrations.
While small particle analysis (for viruses and large
microparticles) using flow cytometry has been con-
ducted for several decades, there is no comprehensive
method for standardization of such studies. Therefore,
we developed a suite of flow cytometry post-acquisition
analysis software (FCMPASS) tools that enable the con-
version of scatter and fluorescent axes to standardized
units using appropriate controls, writing standardized
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units to .fcs files for sharing upon publication with
open repositories, and exporting templates of obtained
data.
Methods: Standalone software packages for scatter and
fluorescent standardization were built using MATLAB.
The scatter software is based upon Mie modelling and
is capable of predicting the optical collection angle of
the instrumentation and reporting the Mie modelling
criteria in a standardized way, making it possible to
reproduce the models and flow cytometry settings.
Fluorescent standardization data uses least-squares lin-
ear regression to enable conversions of arbitrary unit
scales to molecules of equivalent soluble fluorophore
(MESF) using MESF calibration beads.
Results: The FCMPASS software converts arbitrary
fluorescence units to MESF units and writes them to
data files for clearer reporting and sharing of data.
FCMPASS also converts arbitrary scatter units to a mea-
surement of scattering cross-section using modelling
software that predicts the collection angle of the instru-
ments and normalizes the data automatically.
Summary/Conclusion: Utilization of our FCMPASS
software can help the EV flow cytometry more easily
implement standardization into their experimental
analysis and the use of the output templates can make
reporting more consistent. While currently available
MESF controls can be further optimized for small
particles, we believe their utilization along with the
other controls, can bring a new era to the reporting
of EV research using flow cytometry. This will be
particularly useful for future comparison and valida-
tion of translational studies and will enable better
understanding and utilization of EVs across a broad
range of disciplines.
OWP2.07=PF05.08
Biogenesis of JC polyomavirus associated extracellular vesicles
depends on neutral sphingomyelinase 2
Jenna Morris-Lovea, Bethany O’Harab, Gretchen Geea, Aisling Duganb,
Benedetta Assettac, Sheila Haleya and Walter Atwooda
aBrown University, Providence, USA; bAssumption College, Worcester, USA;
cBrown Univerisity, Providence, USA
Introduction: JC polyomavirus is a non-enveloped
virus that causes progressive multifocal leukoencepha-
lopathy (PML) in immunocompromised patients.
JCPyV infects cells by first binding to the major attach-
ment receptor lactoseries tetrasaccharide C (LSTc), fol-
lowed by the serotonin receptor 5-hydroxytryptamine
type 2 required for entry. In PML, JCPyV undergoes
lytic infection in oligodendrocytes and astrocytes, both
of which have been shown to lack LSTc. Further, deep
sequencing has shown that viral quasispecies existing
in PML patients contain mutations in the sialic acid
binding pocket of the major viral capsid protein, ren-
dering these virions incapable of binding LSTc. We
have recently demonstrated that JCPyV is packaged
into extracellular vesicles (EVs) that can spread the
virus, potentially overcoming this paradox. Here, we
begin to characterize the biogenesis of this EV-virus
association by examining endosomal sorting complexes
required for transport (ESCRT) proteins and neutral
sphingomyelinase 2 (nSMase2).
Methods: Cambinol was used to specifically target
nSMase2 activity. Knockdown cell lines were created
with shRNA targeted against ALIX, TSG101 or
SMPD3. SMPD3 was also targeted using CRISPR/
Cas9 genetic knockout in separate cell lines.
Knockdown was confirmed by qPCR and/or Western
blot, and knockout by next generation sequencing. EV
were concentrated by differential centrifugation and
evaluated by transmission electron microscopy,
Western blot, nanoparticle tracking analysis, infection
and qPCR for protected viral genomes. Infection was
scored by immunofluorescence analysis with antibodies
against the major viral capsid protein VP1.
Results: We found that depletion of nSMase2 by cam-
binol, genetic knockdown or knockout caused a reduc-
tion in spread of JCPyV over time. Knockdown and
knockout SMPD3 cell lines produced less infectious
EV. In the absence of nSMase2, cells produced more
EV but there were fewer protected genomes associated
with the EV. Knockdown of Alix or TSG101 had no
effect on the infectivity of EV or the production of EV.
Summary/Conclusion: Overall, our studies found that
biogenesis of JCPyV associated EVs depends upon the
enzymatic activity of nSMase2 and not the ESCRT-
related proteins Alix or TSG101.
Funding: NIH R01NS043097.
OWP2.08=PF05.09
Exosomes mediate the antiviral activity of interferon-β against Zika
virus infection
Shuang Li, Shilin Li and Limin Chen
Provincial Key Laboratory for Transfusion-Transmitted Infectious Diseases,
Institute of Blood Transfusion, Chinese Academy of Medical Sciences and
Peking Union Medical College, Chengdu, China (People’s Republic)
Introduction: IFNβ-induced exosomes (Exo-IFNβ)
may impact on viral dissemination or antiviral immu-
nity and therefore involve in the pathogenesis of many
infectious pathogens. However, little is known about its
underlying mechanisms. To better understand how
Exo-IFNβ perform its antiviral effect, we employed
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RNA sequencing analysis to explore the exosomal
expression profiles of lncRNA and mRNA related to
viral infections. We hypothesized that exosomes can
regulate viral infection through transmitting enclosed
specific lncRNAs into neighbouring cells to inhibit
viral replication.
Methods: Exosomes were purified from A549 with/
without IFNβ treatment by serial centrifugation fol-
lowed by sucrose density gradient purification, and
characterized by TEM and Western Blot. ELISA assay
were performed on purified exosome fractions to
demonstrate that they are free of IFNβ. Zika virus
(ZIKV) replication was assayed by real-time PCR.
Results: ZIKV replication was significantly suppressed
in A549 cells pretreated with Exo-IFNβ followed by
ZIKV infection. Moreover, we found that anti-ZIKV
effect of Exo-IFNβ is IFN-independent because ZIKV
replication was also decreased in U5A cells (IFN-α/β
receptor IFNAR deficient) pre-treated with Exo-IFNβ.
Similar results were observed in Dengue virus and
HCV infections. RNA sequencing analysis found sev-
eral lncRNAs and mRNAs were differentially expressed
and function annotation and pathway analysis demon-
strated that the differentially expressed genes were
involved in many functions and pathways, including
antiviral infection. To validate the RNA sequencing
analysis results, some lncRNAs were selected to test
their expression levels by qPCR. We are in the process
of deciphering the mechanism employed by these exo-
somal lncRNAs in antiviral activity independent of
inteferon.
Summary/Conclusion: We believe that understanding
the antiviral functional molecules wrapped in exosomes
may help design exosomes as efficient vehicles for
antiviral therapy.
Funding: Chinese Academy of Medical Sciences
Innovation Fund for Medical Sciences (2016-12M-
3-025)
OWP2.09=PS02.09
Deciphering the role of extracellular vesicles on the blood–brain
barrier during Zika virus infection
Antonios Fikatas, Sam Noppen, Peter Vervaeke, Jordi Doijen, Mohammed
Benkheil, Christophe Pannecouque and Dominique Schols
Laboratory of Virology and Chemotherapy, Rega Institute, KU Leuven,
Belgium, Belgium
Introduction: The association of Zika virus (ZIKV)
with severe neurological disorders has gained increased
interest over the last decade. However, the mechanism
by which ZIKV crosses the blood–brain barrier (BBB)
and reaches the brain remains to be elucidated. It is
known that viruses incorporate viral material in extra-
cellular vesicles (EVs) as a spreading strategy. These
membrane-enclosed vesicles play a vital role in inter-
cellular communication. Currently, there is a lack of
knowledge on the possible involvement of EVs in
ZIKV pathogenesis. Our study aims to unravel the
role of EVs in ZIKV RNA transmission to the brain,
via the BBB.
Methods: Human brain microvascular endothelial cells
(HBMEC/D3) were used in our study since they repre-
sent the BBB in vitro. Three different EV isolation
methods (precipitation kit, density gradient and size
exclusion chromatography combined with the density
gradient) were performed. Western blot, Transmission
electron microscopy and Nanosight tracking analysis
confirmed the presence of EVs in the supernatant of
HBMEC/D3 cells. The presence of ZIKV RNA in
infected-EVs (IEVs) was evaluated by immunofluores-
cence and qPCR. In addition, the effect of IEVs on the
BBB was assessed using a label-free impedance-based
biosensor (ECIS, Applied BioPhysics).
Results: We confirmed the presence of viral compo-
nents in our IEVs, including the NS1 and E proteins of
ZIKV. The obtained IEVs were able to reinfect suscep-
tible cells, even after being pretreated with RNase A.
This indicates that the viral RNA resides inside the
IEVs. Using impedance measurements on HBMEC/
D3 cell monolayers, we observed that IEVs, as well as
virus control caused similar and temporal disturbances
on the monolayer’s integrity within 30 min post infec-
tion. No disturbances were seen upon addition of non-
infected EVs.
Summary/Conclusion: Our study demonstrates that
EVs-derived from ZIKV-infected cells are able to trans-
fer proteins and viral RNA to recipient cells. Since both
IEVs and viral particles can induce similar changes on
barrier’s integrity it is possible that IEVs are involved
in an alternative mechanism of ZIKV transmission.
OWP2.10=PF12.10
HIV-specific antibody mediated targeting of ENV+ tissues by
exosomes
Zou Xue, Yuan M’eng, Zheng Nan and Wu Zhiwei
Nanjing University, Nanjing, China (People’s Republic)
Introduction: Antiretroviral therapy can effectively
suppress HIV replication in the peripheral blood to
an undetectable level. However, efforts to eradicate
the latent virus in reservoirs remain a challenge and
are a major obstacle in the treatment of HIV patients.
Exosomes exhibit huge promise as an endogenous drug
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delivery nanosystem for delivering drugs to reservoir
tissues given their unique properties, including low
immunogenicity, innate stability, high delivery effi-
ciency and mostly importantly the ability to penetrate
solid tissues due to their lipophilic properties.
Methods: In this study, we engineered and expressed
the ScFv of a high affinity HIV-specific monoclonal
antibody, 10E8, on exosome surface. Exosomes from
293T cells were loaded with curcumin via saponin,
with efficient up to 34%. 10E8ScFv-expressing exo-
somes (10E8-Exo) showed highly efficient targeting of
and curcumin delivery to CHO cell that expresses a
trimeric gp140 on its surface (ENV+ cells) in vitro as
demonstrated by confocal imaging and flow cytometry.
We showed that 10E8-Exo could effectively bind to
CHO cell that expresses a trimeric gp140 on its surface.
The exosomes loaded with curcumin, a chemical that
was shown to kill HIV-infected cells, showed specific
killing of the trimeric gp140-expressing CHO cells. In
an NCG mouse model that was grafted with the
tumorigenic gp140-CHO cells and developed solid tis-
sue tumours intravenously injected 10E8-Exo targeted
the ENV-expressing tissues and delivered curcumin to
induce a strong suppression of the ENV+ tumour
growth with a low toxicity.
Results: Our results demonstrated that engineered exo-
somes can deliver anti-HIV agents to solid tissues by
specifically targeting cells expressing viral env and
induce cell killings.
Summary/Conclusion: It suggesting that such an
approach can be developed for eradicating virus-
infected cells in tissue reservoir.
Funding: This study was supported by The National
Key Research and Development Program of China
(2016YFC1201000), Nature Science Foundation of
Jiangsu Province (BY2015069-02) and National
Nature Science Foundation of China (81672020). The
funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the
manuscript.
OWP2.11=PS02.10
In vivo testing of OMV-based vaccine prototypes against
Gallibacterium anatis
Fabio Antenuccia, Homa Arakb, Jianyang Gaob, Toloe Allahghadryb, Ida
Thøfnerb and Anders Miki Bojesenc
aUniversity of Copenhagen, København S, Denmark; bUniversity of
Copenhagen, Copenhagen, Denmark; cUniversity of Copenhagen,
Copenhagen, USA
Introduction: Outer membrane vesicles (OMVs) are pro-
duced by the majority of Gram-negative bacteria. Thanks
to the antigenic similarity between OMVs and the bacter-
ial outer membrane, OMVs have proven to be promising
for the development of novel vaccines against bacterial
pathogens. In this work, we describe the testing of OMV-
based vaccine prototypes against Gallibacterium anatis, a
Gram-negative pathogen of great veterinary interest.
Methods: OMVs were isolated from a G. anatis hyper-
vesiculating mutant using a modified version of the
Hydrostatic Filtration protocol described by Musante
et al. (2014). 120 16-week-old Lohmann-Brown chick-
ens were divided in six groups and immunized twice
intramuscularly with different combinations of buffer
(controls), OMVs and selected recombinant immuno-
gens. Two weeks after second immunization, the effec-
tiveness of the immunization regimes adopted was
tested by challenging the animals intraperitoneally
with live CFUs from a heterologous G. anatis strain.
One week post-challenge, the animals were sacrificed
and an established lesion score model was used during
necropsy to evaluate the clinical outcome of infection.
Results: Statistical analysis of the recorded lesion
scores showed that the group immunized with G. ana-
tis OMVs presented an average total score of 2.95, as
opposed to an average total score of 8.77 in the control
group. The approximately three-fold reduction in total
average lesion score observed demonstrates that immu-
nization with G. anatis OMVs is able to effectively
decrease the morbidity of G. anatis infection in the
immunized animals.
Summary/Conclusion: Our results show that G. anatis
OMVs represent a promising candidate for the devel-
opment of cost-effective vaccination strategies for the
prevention of G. anatis infections in a cross-serovar
manner. Accordingly, we hypothesize that dose/
response optimization and the enrichment of G. anatis
OMVs with selected immunogens should result in an
improvement of the effectiveness of the vaccination
regime proposed.
Funding: This research project is being funded by a
grant from Huvepharma (https://www.huvepharma.
com/).
OWP2.12=PT05.04
Identification of a protein that presumably controls bacterial
vesiculation in response to the extracellular environments
Fumiaki Yokoyamaa, Jun Kawamotoa, Chen Chena, Tomoya Imaib and
Tatsuo Kuriharaa
aInstitute for Chemical Research, Kyoto University, Uji, Japan; bResearch
Institute for Sustainable Humanosphere, Kyoto University, Uji, Japan
Introduction: Many bacteria utilize extracellular mem-
brane vesicles (EMVs) for survival in their growing
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environments through communicationwith others, patho-
genesis, and biofilm formation. Therefore, the amounts
and the components of EMVs should be tuned in response
to the conditions. Although several vesiculation mechan-
isms are suggested, little is known how bacteria control
vesiculation in response to the environments. A bacterium
Shewanella sp. HM13 has nine fold higher lipid-secretion
capability in EMV fractions than Escherichia coli, and its
EMVs contain amajor protein (P49), which is not required
for vesicle production. We used mutant EMVs that lack
P49 to identify minor components of EMVs that may
control vesiculation.
Methods: EMVs were subjected to 2D gel-based pro-
teomics by peptide mass fingerprinting. Within the
identified proteins, the function of a sensor protein
homolog, HM1275, was analysed by swarming assay
and lipid-staining to quantify EMVs produced in var-
ious media. Changes in the number of EMVs depend-
ing on culture media were quantified by tunable
resistive pulse sensing method.
Results: A protein with a PAS domain and a methyl-
accepting chemotaxis protein (MCP) sensing domain,
HM1275, was identified in the EMVs. Although some
MCPs are related to flagellar motility by binding some
attractants, the flagellar motility of Delta-hm1275 was not
significantly different from that of WT. Although the
amounts of EMVs produced by WT were increased in
response to the concentration of casamino acids in poor
nutrient medium, those by Delta-hm1275 were not.
Summary/Conclusion: A putative sensor protein,
HM1275, was identified in EMVs and may recognize the
extracellular environments by binding signal molecules in
casamino acids to control vesiculation. Although further
studies are required to reveal the signals and the sensing
pathways, the results obtained in this study indicate that
bacterial vesiculation is controlled by extracellular envir-
onments, and artificial control of vesiculation with extra-
cellular signals would be useful in applications such as
suppression of vesicle-dependent pathogenicity.
Funding: Japan Society for Promotion of Science
Research Fellowship for Young Scientists
OWP2.13=PT05.05
Prokaryotic BAR domain-like protein BdpA promotes outer
membrane extensions
Daniel A. Phillipsa, Lori Zacharoffb, Cheri Hamptonc, Grace Chongb, Brian
Eddied, Anthony Malanoskid, Shuai Xub, Lauren Ann Metskase, Lina Birdf,
Grant Jensene, Lawrence Drummyc, Moh El-Naggarb and Sarah Glavend
aAmerican Society for Engineering Education – U.S. Naval Research
Laboratory, Washington, USA; bUniversity of Southern California, Los
Angeles, USA; cMaterials and Manufacturing Directorate, Air Force
Research Laboratory, Dayton, USA; dU.S. Naval Research Laboratory,
Washington, USA; eCalifornia Institute of Technology, Pasadena, USA;
fNational Research Council, Washington, USA
Introduction: Bin/Amphiphysin/RVS (BAR) domains
belong to a superfamily of membrane-associated
coiled-coil proteins that influence membrane curva-
ture. BAR domains are ubiquitous in eukaryotes and
associated with membrane curvature formation, vesicle
biogenesis/trafficking, protein scaffolding and intracel-
lular signalling. While advances in protein domain
prediction have facilitated the identification of several
BAR domain proteins, they have yet to be characterized
in bacteria. Here we identified a putative BAR domain-
containing protein enriched in the outer membrane
vesicles (OMVs) of Shewanella oneidensis MR-1, a dis-
similatory metal-reducing bacteria known to produce
outer membrane extensions (OMEs) that are suspected
to facilitate long distance extracellular electron transfer
(EET) but whose physiological relevance and mechan-
ism of formation remain unknown.
Methods: Purified S. oneidensis OMVs were prepared by
filtration and ultracentrifugation for comparative proteo-
mics with cell-associated outer membrane proteins or for
electrochemical measurements. Protein domains were pre-
dicted using HMMSCAN and CDD-search. OME forma-
tion and phenotype analyses were performed in situ by
confocal and cryo-electron microscopy.
Results: The putative BAR domain-like protein BdpA
was highly enriched in OMVs compared to cell-asso-
ciated outer membranes. During OME biogenesis, WT
S. oneidensis OMEs progress from elongated vesicle
chains to narrow, tubule-like extensions while ΔbdpA
OMEs remain as disordered vesicle chains. Purified
OMVs from these strains are electrochemically active,
with redox signals consistent with multiheme outer
membrane cytochromes, supporting the role of OMEs
in EET. Heterologous BdpA expression promotes OME
formation in Marinobacter atlanticus and Escherichia
coli, suggesting BdpA membrane sculpting activity is
inducible and transferrable.
Summary/Conclusion: The ability of BdpA to promote
OME formation and maturation into tubules in vivo
supports BdpA as a comparator for BAR domain pro-
tein activity in bacteria.
Funding: US DoD Synthetic Biology for Military
Environments (SBME) Applied Research for the
Advancement of Science and Technology Priorities
(ARAP)
NSF Dimensions: DEB-1542527
US DOE: DE-FG02-13ER16415
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Isolation of extracellular vesicles from extracellular matrix based
hydrogel 3D cell cultures
Jens Luotoa, Lea Sistonenb and Eva Henrikssonb
aCell Biology, Biosciences, Faculty of Science and Engineering, Åbo Akademi
University, Turku, Finland; bTurku Centre for Biotechnology, University of
Turku and Åbo Akademi University, Turku, Finland
Introduction: Cancer-derived extracellular vesicles
(EVs) are commonly studied and isolated from two-
dimensional (2D) cell cultures. Nevertheless, three-
dimensional (3D) culture systems with extracellular
matrix (ECM) provide physiologically more relevant
system to mimic in vivo tumour growth and progres-
sion of invasion. However, there are currently no
methods to efficiently isolate EVs from ECM-based
3D cultures. For that purpose, we established a pro-
tocol for isolating EVs from cancer cells growing in a
3D ECM-based hydrogel.
Methods: Human prostate cancer PC3 cells were
grown in 3D to form spheroids in a commercially
available ECM-based hydrogel and the growth media
was collected every two days for a period of 14 days,
during which the spheroids grew invasive. The
respective media were differentially centrifuged at
2, 10 and 100 Kg and the pellets were resuspended
in PBS. The EVs were analysed by western blotting
(WB) against the common EV markers CD81, CD63
and CD9.
Results: Our preliminary data shows a step-wise
increase of the EV markers in the media as the PC3
spheroids formed, expanded and invaded to the sur-
rounding 3D ECM. The EVs produced by non-inva-
sive or invasive spheroids are currently being
characterized with nano tracking analysis, electron
microscopy and WB.
Summary/Conclusion: This study demonstrates that
EVs can be isolated from 3D ECM-based hydrogel
cell cultures, which recapitulate the tissue architecture
of solid tumours. Our results suggest that 3D cancer
cell cultures have dynamic EV secretion determined by
the phenotype of the spheroids. Taken together, we
present a novel protocol for EV isolation from a 3D
culture system and provide a platform to investigate
EVs from in vivo mimicking conditions.
Funding: This project is funded by Magnus Ehrnrooth
Foundation, K. Albin Johansson Foundation and Åbo
Akademi University.
OWP2.15=PT07.07
Diagnostic microRNA biomarkers from circulating extracellular vesicles
for early detection of pneumonia and severe secondary complications
Stefanie Hermanna, Benedikt Kirchnera, Dominik Buschmannb, Melanie
Märtec, Florian Brandesc, Stefan Kotschoted, Michael Bonine, Marlene
Reithmairf, Matthias Kleing, Gustav Schellingc and Michael Pfafflh
aDivision of Animal Physiology and Immunology, School of Life Sciences
Weihenstephan, Technical University of Munich, Germany; bTUM School of
Life Sciences Weihenstephan, Division of Animal Physiology and
Immunology, Freising, Germany; cDepartment of Anesthesiology,
University Hospital, Ludwig-Maximilians-University Munich, München,
Germany; dIMGM Laboratories GmbH, Planegg, Germany; eIMGM
Laboratories GmbH, Planegg, Germany, Martinsried, USA; fInstitute of
Human Genetics, University Hospital, Ludwig-Maximilians-University
Munich, München, Germany; gDepartment of Neurology, University
Hospital, Ludwig-Maximilians-University Munich, München, Germany;
hAnimal Physiology and Immunology, School of Life Sciences
Weihenstephan, Technical University of Munich, Freising, Germany
Introduction: Pneumonia remains one of the most
deadly communicable diseases, causing three million
deaths worldwide in 2016. Extracellular vesicles (EVs)
are pivotal during signal transfer in the pathogenesis of
inflammatory lung diseases. Since identifying pneumo-
nia is particularly challenging in high risk groups (e.g.
the elderly or infants), which often present with atypi-
cal symptoms and are at high risk for secondary com-
plications such as sepsis or acute respiratory distress
syndrom (ARDS), new approaches for early diagnosis
are required. In this study we identified EV
microRNAs (miRNAs) as potential biomarkers for
inflammatory changes of the pulmonary tissue.
Methods: Our study included 13 patients with com-
munity-acquired pneumonia, 14 ARDS patients, 22
patients with sepsis and 31 healthy controls. After pre-
cipitating EVs from 1 mL serum, total RNA was
extracted. Subsequent to library preparation and small
RNA-Seq, differential gene expression analysis was per-
formed using DESeq2. Data were filtered by mean
miRNA expression of ≥50 reads, minimum twofold
up or down regulation and adjusted p-value ≤0.05.
Results: The mean relative miRNA frequency varied
slightly between the different groups and was highest in
volunteers. Short sequences (<16 nucleotides), prob-
ably degradation products from longer coding and
non-coding RNA species, were predominantly detected
in patients. Based on unsupervised clustering, patients
could be distinctly separated from healthy individuals.
Although 21 miRNAs were significantly regulated in all
patient groups compared to healthy controls, different
disorders showed unique miRNA expression profiles.
Distinct miRNA subsets were identified, which are
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applicable to indicate disease progression from limited
inflammation present in pneumonia to severe inflam-
matory changes as seen in ARDS and sepsis.
Summary/Conclusion: This study shows that EV
miRNA biomarkers have potential for diagnosis of
pneumonia and to indicate disease progression
towards severe lung injury. Our findings are of clin-
ical relevance, as the timely diagnosis of pneumonia
can be challenging, and secondary complications
such as ARDS and sepsis might be prevented by
early intervention and treatment.
Funding: This study was supported by the German
Federal Ministry for Economic Affairs and Energy
under the programme “Zentrales Innovationsprogramm
Mittelstand”.
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OWP3.01=LBT02.02
Using plasma to identify neural biomarker for antidepressant
response in a treatment resistant cohort
Corina Nagya, Saumeh Saeedib, Jean-Francois Therouxc, Marina Wakidc,
Naguib Mechawarc and Gustavo Tureckib
aDHRC- McGill University, Verdun, Canada; bMcGill University, Verdun,
Canada; cMcGill University, Verdun, Canada
Introduction: Small extracellular vesicles (SEV) have
emerged as candidate biomarkers in many complex
diseases. An important characteristic of SEVs is their
ability to bidirectionally cross the blood-brain barrier.
This is particularly important in the context of major
depressive disorder (MDD), where biomarkers are
obtained from peripheral tissue and have been hard
to relate to changes in brain functioning. 60% of
MDD patients do not respond to their first antidepres-
sant drug therapy (ADT) and treatment options are
entirely at the discretion of the physician. Findings
that can predict ADT response as well as provide
insight into central mechanistic changes could revolu-
tionize MDD treatment. The aim of this study is to
profile exosomal microRNA (miRNA) in the context of
ADT response in people with treatment-resistant
depression. miRNA can act as biomarkers and might
influence recipient cells to provide insight on disease-
relevant mechanistic changes.
Methods: This pilot uses plasma from 10 controls and
10 patients with MDD (5 ADT responders (RES), and 5
non-responders (NRES)) from baseline (T0, before
treatment). SEVs were isolated using a size exclusion
column from Izon Science (Christchurch, New
Zealand). Each isolation was divided into a “whole
exosome” fraction and an immunoprecipitated
“(NDE)” fraction using neural marker L1CAM.
Quantitation and size determination was done using
Tunable Resistive Pulse Sensing (TRPS) on the qNano
gold. RNA was also extracted from SEVs from both
fractions. The 4N-small RNA-Seq (Galas) protocol was
used for library preparation.
Results: We found that the range of SEVs in the NDE
fraction was smaller than the pool of all exosomes
combined. Further, SEVs from all depressed patients
were significantly smaller than controls irrespective of
the fractions. Our sequencing results showed an
increase of miR-151a-3p and miR-3168 in NRES, and
miR-22-3p in RES. These results were specific to the
NDE fraction.
Summary/conclusion: We have identified three poten-
tial biomarkers for ADT response which are uniquely
present in the neural-derived fraction of peripheral
SEVs.
Funding: Canadian Institutes of Health Research
OWP3.02=PT09.13
Immunocapturing of tumour-derived extracellular vesicles on
micropatterned and antibody-conjugated surfaces for individual
correlative light, probe and electron measurements
Pepijn Beekmana, Agustin Enciso-Martinezb, Cees Ottob and Séverine Le
Gacc
aWageningen University, Wageningen, Netherlands; bMedical Cell
Biophysics, University of Twente, Enschede, Netherlands; cApplied
Microfluidics for BioEngineering Research, University of Twente, The
Netherlands, Enschede, Netherlands
Introduction: Tumor-derived extracellular vesicules
(tdEVs) are promising biomarkers for cancer patient
management. The screening of blood samples for
tdEVs shows prognostic power comparable to screen-
ing of tumour cells. However, due to the overlap in size
between tdEVs, non-cancer EVs, lipoproteins and cell
debris, new approaches, not only based on size, are
required for the reliable isolation of tdEVs and their
quantification. We report an integrated analysis meth-
odology to study single tdEVs using correlative data
from scanning electron microscopy (SEM), Raman
imaging and atomic force microscopy (AFM) to obtain
a comprehensive dataset allowing identifying features
unique to tdEVs.
Methods: Indium tin oxide (ITO)-coated fused silica
was selected for its low Raman background. Substrates
(1 × 1 cm2) featuring position-dependent markings
(“navigation marks”) patterned by photolithography
were modified with a monolayer of amino dodecyl
phosphonic acid. The amine moieties were next reacted
with poly(ethylene glycol) diglycidyl ether, forming an
anti-biofouling layer. Anti-EpCAM antibodies were
subsequently covalently bound on this surface.
Samples of both tdEVs obtained from LNCaP cell
lines and RBC-derived EVs were then introduced to
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the surfaces. Finally, non-specifically bound EVs were
washed away before SEM, AFM and Raman measure-
ments were performed.
Results: Multiple objects were captured on the fully
functionalized ITO surfaces, according to SEM ima-
ging, while in negative control experiments (lacking
functionalization or lacking antibody or using
EpCAM-negative EVs), no object was detected.
Principal component analysis of their Raman spectra,
previously demonstrated to be able to distinguish
tdEVs from RBC-derived EVs, revealed the presence
of characteristic lipid bands (e.g. 2851 cm−1) in the
captured tdEVs. AFM showed a surface coverage of
∽4 × 105 EVs per mm2 with a size distribution similar
to that found by NTA.
Summary/Conclusion: A platform was developed for
multi-modal analysis of selectively isolated tdEVs for
their multimodal analysis. In the future, the scope of
this platform will be extended to other combinations of
probe, light and electron microscopy techniques to
relate additional parameters describing the cap-
tured EVs.
Funding: Funded by NWO Perspectief.
OWP3.03=PT09.14
The development of a scalable extracellular vesicle subset
characterization pipeline
Joshua Welsha, Julia Kepleyb and Jennifer C. Jonesa
aTranslational Nanobiology Section, Laboratory of Pathology, National
Cancer Institute, National Institutes of Health, Bethesda, USA;
bTranslational Nanobiology Lab, Laboratory of Pathology, National Cancer
Institute, National Institutes of Health, Bethesda, USA
Introduction: Liquid biopsies offer an important alter-
native to tumour biopsies that may be limited by the
challenges of invasive procedures. We hypothesize that
circulating Extracellular Vesicles (EVs) and their cargo
may provide a useful surrogate biopsy method. Due to
their small diameter (30–1000 nm), EVs migrate from
the tissue into the peripheral circulation and provide a
snapshot of the producing cells. Our lab has developed
a first-in-class pipeline to use single cell – omics meth-
ods to characterize EV heterogeneity with high-sensi-
tivity by combining multiplex assays and our custom
MultiPlex Analysis post-acquisition analysis software
(MPAPASS), with subsequent high-resolution, single
EV flow cytometric (FCM) methods.
Methods: A stan-dalone software package was devel-
oped in MATLAB to allow importation of multiplex
flow cytometry output data. The package enables data
quality screening of detection antibodies, bead recovery
and data normalization methods. The software is
equipped to handle large data sets comprising hun-
dreds/thousands of phenotypes and samples. Data can
be visualized in a variety of ways along with clustering
using multidimensional data analysis techniques. All
software outputs can be exported in a standardized
templates containing metadata for reporting, as well
as uploaded into atlases such as Genboree, where mul-
tiplex data can be stratified by RNAseq datasets.
Analysis using this pipeline has been conducted using
human samples from a variety of mediums including
CSF, serum and plasma comparing EV phenotypes.
Results: Our multiplex approach and MPAPASS soft-
ware allows the use of single cell -omics tools for EV
subset analysis in a manner that will elucidate the
biological significance and function of different types
of EVs. This high-throughput pipeline evaluates hun-
dreds of EV protein profiles and will allow evaluation
of millions of RNA:protein profiles in an unprece-
dented manner. Integration of RNA sequencing with
protein characterization could provide an entirely new
way of understanding EV regulation and function.
Summary/Conclusion: Our data show this form of EV
profiling provides a way to monitor clinical responses
early in the course of treatment, which may ultimately
improve patient care and outcomes.
OWP3.04=PS04.13
An integrated microfluidic device for selective exosome isolation
from human plasma
Hogyeong Gwaka, Junmoo Kimb, Leila Kashefi-Kheyrabadib, Seung-Il Kimb,
Kyung-A Hyunb and Hyo-Il Jungb
aSchool of Mechanical Engineering, Yonsei University, Seoul, Republic of
Korea; bYonsei University, Seoul, Republic of Korea
Introduction: Extracellular vesicles released by many
cell types circulate in blood vessel and play a key role in
intercellular communication. Exosomes are 30–150 nm
membrane vesicles and are also shed by both normal
and cancer cells. Cancer cells are known as very het-
erogeneous, so exosomes are also heterogeneous and
have different surface expression markers. Cancer-
derived exosomes contain unique cargo determined
by the molecular characteristics of cancer cells.
Therefore, it is very important to selectively separate
exosomes depending on surface expression for down-
stream analysis. We designed an integrated microflui-
dic chip for selective exosome isolation. The
microfluidic chip consists of Hoof Structure (HS) for
mixing exosomes and two different sized aptamer-
coated particles and Multi-Orifice Flow Fractionation
(MOFF) for separating each particle.
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Methods: Biotinylated EpCAM aptamer was immobi-
lized on the surface of 7 μm streptavidin-coated poly-
styrene particle and HER2 on 15 μm. The HS has the
circular expansion channel on the 1st layer to generate
expansion vortices and the two curvature channels on
the 2nd layer to make chaotic advection. It makes
transverse flow and mixes two particles without parti-
cle focusing phenomenon. The 100-nm (exosome), 7-
and 15-μm fluorescence particles were used to test
mixing performance between exosomes and particles
in the HS. The MOFF was designed by a series of
contraction/expansion microchannels for continuous
size-based separation. Separation performance was
tested by using the 7- and 15-μm fluorescence micro-
particles in the MOFF.
Results: The mixing efficiency was the highest at the
flow rate 150 μL/min. Each exosome was continuously
captured by aptamer-conjugated particle in the HS
channel. The capture efficiency of EpCAM positive
exosome was 96.9% and HER 2 was 68.09%. Two
particles were separated in the integrated microfluidic
device at the same flow rate. Also, 96.26% of 15-μm
microparticles were positioned into the centre of the
channel and 89.48% of 7 μm microparticles were sepa-
rated on both sides of the channel.
Summary/Conclusion: Each exosome was continu-
ously captured by mixing aptamer-conjugated particle
in the HS. Exosome-conjugated microparticles were
successfully separated by inertial force in MOFF. This
analysis of each exosome will shed light on diagnosis
and therapy of cancers.
OWP3.05= PF10.11
Aqueous two-phase system to isolate extracellular vesicles for
prostate cancer diagnosis
Hyunwoo Shina, Jiyoon Kima, Mee Young Kimb, Yong Hyun Parkb, Yong
Goo Kimc, Ji Youl Leeb and Jaesung Parkd
aPOSTECH, Pohang, Republic of Korea; bDepartment of Urology, Seoul St.
Mary’s Hospital, The Catholic University of Korea, Seoul, Republic of Korea;
cDepartment of Laboratory Medicine, Mary’s Hospital, The Catholic
University of Korea, Seoul, Republic of Korea, Seoul; dDepartment of
Mechanical Engineering, POSTECH, Pohang, Republic of Korea
Introduction: Analysing extracellular vesicles (EVs) is
an attractive means in prostate cancer diagnosis.
However, existing methods of EVs isolation have low
efficiency, purity and long process time, which induce
low diagnostic ability. To approach the problems, we
adapt a two-phase system to diagnose prostate cancer
by isolating EVs from patients’ urine. Using the two-
phase system, prostate hyperplasia (BPH) patients and
prostate cancer (PCA) patients were diagnosed, and the
diagnostic ability was compared with conventional
diagnostic methods.
Methods: Forty-two prostate cancer (PCA) patients
and 20 benign prostate hyperplasia (BPH) patients’
urine, plasma, saliva was collected and used for iden-
tifying EVs isolation ability of aqueous two-phase
system (ATPS) and for comparing diagnostic ability
of ATPS with conventional diagnosis.
Results: With an optimized ATPS, EVs were isolated with
an efficiency of approximately 90%. In addition, the EV-
isolation time was within approximately 30 min, and the
purity of EVs in ATPS was approximately two times better
than achieved with a conventional methods, ultracentrifu-
gation and polymeric precipitation. After the ATPS iso-
lated EVs from patients’ body fluid, PCR and ELISA were
utilized to detect EVs derived from prostate cancer cells.
The expression levels of RNA and protein markers of
prostate cancer were compared, and the relationship
between expression levels and clinical data was analysed.
The results demonstrated that diagnostic ability based on
ATPS was better than other conventional methods (serum
PSA and sediments). Moreover, sensitivity increased by at
least 10%, and specificity was improved by at least 20%
compared to conventional methods.
Summary/Conclusion: High quality and quantity of
EVs can be obtained from patients’ body fluid using
ATPS. Using the abundant sources, which contains
cancer-related protein and genes, we can perform a
diagnosis with high specificity and sensitivity.
Therefore, ATPS offers a powerful tool for more spe-
cific and sensitive diagnosis.
OWP3.06=PS05.11
In vitro and in vivo investigation of extracellular vesicles (EVs) as
biomarker carriers in the diagnosis of early Alzheimer’s disease
Soraya Moradi-Bachillera, Miriam Cianib, Roberta Zanardinib, Luisa Benussib,
Roberta Ghidonib, J. Mark Cooperc, Gianluigi Forlonia and Diego Albania
aDepartment of Neurosciences, Mario Negri Institute for Pharmacological
Research IRCCS, Milan, Italy; bMolecular Markers Laboratory, IRCCS
Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy;
cDepartment of Clinical Neurosciences, Faculty of Brain Sciences,
University College London – Institute of Neurology, London, UK
Introduction: Extracellular vesicles (EVs) represent an
ideal source of biomarkers due to their role in cellular
communication and their ability to carry protein aggre-
gates. The most investigated EVs are exosomes, active
entities secreted from cells and able to cross the blood
brain barrier. Several neurodegeneration-involved
molecules may undergo intercellular spreading through
exosome release. In Alzheimer’s disease (AD), before
clinical signs appear, several proteins implicated in
exo- and endocytic pathways are altered. In this
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scenario, the identification of a correlation between
variations in proteins carried by EVs and the progres-
sion of AD is the main aim of our project.
Methods: We performed exosome isolation and character-
ization from H4-SW glioma cells (a cell model featuring
mutated β-amyloid overexpression), as well as in mouse-
(triple-transgenic mouse model for familial AD) and
human-plasma samples (Mild Cognitive Impairment
(MCI) and AD subjects). In every case, a differential cen-
trifugation protocol was applied and exosomes were then
characterized using Nanoparticle Tracking Analysis with
the NanoSight. We then explored exosome content, speci-
fically Amyloid Precursor Protein (APP) and its proteolytic
fragments, Microtubule Associated Protein Tau (tau),
Progranulin (PGRN protein), Soluble Triggering
Receptor Expressed on Myeloid Cells 2 (sTREM2) and α-
synuclein (α-syn), usingWestern blot and ELISA. L1CAM
and CD63 were evaluated to define the neural-derived
exosomes amount in human samples.
All the samples were collected after ethical committee
approval respecting Helsinki’s declaration. Informed
consents were provided by all the subjects.
Results: Our preliminary results show that APP, PGRN
and sTREM2 are carried by H4- and human plasma-
derived EVs. H4-SW cell-culture medium and 3Tg
mouse plasma had a decrease in the EVs number
release (≈1*10e8 EVs/mL) in comparison to control
(≈7*10e8 EVs/mL). This decrease was not found in
human plasma samples.
Summary/Conclusion: EVs purified from H4-glioma
cellular AD model, 3xTg mouse-, MCI- and AD-
plasma samples carry proteins relevant for neurodegen-
erative diseases (NDs). EVs release is reduced in cellu-
lar and animal AD-models.
Funding: Horizon 2020 Marie Sklodowska-Curie
Innovative Training Networks – Blood Biomarker-based
Diagnostic Tools for Early Stage Alzheimer’s Disease.
OWP3.07=PF12.07
Shed microvesicles released from human primary and metastatic
colorectal cancer cell lines contain key cancer progression proteins
and RNA species
Wittaya Suwakulsiria, Alin Raia, Rong Xua, Maoshan Chena, David Greeningb
and Richard Simpsona
aDepartment of Biochemistry and Genetics, La Trobe Institute for Molecular
Science, La Trobe University, Melbourne, Australia, Melbourne, Australia;
bDepartment of Biochemistry and Genetics, La Trobe Institute for Molecular
Science, La Trobe University, Melbourne, Australia
Introduction: Extracellular vesicles (EVs) function in
bidirectional cell–cell communication and contribute to
the sustained growth, invasion and metastasis of cancer
cells within the tumour microenvironment (TME). EVs
comprise two main classes – exosomes and shed micro-
vesicles (sMVs, also termed microparticles and ectosomes)
– with distinct modes of biogenesis. Within each EV class,
subtypes exist that can be distinguished by their distinct
protein/ RNA signatures. Whilst much is known about
exosome cargo content and functionality, sMVs are poorly
understood.
Methods: Here, we compare protein/ RNA profiles and
functionality of sMVs and exosomes secreted from
human primary (SW480) and metastatic (SW620) col-
orectal cancer cell lines. Milligram amounts of EVs
were purified from cell culture media using a combina-
tion of differential ultracentrifugation/ isopycnic iodix-
anol density centrifugation. Label-free quantitative
mass spectrometry was performed to obtain protein
profiles for SW480-derived and SW620-derived sMVs.
Results: We show that sMVs, unlike exosomes, are ALIX-,
TSG101-, CD63- and CD9- and contain a different suite of
key cancer progression modulators. Protein/ RNA signa-
tures for SW480-derived sMVs and exosomes differ from
each other and also from their SW620-derived counter-
parts. SW480-derived sMVs are enriched in ITGA/B,
ANXA1, CLDN7, CD44 and EGFR/NOTCH signalling
networks, while SW620-derived sMVs are enriched in
PRKCA, MACC1, FGFR4 and MTOR/MARCKS signal-
ling networks. Fibroblast invasion capabilities of SW480-
derived and SW620-derived sMVs are comparable.
Summary/Conclusion: Furthermore, we report for the
first time a comprehensive biochemical/ functional analy-
sis of a hitherto undescribed subpopulation of sMVs. We
anticipate our in vitro findings will be a starting point for
more sophisticated studies aimed at elucidating the bio-
chemical and functional properties of EV subtypes in vivo.
The emerging roles of specific EV subtypes in the TME we
believe will alter our view of cancer biology and might
present new targets for therapeutic intervention.
Funding: Funding support from La Trobe University,
Melbourne, Australia.
OWP3.08=PF12.08
Mass spectrometry analysis of small extracellular vesicles isolated
from ovarian cancer ascites
Anna Kotrbováa, Kristina Gomoryovaa, David Potesilb, Vit Weinbergerc, Igor
Crhac, Eva Jandakovad, Lubos Minarc, Zbynek Zdrahalb, Vítězslav Bryjaa and
Vendula Pospíchalovaa
aDepartment of Experimental Biology, Faculty of Science, Masaryk
University, Brno, Czech Republic; bCore Facility Proteomics, Central
European Institute of Technology, Masaryk University, Brno, Czech
Republic; cDepartment of Obstetrics and Gynecology, Faculty Hospital
Brno, Brno, Czech Republic; dDepartment of Pathology, University Hospital
Brno, Brno, Czech Republic
Introduction: High-grade serous carcinoma of the ovaries,
fallopian tube and peritoneum (HGSC) is the deadliest
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gynaecological malignancy with 5-year survival rate below
30%. HGSC is frequently accompanied by ascites, a patho-
logical accumulation of fluid in the peritoneum, which can
be exploited as a liquid biopsy containing not only cancer
cells, but also the tumour microenvironment including
extracellular vesicles (EVs). Tumour cells produce substan-
tially more EVs than healthy cells, thus malignant ascites is
the source of enriched pool of EVs of HGSC origin.
Methods: Ascitic fluids depleted of cells were fractioned
using size-exclusion chromatography and two fractions –
containing and not containing EVs – were further ana-
lysed. In parallel, small EVs were also isolated from ascitic
fluids using differential ultracentrifugation followed by
purification step in sucrose/D2O cushion. In total, 24
malignant ascites and 5 non-malignant ascites were used
for EV isolation and further analysed using high-resolution
hybrid mass spectrometer Orbitrap Fusion Lumos Tribrid.
The subsequent data visualization and statistical analyses
were performed using in-house-developed pipelines in
KNIME environment.
Results: We identified 2441 proteins, in total, in the EVs
from the ascites among which 21 were present in all 29 EV
samples and not in non-vesicular fractions. Several of these
proteins were specifically enriched in small EVs in malig-
nant ascites in comparison with non-malignant ascites.
These proteins are now being evaluated as biomarkers.
Summary/Conclusion: Using advanced mass spectro-
metry, we identified candidate proteins which are spe-
cifically enriched in small EVs of HGSC. These
proteins warrant further investigation as they may act
as important players in HGSC progression as well as
serve as potential prognostic/diagnostic/screening bio-
markers of HGSC.
Funding: Czech Science Foundation, Grant No. GJ17-
11776Y.
OWP3.09=PT09.12
Identification of single tumour-derived extracellular vesicles by
means of optical tweezers and Raman spectroscopy
Agustin Enciso-Martineza, Edwin van der Polb, Aufried Lenferinkc, Leon
Terstappena and Cees Ottoa
aMedical Cell Biophysics, University of Twente, Enschede, Netherlands;
bAmsterdam UMC, University of Amsterdam, Department of Biomedical
Engineering and Physics, Amsterdam, Netherlands, Amsterdam,
Netherlands; cUniversity of Twente, Enschede, Netherlands
Introduction: EVs derived from cancer cells play a role
in tumour cell proliferation, migration, invasion and
metastasis. Their presence in body fluids, such as
blood, makes them potential biomarkers for cancer
disease. However, the identification of single tdEVs
can be challenging due to their heterogeneity, their
ultra-small size, their size overlap with many other
normal EVs and contaminants in body fluids and the
lack of knowledge on their chemical composition.
Methods: Synchronized optical tweezers and Raman
spectroscopy have enabled a study of individual EVs.
The new method detects individual trapping events
from Rayleigh scattering. The synchronous recording
of Raman scattering enabled the acquisition of Raman
spectra of both individual and multiple EVs, disclosing
their chemical composition. Furthermore, Mie light
scattering theory has been used to relate the Rayleigh
scattering intensity to the size of trapped EVs.
Results: The light scattered of trapped EVs gave rise to
step-wise time traces that can be used to distinguish
individual trapping events from accumulative cluster
events due to the discrete nature of the steps which
correspond to single trapping events. Next, we con-
firmed the trapping of individual EVs derived from
PC3 cells, red blood cells, platelets and blood plasma
by acquiring both, Rayleigh and Raman scattering sig-
nals. While the step-wise trend in the Rayleigh scatter-
ing signal suggests trapping of single particles, the
Raman scattering signal demonstrates the nature of
the trapped EVs. Through principal component analy-
sis (PCA), the main spectral variations among the four
EV types were identified. The principal component
scores grouped the PC3-derived EVs in a separate
cluster from the rest of the EVs.
Summary/conclusion: We have developed an auto-
mated single particle optical tweezers – Raman and
Rayleigh scattering setup to trap and release single
EVs over time. We demonstrated single-EV trapping
by simultaneous acquisition of Rayleigh and Raman
scattering. PCA enabled the identification of single-
EVs derived from the cancer cell line PC3. This dis-
closes chemical information as a step towards the
identification and characterization of single tumour-
derived EVs in blood.
Funding: Cancer ID – project number 14193, (par-
tially) financed by the Netherlands Organisation for
Scientific Research (NWO)
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Extracellular vesicles provide a capsid-free vector for oncolytic
adenoviral DNA delivery
Heikki Saaria, Tiia Turunenb, Mikko Turunenb, Matti Jalasvuoric, Sarah
Butcherd, Seppo Ylä-Herttualab, Tapani Viitalaa, Vincenzo Cerulloa, Pia
Siljandere and Marjo Yliperttulaa
aDivision of Pharmaceutical Biosciences and Drug Research Program, Faculty
of Pharmacy, University of Helsinki, Helsinki, Finland; bA.I.Virtanen
Institute for Molecular Sciences, University of Eastern Finland, Kuopio,
Finland; cDepartment of Biological and Environmental Science,
Nanoscience Center, University of Jyväskylä, Jyväskylä, Finland; dFaculty of
Biological and Environmental Sciences, Molecular and Integrative Bioscience
Research Programme, and Helsinki Institute of Life Sciences, Institute of
Biotechnology, University of Helsinki, Helsinki, Finland; eEV-group,
Molecular and Integrative Biosciences Research Programme, Faculty of
Biological and Environmental Sciences, University of Helsinki, Helsinki,
Finland
Introduction: Extracellular vesicles (EVs) have been
showcased as auspicious candidates for delivering ther-
apeutic cargo, including oncolytic viruses for cancer
treatment. Delivery of oncolytic viruses in EVs could
provide considerable advantages, hiding the viruses
from the immune system and providing alternative
entry pathways into cancer cells. Here we describe the
secretion and viral cargo of EVs secreted by cancer cells
infected with an oncolytic adenovirus (IEVs, infected
cell-derived EVs) as a function of time after infection.
Methods: IEV-containing cell culture medium was col-
lected from A549 and PC-3 cancer cell cultures every
24 h after being infected with an oncolytic adenovirus
and IEVs were isolated by iodixanol density gradient
centrifugation. IEVs were then characterized by cryo-
TEM, NTA, immunoblotting and qPCR for structural
properties and viral components and their infectivity
was confirmed by cytotoxicity assay and TEM of IEV-
treated cells.
Results: IEVs were secreted already before the lytic
release of virions and their structure resembled nor-
mally secreted EVs, suggesting that they were not just
apoptotic fragments of infected cells. IEVs were able to
carry the viral genome and induce infection in other
cancer cells. The amount of viral cargo associated with
IEVs increased as the infection progressed, although no
intact virions were observed in any of the IEVs visua-
lized by cryo-TEM. The amount of viral cargo also
appeared to be density-dependent, in that heavier
IEVs contained more viral DNA and protein per
vesicle.
Summary/Conclusion: Given that adenovirus is a
DNA-virus that is assembled in the nucleus and
released via induced lytic cell death, the generation of
infective EVs as prescribed here suggests that part of
the produced viral DNA is secreted via IEVs before cell
lysis. As such, the role of EVs in the life cycle of
adenoviruses may be an important part of the success-
ful infection and may also be harnessed for cancer- and
gene-therapy as vectors of viral DNA invisible to the
immune system.
OT05.02
Bacterial growth stage regulates the size, composition and biological
functions of membrane vesicles
Lauren Zavana, Natalie Bittoa, Ella Johnstona, David Greeningb and Maria
Kaparakis-Liaskosa
aDepartment of Physiology, Anatomy and Microbiology, La Trobe
University, Melbourne, Australia; bDepartment of Biochemistry and
Genetics, La Trobe Institute for Molecular Science, La Trobe University,
Melbourne, Australia
Introduction: Outer membrane vesicles (OMVs) are
naturally released by all Gram-negative bacteria as
part of their normal growth and contain many of the
components found in their parent bacterium, including
DNA, RNA and proteins. To date, few studies have
compared the proteome of OMVs to that of their
parent bacterium and examined how it changes
throughout bacterial growth. In this study, we aimed
to elucidate the contribution of bacterial growth stage
on the size, composition and biological functions of
Helicobacter pylori OMVs.
Methods: OMVs were purified from H. pylori cultures
grown to early log, mid log or stationary phase of
bacterial growth, and their size and protein composi-
tion were analysed using NTA and proteomics, respec-
tively. The ability of OMVs isolated from various
growth stages to stimulate an inflammatory response
in human epithelial cells was determined by ELISA.
Results: We found that OMVs became less heteroge-
neous in size throughout bacterial growth. We showed
that the proteome of OMVs was vastly different to that
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of their parent bacterium from each time point, sug-
gesting that there is preferential cargo packaging of
bacterial proteins into OMVs. Gene ontology and
enrichment analyses identified that bacterial growth
stage regulated the type of proteins packaged into
OMVs, as early log and stationary phase OMVs were
enriched in proteins required for metabolic pathways,
whereas late log phase OMVs contained proteins con-
tributing to cell signalling. Finally, we identified that
bacterial growth stage affected the inflammatory
response mediated by OMVs in host epithelial cells,
highlighting that bacterial growth stage regulates the
subsequent biological functions of OMVs.
Summary/Conclusion: Our findings identify that bac-
terial growth stage regulates the size, protein cargo
composition and biological functions of H. pylori
OMVs, and that therefore OMVs from various growth
stages are not comparable. Collectively, these findings
emphasise the importance of considering bacterial
growth stage from which OMVs are isolated from, as
this will ultimately affect their protein content and
biological functions. We are currently determining
whether bacterial growth stage also regulates the com-
position and functions of Gram-positive bacterial
membrane vesicles.
Funding: Australian Research Council.
OT05.03
Can exosomes be used to predict where patients are on the
tuberculosis disease spectrum?
Nicole Kruh-Garcia, Gustavo Diaz, Cristian Oliva Aviles and Karen Dobos
Colorado State University, Fort Collins, USA
Introduction: Mycobacterium tuberculosis (Mtb), the
causative agent of the disease tuberculosis (TB), is a
highly successful human pathogen. Mtb has the ability
to survive within the host macrophage. In response to
the challenges of the intracellular environment, the
bacteria secretes a dynamic subset of proteins reflective
of its metabolic state, some of which are entrapped in
exosomes and released from the host cell. Our ultimate
goal is to improve upon the current diagnostics to
facilitate early and rapid diagnosis of active disease,
which is a key to timely drug invention and further
spread of the disease. Using serum exosomes, we aimed
to determine if a proteomic fingerprint can be used to
discriminate between individuals with TB from non-
TB, as well as to classify TB suspects – individuals with
pulmonary symptoms but without detectible mycobac-
teria in their sputum.
Methods: Hyper Reaction Monitoring Mass Spectrometry
(HRM-MS) was applied to a sample set of serum exosomes
isolated from four groups: TB negative (healthy non-ende-
mic and TB-suspect endemic) and TB positive (smear
negative or positive, all culture positive) individuals. This
allowed us to decipher a host protein profile that is com-
mon with exosomes from individuals who have sputum
confirmed TB and distinct from those of whom do not.
Peptide intensities were normalized and differences were
in abundance, which were determined by t-test.
Results: Nine proteins – including FCGR3A and α-2-
HS-glycoprotein, show distinct patterns, either increas-
ing or decreasing with disease severity. Using adaptive
least absolute shrinkage and selection operator (Lasso)
we are able to discriminate TB patients from healthy
and TB suspects using nine proteins. Application of the
model to a test set of smear and culture negative TB
suspect serum exosomes, we found that nine were
consistent with the negative diagnosis, while one sur-
passed the threshold for positivity. When the same
sample was screened for the presence of mycobacterial
peptides using our published targeted MS assays, it was
positive for several Mtb peptides.
Summary/Conclusion: These results indicate that a
novel assay detecting a combination of host and Mtb
proteins can discriminate TB positivity with greater
sensitivity than the current sputum diagnostics.
Funding: Bill and Melinda Gates Foundation Fund #:
OPP1039688.
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Designed EVs for intracellular delivery of therapeutic antibodies
Oscar Wiklandera, Dhanu Guptaa, Joel Nordina, Heena Sharmab, Xiuming
Lianga, Giulia Corsoa, Dara Mohammada, Rim Jawada, André Görgensc and
Samir El Andaloussid
aClinical Research Center, Department for Laboratory Medicine, Karolinska
Institutet, Stockholm, Sweden; bEvox Therapeutics Limited, Oxford, UK;
cKarolinska Institutet, Department of Laboratory Medicine, Stockholm,
Sweden; dDepartment of Laboratory Medicine, Clinical Research Center,
Karolinska Institutet, Stockholm, Sweden
Introduction: Extracellular vesicles (EV) can be engi-
neered to display various targeting and therapeutic
moieties. Their ability to also act as a natural vector
to shuttle cargo over biological barriers offers a unique
platform for the development of a new class of ther-
apeutics. Here, we introduce a novel concept consisting
of antibody coupled therapeutic EV in order to target
tissues or intracellular pathways.
Methods: By engineering EV to express an Fc-binding
moiety (Fc-EV), antibodies can be displayed on the
surface of the vesicles. We have extensively evaluated
the capacity of these EV to bind antibodies by
immuno-electron microscopy, cellular uptake of
labelled antibodies/EV and flow cytometry analysis,
which indicates that EVs can be decorated with anti-
bodies. As a proof of concept, antibodies bound to Fc-
EV, were assessed in inflammatory models as well as in
cancer settings.
Results: Delivery of anti-STAT3 antibodies in an in
vitro STAT3 dependent inflammatory reporter model
was assessed, with promising results showing inhibi-
tion of STAT3 transcriptional activity. Furthermore,
intracellular delivery of anti-STAT3 antibody using
Fc-EV displays a dose dependent growth inhibition in
pancreatic ductal adenocarcinoma (PDAC) cells. The
Fc-EV platform can also be utilized for decorating EVs
with cancer targeting antibodies, a feature that can be
harnessed to address the differences in uptake dis-
played by different cancers. Certain cancer types are
known to rapidly internalize EV, whereas other cancer
types, such as malignant melanoma are known to take
up EV to a very low extent, if taken up at all. Our
results show that antibodies targeting surface molecules
of cancer cells also aid the internalization of EV into
cancer cells, thus further indicating the potential of
utilizing EV as therapeutic vectors. In order to achieve
specific targeting to B16F10 malignant melanoma cells,
we have decorated the EV surface with antibody target-
ing surface proteins that are known to be displayed on
B16F10 cells, which lead to cellular association of EV to
these cells.
Summary/Conclusion: Overall the Fc-EV platform
offers the prospective of combining antibody and EV
technology, with potential applications including tissue
and cell targeting as well as intracellular delivery of
functional antibodies.
OT06.02
Extracellular vesicles derived from AT-MSCs mediated miR-424
delivery promote apoptosis via the PD-L1/PD-1 pathway in TNBC
Yueyuan Zhoua, Nobuyoshi Kosakab, Zhongdang Xiaoc and Takahiro
Ochiyab
ayueyuanzhou16@hotmail.com, Tokyo, Japan; bDepartment of Molecular and
Cellular Medicine, Institute of Medical Science, Tokyo Medical University,
Shinjyuku-ku, Japan; cSoutheast University, Nanjing, China (People’s
Republic)
Introduction: Extracellular vesicles (EVs) derived from
mesenchymal stem cells (MSCs) showed great potential
as the delivery vehicle of drugs including miRNAs
based on its low immunogenicity and natural homing
ability. Triple-negative breast cancer (TNBC) is an
aggressive and invasive subtype that has limited treat-
ment options. Meanwhile, TNBC is immunogenic with
a greater percentage of tumour-infiltrating lympho-
cytes and increased expression of the programmed
death-ligand 1 (PD-L1) in the tumour microenviron-
ment. The aim of our study is to apply MSC-EVs to
modulate the expression of PD-L1 via the delivery of
miR-424 and contribute to the immunotherapy for
TNBC.
Methods: EVs generated from adipose tissue-derived
MSCs (AT-MSCs) were isolated by differential centri-
fugation and characterized by western blot, nanoparti-
cle tracking analysis and transmission electron
microscopy. Before EV collection, AT-MSCs were
modified to overexpress miR-424 through electropora-
tion, and miRNA mimics transfection. The miRNAs
targeting PD-L1 was predicted according to in silico
analysis. The direct regulation of miR-424 on PD-L1
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was verified via the 3’-UTR luciferase report assays.
The purified EVs were added to the recipient MDA-
MB-231 cells (MM-231). The expression of PD-L1
mRNA and protein was analysed via qRT-PCR and
western blot, respectively.
Results: We found that miR-424 directly regulated the
expression of PD-L1 through the binding to PD-L1
3’UTR. Furthermore, the expression of PD-L1 in
MM-231 cells was down-regulated and the expression
of miR-424 in MM-231 was up-regulated after cocul-
ture with exosomes derived from normal AT-MSCs,
and AT-MSCs with miR-424 overexpression.
Moreover, the cell viabilities of MM-231 were
decreased after coculture with exosomes or transfected
with miR-424 mimics.
Summary/Conclusion: EVs derived from AT-MSCs
could transfer functional miR-424 to TNBC cell lines
and promote the apoptosis via decreased immune-
negative PD-L1/PD-1 pathway.
Funding: This work was supported by Project for
Cancer Research and Therapeutic Evolution [P-
CREATE; grant number:17cm0106402h0002], MEXT
KAKENHI [Grant-in-Aid for Young Scientists (A);
grant number: 17H04991] and China Scholarship
Council [grant number: 201706090122].
OT06.03
Exosomal delivery of NF-κB repressor delays LPS-induced preterm
birth in mouse models
Samantha Sheller-Millera, Kyungsun Choi, George Saade, Chulhee Choib and
Ramkumar Menon
aUniversity of Texas Medical Branch, Galveston, USA; bKAIST, Daejeon,
Republic of Korea
Introduction: Intraamniotic infection and inflamma-
tion are associated with spontaneous preterm birth
(PTB) and preterm premature rupture of the mem-
branes (pPROM). In this study, we tested engineered
extracellular vesicles, or exosomes, cargoing an inhibi-
tor to pro-inflammatory transcription factor (NF-kB),
called super-repressor (SR) IkB, to prolong gestation in
an infection (LPS)-induced PTB mouse model.
Methods: HEK293T (human embryonic kidney cell)
derived exosomes were engineered to contain SR
using a protein loading via optically reversible pro-
tein–protein interaction (EXPLORs) method (Yim, et
al 2016). In this method, SR is actively incorporated
into exosomes during biogenesis. These exosomes were
isolated, quantified and used for our studies.
Intraperitoneal (IP) injection of either LPS (100 g) or
PBS were performed in CD-1 mice on gestational day
15 followed by injection of PBS, SR exosomes
(1 × 1010) or naïve exosomes (exosomes derived
from HEK293T cells under normal culture conditions,
1 × 1010) every 2 h for a total of five injections.
Treatment groups (Group 1-LPS+PBS; Group 2-LPS
+SR; Group 3-LPS+naïve, and Group 4-PBS) were
monitored for preterm birth. Upon delivery of at least
one pup in Group 1, mice were euthanized, and mater-
nal plasma, uterus and cervix were collected for cyto-
kine analysis using Luminex (IL-1β, IL-8 and IL-10)
and Western blot for NF-B activation via RelA phos-
phorylation (P-NF-B), respectively. Survival graphs
were created in GraphPad and one-way ANOVA was
performed to determine statistical significance
(P < 0.05).
Results: Animals injected with PBS delivered at the
expected gestational age (19.5 days). LPS and
LPS + naïve-induced PTB within 10 h; however, injec-
tion of SR exosomes prolonged delivery by an average
of 21 h in this model. Consistently lower levels of pro-
inflammatory cytokines, IL-1β and IL-8, were seen in
maternal plasma of LPS + SR compared to LPS mice,
while anti-inflammatory cytokine, IL-10, levels were
significantly increased in LPS + SR mice compared to
LPS (P = 0.01) and PBS controls (P < 0.0001). In the
cervix and uterus, P-NF-B expression was significantly
decreased in LPS + SR compared to LPS (P = 0.005,
P = 0.03) (Figure 2B).
Summary/Conclusion: Exosomes can be engineered to
carry pharmaceutical agents that can dampen the infec-
tion-induced inflammation associated with PTB and
pPROM.
OT06.04
Technologies for loading RNA-based therapeutics into extracellular
vesicles for drug delivery
Olga Shatnyevaa, Anders Gunnarssonb, Euan Gordonc, Elisa Lázaro-Ibáñezd,
Lavaniya Kunalingamc, Xabier Osteikoetxeae, Kristina Friisc, Marcello
Marescac and Niek Dekkerb
aAstraZeneca, Molndal, Sweden; bAstraZeneca, Mölndal, Sweden;
cAstrazeneca, Mölndal, Sweden; dAstraZeneca, molndal, Sweden;
eAstraZeneca, Macclesfield, UK
Introduction: Extracellular vesicles (EVs) have
emerged as a very potent new delivery system for
drug delivery. Recent advances in RNA-based thera-
peutics have broadened the scope of cellular targeting
of currently undruggable genes. Current approaches
for RNA loading of EVs suffer from poor efficacy.
Our study combines bioengineering of the therapeutic
EVs with post-isolation RNA. We will here present
data showing (1) the use of RNA binding proteins
(RBP) fused to EV protein markers for in vitro loading
of EVs with tagged RNA cargo and (2) post-isolation
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incubation of EVs with RNA-loaded lipid nanoparti-
cles (LNP).
Methods: A library of targeted RNAs fused to a specific
RNA binding protein (RBP) sequence was generated,
varying the position of recognition site. Surface plas-
mon resonance was used to characterize the modified
sgRNAs for binding to the RBP. Activity of the hybrid
sgRNA was also confirmed for functional gene editing
with Cas9. Expi293F cells were co-transfected with the
set of modified sgRNAs and RBP fused to EV proteins
followed by EV purification by differential ultracentri-
fugation. EVs were characterized by nanoparticle track-
ing analysis, Western blotting and single molecule
microscopy. Efficiency of sgRNA loading into EVs
was determined using qPCR. Post-isolation loading of
sgRNA with Expi293 EVs by co-incubation and func-
tional delivery of sgRNA cargo in HEK293 cells were
also evaluated.
Results: The introduction of RNA recognition ele-
ments into sgRNA sequence did not interfere with
binding to RBP. Fusions between RBP and EV proteins
resulted into efficient incorporation of RBP in EVs.
Co-expression of sgRNA resulted in selective targeting
of sgRNA to EVs. Additionally, EVs from cells co-
expressing sgRNA and RBP contained 10-fold more
sgRNA compared to EV from cells who only expressed
sgRNA. Loading of synthetic sgRNA cargo with 40%
encapsulation efficiency was achieved by incubation of
EVs with LNPs and the resulting particles led to func-
tional uptake in HepG2 cells.
Summary/Conclusion: Here, we compare different
techniques for therapeutic cargo loading and delivery
into target cells. All approaches for RNA loading into
EVs demonstrates proof of principle. We envision that
this approach will be useful for RNA loading for ther-
apeutic applications.
OT06.05
Engineering designer exosomes produced efficiently by mammalian
cells in situ and their application for the therapy of Parkinson’s
disease
Ryosuke Kojimaa, Daniel Bojarb and Martin Fusseneggerc
aGraduate School of Medicine, The University of Tokyo. JST PRESTO,
Tokyo, Japan; bETH Zurich, Department of Biosystems Science and
Engineering, Basel, Switzerland; cETH Zurich, Department of Biosystems
Science and Engineering. University of Basel, Faculty of Science, Basel,
Switzerland
Introduction: Exosomes are cell-derived extracellu-
lar nanovesicles 50–150 nm in size, which serve as
intercellular information transmitters in various bio-
logical contexts, and are candidate therapeutic agents
as a new class of drug delivery vesicles. However,
inefficiency of exosome cargo transfer, such as trans-
fer of mRNA contained in exosomes, and lack of
methods to create designer exosomes has hampered
the development of sophisticated therapeutic
interventions.
Methods: We have developed a set of synthetic-biol-
ogy-inspired genetic devices that enable efficient cus-
tomizable in situ-production of designer exosomes in
engineered mammalian cells, and pursued their thera-
peutic applications.
Results: The developed synthetic devices that can be
genetically encoded in exosome producer cells (named
“EXOtic (EXOsomal Transfer Into Cells) devices”)
enhance exosome production, specific mRNA packa-
ging and delivery of the mRNA into the cytosol of
recipient cells. Synergistic use of these devices with a
targeting moiety significantly enhanced functional
mRNA delivery into recipient cells, enabling efficient
cell-to-cell communication without the need to con-
centrate exosomes. Further, the engineered exosome
producer cells implanted in living mice could consis-
tently deliver mRNA to the brain. Moreover, therapeu-
tic catalase mRNA delivery by designer exosomes
attenuated neurotoxicity and neuroinflammation in
both an in vitro and in vivo Parkinson’s disease model.
Summary/Conclusion: These results indicate the
potential usefulness of the EXOtic devices for RNA
delivery-based therapeutic applications. (Nat.
Commun. 2018, 9, 1305)
Funding: This work was supported by the European
Research Council (ERC) advanced grant [ProNet, no.
321381] and in part by the National Centre of
Competence in Research (NCCR) for Molecular
Systems Engineering (to M.F.). R.K. was supported by
a postdoctoral fellowship from the Human Frontier
Science Program.
OT06.06
Protein engineering for loading of Extracellular Vesicles
Xabier Osteikoetxeaa, Josia Steina, Elisa Lázaro-Ibáñezb, Gwen O´Driscollc,
Olga Shatnyevad, Rick Daviesa and Niek Dekkerc
aAstraZeneca, Macclesfield, UK; bAstraZeneca, molndal, Sweden;
cAstraZeneca, Mölndal, Sweden; dAstraZeneca, Molndal, Sweden
Introduction: To date various reports have shown the
utility of extracellular vesicles (EVs) for delivery of
therapeutic protein cargo. Currently, the most com-
mon strategies for loading therapeutic cargoes occur
after EV isolation mixing EVs with desired cargo and
subjecting to passive incubation, electroporation,
freeze-thaw cycling, sonication, extrusion, or mem-
brane permeabilization with saponin among various
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techniques. An alternative approach is to modify
releasing cells to secrete EVs containing the desired
cargo with minimal impact on native EVs by post-
isolation treatments. In this study, we designed differ-
ent constructs to compare Cre and Cas9 loading effi-
ciency into EVs using (1) light-induced dimerization
systems (Cryptochrome 2 (CRY2), Phytochrome B
(PHYB), and Vivid-based “Magnets” (Mag)), (2) fusion
to EV associated proteins (CD9, CD63, CD81, Rab5),
(3) lipidation motifs (Myristoylation, Palmitoylation,
Prenylation) and (4) a novel motif “mXO”.
Methods: For EV production human Expi293F cell line
was transiently transfected with plasmid constructs
using PEI MAX 40K. EVs were then isolated by differ-
ential ultracentrifugation followed by iodixanol gradi-
ent and characterized using nanoparticle tracking
analysis, western blotting and transmission electron
microscopy. Functionality of engineered Cre and Cas9
cargo was assessed in reporter cell assays using fluor-
escent microscopy, qPCR and Sanger sequencing fol-
lowed by TIDE analysis.
Results: Light-induced dimerization using CRY2
resulted in better EV cargo loading for both Cre
and Cas9 than PHYB and Mag systems. Among the
EV associated proteins and lipidation motifs tested
CD9, CD81, Myristoylation and mXO were most
efficient at recruiting Cre and Cas9 cargo by light-
induced dimerization. Using CRY2 in combination
with CD9 or mXO we achieved loading efficiencies
of 10–34 Cre molecules per EV and 23–30 Cas9
molecules per EV.
Summary/Conclusion: Cre and Cas9 loading into EVs
by producing cells is feasible using protein engineering
with light-induced dimerization. Of the designs inves-
tigated CRY2-induced light dimerization and CD9 and
mXO motif were most effective resulting in multiple
copies of functional Cre and Cas9 loaded per EV. We
envision that this approach will be useful for protein
loading in a variety of therapeutic applications.
OT06.07
Engineered extracellular vesicles for drug delivery
Niek Dekkera, Elisa Lázaro-Ibáñezb, Olga Shatnyevac, Nikki Heathd and
Xabier Osteikoetxeae
aAstraZeneca, Mölndal, Sweden; bAstraZeneca, molndal, Sweden;
cAstraZeneca, Molndal, Sweden; dAstraZeneca, Vancouver, Canada;
eAstraZeneca, Manchester, United Kingdom
Abstract: Extracellular Vesicles (EVs) represent an
exciting opportunity as biological delivery vehicle for
therapeutic cargo with excellent safety, low intrinsic
immunogenicity, cell-specific tropism and biological
delivery efficiency.
Methods: There are multiple approaches for the intro-
duction of protein and RNA cargo into EVs, including
physical, chemical and cell engineering. We have engi-
neered Expi293F suspension cells with transient
expression of fusion proteins for reversible loading
with protein cargo with examples for Cre recombinase
and Cas9 for CRISPR gene editing.
Results: We have developed a single molecule fluores-
cence microscopy technique to quantify cargo loading
at a single particle level, showing excellent loading for
GFP fusions with CD63 with on average 70 copies of
the fusion protein per particle. Functional delivery of
Cre recombinase, as measured in a reporter cell line,
was dependent on addition of small molecule or pep-
tide enhancers of endosomal escape. Using RNA-bind-
ing proteins fused to exosomal markers we were able to
enrich EVs with RNA cargo with up to 10-fold higher
loading of sgRNA compared to loading from passive
mass redistribution. Human Expi293F cell-derived EVs
did not trigger any significant immune response in
vitro in human blood. The in vivo assessment following
a single intravenous administration of these EVs in
BALB/c mice did not reveal marked haematological
changes, cytokine induction or histopathological
effects. Labelling of EVs using fluorescent mCherry,
luminescent NanoLuc or radio-isotope 111Indium
marker allowed for on line analysis of bio-distribution
in vivo.
Summary/conclusion: Opportunities of naïve and
engineered EVs for drug discovery and their potential
for therapeutic applications will be discussed.
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PT01.01
Role of circulating extracellular vesicles in brain function and
behaviour
Eisuke Dohi, Indigo Rose, Takashi Imai, Rei Mitani, Eric Choi, Dillon Muth,
Zhaohao Liao, Kenneth Witwer and Shinichi Kano
Johns Hopkins University School of Medicine, Baltimore, USA
Introduction: Accumulating evidence suggests that
extracellular vesicles (EVs) circulate in the blood and
affect cellular functions in an organ distant from their
origins. In neuroscience, systemic circulating factors
such as cytokines/chemokines, hormones and metabo-
lites have been shown to modulate brain function and
behaviour. They are also utilized as biomarkers to
reflect brain disease status. Nonetheless, it remains
unclear whether circulating EVs modulate brain func-
tion and behaviour.
Methods: We used mouse models to study the effects
of EVs from specific cell types on brain function and
behaviour. Because circulating EVs are extremely het-
erogeneous, we focused on immunodeficient mice that
lack specific lymphocytes (T and B cells). We assessed
the changes in their circulating EVs and examined
their potential impact on the corresponding beha-
vioural and neuronal dysregulation.
Results: As expected, immunodeficient mice lack the
expression of T and B cell-related markers in the EV
containing fractions from the peripheral blood.
Immunodeficient mice also displayed social behavioural
deficits, accompanying by enhance c-Fos immunoreac-
tivity in the excitatory neurons in the medial prefrontal
cortex (mPFC). Notably, transfer of splenocytes from
wild-type (WT) rescued the behavioural deficits, serum
EVs and brain c-Fos expression patterns in immunode-
ficient mice. Further analysis on the molecular mechan-
isms is in progress.
Summary/Conclusion: Our study has revealed a
potential periphery-brain communication via EVs
under physiological condition. Future studies are
required to identify the cellular targets of circulating
EVs and their ascending routes in the brain.
Funding: NIMH R01.
PT01.03
In vivo tracking and monitoring of extracellular vesicles with a new
non-lipophilic dye
Sam Noppena, Gareth R Willisb, Antonios Fikatasa, Archana Guptac, Amirali
Afsharic, Christophe Pannecouquea and Dominique Scholsa
aLaboratory of Virology and Chemotherapy, Rega Institute, KU Leuven,
Leuven, Belgium; bDepartment of Pediatrics, Harvard Medical School, MA,
Boston, USA; cSystem Biosciences (SBI), Palo Alto, CA, USA
Introduction: Extracellular vesicles (EVs) are gaining
increasing interest as drug delivery vehicles. However,
there is still a lack of knowledge about the in vivo fate
of exogenous delivered EVs. Noninvasive optical ima-
ging is an important tool to analyse the biodistribution
of EVs. Currently, one of the most popular techniques
is to directly label EVs with fluorescent lipophilic dyes.
A major drawback is that the dye itself rather than EVs
is detected. Hence, there is a need for other dyes that
overcome these limitations. A new non-lipophilic near
infrared (NIR) dye, ExoGlow-Vivo (SBI), was tested in
vivo in mice.
Methods: EVs from human PBMC, HEK and MCF7 cells
were labelled with ExoGlow-Vivo, precipitated with
Exoquick-TC (SBI) and injected intravenously (i.v.) in
adult SCID mice. Human mesenchymal stem cell
(MSC)-derived EVs were labelled with ExoGlow-Vivo
dye, washed via ultracentrifugation and injected i.v. in
post-natal day-4 FVB mice. Fluorescent images were
acquired with an IVIS® Spectrum (PerkinElmer).
Results: Spectral unmixing of ExoGlow-Vivo revealed
optimal excitation/emission at 745/820 nm.
Biodistribution studies in SCID mice showed the liver
as main targeted organ. A high fluorescent signal was
measured in the bladder but almost completely disap-
peared within 4 h. Ex vivo imaging of dissected organs
confirmed the liver as the main organ, followed by
spleen and kidneys. No difference in biodistribution
was observed between PBMC, HEK and MCF7-derived
EVs. MSC-derived EVs accumulated preferentially in
the liver of post-natal mice. Interestingly, ex vivo ima-
ging revealed high positive staining in the lungs. This
may be associated with recent observations that found
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MSC-derived EVs ameliorate core features of experi-
mental bronchopulmonary dysplasia.
Summary/Conclusion: ExoGlow-Vivo has excellent
NIR properties for in vivo imaging with almost negli-
gible background. This non-lipophilic dye is ideal for
biodistribution and kinetic studies of exogenous deliv-
ered EVs. However, uptake of most EVs by liver sup-
plants the signal of other organs.
PT01.04
Exosomal lipids applicable to cancer targeting
Yuki Todaa, Saeka Ukaia, Akari Kobayashia, Shin-ya Moritab, Shigekuni
Hosogia and Eishi Ashiharaa
aDepartment of Clinical and Translational Physiology, Kyoto Pharmaceutical
University, Kyoto, Japan; bDepartment of Pharmacy, Shiga University of
Medical Science Hospital, Kyoto, Japan
Introduction: Cancer-targeting technologies must be a
crucial technology to develop diagnosis and therapy of
cancers. Many basic and clinical studies highlighted
lots of cancer-associated proteins and expected their
ligands to honour the drug carrier with selectivity;
however, their targeting potential were not tolerable
of advanced trials. We have previously identified glio-
blastoma-derived exosomes (Exo-U251) that were
more effectively internalized into some types of cancer
cell lines than into non-cancer cells. Because this trop-
ism was still maintained in the lack of protein ligand
interaction of the exosomes with cells, we focused on
their lipid components.
Methods: Ultrapure exosomes (about 100 nm vesicles
expressing CD63 in d = 1.16 mg/L fraction) were
collected from cell culture media using density-gradi-
ent ultracentrifugation. Exosomal lipids were extracted
by Bligh & Dyer method and reconstructed into lipo-
somes (Exolip-U251) using extrusion method. Each
amount of lipid components was analysed by enzy-
matic fluorometric assay [Morita S.Y. and Terada T.
Sci. Rep., 5:11737, 2015]. Exosomes or reconstructed
liposomes were fluorescent-labelled and applied to can-
cer or non-cancer cells to evaluate the internalization
efficiency using an image analysis of a laser scanning
microscopy. Exolip-U251 conjugating siRNA was pre-
pared by Exo-Fect reagent. Doxorubicin (DOX) was
encapsulated into liposomes using remote-loading
method.
Results: The enzymatic fluorometric assays revealed
the uniqueness of the exosomal lipid components
according to the cells from which they are derived.
The tropism of Exo-U251 lipid-reconstructed lipo-
somes (Exolip-U251) partly mimicked that of the ori-
ginal exosomes. The siRNA conjugated Exolip-U251
was effectively delivered into the inside of cells, but
did not suppress the target gene expression. By con-
trast, DOX-loaded Exolip-U251 significantly sup-
pressed the proliferation of U251 cells. Thus, the
encapsulation was critical for the agents to internalize
more effectively into cancer cells.
Summary/Conclusion: The tropism of exosomes is
partially regulated by their own lipid components
and, mimicking this approach would lead to promising
cancer-targeting technologies.
Funding: MEXT-Supported Program for the Strategic
Research Foundation at Private Universities
PT01.05
The exosome that are released from mechanical stress-stimulated
osteocyte induces osteoclastegenesis
Tomohiro Itoha and Yukihiro Akaob
aGraduate School of Bioresources, Mie University, Tsu, Japan; bGifu
University Graduate School of Drug Discovery and Medical Information
Sciences, Gifu, Japan
Introduction: Osteocyte, which is the most abundant
cell in bone tissues, is well known as a mechanical
stress receiving cell. During bone remodelling, bone
resorptionby osteoclasts precedes bone formation by
osteoblasts. However, its mechanism is still unknown.
In this study, we examined whether exosome released
from osteocyte by MS stimulation are involved in
osteoclast differentiation.
Methods: MC3T3-E1 cells or MLO-Y4 cells were
seeded on 3D scaffold and grown to 70–80% conflu-
ence. The cells were exposed to pressure of 1.5 MPa for
1 h at 37°C consisting a hydrostatic pressure system.
After cultivation, the cultured media harvested and
then isolated then centrifuged at 8,000 ×g for 30 min
at 4°C to remove cell debris. The extracellular exo-
somes were pelleted in a final ultracentrifugation at
100,000 ×g for 1 h at 4°C. Pelleted exosomes were
resuspended in PBS and ultracentrifuged again. The
size distribution of exosomes was examined using a
NanoSight Tracking Analysis LM20 System. The
amount of osteoclast differentiation was estimated by
TRACP staining. The MLO-Y4 cell vesicle membrane
and vesicle internal protein profiles were analysed by
nano-LC-MS/MS based shotgun proteomics.
Results: The vesicles isolated from mechanical stress-
loaded MC3T3-E1 cells facilitated the mechanical
stress-loaded osteoblast differentiation, but no effect
against normal MC3T3-E1 cells. Though the vesicles
isolated from mechanical stress-loaded MLO-Y4 cells
had no effect against osteoblast differentiation, these
vesicles significantly induced osteoclast differentiation.
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To characterize the mechanisms by which mechanical
stress-loaded MLO-Y4 cell vesicles induces osteoclast
differentiation in murine macrophage RAW264 cells,
we analysed vesicle membrane and vesicle internal
proteins by nano-LC-MS/MS-based shotgun proteo-
mics. As a result, Protein X was only detected in
mechanical stress-loaded MLO-Y4 cell vesicles.
Summary/Conclusion: Our data indicated that
mechanical stress-loaded MLO-Y4 cells vesicles are
acting as one of osteoclast differentiation mechanisms.
Now, we are further investigating whether Protein X is
involved in osteoclast differentiation.
Funding: This work was supported by a Grant-in-Aid
for Scentific Research (C) [No. 18K11019] from Japan
Society for the Promotion of Science (JSPS).
PT01.06
A label-free aptasensor for electrochemical detection of gastric cancer
exosomes
lI Zhiyanga and He Nongyueb
aNanjing Drum Tower Hospital Clinical College, Nanjing, China (People’s
Republic); bSoutheast University, Nanjing, USA
Introduction: Emerging evidence indicates exosomes
derived from gastric cancer cells enhances tumour
migration and invasion through the modulation of
tumour microenvironment. Here we represent a label-
free electrochemical aptasensor for specific detection of
gastric cancer exosomes. This platform contains an
anti-CD63 antibody modified gold electrode and a
gastric cancer exosome specific aptamer. The aptamer
is linked to a primer sequence which is complementary
to a G-quadruplex circular template. The presence of
target exosomes could trigger rolling circle amplifica-
tion and produce multiple G-quadruplex units. This
HRP mimicking DNAzyme could catalyses the reduc-
tion of H2O2 and generate electrochemical signal. This
aptasensor exhibits high selectivity and sensitivity
towards gastric cancer exosomes with a linear response
range from 4.8 × 103 to 4.8 × 106 exosomes/mL.
Therefore, we expect this electrochemical apatasensor
to become a useful tool for the early diagnosis of gastric
cancer.
Methods: First of all, several gastric cancer cell or
cancer overexpressed protein aptamers were screened
in order to select gastric cancer exosome specific apta-
mer. Then different kinds of exosomes were captured
in the anti CD-63 antibody modified gold electrode.
Among these exosomes, only gastric cancer exosomes
could trigger RCA to achieve the generation of large
amount of G-quadruplex units. The products were
then incubated with hemin to form hemin-G-quadru-
plex structures and catalysed H2O2 system to produce
electrochemical signal. The aptasensor was also vali-
dated in terms of the linearity and repeatability to
demonstrate its potential in practice.
Results: Anti-CD63, which can bind to the exosome
surface marker was used as the capture probe. And the
joint effects of hemin/G-quadruplex DNAzyme
towards H2O2 reduction and signal amplification pro-
duced by RCA reaction was used to generate signifi-
cantly strong electrochemical and colorimetric
response.
Summary/Conclusion: In this work, we developed
an electrochemical and colorimetric aptasensor for
specific detection of gastric cancer exosomes. A spe-
cific gastric cancer exosome aptamer was selected
and used as the detection probe. The aptasensor
exhibits specificity towards target exosomes and
high sensitivity.
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PT02.01
Placenta extracellular vesicles: a potential protective
role against oxidative damage
Qi Chena, Chunlin Sub and Larry Chamleya
aThe University of Auckland, Auckland, New Zealand; bFudan University of
China, Shanghai, China (People’s Republic)
Introduction: Extracellular vesicles (EVs) are lipid-
enclosed packages of cellular contents including
RNAs, protein and DNA that are produced by all
eukaryotic cells to facilitate intercellular communica-
tion and regulation. Upon reaching their target cells,
EVs may deliver their cargo and can induce signalling
to alter the behaviour of target cells. During pregnancy,
a large number of EVs are extruded from placenta (a
foetal organ) into maternal circulation. Placental EVs
are implicated in maternal immunosuppression and
tissue repair. In this study we investigated whether
placental EVs can prevent cell damage.
Methods: EVs were isolated from first trimester pla-
cental explants (range from 8–12 weeks of gestation)
and separated into micro- and nano-EVs by differential
centrifugation. Human endometrium epithelial cells
(HEE) were cultured for 18 h in the presence or
absence of placental micro- or nano-EVs. After
removal of excess EVs by washing with PBS, HEE
cells were treated with 1 mM H2O2 for 30 min and
then the H2O2 was removed by washing. The culture
was continued for 18 h and proliferation of HEE was
measured by Alamar Blue assay. The expression of
H2AX, a marker of DNA damage in HEE cells was
measured by IHC.
Results: The proliferation of HEE was significantly
reduced when HEE cells were treated with 1 mM
H2O2. However this reduction of proliferation was sig-
nificantly reversed by pre-treatment with either micro-
or nano-placental EVs. In addition, the expression of
H2AX was higher in HEE cells that had been treated
with 1 mM H2O2, but higher expression of H2AX was
reduced in HEE cells that had been pre-treated with
either micro- or nano-EVs.
Summary/Conclusion: In this study, we found that
pre-treatment with placental EVs can reduce the
adverse effects of H2O2 on HEE cell proliferation
death and DNA damage. Our data suggest placental
EVs have the ability to protective cells against oxidative
damage. In pregnancy this property of placental EVs
may assist the function of maternal cells that are
exposed to increased oxidative stress.
PT02.02
Maternal serum miRNA biomarkers for detection of
placenta accreta
Rebecca R. Adamia, Louise Laurentb, Victoria Frattoc, Srimeenakshi
Srinivasana, Cuong Trana, Peter DeHoffa, Melissa Westermannd, Allison
O’Learye, Deborah Wingd and Gladys Ramosa
aUCSD, San Diego, USA; bUCSD, La Jolla, USA; cNaval Medical Center, San
Diego, USA; dUCI, Irvine, USA; eUCSF, San Francisco, USA
Introduction: Failure to diagnose placenta accreta
spectrum (PAS) prior to delivery is associated with
worse outcomes. However, use of ultrasound and mag-
netic resonance imaging for this diagnosis is costly and
imprecise. We hypothesize that levels of specific cell-
free miRNAs in the maternal blood will differ among
women with PAS, placenta previa and normal
placentation.
Methods: Women with suspected PAS, previa or nor-
mal placentation were prospectively recruited at three
academic centres in the UC foetal Consortium. PAS
was confirmed by pathologic evaluation. Maternal
serum was collected antenatally, and total RNA was
extracted, subjected to small RNA sequencing, and
mapped to the miRBase human miRNA database.
Groupwise differential expression analysis identified
13 candidate miRNAs, which were used to generate a
support vector regression model for classification. The
small RNA sequencing results for these candidate
miRNAs were validated using qPCR.
Results: 60 women were recruited: 18 PAS, 15 placenta
previa and 27 normal placentation. The median gesta-
tional age at sample collection was 30w3d (IQR 28w–
33w) and did not differ among groups (p = 0.13). The
abundance of total miRNA reads as a percentage of all
reads in the small RNA sequencing data was highest
among women with PAS and lowest in normal placen-
tation. Thirteen differentially expressed candidate
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miRNAs were identified. Support vector regression
accurately classified samples into the three categories.
Summary/Conclusion: The percent total miRNA was
significantly higher in maternal serum in cases of PAS
compared to normal placentation. Thirteen candidate
miRNAs were differentially expressed among groups
and were used in a training model to accurately classify
samples. Our results suggest that maternal serum
miRNAs have the potential to serve as biomarkers for
accurate antenatal diagnosis of PAS. Studies in a larger
independent cohort are needed for validation of these
results.
PT02.03
Effects of medium term storage on placental extracellular vesicles
Larry Chamley, Julie Wang and Cherie Blenkiron
The University of Auckland, Auckland, New Zealand
Introduction: Studies on the function of isolated extra-
cellular vesicles (EVs) are growing exponentially.
However, as yet there is no consensus on how best to
store EVs. We hereby conducted a term study to exam-
ine the stability of various cargos carried by placental
EVs when stored at 4°C.
Methods: First-trimester placental tissues were cul-
tured for 24 h in medium supplemented with fluores-
cent cell tracker CMTPX (1 µg/mL). Debris was
removed by centrifugation at 2000 ×g. Micro EVs
were harvested by centrifugation at 20,000×g and sub-
sequently nano-EVs were harvested following centrifu-
gation at 200,000×g. The EVs were resuspended in PBS
then aliquoted and stored at 4oC. CMTPX signal
strength was examined by flow cytometry (AriaII)
weekly. DNA was extracted, fortnightly, using
Purelink Genomic DNA kit and measured using a
Qubit dsDNA assay; and total proteins were isolated,
fortnightly, with RIPA and quantified using BCA assay.
Results: The proportions of micro and nano-EVs
showing similar intensity of CMTPX signals did not
change significantly for 3 months (n > 5) but an incon-
sistent and sample-dependent decline was observed
thereafter. In contrast, the DNA content of EVs was
stable for only 2 weeks. DNA quantities extracted from
micro and nano-EVs declined by 40% and 60%, respec-
tively, at week four compared to DNA extracted from
freshly isolated EVs and thereafter remained stable
until 8 weeks. Total protein in micro EVs was stable
for 2 months. Whereas there was a 20% decline in the
total protein extracted from nano-EVs by week 2 but
levels remained stable thereafter. Finally, the corre-
sponding placental tissues also stored at 4oC and
processed in parallel showed continuous decline in
both DNA and protein quantities.
Summary/Conclusion: The CMPTX label incorpo-
rated into placental EVs may be stable for 3 months
when stored at 4oC. However, the DNA of both micro
and nano-EVs was less stable with a rapid decline upon
storage. There was a marked difference in the stability
of EV-associated protein with the protein content of
nano-EVs being less stable than that of micro-EVs.
Notably the total protein content of placental micro-
EVs was remarkably stable when the EVs were stored
at 4oC. Further work is required to assess the intact-
ness/functionality of placental EVs after storage.
Funding: Marsden Fund of the Royal Society of New
Zealand
PT02.04
Deciphering embryo-maternal communication; the dynamics of first
contact between progenitor and progeny
Kasun Godakumaraa, Masoumeh Es-haghib, Keerthie Dissanayakeb, Freddy
Lättekivib, Andres Salumetsc, Ülle Jaakmad and Alireza Fazelib
aDepartment of Pathophysiology, Institute of Biomedicine and Translational
Medicine, University of Tartu, Tartu, Estonia; bDepartment of
Pathophysiology, Institute of Biomedicine and Translational Medicine,
University of Tartu, Estonia; cCompetence Centre on Health Technologies,
Tartu, Estonia; dInstitute of Veterinary Medicine and Animal Sciences,
Estonian University of Life Sciences, Tartu, Estonia
Introduction: Failure of implantation has long been
identified as a major challenge of assisted reproductive
technologies. It is hypothesized that the embryo alters
the endometrium to elevated receptivity by embryo-
maternal cross talk. In previous communications, we
have shown that RNA originating from JAr (analogue
for trophoblast) cell line, packaged in extracellular
vesicles (EVs) are transferred to RL95–2 (an analogue
for endometrium) cell line and induce alterations in
specific endometrial Zinc Finger Protein 81 (ZNF81)
transcript. The objective of the current study was to
test the hypothesis that only EVs from viable embryo
alter ZNF81 transcript in the RL95-2 cell line.
Methods: Human embryos were produced by classic in
vitro fertilization (IVF) or intracytoplasmic sperm
injection (ICSI). They were cultured individually for
20 h in Fert™ media (day 1), 48 h (day-3) in Cleav™
media and additionally 48 h in Blast™ media (day-5). At
day-3, embryos with equal size blastomeres and no
fragmentation were considered as normal. At day 5,
embryos with identifiable inner cell mass, trophoblast
and blastocyst cavity were considered normal while
embryos forming mass of degrading cells were consid-
ered degraded. Conditioned media was collected from
6 normal day-3 embryos (three of which degraded by
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day 5), day-5 normal (n = 3) and degraded (n = 3)
embryos, Cleav™ and Blast™ media. EVs were isolated
using a sequential centrifugation and size-exclusion
chromatography. A monolayer of RL95-2 cells (analo-
gue for endometrium) was treated with isolated EVs.
The change of gene expression of ZNF 81 and control
genes (beta-actin, beta-2-microglobulin) in RL95-2
cells were measured using qPCR with absolute
quantification.
Results: Results exhibited that EVs derived both from
day-5 normal blastocysts and day-3 embryos that
undergo normal development significantly
downregulated ZNF 81 expression in endometrial cells
compared to untreated controls, cells treated with
Cleave™ and Blast™ media EVs, cells treated with day-5
degraded embryos and day-3 embryos degrading on
day-5 EVs. Control genes did not exhibit a significant
change of expression.
Summary/Conclusion: RL95-2 cells respond in differ-
ent manners to EVs from normal and degraded human
embryos. These findings can facilitate development of
biomarkers for differentiating viable and degraded
embryos at early stages after IVF.
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Circulating exosomal miRNAs as potential biomarkers for evaluation
of preterm brain injury
Kenta HT Choa, Bing Xub, Nina Zengb, Randall F. D’Souzac, Cherie
Blenkirond and Mhoyra Fraserb
aDepartment of Physiology, Faculty of Medical and Health Sciences, The
University of Auckland; bDepartment of Physiology, Faculty of Medical and
Health Sciences, The University of Auckland, Auckland, New Zealand;
cDiscipline of Nutrition, Faculty of Medical and Health Sciences, The
University of Auckland, Auckland, New Zealand; dThe University of
Auckland, Auckland, New Zealand
Introduction: Insults such as oxygen deprivation
occurring in utero or during delivery have profound
consequences on the neurological outcome of prema-
ture infants. This is a serious clinical problem, because
treatment is a time-critical emergency and should be
commenced within 6 h following injury. However, we
simply do not know which preterm infants to treat due
to the lack of sensitive biomarkers. Using our foetal
sheep model of preterm brain injury, we sought to
isolate exosomes from foetal plasma to establish
whether they contain miRNA biomarkers that are asso-
ciated with clinically significant neurologic outcomes.
Methods: Chronically instrumented singleton foetal
sheep at 0.7 gestation (term 145 days) received
asphyxia induced by umbilical cord occlusion for
25 min. Size-exclusion chromatography (qEV) was per-
formed for isolation and purification of extracellular
vesicles (EVs) from plasma collected 4 h after occlusion
from asphyxia (n = 10) and sham control (n = 10)
foetuses. EV fractions were assessed for purity and
quantity by nanoparticle tracking analysis and western
blot against major EV protein markers. For biomarker
identification, miRNA expression profiles from plasma
EV fractions were determined by Affymetrix v4
microarrays.
Results: Umbilical cord occlusion was associated with
significant brain injury to areas commonly affected by
asphyxia in preterm infants. Plasma EVs were charac-
terised as rich in CD63 and HSP70, size ~100 nm, and
with an exosome-like morphology by TEM. Profiling of
EV-miRNAs revealed significant differences (log2 fold
change > 2 or < −2 and p value < 0.05) between the
asphyxia and sham control foetal groups. Strikingly,
the majority of miRNAs differentially abundant with
asphyxial-induced brain injury were less abundant,
including miR-30b-5p, miR-30a-5p, miR-27a, let-7f,
miR-223/3p, miR-221, miR-22-3p, miR-151–3p, miR-
411–5p and miR-532 whereas only one miRNA (miR-
455-3p) was more abundant.
Summary/Conclusion: To the best of our knowledge,
this study is the first to determine the usefulness of
plasma exosomal miRNAs as biomarkers for the pre-
diction of preterm brain injury. Our data reveal a
unique plasma-derived exosomal miRNA profile,
which may aid the early diagnosis of preterm brain
injury.
Funding: Neurological Foundation of New Zealand.
PT03.04
Identification and Verification of Differentially Expressed MicroRNAs
in the plasma microvesicles for the Diagnosis of moyamoya Disease
Mi Jeong Oha, Eun Hee Kima, Yeon Hee Chob, Dong Hee Kimc, Ji Hee Sungb,
Eun Kyoung Shina and Oh Young Bangd
asamsung medical center, Seoul, Republic of Korea; bsamsung medical center,
seoul, Republic of Korea; cSungkyunkwan University, seoul, Republic of
Korea; dSamsung medical center, Seoul, Republic of Korea
Introduction: There is no well-recognized miRNA bio-
marker for accurately predicting outcome in the presence
of moyamoya disease (MMD), a unique cerebrovascular
occlusive disease of unknown etiology1,2. We performed a
study of the significance of miRNAs expression in the
plasma microvesicles (MVs) of MMD patients.
Methods: The plasma MVs were purified from 38
healthy donors, 22 intracranial atherosclerotic stenosis
(ICAS) patients and 40 moyamoya disease (MMD)
patients. Plasma MVs were isolated using ultracentri-
fugation. We perfomed miR expression analysis using
miRNome miScript miRNA PCR Array. Specific
miRNAs were validated using real-time polymerase
chain reaction, with normalization to an exogenous
control (cel-miR-39). The angiogenic effects were mea-
sured by over-expressing or inhibiting specific
miRNAs.
Results: MiRNA profiles using miRNome miScript
miRNA PCR array of three pooled plasma MV samples
from patients with MMD, ICAS and controls revealed
222 differentially expressed serum miRNAs, including
115 upregulated and 107 downregulated miRNAs. In
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an independent MMD cohort, qRT-PCR confirmed
that miR-A was significantly upregulated. Hsa-miR-A
in the MMD group exhibited greater performance than
ICAS group (AUC 0.735) in ROC curve analysis. To
select target genes of specific miRNAs, we performed
computational miR target prediction analysis
(TargetScan) and found the seed sequence of CAV1
3’-UTR interacting with hsa-miR-A. The deregulation
of miR-A by the transfection of HUVECs with pre-
miR-A was significantly decreased tube formation of
HUVECs. In addition, miR-A inhibited tube formation
by suppressing the expression of CAV1at the posttran-
scriptional level, respectively, resulting in defective
angiogenesis and MMD pathogenesis.
Summary/Conclusion: Hsa-miR-A is markedly ele-
vated in plasma MV of patients with MMD. The poten-
tial role of these microRNAs in the pathogenesis of
MMD can contribute to find new diagnostic and ther-
apeutic target of MMD.
Funding: This study was supported by a grant from the
Korean Healthcare Technology R&D Project, Ministry
of Health & Welfare (HI17C1256) and Basic Science
Research Program, the Ministry of Science, ICT and
Future Planning (2018M3A9H1023675).
PT03.05
Micro RNA- 451-5p in urinary exosomes for non-invasive monitoring
of reno-protective response
Manju Kumari, Aradhana Mohan, Ravi S. Singh, Rajni Sharma and Swasti
Tiwari
Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India
Introduction: MicroRNA-451 in urinary exosomes
(UE) had been demonstrated as a sensitive predictor
of kidney injury in diabetic rats by us. Here, we deter-
mined whether miR-451 in UE could also assess sever-
ity of kidney injury and/or reno-protective response to
therapy.
Methods: Streptozotocin-induced (STZ, 50 mg/kg of
body weight, i.p) type-1 diabetic rats were fed with
normal chow diet (DM) or high cholesterol diet
(DM + HCD), to increase the severity of nephropathy.
Half rats in DM + HCD group were treated with
atorvastatin (AT, 20 mg/kg body weight,
DM + HCD + AT) for 8 weeks and rest remained
untreated. After 8 weeks, urine was collected for exo-
somes-enrichment and albumin to creatinine ratio
(ACR). Primary cultures of human proximal tubular
cells (hPC) and their secreted exosomes were also stu-
died. Taqman-based real-time qPCR was done for
miR-451-5p.
Results: At the end of the study, DM + HCD had
significantly higher ACR while lower renal miR-451
levels, relative to DM and DM + HCD + AT rats. In
addition, a strong negative correlation of renal miR-
451 was found with ACR. In contrast to kidney tissue,
UE analysis revealed a positive correlation of miR-451
levels with ACR in these rats. Moreover, miR-451 in
UE was significantly higher DM + HCD rats relative to
DM and DM + HCD + AT rats. In vitro studies con-
firmed the direct effect of hyperglycaemia / mechanical
on miR-451 expression.
Summary/Conclusion: Severity of kidney injury in rats
is associated with lower renal miR-451 and higher UE
miR-451. Statin attenuated renal injury and miR-451
levels in UE, while improving renal levels. MiR 451
analysis in UE may assess therapeutic response of
reno-protective drugs non-invasively
Funding: Funded by ICMR and DBT, Govt. of India.
PT03.06
Circulating miR-451a is a useful biomarker for haemolysis
Yukichi Takada, Tatsuki Shibuta and Tsukuru Umemura
International University of Health and Welfare, Okawa City, Japan
Introduction: Red blood cells (RBCs) are circulating
enucleated cells, and its main component is haemoglo-
bin carrying O2/CO2. RBCs contain erythroid lineage-
specific microRNA (miRNA), miR-451a. Biogenesis of
miR-451a depends on the activity of Ago2, and also
circulating miR-451a is mainly Ago2-bound, non-exo-
some miRNA. For utilizing circulating miR-451a for
diagnosis of anaemia which is caused by destruction of
RBCs (haemolysis), it is important to evaluate distribu-
tion pattern of circulating miR-451a.
Methods: We analysed 120 remnant serum samples
obtained from routine blood drawing for laboratory
testing. The study was done under permission of The
Ethical Committies of International University of
Health and Welfare and Kohoukai Takagi Hospital.
Serum miRNAs were analysed using TaqMan
microRNA assay kits and RT-qPCR (ABI 7500fast).
Exosomes were obtained using the ultracentrifugation
method and the precipitation method.
Results: We analysed 120 remnant serum samples
obtained from routine blood. The sensitive Hb detec-
tion method using 414 nm absorbance
(NanoDrop2000, ThermoFischer) showed that 100%
of blood sampling had haemolysis. The levels of
serum miR-451a also increased in all samples.
Ultracentrifugation method and precipitation method
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showed more than 90% of serum miR-451a is in the
non-exosome fraction.
Summary/Conclusion: miR-451 is a unique miRNA
which is in the non-exosome fraction. The measure-
ment of serum miR-451a is a sensitive and specific
biomarker for haemolysis.
Funding: This work was supported in part by a grant
from the Japan Society for the Promotion of Science
(JSPS KAKENHI Grant Number: JP17K09020).
PT03.07
Circumventing qPCR inhibition to improve amplification of exosomal
miRNAs in preterm foetal sheep heparinised plasma
Bing Xua, Mhoyra Fraser1 and Kenta HT Chob
aDepartment of Physiology, Faculty of Medical and Health Sciences, The
University of Auckland, Auckland, New Zealand; bDepartment of
Physiology, Faculty of Medical and Health Sciences, The University of
Auckland
Introduction: Exosomal miRNAs have been identified
in plasma, which has led to an interest in their poten-
tial as biomarkers of neural injury responses in survi-
vors of prematurity. The chronically catheterized
preterm foetal sheep model is a uniquely versatile
model to advance our understanding of the pathophy-
siological mechanisms underlying preterm brain injury
and develop new therapeutic strategies. However, to
ensure patency of catheters implanted into foetal ves-
sels heparinised saline is infused continually. Heparin
can confound detection of plasma miRNAs. Here we
present an optimal procedure to collect and detect
exosomal miRNAs in foetal plasma that improves sen-
sitivity and performance of qRT-PCR.
Methods: Size-exclusion chromatography (SEC; qEV)
and commercial ExoRNeasy were performed for isola-
tion and purification of extracellular vesicles (EVs) on
foetal plasma collected in K2EDTA tubes in which
varying amounts of heparin or enoxaparin (0–160 IU/
mL) had been added post-thawing. RNA was extracted
from qEV fractions (miRNeasy), ExoRNeasy EVs, or
from whole plasma (miRNeasy) and treated with or
without heparinase I to remove contaminating heparin.
Levels of endogenous miR-16 and let-7a were mea-
sured using qRT-PCR.
Results: Important differences in EV-miRNA abun-
dance were observed between isolation methods.
Heparinase I treatment improved detectability of the
miRNAs in a dose-dependent manner in heparin/non-
heparin spiked whole plasma and when isolated using
the ExoRNeasy kit. Strikingly, SEC removed
endogenous heparin from non-heparin spiked plasma
collected from catheters infused with low-dose heparin
and this effect was not improved by heparinise I.
Further, SEC partially removed contaminating effects
of heparin in heparin spiked whole plasma.
Summary/Conclusion: Treatment of foetal sheep
plasma with heparinase I enables utilisation of qRT-
PCR for reliable miRNA quantification. SEC also
enables removal of inhibitory heparin and therefore
should be considered as a standard step for isolation
and detection of EV-miRNAs in foetal plasma.
Funding: Neurological Foundation of New Zealand.
PT03.09
A particle-based multiplex RT-qPCR for measuring circadian rhythm-
associated genes
Kim Mi Yeona, Jung Seungwona, Kim Junsuna, Lee Heon Jungb and Kim
Sangkyunga
aMolecular Recognition Research Center, Materials and Life Science Research
Division, KIST, Seoul, Republic of Korea; bSleep-Wake Disorders Center,
Korea University Anam Hospital, Seoul, Republic of Korea
Introduction: Biological clocks which regulate the
expression of genes related to the circadian metabolism
of living organisms are directly linked to human health
and disease. Many studies also have suggested to ana-
lyse mental health issues such as depression and bipo-
lar disorder through molecular analysis of circadian
rhythm-associated genes recently. These genes are gen-
erally analysed by reverse-transcription real-time PCR
(RT-qPCR) but conventional methods require consid-
erable time, cost and amount of the sample to figure
out multiple genes at the same time.
Methods: We introduce a sensitive and multiplex RT-
qPCR using hydrogel particles. One of the primer pair
used in RT which captures and reverse-transcribes the
target RNA is immobilized in the particle. The other
primer is stored not to react during RT and released
when amplification begins. This strategy can help the
RT process to avoid non-specific products as well as
the amplification to occur effectively.
Results: In order to see RT-qPCR efficiency, PER3
RNA which is synthesized via in vitro transcription
(IVT) of complementary DNA, and total RNA
extracted from LNCAP cell were tested with serial
dilution. As a result, they showed high amplification
efficiency of 95% and 98%, respectively. In addition,
the expression level of genes was successfully measured
even from a single cell. Expression pattern of 8 circa-
dian rhythm-associated genes was acquired from total
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RNA of circadian rhythm-synchronized HeLa cells. In
addition, exosomal RNAs were monitored same cells
every four hours for 48 h in order to obtain molecular
circadian rhythm cycles. Each gene showed unique
pattern of expression.
Summary/Conclusion: For non-invasive diagnosis,
clinical sample of human epithelial cells, saliva
exosome and hair cells were confirmed particular
patterns. Further study will emphasize to take a snap-
shot of molecular circadian rhythm through the com-
bination of expression levels of associated genes
measured at a certain time point for diagnosis of the
mood disorder.
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Unveiling of extracellular exosomal miRNA profiles of breast cancer
Shang-Che Kuoa, Ko-Chien Chena, Takahiro Ochiyab, Wen-Hung Kuoc,
King-Jen Changd, Kuo-Kan Liange and Tang-Long Shena
aNational Taiwan University, Taipei, Taiwan (Republic of China);
bDepartment of Molecular and Cellular Medicine, Institute of Medical
Science, Tokyo Medical University, Shinjyuku-ku, Japan; cNational Taiwan
University Hospital, Taipei, Taiwan (Republic of China); dTaiwan Adventist
Hospital, Taipei, Taiwan (Republic of China); eAcademia Sinica, Taipei,
Taiwan (Republic of China)
Introduction: In an era of precision medicine, biomar-
ker discovery is indispensable for early detection, ther-
apeutic efficacy monitoring and outcome prediction.
MicroRNAs within patient serum exosome have
emerged as significantly measurable biomarkers,
which abundantly existed in the form of liquid biop-
sies, for several diseases, including cancers. They are
essential regulators of global mRNA expression in cells.
Aberrant regulation of miRNA can enables resulting in
tumour initiation, drug resistance and metastasis in
cancer. miRNA assays are convenient for large-scale
studies covering multiple miRNA targets and realistic
in screening across diverse breast cancer types for early
detection or factors that drive cancer progression.
Methods: In this study, we collected patient serum
samples from four major molecular subtypes: luminal
A, luminal B, HER2+ and triple negative types, and
breast cancer patients with benign tumour and ductal
carcinoma in situ (DCIS). Microarray analysis of
miRNA expression was utilized and unique serum
miRNA signatures between non-cancer (including
benign, DICS) and breast cancer patients were identi-
fied with differential expression analysis and the com-
mon features selection method – elastic net. All
combinations of selected miRNAs were modelled with
three different approaches, including generalized linear
model (GLM), linear discriminant analysis (LDA) and
support vector machine (SVM).
Results: To analyse more generally, we applied various
normalization methods and got different outcomes
after feature selection. All the selections were used to
fit prediction models. After applying the filter criteria
based on accuracy evaluation by 10-fold cross-valida-
tion, the top selected miRNAs showed the consistency
of different prediction methods, and the union of these
selections was used in the further modelling. The
results confirmed that few miRNAs are enough to
implement early detection at high accuracy.
Summary/Conclusion: Through identifying these het-
erogeneous compositions of the cancer cells, under-
standing of the molecular mechanisms underlying
these identified biomarkers, which is essential in devel-
oping effective treatments and translational research,
could be established.
PT04.03
Hypoxia may promote tumour aggressiveness and extracellular
vesicle-mediated cell-to-cell communication in multiple myeloma
Kyung Ju Ryua, Ji Young Leeb, Sung Won Limb, Chaehwa Parkc, Kihyun
Kimd and Seok Jin Kimc
aSungkyunkwan University, Seoul, Republic of Korea; bSamsung Medical
Center, Seoul, Republic of Korea; cSungkyunkwan University, Samsung
Medical Center, Seoul, Republic of Korea; dSungkyunkwan University,
Samsung Medical Center, Seoul, Republic of Korea
Introduction: Hypoxia is one of important features of
tumour microenvironment, and tumour cells under
hypoxia can acquire aggressive characteristics including
drug resistance. Thus, tumour progression and resis-
tance to therapy are associated with hypoxic tumour
microenvironment. Multiple myeloma (MM) is a neo-
plasm of bone marrow plasma cells. Bone marrow is
hypoxic compared to other organs, thus, tumour
aggressiveness of MM could be closely associated with
hypoxic microenvironment. Extracellular vesicle is a
small vesicles containing a wide range of functional
proteins, mRNAs and miRNAs that are actively
secreted via exocytosis. In this study, we investigated
the effect of hypoxia on the EV formation of MM cells
to identify the underlying mechanism of tumour
aggressiveness in MM cells.
Methods: We conducted a long-term culture of MM
cell lines under hypoxic conditions (1% and 2% of O2
for 4 weeks), and compared with same MM cell lines
cultured under normal oxygen concentration (20%).
The RNA expression profiles of MM cells under
hypoxia were also compared with that of cultured
cells under normal oxygen condition. The EV derived
from MM cells was isolated using ExoQuick-TC solu-
tion and assessed by transmission electron microscopy,
Nanoparticle tracking analysis and Western blot.
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Results: The overexpression of HIF-1α was demon-
strated in MM cells under long-term hypoxia, and the
expression of stem cell markers were more increased in
MM cells under hypoxic condition compared to nor-
mal oxygen concentration The RNA sequencing
showed up-regulation of gene associated with produc-
tion of EV in hypoxic cultured cells. When we mea-
sured EV from hypoxic cultured MM cells, the amount
of EV was significantly higher in hypoxic MM cells
than normoxic control group. To identify specific
alterations associated with hypoxic MM cells, we pro-
filed miRNAs derived from EV of hypoxic MM cell
lines and those of normoxic MM cell lines. These
results identified eight miRNAs with significantly dif-
ferent expression between MM cells – derived EV.
Summary/Conclusion: We demonstrated the charac-
teristics of long-term hypoxic MM cell-derived EV.
The EV-mediated cell-to-cell communication under
hypoxia might be associated with the content of
miRNA in MM cell-derived EV, and it might influence
tumour aggressiveness of MM cells.
PT04.04
Deep sequencing identified serum exosomal miR-181a-5p as an
indicator for bone-metastatic prostate cancer
Yanqing Wanga, Yu-Xiang Fangb, Baijun Donga, Wei-Qiang Gaob and Wei
Xuea
aDepartment of Urology, Renji Hospital, School of Medicine, Shanghai Jiao
Tong University, Shanghai, China (People’s Republic); bState Key Laboratory
of Oncogenes and Related Genes, Renji-Med X Clinical Stem Cell Research
Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University,
Shanghai, China (People’s Republic)
Introduction: Prostate cancer (PCa) is the most com-
mon male malignancy worldwide with high heteroge-
neity from tumorigenesis to metastasis. Although bone
metastasis is the most critical metastatic event, at pre-
sent, there has been no specific and accurate biomarker
for its diagnosis or differentiation at an early stage of
PCa. Given the fact that the profiling change of exoso-
mal miRNAs can work as a biomaker for metastasis in
multiple tumours, we seek to identify exosomal
miRNAs in patient’s serum as indicators for bone-
metastatic PCa.
Methods: The profiling change of serum exosomal
miRNAs in patients with either benign prostatic hyper-
plasia (BPH) or localized or bone-metastatic PCa was
detected by miRNA-seq and miRNA-chip array, respec-
tively. Prospective miRNAs were further confirmed
using TaqMan miRNA assay in two independent valida-
tion cohorts of total 127 patients with either BPH or
localised or bone-metastasic PCa. Logistic regression
analysis was performed to evaluate the diagnostic
association of candidates with bone metastasis.
Accuracy estimate of each candidate for the diagnosis
of bone-metastatic PCa was quantified using the area
under the receiver-operating characteristic curve (AUC).
Results: By miRNA-seq and miRNA-chip array, we
found four prospective exosomal miRNAs including
miR-181a-5p with significant differences between loca-
lized and bone-metastatic PCa groups (p＜0.05, fold
change ≥1.5 or ≤0.5). In the validation cohorts, logistic
regression analyses indicated that miR-181a-5p and
miR-320a were significantly associated with bone-
metastatic PCa. The AUC analyses identified miR-
181a-5p as the best biomarker with the AUCs 93.1%
for diagnosis of PCa and 73.9% for that of tumour
bone metastasis.
Summary/Conclusion: Serum exosomal miR-181a-5p
is a promising diagnostic biomarker for bone-meta-
static PCa. Further validation is needed.
Funding: National Natural Science Foundation of
China (81630073 to W-QG, 81874097 to Y-XF,
81672850 to BD, 81572536 and 81772742 to WX)
PT04.05
Exosomal miRNAs and proteins signature as prognostic biomarkers
for early stage epithelial ovarian cancer
Shayna Sharmaa, Andrew Laia, Dominic Guanzonb, Terry Morganc, Lewis
Perrind, John Hooperd and Carlos Salomonb
aExosome Biology Laboratory, Centre for Clinical Diagnostics, University of
Queensland Centre for Clinical Research, Royal Brisbane and Women’s
Hospital, The University of Queensland, Brisbane, Australia; bExosome
Biology Laboratory, Centre for Clinical Diagnostics, University of
Queensland Centre for Clinical Research, Royal Brisbane and Women’s
Hospital, The University of Queensland, Brisbane, Australia; cDepartment
of Pathology and Obstetrics, Oregon Health and Science University, Portland,
OR, USA; dMater Health Services, South Brisbane, QLD, Australia, Brisbane,
Australia
Introduction: Epithelial Ovarian Cancer (EOC) is the
leading gynaecological malignancy worldwide due to
the limitations of current detection tests. The 5-year
survival rate with early detection is 90% compared to
20% with late detection. Unfortunately, only 30% of the
cases are detected early. Thus, it is essential to develop
a novel and minimally invasive method to identify
patients at an early stage. Exosomes have shown pro-
mise as biomarkers as they encapsulate vital informa-
tion. Therefore, the aims of this study were to (i)
determine the content of circulating exosomes at early
stages of EOC, and (ii) to determine the prognostic
performance of an early-ovarian cancer screening test
to identify women at risk of developing EOC.
Methods: Exosomes were isolated from the plasma of
patients with either benign disease (n = 50) or Stage I/
II EOC (n = 28), through differential centrifugation
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and size exclusion chromatography. Exosomes were
characterized using Nanoparticle Tracking Analysis,
Western Blot and Electron Microscopy. Exosomal pro-
teins were profiled using Liquid Chromatography–
Mass Spectrometry (LC-MS/MS) and SWATH analysis.
An Illumina TrueSeq Small RNA Library Prep kit was
used for exosomal miRNA profiling. A binomial clas-
sification algorithm was generated using a boosted
logistic regression analysis (WEKA machine learning
software (ver 3.6.12)) of the results obtained from the
benign and Stage I/II samples. The algorithm was built
using 5 miRNAs and 5 proteins identified through
circulating exosome profiling. The expression of speci-
fic miRNAs was confirmed using RT-qPCR to validate
the miRNA sequencing results.
Results: miRNAs and proteins were identified as being
differentially expressed across EOC progression. The
algorithm that we built delivered discrimination
between women with EOC (Stage I/II) compared to
benign. The classification efficiency was assessed by
ROC curve analysis (area under the curve (AUC) was
0.785 ± 0.091 (p = 0.0106)) with positive and negative
predictive values of 75% and 76%, respectively.
Summary/Conclusion: We propose that the combined
measurement of exosomal miRNAs and proteins might
allow for the early identification of women with EOC,
distinguishing between patients with benign disease
and patients with Stage I/II EOC. Future directions
involve the validation of the proposed miRNAs and
proteins in a larger cohort.
Funding: OCRF.
PT04.06
Circulating Extracellular vesicle (EV)-encapsulated microRNAs as a
biomarker of breast cancer
Clodagh O’Neilla, Róisín Dwyerb, Sonja Khana, Katie E. Gilliganc and Peter
Dockeryb
aNational University of Ireland, Galway, Galway, Ireland; bNUI Galway,
Galway, Ireland; 3National University of Ireland Galway, Galway, Ireland
Introduction: Early detection of breast cancer is the
key to improve patient survival. There is currently no
robust biomarker available to detect breast cancer.
Extracellular vesicle encapsulated microRNAs (EV-
miR) provide novel potential in this field. EVs are
tiny nanoparticles released by all cells in the body
that contain various bioactives including miRNA,
believed to reflect the characteristics of the parent
cell. Evidence suggests that tumour associated EVs
have a distinct miRNA expression profile from normal
cells, and could hold novel biomarker potential.
Methods: This study aimed to determine the circulat-
ing EV-miR profile of tumour-bearing animals com-
pared to healthy controls, and relate this to the EV-miR
profile secreted by tumour cells in vitro. EVs were
isolated from the supernatant of HCC-1954 breast
cancer cells expressing luciferase (HCC-luc). EVs
were also harvested from healthy BALB/c nude mice
or those bearing mammary fat pad HCC-luc tumours.
Serum and media EVs were isolated by differential
centrifugation, followed by microfiltration and ultra-
centrifugation. EVs were characterised by Nanoparticle
Tracking Analysis (NTA), western blot and
Transmission Electron Microscopy (TEM). Next-
Generation Sequencing (NGS) targeting miRNA was
preformed to compare the HCC-luc EV-miR profile
in vitro and in vivo.
Results: EVs were successfully isolated and demon-
strated to express CD63, CD9 and CD81. Using NTA,
size distribution was confirmed to be of the predicted
range of 30–120 nm. A range of miRNA was detected
in the HCC-luc EVs in vitro. Interestingly, nine of
these miRNAs were present at significantly higher
levels in the EVs than the cells from which they were
released, e.g. miR-184 and let-7c. Initial analysis
revealed that a number of miRNAs packaged into
EVs by HCC-luc cells In Vitro were also detectable in
circulating EVs isolated from tumour-bearing animals.
Summary/Conclusion: EVs are thought to represent a
fingerprint of the cell from which they are released, and
hold great potential as biomarkers for breast cancer
detection. Further understanding of miRNA trafficking
and transfer in EVs will shed light on their true poten-
tial in the cancer biomarker and therapeutic setting.
Funding: I am funded by the National Breast Cancer
Research Institute (NBCRI).
PT04.07
Role of exosomal microRNA as a biomarker for extranodal NK/T-cell
lymphoma
Kyung Ju Ryua, Chaehwa Parkb, Won Seog Kimb and Seok Jin Kimb
aSungkyunkwan University, Seoul, Republic of Korea; bSungkyunkwan
University, Samsung Medical Center, Seoul, Republic of Korea
Introduction: Extranodal natural killer (NK)/T-cell
lymphoma (ENKTL) is one of aggressive subtype of
non-Hodgkin lymphoma, and all tumour cells are inar-
guably infected with Epstein–Barr virus. The cell to cell
interaction and association with tumour microenviron-
ment could be important for this disease entity.
Exosomes are small membrane vesicles of 30–150-nm
diameter that plays an important role in the tumour
microenvironment, and they are actively secreted by
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most cell types, including cancer cells. In particular, the
intra-exosomal microRNA is known as being impor-
tant for intercellular communications. However, the
clinical significance of exosomal miRNAs in ENKTL
has not been examined. Thus, we characterized exoso-
mal miRNAs in ENKTL and analysed their effect on
the outcomes of patients.
Methods: We isolated exosomes from ENKTL patient
serum and lymphoma cell lines using ExoQuick and
analysed by transmission electron microscopy,
Nanoparticle tracking analysis (NTA) and Western
blot. We performed exosomal microRNA profiling via
the nCounter miRNA expression assay on exosomes
from 45 ENKTL patients and lymphoma cell lines.
Results: We isolated and characterized exosomes from
NKTL patient serum and cell lines using ExoQuick,
and analysed by TEM, NTA and Western blot. The
serum-derived exosomes had a diameter of
95.84 ± 11.37 nm and exosome concentrations ranged
from 0.25 to 14 × 1012/mL. We verified exosomes
morphology and size using TEM, and detected exoso-
mal markers, including Alix, and CD63 by western
bolt. We performed miRNA microarrays to compare
exosomal miRNAs of patients with ENKTL having
good and bad prognosis. As shown in the microarray
results, we found various miRNAs that were differen-
tially contained in the serum – derived exosomes of
NKTL poor relative to good subjects. These results
identified 30 miRNAs with significantly different
expression between NKTL samples. Five of these
miRNAs were up-regulated and 25 ware down-regu-
lated in the serum-derived exosomes of NKTL bad
compared to the good subjects (p value < 0. 05). We
identified two exosomal miRNA signatures, has-miR-
320e and miR-4516, that were associated with poor
outcomes with regard to OS and PFS.
Summary/Conclusion: Our study provides that exoso-
mal miRNA, miR-320e and miR-4516, may serve as
potential diagnostic and prognostic biomarker in
NKTL.
PT04.08
Cancer-derived exosomes enriched from patient plasma strongly
mirror parent tumour and enable subtyping of early stage breast
cancer via liquid biopsy
Christine Coticchiaa, Robert Kitchenb, Sudipto Chakraborttyb, Douglas
Robertsa, Lisa Bedfordc, Sunita Badolac, Sylvie Vincentc, Seth YuB and
Johan Skogd
aExosome Diagnostics, Waltham, USA; bExosome Diagnostics, Inc, Waltham,
USA; cTakeda, Cambridge, USA; dExosome Diagnostics, Inc., Waltham,
MA, USA
Introduction: Tumour-derived molecular signatures of
breast cancer (BCa) have accelerated personalized med-
icine as prognostic and predictive indicators leading to
improved clinical outcomes. Currently, molecular pro-
filing is performed on biopsied breast tumour tissue
but our goal of “liquid biopsy” is to obtain disease-
relevant genetic material non-invasively by capturing
exosomes, cfDNA, or protein from bodily fluids.
Unfortunately, a major limitation of liquid biopsy
stems from the scarcity of disease-relevant material
compared to background. Here we describe an enrich-
ment process in plasma capable of isolating cancer
specific exosomal subpopulations originating from
early stage breast tumours.
Methods: Tumour-specific surface markers on exo-
somes were targeted and enriched from plasma
obtained from stage I/II ER positive / HER2 negative
BCa patients and age-matched controls. RNA-sequen-
cing was performed on total RNA isolated from 15 BCa
tumour tissues (FFPE) and 15 patient-matched plasma
exosome samples (with and without exosome enrich-
ment). We also sequenced RNA from 12 healthy breast
tissues (FFPE) and plasma exosomes from 10 healthy
post-menopausal women (with and without tumour
exosome enrichment). RNA-seq data were used for
gene-level differential abundance analysis.
Results: Tumour-derived exosome enrichment was
observed in 63% of the BCa patients with detectible levels
of the target antigens in their plasma. RNA-seq gene
expression profiles of these enriched exosomes were highly
correlated with those of the breast tumour FFPE samples.
Tumour-enriched exosomal RNA abundance clustered
most tightly with the FFPE tissue derived from the same
patient; evenmore so than BCa FFPE samples correlated to
each other. The strength of the correlation between BCa
enriched plasma exosomes and matched patient tissue was
sufficient to enable correct tumour subtyping (by both
PAM50 & IntClust gene targets) using only the enriched
plasma exosomal RNA.
Summary/Conclusion: Tumour-specific exosome
enrichment improved plasma-derived exosomal RNA
signal to noise and revealed RNA profiles that closely
reflect the donor tumour, thus enabling the detection
and characterization of early stage breast cancers.
PT04.09
Exosomes: the same team for hepatocellular carcinoma development
on the background of HCV and ergotism?
Alisa Petkevich, Alexandr Abramov, Mohamed Kadle and Vadim Pospelov
Peoples’ Friendship University of Russia (RUDN University), Moscow, Russia
62 ISEV2019 ABSTRACT BOOK
Introduction: Hepatocellular carcinoma (HCC) may
be caused by a wide variety of reasons, two possible
of them are hepatitis C virus infection (HCV) and
alkaloids contained in the ergot (Claviceps). Anyway,
not all of the individuals infected with HCV or living in
regions endemic for ergot develop HCC so it is reason-
able to develop biomarker panel for identification of
risk groups for HCC. Exosomes seem to be an ideal
source of such biomarkers as far as they contain exactly
the information molecules packed by cells during its
physiological (or pathological) functioning.
Methods: 48 plasmas of patients with HCC from
Somalia (from a region with a high degree of ergot
alkaloides in food), and 18 plasmas of HCC (Russia) on
the background of cirrhosis due to HCV. Exosomes
were isolated from plasma by differential ultracentrifu-
gation following free-flow electrophoresis. MiRNA let-
7a-5p, −224-5p, −106b-3p, −126-5p, −122-5p, −16-5p
and −34a-5p were determined in exosomes by qPCR-
RT. Same free miRNA from plasma were determined.
PD-L1 expression was assessed on the surface of exo-
somes by TEM and HR-FCM. PD-L1 expression was
also assessed on the surface of exosomes isolated from
plasma of healthy donors (n = 8).
Results: There was a slight difference in exosomal
miRNA profile of plasma from HCC on the back-
ground of HCV and on the background of HCV and
living in ergot region. PD-L1 expression on the surface
of exosomes from HCC plasmas were higher (MV
35,8% for both HCC groups, MV 5% for healthy
donors group). Plasma free miRNA profiles were dif-
ferent inside every HCC group.
Summary/Conclusion: According to our results, exo-
somal miRNA identification in HCC patients seem to
be more accurate than plasma free miRNAs, further
research is needed in order to identify whether it is
reasonable to use both free and exosomal miRNAs. The
difference in miRNA profiles of HCC patients on the
background of HCV or alkaloids of ergot may allow
supposing different epigenetics dysregulation happen
in HCC depending on the trigger factor.
PT04.10
Exosomal sorting of circRNA promotes cancer progression and serves
as a novel biomarker for gastric cancer
Rong Lia, Junyi Wangb, Xu Zhangb, Hui Qianc and Wen Rong Xud
aJiangsu Key Laboratory of Medical Science and Laboratory Medicine, School
of Medicine, Jiangsu University, Zhenjiang, China, Zhenjiang, China
(People’s Republic); bZhenjiang Key Laboratory of High Technology
Research on Exosomes Foundation and Transformation Application,
Jiangsu Key Laboratory of Medical Science and Laboratory Medicine,
School of Medicine, Jiangsu University, Zhenjiang, China (People’s
Republic); cZhenjiang, China (People’s Republic); dZhenjiang Key
Laboratory of High Technology Research on Exosomes Foundation and
Transformation Application, Jiangsu Key Laboratory of Medical Science
and Laboratory Medicine, School of Medicine, Jiangsu University,
ZhenJiang, China (People’s Republic)
Introduction: Exosomes are critical mediators of
intercellular communication and promising biomar-
ker for cancer. However, whether the release of exo-
somes has an effect on donor cells has not been well
investigated. In this study, we aimed to identify the
clinical values of exosomal circRNAs in gastric cancer
(GC). Meanwhile, we explored the biological roles and
mechanisms during GC cells selectively sorting exo-
somal circRNAs.
Methods: Database circ2Traits and starBase v2.0
were used to screen potential GC related circRNAs
and validated their expression levels in over 50
paired serum or exosomes from GC patients and
healthy volunteers, or 100 cancer tissues and adja-
cent normal tissues from GC patients. Receiver
operating characteristic curve, clinicopathological
features analysis and overall survival (OS) and dis-
ease-free survival (DFS) curve were made to evalu-
ate the clinical relevance of these circRNAs and
select circ1477 as potential biomarker for further
studies. Circ1477 overexpression and knockdown
experiments were conducted to assess the effects
on GC progression in vitro and in vivo. RIP, luci-
ferase assay, RNA FISH and rescue experiments
were applied to demonstrate its molecular
mechanism.
Results: We found that the level of circ1477 in serum
or serum exosomes of GC patients was significantly
higher than that in healthy volunteers. Whereas, the
level of circ1477 in cancer tissues and was remarkably
lower compared to adjacent normal tissues of GC
patients, which was associated with lymph node metas-
tasis and prognosis. Also, the expression of circ1477
was observed to be decreased in GC cell lines while
increased in their derived exosomes, suggesting that
circ1477 could be selectively sorted into exosomes by
GC cells. Furthermore, cytoplasmic circ1477 could
suppress the migration and invasion of GC cells acting
as miRNA sponges while knockdown of it could
reverse these effects.
Summary/Conclusion: Taken together, our findings
indicate that tumour suppressive circ1477 could be
selectively sorted into exosomes to promote tumour
progression and serve as a potential biomarker for
gastric cancer.
Funding: National Natural Science Foundation of
China: (81572075); Technology Development Project
of Jiangsu University (20180361)
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PT04.11
Development of non-invasive tests for prostate cancer
David J. Whittakera, Bianca Dobsona, Clare Eltona, Damian Whitea, Nancy
Frédérickxa, Nicola Jacksona, Niha Phukana, Mike Herberta, Rebecca Girvana,
Lia Boottena, Genevieve Johnstonb, Dug Yeo Hana, Ben Currana, Jennifer
Barnesa, Robert Mitchella and Keith Hudsonb
aCaldera Health, Auckland, New Zealand; bCaldera Health, Auckland, USA
Introduction: Prostate cancer (PC) is the most common
non-skin cancer in males and is fast becoming the most
frequently diagnosed cancer in men. Despite significant
advances in diagnosis and treatment PC remains a lead-
ing cause of cancer deaths. Analysis of PSA in blood has
long been used for early diagnosis and monitoring but is
flawed by low sensitivity and a high rate of false posi-
tives, with negative health consequences including the
overtreatment of many indolent prostate cancer
tumours. Caldera Health is developing non-invasive
liquid biopsy tests for prostate cancer to improve upon
and replace the controversial serum PSA test.
Methods: Through a series of clinical studies, Caldera
Health has identified promising RNA biomarkers for
PC diagnosis. Preliminary experiments indicated that
in urine a far greater proportion of prostate RNA is
localised in extracellular vesicles (EVs) than in cellular
material. A simple and reliable process was optimised
to concentrate urinary EVs and a novel method was
developed to specifically isolate the EV’s of prostatic
origin with high efficiency. Subsequently a clinical
study was performed using qRT-PCR to quantify
RNA biomarkers in approximately 300 urine samples
collected from men scheduled for prostate biopsy tests.
The clinical study participants provided informed con-
sent and the study was approved by recognised medical
ethics committees in New Zealand and Australia.
Results: Comparison of the qPCR data for prostate,
bladder and kidney-specific genes indicated our pros-
tate vesicle isolation method successfully reduces con-
tamination with vesicles from both kidney and bladder.
The clinical study data was used to develop accurate
prostate cancer diagnostic models.
Summary/Conclusion: Caldera Health has identified
EV RNA biomarkers associated with prostate cancer
and developed a novel method to specifically isolate
prostate-derived EVs from urine. We have tested multi-
ple biomarkers and developed gene signatures identify-
ing prostate cancer with high sensitivity and specificity.
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PT05.01
Uncovering the role of heparan sulphate proteoglycans in
extracellular vesicle biogenesis: potential tools for improved
therapies
Rebecca L. Morgana, Rebecca Holleyb, Jason Webberc, David Oniond, Cathy
Merryd and Oksana Kehoee
aKeele University, Nottingham, UK; bThe University of Manchester,
Manchester, UK; cCardiff University, Cardiff, UK; dUniversity of
Nottingham, Nottingham, UK; dKeele University, Oswestry, UK
Introduction: Many cell types deliver therapeutic
effects by secreting extracellular vesicles (EVs).
Therefore, EVs could be used as an alternative
approach to cell-based therapies, overcoming many
cell-associated challenges. EVs could be optimised to
generate potent therapies through manipulating the
mechanisms driving EV biogenesis. We aim to prove
this concept by altering the heparan sulphate (HS)
chains found on syndecan, a key component in the
syndecan-syntenin-ALIX mechanism. We predict that
HS is involved in cargo selection due to its ability to
form interactions with a wide range of factors. In
addition, the structure of HS influences the activity of
heparanase, a regulator in the rate of EV production.
Therefore, structural alterations to HS could allow the
cargo (thus therapeutic activity) to be modulated whilst
simultaneously increasing EV yields.
Methods: MCF-7s mutated to alter expression of HS
biosynthetic enzymes were generated using CRISPR-
Cas9. Wild type and mutant MCF-7s were cultured in
bioreactors using media containing EV-depleted
Knockout Serum Replacement. EVs were isolated by
differential ultracentrifugation and characterised
using Transmission Electron Microscopy (TEM),
Nanoparticle Tracking Analysis (NTA) and Western
Blot.
Results: A FACS-based method has been developed to
characterise and sort EVs based on their displayed HS.
The cargo and functional activity of the sorted popula-
tions was then assessed. Since heparanase influences
EV production rates, MCF-7s were incubated with a
heparanase inhibitor (OGT2115). Subsequent altera-
tions to soluble, cellular and vesicular HS composition
was analysed by fluorescent labelling and SAX-HPLC
identification. EV size and concentration was assessed
using TEM and NTA.
Summary/Conclusion: Optimising EVs may generate
highly efficacious and cost-effective treatments in com-
parison to those based on the producer cell line.
Alterations to the HS structures on syndecan could be
an ideal method for optimisation.
Funding: This PhD project is funded by EPSRC
and MRC.
PT05.02
Augmentation by GnRH of ectosome containing annexin A5
formation by blebbing of pituitary gonadotropes and its biological
effect
Mitsumori Kawa “a” minamia, Fungbun Numfab, Makoto Sugiyamac, Ryota
Terashimad and Shiro Kurusue
aVeterinary Physiology, Faculty of veterinary medicine, Okayama University
of Science, Imabari, Ehime, Japan; bKhon Kaen University, Towada, Japan;
cKitasato University, Towada, Japan; dVeterinary Physiology, Kitasato
University, Towada, Japan; eVeterinary Physiology, Kitasato University,
Towada, Japan
Introduction: We have demonstrated that gonadotro-
pin releasing hormone (GnRH) stimulates the synthesis
of annexin A5 (ANXA5), a member of annexin family
protein, in the pituitary gonadotropes and ANXA5
augments GnRH stimulation of gonadotropin secre-
tion. It is, however, obscure how ANXA5 augments
gonadotropin release at gonadotropes. As ANXA5
was demonstrated both in and out of cells, in the
present study, we examined translocation of ANXA5
in response to GnRH stimulation in relation to the
release of luteinizing hormone (LH).
Methods: Rat pituitary tissues, primary pituitary cells
and LβT2 gonadotrope cells were used. The condi-
tioned medium was sequentially centrifuged at 20,000
×g and 110,000 ×g to obtain ectosome and exosome
respectively. Immunochemistry for ANXA5 and LHβ
were performed. Transmission electron-microscope
(TEM) was also used.
Results: GnRH agonist (GnRHa) administration
showed the formation of blebs containing ANXA5 on
LβT2 cells and primary pituitary cells after only 10 and
30 min incubation. Hemi-pituitary gland was cultured
with GnRHa and TEM showed that the boundary of
GnRHa stimulated gonadotrope-like cell became
obscure with many bubble like particles after 30 min
incubation. The 20,000 ×g and 110,000 ×g particles
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were increased by the GnRHa treatment. ANXA5 was
detected dominantly in 20,000 ×g pellet after treatment
with GnRHa. It increased until 180 min. ANXA5 in
110,000 ×g pellet was also shown at 180 min. GnRHa
treated 20,000 ×g particulate fraction significantly sti-
mulated LH release in a dose dependent manner.
Extracellular vesicle fraction prepared from plasma of
one-week ovariectomized rats, in which GnRH secre-
tion was expected to be augmented, showed significant
increase of ANXA5 in the 20,000 ×g pellet. The bleb-
bing induced by GnRH was inhibited by H89, protein
kinase A inhibitor. It is suggested that Gαs signalling is
necessary for GnRH stimulation of blebbing.
Summary/Conclusion: Present study clearly demon-
strates a hormonal regulation of ectosome formation
and a novel mechanism of cell–cell communication by
means of ANXA5 including ectosome.
PT05.03
Investigation into a novel role for the prolyl isomerase cyclophilin A
during Extracellular vesicle signaling in cancer
Yunjie Wua, Kieran Brennanb and Margaret M. Mc Geea
aUCD School of Biomolecular & Biomedical Science, Conway Institute,
University College Dublin, Dublin, Ireland; bUniversity College Dublin, Ireland
Introduction: Extracellular vesicles (EVs) released
from cells mediate local and systemic cell–cell commu-
nication via the horizontal transfer of functional pro-
tein, DNA and RNA into recipient cells. Evidence
reveals that tumour-derived EVs mediated intercellular
communication between tumour cells and normal cells
within the tumour microenvironment to initiate meta-
static niche formation. Thus, disruption of EV-
mediated tumour-niche interactions is a novel strategy
for metastasis prevention. However, significant chal-
lenges in EV biology must be overcome for the transla-
tion of EVs into the clinic; in particular, in
understanding their biogenesis and mechanism of
action within the tumour microenvironment. The pro-
lyl isomerase Cyclophilin A is overexpressed in a large
variety of cancers and is associated with an aggressive
phenotype of metastasis and chemoresistance.
Unpublished data from our lab revealed that loss of
CypA expression significantly reduced tumour growth
and metastasis in vivo supporting a role in tumour
progression. In this study, potential functions of
CypA in EV biology and function are investigated.
Methods: EV Isolation: Differential Ultracentrifugation,
Optiprep Density Gradient
EV characterization: Nanosight Tracking Analysis,
Flow cytometry, Transmission Electron Microscopy,
Mass spectrometry EV identification: Western Blot,
Co-immunoprecipitation
Results: CypA is found to be enriched in cancer-derived
EVs in a range of solid and haematopoietic malignancies.
In addition, CypA is predominantly found in EVs within a
specific density range. Moreover, homozygous loss of
CypA expression reduces the number of EVs within a
specific size range. Investigation of CypA interacting pro-
teins by mass spectrometry reveals potential functions in
EV cargo loading.
Summary/Conclusion: This study reveals a potential
role for CypA in EV biogenesis, and highlights its
potential as a novel EV target for the prevention of
tumour progression. Significance of this study is that
CypA could be a potential target for EV release. This
work contributes to the understanding of CypA-depen-
dent EV subtype for its biology and function during
cancer metastasis and may reveal novel strategies for
the generation of targeted EV subtype therapeutics.
Funding: UCD-CSC Scholarship (not include travel
funding).
PT05.04=OWP2.12
Identification of a protein that presumably controls bacterial
vesiculation in response to the extracellular environments
Fumiaki Yokoyamaa, Jun Kawamotoa, Chen Chena, Tomoya Imaib and
Tatsuo Kuriharaa
aInstitute for Chemical Research, Kyoto University, Uji, Japan; bResearch
Institute for Sustainable Humanosphere, Kyoto University, Uji, Japan
Introduction: Many bacteria utilize extracellular mem-
brane vesicles (EMVs) for survival in their growing
environments through communication with others,
pathogenesis and biofilm formation. Therefore, the
amounts and the components of EMVs should be
tuned in response to the conditions. Although several
vesiculation mechanisms are suggested, little is known
how bacteria control vesiculation in response to the
environments. A bacterium Shewanella sp. HM13 has
9-fold higher lipid-secretion capability in EMV frac-
tions than Escherichia coli, and its EMVs contain a
major protein (P49), which is not required for vesicle
production. We used mutant EMVs that lack P49 to
identify minor components of EMVs that may control
vesiculation.
Methods: EMVs were subjected to 2D gel-based pro-
teomics by peptide mass fingerprinting. Within the
identified proteins, the function of a sensor protein
homolog, HM1275, was analysed by swarming assay
and lipid-staining to quantify EMVs produced in var-
ious media. Changes in the number of EMVs
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depending on culture media were quantified by tunable
resistive pulse sensing method.
Results: A protein with a PAS domain and a methyl-
accepting chemotaxis protein (MCP) sensing domain,
HM1275, was identified in the EMVs. Although some
MCPs are related to flagellar motility by binding some
attractants, the flagellar motility of Delta-hm1275 was
not significantly different from that of WT. Although
the amounts of EMVs produced by WT were increased
in response to the concentration of casamino acids in
poor nutrient medium, those by Delta-hm1275
were not.
Summary/conclusion: A putative sensor protein,
HM1275, was identified in EMVs and may recognize
the extracellular environments by binding signal mole-
cules in casamino acids to control vesiculation.
Although further studies are required to reveal the
signals and the sensing pathways, the results obtained
in this study indicate that bacterial vesiculation is con-
trolled by extracellular environments, and artificial
control of vesiculation with extracellular signals
would be useful in applications such as suppression of
vesicle-dependent pathogenicity.
Funding: Japan Society for Promotion of Science
Research Fellowship for Young Scientists
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Prokaryotic BAR domain-like protein BdpA promotes outer
membrane extensions
Daniel A. Phillipsa, Lori Zacharoffb, Cheri Hamptonc, Grace Chongb, Brian
Eddied, Anthony Malanoskid, Shuai Xub, Lauren Ann Metskase, Lina Birdf,
Grant Jensene, Lawrence Drummyc, Moh El-Naggarb and Sarah Glavend
aAmerican Society for Engineering Education – U.S. Naval Research
Laboratory, Washington, USA; bUniversity of Southern California, Los
Angeles, USA; cMaterials and Manufacturing Directorate, Air Force
Research Laboratory, Dayton, USA; dU.S. Naval Research Laboratory,
Washington, USA; eCalifornia Institute of Technology, Pasadena, USA;
fNational Research Council, Washington, USA
Introduction: Bin/Amphiphysin/RVS (BAR) domains
belong to a superfamily of membrane-associated
coiled-coil proteins that influence membrane curva-
ture. BAR domains are ubiquitous in eukaryotes and
associated with membrane curvature formation, vesicle
biogenesis/trafficking, protein scaffolding and
intracellular signalling. While advances in protein
domain prediction have facilitated the identification
of several BAR domain proteins, they have yet to be
characterized in bacteria. Here, we identified a putative
BAR domain-containing protein enriched in the outer
membrane vesicles (OMVs) of Shewanella oneidensis
MR-1, a dissimilatory metal-reducing bacteria known
to produce outer membrane extensions (OMEs) that
are suspected to facilitate long distance extracellular
electron transfer (EET) but whose physiological rele-
vance and mechanism of formation remain unknown.
Methods: Purified S. oneidensis OMVs were prepared
by filtration and ultracentrifugation for comparative
proteomics with cell-associated outer membrane pro-
teins or for electrochemical measurements. Protein
domains were predicted using HMMSCAN and
CDD-search. OME formation and phenotype analyses
were performed in situ by confocal and cryo-electron
microscopy.
Results: The putative BAR domain-like protein BdpA
was highly enriched in OMVs compared to cell-asso-
ciated outer membranes. During OME biogenesis, WT
S. oneidensis OMEs progress from elongated vesicle
chains to narrow, tubule-like extensions while ΔBdpA
OMEs remain as disordered vesicle chains. Purified
OMVs from these strains are electrochemically active,
with redox signals consistent with multiheme outer
membrane cytochromes, supporting the role of OMEs
in EET. Heterologous BdpA expression promotes OME
formation in Marinobacter atlanticus and Escherichia
coli, suggesting BdpA membrane sculpting activity is
inducible and transferrable.
Summary/conclusion: The ability of BdpA to promote
OME formation and maturation into tubules in vivo
supports BdpA as a comparator for BAR domain pro-
tein activity in bacteria.
Funding: US DoD Synthetic Biology for Military
Environments (SBME) Applied Research for the
Advancement of Science and Technology Priorities
(ARAP)
NSF Dimensions: DEB-1542527
US DOE: DE-FG02-13ER16415
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Development of CD40L-modified small extracellular vesicles for the
effective induction of anti-tumour immune response
Wen Liua, Yuki Takahashib, Masaki Morishitac, Makiya Nishikawad and
Yoshinobu Takakurab
aKyoto University, Kyoto, Japan; bGraduate School of Pharmaceutical
Sciences, Kyoto University, Kyoto, Japan; cKyoto Pharmaceutical University,
kyoto, Japan; dTokyo University of Science, Noda, Japan
Introduction: Tumour-derived small extracellular vesi-
cles (sEVs) are anticipated to be a novel cancer vaccine
because of their inherent encapsulation of tumour anti-
gens. In this research, tumour-derived sEVs were mod-
ified with CD40 ligand (CD40L), which is a ligand for
CD40 expressed on dendritic cells (DCs) and can acti-
vate DCs, in order to induce effective tumour antigen-
specific immune response.
Methods: B16-BL6 murine melanoma cells were
selected as sEVs-producing cells. Plasmid vector
encoding a fusion protein of CD40L and lactadherin
(LA), named as CD40L-LA, was constructed. B16-BL6
cells were transfected with the CD40L-LA-expressing
plasmid vector and CD40L-modified sEVs (CD40L-
sEVs) were collected from the culture medium of the
transfected cells. The collected sEVs were characterized
by using western blot, zeta sizer and transmission elec-
tron microscope (TEM). CD40L-sEVs labelled with
PKH67 were added to DCs and the uptake of CD40L-
sEVs was evaluated by flow cytometer. CD40L-sEVs
were added to DCs and the cytokine release from the
cells was measured by ELISA. Presentation of mela-
noma antigens contained in sEVs were evaluated by
measuring cytokine release from melanoma antigen
gp100-specific T cells, which were co-incubated with
CD40L-sEVs added DCs. The concentrations of cyto-
kines in the culture medium were determined using
ELISA.
Results: The negatively charged sEVs with a diameter
of approximately 100 nm were successfully modified
with CD40L. CD40L-sEVs were more efficiently taken
up by DCs than unmodified sEVs. DCs added with
CD40L-sEVs produced more TNF-alpha and IL-12
than those added with unmodified sEVs. Moreover,
CD40L-modification of sEVs improved the melanoma
antigen presentation efficiency of DCs, which was
demonstrated by increased IL-2 secretion from mela-
noma antigen gp100-specific T cells.
Summary/Conclusion: It was shown that CD40L-
modified sEVs can be used to induce effective anti-
tumour immune response.
PT06.02
Development of Interferon γ-loaded tumour cell-derived extracellular
vesicles applicable to cancer vaccine therapy
Naoki Nakagawaa, Yuki Takahashib and Yoshinobu Takakurab
aGraduate School of Pharmaceutical Sciences, Kyoto University, Kyoto,
Japan; bGraduate School of Pharmaceutical Sciences, Kyoto University,
kyoto, Japan
Introduction: Extracellular vesicles (EVs) contain var-
ious substances such as proteins and nucleic acids
derived from their producing cells. As tumour cell-
derived EV (TEV) contains tumour antigens, TEV is
expected to be used as a cancer vaccine. However, since
the immune activation ability of TEV is low, it is
difficult to induce effective anti-tumour immunity by
simple administration of TEV alone. Hence, in this
study, we attempted to enhance the immune activation
ability of TEV by loading Interferon (IFN)-γ.
Methods: A plasmid vector encoding a fusion protein
of lactadherin that specifically bind to phosphatidylser-
ine contained in EV membrane and mouse IFN-γ was
prepared and the vector was transfected into a mouse
melanoma cell line B16BL6 cells. Then, IFN-γ-loaded
TEV (γ-TEV) was collected from the supernatant of
the transfected cells by ultracentrifugation. IFN-γ
loaded on the collected TEVs was detected by
Western blotting and ELISA. IFN-γ biological activity
of IFN-γ loaded on γ-TEV was evaluated by a reporter
assay. In addition, γ-TEV was added to the mouse
dendritic cell line, DC 2.4, and mRNA and protein
expression levels of antigen presentation-related genes
were analysed using RT-qPCR and FACS analysis.
Finally, splenocytes of mice that had received intrader-
mal administration of γ-TEV were collected and the
amount of IFN-γ produced from the splenocytes incu-
bated with B16BL6 antigens was measured.
Results: It was confirmed that IFN-γ was successfully
loaded to TEV. In addition, the reporter assay con-
firmed that the biological activity of IFN-γ was retained
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in γ-TEV. Addition of γ-TEV to DC 2.4 increased
mRNA and protein expression of MHC class I and
CD86 compared to TEV alone group, which suggests
that immune activation ability of TEV was increased by
loading IFN-γ. Furthermore, in the splenocytes assay,
the amount of IFN-γ production was significantly
increased in the γ-TEV administration group com-
pared with the group administered with simple mixture
of IFN-γ and unmodified TEV.
Summary/Conclusion: These results indicated that
IFN-γ loading to TEV is an effective approach for
cancer immunotherapy using TEV.
PT06.03
Apoptotic neuroblastoma derived extracellular vesicles can prime
mesenchymal stem cells to decrease regulatory T cells differentiation
Anita KY. Li and Godfrey Chan
The University of Hong Kong, Hong Kong, Hong Kong
Introduction: There are many ongoing studies investi-
gating tumour derived extracellular vesicles (EVs). Yet
in cancer patients receiving chemotherapy, a majority of
the tumour are undergoing apoptosis and the difference
between health cancer and dying cancers EVs are still
unknown. Apoptotic tumour cells can secrete EVs con-
taining different messages to the tumour microenviron-
ment and effect the surrounding cells in a different way.
Mesenchymal stem cell (MSC) is a heterogeneous multi-
potent stem cell found within the tumour microenvir-
onment and can regulating the immune system. The
aim of this study is to investigate the role of apoptotic
EVs on mesenchymal stem cell immunomodulatory
function in a tumour microenvironment.
Methods: EVs were obtained from both healthy SK-N-
LP neuroblastoma cell line and those treated with the
chemo drug cisplatin for 24 h. EVs were isolated from
ultracentrifugation at 16,000 g for larger EVs and
100,000 g for smaller EVs. The characterization of the
different populations of EVs was performed by western
blot and nanoparticles tracking analysis. Neuroblastoma
derived EVs were then co-cultured with immortalized
human MSC (hTMSC) for 48 h. The immunomodula-
tory function of hTMSC was determined by their effect
on T cells isolated from PBMC.
Results: T cells co-cultured with hTMSC have an
increase in FoxP3 expression whereas hTMSC that
has been primed with apoptotic EVs from neuroblas-
toma showed a significant decrease in FoxP3 expres-
sion. The DAMP molecule HMGB1 was found to be
present in apoptotic EVs, whilst being absent in healthy
neuroblastoma EVs.
Summary/Conclusion: Although MSCs are commonly
known to have an immunosuppressive function, after
the uptake of EVs derived from apoptotic neuroblas-
toma, MSC was able to switch to an immunostimula-
tory phenotype and decreasing Treg differentiation.
Dying tumour cells may package danger signals and
alarmins in their EVs thereby activating immune
response in the tumour microenvironment.
Funding: The Edward & Yolanda Wong Research
Fund
PT06.04
Chronic Lymphocytic Leukaemia-derived small extracellular vesicles:
a potential strategy for immune escape
Ernesto Gargiuloa, Sandrine Piersonb, Bassam Janjia, Jérôme Paggettia and
Etienne Moussaya
aLuxembourg Institute of Health (LIH), Department of Oncology,
Luxembourg, Luxembourg; bLuxembourg Institute of Health (LIH),
Department of Oncology, Luxembourg, Luxembourg
Introduction: Chronic Lymphocytic Leukaemia (CLL)
is the most common adult leukaemia and characterized
by the accumulation of abnormal B lymphocytes. CLL
cell survival and proliferation are highly dependent on
interactions with the microenvironment. Thus, to iden-
tify effective strategies to impair tumour proliferation,
it is essential to understand the communication
between CLL and surrounding tissues.
Methods: To obtain a biological representation of small
extracellular vesicles (small Evs) in the tumour micro-
environment, we established a new protocol allowing
us to isolate highly pure small Evs directly from the
spleen of leukemic mice. Small Evs quality and sample
purity were evaluated with qNano (TRPS principle),
western blot and conventional bead-based flow cyto-
metry. Next, we screened a wide range of immune
checkpoint ligands on the surface of CLL-derived
small Evs and corresponding receptors on the surface
of T cells.
Results: We have succeeded in isolating small Evs
generated by CLL cells in vivo. Our screen suggested
the presence on immune checkpoint ligands directly
anchored on tumour-derived small Evs. Furthermore,
we identified a promising pair ligand-receptor poten-
tially implicated in immune escape. Validation of can-
didates from the screen is currently being performed
through FACS, iFACS and EM. These techniques will
allow us to better define tumour-derived small Evs
populations presenting different immune checkpoints
and to visualize single small Evs with high resolution.
Summary/Conclusion: In this project, we aimed to
isolate and characterize CLL-derived small Evs to
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define their involvement in tumour development, with
focus on the evaluation of their impact on CLL
immune escape.
Altogether, this study will give insight into the spe-
cific immune and stromal cells involved in CLL devel-
opment, with emphasis on their involvement in
tumour-derived small Ev-mediated tumour immune
escape.
Funding: This project is funded by the Fonds National
de la Recherche (FNR) INTER/DFG/16/11509946/EV-
RNA/Moussay.
Sandrine Pierson and Jérôme Paggetti are supported
by the FNR INTER/DFG/16/11509946/EV-RNA/
Moussay.
Ernesto Gargiulo is supported by the grant FNR
Luxembourg PRIDE15/10675146/CANBIO.
PT06.05
Interaction via exosome miRNAs between myelodysplatic cell and
normal Treg
Tatsuki Shibuta, Yukichi Takada and Tsukuru Umemura
International University of Health and Welfare, Okawa City, Japan
Introduction: Myelodysplastic Syndrome (MDS) is a
clonalhematopoietic disease and develops leukaemia in
some cases. Thus, MDS is a malignant hematopoietic
disease and its prevalence ratio is increasing in Japan.
Hematopoietic microenvironment such as bone mar-
row niche is a crucial factor for maintaining leukaemic
stem cells. To understand mechanisms of interactions
between leukaemic stem cells and microenvironment is
important for the treatment of hematopoietic
malignancies.
In this study, to develop the new therapies and
diagnostic methods for MDS, we focused on the effect
of exosomes released from MDS cells on peripheral T
lymphocytes.
Methods: MDS cell line (MDS-L) was kindly provided
by Kasawaki Medical University and normal peripheral
blood mononuclear cells were obtained from healthy
volunteer donors. Exosomes from MDS cells were pur-
ified by using miRCURY Exosome Cell/Urine/CSF Kit
and labelled by PKH67. Extracted miRNAs were ana-
lysed by microarray method (Genopal, Mitsubishi
Chemical, Japan). Cell surface antigens were analysed
by FACS Aria II and fluorescence conjugated
antibodies.
Results: miRNA-microarray analysis showed that nine
miRNAs were abundant in exosomes from MDS cells
and were not detected in MDS cells. Exosomes labelled
with PKH67 dye were added to liquid culture of
regulatory T cells (Treg) that were sorted from normal
peripheral blood. The exosomes were detected in cyto-
sol of Treg by fluorescent microscopy. Microarray ana-
lysis of miRNAs in Treg intaking MDS-exosomes
showed that significant increases of 9 miRNAs in
MDS-exosomes. The conditioned medium of MDS-
exosomes treated Treg culture reduced the population
of activated CD4 cells (CD38 positive cells was 39%;
control 68%).
Summary/Conclusion: Our data suggested that exo-
somes from MDS cells affected the function of regula-
tory T cells via miRNA transfer. MDS exosomes may
effect on immune cells to avoid the exclusion from
cancer-immune system, and may be a target for the
new therapies or diagnostic methods.
Funding: This work was supported in part by a grant
from the Japan Society for the Promotion of Science
(JSPS KAKENHI Grant Number: JP17K09020 and
17H07059).
PT06.06
Mechanism of antitumor immunity activation by ‘artificial
neoantigen’-presenting exosomes
Yoshiyuki Koyamaa, Tomoko Itoa, Masazumi Eriguchia, Aya Hasegawab,
Wakana Ouchic, Toshio Inabab and Kikuya Sugiurab
aJapan Anti-tuberculosis Association, Shin-Yamanote Hospital, Tokyo, Japan;
bOsaka Prefecture University, Osaka, Japan; cOsaka Prefecture University,
Tokyo, Japan
Introduction: Tumour-derived exosomes are known to
have same antigens as the parent tumour cells, and
were expected as cancer vaccines. However, treatment
with those exosomes often failed to elicit antitumor
immune responses, probably owing to a weak immu-
nogenicity of the tumour-associated antigens (TAAs).
TAAs can be divided into two categories, overex-
pressed self-antigens and tumour-specific mutated
neoantigens. Recently, it was found that immunother-
apy was effective only in patients whose tumours had
neoantigens with high immunogenicity. However, most
tumours do not have such efficient neoantigens. To
overcome the disadvantage, we have developed an
“artiﬁcial neoantigen strategy“. Previously, we prepared
the exosomes expressing strong bacterial antigen, as an
“artificial neoantigen” by transformation of the original
cultured cells with a gene of the Mycobacterium tuber-
culosis antigen, early secretory antigenic target-6
(ESAT-6). Injection of the exosomes induced signifi-
cant antitumor activity in tumour bearing mice. Here
we investigated the mechanism of antitumor immunity
activation by the ”artificial neoantigen”-presenting
exosomes.
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Methods: Mouse B16 melanoma cells were transfected
with ESAT-6, and secreted ESAT-6 antigen-presenting
exosomes (ESAT-Ex) were isolated. Cultured mouse
DCs were treated with the exosomes and expression
of costimulatory molecules and cytokines was assessed.
Antitumor activity of the ESAT-Ex-stimulated DCs was
evaluated in tumour bearing mice. In vivo immune
activating ability of ESAT-Ex was investigated by co-
incubation of the lymphocytes taken from the ESAT-
Ex-treated mice with B16 tumour cells. Immuno-sti-
mulation by the fibroblasts-secreted ESAT-Ex was also
studied.
Results: The DCs stimulated with ESAT-Ex showed
enhanced CD80 and CD86 presentation, and exhibited
significantly improved antitumor activity in tumour-
bearing mice. When the lymphocytes harvested from
the mice injected with ESAT-Ex were co-incubated
with B16 cells, they intensely accumulated around the
tumour cells, and secreted higher level of IFN-gamma.
Increased uptake of thymidine was also observed.
Summary/Conclusion: “Artificial neoantigen”-pre-
senting exosomes effectively stimulated DCs and
evoked antitumor immunity. They are expected as
novel cancer vaccines.
Funding: This work was supported by JSPS KAKENHI
Grant Number 16K01394.
PT06.07
Outer membrane vesicles of Tannerella forsythia induce inflammatory
response in periodontal tissue cells
Sunjin An
Department of Oral Microbiology and Immunology, School of Dentistry,
Seoul National University, Seoul, Republic of Korea
Introduction: Tannerella forsythia, a Gram-negative
oral bacterium, is one of the major periodontal patho-
gens which can cause inflammatory responses.
Inflammasome is crucial for host defence against
pathogens, but excessive inflammasome activation can
lead to tissue damage. Outer membrane vesicles
(OMVs) are derived from the cell envelope of Gram-
negative bacteria. OMVs can contain DNA, RNA, lipo-
polysaccharide, proteins, toxins and peptidoglycan. T.
forsythia induces maturation of IL-1α/IL-1β and cell
death via activation of caspase-1/4 in THP-1 macro-
phages and human gingival fibroblasts (HGFs). The
aim of this study was to investigate whether T. forsythia
OMVs are involved in inflammasome activation which
may contribute to periodontitis, a chronic inflamma-
tory disease.
Methods: T. forsythia OMVs were isolated using Exo-
bacteria OMVs isolation kit. THP-1 macrophages
differentiated with PMA and HGFs were treated with
T. forsythia and OMVs at various does. The expression
of caspase-1/4 and pro-inflammatory cytokines was
determined by immunoblotting and ELISA, respec-
tively. Cell death was measured by LDH cytotoxicity
assay kit.
Results: T. forsythia OMVs activated caspase-1 and −4,
resulting in increased IL-1α and IL-1β release and
inflammatory cell death. The OMVs also induced the
expression of IL-6 and IL-8.
Summary/Conclusion: The results indicated that T.
forsythia OMVs may play an important role in inflam-
matory response in T. forsythia-infected cells.
Funding: This work was supported by National Research
Foundation of Korea grants (No. NRF-2018R1A5A
2024418 and NRF-2018R1A2A2A05018558).
PT06.09
Specific decrease of CD19+extracellular vesicles enhances post-
chemotherapeutic CD8+T cell responses
Fanghui Zhang, Xuefeng Fei and Zhijian Cai
Institute of Immunology, School of Medicine, Zhejiang University,
Hangzhou, China (People’s Republic)
Introduction: Chemotherapy has long been related
with induction of systemic immunosuppression.
Systemic immunosuppression greatly affects che-
motherapeutic antitumor effect. Therefore, ameliora-
tion of systemic immunosuppression following
chemotherapy is necessary to improve post-chemother-
apeutic antitumour immunity.
Methods: CD19+EVs were isolated and identified by EM,
NTA, FACS and western blotting. CD19+EVs functions
on degrading ATP and their immunosuppressive func-
tions were assessed in vitro and in vivo. The effects of
CD19+EVs on antitumour effect of chemotherapy were
detected by transfer of exogenous EVs into tumour mice
or in Rab27a or Hif1a conditional knockout tumour
mice. The effects of CD19+EVs on antitumor effect of
chemotherapy were also evaluated in humanized NSG
mice by knocking down Rab27a with inactivated EBVs
loading with Rab27a siRNA.
Results: CD19+extracellular vesicles (EVs) from B cells
hydrolyse ATP from chemotherapy-treated tumour cells
into adenosine by CD39 and CD73, resulting in impaired
CD8+T cell responses. Serum CD19+EVs increase in
tumour mice and patients. Patients with fewer serum
CD19+EVs have a better prognosis following chemother-
apy. Up-regulated HIF-1α promotes B cells releasing
CD19+EVs by inducing Rab27a mRNA transcription.
Rab27a or HIF-1α deficiency in B cells inhibits CD19
+EV production and strikingly improves
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chemotherapeutic antitumor effect. Knockdown of
Rab27a in B cells by inactivated Epstein-Barr viruses
carrying Rab27a siRNA greatly improves chemotherapeu-
tic efficacy in humanized NSG mice.
Summary/Conclusion: Our findings unravel a mechan-
ism underlying systematic immunosuppression after che-
motherapy. Combination of chemotherapy and iEBVs/
Rab27a siRNA holds high potential for cancer treatment.
Funding: This work was supported by grants from the
National Key Basic Research Program of China
(2015CB943301), the National Key R&D Program of
China (2016YFA0501800), and the National Natural
Science Foundation of China (31770951 and
31670877).
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PT07.01
Circulating microvesicles as potential biomarkers of Acute
Respiratory Distress Syndrome in Sepsis
Marcelo Fernando do Nascimentoa, Ana Cláudia Aparecida Santos
Nussbaumb, Ludhmila Abrahao Hajjarc, Luciano Cesar Pontes Azevedod,
José Mauro Vieira Juniord, Daniel Deheinzelind, Roger Chammasc, Juliana
Monte. Realc
aInstituto do Servidor Publico Estadual, Santo André, Brazil; bHospital do
Coracao, sao paulo, Brazil; cInstituto do Cancer do Estado de Sao Paulo, Sao
Paulo, Brazil; dHospital Sirio-Libanes, Sao Paulo, Brazil
Introduction: Acute respiratory distress syndrome
(ARDS) is a clinical condition of sudden respiratory
failure in critically ill patients. ARDS-related mortality
rate is higher when is associated with Sepsis (>50%).
Recently, we screened 754 miRNAs and discovered a
different cargo transported by circulating extracellular
vesicles (EVs) and exosomes from patients with sepsis,
remarkably in those who progressed to death. The early
sequence of events of respiratory failure after the onset
of sepsis are still unknown. Our hypothesis is that lung
should signal through EVs that it is being affected
by SIR.
Methods: Blood samples were obtained from septic
patients with (n = 8) and without ARDS (n = 5) at
24 h of intensive care unit (ICU) admission and 3 days
later at Sirio-Libanes Hospital. Pulmonary originated
sepsis was not considered. Eight patients under
mechanical ventilation (MV) without pulmonary dis-
ease and 12 healthy volunteers were used as controls.
Plasma was 0.22 µM filtered, EVs were isolated by
ultracentrifugation and analysed by nanoparticle track-
ing analysis. Based on our previous data, 48 miRNAs
were measured by Taqman Low Density PCR array and
normalized by RNU6.
Results: The main population of EVs peaked at size of
155–165 nm with no difference in the mean concen-
tration between groups. Patients with sepsis + ARDS
showed a significant decrease in plasma EVs 3 days
after ICU stay (234 to 137 x 10e8/mL, p = 0.0175).
Compared to healthy donors, sepsis promotes an even
significant alteration of EVs-miRNAs when it is asso-
ciated with ARDS. Comparing all samples from
patients with sepsis + ARDS to sepsis only, nine
miRNAs are transported in smaller amounts: miR-766
(−35.7, p = 0.002), miR-127 (−23.8, p = 0.001), miR-
340 (−13.5, p = 0.006), miR-29b (−12.8, p = 0.001),
miR-744 (−7.1, p = 0.05), miR-618 (−4.0, p = 0.02),
miR-598 (−3.8, p = 0.035), miR-1260 (−2.5, p = 0.035);
and miR-885-5p is expressed at higher levels (9.5;
p = 0.028). In paired samples, the set of altered
miRNAs is generally different (p < 0.05) between
sepsis + ARDS (miR-148a, −193a-5p, 199a-3p, −222,
−25, −340, 744) or sepsis only (miR-1183, −1267,
−1290, −17, −192, −199a-3p, −25, −485-3p,
−518d, −720).
Summary/Conclusion: Circulating EV-miRNAs cargo
could be potential biomarkers of lung inflammation
during sepsis in patients who will require MV.
Funding: FAPESP.
PT07.02
Innate/ inflammatory cross talk between macrophages (Mps) and RPE
cells are mediated by exosomes secreted by RPE cells: Proposal of
new trait for the pathogenesis of age-related macular
degeneration (AMD)
Atsushi Mukaia, Eiko Itoa, Morio Uenoa, Shigeru Kinoshita, Chie Sotozonoa
and Junji Hamuroa
aDepartment of Ophthalmology, Kyoto Prefectural University of Medicine,
Kyoto, Japan; bDepartment of Frontier Medical Science and Technology for
Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan
Introduction: The pathogenesis of AMD is aggravated
by chronic inflammation. Intact RPE down-regulates
the production of TNF-alpha by choroid-infiltrating
Mps, whereas degenerated RPE by oxidative stress
were devoid of this regulatory function. Subsequently,
locally produced TNF-alpha induces the production of
some pro-inflammatory cytokines and angiogenic fac-
tor VEGF by RPE (Yamawaki et al., 2016). This implies
that innate/inflammatory cross talk between Mps and
RPE may be the indispensable trait for AMD
pathogenesis.
The purpose of this study is to elucidate the signal
that causes up-regulated TNF-alpha production in con-
genital / inflammatory crosstalk between Mps and RPE.
Methods: Mps cell line RAW 264.7(RAW) was co-
cultured with primary RPE taken from C57BL/6 mice.
Some cytokines in the culture supernatants (CSs) were
quantified by ELISA. The expression profiles of com-
plement-associated genes, TNF-alpha, and
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angiogenesis-associated genes (VEGF & PEDF) were
analysed by qRT-PCR. For the preparation of exosomes
(Exo), CSs were harvested after co-cultures of RAW
with primary RPE, then Exo in each CSs were purified
by either EVsecondTM or ultracentrifugation. The
incorporation of the Exo either into RPE or RAW
was histologically quantified using Qdot 655 streptavi-
din conjugated biotinylated Exo.
Results: Elevated levels of CD63 positive Exo in co-
cultures were detected by western blot or FACS analy-
sis. The produced Exo in co-culture CSs were incorpo-
rated solely into RAW, but not into RPE. The semi-
purified Exo, but not the Exo depleted residual CSs
enhanced the secretion of MCP-1 and IL-6 in co-cul-
ture of Mps and RPE, while the enhancement of VEGF
are similarly detected by the Exo deprived residual CSs.
Most remarkable elevation was observed in TNF-alpha
production by RAW in a dose-dependent manner even
in the absence of RPE. The down-regulated TNF-pro-
duction by RAW in the presence of RPE was not
reconstituted by the addition of Exo even in the co-
culture.
Summary/Conclusion: Exosome displays a critical role
in the triggering of vicious inflammatory cytokines
cycle through the elevation of TNF- production
by Mps.
Currently, in order to construct an experimental
system closer to the pathology of AMD, we are study-
ing a co-culture system using human Mps and human
iPS-derived RPE.
PT07.03
Epithelial exosomes regulated by phosphatase Shp2 promote
macrophage activation
Yuefei Zhanga, Yiqing Lib, Dacheng Gongb, Hongqiang Chengb, Xue Zhangc
and Yuehai Keb
aZhejiang University, Hangzhou, China (People’s Republic); bZhejiang
University, School of Medicine, Hangzhou, China (People’s Republic);
cZhejiang University, School of Medicine, Hangzhou, China (People’s
Republic)
Introduction: Acute lung injury (ALI) and its more
severe form, acute respiratory distress syndrome
(ARDS), are life-threatening diseases that are asso-
ciated with high mortality rates due to treatment lim-
itations. Increasing researches suggest exosomes play
an important role in pathogenesis, diagnosis and treat-
ment of ALI. However, it’s not clear how exosomes are
formed, secreted, transferred during ALI.
Phosphorylation of signalling proteins are reported to
control exosome biogenesis (e.g. syntenin phosphory-
lation promotes exosome formation). Shp2 is a widely
expressed cytoplasmic phosphatase which can regulate
signalling pathway by its dephosphorylation function.
Here we reveal that Shp2 inhibits the biogenesis of
epithelial exosomes which have proinflammatory
effects on macrophages during ALI. It’s uncovered in
our study that Shp2 is a protective factor of ALI by
inhibiting release of proinflammatory epithelial
exosomes.
Methods: Exosomes were isolated by differential ultra-
centrifugation and filtration, and they were character-
ized by nanoparticle tracking analysis (NTA),
transmission electron microscopy (TEM) and western
blot (e.g. CD9, CD63, CD81, ALIX, TSG101). In vitro
transwell system for exosome transfer model indicated
the direction of exosome transfer. Nanoscale flow cyto-
metry (CytoFLEX) was used for detecting exosome
subpopulation.
Results: Exosomes were increased in Bronchoalveolar
Lavage Fluid (BALF) of LPS-induced ALI murine
model. In vitro transwell system revealed that exosomes
were transferred from epithelial cells to macrophages
in inflammation environment. Shp2 was revealed to
inhibit the biogenesis of epithelial exosomes without
changing their size and subpopulation. Adaptor protein
Gab2, which can bind Shp2, was found to interact with
Syntenin. It suggests that with the help of adaptor
Gab2, Shp2 was involved in dephosphorylating synte-
nin whose phosphorylation can facilitate exosome bio-
genesis. Shp2-disruption derived epithelial exosomes
promoted macrophage inflammation, thus aggravat-
ing ALI.
Summary/Conclusion: Our study shows that phospha-
tase Shp2 inhibits proinflammatory epithelial exosome
release, which can promote M1-macrophage polariza-
tion. It offers a potential target for ALI mechanism
study and treatment.
PT07.04
Detection of CD11b-expressing exosomes in plasma of mice with
sepsis
Yasunori Fujita, Kyojiro Kawakami and Masafumi Ito
Research Team for Mechanism of Ageing, Tokyo Metropolitan Institute of
Gerontology, Itabashi-ku, Japan
Introduction: Cells communicate with each other
through extracellular vesicles including exosomes,
which contain host cell-derived molecules such as pro-
teins, lipids and nucleic acids. Secreted exosomes
migrate not only to neighbouring cells but also to
distant organs. Monocyte and macrophage have been
reported to secret exosomes that modulate immune
responses. However, the characteristics of monocyte/
macrophage-derived exosomes in blood during
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systemic immune response remain largely unknown. In
this study, we characterized exosomes released from
monocyte/macrophage-like cells and determined the
temporal change in monocyte/macrophage-derived
exosomes in plasma of mice with sepsis.
Methods: Exosomes collected by ultracentrifugation
from the conditioned medium of lipopolysaccharide
(LPS)-stimulated murine monocyte/macrophage-like
RAW264.7 cells were subjected to quantitative proteo-
mic analysis using iTRAQ labelling and LC-MALDI-
TOF/TOF. Plasma exosomes isolated from LPS-
injected mice were analysed by Western blot analysis.
CD11b-expressing exosomes in plasma were measured
by sandwich ELISA. Plasma TNF-α level was deter-
mined by ELISA.
Results: Proteomic analysis showed that monocyte/
macrophage marker proteins such as CD11b, CD14
and F4/80 were detected in exosomes from
RAW264.7 cells. Glucose metabolism-related proteins
including GLUT1, PKM2 and GAPDH increased in
exosomes from LPS-stimulated cells compared with
those from non-treated cells. Western blot analysis
demonstrated that GLUT1 and CD11b were signifi-
cantly increased in plasma exosomes from LPS-injected
mice. After LPS stimulation, TNF-α transiently
increased, whereas CD11b-expressing exosomes
increased and remained high in plasma of mice with
sepsis.
Summary/Conclusion: We characterized monocyte/
macrophage-derived exosomes in plasma of mice with
sepsis and developed a sandwich ELISA for detection
of CD11b-expressing exosomes in plasma, which could
be a novel marker for systemic immune response as
well as sepsis.
Funding: JSPS KAKENHI Grant Number JP17K01888.
PT07.05
Systemic inflammatory activity and proteome analysis of extracellular
vesicles from faeces
Kyongsu Parka, Jaewook Leeb, Yein Juna, Daekyum Kima, Jungwook Kima
and Yong Song Ghoc
aPohang University of Science and Technology (POSTECH), Pohang,
Republic of Korea; bDepartment of Life Sciences, Pohang University of
Science and Technology (POSTECH), Pohang, Republic of Korea;
cDepartment of Life Sciences, Pohang University of Science and
Technology, Pohang, Republic of Korea
Introduction: Substantial quantities of bacteria reside
in the gastrointestinal tract. Severe inflammatory
responses are induced when the bacteria went through
the peritoneum from the gastrointestinal tract. In this
study, extracellular vesicles isolated from faeces (fEVs)
were assessed to see whether they could mediate
inflammatory responses. In addition, proteomic com-
positions of fEVs were further investigated.
Methods: The faeces of wild-type mice were utilized to
isolate fEVs. The fEVs were characterized with trans-
mission electron microscopy, dynamic light scattering,
ELISA, and Western blot. The fEVs were intraperito-
neally administered into the mice, and the number of
infiltrated cells as well as the concentrations of TNF-α
and IL-6 were measured from the peritoneal lavage
fluid, serum, and bronchoalveolar lavage fluids.
Proteomic analyses on the fEVs were conducted by
the combination of one-dimensional SDS-PAGE and
LC-MS/MS.
Results: Significant amounts of fEVs were isolated
from mouse faeces, and the fEVs were derived from
bacteria and host cells. Upon intraperitoneal adminis-
tration, the fEVs mediated peritoneal, systemic, and
pulmonary inflammation by increasing the numbers
of infiltrated immune cells and the pro-inflammatory
cytokines such as TNF-α and IL-6 in the peritoneal
lavage fluid, serum, and bronchoalveolar lavage fluid.
Proteomic analyses on the fEVs identified a total of 295
proteins, comprising 222 bacterial proteins and 73
murine proteins.
Summary/Conclusion: The fEVs derived from bacter-
ial and host cells could mediate local and systemic
inflammation, and composed of bacterial and host
proteins. These results shed lights on the roles of com-
mensal bacterial EVs in the pathogenesis of inflamma-
tory diseases.
Funding: National Research Foundation of Korea
(NRF) Herman Krefting Foundation for Allergy and
Asthma Research, Lundberg Foundation
PT07.06
Opioid-mediated release of astrocytic EV miR-23 induces pericyte
migration and blood-brain barrier breach
Shilpa Buch, Ke Liao, Fang Niu and Guoku Hu
University of Nebraska Medical Center, Omaha, USA
Introduction: Pericytes are important constituents of
the cerebrovascular unit and play a key role in main-
taining the integrity of the blood-brain barrier. It is
well recognized that drugs of abuse such as opioids can
result in breach of the BBB, ultimately leading to
enhanced monocyte transmigration and ensuing neu-
roinflammation. Mechanism(s) by which pericytes con-
tribute to morphine-mediated neuroinflammation,
however, remains less understood.
Methods: EVs were isolated from morphine-stimulated
mouse/human primary astrocytes using the standard
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differential ultracentrifugation method and character-
ized by transmission electron microscopy, NanoSight &
western blot analyses. Among the various miRs dysre-
gulated in morphine-stimulated astrocyte EV cargo,
miR-23 was found to be upregulated by real-time
PCR. Confocal microscopy identified uptake of astro-
cytic EVs by pericytes. Functional assessment of astro-
cytic EV uptake by pericytes involved cell migration
using Boyden chamber and wound healing assays.
Additionally, an in vitro 3D model comprising of peri-
cytes and human endothelial cells was also used to
assess astrocyte EV-mediated migration of pericytes
in presence of morphine.
Results: Exposure of astrocytes to morphine induced
the expression and secretion of miR-23 in the EVs,
which, upon uptake by the pericytes resulted in their
migration. Additionally, in the pericytes that had taken
up morphine stimulated astrocyte EVs, there was
downregulation of phosphatase and tensin homologue
(PTEN), a target of miR-23.
Summary/Conclusion: Our findings indicate that
morphine-mediated dysregulation of miRNA expres-
sion in the CNS involves astrocyte-pericyte communi-
cation via the extracellular vesicles, leading, in turn, to
loss of pericyte coverage at the BBB.
Funding: This work was supported by grants
DA040397, MH112848 (S.B.) and DA042704,
DA046831 (G.H.) from the National Institutes of
Health. The support by Nebraska Center for
Substance Abuse Research is acknowledged.
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Diagnostic microRNA biomarkers from circulating extracellular
vesicles for early detection of pneumonia and severe secondary
complications
Stefanie Hermanna, Benedikt Kirchnerb, Dominik Buschmannc, Melanie
Märted, Florian Brandesd, Stefan Kotschotee, Michael Boninf, Marlene
Reithmairg, Matthias Kleinh, Gustav Schellingd and Michael Pfaffld
aDivision of Animal Physiology and Immunology, School of Life Sciences
Weihenstephan, Technical University of Munich, Freising, Germany;
bAnimal Physiology and Immunology, School of Life Sciences
Weihenstephan, Technical University of Munich, Freising, Freising,
Germany; cTUM School of Life Sciences Weihenstephan, Division of
Animal Physiology and Immunology, Freising, Freising, Germany;
dDepartment of Anesthesiology, University Hospital, Ludwig-Maximilians-
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Introduction: Pneumonia remains one of the most
deadly communicable diseases, causing three million
deaths worldwide in 2016. Extracellular vesicles (EVs)
are pivotal during signal transfer in the pathogenesis of
inflammatory lung diseases. Since identifying pneumo-
nia is particularly challenging in high risk groups (e.g.
the elderly or infants), which often present with atypi-
cal symptoms and are at high risk for secondary com-
plications such as sepsis or acute respiratory distress
syndrome (ARDS), new approaches for early diagnosis
are required. In this study we identified EV
microRNAs (miRNAs) as potential biomarkers for
inflammatory changes of the pulmonary tissue.
Methods: Our study included 13 patients with com-
munity-acquired pneumonia, 14 ARDS patients, 22
patients with sepsis and 31 healthy controls. After pre-
cipitating EVs from 1 ml serum, total RNA was
extracted. Subsequent to library preparation and small
RNA-Seq, differential gene expression analysis was per-
formed using DESeq2. Data were filtered by mean
miRNA expression of ≥ 50 reads, minimum twofold
up or down regulation and adjusted p-value ≤ 0.05.
Results: The mean relative miRNA frequency varied
slightly between the different groups and was highest in
volunteers. Short sequences (< 16 nucleotides), prob-
ably degradation products from longer coding and
non-coding RNA species, were predominantly detected
in patients. Based on unsupervised clustering, patients
could be distinctly separated from healthy individuals.
Although 21 miRNAs were significantly regulated in all
patient groups compared to healthy controls, different
disorders showed unique miRNA expression profiles.
Distinct miRNA subsets were identified, which are
applicable to indicate disease progression from limited
inflammation present in pneumonia to severe inflam-
matory changes as seen in ARDS and sepsis.
Summary/conclusion: This study shows that EV
miRNA biomarkers have potential for diagnosis of
pneumonia and to indicate disease progression towards
severe lung injury. Our findings are of clinical rele-
vance, as the timely diagnosis of pneumonia can be
challenging, and secondary complications such as
ARDS and sepsis might be prevented by early inter-
vention and treatment.
Funding: This study was supported by the German
Federal Ministry for Economic Affairs and Energy
under the program “Zentrales Innovationsprogramm
Mittelstand”.
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Elevated levels of platelet and endothelial extracellular vesicles in
type 1 diabetes, a cohort study of 236 patients
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Jörneskogd, Håkan Wallénb and Sara Tehranid
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Introduction: We have recently presented data on
increased levels of circulating extracellular vesicles
(EVs) in patients with type 1 diabetes. In the same
cohort, we have now analysed subpopulations of plate-
let- and endothelial EVs in relation to diabetic micro-
angiopathy and sex.
Methods: Two hundred and thirty-six patients (107
women) and 100 healthy controls matched for age,
sex and body mass index (BMI) gave written informed
consent to the study. Plasma platelet EV (PEV) and
endothelial EV (EEV) levels were assessed using flow
cytometry with labelled antibodies directed against pla-
telet (CD42a and CD61) and endothelial specific
(CD144 and CD62E) antigens. EV expression of pro-
coagulant phosphatidylserine (PS) and tissue factor
(TF) were assessed using lactadherin (lac) and CD142
antibody. The study was approved by the local ethics
committee.
Results: PEV and EEV levels with or without expres-
sion of procoagulant PS and TF were statistically
higher among patients than in controls (p < 0.05 for
all). The patients had about 50% higher PEV levels and
up to a 50-fold increase in EEV levels compared to
controls. No statistically significant differences were
found between PEV or EEV levels in patients with or
without clinical microangiopathy. Healthy women had
lower PS+, PS− and total PEV levels compared to
healthy men (p < 0.05 for all), whereas no differences
between sex were found in the patients. PEV and EEV
levels in patients did not correlate with glycaemic con-
trol (HbA1c), BMI, blood pressure, blood lipids or
diabetes duration.
Summary/Conclusion: Elevated levels of PEVs and
EEVs found in patients with type 1 diabetes are unre-
lated to clinical microangiopathy, indicating that type 1
diabetes is a procoagulant state per se. Comparison of
PEV levels between the sexes showed a more favour-
able phenotype in healthy women compared with
healthy men, while no sex differences were found
among patients. This could be linked to the loss of
female protection against cardiovascular disease in
type 1 diabetes.
Funding: Berth von Kantzow Foundation, Swedish
Diabetes Foundation, Wallenius Foundation, Swedish
Heart-Lung Foundation, Foundation of Women and
Health
PT08.02
Role of extracellular vesicles in the regulation of inflammation and
metabolism in obesity
Takahisa Nakamuraa, Ahlee Kimb, Esam Salemb, Kazutoshi Murakamib and
Vishnupriya Borrab
aCincinnati Children’s Hospiltal Medical Center, Cincinnati, USA;
bCincinnati Children’s Hospital Medical Center, Cincinnati, USA
Introduction: The worldwide prevalence of obesity has
reached pandemic proportions. Obesity has strong
inflammatory underpinnings, which are associated
with the development of type 2 diabetes (T2D) and
non-alcoholic steatohepatitis (NASH). However, the
mechanisms by which obesity provokes aberrant
inflammation have yet to be clearly defined.
Extracellular vesicles (EVs), including exosomes and
microvesicles, are a novel mode of tissue-to-tissue
communication. Recent studies indicate that EVs are
involved in many pathophysiological events including
inflammatory responses and metabolic dysfunctions.
We hypothesize that EVs play critical roles in the
induction of obesity-associated aberrant inflammation
and the development of metabolic diseases.
Methods: To investigate the role of EVs in the patho-
genesis of obesity, we have taken systematical
approaches including novel computational methods,
analyses of EVs collected from human obese patients
undergoing bariatric surgery, utilization of novel
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mouse models monitoring cell type-specific EVs, and
cellular-based EV functional assays.
Results: Using novel computational methods, we have
identified strong associations with EV-related genes in
metabolic syndrome associated with T2D. Our analyses
of EVs from adolescent obese patients undergoing bar-
iatric surgery have shown that serum EV concentration
is inversely correlated to metabolic improvements in
glucose metabolism and inflammation post-surgery,
with unique EVs’ extracellular RNA (exRNA) profiles.
Further, our newly established mouse models monitor-
ing specific cell type-derived EVs in vivo indicates that
in obesity, EVs from metabolic tissues behave like a
pathogen and induce inflammation.
Summary/Conclusion: While the research of EVs has
attracted much attention, therapeutic targeting and
significance of EVs in metabolic diseases are still a
controversial area of research. By utilizing our novel
mouse models coupled with access to human samples,
our systematical approaches allow to propose novel
mechanisms by which pathologic EVs induce aberrant
inflammation and deteriorate metabolism in obesity.
PT08.03
Characterization of exosomal proteins derived from contracting
skeletal muscle as potential mediators of beneficial metabolic effects
of exercise
Henrike Sell, Elisabetta De Filippo, Sonja Hartwig, Lucia Mastrototaro, Maria
Apostolopoulou, Dominik Pesta, Julia Szendrödi, Hadi Al-Hasani, Stefan
Lehr and Michael Roden
German Diabetes Center, Düsseldorf, Germany
Introduction: Exercise training improves glucose
metabolism and insulin sensitivity supporting the con-
cept that lifestyle modification is useful for patients to
prevent and treat type 2 diabetes. Skeletal muscle also
releases circulating factors following exercise affecting
metabolism of other organs probably involving the
release of exosomes. However, little is known about
muscle-specific release of exosomes and the differential
protein content of exosomes during exercise. Thus, we
aimed to identify exosomal proteins regulated by exer-
cise in vitro and in vivo and to discover pathways
regulated by exosomal cargo.
Methods: Exosomes from human skeletal muscle cells
(hSkMC), contracted by electrical pulse stimulation
(EPS), were isolated by differential ultracentrifuga-
tion/ultrafiltration. Exosomes were also isolated by
size exclusion chromatography from plasma of patients
with and without type 2 diabetes on high intensity
interval training (HIIT). In order to allow reliable
label-free quantification of the very limited muscle
exosomal material, we performed proteomic profiling
using data independent acquisition (DIA) on an
OrbitrapTM Fusion Lumos instrument. Spectronaut
TM Pulsar software was used to integrate spectral
libraries and perform quantitative proteomic profiling
of exosomes derived from different human primary
cells as well as human serum and plasma.
Results: EPS stimulated the release of exosomes from
hSkMC and regulated the release of 408 exosomal
proteins. Ingenuity pathway analysis (IPA) revealed
significant regulation of, e.g. integrin, vascular
endothelial growth factor, Liver X receptor/Retinoid X
receptor and PI 3-kinase/Akt signalling by these pro-
teins. HIIT regulated the amount of 62 exosomal
plasma proteins in vivo, of which nine candidates
were also similarly regulated by EPS in vitro. IPA
links these exosomal proteins to pathways involved in
metabolic diseases and lipid metabolism.
Summary/Conclusion: We identified various exercise-
regulated exosomal proteins with predicted metabolic
effects. Further analysis of these novel tissue-specific
candidates will help to better understand systemic
metabolic effects of exercise.
PT08.04
Transcriptome and proteome of extracellular vesicles derived from
cellular targets of diabetic kidney disease
Karina A. Barreiroa, Abigail Layb, Wei Liangc, Xiaomeng Xud, Sihui Luod,
Tillmann Borkc, Richard Cowarde, Denis Delicf, Tobias B. Huberg and Harry
Holthöferh
aFIMM, University of Helsinki, Helsinki, Finland; bUniversity of Bristol, Bristol,
UK; cUniversity Hospital Freiburg, Freiburg, Germany; dInstitute for Molecular
Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland; eBristol
Univ Medical School, Bristol, UK, Bristol, UK; fBoehringer Ingelheim Pharma
GmbH & Co. KG, Biberach a.d. Riss, Germany; gIII. Department of Medicine,
University Medical Center Hamburg-Eppendorf, Hamburg, Germany,
Hamburg, Germany; hProfessor
Introduction: Kidney disease (DKD) is common,
costly and the most feared complication of long stand-
ing diabetes. Its root causes remain unknown.
Interestingly the characteristic changes in circulating
glucose levels in this disease appear to alter the signa-
ture of extracellular vesicles as found in the urine. Here
we wanted to explore the EV secretion pattern by key
DKD target cells in the glomerulus (podocytes,
endothelial and mesangial cells) and proximal tubular
cells by harvesting the entire EV repertoire using
Hydrostatic Filtration Dialysis (HFD).
Methods: We used cell culture media from podocytes,
proximal tubule, mesangial and glomerular endothelial
cells in four conditions: (1) Insulin sensitive, (2)
Insulin resistant, (3) Insulin receptor transfected and
insulin sensitive, (4) Insulin receptor transfected and
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insulin resistant. EVs were isolated from 50 mL of cell
culture media, respectively, by HFD. Quality of the EV
yield was verified with negative staining Electron
Microscopy (EM) and Western blotting (WB). Vesicle
concentration was determined by Nanoparticle
Tracking Analysis (NTA). Isolated RNAs were profiled
with Bioanalyzer Pico kit and subjected to miRNAseq
and RNAseq. EV proteins were analysed using tandem
mass tag labelling.
Results: The isolated EVs appeared typical at EM and
were positive for the EV-marker TSG101 in WB. RNA
quantity and quality proved appropriate for both
miRNA and RNAseq. Diﬀerent treatments aﬀected
characteristically the vesiculation from the investigated
target cells of diabetes. Ninety-six EV miRNAs could
characteristically discriminate between the cell types
and special treatments studied. Some EV miRNAs
showed treatment eﬀects and the analysis of their target
genes using KEGG disease database showed a clear link
to kidney diseases. Integrated miRNA-mRNA and pro-
tein analysis was also performed.
Summary/Conclusion: EV analysis provides a novel
approach to reveal valuable pathophysiology, pathway
and signalling information of cultured disease target
cells. Changes in EV miRNAs, mRNA and proteomics
may thus give valuable insight into mechanisms and
targets to insulin resistance on DKD target cells.
Funding: BEAt-DKD, Paulo Foundation and Novo
Nordisk Foundation.
PT08.05
Effects of an acute exercise on circulating extracellular vesicles:
tissue-, gender- and BMI-related differences
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Federica Rotac, Sabrina Cicolinib, Gabriella Tringalib, Roberta De Michelib,
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Introduction: Exercise is recognized to evoke multi-
systemic adaptations that, particularly in obese sub-
jects, reduce body weight, improve gluco-metabolic
control, counteract sarcopenia and lower the risk of
cardiometabolic diseases. Understanding the molecular
mechanisms of exercise-induced benefits is of great
interest due to the ensuing therapeutic implications
against obesity.
Aims: To characterize extracellular vesicles (EVs) in
obese (F/M = 8/8; age = 21.0 ± 8.5 years,
BMI = 37.9 ± 6.0 kg/m2) and normal-weight (F/
M = 4/4; age = 25.1 ± 8.2 years, BMI = 20.9 ± 1.5 kg/
m2) subjects who underwent a moderate-intensity
(60% VO2max for 30 min or until exhaustion) exercise
on a treadmill
Methods: Blood samples were drawn before, at the end
and during post-exercise recovery period (3 and 24 h).
EVs were analysed by Nanosight and flow cytometry
after labelling with the following markers: CD14+
(monocyte), CD61+ (platelet), CD62E+ (activated
endothelium), CD105+ (resting endothelium),
HERVW+ (human endogenous retrovirus W), SCG+
(muscle) and FABP+ (adipose tissue).
Results: After exercise, 100–200 nm EVs significantly
decreased (p < 0.01). There was a significantly higher
post-exercise release of these EVs in normal-weight
than obese subjects (p = 0.025). Considering the 30–
130 nm size range, there was a significant lower release
of EVs in females than males (p < 0.01). After exercise,
the 130–700 nm EVs significantly decreased
(p = 0.016). There was a higher release of these EVs
in females than males (p = 0.05). After exercise, CD61
+ EVs significantly decreased in all subjects (p = 0.02).
SCG+ EVs were increased after exercise (p = 0.06).
There were no significant associations of other
biomarkers
Summary/Conclusion: An acute exercise induces
changes in the release of plasma EVs, which are tis-
sue-, gender- and BMI-specific, suggesting that the
exercise-related benefits might depend upon a complex
interaction of tissue, endocrine and metabolic factors
Funding: The study was supported by Progetti di
Ricerca Corrente, Istituto Auxologico Italiano, IRCCS,
Milan, Italy.
PT08.06
Profiling of extracellular vesicles from human hepatic stellate cells
Cristina Zivkoa, Gina Valentinoa, Kathrin Fuhrmannb, Gregor Fuhrmannc
and Paola Luciania
aFriedrich Schiller University Jena, Jena, Germany; bHIPS, Saarbrücken,
Germany; cHelmholtz-Institut for Pharmaceutical Research Saarland
(HIPS), Saarbrücken, Germany
Introduction: The role of extracellular vesicles (EVs)
in intercellular communication makes them particu-
larly interesting in the research of many pathologies,
especially those diagnosed invasively. In this study we
evaluated differences in the EVs shed from human
hepatic stellate cells (HSCs) in their different pheno-
typical states, since the activation of HSCs plays a
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pivotal role in the progression of hepatic fibrosis, for
which liver biopsy is still the diagnostic gold standard.
Methods: Protocols were optimized as to induce the
different activation states in the cells; untreated HSCs
were compared to their activated and quiescent coun-
terparts. EVs were isolated from conditioned cell cul-
ture medium (CCM) after differential centrifugation
followed by an ultracentrifugation (UC) step, and
they were purified by size exclusion chromatography
(SEC). The purification was evaluated by protein con-
tent determination by bicinchoninic acid (BCA) assay.
The concentration and size distribution profiles of EVs
in the SEC fractions were determined by nanoparticle
tracking analysis (NTA). EV-morphology was observed
by scanning and cryogenic transmission electron
microscopy (SEM and cryo-TEM).
Results: Purification by SEC resulted in a distinct reso-
lution between EVs and protein aggregates as deter-
mined by BCA assay. Protein content associated with
EVs was only detectable in the SEC-fractions with the
highest EV-yields and was comparable in all groups.
Differently treated HSCs yielded EVs in similar
amounts and size distributions. Quantile subtraction
of the distribution curve obtained from untreated
cells shows that activated HSCs produce smaller EVs
(80–150 nm) more prominently than quiescent cells.
SEM imaging confirmed the polydispersity in the
samples.
Summary/Conclusion: EVs originating from differ-
ently treated HSCs were isolated and characterized in
terms of yield, size, morphology and general protein
content. Our results were consistently indicative of
differences in EV populations originating from the
same cells in either healthy or diseased state (quiescent
or activated respectively), thus creating an important
basis for the potential non-invasive detection of liver
diseases.
Funding: The Phospholipids Research Center is grate-
fully acknowledged for its support to the project and
Lipoid GmbH for the endowment to the University of
Jena.
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Role of exosomal miR-15a in diabetic retinopathy
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Nadia Hanib, Nur Hasyimah Azemi and Samarjit Das
University of Malaya, Kuala Lumpur, Malaysia
Introduction: Diabetic retinopathy is a debilitating
complication of diabetes mellitus which results in irre-
versible blindness. Currently treatment is only initiated
when significant damage from diabetic retinopathy has
occurred. Early signs of damage typically remain unno-
ticed until it has reached advanced stages of disease.
Identifying early biomarkers of disease will allow clin-
icians to detect the progression of disease before the
onset of complications. Circulating microRNA con-
tained in extracellular vesicles such as exosomes are
potential early biomarkers and can be targeted to pre-
vent diabetes from progressing. The aim of our project
is to validate and determine the role of miR-15a as a
potential early biomarker in diabetic retinopathy.
Methods: This project was approved by the University
of Malaya Medical Centre (UMMC) Medical Research
Ethical Committee. A total of about 100 subjects (con-
trols and patients with Type 2 DM) was recruited from
UMMC, Kuala Lumpur. All subjects underwent com-
plete eye examination and graded for diabetic retino-
pathy. Clinical information collected included HbA1C,
renal function testing, hypertension and smoking.
Extracellular vesicle (EV) isolation was performed
using differential ultracentrifugation and quantified.
Results: In this study, we analysed miR-15a concentra-
tions in plasma and exosomal-enriched fractions using
droplet digital and real-time PCR. There was no differ-
ence in microRNA levels in plasma observed. However,
there was a significant increase in exosomal concentra-
tion (average diameter <130nM) in patients with dia-
betic retinopathy compared to controls (p < 0.05).
There was also an increasing trend of miR-15a level
among diabetic patients compared to controls.
Summary/Conclusion: The findings from this study
corroborated with our previous findings of increase in
miR-15a levels in diabetes prior to the onset of retino-
pathy compared to controls. This suggests that miR-
15a is involved in the early development of diabetic
microvascular complications and may be a potential
biomarker for early complications of diabetes.
Funding: 1. Bayer Global Ophthalmology Award
Program Grant. 2. University of Malaya Special
Research Fund (BKS056-2017). 3. BioRad Institutional
Funding (Materials and Lab consumables). 4. Fulbright
Visiting Research Scholar Grant
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The effects of outer membrane vesicles delivered from
Porphyromonas gingivalis on hepatic glucose metabolisms
Kaya Yoshidaa, Mariko Seyamab, Natsumi Fujiwarab, Hirohiko Okamurac
and Kazumi Ozakid
aDepartments of Oral Healthcare Education, Institute of Biomedical Sciences,
Tokushima University Graduate School, Tokushima, Japan; bDepartments of
Oral Healthcare Promotion, Institute of Biomedical Sciences, Tokushima
University Graduate School, Tokushima, Japan; cDepartment of Oral
Morphology, Okayama University Graduate School of Medicine, Dentistry
80 ISEV2019 ABSTRACT BOOK
and Pharmaceutical Sciences, Tokushima, Japan; dDepartments of Oral
Healthcare Promotion, Institute of Biomedical Sciences, Tokushima
University Graduate School, Tokushima, Japan
Introduction: The outer membrane vesicles (OMVs) of
Porphyromaons gingivalis (Pg), a gram-negative bacteria
known as a major pathogen of periodontal diseases,
include its virulence factors and regulate the aetiology
of periodontal diseases by affecting microbial environ-
ment and the host cells in the oral cavity. However, it is
unknown whether Pg OMVs in oral cavity could trans-
locate to distant organ and affect the systemic diseases,
whereas periodontal diseases are well known to influ-
ence the develop of diabetes mellitus. To elucidate the
mechanisms by which periodontal diseases progress dia-
betes mellitus, we identified Pg OMV cargo proteins and
verified its effects on the insulin signalling in vitro. We
also analysed the translocation of Pg OMVs to the
organ, and assessed the changes of hepatic glucose mata-
bolisms in Pg OMV-treated mice.
Methods: We identified the OMV cargo proteins by
LC-MS/MS analyses. The effects of Pg OMV on the
insulin signalling in HepG2 cells is analysed by western
blot. The organ distribution of OMV was analysed by
IVIS sectrum after injecting intraperitoneally Cy7-
labelled Pg OMV. We also estimated the insulin sensi-
tivity using glucose tolerance test (GTT), insulin toler-
ance test (ITT) in mice treated with Pg OMV for 3
weeks.
Results: Pg selectively sorted its specific proteases such
as arginine-specific gingipain (Rgp) and lysine-specific
gingipain (Kgp) into OMVs. The treatment with Pg
OMV attenuated the insulin signalling in HepG2
cells, and its effects were eliminated by OMVs from
gingipain-deleated Pg. A Cy7 fluorescent signal was
detected in the liver in mice injected with Cy7-
labelled-Pg OMVs. The exposure of Pg OMVs for 3
weeks slightly increased casual blood glucose and insu-
lin tolerance level in mice.
Summary/Conclusion: Pg OMVs packaging gingipains
were delivered to the liver, resulting in the reduction of
insulin sensitivity. These capabilities of Pg OMVs may
contribute to the progress of diabetes mellitus.
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Extracellular vesicle concentrations in human plasma and serum as
revealed by microfluidic resistive pulse sensing and size exclusion
chromatography coupled with on-line fluorescence detection
Diana Kitkaa, Zoltan Vargab, Gergo Bartab, Judith Mihalya and Jean-Luc
Fraikinc
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Introduction: Blood is one of the most important
sources of EVs in biomarker applications. However,
there is a huge variation in the reported values of EV
concentrations in plasma and serum in the current
literature. Therefore, there is a continuous demand
for new techniques for accurate determination of EV
concentration. The aim of this study was to character-
ize EVs in normal plasma and serum using novel
techniques such as microfluidic resistive pulse sensing
(MRPS) and size exclusion chromatography (SEC)
coupled with on-line fluorescence detection.
Methods: To obtain cell free serum and plasma, blood
was collected from healthy volunteers using serum
activator and EDTA vacutainer tubes, respectively.
Cells were removed by centrifugation at 2500 x g
twice. Samples were further purified with a Sepharose
CL-2B gravity column and analysed by MRPS using the
nCS1 instrument (Spectradyne LLC, USA). For the
fluorescence SEC experiments, samples were labelled
with PE-conjugated anti-CD61 and analysed with a
JASCO (Japan) liquid chromatography system supple-
mented with an FP-2020 fluorescence detector and
using a 1 mL column filled with CL-2B gel.
Results: The particle concentrations of serum and
plasma determined by MRPS in the 65–250 nm size
range were 2.06E+10 1/mL and 1.77E+10 1/mL, respec-
tively. In the 250–2000 nm range, we found 2.22E+8 1/
mL and 5.50E+7 1/mL for serum and plasma. These
concentrations correspond to 0.29 E+10 1/mL increase
for the smaller size range, and 1.67E+8 1/mL for the
larger size range, which can be accounted for the EVs
produced during clotting. Fluorescence SEC experi-
ments with PE-CD61 revealed that the percentage of
CD61 bound to EVs increased from 2.25% (plasma) to
36% (serum). Using these data, we obtained that one
platelet-derived EV contains approx. 15 CD61 glyco-
proteins in average.
Summary/Conclusion: By the combination of MRPS
and fluorescence SEC we quantified the overall particle
concentrations in serum and plasma, and using a pla-
telet-specific fluorescently labelled antibody, we deter-
mined the average number of CD61 glycoproteins on
platelet-derived EVs formed during blood clotting.
Funding: This work was supported under grant num-
bers PD 121326 and NVKP_16-1-2016-0007 by NKFIH
(Hungary). ZV was supported by the János Bolyai
Research Fellowship.
PT09.02
The nanobioanalytical platform, a tuneable tool for a sensitive
detection & characterization of extracellular vesicles subsets from
biological samples
Balasubramaniam Namasivayama, Yu-Wen Wub, Liling Delilab, Annie Frelet-
Barranda, Thierry Burnoufb, Celine Elie-Caillea and Wilfrid Boireaua
aFEMTO-ST Institute, UBFC, CNRS, Besançon, France; bCollege of
Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
(Republic of China)
Introduction: The NanoBioAnalytical (NBA) platform
is an established, calibrated and label-free system to
characterize Extracellular Vesicles (EVs), without lim-
itation in size, in different biological samples [1, 2].
NBA benefits were recently highlighted in latest
MISEV guidelines [3]. The NBA platform combines
biodetection and phenotyping of EVs subsets by
immunocapture monitored by Surface Plasmon
Resonance (SPR) on biochip, followed by EVs quanti-
tation and sizing thanks to metrological evaluation by
Atomic Force Microscopy (AFM). Our aim is to push
the limit of the NBA to address clinical studies invol-
ving EVs.
Methods: We emphasise here the performance of the
NBA platform for establishing its dynamic range and
limit of detection (LOD) for blood derived EVs.
Concentration of EVs was first determined in solution
by Tunable Resistive Pulse Sensing; NBA sensitivity
and reliability was then studied by SPR on biochips
presenting a-CD41 antibody arrays. Finally, even on
1000-fold diluted samples, reliable and complementary
information to SPR measurements on size distribution,
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counting and shape deciphering could be obtained
by AFM.
Results: Optimizing different factors (flow rate, density
of receptors on the surface, etc.) enabled detection of
blood derived EVs at dynamic range from 106 to 109
particles /mL on a-CD41 surface. The determination of
the LOD of EVs and their subsets size distribution at
different capture levels are currently in progress.
Summary/Conclusion: The NBA platform is modular
and capable of detecting EVs reliably even in highly
diluted samples. Such characterization and correlation
studies are crucial for accurate and comprehensive
characterization of EVs in biological samples with
good reproducibility.
References
1. Obeid et al., B&B. 2017. 93:250–259
2. Obeid et al., NBM. 2019 (in revision)
3. Thery et al., JEV. 2018. 8;1535750
Funding: Region Franche-Comté 2017–2020.
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Multi-parametric single vesicle analysis using an interferometric
imaging platform
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aNanoView Biosciences, Brighton, USA; bNanoView Biosciences, Boston,
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Introduction: Current single vesicle analysis techni-
ques like electron microscopy and atomic force micro-
scopy require high expertise and are limited in
throughput. Flow cytometry (FC), which is regularly
used to for single cell analysis and sorting, has limited
sensitivity in light scatter mode for detection of highly
abundant populations of EVs smaller than a 100 nm.
Recent publications show that the exosome average
diameter is around 50 nm, which has been measured
by super-resolution imaging, nanoFCM, and TEM. The
more sensitive fluorescence-based detection of EVs is
also difficult because EVs could have much less than 10
epitopes of the marker of interest, a limit for most FC
systems.
Methods: To address the limitation in single vesicles
analysis we have developed a technique that can size,
enumerate, and co-localize 4 markers (surface and
cargo) on single vesicles across 10 different subpopula-
tions on a single sensor surface. The technique is
termed SP-IRIS and commercialized as ExoView™ by
NanoView Biosciences. EvoView™ relies on a bilayer
substrate (silicon/silicon dioxide) that forms a common
path interferometer for enhanced nanoparticle analysis.
The calculated fluorescence detection limit approaches
single fluorescence sensitivity established using fluor-
escent polystyrene nanoparticles (20–200nm diameter)
corresponding to 180–110,000 MESF.
Results: A tetraspanin assay was developed on the
ExoView™ platform for the detection of CD81, CD63,
CD9 positive vesicles directly from cell culture samples
without the need for purification. We can also permea-
bilize the vesicles to probe the cargo of individual
vesicles. To validate the detection of tetraspanins and
internal cargo proteins we used knockout cell lines as
negative controls. The assay can also be used for detec-
tion of vesicles from other biological fluids like urine,
plasma, CSF, and saliva. We demonstrated that most
tetraspanin positive vesicles have a diameter around
50 nm, which agrees with TEM, versus the widely
reported diameter of 100nm in the literature.
Summary/Conclusion: The ExoView platform is a
scalable single vesicle analysis platform that can size,
enumerate and run multi-parametric co-localization
experiments directly from sample. The platform can
be applied for basic research as well as biomarker
discovery for liquid-biopsy applications.
PT09.05
Quantification of circulating extracellular vesicles from human
plasma by utilizing a membrane-based microfluidic system
Yi-Sin Chena, Gwo-Bin Leea and Chihchen Chenb
aDepartment of Power Mechanical Engineering, National Tsing Hua
University, Taiwan, Hsinchu, Taiwan (Republic of China); bInstitution of
NanoEngineering and MicroSystems, National Tsing Hua University,
Hsinchu, Taiwan (Republic of China)
Introduction: Extracellular vesicles (EVs) have served
as biomarkers for cancer diagnosis and prognosis based
on their carried cargos such as proteins and nucleic
acids. To accurately and specifically quantify tumour-
derived EVs from complex biofluids such as human
plasma is potentially significant for precise diagnosis.
Many techniques for EVs quantification have been
developed in the past decade, including nanoparticles
tracking analysis, total internal reflection fluorescence
microscopy, flow cytometry and enzyme-linked immu-
nosorbent assays (ELISA). However, bulky and expen-
sive instruments are required for these approaches.
Therefore, this study provides a simple and low-cost
approach to quantify circulating EVs from human
plasma by using the ELISA method and a fluorescent
microscope on a membrane-based integrated micro-
fluidic platform.
Methods: In this study, a membrane-based integrated
microfluidic platform was used for EVs collection,
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enrichment and fluorescent detection process. A track-
etched membrane filter with a pore size of 0.03 μm that
could enrich EVs and deplete small molecules during
washing steps was packaged in a polydimethylsiloxane-
based microfluidic platform. After EVs enriching, an
on-chip ELISA assay was performed involving the fol-
lowing steps including (1) anti-CD63 antibody
(EPR5702) incubation, (2) horseradish peroxidase
(HRP) conjugated anti-rabbit antibody incubation,
and (3) tetramethylrhodamine-labelled tyramide incu-
bation. It is worth noting that tyramide molecules
could be accumulated on the surface of EVs to amplify
the fluorescent signal and observed under a fluorescent
microscope. With this approach, absolute quantifica-
tion of EVs with high specificity could be achieved.
Results: The experimental results showed that CD63-
positive circulating EVs in human plasma could be
individually observed under a fluorescent microscope.
By using imaging software (ImageJ) to perform image
analysis, the total number of EVs could be quantified
such that the concentration of EVs in plasma could be
measured.
Summary/Conclusion: The developed method could
be used to quantify EVs with high specificity and
could be widely used in most general laboratory for
precise diagnosis of circulating EVs from human
plasma.
Funding: Ministry of Science and Technology of
Taiwan (MOST 106–2221-E-007–001, MOST 107–
2221-E-007–013-MY3)
PT09.06
Electrophoretic separation of EVs using a microfluidic platform
Takanori Ichiki and Hiromi Kuramochi
The University of Tokyo, Tokyo, Japan
Introduction: Absence of adequate tools for analysing
and/or identifying mesoscopic-sized particles ranging
from tens to hundreds of nanometres is the potential
obstacle in both fundamental and applied studies of
extracellular vesicles (EVs), and hence, there is a grow-
ing demand for a novel analytical method of nanopar-
ticles with good reproducibility and ease of use.
Methods: In the last several years, we reported the
usefulness of electrophoretic mobility as an index for
typing individual EVs based on their surface properties.
To meet the requirement of separation and recovery of
different types of EVs, we demonstrate the use of
micro-free-flow electrophoresis (micro-FFE) devices
for this purpose. Since the 1990s, micro-FFE devices
have been developed to allow for smaller sample
volume and reagent consumption. To solve several
technical problems involving the generation of electro-
lysis gas on the electrodes, most of the micro-FFE
devices reported in the past were fabricated using ela-
borate micromachining process on silicon or glass sub-
strates. However, high-cost micromachining processes
were required, and these were not suitable for mass
production.
Results: Based on these backgrounds, we recently
developed a polymer-based easy-to-fabricate micro-
FFE device and overcame the problems mentioned
above. In this presentation, we will introduce the appli-
cation of this device to EV separations in this presenta-
tion. Electrophoretic separation of Sk-Br-3 derived
exosomes expressed with HER2 antigen were demon-
strated with and without the combination use of the
anti-HER2 antibody for molecular specific separation.
Summary/Conclusion: The present method will be
one of the promising candidates for separating favour-
able types of EVs from heterogeneous samples.
Funding: Center of Innovation Program (COI
STREAM) from Japan Science and Technology
Agency (JST)
PT09.07
Size distribution of extracellular vesicles by microfluidic resistive
pulse sensing and small-angle neutron scattering
Zoltan Vargaa, Bence Feherb, Diana Kitkac, Vitaliy Pipichd and Jean-Luc
Fraikine
aResearch Centre for Natural Sciences, Hungarian Academy of Sciences,
Budapest, Hungary; bEötvös Loránd University, Budapest, Hungary; cRCNS
HAS, Budapest, Hungary; dJülich Centre for Neutron Science JCNS,
Garching, Germany; eSpectradyne LLC, Torrance, USA
Introduction: Accurate size determination of extracel-
lular vesicles (EVs) is still challenging because of the
detection limit and sensitivity of the methods used for
their characterization. In this study, we used two novel
techniques such as microfluidic resistive pulse sensing
(MRPS) and small-angle neutron scattering (SANS) for
the size determination of reference liposome samples
and red blood cell derived EVs (REVs) and compared
the obtained mean diameter values with those mea-
sured by dynamic light scattering (DLS).
Methods: Liposomes were prepared by extrusion using
polycarbonate membranes with 50 and 100 nm pore
sizes (SSL-50, SSL-100). REVs were isolated from red
blood cell concentrate supernatant by centrifugation at
16.000 x g and further purified with a Sepharose CL-2B
gravity column. MRPS experiments were performed
with the nCS1 instrument (Spectradyne LLC, USA).
SANS measurements were performed at the KWS-3
instrument operated by Jülich Centre for Neutron
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Science at the FRMII (Garching, Germany). DLS mea-
surements were performed using a W130i instrument
(Avid Nano Ltd., UK).
Results: MRPS provided particle size distributions with
mean diameter values of 69, 96 and 181 nm for SSL-50
and SSL-100 liposomes and for the REV sample,
respectively. The values obtained by SANS (58, 73
and 132 nm, respectively) are smaller than the MRPS
results, which can be explained by the fact that the
hydrocarbon chain region of the lipid bilayer gives
the highest scattering contribution in case of SANS,
which corresponds to a smaller diameter than the over-
all size determined by MRPS. In contrast, DLS pro-
vided the largest diameter values, namely 109, 142 and
226 nm, respectively.
Summary/Conclusion: Size determination methods
based on different physical principles can result in
large variation of the reported mean diameter of lipo-
somes and EVs. Optical methods are biased due to
their size-dependent sensitivity. SANS can be used for
mono disperse samples only. In case of resistive pulse
sensing, the microfluidic design overcomes many prac-
tical problems accounted with this technique, and as a
single particle, non-optical method, it is less affected by
the above-mentioned drawbacks.
Funding: This work was supported under grant num-
bers PD 121,326 and NVKP_16-1–2016-0007 by
NKFIH (Hungary). ZV was supported by the János
Bolyai Research Fellowship.
PT09.09
Analysis of intracellular dynamics of exosomes and changes of
surface markers
Takeo Shimasaki and Satoko Yamamoto
Kanazawa Medical University, Uchinada, Japan
Introduction: In the biological study, a standard
method for observing natural interactions between
cells is co-culturing technique. The existing co-culture
research method is generally classified into two main
groups depending on the state of adhesion between
cells: direct co-culture or indirect co-culture. In indir-
ect co-culture, standard methods for filter separation of
cells include methods using vertical-insert type co-cul-
ture plate (VTCP) named after the structure or trade-
mark (i.e. cell-culture insert, Transwell). These
methods have been used in many studies thus far, its
application to exosomes research has been limited. It is
difficult to obtain high-quality images of cells in the
upper culture chamber due to the short focal length of
the microscope. We developed a novel cell culturing
chamber (horizontal connection type co-culture plate;
HTCP). HTCP made it possible to analyse intracellular
kinetics and changes in surface markers of exosomes.
Methods: To examine the essential interactions of exo-
somes, we evaluated the uptake of extracellular exo-
somes using this HTCP. Culturing cells with GFP-
labelled exosomes in only one container and detecting
the presence of GFP in cells in the adjoining container.
Also, various chemicals were added, and analysis
was made on changes in the kinetics of exosome and
changes in surface markers.
Results: It was possible to confirm the exosome passed
through the filter and to identify the origin of exo-
somes and to analyse the distribution of the exosome
in the cells. We found that the amount of exosome
secreted by cells increased by an agent. As a result of
the analysis, although the amount of CD63 per one
exosome was decreased, the amount of CD63 per one
cell was increased.
Summary/Conclusion: This fact indicates that there
may be no point in comparing the amount of protein
or miRNA contained in exosomes. Detailed data will be
presented at this workshop.
PT09.10
Protease biomarker detection using functionalized bioplastic-based
biosensors
Richard Kelwicka, Alexander Webbb, Yizhou Wanga, Fiona Allanb and Paul
Freemontc
aImperial College London, London, UK; bNatural History Museum London,
London, UK; cThe London DNA Foundry, Imperial College London,
London, UK
Introduction: Extracellular vesicles (EVs) are poten-
tially the “seeds”, that were famously metaphorized by
Dr Stephen Paget in 1889 when he noted that particu-
lar primary tumours preferentially metastasized to par-
ticular organs. EV-associated metalloproteinases
conceivably play important roles in priming metastatic
sites. Indeed, many studies demonstrate the complex
roles that metalloproteinases have in cancer biology.
EVs can be readily accessed from patient liquid biop-
sies and an analysis of EV-associated metalloproteinase
biomarkers may enable early-stage cancer detection.
Methods: In order to detect EV-associated metallopro-
teinases we developed a library of biosensors. These
biosensors utilize PhaC-reporter fusion proteins that
are bound to microbially manufactured bioplastic
beads. These PhaC-fusions also incorporate specific
metalloproteinase cleavage sites. In the presence of a
specific metalloproteinase, the reporter protein is
cleaved off the bioplastic bead – resulting in a loss of
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bead fluorescence that can be measured using high-
throughput flow cytometry. These biosensors were
assayed using either recombinant proteinases or iso-
lated EVs from in vitro cancer models.
Results: Human metalloproteinase recognition motifs
were identified in the literature and a total of 70 dif-
ferent metalloproteinase biosensors were designed. A
control biosensor (PhaC-112L-T-G) detected 0.5 U of
tobacco etch virus protease (AcTEV) activity and the
PhaC-112L-P14-G biosensor, despite some background
off-target activity, was able to detect 0.033 mU of
recombinant MMP14 activity. Membrane-bound
metalloproteinases MMP14 and ADAM10 were also
detected in EVs isolated (ultracentrifugation) from in
vitro cancer models.
Summary/Conclusion: Our biosensors detected EV-
associated metalloproteinases and could serve as useful
research tools for EV-biomarker discovery.
Funding: Dr Richard Kelwick is funded by a Royal
Society of Edinburgh Enterprise Fellowship and an
Imperial Confidence in Concept 2018 grant. We also
acknowledge the support of Engineering and Physical
Science Research Council (EPSRC) grants [EP/
L011573/1; EP/P028519/1] and the Biotechnology and
Biological Sciences Research Council (BBSRC)
Foundry grant [BB/L027852/1].
PT09.11
Single exosome size analysis using super resolution microscopy
Xia Lia, Mina Hoorfarb and Isaac Lia
aUniversity of British Columbia Okanagan, Kelowna, Canada bDepartment of
Chemistry, University of British Columbia Okanagan, Kelowna, Canada
Introduction: Exosomes are a type of extracellular
vesicle (EV) with diameters of 30–150 nm and are
secreted from most cell types. Owing to their signifi-
cant role as cellular messengers and potential applica-
tions in disease detection, treatment and targeted
delivery, growing efforts have been made in this rela-
tively new field. However, exosome research is hin-
dered by significant challenges including inefficient
separation methods, difficulties in characterization
and lack of definitive biomarkers. Particularly, exo-
somes are difficult to visualize since their small size
falls below the resolution limit of conventional micro-
scopes (~200 nm).
Methods: Recent progress in super-resolution has pro-
vided novel tools in exosome characterization. In this
study, we present a single platform to capture pre-
coarsely isolated exosomes onto an imaging flow cham-
ber through specific anti-bodies and perform super-
resolution imaging on the same device. Specifically,
the surface of the imaging chamber is passivated with
anti-CD 63 to capture the DiD stained vesicles. The
acquisition of the raw image series was done using total
internal reflection fluorescence microscopy (TIRF)
with a 642-nm diode laser for excitation. Two types
of super-resolution techniques were tested including
super resolution radial fluctuations (SRRF) and sto-
chastic optical reconstruction microscopy (STORM).
Results: The size of single exosomes in the final images
were estimated by the full-width at half-maximum
(FWHM) of Gaussian fitted to the distribution of single
molecules. We have found that the resolution limit of
the single particle is reduced to 70 nm. The preliminary
data from SRRF and STORM showed the particle size
and size distribution were compared to nanoparticle
tracking analysis (NTA) results.
Summary/Conclusion: This method provides in-depth
size analysis of single exosomes below the diffraction
limit. Additionally, capturing exosomes from coarsely
isolated samples via specific antibodies would reduce
the time required for sequential ultracentrifugation, the
current standard technique for exosome isolation.
Finally, this imaging chamber presents a versatile plat-
form for protein profiling as the captured exosomes
can be labelled with specific antibody-dye conjugates to
reveal the surface proteins contents.
PT09.12=OWP3.09
Identification of single tumour-derived extracellular vesicles by
means of optical tweezers and Raman spectroscopy
Agustin Enciso-Martineza, Edwin van der Polb, Aufried Lenferinkc, Leon
Terstappena and Cees Ottoa
aMedical Cell Biophysics, University of Twente, Enschede, Netherlands;
bAmsterdam UMC, University of Amsterdam, Department of Biomedical
Engineering and Physics, Amsterdam, Amsterdam, Netherlands; cUniversity
of Twente, Enschede, Netherlands
Introduction: EVs derived from cancer cells play a role
in tumour cell proliferation, migration, invasion and
metastasis. Their presence in body fluids, such as
blood, makes them potential biomarkers for cancer
disease. However, the identification of single tdEVs
can be challenging due to their heterogeneity, their
ultra-small size, their size overlap with many other
normal EVs and contaminants in body fluids and the
lack of knowledge on their chemical composition.
Methods: Synchronized optical tweezers and Raman
spectroscopy have enabled a study of individual EVs.
The new method detects individual trapping events
from Rayleigh scattering. The synchronous recording
of Raman scattering enabled the acquisition of Raman
spectra of both individual and multiple EVs, disclosing
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their chemical composition. Furthermore, Mie light
scattering theory has been used to relate the Rayleigh
scattering intensity to the size of trapped EVs.
Results: The light scattered of trapped EVs gave rise to
step-wise time traces that can be used to distinguish
individual trapping events from accumulative cluster
events due to the discrete nature of the steps which
correspond to single trapping events. Next, we con-
firmed the trapping of individual EVs derived from
PC3 cells, red blood cells, platelets and blood plasma
by acquiring both, Rayleigh and Raman scattering sig-
nals. While the step-wise trend in the Rayleigh scatter-
ing signal suggests trapping of single particles, the
Raman scattering signal demonstrates the nature of
the trapped EVs. Through principal component analy-
sis (PCA), the main spectral variations among the four
EV types were identified. The principal component
scores grouped the PC3-derived EVs in a separate
cluster from the rest of the EVs.
Summary/conclusion: We have developed an auto-
mated single particle optical tweezers – Raman and
Rayleigh scattering setup to trap and release single
EVs over time. We demonstrated single-EV trapping
by simultaneous acquisition of Rayleigh and Raman
scattering. PCA enabled the identification of single-
EVs derived from the cancer cell line PC3. This dis-
closes chemical information as a step towards the
identification and characterization of single tumour-
derived EVs in blood.
Funding: Cancer ID – project number 14193, (par-
tially) financed by the Netherlands Organisation for
Scientific Research (NWO)
PT09.13=OWP3.02
Immunocapturing of tumour-derived extracellular vesicles on
micropatterned and antibody-conjugated surfaces for individual
correlative light, probe and electron measurements
Pepijn Beekmana, Agustin Enciso-Martinezb, Cees Ottob and Séverine Le
Gacc
aWageningen University, Wageningen, Netherlands; bMedical Cell
Biophysics, University of Twente, Enschede, Netherlands; cApplied
Microfluidics for BioEngineering Research, University of Twente, The
Netherlands, Enschede, Netherlands
Introduction: Tumour-derived extracellular vesicles
(tdEVs) are promising biomarkers for cancer patient
management. The screening of blood samples for
tdEVs shows prognostic power comparable to screen-
ing of tumour cells. However, due to the overlap in size
between tdEVs, non-cancer EVs, lipoproteins and cell
debris, new approaches, not only based on size, are
required for the reliable isolation of tdEVs and their
quantification. We report an integrated analysis
methodology to study single tdEVs using correlative
data from scanning electron microscopy (SEM),
Raman imaging (RI) and atomic force microscopy
(AFM) to obtain a comprehensive dataset allowing
identifying features unique to tdEVs.
Methods: Indium tin oxide (ITO)-coated fused silica
was selected for its low Raman background. Substrates
(1 x 1 cm2) featuring position-dependent markings
(“navigation marks”) patterned by photolithography
were modified with a monolayer of amino dodecyl
phosphonic acid. The amine moieties were next reacted
with poly(ethylene glycol) diglycidyl ether, forming an
anti-biofouling layer. Anti-EpCAM antibodies were
subsequently covalently bound on this surface.
Samples of both tdEVs obtained from LNCaP cell
lines and RBC-derived EVs were then introduced to
the surfaces. Finally, non-specifically bound EVs were
washed away before SEM, AFM and Raman measure-
ments were performed.
Results: Multiple objects were captured on the fully
functionalized ITO surfaces, according to SEM ima-
ging, while in negative control experiments (lacking
functionalization or lacking antibody or using
EpCAM-negative EVs), no object was detected.
Principal component analysis of their Raman spectra,
previously demonstrated to be able to distinguish
tdEVs from RBC-derived EVs, revealed the presence
of characteristic lipid bands (e.g. 2851 cm−1) in the
captured tdEVs. AFM showed a surface coverage of
,4 × 10^5 EVs per mm2 with a size distribution
similar to that found by NTA.
Summary/conclusion: A platform was developed for
multi-modal analysis of selectively isolated tdEVs for
their multi-modal analysis. In the future, the scope of
this platform will be extended to other combinations of
probe, light and electron microscopy techniques to
relate additional parameters describing the cap-
tured EVs.
Funding: Funded by NWO Perspectief
PT09.14=OWP3.03
The development of a scalable extracellular vesicle subset
characterization pipeline.
Joshua Welsha, Julia Kepleyb and Jennifer C. Jonesa
aTranslational Nanobiology Section, Laboratory of Pathology, National
Cancer Institute, National Institutes of Health, Bethesda, USA;
bTranslational Nanobiology Lab, Laboratory of Pathology, National Cancer
Institute, National Institutes of Health, Bethesda, USA
Introduction: Liquid biopsies offer an important alter-
native to tumour biopsies that may be limited by the
challenges of invasive procedures. We hypothesize that
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circulating Extracellular Vesicles (EVs) and their cargo
may provide a useful surrogate biopsy method. Due to
their small diameter (30-1000 nm), EVs migrate from
tissue into the peripheral circulation and provide a
snapshot of the producing cells. Our lab has developed
a first-in-class pipeline to use single cell – omics meth-
ods to characterize EV heterogeneity with high-sensi-
tivity by combining multiplex assays and our custom
MultiPlex Analysis post-acquisition analysis software
(MPAPASS), with subsequent high-resolution, single
EV flow cytometric (FCM) methods.
Methods: A standalone software package was devel-
oped in MATLAB to allow importation of multiplex
flow cytometry output data. The package enables data
quality screening of detection antibodies, bead recovery
and data normalization methods. The software is
equipped to handle large data sets comprising hun-
dreds/thousands of phenotypes and samples. Data can
be visualized in a variety of ways along with clustering
using multidimensional data analysis techniques. All
software outputs can be exported in a standardized
templates containing metadata for reporting, as well
as uploaded into atlases such as Genboree, where mul-
tiplex data can be stratified by RNAseq datasets.
Analysis using this pipeline has been conducted using
human samples from a variety of mediums including
CSF, serum, and plasma comparing EV phenotypes.
Results: Our multiplex approach and MPAPASS soft-
ware allows the use of single cell -omics tools for EV
subset analysis in manner that will elucidate the biolo-
gical significance and function of different types of
EVs. This high-throughput pipeline evaluates hundreds
of EV protein profiles and will allow evaluation of
millions of RNA:protein profiles in an unprecedented
manner. Integration of RNA sequencing with protein
characterization could provide an entirely new way of
understanding EV regulation and function.
Summary/conclusion: Our data show this form of EV
profiling provides a way to monitor clinical responses
early in the course of treatment, which may ultimately
improve patient care and outcomes.
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PT10: EVs and Stem Cells
Chairs: Takashi Asada; Myung-Shin Lee
Location: Level 3, Hall A
15:30–16:30
PT10.01
3D culture of dental pulp pluripotent-like stem cells (DPPSC)
improves their pluripotency and provides a serum-free culture
condition for exosome production
Farid N. Faruqua, Khuloud Al-Jamala, Shuai Zhoub, Noor Samia, Fatemeh
Gheidaric and Maher Atarid
aKing’s College London, London, UK; bKing’s College London, XuZhou,
China (People’s Republic); cKing’s College London, Tehran, Iran;
dUniversitat Internacional de Catalunya, Barcelona, Spain
Introduction: Exosomes from stem cells have been
identified as a novel cell-free therapeutic for regenera-
tive medicine. Culturing them in a serum-free condi-
tion for exosome isolation still poses a major challenge.
This work focused on the establishment of a 3D culture
of Dental Pulp Pluripotent-like Stem Cells (DPPSC) – a
newly characterized pluripotent-like stem cell from
adult tissue, for exosome production.
Methods: DPPSC were initially cultured in monolayer
(2D) in their basal medium with four different supple-
mentations: human serum (HS), exosome-depleted
human serum (ED-HS), and two different serum repla-
cements (SR1 & SR2). Morphology and growth rate of
cells were analysed by bright-field microscopy and
regular cell counting. DPPSC were then transferred to
a microwell culture plate for 3D culture in the four
differentially supplemented media and maintained for
24 days. Spheroid formation and morphology was
observed throughout culture using bright-field micro-
scopy. Spheroids were harvested on Day 24 and the
expression of pluripotency genes Oct4A and Nanog
were analysed by qPCR. Vesicles isolated from
DPPSC conditioned-medium were characterized for
size, yield and exosomal markers using Nanoparticle
Tracking Analysis (NTA) and dot blot.
Results: In 2D culture, only DPPSC cultured in the
default HS medium proliferated and showed the
expected morphology. In 3D culture, DPPSC in SR1
medium formed spheroids of similar morphology and
size to that of HS medium. Significantly smaller spher-
oids were formed by DPPSC in ED-HS medium, while
DPPSC barely formed spheroids in SR2 medium. qPCR
analysis showed that while expression of Oct4A gene in
DPPSC cells from 2D and 3D culture (both in HS and
SR1 media) was similar, expression of Nanog in
DPPSC spheroids in SR1 medium was significantly
higher than the spheroids in HS medium and the
cells from 2D culture. Vesicles isolated from DPPSC
spheroid in SR1 conditioned medium from Day 1–12
and Day 13–24 of culture showed sizes that fall within
the exosomal size range, and are positive for the exo-
somal markers CD81, CD9 and CD63. Vesicle yield for
Day 13–24 was higher than that of Day 1–12, but a
larger percentage of particles from the latter were posi-
tive for the three exosomal markers.
Summary/Conclusion: 3D spheroid culture of DPPSC
in SR1 medium showed improvement in pluripotency,
and allows for a serum-free culture for exosome
production.
PT10.02
Increased exosome secretion is essential for myeloma stem cells to
survive in hypoxic condition
Sayaka Nakayama, Yuki Toda, Shigekuni Hosogi and Eishi Ashihara
Department of Clinical and Translational Physiology, Kyoto Pharmaceutical
University, Kyoto-shi, Japan
Introduction: Cancer stem cells (CSCs) of the highly
tumorigenic cell population are critically associated
with the poor prognosis of patients in various types
of cancer. In our previous study, the multiple myeloma
(MM) cells which were chronically cultured in a
hypoxic condition (over 6 months, 1% oxygen) exhib-
ited stem cell characteristics. It suggests that MM stem
cells are capable of adapting to hypoxic stress although
the adaptation mechanism remains unclear. We
focused on the excessive secretion of exosomes from
hypoxia-adapted MM cells (HA-MM cells). Exosomes
are considered as a garbage bin to remove unnecessary
molecules from the cytoplasm to maintain cellular
homeostasis, as well as a novel intercellular commu-
nication tool.
Methods: GW4869, an inhibitor of the ceramide-
mediated inward budding of the multivesicular bodies
for exosome biogenesis, was applied to analyse the
response to a deficiency of exosome secretion from
their reduced production in HA-MM cells.
Results: GW4869 increased the rate of Annexin V
positive (apoptotic) cells and induced the expression
of fragmented PARP in HA-MM cells, but not in
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parental cells cultured in a normoxic condition (20%
oxygen). With the addition of HA-MM-derived exo-
somes, GW4869-induced apoptosis was not attenuated.
From these results, HA-MM cells are likely to release
exosomes to maintain the intracellular environment in
a state of homeostasis, but not to receive them for
autocrine signal. Hexokinase 2 (HK2) generates glu-
cose-6-phosphate, which is further metabolized by both
the glycolytic pathway and the pentose phosphate path-
way (PPP). PPP plays a major role in supplying
NADPH for detoxification of intracellular reactive oxy-
gen species (ROS). The upregulated HK2 protein
expression in HA-MM cells was diminished by
GW4869. With dichlorodihydrofluorescein staining
assay, GW4869 increased intracellular ROS production
in HA-MM cells. Thus, the failure of exosome secretion
might alter the energy metabolism leading to ROS-
associated apoptosis.
Summary/Conclusion: Enhancement of exosome
secretion is a survival strategy for hypoxic adaptation
in MM stem cells. This study could provide a critical
insight to develop a novel strategy for CSC-targeted
therapy.
Funding: MEXT-Supported Program for the Strategic
Research Foundation at Private Universities
PT10.04
Extracellular vesicles released from human iPSC-derived 3D retinas
contain small RNAs with roles in development and differentiation
Miguel Flores-Bellvera, Jing Zhoub, Xiufeng Zhongc, Alberto Benito-Martínd,
Jason Mightyb, Jiang Qiane, Jianbo Pane, Hao Wub, Bo-Juen Chenf, Alice
Liangg, Héctor Peinadoh, Maria Valeria Canto-Soleriand Stephen Redentij
aCellSight – Ocular Stem Cell and Regeneration Program, Department of
Ophthalmology, University of Colorado, Denver, USA; bLehman College,
Biology Doctoral Program, The Graduate School and University Center,
City University of New York, New York, USA; cState Key Laboratory of
Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University,
Guangzhou, China; dChildren’s Cancer and Blood Foundation Laboratories,
Departments of Pediatrics, Weill Cornell Medicine, New York, NY, USA;
eWilmer Eye Institute. Johns Hopkins University School of Medicine,
Baltimore, USA; fNew York Genome Center, New York, USA; gNew York
University Langone Medical Center, New York, USA; hMicroenvironment
and Metastasis Laboratory, Molecular Oncology Programme. Spanish
National Cancer Research Center (CNIO), Madrid, Spain; iCellSight –
Ocular Stem Cell and Regeneration Program, Department of
Ophthalmology, University of Colorado, Aurora, USA; jLehman College,
Biology & Biochemistry Doctoral Program, The Graduate School and
University Center, City University of New York, New York, USA
Introduction: Noncoding small RNAs in the retina
regulate gene expression by targeting and repressing
mRNA. Small RNAs are secreted in extracellular vesi-
cles (EVs). Analysis of EVs released from developing
retinal tissue is an essential step in elucidating the role
of EV molecular cargo and signalling during retinogen-
esis. A number of canonical genes are associated with
retinal cell fate determination during development, but
EV-mediated gene regulation in the retinal microenvir-
onment remains undefined. In this study, we charac-
terize the microRNA, tRNA, and piRNA composition
of EVs secreted from human induced pluripotent stem
cell (hiPSCs) – derived 3D retinas at three develop-
mental time points that correlate with hallmarks of
retinal cell differentiation and lamination in vivo.
Methods: Retinal organoids were generated from
hiPSCs. We selected three developmental time points
(day 42, 63 and 90) that represent distinctive stages
during normal retinal cell fate specification and lami-
nation. We analysed the release rate, concentration,
morphology and content (miRNA, tRNA and pi-
RNA) of EVs released from human hiPSCs-derived
3D retinas.
Results: The genetic signalling, developmental time
course and morphogenesis of these retinal organoids
were comparable to those of developing human retinas
in vivo. According to Gene Ontology analysis, miRNA
targets at the earliest stage of development were more
relevant to early differentiation and cell morphogen-
esis, whereas miRNA targets at the later stages were
more relevant to cell proliferation, cell differentiation,
and cell migration.
Summary/Conclusion: For the first time, this work
demonstrates the rate of release and concentration of
EVs from developing hiPSC-derived 3D retinal tissue.
We report a large variety of small RNAs in EVs from
hiPSC-derived 3D retinas, including miRNAs, tRNAs
and piRNAs. The full range of small RNAs detected in
our EVs may act as regulatory elements to modulate
gene activity and may serve as biomarkers of normal
development. This work represents the first sequencing
analysis of small RNA species contained in hiPSC-
derived 3D retinas and their released EVs.
Funding: NIH (R21 EY026752, SC3 GM113782);
Research to Prevent Blindness; Challenge Grant to the
Department of Ophthalmology, CU; NIH/NEI
R01EY022631.
PT10.05
Xeno-free manufacturing of MSC-EVs in scalable bioreactor culture
Katrina Adlerza, Josephine Lembonga, Tim Olsena, Jon Rowleya and Taby
Ahsanb
aRoosterBio. Inc., Frederick, USA; bRoosterBio, Inc., Frederick, USA
Introduction: There have been over 800 clinical trials
using mesenchymal stem/stromal cells (MSCs) for
therapeutic applications. Due to their similar therapeu-
tic effects to MSCs and potential as a key bioactive
agent in regenerative medicine applications, MSC-
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derived extracellular vesicles (MSC-EVs) are being
increasingly investigated as a clinical therapy for a
broad range of indications. It was recently found that
the number of exosomes released from 2M MSCs in 48
h is equivalent to a single dose for a rodent. Hence,
most indications would require a MSC production lot
size that is hardly achievable in 2D culture. Therefore,
larger scalable bioreactor systems will be crucial to
generate enough EVs for clinical doses. This study
developed a protocol for xeno-free (XF) scalable
MSC-EV manufacturing and compared MSC-EV char-
acteristics from 2D culture and various bioreactor
scales.
Methods: Human Bone Marrow-Derived MSCs (hBM-
MSC) were cultured on microcarriers in suspension
using 0.1, 3 and 15L bioreactors. After cell inoculation,
a bioreactor feed was added on Day 3, and cultures
switched to an EV collection media on Day 4. After 1, 2
and 3 days, the collection medium was analysed for
metabolites, particle size, and particle concentration.
The MSC-EVs in the conditioned medium was also
evaluated for protein expression of Alix, CD63, and
CD81, RNA expression and wound healing capability.
Results: A protocol was developed for manufacturing
MSC-EVs in an XF fed-batch bioreactor culture, result-
ing in cell yield of >0.5M cells/mL within 4 days. We
demonstrated that this process was directly scalable
from the small (0.1L) to development (3L) and pilot
scale (15L) bioreactors, maintaining similar cell den-
sity. To remove the residual particles from the expan-
sion media, an additional wash step before the switch
to the collection media was required in bioreactors.
With a similar collection process and comparable cell
density, we expect to see consistent EV production per
cell at these different scales of manufacturing systems.
Summary/Conclusion: Optimizing EV yield will
become increasingly important as EVs become used
in the clinic. We have developed a scalable fed-batch
process for large scale expansion of hMSCs and a
protocol for EV production in suspension bioreactors.
Funding: This work was funded by RoosterBio, Inc.
PT10.06
Proteomic analysis of extracellular vesicles from MSC cultured with
stroke serum
Yeon Hee Choa, Eun Hee Kima, Dong Hee Kimb, Ji Hee Sunga, Mi Jeong Oha,
Eun Kyoung Shina and Oh Young Banga
aSamsung Medical Center, Seoul, Republic of Korea; bSungkyunkwan
University, Seoul, Republic of Korea
Introduction: Serum from stroke patients increases
mesenchymal stem cells trophism towards the infarcted
brain area and increased the proliferation rate and the
neurorestorative capacity of MSCs. Our previous study
confirmed that intravenous infusion of MSC-EVs is
more advantageous than MSCs as a safe treatment.
EVs are lipid enclosed vesicular structures that contain
bioactive RNAs, DNA and proteins, which possess
therapeutic molecules similar to MSCs. Therefore, we
hypothesized that the certain proteins containing EV
released from stroke serum cultured MSCs may affect
the neurogenesis and angiogenesis of recipient cells.
Methods: EVs were purified from conditioned media
of MSC cultured with FBS (FBS-MSC) and MSC cul-
tured with stroke serum (SS-MSC). These EVs were
characterized by nanoparticle tracking analysis. EV
protein profiling in conditioned media was systemati-
cally compared through utilizing LC-MS/MS-based
label-free quantification. Real-time PCR was performed
to determine the difference in the gene expression in
each cell. The protein concentration in the EV was
confirmed by ELISA.
Results: A total of 1068 proteins were identified from
SS-MSC-EV and FBS-MSC-EV through LC-MS.
According to statistical analysis, 22 proteins were
found to be more than 2-fold (p < 0.05) upregulated
in SS-MSC_EV. ITGA5, CLU, and CTSB were signifi-
cantly increased of SS-MSC gene expression levels
compared to FBS-MSC. Among the candidate proteins,
clusterin (CLU) was found to be upregulated in EVs
from SS-MSC compared to those from FBS-MSC.
Summary/Conclusion: These results suggest that SS-
MSC_EVs containing clusterin may promote intercel-
lular communication and affect neurogenesis and
angiogenesis of recipient cells.
Funding: This study was supported by a grant from the
Korean Healthcare Technology R&D Project, Ministry
of Health & Welfare (HI17C1256) and Basic Science
Research Program, the Ministry of Science, ICT and
Future Planning (2018M3A9H1023675).
PT10.07
Adipose-derived Stem/Stromal Cell secretome, containing both
soluble factors and extracellular vesicles, exerts chondroprotective
effects in vitro
Chiara Giannasia, Stefania Niadaa, Sara Casatib and Anna Brinic
aIRCCS Istituto Ortopedico Galeazzi, Milano, Italy; bDepartment of
Biomedical, Surgical and Dental Sciences, University of Milan, Milano,
Italy; cDepartment of Biomedical, Surgical and Dental Sciences, University
of Milan. IRCCS Istituto Ortopedico Galeazzi, Milano, Italy
Introduction: Up to now several clinical trials have
shown the safety and efficacy of the intra-articular
injection of Adipose-derived Mesenchymal Stem/
Stromal Cells (ASCs) in contrasting osteoarthritis.
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Since ASCs act predominantly through paracrine
mechanisms, their secretome represents a promising
cell-free alternative. Here we identified anti-hyper-
trophic and anti-catabolic effects of ASC conditioned
medium (ASC-CM) on TNFα-stimulated human pri-
mary articular chondrocytes (CHs).
Methods: CHs were treated with 10 ng/mL TNFα and/
or ASC-CM administered at a 1:5 recipient:donor cell
ratio. Cell viability was assessed up to day 9. The
activity, expression and/or release of hypertrophy mar-
kers (MMP-13, Collagen X and Osteocalcin), catabolic
mediators (MMP-3) and cartilage-protective factors
were assessed up to day 3 by enzymatic assays, qRT-
PCR, Western Blot and multiplex immunoassays.
Results: ASC-CM blunted TNFα-induced hypertrophy,
reducing the enhanced levels of MMP-13 activity
(−61%), Osteocalcin (−37%) and Collagen X (−18%).
In addition, also MMP-3 activity was diminished by
−59%. We associated the observed reduction of MMP-
3 and MMP-13 activity to the abundancy of TIMPs
(Tissue Inhibitors of MMPs) in ASC secretome, rather
than to a direct down-modulation of their expression
and/or release. Moreover, ASC-CM contains high
levels of OPG and DKK-1, other known chondropro-
tective factors.
Summary/Conclusion: ASC-CM is rich in cartilage-
protective factors and exerts anti-hypertrophic and
anti-catabolic effects on TNFα-stimulated CHs. These
evidences open the way for its possible clinical use as a
cell-free approach in contrasting osteoarthritis. We are
currently investigating through a differential proteomic
analysis if the recognized chondroprotective effectors
are enriched in the vesicular rather than the soluble
component of the secretome.
PT10.08
Epigenetic alterations in mesenchymal stem cells by osteosarcoma
derived extracellular vesicles
Roman Kornilov, Sippy Kaur, Bettina I. Mannerström, Ahmed Abu-Shahba,
Iftekhar Chowdhury, Snehadri Sinha and Riitta Seppänen-Kaijansinkko
Department of Oral and Maxillofacial Diseases, University of Helsinki and
Helsinki University Hospital, Helsinki, Finland
Introduction: Extracellular vesicles (EVs) are central to
intercellular communication and play an important
role in cancer progression and development.
Osteosarcoma (OS) is an aggressive bone tumour,
characterized by presence of malignant mesenchymal
cells. Specific tumour-driving genetic alterations asso-
ciated with OS development are poorly understood.
The cell of origin for OS also remain unknown but
cells of the mesenchymal stem cell (MSC) osteogenic
lineage are likely candidates, thus indicating that MSCs
and the OS stroma cells may be related cell types.
Therefore, this study set out to examine the contribu-
tion of EV-mediated intercellular crosstalk of MSC
and OS.
Methods: MSCs and pre-osteoblasts were treated with
OS-EVs at different time points, and the epigenetic
signature of OS-EVs was assessed by LINE-1 and
tumour suppressor genes methylation analysis. In addi-
tion, surface markers and gene and expression of spe-
cific genes related to bone microenvironment
remodelling (MMP1, VEGF-A, ICAM1) were also
evaluated.
Results: Our data indicated that OS-EVs mediated
LINE-1 hypomethylation in MSCs, whereas an oppo-
site effect was seen in pre-osteoblast, indicating that
MSCs but not pre-osteoblasts were more susceptible to
epigenetic transformation. Thus, OS-EVs dictated the
fate of MSCs by modulating the epigenetic status, and
also influenced the expression of genes related to bone
microenvironment remodelling.
Summary/Conclusion: Overall, this study provided
evidence that epigenetic regulation may appear to be
an early event in the transformation of MSCs.
Elucidating the mechanisms of EV-mediated commu-
nication may lead to new avenues for therapeutic
exploitation.
Funding: This research was supported by University of
Helsinki project funding (WBS490302, WBS73714112),
Helsinki University Hospital State funding for univer-
sity-level health research (Y1014SUL05, TYH2016130),
the Finnish Dental Society Apollonia, Egyptian
Ministry of Higher Education (MoHE) and Selma and
Maja-Lisa Selander foundation.
PT10.09
Comprehensive proteomics and microRNA analyses of adult neural
stem cell derived exosomes after stroke
Xianshuang Liua, Michael Choppb, Chao Lia, Wan Long Pana, Bao Yan Fana,
Albert M Levinc, Rui Lan Zhanga and Zheng Gang Zhanga
aDepartment of Neurology, Henry Ford Health System, Detroit, MI, USA;
bDepartment of Physics, Oakland University, Rochester, MI, USA;
cDepartment of Public Health Sciences, Center for Bioinformatics, Henry
Ford Health System, Detroit, MI, USA
Introduction: Neural stem cells (NSC) are known to
facilitate healing of ischemic brain tissues. Recent stu-
dies show that NSC derived exosomes function as
paracrine effectors to promote neurovascular remodel-
ling including angiogenesis and axonal outgrowth after
stroke; nevertheless, the contents of the non-stroke and
post stroke NSC exosome proteome and miRNA cargo
have not been determined.
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Methods: NSC derived exosomes were purified from
conditioned media of cultured NSCs harvested from
the subventricular zone of non-ischemic and ischemic
rats, respectively. Liquid chromatography mass spec-
trometry (LCMS) and miRNA array were employed to
comprehensively characterize the protein and miRNA
contents of NSCs and their derived exosomes after
stroke. Bioinformatic analyses were performed using
Ingenuity Pathway Analysis (IPA).
Results: Exosome markers including CD63, CD9, Alix
and size distribution (50–200nm) were verified with
Western blot, transmission electron microscopy
(TEM) and Nanosight, respectively. In total, proteo-
mics analysis yielded 2409 and 1770 proteins identified
in ischemic NSC and NSC derived exosomes, respec-
tively. Bioinformatics analysis identified that 52, 39 and
31 proteins in the NSCs-derived exosomes were related
to regulating neuronal cell proliferation, migration and
differentiation, respectively. In addition, 318 miRNAs
were identified in ischemic NSCs with 26% of miRNAs
(84 miRNAs) overlapped with parent NSCs. Gene
ontology analysis showed that up- and down-regulated
miRNAs with the fold change above 1.5 were highly
related to inflammation, invasion, cell proliferation,
cell cycle, cell death, differentiation, etc. The top three
upregulated miRNAs were validated in ischemic NSC-
exosomes using real-time RT-PCR.
Summary/Conclusion: Collectively, the results of our
proteomic and miRNA analysis, to our knowledge,
demonstrate for the first time that NSC derived exo-
somes contain a robust profile of protein and miRNA
effectors. These data provide a platform for beginning
to understand the mechanism by which NSCs are acti-
vated after cerebral ischemia, and may lead to a deeper
mechanistic understanding of their role in tissue repair
after neural injury.
Funding: NIH RO1 DK102861, American Heart
Association (AHA) grant 18IPA34170331, NINDS
RO1 NS075156 and RO1 NS088656.
PT10.10
Anion exchange chromatographic isolation of iPSC-MSC derived
extracellular vesicles ameliorated allergic asthma in mice
Shubin Fang, Hongyu Zhang, Yongdong Lin and Qingling Fu
Otorhinolaryngology Hospital, The First Affiliated Hospital, Sun Yat-sen
University, Guangzhou, China (People’s Republic)
Introduction: The extracellular vesicles (EVs) derived
from mesenchymal stem cells have been shown to
elicited similar therapeutic effects to their patent cells
in many diseases. However, the difficulties in the large-
scale preparation of high-purity EVs largely limited its
clinical application in the future. We sought to apply a
novel anion chromatography for the isolation of iPSC-
MSC EVs, and explored the effects and mechanisms of
iPSC-MSC EVs in the therapy for asthma.
Methods: The EV-enriched supernatants were col-
lected for the isolation of the iPSC-MSC EVs using
the anion chromatography. The morphologies of EVs
were characterized by transmission electron micro-
scope, the markers of EVs were assayed by western
blot and flow cytometry. The anti-inflammatory effects
of the EVs were determined using the macrophage
assay. Also, the uptake activities of macrophages on
RPF-iPSC-MSC EVs were determined. Finally, the
asthma mouse model was developed and the iPSC-
MSC EVs were administrated intravenously. The lung
pathology, the levels of inflammatory cytokines in the
bronchoalveolar lavage fluids (BALF) and the polariza-
tion of lung macrophages were evaluated.
Results: We successfully obtained concentrated iPSC-
MSC EVs after the isolation and the final concentration
of EVs was about 200 µg/mL (Bradford) and 10–
15*1011/mL (Nanosight). The iPSC-MSC EVs were
morphologically intact and were positive for the mar-
kers including CD9/63/81, Alix and TSG101. Most of
the preparations of iPSC-MSC EVs could significantly
decreased the level of IL-6 in the macrophage assay.
The Raw 264.7 macrophages began to uptake iPSC-
MSC EVs at 4 h and the uptake activities peaked at
12 h and then receded at 24 h. Also, our in vivo study
showed that splenic macrophages started to uptake
iPSC-MSC EVs at 4 h and the uptake activities were
augmented at 24 h. In addition, the iPSC-MSC EVs
significantly reduced the inflammatory infiltration, the
epithelial goblet cell numbers, the levels of inflamma-
tory cytokines and inflammatory cells in the BALF as
well as the polarizations of pulmonary macrophages.
Summary/Conclusion: Our results showed that the
anion exchange chromatography was a promising
method for the large preparation of iPSC-MSC EVs,
which could possibly be an alternative therapy for
asthma in the future.
Funding: NSFC (81322012, 81373174, 81471832,
81671882 and 81770984)
PT10.11
Characterization and miRNA expression profiles of exosomes from
HLA homozygous haplotype dental pulp cells and iPS cells
Yuta Shimizua, Tomoko Kawaguchib, Shuhei Otaric, Izumi Kurodad, Yuki
Kuranagae, Hideya Kawasakif, Takahiko Hariyamaf, Toshiyuki Shibatab,
Takahiro Kunisadad, Toshiaki Shibutanic, Yukihiro Akaoe and Ken-ichi
Tezukag
aAsahi University School of Dentistry, Department of Periodontology,
Mizuho, Japan; bGraduate School of Medicine Department of Oral and
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Maxillofacial Science, Gifu, Japan; cAsahi University School of Dentistry
Department of Periodontology, Gifu, Mizuho, Japan; dGifu University
Graduate School of Medicine Department of Tissue and Organ
Development Regeneration and Advanced Medical Science, Gifu, Japan;
eGifu University Graduate School of Drug Discovery and Medical
Information Sciences, Gifu, Japan; fHamamatsu University School of
Medicine Depatment of Preeminent Medical Photonics Education &
Research Center Institute for NanoSuit Research, Hamamatsu, Japan; gGifu
University Graduate School of Medicine Department of Tissue and Organ
Development Regeneration and Advanced Medical Science, Gifu, Japan and
Center for Highly Advanced Integration of Nano and Life Sciences, Gifu
University (G-CHAIN), Gifu, Japan
Introduction: Human leucocyte antigen (HLA) has
played an important role to distinguish between self
and non-self in the immune system. HLA homozygous
cell of the multi-locus has been considered to be less
likely to be rejected in the allograft. In recent years, the
diameter to 100 nm of the extracellular vesicles called
exosomes, to cellular functions secreted from iPS cells
or tissue stem cells, partially responsible, such an
immune response and during communication tools it
has been reported to play a role as a tissue repair. In
this study, we compared the exosomes from HHH-DP
HLA homozygous haplotypes from cell-derived HHH-
iPS cells (HHH) pulp (DP) cells and exosomes.
Methods: Three lines of HHH-DP cells established at
Gifu University and HHH-iPS cells derived from these
cells were used. DP and iPS cells were cultured in
serum-free conditions. Exosomes were purified from
culture supernatants by ultracentrifugation. Purified
exosomes were subjected to particle size determination
with a nanoparticle analysis system (Nanosight LM10),
exosome markers and HLA class I evaluation by
Western blotting (WB), and miRNA expression analy-
sis, and results were compared. HHH-iPS cell exo-
somes were also examined if teratomas were formed
in immunodeficient mice.
Results: Nanosight LM10 confirmed that the particle
size peaks were nearly identical at ~100 nm. WB
revealed that both DP cell exosomes and iPS cell exo-
somes expressed CD81 and HLA class I, but expression
levels of CD81 and HLA class I were lower in iPS cell
exosomes. The miRNA analysis showed that some
miRNAs differed between cells and between exosomes.
In assessment of teratoma forming ability, no tumour
formation was observed.
Summary/Conclusion: HHH-DP cell exosomes and
HHH-iPS cell exosomes were found to have different
surface antigens and miRNA expression profiles.
HHH-iPS cell exosomes showed a reduced level of
HLA expression and no teratoma formation, and thus
are potentially useful for therapeutic purpose.
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Cellular and secreted extracellular vesicles-encapsulated miRNAs in
the 4T1 murine model of breast cancer
Katie E. Gilligana, Róisín Dwyerb, Clodagh O’Neillc, Eimer o’Connellb and
Peter Dockeryb
aNational University of Ireland Galway, Galway, Ireland; bNUI Galway,
Galway, Ireland; cNational University of Ireland, Galway, Ireland
Introduction: Extracellular vesicles (EVs) are secreted
by all cells and are known to contain a range of genetic
material such as microRNAs (miRNAs). EVs have been
implicated in mediating intercellular communication
to support breast cancer progression and also high-
lighted as a potential biomarker of disease. This study
aimed to investigate the miRNA profile of EVs released
by 4T1 breast cancer cells in vitro and to relate this to
the circulating EV profile of an animal model of this
disease.
Methods: 4T1 cells were cultured in EV-depleted
media, and secreted EVs isolated through sequential
differential centrifugation, micro-filtration and ultra-
centrifugation. EVs were also isolated from the sera of
balb/c mice bearing 4T1 tumours. EVs were character-
ized by Nanoparticle Tracking Analysis (NTA),
Western Blot and Transmission Electron Microscopy
(TEM). RNA was extracted from all cells and EVs
using the MagNA pure compact and Next-Generation
Sequencing (NGS) targeting miRNA was performed.
Targets of interest were validated by Polymerase
Chain Reaction (PCR).
Results: EVs were successfully isolated from all sam-
ples with the majority of vesicles falling within the
range of exosomes (30–120 nm). Western blot analysis
confirmed the presence of tetraspanins CD63, CD81
and CD9. The characteristic size and shape (cup) of
EVs were visualized by TEM. Over 380 previously
annotated miRNAs were detected in the 4T1 secreted
EVs, with 11 novel putative miRNA sequences identi-
fied. Twenty-five miRNAs were found to be differen-
tially expressed between the cells and their secreted
EVs. Interestingly, of these, 14 miRNAs were present
at a significantly higher level in the EVs compared to
the cells. Including a range of miRNA previously asso-
ciated with cancer progression, e.g. miR-486-5p. Gene
ontology enrichment identified a range of key
biological processes that could potentially be regulated
by the EV-miR profile detected such as tumour prolif-
eration and bone cell resorption.
Summary/Conclusion: Analysis of EVs from animals
bearing 4T1 tumours is ongoing to determine whether
the EV-miR profile could serve as a biomarker of dis-
ease. The data presented demonstrates the selective
packaging of tumour associated miRNAs into EVs
which could play an important role in disease
progression.
Funding: Irish Research Council, Government of
Ireland Postgraduate Scholar 2016 GOIPG/2016/978.
PT11.03
Delivery of miR-185 enriched EVs from MSCs inhibits the progression
of OPMD
Lin Wanga, Yuanyuan Wangb, Jiaqi Wangb, Congcong Miaob, Haimei Sunb,
Yu Zhouc and Xiaobing Guana
aCapital Medical University, Beijing, USA; bCapital Medical University,
Beijing, China (People’s Republic); cBeijing Ludaopei Institute of
Haematology, Beijing, China (People’s Republic)
Introduction: Oral leucoplakia is one of the most
common oral potentially malignant disorders
(OPMD) and its malignant transformation is asso-
ciated with chronic inflammation. It is clear that the
tumour microenvironment, which is largely orche-
strated by inflammatory cells, is an indispensable par-
ticipant in the fostering proliferation, survival and
migration. Extracellular vesicles (EVs) shuttle complex
molecular cargo between producer and recipient cells
resulting in epigenetic regulation of cell function. EVs
derived from mesenchymal stem cells (MSCs) have
been found to promote therapeutic activities that are
comparable to MSCs themselves.
Methods: Bone marrow derived MSCs were transfected
with high copy numbers of miR-185 mimics and EVs
were harvested using Genexosome Isolation kit.
miR185 enriched EVs were characterized and applied
on the buccal mucosa in the OPMD model exposed to
7,12-dimethylbenz anthracene (DMBA). Pathological
analysis of the buccal mucosa was studied, and the
topical and serum levels of inflammatory cytokines
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and chemokines were measured. In addition, the
expression levels of caspase 3 and 9 were examined.
Results: EVs released from genetically modified MSCs
had ~25-fold higher expression levels of miR-185 than
the control. Confocal microscopic imaging revealed
that the PKH26 fluorescence labelled EVs principally
localized in the buccal mucosa after administration.
After treatment with miR-185 enriched EVs for 3 or
5 weeks, the topical inflammation severity in buccal
mucosa was remarkably attenuated, the levels of IL-6,
IL-1β, JE, MIP-1a, MIP-2 and TREM-1 were decreased,
and the numbers of inflammatory cells were reduced as
well. Pathological analysis of the buccal tissue showed
significantly decreased numbers of cells with hyperpla-
sia or dysplasia after treatment. In addition, miR185
enriched EVs led to significantly increased levels of
caspase 3 and 9 in the buccal tissue, indicating
miR185 promotes the activation of apoptotic pathway.
Summary/Conclusion: miR-185 enriched EVs from
MSCs are anti-inflammatory and anti-proliferative,
and promote apoptosis. Genetically modified MSC-
derived EVs have signiﬁcant potential as a novel ther-
apy for oral leucoplakia.
PT11.04
Identification of exosome secretion inhibitor for cancer therapy
Jong-In Kim, Eun-Ju Im, Chan-Hyeong Lee and Moon-Chang Baek
School of medicine, Kyungpook National University, Daegu, Republic of
Korea
Introduction: Exosomes are nanosize secreting vesicles
that can internalize and interact with other cells to
initiate physiological and pathological signalling path-
ways. Especially, tumour-cell derived exosomes (TDXs)
activate tumour-related mechanism such as prolifera-
tion, metastasis and drug resistance. We hypothesized
that inhibition of exosome secretion may have benefi-
cial effects in the treatment of cancer. Here, we found
an old drug which inhibits exosome secretion from
various cancer cells.
Methods: Human breast cancer and Human melanoma
cancer cell lines were cultured. Immunoblotting was
performed with primary antibodies against RAB27A
and beta-actin. Cells were seeding in 24 well plates
then treated candidate drugs for 24 h. Cell viability
was measured by MTT assay. Exosomes were isolated
by serial centrifugation method, then resuspended in
PBS for further experiments. Exosome concentration
was analysed by NTA.
Results: Exosome secretion was significantly decreased
by drug treatment. In addition, this drug affected
protein expression of RAB27A in various cancer cell
lines. Moreover, migration and invasion activity of
cancer cells were markedly suppressed by drug, sug-
gesting that this drug has possibility to be used for anti-
cancer therapy.
Summary/Conclusion: These findings demonstrate
that a drug to inhibit exosome secretion selectively in
cancer cells could be used for the therapy of various
cancers. Importantly, our study offers a new mechan-
istic insight into drug development by the inhibition of
exosome secretion.
Funding: This work was supported by the National
Research Foundation of Korea (NRF) grant funded by
the Korea government (2014R1A5A2009242)
This research was supported by the Bio &Medical
Technology Development Program of the National
Research Foundation (NRF) funded by the Ministry
of science & ICT (2017M3A9G8083382)
PT11.05
Platelet-derived microparticles as an oriented bullet for cancer
treatment
Yu-Wen Wu and Thierry Burnouf
College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
(Republic of China)
Introduction: Platelets (PLTs) and PLTs-derived
microparticles (PMPs), released by PLTs upon throm-
bin activation, interact closely with cancer cells in the
tumour microenvironment. Some researchers have
been used synthetic nanoparticles loaded with antic-
ancer agents and coated with whole PLT membranes
for cancer therapy. However, isolating PLT membranes
and synthesizing nanoparticles coatings sufficient for
translational applications. Further, procedures for iso-
lating PLT membranes may denature proteins, which
may alter targeting specificity and incur an adverse risk
of immunogenicity in patients. Therefore, our aim is to
isolate and evaluate the ability of PMPs to serve as
Trojan Horse carriers of anticancer drugs for cancer
treatment.
Methods: PLT concentrates were centrifuged at
3000 × g for 15 min at 24 ± 3°C and the pellet
(PLTs) was suspended in thrombin in Tyrode’s buffer
(0.1U/mL) to induce activation and incubated at 37°C
for 1 h. The solution was then centrifuged at 3000 × g
for 10 min at 24 ± 3°C to remove PLTs and the super-
natant (PMPs) was centrifuged at 20,000 × g for 90 min
at 18°C. The PMPs pellet was resuspended in platelet
additive solution (PAS) and stored at −80°C. PMPs
were thawed at 37°C then incubated with 100 μM
doxorubicin (DOX) in PAS at 37°C for 1 h. The
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supernatant was centrifuged at 20,000 × g for 90 min at
18°C. The pellet of PMPs loaded with DOX (PMPDs)
was resuspended in PAS. The sizes and the concentra-
tions of PMPs and PMPDs were measured using a
nanoparticle tracking analysis (NTA). Data were ana-
lysed using NTA software. Transportation of DOX
from PMPDs to breast cancer cell lines was observed
by deconvolution microscopy.
Results: NTA results revealed that the mean size of
PMPDs (234.1 ± 48.01 nm) was slightly larger com-
pared with that of PMPs (200.1 ± 57.71 nm) and that
DOX incorporation did not influence the quantifica-
tion of PMPs. The concentration of them was no sig-
nificant difference. The size distributions and images of
PMPs and PMPDs indicated the absence of aggregated
PMPs associated with DOX loading. When incubated
with MCF-7 and MDA-MB-231 cells, PMPDs trans-
ferred DOX to the nuclei of cancer cells within 30 min.
Summary/Conclusion: These results support the
potential clinical use of PMPDs as novel cell-based
“Trojan Horse” anti-cancer therapeutic strategy.
Funding: This study was supported by the Ministry of
Science and Technology.
PT11.06
Design of an exosome-based drug delivery system transporting
anticancer peptides for targeting breast metastases in the brain
Filipa Oliveiraa, Julia Skalskaa, Tiago Figueiraa, Patrícia Napoleãoa, Érica
Mellob, David Andreuc, Valdirene Gomesb, Miguel Castanhoa and Diana
Gaspara
aInstituto de Medicina Molecular João Lobo Antunes, Faculdade de
Medicina, Universidade de Lisboa, Lisboa, Portugal; bLaboratório de
Fisiologia e Bioquímica de Microrganismos do Centro de Biociências e
Biotecnologia da Universidade Estadual do Norte Fluminense Darcy
Ribeiro, Rio de Janeiro, Brazil; 3Department of Experimental and Health
Sciences, Pompeu Fabra University, Barcelona Biomedical Research Park,
Barcelona, Spain
Introduction: The treatment of breast cancer brain
metastases can be addressed with the effective delivery
of anti-tumoural drugs into the brain. The develop-
ment of a drug delivery system (DDS) that can physio-
logically match the cell membrane, decrease the
development of immune responses and that crosses
biological barriers is significantly valuable for treating
metastatic breast cancer (MBC). When compared to
other nanoparticle delivery vehicles, exosomes repre-
sent an interesting approach to conventional DDS. In
the present work, exosomes from breast cells were
isolated and biophysically characterized. In addition,
their interaction with anticancer peptides (ACPs) was
unravelled envisioning the design of a DDS for MBC.
Methods: Exosomes from breast cell lines were isolated
using a commercially available kit and biophysically
characterized with transmission electron microscopy
(TEM), atomic force microscopy (AFM), flow cytome-
try, Western Blot and dynamic light scattering. The
interaction of PvD1 and vCPP2319 ACPs with the
breast cells and respective exosomes was also followed
with surface plasmon resonance (SPR) as to detail
peptide’s binding to the different exosomes.
Results: Results suggests an intracellular target for
vCPP2319 cytotoxic activity on breast cancer cells.
The binding of the peptides to both membranes of
human cells and exosomes results in cell death and in
strong binding, respectively, pointing to the potential
ability of these breast exosomes in transporting ACPs,
which in turn are highly effective towards tumour cells.
Summary/Conclusion: Even though more studies are
currently in development, the combination of potential
ACPs with human-derived exosomes are shown as a
potential source for a highly selective and effective
DDS aiming to attack breast tumour cells located in
the brain.
Funding: Fundação para a Ciência e a Tecnologia
(FCT I.P., Portugal) is acknowledged for funding –
PTDC/BBBBQB/1693/2014. F. O., J. S. and T. F.
acknowledge FCT I.P., Portugal for fellowships PD/
BD/135046/2017, PD/BD/114177/2016 and SFRH/BD/
5283/2013, respectively. Marie Skłodowska-Curie
Research and Innovation Staff Exchange (RISE) is
acknowledged for funding: call H2020-MCA-RISE-
2014, Grant agreement 644, 167, 2015–2019.
PT11.07
Embryonic stem cells-derived exosomes endowed with targeting
properties as chemotherapeutics delivery vehicles for glioblastoma
therapy
Xiaozheng Ling, Qingwei Zhu, Yunlong Yang, Yang Wang, Zhifeng Deng
Shanghai Jiao Tong University Affliated Sixth People’s Hospital, Shanghai,
China (People’s Republic)
Introduction: Glioma treatment is severely hindered
by blood brain barrier (BBB) which leads to very lim-
ited on-target activity of therapeutic agents. Exosomes
are nanosized extracellular vesicles with efficient BBB
penetration ability and presents a promising drug car-
rier for glioma treatment. However, several reports
have demonstrated that injected exosomes mainly dis-
tribute in liver and spleen rather than brain. In this
study, we find embryonic stem cell derived exosomes
(ES-Exos) show broad spectrum anti-tumour ability
including glioma, and thus we further use ES-Exos as
paclitaxel (PTX) carrier and modify them with tumour
targeting ligand cRGD.
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Methods: CCK-8 analysis and flow cell analysis were
used to test the anti-tumour ability of ES-Exos. cRGD
was incorporated onto the surface of ES-Exos by post-
insertion methods with cRGD-DSPE-PEG2000 (cRGD-
Exos), and PTX was loaded into cRGD-Exos by co-
incubation to get cRGD-Exos-PTX. In situ glioma
model of mice was built by injecting glioma cells in
brain. In vivo imaging was used to test the biodistribu-
tion of cRGD-Exos-PTX. Further, subcutaneous
tumour of mice was also built to evaluate the anti-
tumour ability of ES-Exos and cRGD-Exos-PTX.
Results: Our results showed that ES-Exos could inhibit
tumour cell proliferation of broad spectrum, including
U87, U251, A549, HCC, HepG2, B16, MDA-MB-231
and DU145. Flow cell analysis showed that ES-Exos
induced tumour cell apoptosis. Furthermore, after
cRGD modification, cRGD-Exos showed enhanced
tumour cell uptake compared with ES-Exos. And in
vivo imaging analysis demonstrated that more cRGD-
Exos distributed in glioma site in mice brain. And mice
with in situ glioma treated with cRGD-Exos-PTX lived
more longer than the group treated with Exos-PTX.
Finally, cRGD-Exos-PTX showed the beat anti-tumour
ability in subcutaneous tumour model.
Summary/Conclusion: In this study, we demonstrate
that ES-Exos is antineoplastic, and their tumour site
distribution is enhanced by cRGD modification.
cRGD-Exos-PTX is an efficient therapeutic agent for
glioma treatment.
Funding: NSFC Project No. 81671209 and No.
81471243.
PT11.08
Exosome as a vehicle for delivery of membrane protein therapeutics,
PH20, for enhanced tumour penetration and antitumor efficacy
Yeonsun Hong, Yoon Kyoung Kim and Yoosoo Yang
Korea Institute of Science and Technology, Seoul, Republic of Korea
Introduction: As biochemical and functional studies of
membrane protein remain a challenge, there is growing
interest in the application of nanotechnology to solve
the difficulties of developing membrane protein ther-
apeutics. Exosome, composed of lipid bilayer enclosed
nanosized extracellular vesicles, is a successful platform
for providing a native membrane composition.
Methods: Exosome Preparation and Characterization –
DLS, western blot, TEM Enzymatic Activity Assay in
vitro and in vivo HA Depletion Analysis Tumour Blood
Flow Biodistribution Imaging of Dox Fluorescence
Distribution in Tumours Evaluation of Anti-tumour
Effect in Mouse Model.
Results: This study reports an enzymatic exosome, which
harbours native PH20 hyaluronidase (Exo-PH20), which
is able to penetrate deeply into tumour foci via hyalur-
onan degradation, allowing tumour growth inhibition
and increased T cell infiltration into the tumour. This
exosome-based strategy is developed to overcome the
immunosuppressive and anticancer therapy-resistant
tumour microenvironment, which is characterized by an
overly accumulated extracellular matrix. Notably, this
engineered exosome with the native glycosylphosphatidy-
linositol-anchored form of hyaluronidase has a higher
enzymatic activity than a truncated form of the recombi-
nant protein. In addition, the exosome-mediated codeliv-
ery of PH20 hyaluronidase and a chemotherapeutic
(doxorubicin) efficiently inhibits tumour growth. This
exosome is designed to degrade hyaluronan, thereby aug-
menting nanoparticle penetration and drug diffusion.
Summary/Conclusion: Here, we developed the engi-
neered exosome that facilitates its own penetration into
the HA-containing tumour ECM. Enabling chemical
drugs, nanoparticles, and immune cells to penetrate
deeply into tumour foci is a challenging goal of studies
aimed at achieving antitumor therapeutic efficacy. The
exosome-triggered infiltration of cytotoxic T cells into
tumour tissues, which was observed in the present
work, could induce an adaptive immune response to
help combat cancer. Moreover, we provide a general
strategy that may be used to decorate exosomal sur-
faces with natural-state membrane-bound proteins.
PT11.09
Surface engineering of exosomes to block HIV
infection
Pooja Bhardwaja, Shivani Desaia, Ali Danesha, Amirali Afsharib, Archana
Guptab and Satish K. Pillaia
aVitalant Research Institute, San Francisco, USA; bSystem Biosciences (SBI),
Palo Alto, CA, USA
Introduction: While lifelong antiretroviral therapy has
dramatically reduced the morbidity and mortality of
HIV infection, treated individuals still experience
immune dysregulation and chronic inflammation, driv-
ing interest in alternative therapeutic and curative stra-
tegies. Exosomes, extracellular membrane vesicles 30–
100 nm in size, have shown promise as engineerable
therapeutic agents for a broad range of diseases. We
aimed to engineer exosomes with the capacity to block
HIV infection as a novel antiviral approach.
Methods: Exosomes were isolated from 1 mL of
healthy donor plasma using polymer-based precipita-
tion and column purification. Nanoparticle tracking
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analysis was used to determine the abundance and size
of particles. Exosomes were quantified by fluorometer,
and 200 µg protein equivalents were decorated with
single-chain variable fragment (scFv)-C1C2 fusion pro-
teins with complementarity determining regions target-
ing the HIV envelope protein. The HIV-1 NL4-3 EGFP
reporter virus was incubated with decorated exosomes
for 2 h at 1:1, 1:2 and 1:4 ratios. Virus was incubated
with no exosomes, undecorated exosomes, or anti-PD-
1 scFv-decorated exosomes as negative controls. Jurkat
E6.1 cells and primary human CD4+T cells were
infected with virus-exosome preparations via spinocu-
lation, and GFP fluorescence was measured by flow
cytometry to determine infection levels after 72 h.
Results: Our engineered anti-HIV scFv-decorated exo-
somes significantly inhibited HIV infection in Jurkat
cells with respect to all negative controls (n = 3;
p < 0.05, paired t-test). Anti-HIV scFv-decorated exo-
somes potently inhibited HIV infection in primary
human CD4 + T cells (n = 2 donors) in a dose-depen-
dent manner, suppressing up to 87% of infection in the
absence of toxicity.
Summary/Conclusion: Engineering exosomes ex vivo
represents a promising therapeutic approach for HIV
infection. Future work will test the capacity of our
designer exosomes to inhibit HIV replication in vivo
in humanized mouse models. Beyond viral suppres-
sion, we will determine if designer exosomes can accel-
erate the clearance of HIV latently-infected cells, the
main obstacle to a cure for HIV infection.
Funding: NIH P01AI131374 and R01GM117901
PT11.10
Exosome-mediated RNAi of PAK4 prolongs survival of pancreatic
cancer mouse model after loco-regional treatment
Lizhou Xua, Julie Wangb, Farid N. Faruqub, Kee Limb, Adam Waltersb, Claire
Wellsb and Khuloud Al-Jamalb
aSchool of Cancer and Pharmaceutical Sciences, King’s College London,
London, UK; bKing’s College London, London, UK
Introduction: Pancreatic cancer (PC) remains one of
the most aggressive and devastating malignancies, pre-
dominantly due to the absence of a valid biomarker for
diagnosis and limited therapeutic options for advanced
disease. Exosomes (Exo) as cell-derived vesicles are
widely used as natural nanocarriers for drug delivery.
P21-activated kinase 4 (PAK4) is oncogenic when over-
expressed, promoting cell survival, migration and
anchorage-independent growth. In this study, we vali-
date PAK4 as a therapeutic target in an in vivo PC
tumour mouse model using Exo nanocarriers following
intra-tumoural administration.
Methods: PC derived Exo were firstly isolated by ultra-
centrifugation on sucrose cushion and characterized
for their surface marker expression, size, number, pur-
ity and shape. siRNA was encapsulated into Exo via
electroporation and dual uptake of Exo and siRNA was
investigated by flow cytometry and confocal micro-
scopy. In vitro siPAK4 silencing in PC cells was
assessed by western blotting, flow cytometry, and in
vitro scratch assay. In vivo efficacy (tumour growth
delay and mouse survival) of siPAK4 was evaluated in
PC bearing NSG mouse model. Ex vivo tumours were
examined using Haematoxylin and eosin (H&E) stain-
ing and immunohistochemistry.
Results: High quality PC derived PANC-1 Exo were
obtained. siRNA was incorporated in Exo with 16.5%
loading efficiency. Exo and siRNA co-localization in
cells was confirmed by in vitro imaging. PAK4
knock-down was successful at 30 nm Exo-siPAK4 at
24 h post-incubation in vitro. Intra-tumoral admin-
istration of Exo-siPAK4 (1 µg siPAK4 and 7.7 × 1011
Exo, each dose, two doses) reduced PC tumour
growth and enhanced mice survival (p < 0.001),
with minimal toxicity observed compared to
polyethylenimine (PEI) used as a commercial
transfection reagent. H&E staining of tumours
showed significant tissue apoptosis in siPAK4 treated
groups.
Summary/Conclusion: PAK4 interference prolongs
survival of PC bearing mice suggesting its candidacy
as a new therapeutic target in PC. PANC-1 Exo
demonstrated comparable efficacy but safer profile
than PEI as in vivo RNAi transfection reagent.
Funding: The K. C. Wong Education Foundation and
The Marie Skłodowska-Curie actions, “Horizon 2020”
project, EU (H2020-MSCA-IF-2016).
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PT12.02
Exosomes from adipocyte-derived stem cells reduce the oxidative
stress through the mitochondrial uncoupling in pantothenate kinase
2 mutation in vitro models
Chien Tai Honga and Ruey Meei Wub
aShuang Ho Hospital-Taipei Medical University, New Taipei City, Taiwan
(Republic of China); bNational Taiwan University, Taipei, Taiwan (Republic
of China)
Introduction: The exosome is a promising novel ther-
apy for human diseases. Exosomes-derived from
mesenchymal stem cell is thought to contain plenty of
unique microRNA, which is specific for boosting cel-
lular repair and regeneration. Neurodegenerative dis-
eases are characterized by the neuronal pre-mature
apoptosis and the lack of the ability of regeneration.
It is hypothesized that the supplement of exosomes-
derived from the stem cells could activate the expres-
sion of neuroprotective gene/protein expression,
resume the impaired cellular function and reverse the
degenerative process.
Methods: Patient with pantothenate kinase 2 (PANK2)
mutation-related neurodegeneration with brain iron
accumulation was recruited and the leukocytes were
immortalized to establish the in vitro models. The
adipose-derived stem cell (ADSC) was obtained from
the healthy donors and the exosomes were isolated
from the culture medium at confluent.
Results: The PANK2 mutation resulted in the elevated
oxidative stress and depolarization of mitochondria.
Exosome treatment (5 μg of exosome suspension
upon 3*106 leukocytes) for 24 h up-regulated the pro-
tein level of mitochondrial uncoupling protein 2 and 3,
as well as boosted the mitochondrial biogenesis,
assessed by the protein level of PGC-1α and
TOMM20. Those proteins were undatable in the exo-
somes themselves. Mitochondrial uncoupling proteins
are responsible for the dissipating of mitochondrial
membrane potential and down-regulation of the oxi-
dative phosphorylation from respiration, which is the
major source of free radical and oxidative stress.
Exosome treatment for 24 h led to the obvious mito-
chondrial depolarization, assessed by JC-1 and further
reduction of the oxidative stress, assessed by the
H2DCFDA.
Summary/Conclusion: The exosomes from ADSC
were able to reduce the oxidative stress through manip-
ulating mitochondrial functions. The effect is specu-
lated to achieve by the modulation of genetic
expression in the recipient cells.
Funding: Minister of Science and Technology, Taiwan
(MOST 107–2314-B-038 −086 -MY2)
PT12.03
Extracellular vesicle-secretion system based on agarose gel
encapsulation of cells for cell therapy
Mami Hiranoa, Masaya Hagiwarab, Nahoko Bailey Kobayashic, Tetsuhiko
Yoshidac, Eiichi N. Kodamad and Ikuhiko Nakasea
aGraduate School of Science, Osaka Prefecture University, Sakai-shi, Japan;
bNanoSquare Research Institute, Osaka, Japan; cInstitute for Advanced
Sciences, Toagosei Co., Ltd., Tsukuba, Japan; dTohoku University School of
Medicine, Sendai, Japan
Introduction: Extracellular vesicles (exosomes, EVs,
30 ~ 200 nm in diameter) are released from various
types of cells. Because EVs carry functional molecules
such as e.g. microRNAs and enzymes, EVs play crucial
roles in cell-to-cell communication. On the other hand,
EVs have pharmaceutical advantages as carriers for
intracellular delivery of therapeutic molecules, including,
e.g. encapsulation of natural and/or artificial therapeu-
tic/diagnostic molecules, controlled immunoreaction,
effective usage of cell-to-cell communication routes, infi-
nite secretion and expression of functional proteins in
EV membranes. We are currently developing cell encap-
sulated gel system for secretion of functional EVs in cell
therapy. In this research, agarose gels, which has been
widely used in cell culture and chamber, is used for
encapsulation of cells that secrete functional EVs from
the gels. We here demonstrate our methods for cell
encapsulation in the gels and cellular uptake efficacy of
secreted EVs from the gels.
Methods: CD63 (EV marker protein)-GFP stably
expressing HeLa cells were encapsulated using collagen
and agarose gels. Secreted EVs from the gel system were
separated using ultracentrifuge and analysed by western
blotting, zeta potential, DLS and electron microscope
(TEM). Cellular uptake of secreted EVs from the gels
was observed using confocal laser scanning microscope.
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Results: In the experimental optimization for encapsu-
lation of cells in gels, we successfully attained CD63-
GFP stably expressing HeLa cells-encapsulated agarose
(1.5%) gels (e.g. 5 × 104 cells can be encapsulated in
approx. 2 mm × 25 mm × 25 mm sheet-like gel). DLS
analysis showed 30 ~ 100 nm EVs secreted from the
gels, and zeta potential of the EVs was average −17 mV.
Western blotting confirmed expression of exosomal
marker proteins (e.g. CD63 and CD81). A431 cells
(human epidemoid carcinoma) were cultured with the
CD63-GFP stably expressing HeLa cells-encapsulated
agarose gels for 24 h, and efficient cellular uptake of
secreted EVs (CD63-GFP-EVs) from the gels were
observed using confocal laser scanning microscope.
Summary/Conclusion: Although we have to conduct
further optimization in this system as next step to
obtain sophisticated methodology, these experimental
techniques and findings will contribute to development
for cell therapy based on EVs as basic studies.
PT12.04
Extracellular vesicles from endothelial progenitor cells improve
outcomes of the lipopolysaccharide-induced acute lung injury
Yue Zhou, Pengfei Li, Andrew Goodwin, James Cook, Perry Halushka,
Eugene Chang and Hongkuan Fan
Medical University of South Carolina, Charleston, USA
Introduction: The acute respiratory distress syndrome
is characterized by disruption of the alveolar-capillary
barrier resulting in accumulation of proteinaceous
oedema and increased inflammatory cells in the alveo-
lar space. We previously found that extracellular vesi-
cles (EVs) from endothelial progenitor cells (EPCs)
prevent endothelial dysfunction and lung injury in
sepsis due to their encapsulation of miRNA-126.
However, the effects of EPC EVs in acute lung injury
(ALI) remains unknown.
Methods: To determine if EPC EVs would have bene-
ficial effects in ALI, intratracheal administration of
lipopolysaccharide (LPS) was used to induce ALI in
mice. Lung permeability, inflammation and the role
of miRNA-126 in alveolar epithelial barrier function
were examined.
Results: The intratracheal administration of EPC EVs
reduced lung injury following LPS-induced ALI at 24
and 48 h. Compared to placebo, intratracheal adminis-
tration of EPC EVs significantly reduced the cell num-
ber, protein concentration and cytokines/chemokines
in the bronchoalveolar lavage fluid, indicating a reduc-
tion in permeability and inflammation. Further, EPC
EVs reduced myeloperoxidase activity and reduced the
lung injury score, demonstrating protection against
lung injury. Murine fibroblast (NIH3T3) EVs, which
do not contain abundant miRNA-126, did not provide
these beneficial effects. In human small airway epithe-
lial cells, we found that overexpression of miRNA-126-
3p can target phosphoinositide-3-kinase regulatory
subunit 2, while overexpression of miRNA-126-5p
inhibits the inflammatory cytokine HMGB1 and per-
meability factor VEGFα. Interestingly, both miR-126-
3p and 5p increase the expression of tight junction
proteins suggesting a potential mechanism by which
miRNA-126 may mitigate LPS-induced lung injury.
Summary/Conclusion: Our data demonstrated that
human EPC EVs are beneficial in LPS-induced ALI
mice, in part through the delivery of miRNA-126 into
the injured alveolus.
Funding: 1R01GM113995 (HF), 1R01GM130653 (HF),
1K23HL135263-01A1 (AG), UL1TR001451 (PVH)
PT12.05
Hsa_circ_0000077-overexpressing extracellular vesicle: a new tool to
prevent cartilage degeneration
Shi-Cong Tao and Shang-Chun Guo
Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai,
China (People’s Republic)
Introduction: Trauma and degeneration of articular
cartilage (AC) could trigger the morbidity of one of
the leading disabling disease, osteoarthritis (OA). One
of the most difficult issues in treatment is the poor self-
healing ability of AC. Extracellular vesicle (EV) trans-
plantation has received more and more attention as
potential cell-free therapeutic approaches to promote
tissue healing. In our preliminary study, we found that
decreased expression of hsa_circ_0000077 (circ77) was
closely related to OA. And circ77-overexpression in
chondrocytes can prevent the chondrocyte degenera-
tion. In this study, EVs derived from circ77-overex-
pressing synovium mesenchymal stem cells (SMSC-77-
EVs) were used to promote cartilage regeneration.
Methods: CCK-8, qPCR and western blotting (WB)
were used to investigate the biological functions of
SMSC-77-EVs on the proliferation and cartilage regen-
eration. Furthermore, interleukin 1β (IL-1β) were used
to simulate the inflammatory conditions of OA, and
then, the protective effects of SMSC-77-EVs were con-
firmed by CCK-8, qPCR and WB.
Results: CCK-8 assay confirmed that SMSC-77-EVs
enhanced the proliferation of chondrocytes, compared
with normal control and EVs derived from synovium
mesenchymal stem cells which were transfected by
empty vectors (SMSC-Empty-EVs). WB and qPCR
assays confirmed that SMSC-77-EVs enhanced the
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expression levels of cartilage related proteins including
Type II collagen (Col-II), aggrecan (ACAN) and SOX9,
compared with normal control and SMSC-Empty-EVs.
IL-1β significantly inhibited the proliferation and car-
tilage regeneration-related proteins (Col-II, ACAN and
SOX9). SMSC-77-EVs could observably restrain the
harmful effects of IL-1β, while SMSC-Empty-EVs
showed limited ability.
Summary/Conclusion: These findings suggest that the
novel SMSC-77-EVs provides the preferable function
in promoting the repair of cartilage damage. The use of
SMSC-77-EVs would represent a development trend of
cell-free therapies, using engineered EVs (or modular-
ized EVs), for promoting cartilage regeneration.
Funding: The National Natural Science Foundation of
China [Nos. 81871834, 81802226 and 81301589], and
Shanghai Jiao Tong University K.C.Wong Medical
Fellowship Fund supported this work.
PT12.06
Lymphangiogenesis induced by exosomes derived from adipose-
derived mesenchymal stem cells
Kensuke Tashiroa, Yusuke Yoshiokab and Takahiro Ochiyab
aJichi Medical Unversity, Tochigi, Japan; bDepartment of Molecular and
Cellular Medicine, Institute of Medical Science, Tokyo Medical University,
Shinjyuku-ku, Japan
Introduction: Lymphedema is chronic oedema of
limbs caused by the accumulation of lymphatic fluid
and characterized by a progressive disorder of the
smooth muscle cells of the lymphatic channels.
Transplantation of adipose-derived mesenchymal
stem cells (ADSCs) has been reported to improve the
severity of lymphedema, however, the detailed
mechanism has not been elucidated yet. Extracellular
vesicles(EVs) derived from mesenchymal stem cells
have been reported to have functions such as cancer
development, angiogenesis, suppression of inflamma-
tion, regeneration of damaged organs and treatment of
degenerative disease. ADSCs are thought to be promis-
ing source of regenerative medicine, and EVs derived
from ADSCs are thought to have similar effects as well.
Here, we analysed lymphangiogenesis induced by EVs
derived from ADSCs for treatment of chronic
lymphedema.
Methods: EVs derived from ADSCs were isolated by
ultracentrifugation. The effect of EVs to lymphatic
endothelial cells (LECs) were analysed in proliferation
assay, migration assay and tube formation assay. Gene
expression analyses were also performed by qRT-PCR.
LECs were treated with PBS as control, VEGF-C(10 ng/
ml) and ADSC-EVs(100 μg/ml) one time in each assay.
The incubation time was 48 h in proliferation assay,
16 h in migration assay, 8 h in tube formation assay
and 12 and 24 h in qRT-PCR.
Results: ADSC-EVs group showed almost one point
five to twice increase of proliferation, migration and
tube formation function compared to PBS group.
Furthermore, gene expressions for lymphatic markers
such as VEGFR-3, Lyve-1, Podoplanin, Prox-1 were
also shown almost two to five times increase in the
ADSC-EVs group.
Summary/Conclusion: The present study showed lym-
phangiogenic effects of EVs derived from ADSCs,
which lead to new treatment options for chronic lym-
phedema. Further studies are needed to elucidate what
kind of molecular in ADSC-EVs works in LEC. In vivo
studies using mouse lymphedema model are also
needed to confirm the biological function of ADSC-
EVs. EVs for cell free therapy are less potential risk
compared to stem cell transplantation and could be
promising tool for patients suffering from
lymphedema.
Funding: JSPS Kakenhi; Takeda Science Foundation.
PT12.07
Embryonic stem cell-derived extracellular vesicle-mimetic
nanovesicles rescue erectile function by enhancing penile
neurovascular regeneration in the streptozotocin-induced diabetic
mouse
Kang-Moon Songa, Mi-Hye Kwona, Guonan Yina, Kalyan Ghataka, Nguyen
Nhat Minha, Min Ji Choia, Jiyeon Ocka, Yong Song Ghob, Ji-Kan Ryua and
Jun-Kyu Suha
aNational Research Center for Sexual Medicine and Department of Urology,
Inha University School of Medicine, incheon, Republic of Korea;
bDepartment of Life Sciences, Pohang University of Science and
Technology, Pohang, Republic of Korea
Introduction: Extracellular vesicles (EV)-mimetic
nanovesicles (NVs) contains a variety of protein,
mRNA and miRNA and is known to play an important
role in intercellular communication as a bio-nanopar-
ticle with a diameter of 40 to 100 nm. Recent studies
have demonstrated the therapeutic potential of EV-
mimetic NVs in a variety of animal models for cardi-
ovascular diseases and neuropathies. The aim of this
study was to investigate effectiveness of embryonic
stem cell (ESC)-derived EV-mimetic NVs in restoring
erectile function in diabetic mice.
Methods: Diabetes was induced by intraperitoneal
injection of streptozotocin into 8-week-old C57BL/6
male mice. At 8 weeks after the induction of diabetes,
the animals were distributed into 7 groups: control
non-diabetic mice and diabetic mice receiving two
successive intracavernous injections of HEPES-buf-
fered saline (HBS, days −3 and 0; 20 μL) or ESC-
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derived EV-mimetic NVs (ESC-NVs, days −3 and 0;
0.1 μg, 0.5 μg, 1 μg, 2 μg, or 5 μg in 20 μL of HBS,
respectively). Two week after treatment, we measured
erectile function by electrical stimulation of the caver-
nous nerve. The penis was then harvested for histolo-
gical and biochemical studies. We also examined the
effects of ESC-Exo in primary cultured mouse caver-
nous endothelial cells (MCEC) and pericytes (MCP) in
vitro; and in cultured aortic ring and major pelvic
ganglion (MPG) ex vivo.
Results: Intracavernous injections of ESC-NVs signifi-
cantly improved erectile function in diabetic mice,
which reached up to 90% of control values. ESC-NVs
induced significant restoration of cavernous contents
of endothelial cells, smooth muscle cells, pericytes, and
neuronal cells in diabetic condition. Moreover, ESC-
NVs promoted micro-vascular sprouting from aortic
ring and accelerated tube formation in primary cul-
tured MCEC and MCP mono-culture or co-culture
system in vitro.
Summary/Conclusion: ESC-NVs successfully restored
erectile function through enhanced cavernous angio-
genesis and neural regeneration in diabetic mice. It will
be a better strategy to use ESC-NVs than ESCs for the
treatment of retractable erectile dysfunction although it
remains to be solved for future clinical application of
ESCs.
PT12.08
Human adipose tissue-derived mesenchymal stem cell exosomes for
the treatment of liver fibrosis
Sol Shin, Soyoung Son, Gyeongtaek Lim, Seunglee Kwon and Jaehyung Park
aSungkyunkwan University, Suwon, Republic of Korea
Introduction: Liver fibrosis, often leading to liver cir-
rhosis and cancer, is a challenging health issue for
which there are no effective medicines. Conventional
therapies are merely symptomatic treatment. Hence,
there have been lots of efforts to develop better ther-
apeutic strategies. Cell therapy based on mesenchymal
stem cells (MSCs) is one of the attractive options.
MSCs hold immunomodulatory properties and multi-
potency. However, cell transplantation has limitations
such as teratoma formation and low cell viability in
vivo condition. In order to overcome these limitations,
we suggest MSCs derived exosome-based therapy for
treating liver fibrosis.
Methods: Exosome-derived from ADSCs (A-exo) was
purified using a tangential flow filtration system. The
physical characteristics of A-exo were investigated
using DLS, TEM and NTA. The protein concentration
of A-exo was determined by BCA assay. The effect of
A-Exo on the expression level of α-SMA was evaluated
by IF analysis. Mice were received thioacetamide intra-
peritoneally. Fluorescently labelled A-exo was adminis-
tered to mice and whole-body fluorescence was
observed in order to evaluate the in vivo distribution.
The therapeutic efficacy of A-exo was determined by
measuring the level of ALT, ALP, TBIL and TP in
blood of mice. A-exo was injected intravenously three
times and blood was collected after final injection.
Results: When hepatic stellate cells were activated with
TGF-β1, the expression level of α-SMA was signifi-
cantly increased. While, the level was remarkably
decreased depending on the treatment concentration
of A-Exo. A-exo treatment significantly decreased
expression mRNA of pro-fibrogenic marker: α-SMA,
Collagen I and MMP-2. After systemic administration
of exosome, a substantial accumulation of A-Exo at
liver was observed in both the normal and mice
model of liver fibrosis. Furthermore, liver function of
A-exo treated group was restored to normal. These
results showed A-exo had the high therapeutic efficacy.
Summary/Conclusion: In this study, we investigate the
potential of stem cell-derived exosome as the new
therapeutic approach for liver fibrosis treatment. A-
exo has similar bioactive capacity to its origin cell,
mesenchymal stem cell. The beneficial effect of A-exo
was confirmed in vitro and in vivo tests. The superior
therapeutic efficacy was displayed in A-exo treated
mouse group.
PT12.09
HucMSC exosome confer protection against ultraviolet radiation
induced acute photodamage via modulation of SIRT1 pathway
Peipei Wua, Hui Qianb and Wen Rong Xuc
aJiangsu university, Zhenjiang City, China (People’s Republic); 2ZhenJiang,
China (People’s Republic); cZhenjiang Key Laboratory of High Technology
Research on Exosomes Foundation and Transformation Application, Jiangsu
Key Laboratory of Medical Science and Laboratory Medicine, School of
Medicine, Jiangsu University, Zhenjiang, China (People’s Republic)
Introduction: Exosomes are nano-sized membrane
vesicles secreted by most cells, including human umbi-
lical cord mesenchymal stem cells (hucMSC). hucMSC
derived exosomes (hucMSC-ex) have been reported to
significantly facilitate skin regeneration, resembling the
effect of parental cells. However, the role of hucMSC-
ex in ultraviolet radiation (UV) induced skin damage
and the underlying mechanisms are largely unknown.
Methods: Herein, we examined the benefit of hucMSC-
ex in a rat acute skin photodamage model.
Results: We found that the subcutaneous injection of
hucMSC-ex (1 mg) elicited noted antioxidant and anti-
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inflammatory effects against UV induced DNA damage
and apoptosis in vivo. Further studies shown that sir-
tuin1(SIRT1) expression level in skin keratinocytes
(HaCaT) decreased in a time- and dose-dependent
manner under oxidative stress in vitro, however, the
treatment of hucMSC-ex reverses this phenomenon.
Activation of SIRT1 significantly attenuated UV and
H2O2-induced cytotoxic damage by inhibiting oxida-
tive stress and promoting autophagy activation.
Furthermore, we also discovered that the cytoprotec-
tion function provided by hucMSC-ex carried 14–3-3ζ
was potential associated with modulation of SIRT1
dependent antioxidant response.
Summary/Conclusion: Collectively, our findings indi-
cated that hucMSC-ex is a new potential agent for
preventing and/or treating UV-induced skin photo-
damage and ageing.
Funding: Zhenjiang Key Laboratory of Exosomes
Foundation and Transformation Application High-
tech Research, china: (ss2018003). National Natural
Science Foundation of China: (BE2016717).
PT12.10
Anti-melanogenic effect screening for natural plant-derived exosome-
like nanovesicles
Ruri Leea, Yeon Juhunb, Kim Kimina, Min seo yunc and Kim Jung Ahc
aUniversity of brain education, Cheon-an, Republic of Korea; buniversity of
brain education, cheon-an, Republic of Korea; ckorea basic science institute,
ochang, Republic of Korea
Introduction: Demand for whitening agents is increas-
ing due to their anti-melanogenic effects by improving
skin darkness and decreasing melanin production in
the cosmetics industry. However, there have been side
effects and high toxicity issue as well as poor skin
penetration. Therefore, many researchers have focused
on natural plants as an alternative chemo-therapeutics
agent to avoid various side effects. Recently, it is known
that exosome-like nanovesicles have biocompatibility
and excellent drug delivery capacity. In this study,
leaves and stems-derived exosome-like nanovesicles
were isolated from Dendropanax Morbifera and we
have found that inhibition of those nanovesicles on
melanin products.
Methods: Exosome-like nanovesicles from leaves and
stems were isolated and identified size using DLS and
NTA. These shapes were observed by TEM. The anti-
melanogenic effect was verified by evaluating the mel-
anin content and tyrosinase activity on melanoma cell.
Also, western blot was used to observe melanogenesis-
related protein expression. In addition to, cellular mel-
anin formation was confirmed using TEM. The human
epidermal model was used to evaluate the inhibition of
melanogenesis.
Results: The leaves and stems-derived exosome-like
nanovesicles are able to suppress cellular melanin con-
tent melanoma cells. Also, melanogenesis protein
expression was reduced with leaves- and stems-derived
exosome-like nanovesicles. These results suggest that
leaves- and stems-derived exosome-like nanovesicles of
the D. morbifera could be a candidate of natural sub-
stances for anti-melanogenic agents.
Summary/Conclusion: The leaves and stems-derived
exosome-like nanovesicles are able to suppress cellular
melanin content melanoma cells. Also, tyrosinase activ-
ity and melanogenesis protein expression were reduced
with leaves- and stems- derived exosome-like nanove-
sicles. These results suggest that leaves- and stems-
derived exosome-like nanovesicles of the D. morbifera
could be a candidate of natural substances for anti-
melanogenic agents.
Funding: This work was supported by the Basic
Science Research Program through the National
Research Foundation of Korea (NRF) funded by the
Ministry of Education, Science and Technology (NRF-
2016R1C1B2013345).
PT12.11
Stem cell extracellular vesicles as therapeutics for autoimmunity
Weian Zhaoa, Milad Riazifarb, Rezaa Mohammadib and Jan Lotvallc
aUniversity of California, Irvine, Irvine, USA; bUC Irvine, IRVINE, USA;
cUniversity of Gothenburg, Gothenburg, Sweden
Introduction: Stem cells including mesenchymal stem
cells (MSC) hold great potential in treating autoim-
mune disorders. However, their clinical translation
has been hindered due to incomplete understanding
of mechanisms of action (MOA) and potential safety
concerns. Recent evidence revealed that some of the
MSC MOA may be associated with extracellular vesi-
cles (EV),
Methods: We investigated MSC derived exosomes in
immune modulation in a multiple sclerosis experimen-
tal autoimmune encephalomyelitis (EAE) a mouse
model in vivo as well as in T cell proliferation suppres-
sion and Treg induction in vitro.
Results: Our results indicated that that intravenous
administration of exosomes produced by MSCs stimu-
lated by IFNγ (IFNγ-Exo) (i) enhanced the mean clin-
ical score of EAE mice compared to PBS control, (ii)
home into the spinal cords and reduced demyelination,
(iii) decreased neuroinflammation and (iv) upregulated
the number of CD4+/CD25+/FOXP3+regulatory T
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cells (Tregs). In addition, we found that IFNγ-Exo
significantly reduced the proliferation of T-cells in
vitro and reduced production of proinflammatory fac-
tors including IL-6, IL-17 and IL-22 while enhanced
the production of Indoleamine 2,3-dixygenase (IDO), a
key player in MSC-mediated immunosuppression.
Summary/Conclusion: Our findings suggest that stem
cell derived EVs can serve as promising candidates in
treating autoimmune and neurodegenerative diseases.
Funding: National Institute of Health (1DP2CA195763-
01; #NS082174).
PT12.12
Biocompatible myxobacteria-derived outer membrane vesicles show
inherent antibacterial activity against gram-negative and gram-
positive microbes
Adriely Goesa, Eilien Schulza, Philipp Lapuhsa, Robert Richterb, Fabian Panterc,
Marcus Kochd, Rolf Müllerc, Kathrin Fuhrmanne and Gregor Fuhrmanne
aHelmholtz Institute for Pharmaceutical Research Saarland, Biogenic
Nanotherapeutics (BION), Saarbrücken, Germany; bHelmholtz-Institute for
Pharmaceutical Research Saarland, Department of Drug Delivery (DDEL),
Saarbrücken, Germany; cHelmholtz Institute for Pharmaceutical Research
Saarland, Department of Microbial Natural Products (MINS), Saarbrücken,
Germany; dLeibniz Institute for New Materials (INM), Saarbrücken,
Germany; eHelmholtz-Institute for Pharmaceutical Research Saarland
(HIPS), Saarbrücken, Germany; 6Helmholtz-Institut for Pharmaceutical
Research Saarland (HIPS), Saarbrücken, Germany
Introduction: Myxobacteria are gram-negative bacteria
that live in the soil and can be found in different
habitats and they have been explored for their capabil-
ity of providing natural products with great potential
for antimicrobial therapy. We investigated the antimi-
crobial activity of OMVs isolated from the myxobac-
terial strains Cystobacter velatus (Cbv34) and
Cystobacter ferrugineus (Cbfe23) against E. coli DH5-
alpha and S. aureus Newman. Cbv34 and Cbfe23 are
producers of the antibacterial compound cystobacta-
mid that we hypothesized to be naturally loaded into
the OMVs they shed.
Methods: The OMVs were isolated by differential cen-
trifugation and size-exclusion chromatography. Particle
size, distribution, concentration and morphology were
analysed by nanoparticle tracking analysis and cryo-
transmission electron microscopy. Particle interaction
and uptake into macrophages (THP-1) and lung alveo-
lar epithelial cells (A549) was investigated by confocal
laser scanning microscopy and flow cytometry.
Cytotoxicity and viability assays were performed
using PrestoBlue and lactate dehydrogenase assays.
The antibacterial activity of the OMVs was assessed
by overnight incubation with E. coli or S. aureus, fol-
lowed by optical density measurement and CFU deter-
mination. The OMVs content was investigated by
liquid chromatography coupled mass spectrometry.
Results: Both OMVs did not induce cytotoxicity or
negatively influenced the viability of THP-1 and A549
cells even at concentrations of 10,000 OMVs/cell.
Cbv34 and Cbfe23 OMVs showed a bactericidal activ-
ity against E. coli and S. aureus. The antibacterial effect
of Cbv34 OMVs remained potent upon storage at 4°C
for 4 weeks. The presence of cystobactamid in Cbv34
OMVs was confirmed by MS. Using flow cytometry
and labelled OMVs, we observed 60% positive cells for
Cbv34 OMVs and 40% positive cells for Cbfe23 OMVs
with THP-1, and 50% positive A549 cells for Cbv34
OMVs after 4 h of incubation.
Summary/Conclusion: The biocompatibility, inherent
bacterial activity and uptake into mammalian cells may
be promising for the treatment of infections, especially
those induced by intracellular S. aureus. However, their
mechanism of action needs further investigation.
Funding: This work was supported by the Federal
Ministry for Research and Education through the
NanoMatFutur programme.
PT12.13
Placental MSCs and their exosomes as vehicles for the Na/I symporter
(hNIS): a new theragnostic agent
Alejandra Crespo-Barredaa, Miguel Quintanillab, Maite Iglesiasc, Antonio de
la Viejad and Pilar Martin-Duquee
aInstituto Aragonés de Ciencias de la Salud/ Universidad Francisco de
Vitoria, Majadahonda, Spain; bInstituto de Investigaciones Biomedicas
Alberto Sols, Madrid, Spain; cUniversidad Francisco de Vitoria, Madrid,
Spain; dInstituto de Salud Carlos III, Madrid, Spain; 5Instituto Aragonés de
Ciencias de la Salud/ IIS Aragón/ Fundación Araid, Zaragoza, Spain
Introduction: The Na > I symporter gene (hNIS) is
expressed in the thyroid and allows the accumulation
of iodine from the diet, to form T3 and T4 hormones.
Moreover, it is widely used (i) as a reporter gene for
molecular imaging (when the positron emitter isotope
is I124 for PET or Tc99 for SPECT) or (ii) as a ther-
apeutic gene for cancer therapy, mediated by the accu-
mulation of 1131. An unresolved challenge is how to
direct this gene specifically to the tumoral area.
Previously, our group demonstrated the migratory
capacity of placental mesenchymal stem cells (MSCs),
carrying an adenovirus expressing hNIS to tumours,
with good results as a theragnostic tool. However, as
hNIS is expressed at the placental tissue (because it
transfers iodine to the foetus from the maternal
blood), in this work we decided to study whether
placental MSCs and their derivatives (exosomes) (1)
express hNIS endogenously and therefore transfers
the imaging and therapeutic potentials when adminis-
tered with radioactive iodine (2) are capable to reach
the tumoral areas when they are intravenously injected
JOURNAL OF EXTRACELLULAR VESICLES 105
due to the tumoral tissues extravasation.The aim of this
research was to develop a new anti-tumoural therapy
by the combination of the advantages of both NIS and
the human placental MSCs (hPMSCs).
Methods: Here, we used two approaches using the
endogenous hNIS expression, first in hPMSCs but also
on its exosomes. For both cases, we determined in vitro
NIS location and functionality but also we followed
those vectors by SPECT CT and studied their antitu-
moral effect after radioactive iodine injection.
Results: We proved that human placenta MSCs and
their exosomes have endogenous expression of NIS,
migrate specifically to the tumour and their endo-
genous expression of NIS is enough to visualized in
vivo cells and exosomes accumulation and to see
significant therapeutic effect on cancer treatment
with 131I.
Summary/Conclusion: Our findings highlight the pos-
sibility to use endogenous expression of NIS as therapy
and opening a wide range of new possibilities to treat
cancer.
Funding: This work has been funded by Universidad
Francisco de Vitoria, Instituto de Salud Carlos lll and
Instituto Aragonés de Ciencias de la Salud
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Coagulation influences properties of extracellular vesicles isolated
from autologous blood derived products
Andrea De Lunaa, Alexander Otahala, Olga Kutenb, Zsombor Laczac and
Stefan Nehrera
aDanube University Krems, Krems, Austria; bOrthoSera GmbH, Krems,
Austria; cOrthosera GmbH, Krems, Austria
Introduction: Platelet rich plasma (PRP) is the most
commonly used blood derivative in clinics due to its
high concentration of platelets and perceived high
growth factor levels. Drawbacks of using PRP are dis-
crepancies among preparation protocols and the pre-
sence of cells (platelets, leuxcocytes) which can evoke
cellular processes (e.g. inflammation) when injected
into the host. One possibility is to isolate only the
active components of blood derivatives which may
overcome this problem. In the current study we
focused on extracellular vesicles (EVs) isolated from
two autologous blood derivatives, PRP and hyperacute
serum and investigated whether the clotting cascade
influences EV properties.
Methods: EVs were isolated from citrate-anticoagu-
lated PRP (CPRP) and hyperacute serum using differ-
ential ultracentrifugation followed by a size exclusion
chromatography. Particle concentration and size were
determined by nanoparticle tracking analysis (NTA).
Cryo-electronmicroscopy was performed to visualize
isolated EVs. Expression of miRNAs transported
within EVs as well as in their respective input material
was analysed by qPCR.
Results: NTA revealed higher particle concentrations
and bigger sized EVs within CPRP compared to hyper-
acute serum. These findings were confirmed by cryo-
electronmicroscopy. Profound differences were
detected regarding miRNA expresion between the two
blood derivatives. 126 miRNAs were identified which
were expressed both in input material as well as in the
corresponding EVs. The correlation between miRNAs
in EVs and input material was higher in CPRP com-
pared to hyperacute serum meaning that in hyperacute
serum miRNAs were identified which were higher
expressed in EVs than in the corresponding input
material.
Summary/conclusion: EVs from autologous blood
products represent a novel and cell free regeneration
approach. We observed that the clotting cascade
(plasma versus serum) has an influence on concentra-
tion, size and miRNA expression patterns of EVs.
These differences might have an impact on the biolo-
gical mode of action of blood derived products used in
clinics.
Funding: Financial support was received from the
European Fund for Regional Development (EFRE)
and the Science Fund of Lower Austria. miRNA
expression analysis was performed by TAmiRNA
GmbH. Cryo-electronmicroscopy was conducted at
the Core Facility of the Vienna Bio-Center.
LBT01.02=OWP1.11
Ev-avogadro project: towards a liposomal concentration standard for
extracellular vesicle research
Gergo Bartaa, Diana Kitkaa, Andras Wachaa, Judith Mihalya, Attila Botaa,
Krisztina Nemetha, Pal Szaboa, Jean-Luc Fraikinb and Zoltan Vargac
aResearch Centre for Natural Sciences HAS, Budapest, Hungary;
bSpectradyne LLC, Torrance, USA; cResearch Centre for Natural Sciences,
Hungarian Academy of Sciences, Budapest, Hungary
Introduction: There is an unmet need for standardiza-
tion of concentration measurements in the field of
extracellular vesicles (EVs). Liposomes may serve an
ideal reference system for EVs, but the determination
of the number concentration of liposomes from first
principles was not attempted so far. Inspired by the
International Avogadro project, we aimed to determine
the concentration of liposomes with well-defined size
and composition via counting the number of phospho-
lipid molecules in these “nanospheres”.
Methods: Liposomes composed of phosphocholine and
phosphoglycerol were prepared by the extrusion
method. Wide-angle X-ray scattering (WAXS) was
used to determine the area-per-lipid value. The size
distribution of the liposomes was determined by
microfluidic resistive pulse sensing (MRPS) and
freeze-fracture combined TEM. Small-angle X-ray scat-
tering (SAXS), differential scanning calorimetry (DSC),
and infrared spectroscopy (IR) were used to prove the
unilamellarity, the ideal miscibility of the lipids and the
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ordered packing of the hydrocarbon chains of the
lipids, respectively. Concentration of the lipids was
determined by liquid chromatography–mass spectro-
metry (LC-MS).
Results: The prepared liposomes proved to be unila-
mellar with narrow size distribution (83 nm avg.), as
obtained by MRPS and TEM. DSC and IR measure-
ments confirmed that the phospholipid bilayer of these
liposomes is in the liquid-ordered phase, hence the
area-per-lipid of 0.41 nm2 was determined from
WAXS measurements. Using the concentration of
phospholipids from LC-MS measurements, the number
concentration of liposomes was determined (8E+13
1/mL).
Summary/conclusion: Liposomes containing saturated
phospholipids are in the liquid-ordered phase, which
can be utilized to determine the area-per-lipid using
WAXS. This value, together with the independently
determined size, and lipid concentration can be used
to calculate the number concentration of liposomes. As
the light scattering properties of liposomes matches
that of EVs, liposome based standards for optical mea-
surements of EVs can be obtained with the presented
techniques.
Funding: This work was supported under grant num-
bers PD 121326 and NVKP_16-1-2016-0007 by NKFIH
(Hungary). ZV was supported by the János Bolyai
Research Fellowship.
LBT01.03
Standards for EV research
John Nolana, Erika Duggana, Ngoc Dob, Franklin Monzonb, Jean-Luc Fraikinc
and Tom Maslanikd
aScintillon Institute, San Diego, USA; bSpectradyne, Torrance, USA;
cSpectradyne LLC, Torrance, USA; dCellarcus Biosciences Inc, San
Diego, USA
Introduction: Progress in understanding the origins,
composition, and effects of extracellular vesicles (EVs)
depends on the reproducibility and rigor of experimen-
tal results. Standards can improve experimental rigor
and reproducibility and promote data sharing. To
address the needs for standards for single EV analysis,
we have developed a set of standardized vesicle pre-
parations and characterized them with respect to num-
ber, size, and cargo using a suite of single EV
characterizations methods.
Methods: We prepared synthetic lipid vesicles with a
lipid composition approximating that of a mammalian
cell plasma membrane and extruded through a nucleo-
pore membrane (100 nm mean pore diameter). We
prepared cell-derived EVs from washed red blood
cells (RBCs) and platelets (PLTs), and from cultured
cell lines using centrifugation and ultrafiltration. EV
size and number were evaluated using microfluidic
resistive pulse spectroscopy (MRPS), nanoparticle
tracking analysis (NTA), cryo-electron microscopy
(cryo-EM), conventional light scatter-based flow cyto-
metry (FC), and fluorescence-based vesicle flow cyto-
metry (VFC). EV surface markers were measured using
VFC with well-characterized fluorescence-labelled anti-
bodies and calibrated using fluorescence intensity and
antibody binding standards.
Results: Cell-derived EVs are stable for months at
−80C and weeks at 4C, as assessed by measurement
of number, size distribution, and surface markers. RBC
EVs had a median diameter of 115 nm and expressed a
median of ~2700 anti-CD235ab binding sites per EV,
while PLT EVs had a median diameter of 145 nm and
expressed a median of ~1200 anti-CD41 binding sites
per EV.
Summary/conclusion: EV standards that are well char-
acterized at the single EV level in terms of number,
size, and molecular cargo can facilitate assay validation,
sharing of data and results between labs, and support
the development of new analysis technologies with
improved sensitivity, resolution, and throughput.
Funding: Supported by the US National Institutes of
Health.
LBT01.04
Cell-specific EV tetraspanin expression
John Nolan and Erika Duggan
Scintillon Institute, San Diego, USA
Introduction: Tetraspanins (TSs) are integral mem-
brane proteins present on plasma and internal mem-
branes and are thought to affect membrane
organization and function. Tetraspanins can also be
found in extracellular vesicles released from cells and
have been considered canonical EV markers. To gain
insight into the significance of TS expression on EVs,
we used single vesicle flow cytometry (VFC) to mea-
sure the TS expression on individual EVs from differ-
ent cell sources.
Methods: EVs were prepared from 10 different cell
lines cultured in seru-free media and enriched by ultra-
centrifugation or ultrafiltration. EVs from washed red
blood cells (RBCs) and platelets (PLTs) by were iso-
lated by centrifugation, and characterized by nanopar-
ticle tracking analysis (NTA), microfluidic resistive
pulse spectroscopy (MRPS), cryo-electron microscopy
(cryo-EM), and vesicle flow cytometry (VFC). TS
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expression was measured using a panel of phycoery-
thrin-conjugated monoclonal antibodies against CD9,
CD63, CD81, CD82, CD151, CD53 and CD231. The
fluorescence scale was calibrated using intensity stan-
dard meads and expressed as PE MESF (mean equiva-
lent soluble fluorochromes).
Results: The “canonical” TS EV markers CD9, CD63,
and CD81 were expressed on EVs from all cells except
RBCs, which expressed detectable amounts (LOD ~25
MESF) of no TS, but the relative and absolute amounts
varied drastically from cells which expressed primarily
CD9 molecules on EVs (PLT and A431), to those that
expressed predominantly CD63 (MCF7, U87) to those
that expressed predominately CD81 (293T, iPSC-
derived neurons). Moreover, EVs from most cells
expressed some level of CD151, while CD82 was
detected on EVs from A431 and U87MG cells.
Summary/conclusion: Tetraspanins appear to be
involved in many different cellular processes and
their specific roles in EV-related physiology is not
understood. Single vesicle analysis of TS expression
using VFC reveals the diversity in TS expression and
abundance on EVs from different cell types.
Understanding the tetraspanin expression on EVs
may provide information about the cellular origin of
EVs, their effects on recipient cells, or both.
Funding: Supported by the US National Institutes of
Health.
LBT01.05
Characterization of lipid profile of extracellular vesicles and
lipoproteins in human plasma and serum
Yuchen Suna, Kosuke Saitob and Yoshiro Saitob
aDivision of Medical Safety Science, National Institute of Health Sciences,
Kanagawa, Japan; bDivision of Medical Safety Science, National Institute of
Health and Sciences, Kawasaki, Japan
Introduction: Extracellular vesicles (EVs) are lipid
bilayer nano-vesicles existing in various biofluids, and
regarded as valuable sources for biomarker. To data,
the main target field of previous biomarker studies on
EVs are proteome and transcriptome. Meanwhile,
liquid chromatography coupled with high resolution
mass spectrometry (LC-MS) has recently been
employed to study comprehensive lipid profiles of in
vitro EVs and their parental cells. However, lipid pro-
file of EVs in biolfluids, especially blood specimens
such as plasma and serum, has not been well-charac-
terized. To use control data for EVs, we aimed to
characterize lipid profile of EVs in human healthy
plasma and serum, and to compare their lipid profile
with that of other lipid-containing particles in blood,
high density lipoproteins (HDL) and low/very low
density lipoproteins (LDL/VLDL).
Methods: EVs, HDL and LDL/VLDL fraction were
collected from 12 plasma or serum samples obtained
from young healthy African Americans using commer-
cially available isolation kits. Written informed con-
sents were obtained from all participating donors.
Protein marker expression of each fraction was ana-
lysed by Western blotting. Lipidomic analysis was per-
formed using LC-MS operating in negative ion mode.
Results: Successful EVs, HDL and LDL/VLDL isola-
tions were validated by confirming corresponding mar-
ker proteins (CD9; EVs, apoA-I; HDL, apoB; LDL/
VLDL). As a result of lipidomic analysis, we identified
264 lipids in plasma EVs, HDL and LDL/VLDL frac-
tions. We also found that EVs showed strikingly higher
levels of lyso-glycerophospholipids than HDL and
LDL/VLDL. Additionally, compared with EVs, higher
sphiongolipid species levels were observed in LDL/
VLDL, while polyunsaturated phosphatidylcholine
were highly detected in HDL. Similar profiles were
also observed in each fraction derived from human
serum.
Summary/conclusion: Lipidomic profiling demon-
strates that EVs has a unique lipid profile compared
with lipoprotein particles, although the biological
meaning of these differences should be further evalu-
ated in future studies. Nevertheless, the method pre-
sented in this study can be useful for lipid biomarker
screening for EVs as well as lipoprotein particles
derived from both plasma and serum for human
diseases.
Funding: Japan Agency for Medical Research and
Development
LBT01.06
Enhancing extracellular vesicle isolation of human plasma verified by
high resolution lipidomics
Amani M. Batarseha, Alex Chenb, Kim Ekroosc, Susannah Hallald, Kimberley
Kaufmane and Michael Marianif
aBCAL Dx, Eveleigh, NSW, Australia 2015, Eveleigh, Australia; bThermo
Fisher Scientific, Scoresby, VIC, Australia 3179, Scoresby, Australia;
cLipidomics Consulting Ltd., Esbo, Finland 02230, Esbo, Finland;
dDiscipline of Pathology, Brain and Mind Centre, Sydney Medical School,
University of Sydney, Camperdown, NSW, Australia 2050, Camperdown,
Australia; e1-Department of Neurosurgery, Chris O’Brien Lifehouse,
Camperdown, NSW, Australia 2050, 2-Discipline of Pathology, Brain and
Mind Centre, Sydney Medical School, University of Sydney, Camperdown,
NSW, Australia 2050, Camperdown, Australia; fThermo Fisher Scientific,
North Ryde, NSW, Australia 2113, North Ryde, Australia
Introduction: Extracellular vesicles (EVs) are secreted
from many cell types and play important roles in
intercellular communication. EVs carry a range of bio-
molecules that reflect the identity and molecular state
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of their parental cell and are found in biological fluids.
Omics studies have extensively focused on character-
isation of the protein and nucleic acid cargo of EVs
while lipids are less studied. EVs are increasingly being
utilised in disease diagnosis as they are considered to
carry valuable information about the disease state.
Thus, novel disease biomarkers might be identified
EV lipidomes.
Methods: EVs were enriched from 1ml normal human
plasma samples using ultracentrifugation (UC), consid-
ered the gold standard approach for EV enrichment,
and size exclusion chromatography (SEC) using qEV
original columns (Izon, NZ). Lipids extracted accord-
ing to Matyash et al. (2008) were loaded on a C30
Acclaim column (Thermo, AU) using a Vanquish
liquid chromatography (LC) system and analysed
using a Fusion orbitrap mass spectrometer (MS)
using targeted and untargeted lipidomics approaches.
LipidSearch software was used to annotate and quan-
tify lipid species.
Results: More than 250 lipid species were identified
and quantified in the plasma EVs following both
enrichment methods. The two methods also generated
highly similar lipid profiles, indicating that SEC may be
a viable alternative to the cumbersome UC method.
Interestingly, the SEC approach yielded less lysopho-
sphatidylcholine (LPC) lipids, which may be related to
a more homogenous vesicle population captured by
SEC. Various literature reviews refer to glycerolipids,
likely originating from co-isolating vesicles such as
low-density lipoproteins, as contaminants in the EV
fractions. We detected these lipids and propose that if
they are differentially expressed in states of disease,
they can be used as biomarkers independent of their
origin.
Summary/conclusion: This study presents a workflow
for comprehensive lipidomics of EVs using two isola-
tion methods that are compatible with downstream
state-of-the art LCMS, improving our ability to study
the lipid components of EVs and identifying new dis-
ease biomarkers. As lipidome profiles were similar
between the two isolation methods, large scale diagnos-
tic assays should consider employing the SEC, which is
by far the more efficient, scalable approach.
LBT01.07
Extracellular vesicle measurements with nanoparticle tracking
analysis – An accuracy and repeatability comparison between
NanoSight NS300 and ZetaView
Daniel Bachurskia, Maximiliane Schuldnerb, Phuong-Hien Nguyena,
Alexandra Malzb, Katrin S. Reinersc, Patricia C. Grenzid, Felix Babatze,
Astrid C. Schausse, Hinrich P Hansena, Michael Halleka and Elke Pogge
von Strandmannb
aDepartment I of Internal Medicine, University Hospital of Cologne,
University of Cologne, Cologne, Germany; bExperimental Tumor Research,
Center for Tumor Biology and Immunology, Department of Hematology,
Oncology and Immunology, Philipps University Marburg, Marburg,
Germany; cInstitute for Clinical Chemistry and Clinical Pharmacology,
University of Bonn, Bonn, Germany; dDepartment I of Internal Medicine,
University Hospital of Cologne, University of Cologne, Cologne, Germany,
São Paulo, Brazil; eCECAD Center of Excellence on ‘‘Cellular Stress
Responses in Aging-Associated Diseases’’, University of Cologne, Cologne,
Germany
Introduction: The expanding field of extracellular vesi-
cle (EV) research needs reproducible and accurate
methods to characterize single EVs. Nanoparticle
Tracking Analysis (NTA) is commonly used to deter-
mine EV concentration and diameter. As the EV field
is lacking methods to easily confirm and validate NTA
data, questioning the reliability of measurements
remains highly important. In this regard, a comparison
addressing measurement quality between different
NTA devices such as Malvern’s NanoSight NS300 or
Particle Metrix’ ZetaView has not yet been conducted.
Methods: To evaluate the accuracy and repeatability of
size and concentration determinations of both devices,
we employed comparative methods including transmis-
sion electron microscopy (TEM) and single particle
interferometric reflectance imaging sensing (SP-IRIS)
by ExoView. Multiple test measurements with nano-
spheres, liposomes and ultracentrifuged EVs from
human serum and cell culture supernatant were per-
formed. Additionally, serial dilutions and freeze-thaw
cycle-dependent EV decrease were measured to deter-
mine the robustness of each system.
Results: Strikingly, NanoSight NS300 exhibited a 2.0–2.1-
fold overestimation of polystyrene and silica nanosphere
concentration. By measuring serial dilutions of EV sam-
ples, we demonstrated higher accuracy in concentration
determination by ZetaView (% BIAS range: 2.7–8.5) in
comparison to NanoSight NS300 (% BIAS range: 32.9–
36.8). The concentration measurements by ZetaView were
also more precise (% CV range: 0.0–4.7) than measure-
ments by NanoSight NS300 (% CV range: 5.4–10.7). On
the contrary, quantitative TEM imaging indicated more
accurate EV sizing by NanoSight NS300 (% DTEM range:
79.5–134.3) compared to ZetaView (% DTEM range:
111.8–205.7), while being equally repeatable (NanoSight
NS300% CV range: 0.8–6.7; ZetaView: 1.4–7.8). However,
both devices failed to report a peak EV diameter below
60 nm compared to TEM and SP-IRIS.
Summary/conclusion: Taken together, NTA devices
differ strongly in their hardware and software affecting
measuring results. ZetaView provided a more accurate
and repeatable depiction of EV concentration, whereas
NanoSight NS300 supplied size measurements of
higher resolution.
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Exodisc for fast and robust isolation of extracellular vesicles from
whole-blood
Vijaya Sunkaraa, Chi-Ju Kimb, Juhee Parkc, Hyun-Kyung Wood, Dongyoung
Kima and Yoon-Kyoung Chod
aCenter for Soft and Living Matter, Institute for Basic Science (IBS), South
Korea, Ulsan, Republic of Korea; bUlsan National Institute of Science and
Technology (UNIST), South Korea, Ulsan, Republic of Korea; cCenter for soft
and living matter, institute for basic science (IBS), South Korea, Ulsan,
Republic of Korea; dUlsan national institute of science and technology
(UNIST), South Korea, Ulsan, Republic of Korea
Introduction: The circulating nano-vesicles, known as
extracellular vesicles, are abundant in most of the body
fluids and play vital roles in regulation of various
biological processes, including signalling in the tumour
microenvironment. They possess significant potential
for disease diagnosis and treatment monitoring, how-
ever, their use in clinical settings is limited due to lack
of simple and robust isolation methods. To address
this, earlier we have developed Exodisc for isolation
and analysis of the EVs from urine. In this study, lab-
on-a-disc for the isolation of EVs from whole blood,
Exodisc-B, is demonstrated.
Methods: Exodisc-B comprises of blood separation and
filtration chambers connected with individually addres-
sable diaphragm valves for the automatic control of
sequential transfer of liquid samples. The device con-
sists of two nano-porous membrane filters with pore
sizes of 600 nm (track-etched PC membrane) and
100 nm (AAO membrane). First, the plasma was sepa-
rated and passed through two filters sequentially to
concentrate the EVs on filter-II. Then the EVs were
washed and transferred to a collection chamber for
retrieval. The performance of the device in comparison
to ultracentrifugation (UC) was evaluated by analysing
yield, purity, RNA and protein content of the iso-
lated EVs.
Results: Compared with the UC technique, the
Exodisc-B is capable of isolating at least an order of
magnitude higher number of EVs with about 30-fold
higher mRNA count within 40 min. Sandwich ELISA
of EV-specific membrane proteins – CD9-CD81 – con-
firmed that it can isolate EVs with a capture efficiency
>75%. The device also facilitates temporal monitoring
of tumour progression within live mouse xenograft
models over a period of 13 weeks while using minimal
volumes of weekly collected blood samples. Further, in
ELISA analyses of multiple cancer-related proteins
extracted from EVs isolated from human plasma, 43
patients were differentiated from 30 healthy donors.
Summary/conclusion: We have demonstrated the per-
formance of Exodisc-B for label-free and automatic
isolation of EVs from whole-blood. The device offers
a simple, fast and efficient means of intact EV isolation
in a reproducible manner, from small sample volumes
measuring as small as 30 µL of whole-blood.
Funding: This work was supported by grants A121994
and IBS-R020-D1 funded by the Korean Government.
LBT01.10
Optimization and characterization of low vacuum filtration procedure
– novel method for the isolation of extracellular vesicles
Anna Elżbieta. Drożdża, Agnieszka Kamińskaa, Magdalena Surmanb,
Agnieszka Gonet-Surówkac, Andrzej Wróbeld and Ewa Łucja Stępieńd
aFaculty of Physics, Astronomy and Applied Computer Science of the
Jagiellonian University, Kraków, Poland; bInstitute of Zoology and
Biomedical Research of the Jagiellonian University, Kraków, Poland;
cFaculty of Chemistry of the Jagiellonian University, Kraków, Poland;
dFaculty of Physics, Astronomy and Applied Computer Science of the
Jagiellonian University, Kraków, Poland
Introduction: Despite recent developments in the field
of extracellular vesicles (EVs) isolation methods, the
process remains challenging, mainly due to the low
isolation yield, co-precipitation of proteins, changes in
biophysical properties of EVs and time consuming
procedures. Answering these problems, we created
and validated new EVs isolation method – Low
Vacuum Filtration (LVF) and compared it with two
most commonly applied procedures – differential cen-
trifugation (DC) and ultracentrifugation (UC).
Methods: The main element of the isolation system is
dialysis membrane (MWCO = 1,000 kDa) combined
with the low vacuum pump, assuring the high yield of
isolation and short procedure time. EVs isolated from
endothelial cells culture media have been characterized
by (a) transmission electron microscopy (TEM) (b)
nanoparticle tracking analysis (NTA), (c) western blot
and (d) Fourier-Transform Infrared Spectroscopy
(FTIR).
Results: TEM measurement visualized EVs with size of
(a) LVF: 201 ± 136 nm, (b) DC: 256 ± 140 nm and (c)
UC: 78 ± 25 nm. For LVF and DC EVs size was
confirmed by NTA, for UC estimated size was higher
(224 ± 112 nm). NTA showed substantial increase in
EVs concentration, compared to the initial sample: (a)
LVF: 22 fold, (b) DC: 13 fold, (c) UC: 35 fold. Western
blot analysis confirmed the presence of exosome’s
(hsp70) and ectosome’s (Arf6) markers in (a) LVF –
CHsp70 = 0.48 ± 0.14 AU and CArf6 = 0.05 ± 0.02 AU,
(b) DC – CHsp70 = 0.04 ± 0.01 AU and
CArf6 = 0.07 ± 0.02 AU) and (c) UC
(CHsp70 = 0.23 ± 0.12 AU and CArf6 = 0.07 ± 0.04
AU). We observed correlation between ATR-FTIR
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spectra quality (amid I:lipids ratio) and the EVs and
proteins concentration.
Summary/conclusion: LVF method is an easy and fast
EVs isolation method which allows for isolation of
both ectosomes and exosomes from high volume
sources and could be an efficient alternative for com-
monly applied methods.
Funding: The authors acknowledge financial support
from National Science Centre Poland [grant no. 2017/
25/N/ST5/00831].
LBT01.11
Heterogeneity of erythrocytes derived microvesicles: their size and
concentration
Roberta Cordeiro Freezora and Sheelagh Heughb
aLondon Metropolitan University, London, United Kingdom; bline manager,
London, United Kingdom
Introduction: Extracellular Vesicles (EV) are hetero-
geneous populations of vesicles with different compo-
sitions, physiochemical properties and sizes. Random
sampling is convenient when the population members
are similar to one another on variables, ensuring a high
degree of representativeness because it can critically
construct generalizability of results. These key concepts
can be misconstrued and blended, concealing the gen-
eral drawbacks of validity. Here, erythrocytes MV
(eMV) samples were derived from the same blood
donor and are not to be presented as representative
data of the general type of MV population, but to
compare their heterogeneity (induced and non-
induced).
Methods: Blood cells were purified and isolated utilis-
ing the Ficoll-Paque PLUS method. Erythrocytes con-
centrate pellets were used in 3 different ways (in
triplicates): 1. eMVc- erythrocyte pellet with 10 mL
200 nm filtered PBS pH 7.4; 2. eMV CaCl2- As in 1
plus 20 µL of 2 mM of CaCl2 and; 3. eMV NHS- as in 2
plus 1 mL 20 nm filtered normal human serum (NHS).
Samples were incubated for 45mins at 37°C and eMV
were isolated by ultracentrifugation and suspended in
200 nm filtered PBS then analysed using the Guava
flow cytometry (FC) EasyCyte HT system and qNano
instrument.
Results: FC analyses showed similar characteristics in
sizing and FC position (>800nm), the majority of sam-
ples laying within the MV gate created (size beads
used), but eMV CaCl2 (3.4x10 6/mL) and eMV NHS
(2.9x 10 7/mL) showed a significant increase in their
amount of release (P value/mL). qNano analyses
showed an increase in concentration distribution for
induced samples (100nm to 800nm). eMVc peaks were
concentrated between 170 nm to 220 nm (ranging
100 nm to 370 nm). eMV CaCl2 showed a greater
concentration between 150 nm to 250 nm (ranging
100 nm to 600 nm) and eMV NHS was between
120 nm to 350 nm (ranging 100 nm to 750 nm).
Summary/conclusion: Here, the FC size beads proved
to be useful not only for the measurement of MV sizes,
but also for the concentration as MV samples fitted
with the created gate. In relation to MV concentration
distribution, the qNano proved to be a helpful appara-
tus by accurately distributing the concentration of MV
according to their size spectrum. A combination of the
different approaches may be able to provide useful
information on the amount of MV released from
inducements.
LBT01.12
Pentapartite fractionation of particles in oral fluids by differential
centrifugation
Chiho Hiragaa, Tamiko Minamisawab, Sachiko Matsumurac and Kiyotaka
Shibad
aDivision of protein Engineering, Japanease Foundation for Cancer Research,
Koto-ku, Japan; bJapanese Foundation for Cancer Research, Tokyo, Japan;
cJapaese Foundation for Cancer Research, Koto-ku, Japan; dJapaese
Foundation for Cancer Research, Tokyo, Japan
Introduction: Novel diagnostic methods are being
developed for various oral maladies by using extracel-
lular vesicles (EVs) contained in oral fluids because
EVs carry condensed diagnostic information.
However, our knowledge on the comprehensiveness
of oral EVs is still very limited. In particular, cross-
contamination of desquamated epithelial cells in oral
fluids with EV fractions is our current interest because
this contamination could interfere with the diagnostic
information. To understand the possible interference of
desquamated epithelial cells in oral EVs, we fractio-
nated human oral fluids into 5 fractions by differential
centrifugation and analysed the protein markers and
nucleic acids in the fractions.
Methods: We obtained oral fluids from three healthy
volunteers with informed consent. Each sample was
separated into 5 fractions (0.3K, 2K, 10K, 160K and
supernatant) by differential centrifugation. The num-
bers and the sizes of the particles in the fractions were
analysed by nanoparticle tracking analysis (NTA). The
expression levels of the protein markers were estimated
by western blotting (WB). The amounts of mitochon-
drial and bacterial DNAs were quantified by PCR-
based methods targeting the ND1 gene and rRNA
gene, respectively. The numbers of cells were estimated
by Trypan blue and Papanicolaou staining.
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Results: Trypan blue staining showed that the 0.3K and
2K fractions contained 1.35 × 105 and 2.22 × 102 cells/
mL of nucleated cells, respectively, while no intact cell
was observed in the 10K and 160K fractions by
Papanicolaou staining. NTA showed that the average
diameters of the particles in the 10K, 160K, and the
supernatant were 206.1 ± 17.0 nm, 122.1 ± 9.2 nm and
139.4 ± 29.4 nm, respectively. WB analyses showed that
CD81, CD9, Alix, and Aquaporin 5 were mostly
enriched in the 160K fraction, whereas HSP70, Ago2,
and ATP5A were the most abundant in the 0.3K frac-
tion. Mitochondrial DNA was abundant in the 0.3K
fraction, and bacterial ribosomal DNAs were present in
the 0.3K and 2K fractions.
Summary/conclusion: The WB suggested that HSP70,
Ago2, and ATP5A can be used as markers of whole
cells (mostly desquamated cells). Because the expres-
sion levels of these markers in 10K and 160K were very
limited, we concluded that cross-contamination of des-
quamated epithelial cell-derived particles in 10K and
160K would be very less, if any.
LBT01.13
Heat shock protein-accessorized exosomes: presence in states of
danger, disease, and disruption
Xiaoli Yua, Mary Wanga, Anthony Fringuelloa, Steve Griffithsb and Michael
Granera
aUniversity of Colorado Denver, Aurora, USA; bminervagen biotechnologies
corporation, tucson, USA
Introduction: Heat shock proteins (HSPs) function as
chaperones under both normal and pathologic condi-
tions. As chaperones they assist in protein folding, in
holding protein complexes for current or future
activation, and in the degradation of senescent proteins
for recycling of components and displaying for
immune surveillance. During stressful situations, HSP
quantities and/or activities are increased as cells and
tissues seek protection from insults. On occasion, these
insults can result in the cell surface display of HSPs,
which can then lead to the surface display of HSPs on
exosomes, membrane-enclosed vesicles released extra-
cellularly after passage through the endosomal system.
HSPs present on the cell surface or in the extracellular
space are regarded as “danger signals” in an ancient
biologic paradigm. HSP-accessorized exosomes may act
as “danger boli”, carrying not only the HSPs, but hun-
dreds of components of the stressed parental cell, cap-
able of prompting immune responses, or possibly
immune suppression, depending on the status of the
recipient cell.
Methods: Exosomes from the plasma of patients suf-
fering from neurological maladies (glioblastoma grade
IV, traumatic brain injury, multiple sclerosis) are pre-
cipitated by peptides designed to bind HSPs and ana-
lysed by metabolomics.
Results: The metabolome of exosomes purified by HSP
peptides from plasma of patients with various neuro-
logical disorders is distinct from that of blood exo-
somes from healthy donors (>80 distinct compounds
in GBM exosomes, and TBI exosomes; >30 compounds
in MS exosomes; all are unique to those groups). There
are also numerous lipid and metabolic pathways linked
to those compounds.
Summary/conclusion: Such HSP-accessorized exo-
somes thus possess metabolites with possible ties to
the different CNS pathologies that may represent dis-
ease-specific biomarkers in a “liquid biopsy” setting.
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LBT02.01
Cancer stem cell-derived exosomes：potential for early detection in
pancreatic cancer
Haobin Wanga, Yingshu Luob, Margot Zoellerc and Shijing Yued
aThe third people‘s hospital of Chengdu/Affiliated hospital of Southwest
Jiaotong University, Chengdu, China (People‘s Republic); bUniversity of
Electronic Science and Technology of China, Chengdu, China (People‘s
Republic); cHeidelberg University, Heidelberg, Germany; dNankai
University, Tianjin, China (People‘s Republic)
Introduction: Pancreatic cancer (PaCa) is the most
deadly malignancy, due to late diagnosis and early
metastatic spread, which prohibits surgery. it is
urgently for reliable, early detection. Research shows
that tumour-derived exosomes, which had been present
in the blood in the early stage of tumour formation and
before metastasis, is the vanguard forces of tumour
formation and metastasis; Cancer stem cell-derived
exosomes (CSC-Exos) has stronger migration ability,
so the detection of blood CSC-Exos for early diagnosis
and monitoring of progress for PaCa has great research
potential and the value of application.
Methods: Protein markers were selected according to
expression in exosomes of PaCa cell line culture super-
natants, but not healthy donors’ serum- exosomes.
According to these preselections, serum-exosomes
were tested by flow cytometry for the pancreatic cancer
stem cell marker Tspan8.
Results: The majority (95%) of patients with PaCa and
patients with nonPa-malignancies reacted with anti-
Tspan8. Serum-exosomes of healthy donors’ and
patients with nonmalignant diseases were not reactive.
Recovery was tumour grading and staging independent
including early stages.
Summary/conclusion: Thus, the evaluation of pan-
creatic CSC-derived exosomes awaits retrospective ana-
lyses of larger cohorts, as it should allow for a highly
sensi- tive, minimally-invasive PaCa diagnostics.
Funding: Supported by the National Natural Science
Foundation of China (No. 81702963)
LBT02.02=OWP3.01
Using plasma to identify neural biomarker for antidepressant
response in a treatment resistant cohort
Corina Nagya, Saumeh Saeedib, Jean-Francois Therouxc, Marina Wakidc,
Naguib Mechawarc and Gustavo Tureckib
aDHRC- McGill University, Verdun, Canada; bMcGill University, Verdun,
Canada; cMcGill University, verdun, Canada
Introduction: Small extracellular vesicles (SEV) have
emerged as candidate biomarkers in many complex
diseases. An important characteristic of SEVs is their
ability to bidirectionally cross the blood-brain barrier.
This is particularly important in the context of major
depressive disorder (MDD), where biomarkers are
obtained from peripheral tissue and have been hard
to relate to changes in brain functioning. 60% of
MDD patients do not respond to their first antidepres-
sant drug therapy (ADT) and treatment options are
entirely at the discretion of the physician. Findings
that can predict ADT response as well as provide
insight into central mechanistic changes could revolu-
tionize MDD treatment. The aim of this study is to
profile exosomal microRNA (miRNA) in the context of
ADT response in people with treatment-resistant
depression. miRNA can act as biomarkers and might
influence recipient cells to provide insight on disease-
relevant mechanistic changes.
Methods: This pilot uses plasma from 10 controls and
10 patients with MDD (5 ADT responders (RES), and 5
non-responders (NRES)) from baseline (T0, before
treatment). SEVs were isolated using a size exclusion
column from Izon Science (Christchurch, New
Zealand). Each isolation was divided into a “whole
exosome” fraction and an immunoprecipitated
“(NDE)” fraction using neural marker L1CAM.
Quantitation and size determination was done using
Tunable Resistive Pulse Sensing (TRPS) on the qNano
gold. RNA was also extracted from SEVs from both
fractions. The 4N-small RNA-Seq (Galas) protocol was
used for library preparation.
114 ISEV2019 ABSTRACT BOOK
Results: We found that the range of SEVs in the NDE
fraction was smaller than the pool of all exosomes
combined. Further SEVs from all depressed patients
were significantly smaller than controls irrespective of
the fractions. Our sequencing results showed an
increase of miR-151a-3p and miR-3168 in NRES, and
miR-22-3p in RES. These results were specific to the
NDE fraction.
Summary/conclusion: We have identified three poten-
tial biomarkers for ADT response which are uniquely
present in the neural-derived fraction of peripheral
SEVs.
Funding: Canadian Institutes of Health Research
LBT02.03=OWP1.08
Isolation of neuron-specific extracellular vesicles
Dmitry Ter-Ovanesyana, Maia Kipmanb, Emma Kowalc, Ju Hyun Leeb,
Wendy Trieub, Aviv Regevd, David Waltb and George Churchb
aHarvard, Cambridge, USA; bWyss Institute, Boston, USA; cMIT, Cambridge,
USA; dBroad Institute, Cambridge, USA
Introduction: Human biological fluids contain extra-
cellular vesicles (EVs) from different cell types. It
would be incredibly useful to be able to isolate EVs
that originated from specific cell types for diagnostic
purposes as a way to gain molecular information
(RNA, protein) from inaccessible cell types non-
invasively.
Methods: We have developed a general framework for
identifying EV surface markers that can be used for
immuno-isolation of cell type specific EVs. As a proof
of principle, we have applied this framework to the
isolation of neuron-derived EVs from human cere-
brospinal fluid or plasma. In addition to the computa-
tional analysis, we have developed an in-vitro system of
human neurons differentiated from human induced
pluripotent (iPS) cells. We performed mass spectro-
metry on EVs isolated from these neurons to identify
neuron-specific proteins. We also used this system to
develop a robust immune-isolation method for neuron
EV markers.
Results: We have characterized the proteins present in
neuron exosomes by mass spectrometry and then used
computational analysis of published gene expression
and proteomics data to come up with a list of candidate
neuron-specific EV markers. After developing methods
for immuno-isolation of neuron EVs with these mar-
kers, we applied our methods to human cerebrospinal
fluid and plasma.
Summary/conclusion: We have developed a frame-
work for the isolation of cell type specific EVs through
the combination of an experimental in vitro system and
computational analysis of gene expression and proteo-
mics data. We have applied this framework to the
isolation of neuron-specific EVs in human biological
fluids. We envision these methods being broadly
applicable to the development of novel diagnostic bio-
markers for a variety of diseases.
LBT02.04
Labelling and tracking extracellular vesicles using a RNA-targeting
AIE fluorogen
Bo Situ, Xiaojing He and Lei Zheng
Nanfang hospital, southern medical university, guangzhou, china (people‘s
republic)
Introduction: Extracellular vesicles (EVs) are consid-
ered as crucial carriers in cell-to-cell communication,
immune response, tumourigenesis and metastasis. To
gain direct insights into EVs functions, it is necessary
to observe their intracellular localizations and biodis-
tribution. Given the fact that EVs carry various RNA
species, fluorescence labelling of RNA in EVs is one of
the most high-profile strategies. However, ideal probes
are still lacking.
Methods: In this work, we report that a commercial
cell-permeant dye HSP may serve as a simple and facile
probe for staining RNA within EVs. The good perfor-
mance of HSP allows EVs to be analysed and imaged
by nano-flowcytometry and structured illumination
microscopy (SIM), respectively. Additionally, for the
first time we uncover that HSP exhibits typical AIE
(aggregation-induced emission) property. The labelling
procedure can thus be performed in a wash-free man-
ner due to the low fluorescent background of HSP in
water before binding to RNA, which greatly avoid EVs
losing during the experiment.
Results: HSP shows advantages over traditional
SytoRNASelect in labelling EVs RNA in terms of its
superior brightness, high specificity and excellent
photostability.
Summary/conclusion: HSP may serve as a new probe
for EVs labelling and shows great potential in studying
behaviours and bio-distributions of EVs in a wide
range of research fields.
LBT02.05
The identification of extracellular vesicles proteins in glioblastoma
diagnosis
Szu-Yi Choua, Che-Chang Changb and Shun-Tai Yangc
aGraduate Institute of Neural Regenerative Medicine, Taipei Medical
University, Taipei, Taiwan (Republic of China); bGraduate Institute of
Translational Medicine, Taipei Medical University, Taipei, Taiwan
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Introduction: Glioblastoma multiforme (GBM) is a
highly malignant type of brain tumour in humans.
GBM cells reproduce quickly and the median survival
time for patients is about 1 ~ 2 years. Current diag-
nostics and treatments for GBM are limited. Recently,
many studies used proteomic analyses of GBM extra-
cellular vesicles (EVs) or secretomes have been helpful
in identifying biomarkers and potential treatment stra-
tegies for GBM.
Methods: Herein, our study used mass spectrometry
(MS) to analysis the EV proteins from GBM cell lines –
U87 and A172, and normal human astrocyte – SVG-
p12 cultures. IPA analysis identified several proteins
from GBM cell lines EVs are significantly different
from the normal astrocytes cultures. EVs from 30
patients plasma with different grades of glioma were
isolated and analysed to conform the findings from
IPA analysis
Results: We identified several signalling pathways have
been changed in different GBM cultures. Further vali-
dation with 30 different grade of glioma patients, we
identified three proteins – chaperonin containing
TCP1 subunit 8 (CCT8), Glypican (GPC1) and
Periostin (POSTN) which levels in plasma EVs are
associated to GBM but not plasma which also have
been reported associated to GBM progression.
Database analysis also found the EVs level of CCT8,
GPC1 and POSTN in different grade of glioma can
represent the RNA level in tumour from microarray.
Additionally, we also found some specific signalling
pathways changes in different GBM lines such as trans-
forming growth factor beta induced (TGFB1) in U87
EVs and prosaposin (PSAP) in A172 EVs. The eleva-
tion of different molecules in EVs provides specific
characters to individual GBM.
Summary/conclusion: We found EV contents – CCT8,
GPC1 and POSTN were associated in GBM which
could be used for clinical diagnosis; also some different
GBM EV proteins – TGB1 and prosaposin could be
used in characterization and targeting therapy of GBM
in the further.
Funding: Ministry of Science Technology – MOST
105-2628-B-038-005-MY3
LBT02.06
Universal reference transcripts for miRNA normalization – a meta-
analysis on human blood extracellular vesicle RNA sequencing data
sets
Alexander Hildebrandta, Benedikt Kirchnera, Chenna R. Galivetib, Esther N.
Nolte-‘t Hoenb and Michael Pfaffla
aAnimal Physiology and Immunology, School of Life Sciences
Weihenstephan, Technical University of Munich, Freising, Germany,
Freising, Germany; bDepartment of Biochemistry and Cell Biology, Utrecht
University, Utrecht, The Netherlands, Utrecht, Netherlands
Introduction: Due to their importance in intercellular
communication, extracellular vesicles (EV) have
emerged as important sources of biomarkers for pro-
and diagnostic purposes. With the advent of RNA-seq
as the tool of choice for unbiased biomarker screening,
a major focus has been laid on miRNAs, important
regulators of post-transcriptional gene expression.
Feasibility of RNA biomarkers presently still relies on
validation and analysis by RT-qPCR which in turn is
depending on stably expressed reference transcripts for
normalization. To assess whether a set of universal
reference miRNA transcripts for normalization exists,
a meta-analysis on blood derived EV samples was
conducted.
Methods: From eight different research studies, we
analysed small RNA-seq reads of 531 EV samples
that were isolated from various pathological condi-
tions or healthy controls and enriched by standar-
dized methods (SEC, UC or precipitation). To
account for the variety of commonly utilized RNA-
seq analysis methods, a standardized big-data analysis
pipeline was established, that combined robust filter-
ing by six different normalization methods and three
algorithms to detect suitable reference transcripts. Sets
of stably expressed transcripts were finally compared
across different studies, isolation methods and data
analysis combinations.
Results: Results of our pipeline showed substantial
overlap for miRNAs ranked by stability for different
normalizations and algorithms over all samples albeit
compromised by high variances in general.
Contrarily reference miRNAs determined within a
single research study showed much higher stability
values and were consistent over multiple analysis
combinations.
Summary/conclusion: Although first results suggest
the possibility that blood EVs contain a common set
of miRNAs that may be used as universal reference
transcripts, different EV isolation methods, pathophy-
siological conditions and sequencing methodology
have a major influence on expression profiles. With
the availability of additional small RNA-seq data sets
in the future, robustness and validity of miRNA refer-
ences will continue to grow, but success will ultimately
be depending on further standardization of EV isola-
tion and data analysis. Based on the current data, we
recommend analysing reference transcripts in each
study individually.
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LBT02.07
Small extracellular vesicle content in porcine blood plasma,
cerebrospinal fluid and seminal plasma for proteomic analyses in
biomarker discovery
Helena Kupcova Skalnikovaa, Jakub Cervenkaa, Karolina Turnovcovab,
Bozena Bohuslavovaa, Jana Juhasovaa, Stefan Juhasa and Petr Vodickaa
aCzech Academy of Sciences, Institute of Animal Physiology and Genetics,
Libechov, Czech Republic, Libechov, Czech Republic; bCzech Academy of
Sciences, Institute of Experimental Medicine, Prague, Czech Republic,
Prague, Czech Republic
Introduction: Extracellular vesicles (EVs) released to
body fluids carry molecules of the source cells and are
subjects of intensive research of protein and nucleic acid
biomarkers of diseases. Pig represents a valuable experi-
mental biomedical model to study human diseases due to
close anatomic and physiologic similarity to human. The
aim of this work was to compare suitability of porcine
blood plasma, cerebrospinal fluid and seminal plasma for
EV isolation for proteomic analyses and optimize sample
preparation for mass spectrometry.
Methods: EVs were isolated from porcine body fluids
by differential centrifugation and ultracentrifugation
and characterized by transmission electron microscopy,
flow cytometry and western blotting. Three different
lysis buffers (RIPA, Triton X100 and SDS) were com-
pared in efficacy to extract EV proteins in combination
with filter-aided sample preparation (FASP) for LC-
MS/MS analysis (triple TOF).
Results: Seminal plasma yielded largest amount of EVs,
followed by blood plasma. In cerebrospinal fluid, the EV
content was very low. Proteomic analysis of seminal
plasma-derived EVs enabled identification of approxi-
mately 1200 proteins, including 76 of the top 100 mainly
identified proteins in EVs (Exocarta). Approximately 550
proteins were quantified by SWATH-MS. In contrast,
only 200 proteins were identified in the crude seminal
plasma used for EV isolation.
Summary/conclusion: We have optimized techniques
for the EV enrichment from porcine body fluids and
for characterization of their protein content by mass
spectrometry. Such techniques may be applied to bio-
marker discovery in porcine model of diseases as well
as adopted to other species, including human.
Funding: This study was supported by Czech Science
Foundation (reg. No. 19-01747S), Operational
Programme Research, Development and Education (reg.
No. CZ.02.1.01/0.0/0.0/16_019/0000785), and National
Sustainability Programme I. of the Czech Ministry of
Education, Youth and Sports (reg. No. LO1609).
LBT02.08
Quantitative proteomic profiling of tissue-exudative EVs identified a
novel diagnostic antigen for early detection of colorectal cancer
Makoto Konishia, Makoto Sumazakia, Satoshi Nagayamab and Koji Uedaa
aCancer Proteomics Group, Cancer Precision Medicine Center, Japanese
Foundation for Cancer Research, Tokyo, Japan; bDepartment of
Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation
for Cancer Research, Tokyo, Japan
Introduction: Development of biomarkers for early
detection of colorectal cancer (CRC) is demanded as
the number of CRC patients is increasing. Recent
studies exhibit that extracellular vesicles (EVs) are
expected as biomarker carriers in any body fluids.
To explore CRC-specific antigens, we isolated EVs
from viable CRC or adjacent normal tissues
(n = 17), followed by global quantitative proteome
analysis.
Methods: Tissue-exudative EVs (Te-EVs) were purified
from serum-free media of freshly resected CRC and
adjacent normal tissues, using the sequential ultracen-
trifugation method (n = 17). Purified Te-EVs were
analysed by Orbitrap Fusion Lumos LC/MS system
(Thermo Scientific). Protein identification, label-free
quantification, and statistical analysis were performed
on MaxQuant and Proteome Discoverer softwares. A
statistically valid biomarker candidate protein
(TMAM) was further evaluated by plasma exosome
sandwich ELISA (n = 357). Additional clinical and
functional assessments were also performed including
IHC staining and cell growth assays.
Results: Among 6,149 identified Te-EV proteins, 393
proteins were significantly overexpressed (p < .05 and
fold change > 4.0) in EVs from CRC tissues compared
to those from normal mucosa. We especially focused
on transmembrane protein TMAM (p = 3.62 E-5, fold
change = 7.0) which was known to be a key regulator
of cell growth and also overexpressed in CRC cells.
Exosome sandwich ELISA confirmed significant eleva-
tion of TMAM level in plasma EVs even in stage-I
CRC patients (n = 72) compared to healthy donors
(n = 72, p = .040). IHC staining analysis also showed
that TMAM was specifically overexpressed in CRC
tissues. Interestingly, TMAM-overexpressed EVs
decoyed its inhibitory ligand away from cancer cells,
resulting in their outgrowth.
Summary/conclusion: These results indicate that
TMAM on EVs should have great potential as a novel
target for CRC diagnosis and therapy.
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Single-molecule co-Immunoprecipitation reveals functional
inheritance of epidermal growth factor receptors in extracellular
vesicles
Mi Sook Sunga, Jik Han Jungb, Tae-Young Yoonc, Ji-Ho Parkb and Cherlhyun
Jeonga
aCenter for Theragnosis, Korea Institute of Science and Technology, Seoul,
Republic of Korea; bDepartment of Bio and Brain Bioengineering, Korea
Advanced Institute of Science and Technology (KAIST), Daejeon, Republic
of Korea; cSchool of Biological Sciences and Institute for Molecular Biology
and Genetics, Seoul National University, Seoul, Republic of Korea
Introduction: Cancer cells actively release extracellular
vesicles (EVs) as important carriers of cellular informa-
tion to tumour microenvironments. Although the com-
position and quantity of the proteins contained in EVs
are characterized, it remains unknown how these pro-
teins in EVs are related to those in the original cells at
the functional level. Ultimately, the question should be
resolved to ensure the use of EVs in diagnosing the
status of cancer patients by liquid biopsy.
Methods: Using the recently developed single-molecule
immunolabelling and co-immunoprecipitation
schemes, the quantity and PPI strengths of EGFRs
derived from EVs and the original lung adenocarci-
noma cells are determined.
Results: It is found that the microvesicles exhibit
higher correlations with the original cells than the
exosomes in terms of the EGFR levels and their PPI
patterns. In spite of these detailed differences between
the microvesicles and exosomes, the EGFR PPI
strengths measured for EVs generally show a tight
correlation with those determined for the original cells.
Summary/conclusion: With epidermal growth factor
receptor (EGFR) in lung adenocarcinoma cells as a
model oncoprotein, it is studied how distinct types of
EVs, microvesicles and exosomes, represent their ori-
ginal cells at the protein and protein–protein interac-
tion (PPI) level. The results suggest that EGFRs
contained in EVs closely reflect the cellular EGFR in
terms of their downstream signalling capacity.
Moreover, it gives a possibility that EGFRs derived
from different types of EVs may work as a biomarker
for the intensity of the EGFR signalling pathway in the
parental cancer tissue.
118 ISEV2019 ABSTRACT BOOK
LBT03: Late Breaking- EVs and Stem Cells
Chairs: Sicheng Wen; Hiroaki Tateno
Location: Level 3, Hall A
15:30–16:30
LBT03.01
Regenerative potential of extracellular vesicles-derived from
mesenchymal stem cells on epithelial wound healing
Tatiana Lopatinaa, Chiara Gaib, Giovanni Camussic and Giuseppe
Montrucchiod
aPostdoc, Turin, Italy; bDepartment of Medical Sciences, University of Turin,
Turin, Italy; cDepartment of Medical Sciences, University of Turin, Turin,
Italy; dUniversity of Turin, Turin, Italy
Introduction: Wound healing is a complex process
involving cell death, migration, proliferation, differen-
tiation, inflammation, and extracellular matrix remo-
delling. A key role in this context is played by resident
stem cells. Mesenchymal stem cells (MSCs) favour
wound healing via extracellular vesicles (EVs), which
transfer transcription modulators and nucleic acid,
including mRNA and micro-RNA.
Methods: We found that MSC-derived EVs favour
epithelial wound healing in vitro, and that EVs regulate
the EGFR/PI3K/Akt/mTOR pathway, a key player in
keratinocyte stem cells biology, glucose homeostasis
and aging. Moreover we have characterized the
mRNA and miRNA content of MSC-derived EVs and
our analysis revealed several miRNA potentially
involved in wound healing. To identify potential miR
candidates, we clustered miRNAs expressed by EVs
into families, according to their seed sequence and
scanned the 3ʹ-UTR of keratinocyte expressed genes
for perfect seed-match occurrences. To account for
potential cooperative action of different miRNAs, we
will restrict our research to those genes targeted by at
least 2 expressed miRNA families.
Results: We selected several miRNAs which target
wound healing cellular pathways and carried by MSC-
EVs (miR-let-7a-5p, miR-10a-5p, miR-10b-5p, miR-21-
5p, miR-22-3p, miR-100-5p, miR-143-3p, miR-146a,
miR-191-5p, miR-181a-5p, miR-27b-3p). We have
found that miRNA146a is a key activator of the
Notch1/Akt pathway. Notably, Notch1 levels are ele-
vated in limbal-corneal epithelial stem cells relative to
their migratory cell progenies, and abnormally elevated
miRNA146a levels are implicated in defective corneal
wound healing in diabetes. Thus, miRNA146a may
regulate the balance between LESC self-renewal versus
migration/differentiation via Notch/Akt regulation.
Summary/conclusion: We have shown that transfec-
tion of MSC by siRNA anti miR-146a decrease the
biologic effect of MSC-EVs on migratory capacity of
epithelial cells. It could be a direct effect of the absence
of miR-146a in MSC-EVs or consequence of the miR-
146a signalling pathway disruption.
Funding: CAMG_PRIN_2015_16_01
LBT03.02
Intravenous administration of xenogenic adipose-derived
mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes
markedly reduced brain infarct volume and preserved neurological
function in rat after acute ischemic stroke
Shun-Cheng Wua, Pei-Lin Shaob and Hon-Kan Yipc
aOrthopaedic Research Center, College of Medicine, Kaohsiung Medical
University, Kaohsiung, Taiwan (Republic of China); bDepartment of
Nursing, Asia University, Kaohsiung, Taiwan (Republic of China); cDivision
of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung
Memorial Hospital and Chang Gung University College of Medicine,
Kaohsiung, Taiwan (Republic of China)
Introduction: We tested the hypothesis that combined
xenogenic (from mini-pig) adipose-derived mesenchy-
mal stem cell (ADMSC) and ADMSC-derived exosome
therapy could reduce brain-infarct zone (BIZ) and
enhance neurological recovery in rat after acute
ischemic stroke (AIS) induced by 50-min left middle
cerebral artery occlusion.
Methods: Adult-male Sprague-Dawley rats (n = 60)
were divided equally into group 1 (sham-control),
group 2 (AIS), group 3 [AIS-ADMSC (1.2 × 106
cells)], group 4 [AIS-exosome (100 μg)], and group 5
(AIS-exosome-ADMSC). All therapies were provided
intravenously at 3h after AIS procedure.
Results: BIZ determined by histopathology (by day-60)
and brain MRI (by day-28) were highest in group 2,
lowest in group 1, higher in groups 3 and 4 than in
group 5, but they showed no difference between groups
3 and 4 (all p < .0001). By day-28, sensorimotor func-
tional results exhibited an opposite pattern to BIZ
among the five groups (p < .005). Protein expressions
of inflammatory (inducible nitric oxide synthase/
tumour necrosis factor-α/nuclear factor-κB/interleu-
kin-1β/matrix metalloproteinase-9/plasminogen activa-
tor inhibitor-1/RANTES), oxidative-stress (NOX-1/
NOX-2/oxidized protein), apoptotic (caspase-3/Poly-
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ADP-ribose polymerase), and fibrotic (Smad3/trans-
forming growth factor-β) biomarkers, and cellular
expressions of brain-damaged (γ-H2AX+/XRCC1-
CD90+/p53BP1-CD90+), inflammatory (CD11+/CD68
+/glial fibrillary acid protein+) and brain-oedema
(aquaporin-4+) markers showed a similar pattern of
BIZ among the groups (all n < 0.0001).
Summary/conclusion: In conclusion, xenogenic
ADMSC/ADMSC-derived exosome therapy was safe
and offered the additional benefit of reducing BIZ
and improving neurological function in rat AIS.
LBT03.03
Changes in amino acid concentration of umbilical cord mesenchymal
stem cell culture medium
Angliana Chouw, Geofanny Facicilia, Cynthia Retna Sartika, Emilia
Rahmadania Utami, Julia Riswandani, Yanni Dirgantara, Dwi Ajeng
Permata Dewi and Endah Dianty Pratiwi
PT prodia stemcell Indonesia, Jakarta, Indonesia
Introduction: Mesenchymal Stem Cell is a multipotent
cell that works in two ways, replacing the injured cells
and releasing active biomolecules that work as a para-
crine signal for cell migration and proliferation. Recent
discoveries suggest that potential cytokine, growth fac-
tors, and many different soluble factors are released by
MSCs during the culturing process into its environ-
ment. In this study, we aim to analyse that changes of
amino acid concentration from the fresh complete
growth medium and post-culture medium from umbi-
lical cord mesenchymal stem cell (UC-MSC) cultured.
Methods: UC-MSC was cultured with the seeding den-
sity of 5000 cells/cm2 in tissue culture plasticware.
When the cells, reached 70–80% confluency, the cul-
ture medium was collected and centrifuged to remove
the unwanted debris. Collected medium was stored in
−80°C until the amino acid concentration was analysed
using Mass Spectrophotometry.
Results: The fresh and post-culture media contains
both essential and non-essential amino acid. The
post-culture culture media contains higher amino acid
compared to the fresh medium. In this study, there is
an increasing concentration of glycine, l-arginine, l-
phenylalanine, l-histidine, l-leucine, l-lysine, l-serine,
l-threonine, l-tyrosine and l-valine concentration. The
concentration of L-glutamine from post-cultures is
decreasing compared to fresh medium while the con-
centration of L-glutamic acid (+959 mg/ml) is increas-
ing. This due to the regulation of glutamate synthase
which changes the L-glutamine into L-glutamate (L-
glutamic acid). The methionine and cysteine cycle also
show by comparing both media, where methionine and
cysteine are decreasing to produce cystine.
Summary/conclusion: Glutamate-Glutamine cycle and
Methionine-Cysteine cycles were shown in the meta-
bolism of UC-MSC proliferation during cell culture.
This cause changes in amino acid concentration
between fresh and post-culture media.
Funding: All the research were funded by PT. Prodia
StemCell Indonesia
LBT03.04
Combination of adipose-derived mesenchymal stem cells (ADMSC)
and ADMSC-derived exosomes for protecting kidney from acute
ischemia-reperfusion injury
Shun-Cheng Wua, Pei-Lin Shaob and Hon-Kan Yipc
aOrthopaedic Research Center, College of Medicine, Kaohsiung Medical
University, Kaohsiung, Taiwan (Republic of China); bDepartment of
Nursing, Asia University, Kaohsiung, Taiwan (Republic of China); cDivision
of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung
Memorial Hospital and Chang Gung University College of Medicine,
Kaohsiung, Taiwan (Republic of China)
Introduction: In this study, we tested the hypothesis
that a combined adipose-derived mesenchymal stem
cell (ADMSC) and ADMSC-derived exosome therapy
protected rat kidney from acute ischemia-reperfusion
(IR) injury (i.e., ligation of both renal arteries for 1h
and reperfusion for 72h prior to euthanization).
Methods: Adult-male SD rats (n = 40) were equally
categorized into group 1 (sham control), group 2 (IR),
group 3 [IR+exosome (100 μg)], group 4 [IR+ADMSC
(1.2 × 10(6) cells)] and group 5 (IR-exosome-ADMSC).
All therapies were performed at 3 h after IR procedure
from venous administration.
Results: By 72h, the creatinine level and kidney injury
score were the lowest in group 1 and the highest in
group 2, significantly higher in group 3 than in groups
4 and 5, and significantly higher in group 4 than in
group 5 (all P < .0001). The protein expression of
inflammatory (TNF-α/NF-κB/IL-1β/MIF/PAI-1/Cox-
2), oxidative-stress (NOX-1/NOX-2/oxidized protein),
apoptotic (Bax/caspase-3/PARP) and fibrotic (Smad3/
TGF-β) biomarkers showed an identical pattern,
whereas the anti-apoptotic (Smad1/5, BMP-2) and
angiogenesis (CD31/vWF/angiopoietin) biomarkers
and mitochondrial cytochrome-C showed an opposite
pattern of creatinine level among the five groups (all
P < .001). The microscopic findings of glomerular-
damage (WT-1), renal tubular-damage (KIM-1),
DNA-damage (γ-H2AX), inflammation (MPO/MIF/
CD68) exhibited an identical pattern, whereas the
podocyte components (podocin/p-cadherin/
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synaptopodin) displayed a reversed pattern of creati-
nine level (all P < .0001).
Summary/conclusion: Combined exosome-ADMSC
therapy was superior to either one for protecting kid-
ney from acute IR injury.
LBT03.05
Adipose-derived mesenchymal stem cell-derived exosomes alleviate
overwhelming systemic inflammatory reaction and organ damage
and improve outcome in rat sepsis syndrome
Pei-Lin Shaoa, Shun-Cheng Wub and Hon-Kan Yipc
aDepartment of Nursing, Asia University, Kaohsiung, Taiwan (Republic of
China); bOrthopaedic Research Center, College of Medicine, Kaohsiung
Medical University, Kaohsiung, Taiwan (Republic of China); cDivision of
Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung
Memorial Hospital and Chang Gung University College of Medicine,
Kaohsiung, Taiwan (Republic of China)
Introduction: This study tested the hypothesis that
healthy adipose-derived mesenchymal stem cell
(ADMSC)-derived exosomes (HMSCEXO) and apopto-
tic (A) (induced by 12 h hypoxia/12 h starvation)-
ADMSC-derived exosomes (AMSCEXO) were compar-
ably effective at alleviating sepsis syndrome [SS;
induced by cecal-ligation and puncture (CLP)]-induced
systemic inflammation and reduced organ damage and
unfavourable outcomes in rats.
Methods: SD rats were divided into sham control (SC),
SS only, SS + HMSCEXO (100 µg intravenous admin-
istration 3 h after CLP), and AMSCEXO.
Results: By day 5 after CLP procedure, the mortality
rate was significantly higher in SS than in SC and
HMSCEXO (all P < .01), but it showed no significant
different between SC and HMSCEXO, between
AMSCEXO and HMSCEXO or between SS and
AMSCEXO (P > .05). The levels of inflammatory med-
iators in circulation (CD11b/c/Ly6G/MIF), bronchioal-
veolar lavage (CD11b/c/Ly6G) and abdominal ascites
(CD11b/c/CD14/Ly6G/MIF) were highest in SS, lowest
in SC and significantly higher in AMSCEXO than in
HMSCEXO (all P < .001). The circulating/splenic levels
of immune cells (CD34+/CD4+/CD3+/CD8+) were
expressed in an identical pattern whereas the T-reg+
cells exhibited an opposite pattern of inflammation
among the groups (all P < .001). The protein expres-
sions of inflammation (MMP-9/MIF/TNF-α/NF-κB/IL-
1β) and oxidative stress (NOX-1/NOX-2/oxidized pro-
tein), and cellular expressions (CD14+/CD68+) in
lung/kidney parenchyma exhibited an identical pattern
of inflammatory mediators (all P < .001). The kidney/
lung injury scores displayed an identical pattern of
inflammatory mediators among the groups (all
P < .001).
Summary/conclusion: In conclusion, HMSCEXO
might be superior to AMSCEXO for improving survi-
val and suppressing the inflammatory reactions in rats
after SS.
LBT03.06
Bile acids hybrid extracellular vesicles derived from mesenchymal
stem cells for cartilage tissue regeneration
Yoshie Araia, Hyoeun Parka, Sunghyun Parkb, Alvin Belloc, Jinsung Ahna,
Dohyun Kima, Byoung Ju Kima, Hansoo Parkd and Soo-Hong Leee
aDongguk University, Goyang-si, Republic of Korea; bCHA University,
Goyang-si, Republic of Korea; cChung-Ang University, Goyang-si, Republic
of Korea; dChung-Ang University, Seoul, Republic of Korea; eDongguk
University, goyang, Republic of Korea
Introduction: Tauroursodeoxycholic acids (TUDCA)
has been known as an amphiphilic therapeutic drug
for a variety of diseases such as cholestasis, amyo-
trophic lateral sclerosis, type 1 diabetes and so on.
Recently, we reported TUDCA has a role in bone and
cartilage regeneration through leading to osteogenic or
chondrogenic differentiation of mesenchymal stem
cells (MSCs). In addition, TUDCA is also able to
form a nano-sized micelle, penetrate and incorporate
into the membrane of cells depending on the concen-
tration, therefore, suggesting that TUDCA would be a
useful drug to modify cell membrane and extracellular
vesicles (EVs).
Methods: In this study, we investigated whether the
EVs derived from the amphiphilic bile acids-treated
cells could produce hybrid EVs composed with cell
membrane and bile acid and also they include
mRNA, micro RNA and proteins at the core of EVs.
To aim this, we isolated EVs from TUDCA-treated
mesenchymal stem cells (MSCs) and identified their
characteristics. In addition, the regenerative effect of
EVs was also evaluated using degenerated chodnro-
cytes (DC) derived from the knee cartilage of osteoar-
thritis (OA) patients.
Results: It was found that TUDCA-hybrid EVs
(TUDCA-EVs) was successfully isolated and the total
amount of EVs was increased with the treatment of
TUDCA. We also tried to characterize the size and
zeta-potential of TUDCA-EVs as well as the expression
of genes which are contained in TUDCA-EVs com-
pared to control EVs. Next, TUDCA-EVs were treated
to DC. TUDCA-EVs treatment on degenerated chon-
drocyte (DC) increased IL-6 expression associated with
the differentiation of M2 macrophage and anti-inflam-
matory signalling. In addition, TUDCA-EVs increased
COL2 expression while they decreased RUNX2 and
MMP13, as a hypertrophic marker gene, expression
in DC.
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Summary/conclusion: These indicated that TUDCA-
EVs have the potential to restore the chondrogenic
properties of degenerated chondrocytes. Therefore, it
is concluded that TUDCA-EVs would be a useful sys-
temic drug for OA therapy. In ongoing in vivo study,
we are confirming whether TUDCA-EVs indeed have
an influence on cartilage tissue regeneration and alle-
viate OA symptoms.
LBT03.07
Role of stem cell-derived extracellular vesicles and their enriched
microRNAs during alcoholic liver injury
Nan Wua, Heather Francisa, Gianfranco Alpinib and Fanyin Menga
aIndiana University School of Medicine, Indianapolis, USA; bIndiana
University School of Medicine, Pittsburgh, USA
Introduction: Senescence of activated stellate cells lim-
its hepatic fibrogenesis. Stem cell-derived extracellular
vesicles (EVs) and their related microRNAs mediate
genetic changes that promote recovery of liver disor-
ders. The present study was aimed to characterize the
functional role of liver stem cell-derived EVs and spe-
cific miRNAs in the regulation of hepatic stellate cell
senescence during alcohol induced liver injury.
Methods: microRNA expression was assessed using
microarray and real-time PCR assays in isolated EVs
from human mesenchymal stem cells (MSCs) and liver
stem cells (LSCs). HSCs were also isolated from lin28
knockout mice with or without ethanol feeding for
5 weeks by laser capture microdissection (LCM) and
the senescence and fibrosis genes are evaluated by
Western blot and real-time PCR analysis.
Results: We found that expression of several miRNAs
were consistently up-regulated in both MSCs and LSC-
derived EVs compared to normal hepatocyte-derived
EV controls, including let-7 family members.
Treatment of human HSCs with TGF-β/LPS (20 ng/
ml) for 72 h induced a significant decrease of let-7a and
let-7b in both activated and control states. Transfection
of let-7a and let-7b precursors in human HSCs mark-
edly induced the expression of cellular senescence mar-
kers p16 and CCl2, and blunted the enhanced
expression of α-SMA, collagen a1, MMP-2 and MMP-
9 (key genes involved in the activation of HHSCs) by
TGF-β/LPS treatment. Treatment with MSC/LSC
derived EVs (30 μg/ml, 72 h) phenocopied the senes-
cence/anti-fibrosis effects of let-7 overexpression in
activated HHSCs by TGF-β/LPS. A complementary
mass spectrometry-based proteomics approach with
luciferase reporter assay identified TLR4, the key LPS
receptor, as putative let-7 cluster target. Furthermore,
the expressions of senescent hepatic stellate markers
and verified let-7 target genes, including α-SMA, col-
lagen a1, p16, CCl2, TLR4, MMP-2, MMP-9 and
TIMP-3, were significantly altered in liver specimens
and LCM isolated HSCs from lin28 knockout mice
with ethanol feeding relative to WT ALD mice
controls.
Summary/conclusion: Our findings provide new
insight into the function of specific miRNAs in stem
cell-derived EVs regulating HSC senescence, and their
therapeutic potentials in alcoholic liver injury and
fibrosis.
LBT03.08
Interferon-gamma priming, but not hypoxia, modifies the miRNA
landscape of human mesenchymal stromal cells (MSC) extracellular
vesicles (EV)
Juliette Peltzera, Kyle Lundb, Philippe Mauduitc, Jean-jacques Latailladeb and
Sebastien Banzetd
aInstitut de Recherche Biomédicale des Armées, INSERM UMR-MD-1197,
Clamart, USA; bInstitut de Recherche Biomédicale des Armées, INSERM
UMR-MD-1197, Clamart, France; cINSERM UMR-MD-1197, Villejuif,
France; dInstitut de Recherche Biomédicale des Armées, INSERM UMR-
MD-1197, CLAMART, France
Introduction: MSC-based cell therapy has received
great interest in the past years, especially in regenera-
tive medicine and tissue repair. The concept of priming
consists in preconditioning the cells during the culture
phase (often with cytokines or hypoxia) to improve
their effects. The literature shows that MSC EVs can
recapitulate a substantial part of the beneficial effects of
the cells they originate from, and that miRNAs are key
players in EVs action. Therefore, in the present work,
our aim was to determine if IFN or hypoxia priming of
MSC could modify their EVs miRNA content.
Methods: Human bone marrow MSC from five healthy
donors were isolated and cultured at 20% of O2 in
MEM-alpha/FBS medium until 60–70% confluence,
then with (IFN) or without (CONT) interferon-
gamma (25ng/ml, 48 h) or in hypoxia (3% O2 through-
out the duration of the culture process). Then the cells
were rinced with PBS and placed in serum free MEM
for 48 h. The conditioned media was collected and EV
were isolated by ultracentrifugation (100 000g for
1h10). Total RNA was isolated and reverse transcribed.
Pools of CONT, IFN and HYP cDNA were prepared,
miRNA profiling was performed using Exiqon
miRnome PCR panel I and II. Then, selected
miRNAs were measured on each sample.
Results: A set of 89 miRNAs was detected (quantifica-
tion cycle < 35) in at least one of the pools of MSC
EVs. They were measured on each individual sample.
41 miRNAs were measured in all samples; results were
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normalized with 5 endogenous miRNAs. Hypoxia
induced no significant modification of EVs miRNA
content. IFN priming induced a significant increase in
hsa-miR-106a-5p, 25-3p, 126-3p, 451a and 665. Their
validated targets were determined with miRTarBase
and the proteins were analysed with Panther classifica-
tion system. Among the most cited pathways, we found
p53, inflammation, Wnt signalling, Apoptosis signal-
ling and Angiogenesis.
Summary/conclusion: MSC priming can modify the
miRNA landscape of their EVs. IFN priming modifies
MSCs EVs miRNA involved in biological pathways
relevant to tissue repair. Functional analysis of these
EVs with selected miRNAs inhibition is needed to
evaluate the biological effects of such an approach.
Funding: This work has been funded by the french
Direction Générale de l’Armement, Biomedef PDH-1-
SMO-1–218
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IP.01
Standardizing F-NTA measurements: evaluation of four-wavelengths
nanoparticle tracking analysis with cell-line derived EVs
Clemens Helmbrechta and Paolo Guazzib
aParticle Metrix GmbH; bHansaBioMed Life Sciences
Introduction: Nanoparticle tracking analysis (NTA)
has emerged to a vital and fast characterization tech-
nology for exosomes, microvesicles or viruses. In com-
bination with fluorescence detection (F-NTA), NTA
enables the user to perform biomarkers detection on
the single particle level, thus enhancing real EV con-
centration measurement. Classic NTA instruments are
equipped with one laser, requiring phenotyping in
sequence. Multi-fluorescence detection of four biomar-
kers in one sample by NTA is shown for the first time.
Methods: A four-laser NTA instrument (ZetaView
PMX-420) equipped with excitation wavelengths of
405, 488, 520 and 640 nm and dedicated long-pass
filters was evaluated. Concentration and particle size
measurements were performed with fluorescent stan-
dard beads and proprietary labelled sub-micrometre
sized vesicles. Phenotyping was performed on EVs
from HCT116 cell line (HansaBioMed Life Sciences).
Results: The efficiencies of the individual laser chan-
nels were determined by fluorescently labelled vesicles.
SOPs for conjugation of EVs were optimized regarding
antibody to vesicle ratio and incubation time.
Phenotyping by single and multi-wavelength NTA for
wash and no-wash strategies were compared regarding
background and efficiency.
Summary/conclusion: Standardization of SOPs is a
key to improve repeatability for concentration mea-
surements. Using four wavelengths, phenotyping of
EVs was performed with four-fold reduction of sample
amount in shorter time compared to sequential one
laser measurements. NTA delivers total particle count,
biomarker count and/or vesicle count on one sample
including size distributions. Cross-validation with
complementary techniques such as ELISA and FC/
IFC becomes imperative.
IP.03
Double tangential flow filtration and size exclusion chromatography
for scalable and reproducible EV isolation and size fractionation
Elina Aleksejevaa, Julia Gavrilovaa, Maija Puhkab, Karina A. Barreiroc,
Clemens Helmbrechtd and Paolo Guazzie
aHansaBioMed Life Sciences; bInstitute for Molecular Medicine Finland and
EV Core, University of Helsinki; cInstitute for Molecular Medicine Finland
(FIMM), University of Helsinki, Finland; dParticle Metrix; eHansaBioMed
Life Sciences
Introduction: The purification of Extracellular Vesicles
(EVs) for industrial processes is still missing of repro-
ducible, scalable and high throughput method, applic-
able to multiple sources of material (cell conditioned
media, biofluids, plant extracts). HansaBioMed Life
Sciences (HBM-LS) has developed a scalable EV pur-
ification process combining two tangential flow filtra-
tion steps followed by size exclusion chromatography.
We set a standardized procedure which easily allows
the isolation and the collection of big EVs (>200 nm),
the fluid concentration and the removal of small mole-
cules (< 500 kDa) with minimal loss of EVs, finally
purified by SEC. The quality of vesicles has been
assessed in terms of particle size distribution, morphol-
ogy, concentration, phenotyping and storage stability.
Methods: EVs were isolated from cell conditioned
media combining 2 TFF steps (HBM-TFF: HBM-TFF-
MV) and SEC (maxiPURE-EVs HBM-LS). EV mor-
phology and phenotype was analysed by NTA
Zetaview (Particle Metrix), ExoTEST ELISA (HBM-
LS), and electron microscopy.
Results: Analysing different purifications performed
combining the double TFF and SEC we defined quality
parameters for EVs in term of size distribution, con-
centration and maker expression, showing high repro-
ducibility and EV stability under defined storage
conditions.
Summary/conclusion: The combination of two TFF
steps and SEC allows an efficient fractionation of dif-
ferent EV sizes and works as a scalable and reproduci-
ble method for EV production from large quantity of
different fluids.
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Development of an automated, high-precision, standardizable
extracellular vesicle isolation platform for clinical studies
Anoop Pala, Shayne Harrela, Robert Vogelb and Murray Broomb
aIzon Science US Ltd; bIzon Science Ltd
Introduction: Extracellular Vesicles (EVs) derived
from biological fluids possess extensive heterogeneity
with regards to size, number, membrane composition
and cargo. Tremendous research interest exists towards
development and use of EV fraction of bio-fluids as
rich sources of diagnostic and prognostic biomarkers.
High precision fractionation of the nanobiological con-
tent of biofluids can dramatically reduce background,
increase purity and inform on the biology of the bio-
markers and therapeutic biomolecules.
Methods: Size exclusion chromatography (SEC) is the
most standardizable technique, already widely used for
the purification of EVs from biofluids. Significant
improvement to the use of SEC is possible through
automation and precision. Here, we developed a
range of SEC columns of various sizes, with 2 resin
types, separating down to 35 nm or 70 nm. We also
developed a low-cost prototype automatic fraction col-
lector (AFC) that adds high precision, improves repeat-
ability, speeds up workflow. RFID tags are proposed to
ensure high quality of data capture and transfer.
Moreover, Tunable Resistive Pulse Sensing technology
was used for accurate, high-resolution particle analysis
(size, size range, concentration, and electrophoretic
mobility) and normalization.
Results: SEC columns provide a convenient, reprodu-
cible and highly effective means of eliminating >99% of
non-vesicular protein from biological fluid samples,
and separating exosomal and non-exosomal volumes
for further downstream analysis. 35 nm pore sized SEC
gel leads to increased resolution, higher yield and one
fraction earlier elution of EVs from plasma compared
to the 70 nm pore size. Use of AFC allowed precise
mass-based measurements and tunability within 30 ul
of volume exiting the column.
Most importantly, due to the additional functionality
provided by AFC, the EV field needs to revisit the way
fraction numbers, post-SEC are used. That will be
replaced with a more logical framework, wherein the
void volume is measured and disposed of, and precise
volumes are used instead of the somewhat arbitrary
fraction numbers.
Summary/conclusion: Thus, the qEV-AFC platform
allows for QA, high-precision EV volume collection
and minimizes samples processing related reproduci-
bility issues for clinical studies.
IP.05
Faster, More Reproducible Exosomes Data – Hands Free!
Kohei Shiba, Pauline Carnell-Morris, Matthew McGann and Agnieszha Siupa
Malvern Panalytical
Introduction: In analytical data collection, the most
common form of error is that generated by human
error. From simple pipetting to manually adjusting
optical settings on an instrument all these sources of
error result in data sets that are less reproducible and
increasingly difficult to interpret. The introduction of
the NanoSight Sample Assistant for the NS300 brings
about a new level of repeatability and reproducibility in
analysis of Extracellular Vesicle (EV) samples. This
work will examine the benefits of using the sample
assistant for sample handling including time saving,
and improved data quality.
Methods: The particle size distribution and concentra-
tion of exosome samples isolated from urine (20 x
1 mL) and SKOV3 cells (96 x 1 mL) was determined
using the NanoSight NS300 system (Malvern
Panalytical, UK) integrated with the NanoSight
Sample Assistant (1mL). All samples were analysed
under the same capture and process settings and the
total time of analysis recorded. A series of experiments
were also completed using SKOV3 samples, acquired
manually on the NanoSight NS300 system to compare
repeatability, reproducibility of data to that acquired by
the sample assistant.
Results: Analysis of the data shows that data acquisi-
tion of 96 EV samples can be completed in approxi-
mately 15 h using the Sample Assistant, a 70%
improvement compared to an estimated 50 h of man-
ual acquisition. Setup time of the instrument however
was approximately 30 min, reducing hands on instru-
ment time by ~99%. An additional dataset of EV sam-
ples was measured as a dilution series, both manually
and using the Sample Assistant. Data showed a mea-
surable improvement in both repeatability of the con-
centration as well as linearity of the series.
Summary/conclusion: The new NanoSight sample
assistant accessory for NS300 provides size and con-
centration data measurements of up to 96 samples in as
little as 15 h, including under 30 min of set-up time.
Data quality is typically improved by the elimination of
user error and subjectivity. The Sample Assistant is
compatible with many sample types, and generates
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key exosome characterization data, whilst freeing up
valuable scientist time to work on other tasks.
Funding: This project received funding from the
European Union’s Horizon 2020 research and innova-
tion programme under grant agreement No 646,002
IP.06
Identifying, characterizing and quantifying extracellular vesicles
using multispectral imaging flow cytometry
Haley R. Pugsley, Sherree Friend, Bryan Davidson and Phil Morrissey
Amnis part of Merck KGaA
Introduction: Extracellular vesicles (EV) are a hetero-
geneous group of membrane derived structures that
include exosomes, microvesicles and apoptotic bodies.
Quantifying and characterizing EVs in a reproducible
and reliable manner has been difficult due to their
small size (down to 30 nm in diameter). Attempts to
analyse EVs using traditional PMT based flow cyt-
ometers has been hampered by the limit of detection
of such small particles, their low refractive index and
the swarming effect. To overcome these limitations, we
have employed multispectral imaging flow cytometry
that has the advantage of high throughput flow cyto-
metry with higher sensitivity to small particles due to
the CCD based, time-delay-integration image capturing
system. Several recent publications have reported using
multispectral imaging flow cytometry to identify and
characterize EVs; however, the collection settings and
gating strategies used to identify and characterize EVs
is not consistent between publications.
Methods: Here we demonstrate the optimal collection
settings, parameters and gating strategy to identify,
characterize and quantify a variety of EVs using multi-
spectral imaging flow cytometry. EVs obtained from
commercial sources are identified using a combination
of CD markers, membrane stain and 405 nm SSC. In
each case, the membrane stain and 405 nm SSC initi-
ally identify an EV and CD markers are used for
characterization and immunophenotyping the EV.
Results: Data will be presented using the ImageStream
multispectral imaging flow cytometer to identify, char-
acterize and quantify a variety of EV samples.
Strategies for optimal collection and analysis of the
multispectral imaging flow cytometry EV data will
also be discussed.
Summary/conclusion: Multispectral imaging flow
cytometry is able to characterize and quantify EVs
with very high sensitivity due to the CCD based time-
delay-integration image capturing system.
IP.07
Microfluidic Resistive Pulse Sensing (MRPS) Measurements of EVs and
EV Standards
Franklin Monzona, Jean-Luc Fraikinb, Ngoc Doa, Tom Maslanikc, Erika
Duggand and John Noland
aSpectradyne; bSpectradyne LLC; cCellarcus Biosciences Inc; dScintillon
Institute
Introduction: As science-based on EVs advances, it is
important to be able to compare measurements of
vesicles across different manufacturing sites and man-
ufacturing methods. To isolate differences or drifts in
EV formulations, it is necessary to have stable metrol-
ogy so that these differences can be properly attributed
to changes in the formulation and not the metrology.
Establishing stable metrology in turn relies on the
development of standards measured by multiple ortho-
gonal methods. With this goal in mind, this paper
discusses measurements of EVs and EV standards
using Microfluidic Resistive Pulse Sensing (MRPS)
and other measurement techniques.
Methods: The size distribution and concentration of
EV standards and EVs derived from various sources
were characterized by MRPS, Nanoparticle Tracking
Analysis (NTA), cryo-Electron Microscopy (EM), and
Vesicle Flow Cytometry (VFC). In some cases, EVs
were destroyed by lysing agents and measurements
were repeated to demonstrate this effect.
Results: MRPS measurements gave high resolution size
and concentration information down to ~ 50 nm dia-
meter for all samples. Because MRPS is an electrical
technology, it did not suffer from sensitivity limitations
related to the low index of refraction contrast between
the nanoparticles (be they EVs or standards) and the
surrounding liquid. MRPS could not distinguish parti-
cles based on type (in contrast to VFC), however it was
more sensitive to the presence of non-EV nanoparticles
in the samples. Concentration reproducibility was in
the range of ± 20% and sizing reproducibility in the
range of ± 5% independent of particle material.
Summary/conclusion: Quantifying the purity of an EV
population is important. Techniques such as VFC do
an excellent job in quantifying the EV population of
interest but are not necessarily sensitive to contamina-
tion or the presence of non-target EVs. MRPS, on the
other hand, gives high resolution information on all
nanoparticles present in a mixture. From a process
development standpoint, this information is critical to
the improvement of a formulation. The orthogonal
nature of MRPS measurements, compared to optical
methods, is therefore an important part of the
126 ISEV2019 ABSTRACT BOOK
development of robust EV standards, and the asso-
ciated measurement protocols, that will be required
for the successful wide deployment of EV-based diag-
nostics and therapeutics.
IP.08
Development of EV-targeting tools for novel liquid biopsy
approaches in Lung Cancer
Diogo Fortunatoa, Laura Bianciardib, Gaia Papinic, Mattia Criscuolic, Davide
Zoccod and Nataša Zarovnib
aExosomics/University of Siena; bExosomics; cExosomics Siena, University of
Siena; dExosomics Siena
Introduction: Mounting clinical evidence suggests that
liquid biopsy may revolutionize the way cancer patients
are currently managed. Within this context, our study
aims to assess and reinforce unique and complemen-
tary advantages of EV/exosome-based approaches,
through identification and quantitative detection of
non-small cell lung cancer (NSCLC) EV biomarkers.
Current technology and methods for exosome isolation
from complex biological samples (i.e. plasma), have
shown to be unreliable. There is a need to substantially
improve them to enable multiparameter EV analysis.
Therefore, in addition to EV-biomarker discovery, we
are testing plasma processing and preanalytical tools,
devices and optimized immunoaffinity protocols that
tackle fundamental obstacles, such as complex matrix
effects. Our goal is to provide an EV immunocapture
approach with enough sensitivity, specificity and
robustness for clinical grade diagnostic applications.
Methods: Size-based vs. immunocapture methods for
exosome isolation. Enzymatic and immunological
assays for plasma pre-clearing; Flow cytometry,
ELISA, nanoparticle tracking analysis, Western Blot,
SPR and ddPCR for antibody and exosome
characterization.
Results: Exosomes derived from NSCLC cell lines dis-
play distinct membrane markers recognized by a panel
of proprietary Abs, screened by flow cytometry, SPR,
IP, ELISA and PCR. We developed and tested a screen-
ing platform based on endogenously labelled EVs to
identify NSCLC EV antigens. Selected antibodies will
be used to develop an immune-isolation protocol,
coupled to state-of-the-art analytics for a rapid and
sensitive readout, thus enabling a comparative evalua-
tion of a repertoire of plasma pre-analytical protocols.
Summary/conclusion: Different plasma pre-analytical
protocols are ranked and orthogonally combined to
optimally counteract matrix effects, increment EV
yield by immune-isolation approaches and facilitate
the analysis of enriched EV subpopulations.
Funding: The project is funded under the Marie
Skłodowska-Curie grant agreement No. 765,492
“ELBA – European Liquid Biopsies Academy” and
internal Exosomics R&D Funds.
IP.09
Side scatter module for enhanced detection of Extracellular Vesicles
by flow cytometry.
Tina Van Den Broecka, Ludovic Monheimb, Ihor Berezhnyya, Oleg Guryeva,
Tatyana Chernenkoa, Marybeth Sharkeya and Geoffrey Osbornea
aBD Biosciences; bBD Life Sciences, Erembodegem, Belgium
Introduction: EVs are nanosized (20 ~ 5000 nm)
membrane vesicles released from cells that can trans-
port cargo – including miRNA and proteins – between
cells as a powerful way of intercellular communication.
Currently, flow cytometry is the only high throughput
technique capable of single particle cell surface pheno-
typing and sorting with the possibility of concentration
determination. Unfortunately, the drawback of stan-
dard flow cytometry is lack of sensitivity to detect
smallest particles, especially for those with a size less
than or equal to the dimensions of the excitation laser
wavelength.
Methods: BD has developed an accessory side scatter
(SSC) module for enhanced scatter detection of small
particles by flow cytometry: the SP SSC module. The
SP SSC module should be used in combination with a
laser power of at least 100 mW. Small particle detection
enhancement is achieved by significantly increasing the
signal-to-noise ratio of the SSC.
Results: The SP SSC module can be installed on most
commercially available BD flow cytometers, which
have sufficient laser power, as an additional option.
The normal SSC detector remains in place and the SP
SSC module has minimal impact on regular SSC and
fluorescent performance therefore use of the system for
cell analysis applications is still possible. Initial results
using the SP SSC module were obtained using a BD
FACSCelesta™ SORP and a BD FACSAria™ Fusion,
respectively having a 100 and 200 mW 488 laser.
Side-by-side comparison of the regular SSC detection
vs. SP SSC detection was done using polystyrene beads,
silica beads, EV reference material and antibody-
stained EV material.
Summary/conclusion: Utilization of the SP SSC mod-
ule for sorting of natural (plasma EVs) and artificial
JOURNAL OF EXTRACELLULAR VESICLES 127
(liposomes) membrane particles is currently being
undertaken.
IP.10
Quantitative imaging and phenotyping of EVs with 20 nm resolution
Andras Miklosi, Zehra Nizami, Blanka Kellermayer and Mariya Georgieva
ONI (Oxford Nanoimaging ltd)
Introduction: Complex extracellular vesicle (EV) phe-
notyping is a major technical challenge that hinders
clinical translation. Single-molecule localization micro-
scopy (SMLM) is a Nobel-Prize winning technique that
allows quantitative imaging below the diffraction limit
necessitating only simple and fast sample preparation.
The data presented here constitutes one of the first
accounts of single-molecule imaging used to success-
fully resolve the structure, protein (CD9, CD63, and
CD81) and nucleic acid content of EVs with 20 nm
resolution.
Methods: EV isolation was performed from keratino-
cyte culture media. EV suspensions were stained using
fluorescently labelled primary antibodies raised against
known exosome markers, and commercially available
membrane and nucleic acid labels. Characterization of
the molecular content and structural properties of sur-
face-immobilized EVs was performed using the SMLM
mode of the ONI Nanoimager. Sizing of EVs in solu-
tion was performed using the dual-colour single-parti-
cle tracking mode of the ONI Nanoimager.
Results: Multicolour super-resolution microscopy ima-
ging of purified EVs revealed the phenotypic and struc-
tural properties of hundreds of individual vesicles at a
time. The membrane staining allowed to visualize EVs
with sizes ranging from ~20 nm to >250 nm, and sizing
by tracking confirmed this distribution and a mean size
of 120 nm. For EVs of >40 nm the membrane appeared
as a ring and was a confirmation of their intact struc-
ture. CD63, CD9 and CD81 co-localized with the
membrane staining at the nm scale, thus allowing to
determine the molecular ID of EV subpopulations and
correlate the protein marker levels with the size of EVs.
Summary/conclusion: The quantitative nature of sin-
gle-molecule imaging and tracking significantly
improves EV characterization. This work provides evi-
dence of the use of SMLM imaging as a novel and
powerful tool for rapid and multiplexed EV character-
ization with unique combination of structural and
phenotypic insight.
IP.11
Benchmarking of established exosome isolation methods (density
gradient centrifugation, size-exclusion chromatography and immune-
bead separation) with glycan recognizing EXÖBead
Dapi Meng Lin. Chianga, Chin-Sheng Linb and Michael Pfafflc
aBiovesicle; bDivision of Cardiology, Tri-Service General Hospital, Taiwan &
National Defense Medical Center, Taiwan; cAnimal Physiology and
Immunology, School of Life Sciences Weihenstephan, Technical University
of Munich, Freising, Germany
Introduction: Exosomes are small vesicles (30–
150 nm) found in various human biofluids, such as
plasma. OptiPrep density gradient centrifugation
(DGC) is widely accepted as a pure exosome isolation
method. Size-exclusion chromatography (SEC) is a fast
exosome isolation method, but exhibit contaminations
such as lipoprotein or aggregated proteins. Immuno-
beads (HBM) are based on high specific recognition of
exosome CDs, but uses a harsh elution procedure to get
intact exosome. EXÖBead (Biovesicle) are glycan
recognition magnetic beads and show high exosome
specificity by FACS, NTA and TEM analysis. In this
study, we compared these four isolation methods based
on FACS established exosomal markers, intact exo-
some size/number and lipoprotein contamination.
Methods: Mix plasma samples were collected from
healthy donors (n = 5) and patients undergoing cor-
onary angiography (n = 6). Exosomes were isolated
from 250 μl plasma by SEC and DGC, fractions were
collect from SEC (7 ~ 10) or DGC (6 ~ 8), and then
covalent-coated on 1 μm magnetic beads (followed
Chemicell). We also covalent-coated 1 ml 10% exo-
some free (EF) FBS in PBS as a negative control. We
directly incubated 250 μl plasma with 1 μm glycan
recognition magnetic beads EXÖBead (37°C, 1 h) or
1 μm latex HBM immunobeads (4°C, 16h). As a nega-
tive control 1 ml (EF) FBS was incubated. Universal
antibody mix (PE-Cy7-CD63, FITC-CD81 and APC-
CD9) was used for all isolation methods. The negative
control reduced fluorescence data are presented by
median fluorescence intensity (MFI). NTA data were
collected only from intact exosomes.
Results: EXÖBead represents highest MFI of CD63
(247.9) compared to SEC (232.42), DGC (25.72) and
HBM (5.13). EXÖBead also showed highest MFI of
CD9 (475.4) compared to SEC (42.3), DGC (5.1) and
HBM (0). Only SEC (88.9) and EXÖBead (41.1) could
detect CD81. Experiment processing time for EXÖBead
is 2h, SEC is 4h, HBM is 19h, and DGC even 22h. SEC
represents highest intac
t exosomes/ml (4.9E+10), EXÖBead (1.7E+9), HBM
(1.9E+8), and DGC (1.5E+8), measured by NTA.
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Median exosome sizes are EXÖBead 72.0 nm, SEC
107.0 nm, DGC 89.6 nm and HBM 96.1 nm.
Summary/Conclusion: EXÖBead serves as a new time-
saving plasma isolation method with high exosome
yield and specificity.
IP.12
Characterizing the cellular uptake of neural stem-cell derived
exosomes using live-cell imaging techniques
Samuel Jonesa, Thomas Cawsb, Anthony Hayesa, Victoria Marsh Durbanb,
Randolph Cortelingb and Peter Watsona
aSchool of Biosciences, Sir Martin Evans Building, Cardiff University,
Museum Avenue, Cardiff, Wales, UK; bReNeuron Limited, Pencoed
Business Park, Pencoed, Bridgend, Wales, UK
Introduction: Neural stem cell derived exosomes
(“ExoPr0”); purified from the conditioned medium of
a GMP manufactured, conditionally-immortalized
human neural stem cell line (“CTX0E03”), demon-
strates a unique biodistribution profile in mice com-
pared to exosomes derived from a control producer cell
line. We have previously shown that ExoPr0 is able to
cross the blood brain barrier, and to further explicate
these findings, we investigated the uptake of ExoPr0 at
the cellular level using live-cell imaging techniques.
Methods: We employed live-cell confocal microscopy
to directly visualize uptake of fluorescently labelled
exosomes. A quantitative image analysis protocol was
developed and applied to assess the uptake of exosomes
in a number of cell types.
Results: Time course incubations of cells treated with
ExoPr0 produced data that revealed heterogeneity in
uptake between cell types. ExoPr0 was compared to
exosomes derived from a control producer cell line,
highlighting source-specific differences in uptake
kinetics. Uptake was observed to occur through more
than one pathway resulting in trafficking through
endo-lysosomal compartments. The effect of cell cycle
on the uptake of ExoPr0 was investigated, but was not
observed as having a significant influence.
Summary/conclusion: Findings from this study have
eluded to the specificity of ExoPr0 towards different
cell types and work is ongoing to further elucidate the
delivery mechanism of ExoPr0 and understand the
subcellular trafficking in recipient cells.
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OT07.01
Aggregation-induced emission probe/graphene oxide aptasensor for
label-free and “turn-on” fluorescent aptasensor for cancerous
exosomes
Bo Li, Weilun Pan, Chunchen Liu and Lei Zheng
Clinical Laboratory Department, Nanfang Hospital, Southern Medical
University, Guangzhou, China (People’s Republic)
Introduction: Exosomes are the smallest subset (30–
150 nm) of extracellular vesicles (EVs), a heteroge-
neous population of vesicles originate from all types
of tissue cells, which can freely pass through the blood
vessel wall and distribute in various body fluids.
Exosomes carry different macromolecules, such as
nucleic acids, proteins and lipids for intercellular com-
munication. In the last decade, numerous researches
demonstrated that exosomes’ cargo is affected in the
progression of malignant tumours, positioning exo-
somes as potential sources for the discovery of novel
biomarkers. For example, it is confirmed that PSMA is
enriched in the membrane of exosomes from prostate
cancer cells. So, PSMA positive exosomes subpopula-
tion is regarded as the diagnostic biomarker for pros-
tate cancer. But conventional methods can hardly
quantify low-concentration PSMA positive exosomes
subpopulation in small volumes of clinical samples
rapidly.
Methods: In this work, we constructed the label-free
and “turn-on” aptasensor for the detection of the
PSMA positive prostate cancer exosome based on
PSMA aptamer as the recognition element,
Aggregation-Induced Emission (AIE) probes: TTAPE
as fluorescent indicators and Graphene Oxide (GO) as
fluorescent quencher. In the absence of PSMA positive
exosomes, the fluorescence of TTAPE aggregated in the
aptamer would be quenched efficiently by GO.
However, in the presence of PSMA positive exosomes,
the specific and stronger binding between aptamers
and PSMA positive exosomes could weaken the bind-
ing interaction between aptamer and GO. So the fluor-
escence of TTAPE aggregated in the aptamer would
recover, which could appear “turn-on” fluorescent
property.
Results: Under optimal conditions (37°C, 15 min), the
linear range of detection for prostate cancer exosomes
is estimated to be 4.07 × 105–1.83 × 107 exosomes/μL
with a detection of limit (LOD) of 3.43 × 105 exo-
somes/µL. We further successfully applied it for exo-
somes quantification in plasma samples from prostate
cancer patients.
Summary/Conclusion: This aptasensor is expected to
become a powerful tool for rapid and simple cancer
liquid biopsy.
Funding: This study was financed by grants from the
National Natural Science Foundation of China
(81371901, 81702100), the Science and Technology
Planning Project of Guangdong Province
(2017A020215123).
OT07.02
Single extracellular vesicle (EV) profiling and EV subpopulation
analysis of cancer related EVs in human plasma
Yanling Caia, Zesong Lia and Di Wub
aShenzhen Second People’s Hospital, First affiliated hospital of Shenzhen
University, Shenzhen, China (People’s Republic); bDepartment of
Biochemistry and Biophysics, Science for Life Laboratory, Stockholm
University, Solna, Sweden., Solna, Sweden
Introduction: Extracellular vesicles (EV) carry impor-
tant information of their parental cells, and are there-
fore promising biomarkers for liquid biopsy and early
diagnosis of multiple diseases including cancer.
However, the detection of disease specific EV among
huge numbers of EVs in the clinical sample, e.g. plasma
remains a challenge, which makes single EV and EV
subpopulation analysis preferable to bulk analysis.
Methods: In the presented work, in order to recognize
the cancer cell line specific EVs, we utilized a proximity
barcoding assay (PBA) to analyse the surface protein
composition of single EVs and investigated the EV
subpopulation. A pool of hundred-plex oligonucleo-
tide-conjugated antibodies against reported cancer bio-
markers candidates was employed to recognize the
surface proteins of individual EVs. Then all the oligo-
nucleotides on the same EV obtained an unique EV tag
in a PBA. The pool of extension products can be
amplified and sequenced by next generation sequen-
cing. After sorting the reads, we could reconstruct the
surface protein composition of individual EVs.
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Results: We applied PBA to analysed EVs purified
from cancer cell lines and from human plasma. We
could identify different subpopulation EVs, that are
specific for certain cell lines and human plasma. We
then spiked in different amount cancer cell-line derived
exosomes in the plasma derived EVs from healthy
donors in different ratio. We could observe en expected
increase of certain population of exosomes in the
human plasma.
Summary/Conclusion: In summary, PBA is a multi-
plexed and high throughput approach to analyse sur-
face proteins of individual EVs. The cancer cell line
EVs mixed into healthy control plasma were success-
fully detected, indicating this technique can be applied
to search for rare population of EVs in the plasma
samples of patients.
Funding: National Natural Science Foundation of
China, project 81802052
OT07.03
miRNA signature derived from GBM plasma exosomes as a diagnostic
biomarker
Luz M. Cumba Garciaa, Pritha Chananab and Ian Parneyc
aMayo Clinic Graduate School of Biomedical Sciences, Department of
Immunology, Rochester, USA; bMayo Clinic, Department of Health
Sciences Research- Division of Biomedical Statistics and Informatics,
Rochester, USA; cMayo Clinic, Department of Neurologic Surgery,
Department of Immunology, Rochester, USA
Introduction: Gliomas including glioblastoma (GBM)
are the most common malignant brain tumours.
Glioma extracellular vesicles (EVs), especially plasma
exosomes, have biological effects such as mediating
immunosuppression and contain signature tumour-
specific cargo that could serve as liquid biopsies.
Increasing interest in molecular biomarkers to deter-
mine patient prognosis in GBM has suggested that EV
miRNA-based signatures may be able to predict pro-
gression-free and overall survival, differentiate normal
donors from GBM patients, and distinguish true pro-
gression from treatment-related pseudo-progression.
Methods: We have established a simple technique,
using density gradient ultracentrifugation, to isolate
plasma exosomes from glioma patients and normal
donors. Purification of total RNA, including miRNA,
was performed on plasma exosomes from normal
donors (n = 8) and GBM patients (n = 7) using the
miRNeasy kit (Qiagen). Next generation short non-
coding RNA sequencing was performed by Illumina
HiSeq 4000.
Results: RNA sequencing revealed many differentially
expressed miRNAs in GBM patients with high fold
change/low false discovery rates compared to normal
donor plasma exosomes. Ingenuity Pathway Analysis
showed that these differentially expressed miRNAs tar-
get mRNAs that are associated with distinctive GBM
and cancer pathways. In order to test the diagnostic
accuracy of the proposed technique, ROC analysis was
performed based on the top 33 differentially expressed
miRNA samples. The area under the ROC curve (AUC;
a figure of merit to determine the optimal miRNA
signature) was 0.968. In addition, multiple novel
miRNAs and other short non-coding RNA species
(Y-RNA, piRNA, snoRNA) were found with some dif-
ferential expression.
Summary/Conclusion: In conclusion, miRNA sequen-
cing from plasma exosomes shows marked differential
miRNA expression between healthy donors and GBM
patients. These findings as well as additional differen-
tially expressed short non-coding RNA species suggest
plasma EVs may serve as a robust platform to develop
GBM liquid biopsies.
Funding: Mayo Clinic Center for Individualized
Medicine (CIM) Brains Together For a Cure
OT07.05
Isolation of extracellular vesicles by nanoDLD lab-on-a-chip
technology for clinical applications
Stacey M. Gifforda, Joshua Smitha, Benjamin Wunscha, Navneet Dograa,
Mehmet Ahsenb, Kamlesh Yadavc, Ashutosh Tewarid, Carlos Cordon-
Cardoe and Gustavo Stolovitzkya
aIBM T.J. Watson Researc Center, Yorktown Heights, NY, USA; bDepartment
of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai,
New York, NY, USA; cDepartment of Urology, Icahn School of Medicine at
Mount Sinai, New York, NY, USA; dDepartment of Urology, Icahn School of
Medicine at Mount Sinai, New York, NY, USA; eDepartment of Oncology
Sciences and Pathology, Icahn School of Medicine at Mount Sinai, New York,
NY, USA
Introduction: There is great interest in exosome isola-
tion and analysis to develop non-invasive “liquid biop-
sies” for diagnosis, prognosis, and surveillance of
diseases. However, current exosome isolation methods
lack purity, yield and reproducibility and the inability
to rapidly and reliably separate exosomes hinders clin-
ical application. Thus, there is an urgent need to
develop novel tools to isolate exosomes as a promising
source of new biomarkers.
Methods: We have developed a lab-on-a-chip tech-
nology based on deterministic lateral displacement at
the nanoscale (nanoDLD) which separates and con-
centrates particles in continuous flow and in specific
size ranges, going to scales as small as 20 nm. We used
nanoDLD to isolate EVs from urine and serum and
characterized these EVs by NTA and RNA
sequencing.
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Results: Benchmarking studies of nanoDLD isola-
tion of exosomes show comparable or improved
yield and concentration compared to standard tech-
niques such as SEC and UC at volumes suitable for
clinical applications. We isolated EVs from the
urine and serum of prostate cancer (PCa) patients.
Our preliminary data show PCa patient serum exo-
somes are enriched in known PCa biomarkers.
Screening for an EV RNA panel associated with
aggressiveness could aid detection of clinically sig-
nificant PCa and reduce unnecessary radical
prostatectomies.
Summary/Conclusion: We have developed a chip-
based tool for EV separation and demonstrated
improved yield, concentration and processing time
compared to existing isolation methods. This technol-
ogy has enabled high-resolution temporal studies of
urinary EVs to better understand the impact of pre-
analytical challenges on EV studies. Finally we used
nanoDLD to isolate EVs from prostate cancer patient
samples and detect an enrichment of known mRNA
prostate cancer markers in serum EVs. Our nanoDLD
technology enables frequent, rapid isolation of EVs at
improved yield and concentration enabling the use of
smaller sample volumes.
Funding: Work was funded by IBM Research and the
Icahn School of Medicine at Mount Sinai.
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OT08.01
Magnetically navigated intracellular delivery of extracellular vesicles
using nanogels
Yoshihiro Sasaki, Ryosuke Mizuta and Kazunari Akiyoshi
Kyoto University, Kyoto, Japan
Introduction: Extracellular vesicles can control impor-
tant biological phenomena such as cell differentiation
and cell death. In addition, extracellular vesicle is also
regarded as a promising material for biomedical appli-
cation. However, due to their low efficiency of intra-
cellular uptake, development of effective intracellular
delivery method has been remained challenging issue.
We report here the complexation of extracellular vesi-
cles and magneto-responsive nanogels, and efficient
intracellular delivery of extracellular vesicles into cells
by magnetic guidance for induction of differentiation
of stem cells by delivered extracellular vesicles.
Methods: Magnetic nanogels were prepared by mixing
oleic acid-coated iron oxide nanoparticles dispersed in
an organic solvent to nanogels composed of cholesteryl
group-substituted pullulan. Magnetic nanogel-exosome
complexes were prepared by isolating exosomes from
culture supernatants of myoblasts and nerve cells by
ultracentrifugation and mixing this exosome with mag-
netic nanogels. The resulting magnetic nanogel-exo-
some complex was delivered to the cells by magnetic
induction and its intracellular dynamics were investi-
gated using a confocal laser microscope and flow
cytometry.
Results: In 24 h, 90% of exosome could be complexed
with magnetic nanogel. The obtained magnetic nano-
gel-exosome complex was delivered to adipose-derived
mesenchymal stem cells (ADSC) by magnetic induc-
tion. As a result, the introduction of magnetic nanogel
and exosome into the cytoplasm was confirmed. From
the results of immunostaining, expression of the differ-
entiation marker was confirmed in which the complex
was introduced to ADSC by magnetic induction for
both myoblasts and nerve cells.
Summary/Conclusion: Differentiation was induced to
ADSC by efficient magnetic delivery of exosome. This
magnetic nanogel introduction method is expected to
be used as analysis of exosomes whose function is
unclear or as a novel cell function control technique
using exosome.
OT08.02
Tissue distribution of extracellular vesicle-binding proteins after in
vivo gene transfer into mice
Yoshihiko Shimazawaa, Kosuke Kusamorib, Yuki Takahashic, Yoshinobu
Takakurac and Makiya Nishikawab
aFaculty of Pharmaceutical Sciences, Tokyo University of Science, Noda,
Japan; bTokyo University of Science, Noda, Japan; cKyoto University,
Kyoto, Japan
Introduction: Successful application of extracellular
vesicles (EVs) as delivery systems for bioactive mole-
cules, including miRNAs and tumour antigens,
requires the understanding and control of their tissue
distribution. Our previous studies demonstrated that
the exogenously administered EVs of about 100 nm in
diameter quickly disappeared from the systemic circu-
lation after intravenous injection into mice. Despite
these results, endogenous EVs might have different
tissue distribution properties from exogenously admi-
nistered ones. To test this hypothesis, it is important to
develop a method to analyse the properties of endo-
genous EVs. In this study, as a first step, we selected
Gaussia luciferase (gLuc) and lactadherin (LA) as a
reporter protein and an EV-binding protein, respec-
tively, and examined whether the fusion of LA to gLuc
could alter the tissue distribution of gLuc after in vivo
gene transfer into mice.
Methods: pcDNA3.1 plasmid vectors encoding gLuc, a
fusion protein of gLuc and LA (gLuc-LA), or a fusion
protein of gLuc and a mutated LA which has low
affinity to EVs (muLA) were constructed (pCMV/
gLuc, pCMV/gLuc-LA and pCMV/gLuc-muLA). Each
plasmid was injected into 4-week-old male ddY mice
using the hydrodynamic injection method, and blood
was collected at several time points to obtain plasma.
Then, EVs in plasma were separated and collected by
the ultracentrifugation method. The characteristics of
the EVs were evaluated by western blotting and
dynamic light scattering. The luciferase activity of the
plasma and the EVs was measured in a luminometer.
Results: In all the cases examined, the luciferase activ-
ity in the plasma was very high soon after
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hydrodynamic injection of the plasmid vectors, then it
decreased with time. No significant luciferase activity
was detected in the EVs when pCMV/gLuc or pCMV/
gLuc-muLA was injected. By contrast, about 5% of
luciferase activity of the plasma was recovered in the
EV fraction when mice received an injection of pCMV/
gLuc-LA.
Summary/Conclusion: These results indicate that
gLuc-LA binds to EVs in mouse blood through LA
after in vivo gene transfer, which suggests that gLuc-
LA can be used to analyse the tissue distribution of
endogenous EVs.
OT08.03
Capabilities of HEK293T cell-exosomes as a non-invasive delivery tool
for mammalian sperm
Teresa Vilanovaa, Celine Jonesa, Rebecca Dragovica, Kevin Cowarda and Marc
Yestea
aUniversity of Oxford, Oxford, UK; bUniversidad de Gerona, Girona, Spain
Introduction: Male infertility accounts for 35–50% of
human infertility, and 2.5–12% of men present some
form of infertility. Several non-invasive approaches to
treat sperm-borne aberrations are being developed
such as exosomes for compound delivery. Human
Embryonic Kidney (HEK)293T cell-exosomes appear
to be safe and versatile in terms of their targeting
abilities. However, the safety aspects for gametes need
to be investigated. In this study we developed
HEK293T cell-exosomes for in vitro co-incubation
with boar sperm. Exosome binding and exposure
effects (for viability, mitochondrial membrane poten-
tial (MMP) and membrane fluidity (MF)) were
examined.
Methods: HEK293T-exosomes were characterised by
Nanoparticle Tracking Analysis, Western Blotting and
Transmission Electron Microscopy. Boar sperm sam-
ples (n = 3) were in vitro co-incubated at an exosome:
sperm ratio of 10:1 (4h pH<7). Sperm aliquots at 0, 2
and 4h post-incubation were analysed for exosome
binding. Moreover, boar sperm (n = 5) was in vitro
co-incubated at different ratios (1:1, 10:1 and 100:1)
under capacitating and progesterone-induced hyper-
activating conditions. Analysis at 0h, 2h, 4h, 4h 10
min, 4h 30 min and 5h post-incubation by flow cyto-
metry for viability, MMP and MF of exosome-treated
samples was performed by staining with SYBR-14/PI,
JC-1 and YO-PRO-1/Merocyanine-540, respectively.
Data were analysed with a mixed model (between-sub-
jects factor: treatment; within-subjects factor: incuba-
tion time) followed by the post-HOC Sidak test.
Results: Data revealed an homogeneous exosome-
enriched sample in terms of exosome-like morphology
and size. Exosome-sperm binding to the head, mid-piece
and tail was confirmed with up to two exosomes/sperm
cell. No statistically significant differences were found in
terms of viability, MMP and MF for any of the tested
ratios at each time point, compared to controls.
Summary/Conclusion: HEK293T cell-derived exo-
somes bound to all sperm parts soon after the incuba-
tion began. A high exosome concentration did not
compromise the viability nor the response of boar
spermatozoa to induced capacitation and acrosome-
exocytosis in vitro. In conclusion, HEK293T cell-exo-
somes have shown to have potential as a future clinical
delivery system in the context of male infertility.
Funding: SRF and St. Peter’s College (University of
Oxford).
OT08.04
Extracellular vesicles from de-differentiated human adipose tissue
endothelial cells have potential to disseminate angiostatic signals in
human obesity
Anca D. Dobriana, Bronson Haynes, Ryan Huyck, Lifang Yang, Vanessa
Correll, William McPheat and O. John Semmesb
aEastern Virginia Medical School, Norfolk, USA; bLeroy T. Canoles Jr. Cancer
Research Center, Eastern Virginia Medical School, Norfolk, USA
Introduction: Endothelial-to-mesenchymal transition
(EndoMT) characterized by endothelial cell (EC) de-
differentiation into a mesenchymal phenotype is a focal
event present in the vasculature of obese adipose tissue
(AT) and has been shown to contribute to various
vascular pathologies. EC from human AT impacted
by EndoMT are angiostatic and have a quiescent meta-
bolic phenotype. We hypothesize that extracellular
vesicles (EV) produced by such EC may lead to propa-
gation of angiostatic signals which may contribute to
hypoxia and insulin resistance in obese AT.
Methods: We modelled EndoMT in vitro by treatment
of human AT ECs with pro-inflammatory cytokines
and prepared EV from conditioned media by ultracen-
trifugation. Uptake of EVs by naïve EC was measured
by flow cytometry; angiogenesis by in vitro tube for-
mation; and mitochondrial energetics with Seahorse
bioanalyzer. The miRNA cargo of the EVs was analysed
using the Nanostring platform and the proteome was
determined using LC/MS/MS.
Results: EV from EndoMT cells produced a dramatic
angiostatic effect on recipient EC without affecting
migration or proliferation. Recipient EC became quies-
cent and had lower ATP production compared to con-
trols. Pathway analysis of EV cargo showed significant
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targeting of fatty acid synthesis and oxidation in reci-
pient EC. We found abundant miR-155-3p in EV and
reduced expression of its metabolic enzyme targets
CPT1a and ACLY in recipient EC. Treatment of EC
with the CPT1a inhibitor etomoxir recapitulated the
angiostatic effect of the EVs. The EV proteome was
also enriched in peptide signatures for VEGFR1,
VEGFR2 and neuropilin.
Summary/Conclusion: We show that the metabolic
shift produced by EV from EndoMT cells may explain
their angiostatic effect. miR-155 delivered via EV may
be key for metabolic quiescence via inhibition of CPT1
and ACLY. We report a novel mechanism by which
EndoMT in EC produces EVs that may propagate
angiostatic effects throughout the AT vasculature in
obesity.
Funding: NIHR15NHLBI, American Heart Association-
AIREA.
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OT09.01
Different exosome subtypes have distinct ESCRT-associated biology
and control tumour cell adaptation in vivo
Shih-Jung Fana, Benjamin Kroegerb, Pauline Mariea, Esther Bridgesa, Kristie
McCormicka, John Masona, Helen Sheldona, Claudia Mendesa, Mark
Wainwrighta, John Morrisa, Adrian Harrisa, Clive Wilsona and Deborah C
I. Goberdhana
aUniversity of Oxford, Oxford, UK; bPeter MacCallum Cancer Centre,
Melbourne, Australia
Introduction: Determining the function of specific
extracellular vesicle (EV) and exosome subtypes has
proved challenging, in part due to the difficulty in
untangling the mechanisms leading to their generation.
Methods: We investigated the cell biology behind exo-
some formation using the large endosomal compart-
ments offered by an in vivo fly model, and analysis in
human HCT116 and other cancer cell lines. EV pre-
parations were also tested in vivo following injection in
to human xenografts in mice. We analysed different EV
preparations by mass spectrometry using Tandem
Mass Tag labelling to identify changes in protein
cargo of EVs in response to microenvironmental stress.
Results: Using these complementary approaches, we
show that microenvironmental stress, such as gluta-
mine depletion, leads to a switch in membrane traffick-
ing from the classic late endosomal multivesicular
endosomes to Rab11a-positive recycling endosomes
and the production of Rab11a-positive exosomes,
which promote cell growth under stress conditions.
This activity is suppressed by blocking Rab11a-depen-
dent trafficking and ESCRT function. Our proteomics
and fly data suggest that some ESCRTs are differen-
tially involved in these two exosome-generating pro-
cesses. Furthermore, mouse xenografts highlight roles
for stress-induced EVs in increasing the turnover of
tumour cells, leading to an increase in hypoxic stress,
associated with selection for aggressive cells that can
promote tumour progression. These stress-induced
vesicles also have a potent effect on blood vessel growth
in vivo.
Summary/Conclusion: We conclude that stress-
induced EVs and exosomes made in Rab11a-positive
recycling endosomes are involved in tumour
adaptation.
Funding: This work was funded by Cancer Research
UK [C19591/A19076], the CRUK Oxford Centre
Development Fund [C38302/A12278], BBSRC [BB/
K017462/1, BB/N016300/1, BB/R004862/1], John Fell
Fund, Oxford, Wellcome Trust [MICRON; #091911,
#107457], Royal College of Surgeons.
OT09.02
Emerging role of L-type calcium channel-mediated calcium influx in
regulating apoptotic bodies formation
Thanh Kha Phana, Bo Shib, Niall Geogheganc, Kelly Rogersd and Ivan Poone
aDepartment of Biochemistry and Genetics, La Trobe Institute for Molecular
Science, La Trobe University, Bundoora, Australia; bDepartment of
Biochemistry and Genetics, La Trobe Institute for Molecular Science, La
Trobe University, Melbourne, Australia; cCentre for Dynamic Imaging,
Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia;
dCentre for Dynamic Imaging, Walter and Eliza Hall Institute of Medical
Research, Melbourne, Australia; eLa Trobe University, Bundoora, Australia
Introduction: Dying cells often break into smaller
membrane-bound fragments, called apoptotic bodies
(ApoBD), via apoptotic cell disassembly (ACD), an
essential physiological or pathophysiological event
downstream of apoptosis. Emerging evidence implies
the importance of ApoBD formation in mediating effi-
cient phagocytic removal of apoptotic debris and facil-
itating intercellular communication through trafficking
of biomolecules and pathogen-derived materials. In
contrast to long-lasting belief, our recent findings
have demonstrated that apoptotic cell disassembly is a
tightly regulated and temporally-controlled three-step
process: (i) membrane blebbing, (ii) formation of thin
membrane protrusion promoting bleb separation and
(iii) protrusion fragmentation to form ApoBD.
However, detailed insights to the underlying mechan-
ism, particularly ion channels and chemical signalling,
undoubtedly require further investigations.
Methods: To identify ion channel(s) involved in ACD
process, cells were treated channel blockers prior to
UV irradiation. ApoBD formation was monitored
using DIC microscopy and quantified by our
recently-developed multi-parametric flow cytometry
analysis using TOPRO-3 dye and Annexin V. Lattice
light sheet microscopy allowed us to obtain high-reso-
lution imaging of calcium-mediated ACD in presence
of various fluorescent stains.
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Results: Our data showed that calcium influx preceded
disassembly step of apoptotic cell, blockade of which,
using calcium channel inhibitors, abolished ApoBD
formation. Strikingly, calcium channels contain a ten-
tative caspase cleavage site, immediately preceding cal-
modulin-binding IQ motif which mediates calcium-
dependent feedback inactivation of the channels.
Thus, maximised calcium influx by caspase-cleaved
calcium channels could be a novel regulatory mechan-
ism of ACD. Furthermore, we could monitor the
detailed progression of the process, from cytosolic cal-
cium accumulation to form electrochemical force, driv-
ing protrusion formation and ACD process.
Summary/Conclusion: Our findings therefore provide
further molecular insights into dying cell disassembly
and calcium-induced ApoBD-associated pathogenesis,
particularly vascular calcification.
OT09.03
A novel UBL3 modification influences protein sorting to small
extracellular vesicles
Hiroshi Agetaa, Natsumi Ageta-Ishiharab, Keisuke Hitachia, Takanori
Onouchia, Hisateru Yamaguchia, Yusuke Yoshiokac, Nobuyoshi Kosakad,
Tomihiko Idea, Makoto Kinoshitab, Takahiro Ochiyad, Mitsutoshi Setoue
and Kunihiro Tsuchidaa
aFujita Health University, Toyoake, Japan; bNagoya University, Nagoya,
Japan; cTokyo Medical University, Shinjyuku-ku, Japan; dDepartment of
Molecular and Cellular Medicine, Institute of Medical Science, Tokyo
Medical University, Shinjyuku-ku, Japan; eHamamatsu University School of
Medicine, Hamamatsu, Japan
Introduction: Small extracellular vesicles (sEVs) are
nanometre-sized vesicles secreted from various cell
types. Exosomes, a type of sEVs, derived from multi-
vesicular bodies (MVBs), mediate cell-to-cell commu-
nication by transporting proteins, mRNAsand
miRNAs. The delivery of proteins between cells by
sEVs, including exosomes, is related to tumour pro-
gression and neurodegenerative diseases. However, the
molecular mechanism by which proteins are sorted to
sEVs is not fully understood.
Methods: By using immunoprecipitation, immunocy-
tochemical, electron microscopic and proteomics ana-
lysis, we report that ubiquitin-like 3 (UBL3)/
membrane-anchored Ub-fold protein (MUB), an evo-
lutionarily conserved protein, acts as a novel posttran-
slational modification (PTM) factor that regulates
protein sorting to sEVs.
Results: We find that UBL3 modification is through
cysteine residues only under non-reducing conditions
and is indispensable for sorting of UBL3 to MVBs and
sEVs. Furthermore, we observe a 60% reduction of
total protein, but not RNA, levels in serum sEVs pur-
ified from UBL3-knockout (KO) mice compared with
those from wild-type mice. To identify the types of
proteins that are modified by UBL3, we perform com-
prehensive proteomics analysis and find 1,241 UBL3-
interacting proteins depending on the two C-terminal
cysteine residues. Among these, 369 proteins are anno-
tated as “extracellular vesicular exosome” by Gene
Ontology (GO) analysis, and there are at least 22 dis-
ease-related molecules, including Ras. To investigate
whether UBL3 modification affects protein sorting to
sEVs, we choose Ras as a model protein. We show that
Ras and oncogenic RasG12V mutant are post-transla-
tionally modified by UBL3, and that increased sorting
of RasG12V to sEVs by UBL3 modification enhances
activation of Ras signalling in the recipient cells.
Summary/Conclusion: Collectively, these results indi-
cate that a novel PTM by UBL3 influences the sorting
of proteins to sEVs. UBL3 modification could be a
novel therapeutic target for sEV-related disorders.
OT09.04
Stringent small extracellular vesicle purification and ligation-
independent small RNA-seq: new insights into released RNA
populations
Kenneth W. Witwera, Tine Schøyena, Yiyao Huanga, Andrey Turchinovichb,
Senquan Liua, Linzhao Chenga and Vasiliki Machairakic
aJohns Hopkins University School of Medicine, Baltimore, USA; bSciBerg,
Heidelberg, Germany; cJohns Hopkins University, Baltimore, USA
Introduction: MicroRNAs are a major focus of exRNA
and EV studies. Many publications report miRNAs as
the plurality or majority of released small RNAs.
However, legacy sRNA profiling methods are biased
towards miRNAs. Abundant RNAs outside vesicles
also contaminate many EV preparations. We
sequenced exRNA from induced pluripotent stem
cells (iPSCs) with a ligation-independent method:
ultra-low-input capture and amplification by tailing
and sequencing (CATS).
Methods: Culture conditioned medium (CCM) was
collected from 4 lines of count-normalized iPSCs over
3 passages (> 200 mL/passage). Fractions were: cells
(washed/lysed); “whole releasate" = clarified CCM (300
x g, 2k x g); “large EVs (lEVs)" = pellet of 10k x g spin;
“small EVs (sEVs) = preparation by tangential flow
filtration (100 kDa cutoff) and size exclusion chroma-
tography (Izon); and “soluble" = flow-through from
sEV preparation. Particles were counted by
ParticleMetrix, visualized by TEM, and tested for up
to 7 positive or negative markers per MISEV2014/18.
lEVs and sEVs were treated with nucleases. CATS
sRNA libraries were analysed for contribution of
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RNA classes. Statistics were corrected for multiple
comparisons; significance = corrected p < 0.01.
Results: Using CATS, miRNAs mapped at only a small %
of total sRNA reads; typically less than 1%. Nuclease-
treated sEVs had significantly lower relative miRNA
levels than cells or soluble releasate. tRNAs/fragments
had highest relative abundance in whole releasate and
soluble fractions, albeit with substantial variability.
Significantly different in most releasate fractions vs cells
were sno/scaRNA, mRNA, and lncRNA. Cellular distri-
bution differed only from lEV and sEV for RNU RNAs,
and only from sEV for Y RNAs. rRNAs/fragments did
not differ significantly. Medium-only process controls
had only a small per cent of human mapping.
Summary/Conclusion: miRNAs are found at lower
relative levels in cells and releasate than indicated by
legacy sequencing methods. miRNAs also tend to be
excluded from sEVs vs. cells or other releasate frac-
tions. While this study uses iPSCs, similar results
would likely be obtained with other cells. We do not
discount the role for miRNAs in cell-cell communica-
tion but suggest that sEVs may not be a vastly superior
source of miRNAs.
Funding: This work was supported by the US NIH:
NIA (AG057430), NIDA (DA040385 and DA047807)
and NIMH (MH118164).
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OT10.01
Different ATT isoforms are associated to EVs from ATT type II
deficient patients
Annalisa Radeghieria, Silvia Alacquab, Giuliana Martinic, Eugenio Montib and
Paolo Bergesed
aDepatment of Molecular and Translational Medicine and CSGI, Università
degli Studi di Brescia, ITALY, Brescia, Italy; bDepartment of Molecular and
Translational Medicine, Università degli Studi di Brescia, Brescia, Italy;
cSpedali Civili of Brescia, Clinical Chemistry Laboratory, Brescia, Italy;
dDepartment of Molecular and Translational Medicine and CSGI,
Università degli Studi di Brescia, Italy
Introduction: Antithrombin (AT) is a glycoprotein
involved in the regulation of blood coagulation. It
belongs to the family of serine-protease inhibitors and
acts as the most important antagonist of different clot-
ting factors. Two types of inherited AT deficiency can
be distinguished: Type I (quantitative deficit), and
Type II (qualitative deficit). The latter is characterized
by an impaired inhibitory activity related to dysfunc-
tional domains of the protein. Three Type II subtypes
can be defined: Type IIa (reactive site defect), Type IIb
(heparin binding site defect) and Type IIc (pleiotropic
defect). This classification has clinical importance since
these subtypes have a different thrombotic risk. No
functional routine diagnostic assay, however, can be
assumed to detect all forms of Type II deficiencies
since false-negative results may hamper the diagnosis.
Methods: We analysed the biochemical/biophysical
association of ATT to EVs. We separated EVs from
plasma of healthy or Type II affected patients or from
cultured hepatocytes through differential ultracentrifu-
gation followed by sucrose density gradient and/or
immunoprecipitation. We next combined dot blot ana-
lysis, WB, 2D electrophoresis and enzymatic assays to
reveal the nature of ATT association to EVs.
Results: We evidenced that ATT is associated to the
external leaflet of EVs. We also found that specific ATT
isoforms are enriched in EV preparations in respect to
total plasma and that those isoforms are selectively
associated to EVs when comparing healthy or ATT
type II deficient patients.
Summary/Conclusion: ATT selective association pat-
tern to EVs might be related either to mutations in the
primary sequence of the protein or alterations in the
glycosylation process, hence experiments are ongoing
to reveal the nature of this phenomenon. Our findings
suggest that analysis of ATT enriched in EV prepara-
tions might be useful to gain insights into the patho-
genesis and be of support in the diagnostic algorithm
of ATT deficiency.
Funding: This work acknowledges FFABR (Fondo
finanziamento attività Base di ricerca from MIUR,
Ministry of Education, Universities and Research,
Italy) for financial support.
OT10.02
Search for EV signature in sickle cell disease
Sisareuth Tana, Celine Gounoua, Marc Romanab, Stephane Mornetc, Alain R.
Brissond
aUMR-CBMN, Pessac, France; bUMR-1134 INSERM-Université Antilles-
Guyanne, Pointe à Pitre, France; cUMR-5026-ICMCB, Pessac, USA;
dUniversity of Bordeaux, Pessac, France
Introduction: Sickle cell disease (SCD) is a hereditary
haemoglobinopathy characterized by the production of
sickled red blood cells (RBC), anaemia and vascular
occlusion crises. The presence of extracellular vesicles
(EV) in blood from SCD patients has long been recog-
nized, yet with a large divergence of results (1). Our
objective was to characterize in details EV in plasma
from SCD patients, by combining flow cytometry and
immuno-gold cryo-electron microscopy (2,3). We
focused on two EV populations: 1) EV exposing phos-
phatidylserine (PS), because the increased exposure of
PS at the RBC surface is a hallmark of SCD (4), and 2)
exosomes exposing CD71 (CD71-Exo), because the
reticulocyte count is a marker of anaemia and CD71-
Exo are released during the maturation of reticulocytes
into erythrocytes (5).
Methods: Platelet-free plasma (PFP) was obtained from
11 SCD patients and 18 control individuals. Annexin-5,
anti-CD235a- and anti-CD71-IgGs, either fluorescently
labelled or conjugated to gold particles, were used to
detect PS+ EV, RBC-derived EV and CD71-Exo,
respectively, by flow cytometry and immuno-cryo-
EM (2,3).
Results: By flow cytometry, seven populations of RBC-
derived EV were identified in SCD plasma, based on
the presence vs. absence of PS, EV size and morphol-
ogy. The main difference between SCD and control
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PFP was the presence in SCD PFP of large amounts of
PS+ EV of small size (100 to 200 nm, as determined by
immuno-cryo-EM) (250,000 ± 20,000 / µL for SCD
PFP vs. 30,000 ± 10,000/µL for control PFP).
In addition, CD71-Exo were detected in SCD PFP by
immuno-cryo-EM, while they are almost absent in
control PFP. As expected, CD71-Exo were highly
homogeneous in size, ranging from 50 to100 nm.
Their concentration was determined by fluorescence-
triggered flow cytometry: 70,000 ± 40,000 / µL for SCD
PFP vs. 7,000 ± 5,000 / µL for control PFP.
Summary/Conclusion: We have identified two EV
populations present in large amounts in SCD plasma,
while they are almost absent in control plasma. Further
study is needed to evaluate the use of these EV as
biomarkers of the coagulation or endothelium activa-
tion states in SCD.
1. Hebbel & Key. Brit J. Haem 2016 174:16
2. Arraud et al., J. Thromb Haemost 2014 12:614
3. Arraud et al., Cytometry A. 2016 9:184
4. Chiu et al., Blood 1981 58:398
5. Harding et al., J. Cell Biol 1983 97:329
Funding: Labex GR-Ex
OT10.03
Surface protein cargo of extracellular vesicles in blood plasma; the
effect of an inflammatory disease on the vesicle surface protein
interactome
Eszter Á. Tóth, Katalin É. Szabó-Taylor, Tamas Visnovitz, György Nagy and
Edit I Buzás
Semmelweis University, Department of Genetics, Cell and Immunobiology,
Budapest, Hungary
Introduction: Extracellular vesicles (EVs) are endogen-
ous nanoparticles produced by cells. Artificial nanopar-
ticles used for targeted therapy have been found to
develop a protein corona altering their biodistribution
and bioavailability in biological media. Here we set the
aim to study if a similar protein corona is formed at the
surface of EVs in biofluids and if inflammation had an
effect on the protein corona formation.
Methods: Blood plasma depleted in both platelets and
EVs was generated from blood samples of healthy
subjects (n = 12) and rheumatoid arthritis patients
(n = 10). Nascent EVs of THP1 cells and platelets
were isolated and incubated in the plasma samples for
30 minutes. EVs were then washed and were studied by
mass spectrometry (MS/MS), immune electron micro-
scopy and flow cytometry. Controls included i) plasma
without the addition of EVs; ii) EVs incubated in
buffer. The effect of different protein coronas was
also studied by phagocytosis and TaqMan® assays.
Flow cytometry was also performed after saline wash-
ing and protease digestions. All experiments were per-
formed in accordance with the Declaration of Helsinki.
Infomed consent was obtained from all participants.
Results: A significantly higher number of proteins was
found in the plasma+EV samples compared with the
summed number of proteins found in the only plasma
and the only EV samples (p < 000.1). Subtracting the
proteins that were found in pure EV samples from the
list of proteins of EV samples incubated in plasma for
30 min and washed 2 times, a high number of proteins
were found, out of which several were more character-
istic of rheumatoid arthritis samples and only a few
were more prevalent in healthy samples. Interactions
between fibrinogen, haptoglobin, complement protein
C3. and EVs were also confirmed by flow cytometry
and immune electron microscopy.
Summary/Conclusion: Our data suggest the existence
of a protein corona on EVs of blood plasma. The
differences in protein coronas found between healthy
controls and patients with rheumatoid arthritis suggest
that EV surface-associated proteins may play a role in
disease pathology and may serve as biomarkers.
Funding: NKFIH-OTKA PD 104369; PD 112058;
111958; 120237, NVKP_16, MTA-SE Immun-
Proteogenomikai EV Kutatócsoport, VEKOP-2.3.2-16-
2017–000002, VEKOP-2.3.3-15-2017-00016 H2020
MSCA ITN TRAIN-EV, SE STIA-2017
OT10.04
Oxidized LDL stimulates production of inflammatory extracellular
vesicles by platelets
Maarit Neuvonena, Katariina Öörnib, Erja Kerkeläc, Kati Hyvärinenc, Saara
Laitinenc and Pia Siljanderd
aEV-Group, Faculty of Bio- and Environmental Sciences and Faculty of
Pharmacy, Helsinki, Finland; bWihuri Research Institute, Helsinki, Finland;
cFinnish Red Cross Blood Service, Helsinki, Finland; dEV-group, Molecular
and Integrative Biosciences Research Programme, Faculty of Biological and
Environmental Sciences, University of Helsinki, Helsinki, Finland
Introduction: Platelets may become activated under
hyperlipidemic conditions and are thought to promote
atherosclerotic plaque development. Platelets can gen-
erate a diverse mixture of extracellular vesicles (EVs)
when they are activated through different signalling
pathways. In this study, we investigated in detail the
EV-generating capacity of different lipoproteins and
compared the cellular effects of the resulting EVs on
macrophage differentiation.
Methods: Platelets (isolated by gel-filtration from fresh
concentrates) were stimulated by LDL, oxidized LDL or
HDL together with thrombin + collagen co-stimulus, a
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potent EV-inducing signal. After careful platelet
removal, EVs were isolated by serial ultracentrifuga-
tion. Platelet activation was monitored by P-selectin
exposure in flow cytometry. EVs were analysed by an
EV-dedicated high-resolution flow cytometer and
Western blotting, and quantified by protein concentra-
tion and particle number. Macrophage differentiation
was induced by GM-CSF in the presence or absence of
the different EVs. After 6 days, macrophages were
activated by IFN-γ and LPS, and after a further
3 days, the macrophages were profiled by flow cytome-
try and their secreted cytokines.
Results: Lipoproteins induced platelet EV production
in a concentration- and time-dependent manner at
concentration levels relevant to hyperlipidemic
conditions. Oxidized LDL increased EV formation by
platelets, whereas co-incubation with HDL inhibited
this effect. Platelet derived EVs modulated the macro-
phage differentiation as seen by the changes in their
pro-inflammatory cytokines and surface marker
profiles.
Summary/conclusion: In conclusion, hyperlipidemic
lipoprotein profiles in plasma can manifest in (1)
altered platelet EV generation which in turn (2) may
program macrophage differentiation in a manner rele-
vant for atherosclerotic plaque development.
Funding: Academy of Finland grant 287089, Finnish
Foundation for Cardiovascular Research
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Exosomes from cerebral endothelial cells suppress chemotherapy-
induced peripheral neuropathy and sensitize anti-tumour effects of
platinum drugs
Yi Zhanga, Zheng Gang Zhangb, Michael Choppc and Chao Lid
aHenry Ford Health System, Detroit, USA; bDepartment of Neurology, Henry
Ford Hospital, Detroit, MI, USA, Troy, USA; cDepartment of Neurology,
Henry Ford Health System, Detroit, MI, Department of Physics, Oakland
University, Rochester, MI, USA; dDepartment of Neurology, Henry Ford
Health System, Detroit, MI, USA
Introduction: Platinum-based drugs are commonly
used to treat cancers. However, peripheral neuropathy
is a common adverse effect of platinum-based che-
motherapy. Neurotoxicity often requires platinum
drug dose reduction thereby, compromising therapeu-
tic efficacy of platinum drugs to suppress tumour
progression.
Methods: Using differential ultracentrifugation, we iso-
lated exosomes from cultured human primary cerebral
endothelial cells (CEC-exos). Ovarian tumour was
induced in mice by implantation of human ovarian
cancer cells. Platinum-induced CIPN start from distal
axons. Thus, we examined the direct effect of platinum
drugs on distal axons of dorsal root ganglia (DRG)
neurons using a microfluidic device that separates dis-
tal axons from their parent cell bodies.
Results: We found that addition of oxaliplatin or car-
boplatin into the axonal compartment significantly
suppressed axonal elongation, whereas application of
CEC-exos into the axonal compartment completely
abolished oxaliplatin-inhibited axonal growth. In vivo,
treatment of tumour-bearing mice with platinum drugs
(n = 7/group) induced CIPN characterized by tactile
and cold allodynia, reduction of sensory nerve conduc-
tion velocity, and decreases of the number of epidermal
nerve fibres compared to the control mice (n = 7/
group). However, tumour-bearing mice treated with
platinum drugs along with CEC-exos (n = 7/group)
exhibited a significant reduction of platinum-drug
induced peripheral neuropathy. Moreover, CEC-exos
in combination with platinum drugs significantly
decreased tumour size by 80–91% compared to plati-
num drugs alone which reduced tumour growth only
by 50–72%. In sciatic nerve tissues, CEC-exos in com-
bination with platinum drugs significantly increased
miR-15b, −26a, and −214, and substantially reduced
axonal damage protein levels of PTEN, SARM1, and
TRPV1. In tumour tissues, the combination treatment
significantly increased miR-15b and −26a, and reduced
their target chemoresistant protein levels of P-gp and
ABCC1.
Summary/Conclusion: Our data demonstrate that
CEC-exos reduce CIPN by reversing the platinum-
inactivated neuroprotective network and that CEC-
exos suppress a chemoresistant network of miRNAs/
protein-coding genes to enhance the anti-tumour effect
of platinum drugs.
Funding: NIH R01CA219829; NIH R01NS088656;
AHA 16SDG29860003.
OF11.02
EV-mediated in vitro transcribed (IVT) mRNA-based gene delivery for
specific pro-drug activation in the tumour treats breast cancer in mice
with no offsite toxicity
Alexis Forterrea, Jing-Hung Wanga, Alain Delcayreb, Kyuri Kimc, Carol
Greenc, Mark Pegramd, Stefanie Jeffreye and Ac Matinf
aDepartment of Microbiology & Immunology, Stanford University School of
Medicine, Stanford, USA; bExoThera LLC, Menlo Park, USA; cSRI
Biosciences, Menlo Park, USA; dDepartments of Medicine and Oncology,
Stanford University School of Medicine, Stanford, USA; eDepartment of
Surgery, Stanford University School of Medicine, Stanford, USA;
fDepartment of Microbiology & Immunology Stanford University School of
Medicine, Stanford, USA
Introduction: We previously reported EV-mediated
specific delivery of a gene (as mRNA) encoding the
HChrR6 enzyme to orthotopically implanted HER2+
breast cancer tumours in mice. HChrR6 activated the
pro-drug CNOB and completely inhibited tumour
growth. EVs and CNOB were delivered systemically.
A new plasmid loaded the EVs with the mRNA; they
displayed the EVHB protein containing anti-HER2
scFv (“PEVs”). However, no direct evidence was pre-
sented that the treatment was free of off-target toxicity.
Here, three aspects, relevant to clinical transfer of the
regimen, are explored: IVT- instead of plasmid-based
mRNA loading; use of the pro-drug CB1954 whose safe
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dose in humans is known (HChrR6 also activates
CB1954); haematological and histopathologic studies
to detect off-target toxicity.
Methods: Exogenous mRNA delivery using exosomes
is difficult because of its fragmentation. To ensure the
mRNA integrity (at synthesis, loading, and delivery),
we used the “MCHB” test. MCHB is the product of
CNOB activation and is strongly fluorescent, providing
a facile method to test this. The mRNA was transcribed
in vitro from the HChrR6 gene (standard kits) and was
tested by translating it into the enzyme and ascertain-
ing the enzyme’s ability to produce fluorescence upon
CNOB addition. mRNA copy number in the EVs and
the recipient cells was determined by qRT-PCR. The
loaded EVs were HER2 targeted as above, using EVHB
(“IEVs”). HER2+ BT474 breast cancer tumours were
orthotopically implanted in mice.
Results: While 5,000 PEVs were needed to deliver one
copy of the mRNA, <50 IEVs delivered this. BT474 cells
transfected in vitro with IEVs showed significantly higher
mRNA expression than those transfected with PEVs.
Expression of the latter peaked at ca. 72 h; of the former
continued throughout the length of the experiment
(120 h). We found that CB1954 (20 mg/kg) completely
arrested tumour growth with 220-fold fewer IEVs (3.4 x
10^8) than PEVs; experiments in progress suggest that
even lower IEVs may be sufficient. Extensive haematolo-
gical and histopathologic studies showed no significant
toxicity.
Summary/Conclusion: IEV + CB1954 therapy comple-
tely arrests tumour growth at a much lower IEV dose
and without introducing potentially harmful plasmid
DNA and off-target toxicity. The findings move this
approach closer to clinical transfer.
Funding: NIH NCATS UH3TR000902.
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High yield hMSC derived mechanically induced xenografted
extracellular vesicles are well tolerated and induce potent
regenerative effect in vivo in local or IV injection in a model of
chronic heart failure
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Introduction: On the road towards the use of extra-
cellular vesicles (EVs) for regenerative medicine, tech-
nological hurdles remain unsolved: high-yield, high
purity and cost-effective production of EVs.
Methods: Pursuing the analogy with shear-stress
induced EV release in blood, we are developing a
mechanical-stress EV triggering cell culture approach
in scalable and GMP-compliant bioreactors for cost-
effective and high yield EV production. The third gen-
eration setup allows the production of up to 300,000
EVs per Mesenchymal Stem Cell, a 100-fold increase
compared to classical methods, i.e physiological spon-
taneous release in depleted media (around 2000 EVs/
cell), with a high purity ratio 1 × 10e10 p/µg
Results: We investigated in vitro the regenerative poten-
tial of high yield mechanically induced MSC-EVs by
demonstrating an equal or increased efficiency compared
to classical EVs with the same amount of EVs. The
regenerative properties of mechanically induced MSC-
EVs was confirmed in vivo in a murine model of chronic
heart failure demonstrating that high, medium shear
stress EVs and serum starvation EVs or mMSCs had the
same effect using local injection. We later on tested the
effect of the injection route and the use of xenogenic
hMSC-EVs on their efficiency in the same model of
murine chronic heart failure. Heart functional para-
meters were analysed by ultrasound 2 months (1 month
post EV injection) post infarction. Interestingly, hMSC-
EVs had the same effect compared tomMSC-EVs in local
injection, showing that xeno-EVs in immunocompetent
mices was well tolerated. Moreover, hMSC EV IV injec-
tion was as efficient as local intra-myocardium muscle
injection with an increase in the left ventricular ejection
fraction of 26% compared to pre-treatment values,
whereas PBS injected controls lost 13%.
Summary/Conclusion: We demonstrated an equal or
superior regenerative effect of high yield mechanically
produced EVs compared to spontaneously released
EVs or parental cells in vitro and in vivo, and good
tolerance and efficacy of hMSC EV both with local and
IV injection. This unique technology for EV produc-
tion combines decisive assets for clinical translation of
EV-based regenerative medicine : a GMP-compliant
setup, high density cell culture, high yield release of
EVs per cell, high purity EVs.
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Introduction: Achieving robust and durable host
immune tolerance of allogeneic transplants is the ulti-
mate goal in clinical transplantation. Mixed chimerism
induced via donor bone marrow transplantation and
host non-myeloablative conditioning has reliably
achieved tolerance of allogeneic organ transplants in
mice and humans. Tolerance in this model is believed
to rely essentially on the presentation of donor MHC
molecules in the host’s thymus. In this study, we inves-
tigated whether donor MHC chimerism could be
achieved via donor extracellular vesicles (EVs) injec-
tions and subsequent cross-dressing of recipient cells in
the host’s thymus.
Methods: Conditioned SJL (CD45.1+, H2-Ks+) recipi-
ent mice received a single IV dose of purified bone
marrow derived exosome-enriched EVs (BM-EVs) iso-
lated from C57BL/6 (CD45.2+, H2-Kb+) donors
through sequential centrifugation or using a commer-
cially available exosome isolation kit. Nanoparticle
tracking showed vesicles of approximately 100nm in
size in the BM-EVs preparation and Western Blot
showed the presence of MHCI. Image flow cytometry
was used to detect the presence of cross-dressed cells
from day 10 through 100 after exosome injection. For
NHP studies, MHC class I H38+ BM-EVs were
injected into a H38- conditioned cynomolgus macaque
prior to a combined heart and kidney transplant.
PBMCs, thymus, spleen and mesenteric lymph nodes
were collected for image flow cytometry.
Results: Intravenous injection of BM-EVs into condi-
tioned mice resulted in the presentation of donor MHC
and CD45.1 molecules by host’s thymic and splenic
cells. Similarly, H38+cross-dressed cells were detected
at D33 after exosome injection in all of the NHP
recipient tissues collected. In mice, donor but not syn-
geneic or third-party BM-EVs significantly prolonged
skin allograft survival (median survival = 17 VS
11 days, p < 0.001).
Summary/Conclusion: These results show that deliv-
ery of donor-derived extracellular vesicles can induce
donor MHC chimerism via cross-dressing of recipient
APCs with allogeneic MHC molecules in the host’s
thymus. This suggests that donor EVs could be used
in place of bone marrow cells to induce chimerism and
allograft survival with minimal conditioning and no
risk of graft versus host disease (GVHD).
Funding: NIH R01DK115618.
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Introduction: The potential of utilizing exosomes
(endosomal derived vesicles) as a therapeutic delivery
system of biological and chemical drugs are an active
area of clinical phase investigation. However, the field
is currently facing challenges such as the insufficient
release of exosomes, their heterogeneity and reprodu-
cibility of isolation. These issues may be overcome
through the development of artificial extracellular
vesicles (EVs). Cell-derived mimetic nanovesicles
(M-NVs) can be generated from numerous cell lines
with advantages such as, reproducibility, large scale
production, uniformity, cost effectiveness and a sim-
ple purification method. Although several studies
have shown that M-NVs have similar morphology,
size and therapeutic potential to exosomes, compre-
hensive characterization and to what extent these
artificial EV components mimics exosomes remain
elusive.
Methods: In this study, M-NVs generated by subject-
ing cells to the extrusion, were comprehensively char-
acterized and compared to the exosomes by proteomic
and transcriptomic analysis.
Results: We analysed the proteome between M-NVs
and exosomes to provide key insights into key mem-
brane surface features of exosomes for cargo sorting
and therapeutics delivery are preserved in M-NVs (158
proteins). Furthermore, our study highlighted differ-
ences in protein post-translational modifications
among M-NVs, as distinct from exosomes, using a
non-targeted informatic approach, specifically showing
phosphorylation, ubiquitination, and thiophosphoryla-
tion as enriched protein modifications in M-NVs.
Small RNA analysis reveals that unlike exosomes, the
RNA cargo of M-NVs is similar to that of the parental
cells. In addition, we found that M-NVs could be useful
for packaging proteins or RNA which are globally
enriched in cells. Indeed, this may overcome the chal-
lenges involved in selective packaging of therapeutic
proteins or RNAs into exosomes.
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Summary/Conclusion: In summary, results from this
study provides key insights into omics of M-NVs cargo
in comparison to exosomes and ultimately its potential
as therapeutic delivery system.
Funding: Grants from the Australian Research
Council, Lundbeck Foundation and the Danish
National Mass Spectrometry Platform for Functional
Proteomics.
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Introduction: Periodontal ligament-derived mesench-
ymal stromal cells (PDL-MSCs) represent an attractive
source of cells for regenerative medicine due to four
reasons; 1) similarly to other MSCs, they exhibit pro-
regenerative properties, 2) accessibility is great due to
abundance of extracted teeth, 3) they can easily be
expanded and 4) they can be used in an allogeneic
fashion. We are currently investigating the use of
sheets produced from these cells to regenerate period-
ontal tissue. In this study we aimed to investigate the
potential of exosomes from human PDL-MSCs to sti-
mulate wound healing.
Methods: We used ultrafiltration and size-exclusion
chromatography to isolate vesicles from serum-free
conditioned media. BCA-assay and nanoparticle track-
ing analysis (NTA) was used to determine yield. We
performed Western Blot for positive and negative
extracellular vesicle-markers, and transmission electron
microscopy was used to evaluate morphology. We then
performed wound healing assay in immunocompetent
rats. Each rat received two full-thickness wounds, trea-
ted with either topical application or perilesional injec-
tions, and PBS was used in control rats. The animal
weights were measured and wounds were photo-
graphed every other day. The animals were sacrificed
on day 7 and the tissue was collected for histopatholo-
gical analysis.
Results: Exosome yield was on average 0.83 µg proteins
per million cells per 24 h. The exosomes had a mean
size of 130 nm, showed positivity for CD9 and
Flotillin-1 and negativity for GRP94 and had a spheri-
cal morphology. The exosomes were applied to wounds
and rats receiving exosomes gained significantly more
weight than controls. Topical application proved to be
superior to injections based on macroscopic wound
evaluation and histopathology.
Summary/Conclusion: PDL-MSC-derived exosomes
stimulate wound healing in a xenogeneic setting and
topical application is superior to local injections.
Funding: This work was supported by The Swedish
Society of Medicine, Erik och Edith Fernströms stiftelse
för medicinsk forskning, Misao-Yanagihara-Grant for
regenerative medicine research and JSPS KAKENHI
Grant Number JP18H02985.
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Introduction: Peritoneal dialysis (PD) is considered
the best renal replacement therapy for patients waiting
for a kidney transplant. Many patients eventually suffer
ultrafiltration failure of the peritoneal membrane (PM),
leading to severe clinical complications and the urgent
need to change the dialysis technique. Currently, PM
functionality is monitored by the peritoneal equilibra-
tion test (PET), a tedious technique that only shows
changes when the PM damage is advanced. We
hypothesized that peritoneal dialysis efflux (PDE)-
extracellular vesicles (EV) may contain biomarkers of
PM state. In a previous study (Carreras-Planella, et al.,
PLoS One 2017), we showed for the first time that
PDE-EVs could be isolated and their protein content
showed differences between newly enrolled and long
term PD patients. Here, we present the results of a
longitudinal study in a new cohort of PD patients.
Methods: PDE was collected from 12 PD patients every
6 months (coincident with PET controls) up to
24 months follow up. PDE-EV were isolated by size-
exclusion chromatography and characterized by
expression of classical tetraspanin EV markers. EV
proteome was analysed by Mass Spectrometry (LC-
MS/MS).
Results: In accordance with our previous study, PDE-
EV proteome showed reduced expression of several
proteins at longer timer points (>12 months) of treat-
ment. In addition, statistical analysis revealed confi-
dently identified proteins – potentially involved in
fibrotic processes – that are significantly deregulated
in patients showing alterations in PET monitoring at
12 months of treatment.
Summary/Conclusion: Our results confirm the poten-
tial of analysing PDE-EV as biomarkers of PM altera-
tion allowing improved monitoring of PD patients
compared to PET.
Funding: The IGTP is member of the CERCA network
of institutes. LCP is sponsored by the FPU scholarship
(FPU17/01444) from the Ministerio de Ciencia,
Innovación y Universidades of the Spanish
Government. MF is sponsored by the PERIS contract
SLT002/16/00069, from the Generalitat de Catalunya.
F.E.B. is a researcher from Fundació Institut de Recerca
en Ciències de la Salut Germans Trias i Pujol sup-
ported by the Health Department of the Catalan
Government (Generalitat de Catalunya).
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Introduction: Prostate cancer (PCa) is the most com-
mon cancer in men and can be detected early through
screening of asymptomatic men. Most prostate cancers
are indolent at time of diagnosis and current prognos-
tic protocols do not accurately predict disease aggres-
sion and clinical outcome, which limits optimal patient
management. For example, high serum prostate-speci-
fic antigen (PSA) levels could be indicative of meta-
static cancer or benign prostatic conditions, while
needle biopsies are invasive and can undersample the
prostate, resulting in uncertainty of cancer grading. We
hypothesize that small extracellular vesicles (sEVs) iso-
lated from post-digital rectal exam urine (pDRE-urine)
contain protein biomarkers will allow for non-invasive
PCa risk stratification.
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Methods: We have performed deep proteomics analy-
sis on pDRE-urine-derived sEVs from 105 treatment-
naïve, richly annotated patients (age, T-stage, Gleason
score, PSA, etc.). sEVs were isolated by differential
ultracentrifugation and processed for proteomics (LC-
MS). Size and morphology of sEVs were verified by
nanoparticle tracking analysis and TEM.
Results: We detected 3,688 proteins in sEVs, 80% of
which are shared with the prostate cancer tissue pro-
teome (unpublished). sEV proteins were enriched in
cytoplasmic and membrane proteins and depleted in
nuclear proteins. Interestingly, sEVs were also enriched
for prostate-specific proteins compared to the pro-
teome of urine that was analysed in parallel, suggesting
enrichment for low-abundance tissue-originating pro-
tein cargo in sEVs. Samples clustered into three groups
based on global protein expression, suggesting that
there may be subtypes of sEVs within pDRE-urine.
Summary/Conclusion: We are currently applying
machine learning approaches to identify biomarkers
that could supplement current diagnostic tests and
improve stratification of patient risk groups. In the
future, we will confirm differential protein expression
by targeted proteomics assays using an active surveil-
lance cohort and perform parallel profiling of sEV
RNA cargo. Ethics approval at University Health
Network.
Funding: National Cancer Institute-Early Detection
Research Network.
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Introduction: It was recently reported that plasma
neuronal-enriched extracellular vesicles (EVs) of
Alzheimer’s disease (AD) patients exhibit elevated
levels of phosphorylated tau, Aβ42, and phosphory-
lated insulin receptor substrate-1 (IRS1). To validate
them as AD predictors, we interrogated preclinical
samples from Baltimore Longitudinal Study of Ageing
participants.
Methods: We blindly analysed 931 longitudinal plasma
samples from 138 cognitively normal participants who
eventually developed AD (cases) and 233 age and sex-
matched Controls who remained cognitively normal.
The earliest samples preceded AD symptom onset by a
median of 4.1 years. We precipitated total particles
using Exoquick and then immunoprecipitated neuro-
nal-enriched EVs using antibody against neuronal cell
adhesion molecule L1CAM. We lysed isolated EVs and
quantified proteins by immunoassays. We adjusted
values for EV concentration and diameter to normalize
for EV yield. We compared cross-sectional and long-
itudinal trajectories of EV biomarkers between future
AD and Control participants and performed stepwise
logistic regression with internal cross-validation and
receiver operating characteristic analysis to assess the
ability of EV biomarkers to discriminate future AD
cases from Controls.
Results: Future AD cases had cross-sectionally and
longitudinally higher p181-Tau, p231-Tau, pSer312-
IRS1, pY-IRS1 and EV diameter than Controls but
similar Aβ42, total Tau, TSG101 and EV concentration.
A model optimally combining longitudinal data for
multiple biomarkers achieved 90.2% sensitivity (95%
confidence interval [CI], 81.2–95.4%), 83% specificity
(95% CI, 76–88%) and 91.6% area under-curve (95%
CI, 87.9–95.4%) for predicting AD. Preclinical levels of
several EV biomarkers were associated with cognitive
performance.
Summary/Conclusion: We validated several neuronal-
enriched EV biomarker candidates and further demon-
strated that their preclinical longitudinal trajectories
predict AD diagnosis with high sensitivity. These
findings motivate further development of EV biomar-
kers towards a clinical blood test for AD.
Funding: This research was supported entirely by the
Intramural research Program of the NIH, National
institute on Aging
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Introduction: Extracellular vesicles (EVs) represent
important mediators of cell-cell communication and
are secreted by many types of cells, including tumour
cells, into the extracellular milieu. Tumour-derived
EVs hold a lot of promise for non-invasive diagnostic
tests, also known as liquid biopsy, because they are
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present in all kind of biological fluids and carry a large
variety of proteomic and genetic information. There is
now an ever-growing need for new specific biomarkers,
which allow for the isolation of distinct EV subclasses
in order to improve EV-based diagnostics. We show
for the first time that CD315 (also known as PTGFRN,
EWI-F or CD9P-1) may represent a new potential
biomarker for tumour-derived EVs.
Methods: The expression of CD315 was studied in cell
lines, primary tumour samples and corresponding EVs.
CRISPR/Cas9 CD315 knockout cells were used to
investigate the impact of CD315 on cell proliferation
and EV secretion. Furthermore, we generated a
CD315-specific monoclonal antibody to elucidate the
diagnostic potential of CD315+EVs in blood samples of
cancer patients.
Results: We demonstrated that CD315 is highly
expressed on a large variety of tumour cells and is
present on the surface of tumour-derived EVs. In
vitro knockout of CD315 hampered proliferation and
migration of tumour cells and affected cellular EV
production. Moreover, our CD315-specific antibody
was successfully used to capture and isolate CD315
+EVs by immunoaffinity.
Summary/Conclusion: We identified CD315 as a pro-
mising new biomarker with diagnostic potential.
Although its specific function still remains to be eluci-
dated, we were the first to show that CD315 is highly
abundant in tumour-derived EVs. Additionally, we
generated a CD315-specific antibody as a valuable
tool for immunoisolation of distinct EV subclasses.
OF12.05
Analysis of urinary extracellular vesicles auto fluorescence in imaging
flow cytometry and spectral flow cytometry.
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Introduction: Urinary extracellular vesicles (uEVs)
provide a source of valuable biomarkers for kidney
and urogenital diseases. Analysis of uEVs in imaging
flow cytometry is challenging for its intrinsic natural
auto fluorescence emission across the whole electro-
magnetic spectrum. To date it is not known what the
rate of the autofluorescence interference is with respect
to the detection of specific marker uEVs markers
Methods: First morning void urine and citrate blood
from the same donor were centrifuged at 4,600 g for 30
and 15 min, respectively. The supernatant was centri-
fuge at 20,000g to collect urinary (uEVs) and plasma
(pEVs) which were stained with the same commercial
clone antibody (3D3) anti podocalyxin (PODXL) con-
jugated with 3 different fluorescent dyes: Alexa Fluor®
405 (AF405), Alexa Fluor® 488 (AF488) and Alexa
Fluor® 647 (AF647). Stained EVs were acquired with
both imaging flow cytometry and spectral flow cyto-
metry. Gate strategy was based on the low scatter of the
unstained uEVs and the negative control was the fluor-
escent probe alone in buffer.
Results: Acquisition of uEVs alone showed auto-fluor-
escence emission in channel 2 (λex 488 nm; λem 480–
560 nm) camera 1 and channel 11 (λex 658 nm; λem
660–740 nm) but not channel 7 (λex 405 nm; λem 420–
505 nm) for camera 2 for the imaging flow cytometry
meanwhile the spectral flow cytometry revealed a spec-
tral fingerprint spanning from the violet to the red
emission. Autofluorescence was detected for uEVs but
not pEVs. Podocalyxin-AF405 conjugated stained both
uEVs and pEVs with a double staining for the auto-
fluorescence and PODXL on the same uEV. While
PODXL-AF488 and AF647 stained pEVs both the anti-
body conjugated failed to detect the uEVs as per
PODXL-AF405. Same results were obtained for both
flow cytometry instruments.
Summary/Conclusion: While imaging flow cytometry
represent a major advancement in the identification of
uEVs, our results showed an unexpected additional
complication of the analysis originated from the auto-
fluorescence of the uEVs fraction. In fact, The auto-
fluorescence quenched the emission of PODXL-AF488
and AF647 but not AF405. uEVs auto-fluorescence
needs to be taken into account especially when simul-
taneous co-detection of uEVs markers of podocyte
origin is planned with particular emphasis on the cri-
tical selection of the antibody conjugated fluores-
cent dye.
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Introduction: The ability to isolate extracellular vesi-
cles (EVs) from blood is paramount in the develop-
ment of EVs as disease biomarkers. However, this is
complicated by the profuse presence of plasma proteins
and lipoprotein particles, making blood one of most
difficult body fluids to isolate EVs from. We have
previously developed a method to isolate EVs from
blood with minimal contamination of lipoprotein par-
ticles (Karimi et al 2018). The aim of this study was to
compare the amount of EVs and their protein cargo
isolated from plasma and serum.
Methods: Blood was collected from healthy subjects,
from which plasma and serum were isolated. EVs were
isolated using a combination of density cushion and
size exclusion chromatography (SEC). Purity and yield
of EVs were determined by nanoparticle tracking ana-
lysis (NTA), Western blot, electron microscopy (EM),
and mass spectrometry (LC-MS/MS). Additionally,
Cy7-labelled cell line-derived EVs were spiked in to
blood prior to isolation of plasma and serum to com-
pare the recovery.
Results: As determined by NTA and protein measure-
ment more EVs could be isolated from plasma. This
result was supported by experiments were labelled EVs
were spiked in to blood, which demonstrated that less
labelled EVs could be retrieved from serum compared
to plasma. Enough plasma EVs could be isolated for
proteomic analysis from 12 ml blood, which was not
possible for serum-derived EVs from the same amount
of blood. When larger amount of serum and plasma
was used as starting material 1789 proteins could be
identified in plasma-derived EVs, while only 628 pro-
teins could be identified in serum-derived EVs. Both
proteomes were strongly associated with the GO term
“Extracellular exosome”, while the serum derived EVs
were more associated with “Complement activation”.
Summary/Conclusion: This study shows that a larger
amount of EVs could be isolated from plasma com-
pared to serum. We currently don’t have the explana-
tion why this is so, however it might be due to the fact
that EVs get trapped in the clot during serum forma-
tion. Future studies are needed to answer how this
affects the use of blood-derived EVs as biomarkers
from serum and plasma.
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Introduction: Acute Myeloid Leukaemia (AML) is a
hematopoietic cancer that arises from mutations in
hematopoietic stem cells (HSC). Genomewide sequen-
cing has revealed that patients harbour multiple leu-
kaemic clones operating in dynamic succession.
Molecular abnormalities have also been uncovered in
phenotypically normal residual HSC from AML
patients. Independently, several groups showed
enforced quiescence in residual long-term (LT-) HSC
in the AML microenvironment. Neither observation is
fully understood.
Methods: Our previous studies in AML xenografts
showed that extracellular vesicles (EV) contribute to
the erosion of hematopoietic progenitor function.
Here we hypothesized that AML EV may similarly
shape fate and function of residual HSC in the AML
niche. We used a combination of in vivo, ex vivo and
in vitro approaches and utilizing both AML cell lines
and primary AML patient cells.
Results: We confirmed the relative enrichment of resi-
dual HSC in the BM due to gains in quiescence even at
low leukaemic burden, or following AML EV injec-
tions. We also observed in vivo AML-EV trafficking
to LT-HSC associated with p53 hyperphosphorylation,
but not apoptosis or senescence. Next, a proteomic
screen of EV-exposed HSPC identified the systematic
suppression of ribosome biogenesis as the most highly
enriched Gene Ontology category. The mTOR pathway
governs ribosome biogenesis and protein synthesis, and
we went on to show that AML-EV trafficking of micro
RNA-1246 targets Raptor, a pathway component.
Translational suppression of Raptor In turn caused
ribosomal protein S6 hypo-phosphorylation and sup-
pressed protein synthesis. Quiescent HSC are known to
rely on error prone mechanisms of DNA repair, and
we demonstrate that residual HSC accrue DNA
damage, gain replating competency and show increased
in vivo repopulation.
Summary/Conclusion: Altogether, our studies suggest
that EV miRNA dysregulate proteostasis and confer
HSC quiescence in the AML BM. We uncover evidence
of long-lasting DNA damage in residual LT-HSC via
AML EV.
Funding: Institutional,; Hyundai Hope on Wheels
Foundation.
OF13.02
Extracellular vesicles contribute to the development of ionizing
radiation-induced late bone marrow pathologies
Dávid Kisa, Rita Hargitaib, Nikolett Sándora, Eszter Persaa, Tünde Szatmárib,
Enikő Kisa, Géza Sáfrányb and Katalin Lumniczkyb
aNational Public Health Center, Budapest, Hungary; bNational Public Health
Center, Division of Radiobiology and Radiohygiene, Department of Radiation
Medicine, Budapest, Hungary
Introduction: Bone marrow (BM) is a particularly
radiosensitive organ; haematological malignancies,
myelodysplastic syndrome and chronic bone marrow
insufficiency are considered long-term consequences of
bone marrow irradiation. Ionizing radiation (IR)
damages the stem and progenitor cells and alters sig-
nalling between the stem cell compartment and the BM
stroma. The major objective of our work was to inves-
tigate extracellular vesicles (EVs) mediated IR effects in
the BM and stroma at low and high irradiation doses
and to study possible underlying mechanisms using an
in vivo murine model.
Methods: C57Bl/6 mice were irradiated with 0.1 Gy or
2 Gy and EVs isolated from the BM supernatant were
injected systemically into naive animals. EV-mediated
phenotypical changes were determined by flow cyto-
metry in the stem and progenitor cell compartment
and in the BM stroma. Apoptosis in various cellular
subpopulations was measured by Tunnel assay, DNA
damage by immunostaining using the γH2AX assay,
senescence by β-gal staining. Oxidative damage was
evaluated in the BM cells by measuring protein oxida-
tion and lipid peroxidation and systemically by deter-
mining the level of 8-hydroxy-2’ -deoxyguanosine in
the urine.
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Results: Treatment of naïve mice with BM-derived EVs
from irradiated animals induced apoptosis in certain
cellular subpopulations, led to local and systemic oxi-
dative damage, decreased the number of haematopoie-
tic and mesenchymal stem cells and of lymphoid
progenitors, changed the ratio between the long term
and short term stem cells, increased systemic release of
immature progenitors into the circulation. Stroma was
less affected; endothelial cells were the most sensitive.
Summary/Conclusion: BM-derived EVs mediated IR-
induced damage in the bone marrow and stroma,
which raise the role of BM-derived EVs in the devel-
opment of IR-induced late BM pathologies.
Funding: Euratom research and training programme
2014–2018 under grant agreement No 662287
(CONCERT)
OF13.03
Myeloid derived extracellular vesicular WNT induces rectal stem cell
regeneration
Payel Bhanjaa, Felipe Rodrigueza, Giselle Sanchez Guerreroa and Subhrajit
Sahab
aKUMC, Kansas City, USA; bDepartment of Radiation Oncology, University
of Kansas Medical Center, Kansas City, USA
Introduction: Rectal epithelial injury is the major lim-
iting factor for pelvic radiotherapy. Activation of
regenerative response of rectal stem cells (RSCs) is
critical to mitigate radiation injury. Wnt β catenin
signalling plays a critical role in homeostasis and
regeneration of intestinal stem cell (ISC). Both epithe-
lium and stroma are the major source of WNT ligands.
Intestinal stroma consists of several cell types including
mesenchymal cells and myeloid/macrophages (Mφ).
Genetic or pharmacological inhibition of WNT release
from mesenchymal stromal cells did not affect the ISC
homeostasis or regeneration. In the present study we
have examined the effect of Mφ derived extracellular
vesicle (EV) packaged WNT in homeostasis and repair
of RSCs.
Methods: Csf1r.iCre;Porcnfl/fl mice deficient in Mφ
derived WNT due to Mφ-restricted ablation of
Porcupine, a gene essential for WNT synthesis were
used to determine effect of Mφ derived in EV-WNT in
RSC homeostasis and regeneration. Mice were exposed
to lethal dose of pelvic irradiation (PIR) (18Gy) to
deplete RSCs and therefore evaluate the regenerative
response following treatment with Mφ derived EV
packaged WNT. Effect of Mφ-EV WNT on RSCs
were also examined in ex-vivo rectal organoid system
developed from Lgr5/GFP-IRES-Cre-ERT2 knock-in
for visualization and quantification of Lgr5+ve RSCs.
Results: Histopathological analysis of Csf1r.iCre;
Porcnfl/fl mice rectum demonstrated no differences in
epithelial morphology compared to wild type mice.
However, exposure to PIR which depletes all RSCs
demonstrated higher radio-sensitivity and significant
damage in rectum epithelium in Csf1r.iCre;Porcnfl/fl
mice compared to wild type mice. EV purified from
Mφ conditioned medium demonstrated presence of
functionally active WNT ligands and improve regen-
erative capacity of RSCs in both human and mice rectal
organoid model ex-vivo. Treatment with Mφ condi-
tioned medium containing EV promote regenerative
capacity of Lgr5+ ve RSCs in Lgr5/GFP-IRES-Cre-
ERT2 knock-in mice exposed to PIR. However, treat-
ment with EV depleted condition medium failed to
rescue RSCs against irradiation.
Summary/Conclusion: Homeostasis of rectal epithe-
lium is not dependent on Mφ derived EV packaged
WNT. However, Mφ derived EV packaged WNT is
critical for regenerative response of RSCs against
injury.
OF13.04
Glycome analysis of extracellular vesicles derived from stem cells
using lectin microarray
Sayoko Saito, Keiko Hiemori, Kayo Kiyoi and Hiroaki Tateno
National Institute of Advanced Industrial Science and Technology, Tsukuba,
Japan
Introduction: In addition to proteins, nucleic acids
and lipids, extracellular vesicles (EVs) are also com-
posed of glycans. EV glycome may provide vital clues
for a better understanding the biogenesis, release and
transfer of vesicles. However, little is known regarding
glycans on EVs. Do glycans on EVs change depending
on cell types and cellular conditions? More specifically,
do stem cell-derived EVs carry stem cell glycan mar-
kers? Such basic questions remain unclear.
Methods: Here, we performed glycome analysis of EVs
derived from stem cells including human induced plur-
ipotent stem cells (hiPSCs) and human messenchymal
stem cells (hMSCs) using high-density lectin microar-
ray and flow cytometry.
Results: Detailed analysis of the results obtained by
lectin microarray and flow cytometry revealed that
hiPSC-derived EVs carry characteristic features of cell
surface glycans. rBC2LCN, a specific lectin for hPSCs,
bound to hiPSC-derived EVs, but not to non-hiPSC-
derived EVs. One of the glycoprotein ligands of
rBC2LCN on EVs was identified as podocalyxin,
which is a cell surface glycoprotein ligand of
rBC2LCN. Other hiPSC surface glycan markers were
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also detected on the surface of EVs. Finally, we devel-
oped a sandwich assay to specifically detect hiPSC-
derived EVs using rBC2LCN and Tim4, which binds
to phosphatidylserine (PS). rBC2LCN is useful for the
specific detection of hiPSC-derived EVs.
Summary/Conclusion: The EV glycome reflects its
cellular origin, which could be a novel target for the
development of the quality control system of stem cells
used for regenerative medicine.
Funding: JST CREST
OF13.05
Exosomes derived from human MSC mediate monocyte mobilization
to orchestrate neovascularization in radiation-induced skin injury
Alexandre Ribaulta, Bruno Lhommea, Celine Loinarda, Marc Benderittera,
Stephane Flamanta, Ruenn Chai Laib, Sai Kiang Limc and Radia Tamarata
aIRSN, Paris, France; bIMB ASTAR, Singapore, USA; cInstitute of Medical
Biology, Agency for Science, Technology and Research, Singapore, Singapore
Introduction: Emerging evidences indicate that extra-
cellular membrane vesicles, such as exosomes, could
recapitulate the therapeutic effects of huMSC. Of
note, exosomes displayed marked pro-angiogenic activ-
ity, however a better understanding of their underlying
mechanisms of action remained to be defined. This
study aims to investigate the mechanisms governing
the pro-angiogenic effects of huMSC derived exosomes
(huMSC-Exo) in a mouse model of radiation-induced
musculo-cutaneous injury.
Methods: Mice lower limb was exposed to 80Gy X-ray
irradiation to induce radiation injury. After 14 days, mice
received an intramuscular injection of 106 human MSCs,
400 µg MSC-EXO, or PBS. Angiogenesis was estimated
by skin perfusion (laser Doppler imaging), immunohis-
tochemistry (CD 31 endothelial marker) and microangio-
graphy (barium sulphate). Mice were sacrificed at several
time points, and tissues of both irradiated and contral-
ateral limbs were harvested for histological and biochem-
ical analyses. Bone marrow, spleen and blood were
collected for analysis of inflammatory cells and circulating
factors. In vitro assays were used to validate the pro
angiogenic effet of HuMSC- exo.
Results: The huMSC-Exo stimulated vascular growth
as revealed by the increase in cutaneous blood perfu-
sion, capillary density and angiographic score with
stimulation of pro-angiogenic factor levels such as
VEGF-A and eNOS. In vitro, huMSC-Exo fostered
endothelial cells and fibroblast migration in a PI3K/
AKT and TGF-β/SMAD2 dependent pathways. Finally,
huMSC-Exo triggered the mobilization of both Ly6Chi
and Ly6Clo monocytes from the spleen and the bone
marrow and their recruitment into the irradiated
muscle. Additionally, monocyte and macrophage
depletion through clodronate treatment completely
abrogated the pro angiogenic effect of huMSC-Exo.
Summary/Conclusion: This study demonstrates, for
the first time, that huMSC derived exosomes enhance
the angiogenic process in the radiation-induced
ischemic tissue by stimulating the mobilization and
recruitment of innate cells to the lesion and nurturing
neovascularization. These results highlight the concept
that huMSC-Exo administration represents a suitable
innovative approach for therapeutic angiogenesis in
irradiated tissue.
OF13.06
hucMSCs derived exosomes enhance lymphangiogenesis in
experimental lymphedema via exosomal transfer of Ang-2 and Tie2
Ting Zhao and Yongmin Yan
Jiangsu University, Zhenjiang, China (People’s Republic)
Introduction: Exosomes are small biological mem-
brane vesicles secreted by cells, including MSCs. Here,
we evaluated lymphangiogenic potential and key exo-
somal prolymphangiogenic factors of human umbilical
cord MSC-derived exosomes (hucMSC-Ex) to provid-
ing a mechanistic basis for optimizing future hucMSC-
Ex-based lymphedema therapies.
Methods: hucMSC-Ex were extracted from condition
medium of hucMSCs. Using a murine lymphedema
model, we evaluated oedema at various time points
post hucMSC-Ex injection. HE stain and
Immunohistochemical stain were applied to analyse
the lymphaniogenesis. In vitro, human dermal lympha-
tic endothelial cells (HDLECs) were treated with
hucMSC-Ex, and cell proliferation, migration and
tube formation were assayed using cell counting Kit-8
(CCK-8), transwell chamber inserts, and matrigel-
based tube formation assays, respectively. Western
blot and immunofluorescence stain were performed
to test the expression level of proteins which were
associated with lymphaniogenesis after co-cultured
with hucMSC-Ex in HDLECs.
Results: Mice treated with hucMSC-Ex showed signifi-
cantly decreased oedema formation and restored drai-
nage of intradermally injected methylene blue after 6
weekly injections. HE stain showed subcutaneous
oedema of tail faded obviously after hucMSC-Ex injec-
tion. Immunohistochemical analysis revealed that mice
tails receiving hucMSC-Ex injections had enhanced
lymphangiogenesis compared to the PBS-treated
groups as determined by staining of lymphatic marker
LYVE-1. The proliferation, migration, and tube
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formation of HDLECs were significantly increased by
hucMSC-Ex. Also, the expression level of Ang-2,
Lyve1, Prox1, VEGFR3, p-Akt in HDLECs was
up-regulated both in western blot and
Immunofluorescence stain. Mechanically, hucMSC-Ex
derived Ang-2 and Tie2 proteins were transferred to
HDLECs. Ang-2 controlled the proliferation, migration
and tube formation of HDLECs. And hucMSC-Ex
delivered Ang-2 and Tie2 activated the expression of
lymphangiogenic factors.
Summary/Conclusion: Ang-2 and Tie2 are essential
for hucMSC-Ex effects on lymphangiogenesis in vitro
and in vivo.
Funding: Zhenjiang Key Laboratory of Exosomes
Foundation and Transformation Application High-
tech Research,china: (ss2018003);National Natural
Science Foundation of China: (81670549)
JOURNAL OF EXTRACELLULAR VESICLES 153
Symposium Session 14: Parasite and Bacterial EVs
Chairs: Yong Song Gho; Mariko Ikuo
Location: Level B1, Hall A
08:30–10:00
OF14.01
Macrophage-derived exosomes encapsulate Salmonella antigens and
stimulate the activation of Type 1 T-helper cells in vivo
Winnie W. Huia, Mark Oub, Beata Clappc, David Pascualc and Mariola
Edelmanna
aUniversity of Florida Dept of Microbiology and Cell Science, Gainesville,
USA; bUniversity of Florida Dept of Microbiobiology and Cell Science,
Gainesville, USA; cUniversity of Florida Dept of Infectious Disease,
Gainesville, USA
Introduction: Salmonella enterica serovar
Typhimurium is a Gram-negative, intracellular bacter-
ium which invades macrophages and leads to the pro-
duction of pro-inflammatory exosomes. S.
Typhimurium is the causative agent of salmonellosis
affecting 1.2 million people annually in the USA.
There are no FDA approved vaccines against non-
typhoidal Salmonella infections for human thus show-
ing a significant limitation in current prevention meth-
ods. Exosomes are a subclass of extracellular vesicles
characterized by their size, morphology and biogenesis.
The cargo, including protein, nucleic acids and meta-
bolites, carried by exosomes vary depending on the
physiological conditions present and the origin of the
cell. We hypothesize that during Salmonella infections,
exosomes transport Salmonella antigen to alert neigh-
bouring cells which can lead to the stimulation of naïve
T-lymphocytes.
Methods: We focus on the release of exosomes by S.
Typhimurium-infected macrophages and their function
in stimulating an adaptive immune response in vivo.
To determine if exosomes have any effect on the adap-
tive immune response, mice were given doses of exo-
somes derived from S. Typhimurium infected
macrophage. Fluorescent activated cell sorting was
used to monitor T- lymphocyte response.
Results: Exosomes stimulate a distinct cytokine secre-
tion pattern among CD4+T lymphocytes in vivo. The
cytokines milieu, including IFN-, TNF- and IL-2,
expression by T-lymphocytes suggest that the CD4 T-
lymphocytes differentiated in to Type 1 T-helper set
producing pro-inflammatory cytokines. Additionally,
mouse serum was taken to analyse for antibody pro-
duction against Salmonella in which we observe exo-
somes derived from Salmonella infected cells provide a
similar antibody production to the live vaccine. Based
on our -omics study, we identify Salmonella antigens
and other pro-inflammatory molecules in exosomes
isolated from Salmonella infected-macrophages from
24 and 48 h infections. Hence, the cargo plays a critical
role in intercellular communication in response to
infection as naïve macrophages treated with these exo-
somes result in M1 polarization.
Summary/Conclusion: Our data support the hypoth-
esis that exosomes isolated from Salmonella infected
macrophages carry Salmonella antigens as a cargo and
stimulates the activation of Type 1 effector T
lymphocytes.
OF14.02
Extracellular vesicles from Leishmania donovani infected
macrophages contain infection-specific cargo that contribute to
lesion development
Anna E. Gioseffi and Peter Kima
University of Florida, Gainesville, USA
Introduction: Extracellular vesicles (EVs) have
emerged as important mediators of cell-to-cell commu-
nication and have been shown to contribute to the
pathogenesis of infectious microorganisms.
Leishmania is an intracellular eukaryotic parasite and
causative agent of leishmaniasis. This work aims to
evaluate EVs in the context of Leishmania donovani
infection.
Methods: To better understand the properties and
function of EVs produced by L. donovani infected
RAW264.7 macrophages (iEVs), we used a series of
approaches, including comparative proteomics of
iEVs or EVs derived from uninfected RAW 264.7
macrophages, pathway analysis to infer activity, and
functional assays such as in vitro migration assays
and flow cytometry to evaluate endothelial cell activa-
tion after EV treatment.
Results: We obtained a profile of host and parasite
proteins in iEVs, EVs from uninfected macrophages,
and EVs from macrophages infected with Centrin
knockout (CenLd) parasites. CenLd parasites are
unable to mature into the amastigote form within
macrophages. In addition to host derived molecules
previously identified by others in exosome
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preparations, we identified host and parasite derived
molecules, such as parasite PI3K, vasohibin, and serine/
threonine protein phosphatase, and mouse histone 2B,
annexin A3, and galectin-3 within iEVs. Our results
showed that EVs from macrophages infected with
CenLd parasites have a molecular composition that is
qualitatively different from iEVs released by macro-
phages infected with wild type parasites. Pathway ana-
lysis of the host-derived proteins in iEVs suggested
their involvement in cell migration and neovasculariza-
tion. In vitro cell migration assays validated the obser-
vation that intact iEVs enhance cell migration, which is
in contrast to EVs from Cen-/-Ld infected macrophage
or disrupted iEVs that do not induce cell migration. In
addition, flow cytometry analysis of endothelial cells
treated with iEVs suggested that EVs from infected
macrophages activate endothelial cells. The latter
observations were surrogate indicators of pathogenic
neovascularization.
Summary/Conclusion: Taken together, we present a
comprehensive molecular profile of the molecules
released in EVs from L. donovani-infected macro-
phages which includes infection-specific molecules
that contribute to lesion development.
Funding: NIH.
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The role of extracellular vesicles in neurophysiological changes
induced by chronic Toxoplasma gondii infection
Ellie Tedforda and Glenn McConkeyb
aUniversity of Cambridge, Cambridge, UK; bUniversity of Leeds, Leeds, USA
Introduction: During chronic Toxoplasma gondii
infection, parasites become encysted in neurons in the
host brain. Infection is associated with a plethora of
behavioural and neurophysiological changes despite
only a small number of neurons infected.
Perturbations in dopamine metabolism have been
observed with infection. We have previously described
parasite induced down-regulation of dopamine β-
hydroxylase. In this study, the role of extracellular
vesicles during chronic T. gondii infection was
investigated.
Methods: Primarily transwell culturing and extracellu-
lar vesicle purification via ultracentrifugation were
used during this study. Extracellular vesicles were col-
lected from chronically infected human and rat cate-
cholaminergic cells. Purification via a 12 step sucrose
gradient was performed prior to conditioning in vitro
and in vivo.
Results: Altered DBH mRNA expression was identified
during T. gondii infection in rat catecholaminergic and
human neuronal cells. This down-regulation of DBH
was identified in de novo RNA, suggesting that regula-
tion occurs at the transcriptional level. Using MSRE-
qPCR, hypermethylation in the 5‘ upstream region of
the DBH promoter was identified in infected rat cate-
cholaminergic cells and human neuronal cells.
Surprisingly, DBH mRNA down-regulation and
methylation in the 5’ promoter were globally altered
in vivo, despite the fact that only a small number of
cysts can be identified in the host brain. DBH silencing
was observed in cells only exposed to infected cells.
Extracellular vesicles purified from infected rat cate-
cholaminergic cells induced transcriptional silencing of
DBH. This effect could also be generated in vivo when
rats received intracererbral injections with purified
extracellular vesicles from infected cells. This repre-
sents a new perspective of the host-pathogen
interaction.
Summary/Conclusion: Through this mechanism T.
gondii may be able to induce many of neurophysiolo-
gical changes associated with chronic infection. In
addition, T. gondii is a unique model to study mam-
malian neurological function, by examining the influ-
ence the parasite is able to exert over cell-cell
communication, we may be able to further understand
the mechanisms governing CNS function and
dysfunction.
Funding: The University of Leeds.
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Bacterial membrane vesicles as vaccines in aquaculture
Julia Tandberga, Leidy Lagosb, Alexander Kashulin-Bekkelundc, Petter
Langletea and Hanne C. Winther-Larsena
aUniversity of Oslo, Oslo, Norway; bNorwegian University of Life Sciences,
Ås, Norway; cNorwegian University of Life Sciences, Oslo, Norway
Introduction: Infections by two Gram-negative intra-
cellular bacterial pathogens Piscirickettsia salmonis and
Francisella noatunensis, are causing major problems in
aquaculture world-wide. F. noatunensis sp hampers the
development of fish farming based on cod in and is
deleterious to tilapia. P. salmonis infections have been
devastating for salmon aquaculture. As of today no
effective treatments are available against the diseases.
Both P. salmonis and F. noatunensis secrete membrane
vesicles (MV). Bacterial MV has been reported as
potential vaccine candidates for a range of host includ-
ing humans, mice and fish against infection caused by
intracellular pathogenic bacteria as they induce both a
humoral and cellular immunity.
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Methods: We have isolated MVs from both Francisella
and Piscirickettsia by the ultracentrifugation Method.
The MVs were characterized by their size distribution,
by transmission electron microscopy (TEM) and pro-
teomics. Their toxicity were tested by injecting MVs
into both our zebrafish vaccine and challenge model as
well as in cod, tilapia and salmon. A vaccine trail was
performed first in our zebrafish model, and then in
cod, tilapia and salmon.
Results: The MV size analysis showed that the MVs
size distribution ranged from 20–250 nm in size with
most ranging from 70–100 nm. Both single and double
membrane MV were found in the population as inves-
tigated by TEM. Further, immune-gold labelling
revealed the presence of DNA in both populations.
Proteomics analysis revealed that the MV content var-
ied between bacterial strains. Immunization with MV
gave protection against disease caused by both P. sal-
monis and F. noatunensis in our zebrafish model, how-
ever, did not protect cod, tilapia nor salmon.
Summary/Conclusion: The MVs from P. salmonis and
F. noatunensis revealed a similar size distribution and
that the content contains various bacterial virulence
factors as well as DNA that can be transferred to the
host. As for their immunogenic properties this seems
to vary between the vaccine and challenge model com-
pared to the natural hosts. The use of the MVs as
vaccines in their natural hosts such as strain-specificity
and cross-immunity need further investigation.
Funding: Research Council of Norway (RCN) and
University of Oslo.
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Bacterial membrane vesicles enter polarised epithelial cells and
deliver their protein cargo to exosomes
Lorinda Turnera, Nestor Solisb, Georg Rammc, Viola Oorschotc, Amanda De
Paolia, Hassan Chaudhrya, Stuart Manneringd, Stuart Cordwellb, Maria
Kaparakis-Liaskose and Richard Ferreroa
aHudson Institute of Medical Research, Melbourne, Australia; bThe
University of Sydney, Sydney, Australia; cMonash University, Melbourne,
Australia; dSt. Vincent’s Institute of Medical Research, Melbourne,
Australia; 5Department of Physiology, Anatomy and Microbiology, La
Trobe University, Melbourne, Australia
Introduction: Gram-negative bacteria use outer mem-
brane vesicles (OMVs) to deliver a range of factors to
host cells. Although OMVs are highly effective at enter-
ing simple non-polarised cell monolayers, it is not
known whether these nano-sized vesicles can penetrate
an intact epithelial barrier and, potentially, disseminate
their protein cargo to tissues.
Methods: We have addressed this question using a cell
culture model that reproduces the transepithelial
resistance and apical-basolateral polarity of normal
epithelium. For this, colonic epithelial cells of the T84
line were grown on Transwell filters to generate trans-
epithelial electrical resistance (TEER), a measure of
epithelial monolayer integrity. The cells were then co-
cultured with Alexa Fluor-labelled OMVs from the
gastric pathogen, Helicobacter pylori.
Results: We showed that H. pylori OMVs readily
entered polarised epithelial cells, but had no effect on
the TEER nor permeability of these monolayers. OMVs
induced the basolateral secretion of the neutrophil
chemoattractant, interleukin-8 (IL-8) and expression
of human leukocyte antigen class I and II molecules.
In exosomes isolated from the basolateral compartment
of OMV-stimulated cells, we identified peptides
derived from eight H. pylori proteins, of which seven
are surface- or membrane-associated and are known to
localise within OMVs.
Summary/Conclusion: Collectively, the data show that
OMVs can enter polarised epithelial cells and deliver
their protein cargo to exosomes. We propose that these
exosomes may directly or indirectly present antigen to
immune cells and even transport bacterial proteins to
other tissue sites.
Funding: This project was supported by funding from
the National Health and Medical Research Council
(NHMRC), the Australian Research Council, The
Juvenile Diabetes Research Foundation and the
Victorian Government’s Operational Infrastructure
Support Program. R.L.F. is supported by an NHMRC
Senior Research Fellowship. N.S. is funded through a
Canadian MSFHR Research Trainee Fellowship and an
NHMRC Early Career Fellowship. L.T. was funded by
an Australian Postgraduate Award and an Excellence
Award from Monash University FMNHS.
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Bacterial Extracellular Vesicles: intercellular package or intracellular
garbage? The example of RNAs associated to Salmonella enterica EVs
Antoine Malabiradea, Janine Habiera, Anna Heintz-Buschartb, Patrick Maya,
Julien Godetc, Rashi Haldera, Alton Etheridged, David Galasd, Joëlle V. Fritza
and Paul Wilmesa
aLuxembourg Centre for Systems Biomedicine, University of Luxembourg,
Esch-sur-Alzette, Luxembourg, Belval, Luxembourg; bDepartment of Soil
Ecology, Helmholtz-Centre for Environmental Research – UFZ, Halle,
Germany, Belval, Luxembourg; cUMR CNRS 7021, Laboratoire de
BioImagerie et Pathologies, Université de Strasbourg, Strasbourg, France,
Strasbourg, France; dPacific Northwest Research Institute, Seattle, WA,
United States, Seattle, USA
Introduction: Bacteria have developed many ways of
communicating with one another and with other pro-
karyotic or eukaryotic species. The secretion of
Extracellular Vesicles (EVs) is one of them. Bacterial
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EVs are small spherical containers filled with a wide
range of biomolecules originating from the mother cell,
including RNAs. The protection conferred by the phy-
sical envelope of EVs to these delicate components is of
prime importance for message delivery to other cells.
However, this idea of EVs being mail carriers competes
with the concept of a simple trash bin used by bacteria
to get rid of unnecessary components.
Methods: Taking Salmonella enterica as an example,
we purified EVs and sequenced their RNA content.
The strain was cultivated in different conditions
mimicking separate stages of a gut infection. Growth
until stationary phage in Lysogeny Broth (LB) medium
induces Salmonella pathogenicity island 1 (SPI-1),
which is required for virulence during the intestinal
phase of infection. Growth in acidic and phosphate-
depleted medium triggers the expression of Salmonella
pathogenicity island 2 (SPI-2) and is comparable to the
macrophage environment.
Results: Every type of RNA was exported, including
ribosomal, messenger and non-coding RNAs. By
comparison with the intracellular RNA composition,
our data demonstrate that a proportion of RNAs
exported through EV secretion were enriched. This
export is depending on the environmental conditions
and reflects the adaptation to each infection step. Some
transcripts were confirmed to be in their native state
and not degradation products, opening the possibility
for a functional RNA delivery to surrounding cells.
Finally, we show by a digestion protection assay that
vesicles prevent enzymatic degradation of given full-
length transcripts (SsrS, CsrC, 10Sa and rnpB).
Summary/conclusion: These results reinforce the idea
of a complex interaction network existing in the gut
microbiome and more generally in microbial
ecosystems.
Funding: Luxembourg National Research Fund (FNR)
(CORE Junior/14/BM/8066232, CORE/15/BM/
10404093, CORE/16/BM/11276306), NIH Common
Fund Extracellular RNA Communication Consortium
(1U01HL126496), Baylor subaward (5U54DA036134).
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Self-assembled supramolecular nanosystems for Smart diagnosis and
targeted therapy of intractable diseases
Kazunori Kataoka
Innovation Center of NanoMedicine, Kawasaki Institute of Industrial
Promotion, Kawasaki 210-0821, Japan; Institute for Future Initiatives, The
University of Tokyo, Tokyo113-0033
kataoka@bmw.t.u-tokyo.ac.jp
Nanotechnology-based medicine (Nanomedicine) has
received progressive interest for the treatment of
intractable diseases, such as cancer, as well as for the
non-invasive diagnosis through various imaging mod-
alities. Engineered polymeric nanosystems with smart
functions play a key role in nanomedicine as drug
carriers, gene vectors and imaging probes. This presen-
tation focuses present status and future trends of
supramolecular nanosystems self-assembled from
designed block copolymers for therapy and non-inva-
sive diagnosis of intractable diseases. Nanosystems with
10 to 100 nm in size can be prepared by programmed
self-assembly of block copolymers in aqueous entity.
Most typical example is polymeric micelle (PM) with
distinctive core-shell architecture. PMs have several
properties relevant for nanosystems, including con-
trolled drug release, tissue penetrating ability, and
reduced toxicity1,2. Furthermore, smart functionalities,
such as pH- and/or redox potential responding proper-
ties, can be integrated into the PM structure3. These
smart PMs loaded with various chemotherapy reagents
were evidenced to have a significant utility in the
treatment of intractable and metastatic cancers, includ-
ing pancreatic cancer4, glioblastoma5 and tumours har-
bouring recalcitrant cancer stem cells (CSCs)6.
Eventually, five different formulations of the PMs
developed in our group have already been in clinical
trials world-wide, including Japan, Asia, USA and
European countries7.
Versatility in drug incorporation is another relevant
feature of supramolecular nanosystems for drug deliv-
ery. Nucleic acid-based medicine can be assembled into
nanosytstems through the electrostatic interaction with
oppositely-charged polycationic block copolymers8. In
this way, siRNA- or antisense oligo (ASO)-loaded
micellar or vesicular nanosystems were prepared, and
their utility in molecular therapy of cancer has been
revealed9-11. Recently, nanosystem-based imaging
reagents were developed, opening a new avenue for
the novel type of theranostic nanomedicines12.
Furthermore, nanosysems hold promise for the treat-
ment of intractable diseases other than cancer. Very
recently, we developed nanosystems decorated with
glucose to crossing blood-brain barrier by recognizing
glucose-transporter overexpressing on brain endothe-
lial cells, indicating a novel route to deliver versatile
drugs into brain for the treatment of neurodegenerative
diseases, including Alzheimer’s disease13.
[1] H. Cabral and K. Kataoka, J. Control. Rel. 190
(2014) 465–476; [2] Y. Matsumoto, et al, Nature
Nanotech. 11 (2016) 533–538; [3] H. Cabral, K.
Miyata, K. Osada, and K. Kataoka, Chem. Rev. 118
(2018) 6844–6892; [4] H. Cabral, et al, Nature
Nanotech. 6 (2011) 815–823; [5] Y. Miura, et al, ACS
Nano 7 (2013) 8583–8592; [6] H. Kinoh, et al, ACS
Nano 10 (2016) 5643–5655; [7] N. Nishiyama, et al,
Cancer Sci. 107 (2016) 867–874; [8] K. Miyata, et al,
Chem. Soc. Rev. 41 (2012) 2562–2574; [9] Y. Yi, et al, J.
Control. Rel. 295 (2019) 268–277; [10] K. Katsushima,
et al, Nature Commun. 7 (2016) 13616; [11] B.-S. Kim,
et al, J. Amer. Chem. Soc. 141 (2019) 3699; [12] P. Mi,
et al, Nature Nanotech. 11 (2016) 724–730; [13] Y.
Anraku et al, Nature Commun. 8 (2017) 1001.
MSC-sEV translation: back to basics
Sai Kiang Lim
Institute of Medical Biology (IMB)
Mesenchymal stromal cell (MSC) are presently the
most used cell type in clinical testing and are being
tested against a wide spectrum of diseases. Their ther-
apeutic efficacy is increasingly shown to be mediated
by their secretion and in particular, the secreted extra-
cellular vesicles (sEVs) of 50–200 nm. In this talk, I will
elaborate on the development of clinical applications
for MSC sEVs and the associated challenges. A major
challenge is the complexity of a typical MSC-sEV pre-
paration. As the size ranges of many EV types such as
exosomes, microvesicles, and ectosomes overlap signif-
icantly and most EV types include EVs of 50–200 nm,
the term “sEVs” essentially describes a complex popu-
lation of similarly sized EVs consisting of many known
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and possibly unknown EV types. This complexity is
further compounded by the heterogeneity in the source
and culture of MSCs, and in the downstream proces-
sing of MSC secretion. Together, this poses a challenge
to data sharing by the research community and to the
regulation of MSC sEVs as therapeutic products.
Unfortunately, resolution of this conundrum through
process standardization or purification of specific EV
type is presently not practical and/or technically chal-
lenging. To circumvent this, about 20 members from
the ISCT, ISEV, ISBT and SOCRATES have recently
proposed several metrics to quantify distinctive fea-
tures of a MSC-sEV preparation that will identify the
cellular origin of the sEVs in a preparation, presence of
lipid-membrane vesicles, and the degree of physical
and biochemical integrity of the vesicles. Such metrics
will facilitate comparison among different MSC-sEV
preparation as differences could then be mapped to
quantified differences in the features. The biological
significance of such mapping would then be testable.
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Molecular basis for contradictive roles of melanoma-derived EVs in
metastasis
Maximiliane Schuldnera and Elke Pogge von Strandmannb
aExperimental Tumor Research, Center for Tumor Biology and Immunology,
Clinic for Hematology, Oncology and Immunology, Philipps University of
Marburg, Marburg, Cologne, Germany, Germany; bExperimental Tumor
Research, Center for Tumor Biology and Immunology, Department of
Hematology, Oncology and Immunology, Philipps University Marburg,
Marburg, Germany
Introduction: Recent studies have highlighted the role
of melanoma cell-derived EVs in the formation of pre-
metastatic niches or, on the contrary, in tumour
immune surveillance. The molecular machinery and
mechanisms directing distinct cargo loading, regula-
tory release and function of stress-induced EVs remain
unknown.
Methods: EV release was quantified by NTA. EVs were
isolated by ultracentrifugation and analysed by proteo-
mics and transcriptomics. EV function was investigated
in vivo by intravenous injections followed by lung
transcriptomics and by using an experimental metas-
tasis transplantation model. The mechanistic release of
EVs was analysed using diverse molecular, cell biologi-
cal, spectroscopic and microscopic techniques.
Results: Our study reveals a crucial role of the chaper-
one and NK cell ligand BAG6 for the formation and
reprogramming of pro- and anti-tumour EVs. Loss of
BAG6 led to an increase in EV production and a
decrease in EV size. In contrast to the melanosome-
like protein signature observed for WT-EVs, BAG6KO-
EVs showed an exosome-like profile and induced a
neutrophil gene signature in the lungs of mice.
Education with B-16V WT-EVs, but not BAG6KO-
EVs, suppressed lung metastasis concomittant with
the accumulation of anti-tumour Ly6Clow patrolling
monocytes. Mechanistically, the formation of anti-
tumour EVs was dependent on BAG6 mediating the
nucleo-cytoplasmic shuttling of CBP/p300 acetyltrans-
ferases to acetylate p53. We have identified a late
endosomal P(S/T)AP motif in BAG6 which mediated
its direct recruitment to the ESCRT machinery, thereby
providing a molecular link between the regulatory role
of BAG6 to EV cargo loading.
Summary/Conclusion: Our findings provide a concep-
tual advance in the understanding of the biogenesis
and function of EVs, identifying BAG6 as an ESCRT-
associated protein and a molecular switch for the for-
mation of anti- versus pro-tumourigenic EVs in
tumour immune surveillance.
FA1.02
Development of a live-cell imaging technique for secretion activity of
extracellular vesicles of individual cells
Yoshitaka Shirasakia, Keisuke Tsukadab, Nobutake Suzukic, Tamiko
Minamisawad, Mai Yamagishie, Nobuyoshi Kosakaf, Takahiro Ochiyaf,
Osamu Oharag, Kiyotaka Shibah and Sotaro Uemurai
aJST PRESTO, Tokyo, Japan; bThe University of Tokyo, bunkyo, Japan; cThe
university of Tokyo, Bunkyo-ku, Japan; dJapanese Foundation For Cancer
Research, Koto-ku, Japan; eDepartment of Biological Sciences, Graduate
School of Science, The University of Tokyo, Japan; fDepartment of
Molecular and Cellular Medicine, Institute of Medical Science, Tokyo
Medical University, Shinjyuku-ku, Japan; gRIKEN Institute for Integrative
Medical Sciences, Yokohama, Japan; hJapaese Foundation for Cancer
research, Tokyo, Japan; iThe University of Tokyo, Tokyo, Japan
Introduction: The cells in our body exchange their
information using various methods to control the
expression of functions, to form higher order systems
and to maintain homeostasis. Particularly in the com-
munication between spatially separated cells, mediation
of humoral factors such as cytokines can be mentioned.
Addition to this, extracellular vesicles (EVs) have been
reported to participate in intercellular communication.
The EVs classically include exosomes, microvesicles
and apoptotic bodies. Also, vesicular autophagosome
and transport vesicles in the intercellular space might
be released during necrosis-like cell death (pyroptosis,
necroptosis etc.). Although conventional biochemical
methods can classify these EVs by size, density or
antigens on their membrane, it is difficult to distin-
guish individual vesicles depending on their biogenesis.
Methods: We have developed LCI-S (Live Cell Imaging
for Secretion activity), which is a time-resolved micro-
scopic observation technology of secreted humoral fac-
tors from individual cells. LCI-S utilises sandwich
fluoroimmunoassay and in situ detection of the immu-
nocomplex by total internal reflection microscopy.
LCI-S reveals intercellular variability of secretion activ-
ity and time-correlation with the cellular state such as
intracellular enzymatic activity, cell shape or viability.
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In this study, we focused on the release of EVs having
the same topology as cell membranes such as exo-
somes, targeting membrane surface antigens such as
CD63 and CD9.
Results: We have evaluated EVs secretion from
kinds of cancer cell lines and succeeded in detecting
vesicle-like adherent plaque under the cells and also
free-diffusion type vesicles (free-EVs). We also
found that the minor population showed higher
secretion activity of free-EVs in our experimental
condition. Furthermore, free-EVs secretion activity
was not uniform nor constant. Some cells showed a
burst secretion mode, and some showed an acceler-
ated secretion mode. The cells bursting free-EVs
tended to be associated with membrane blebbing,
suggesting that they were in an excessive stress
state.
Summary/Conclusion: In this study, we demonstrated
that LCI-S has the potential to distinguish individual
EVs depending on their biogenesis.
Funding: This research was supported by JST,
PRESTO Grant Number JP17940748, Japan.
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Transfer of functional cargo in exomeres
Qin Zhanga, James Higginbothamb, Dennis Jeppesena, Yu-Ping Yanga, Wei
Lib, Ramona Graves-Deala, Jie Pinga, Colleen Britainc, Kaitlyn Dorsettc,
Celine Hartmand, David Fordd, Ryan Allena, Kasey Vickersa, Qi Liua,
Jeffrey Franklina, Susan Bellisc and Robert Coffeya
aVanderbilt University Medical Center, Nashville, USA; bVanderbilt
University Medical Center, Nashville, USA; cUniversity of Alabama at
Birmingham, Birmingham, USA; dSaint Louis University School of
Medicine, Saint Louis, USA
Introduction: There is an increasing appreciation that
secreted nanoparticles are a heterogeneous mixture of
distinct entities. One newly identified nanoparticle,
exomeres (< 50 nm), were recently identified by the
Lyden lab using asymmetric flow field-flow fractiona-
tion (AF4), a method that is not widely available. No
known biological function has been assigned to these
nanoparticles. In this study, we employed a simplified
ultracentrifugation method to isolate and characterize
subpopulations of exomeres and distinguish them from
exosomes.
Methods: A two-step ultracentrifugation method was
used to separate exomeres from exosomes. Purified
exomeres were characterized by NTA, TEM, proteo-
mics, lipidomics, DNA and RNA analysis Cell surface
target sialylation by exomeres was measured by flow
cytometry using fluorescence-labelled SNA lectin.
Subpopulations of exosomes were purified by fluores-
cence-activated vesicle sorting (FAVS) and analysed for
distinguishing cargos. Normal and neoplastic mouse
colonic organoids were used for functional studies
comparing exosome and exomere activities.
Results: Our analysis of the content of exomeres lar-
gely confirms what has been reported by Lyden and co-
workers. We identify distinct functions of exomeres
mediated by two of their cargos, the β-galactoside α2,
6-sialyltransferase 1 (ST6Gal-I) that α2,6- sialylates N-
glycans, and the EGF Receptor (EGFR) ligand, amphir-
egulin (AREG). Functional ST6Gal-I in exomeres can
be transferred to recipient cells resulting in hypersialy-
lation of cell surface proteins, including β1-integrin.
AREG-containing exomeres elicit prolonged EGFR
and downstream signalling in recipient cells, modulate
EGFR trafficking in mouse-derived colonic organoids,
and dramatically enhance the growth of tumour
colonoids.
Summary/Conclusion: This study describes a simpli-
fied method for exomere isolation and provides the
first demonstration of transfer of functional cargo by
exomeres and underscores the functional heterogeneity
of secreted nanoparticles.
OF15.02
Exosomes secreted from senescent cells provoke chromosomal
instability
Kenichi Miyataa, Kazuhiro Hitomia, Tomoka Misawaa, Ryo Okadaa and
Akiko Takahashib
aProject for Cellular Senescence, Cancer Institute, Japanese Foundation for
Cancer Research, Tokyo, Japan; bProject for Cellular Senescence, Cancer
Institute, Japanese Foundation for Cancer Research, Koto-ku, Japan
Introduction: Cellular senescence is the state of irre-
versible cell cycle arrest that can be induced by a
variety of potentially oncogenic stimuli and is therefore
considered to act as an important tumour suppression
mechanism in vivo. However, cellular senescence is
also associated with the increasing expression and
secretion of inflammatory and pro-proliferative factors.
This phenotype, termed the senescence-associated
secretory phenotype (SASP), contributes to cancer
development. In addition to inflammatory proteins,
we reported that exosome secretion has dramatically
increased in senescent cells, acting as harmful SASP
factors. Recently, we found that senescence-associated
non-coding RNAs (SA-ncRNA) are enriched in exo-
somes and these exosomes provoke chromosomal
instability in normal cells.
Methods: Pre-senescent normal human diploid fibro-
blasts were rendered senescent by either serial passage,
ectopic expression of oncogene or X-ray irradiation.
Then we collected the exosomes secreted from young
or senescent cells and checked the component of exo-
somes. To analyse the biological function of these exo-
somes, colony formation analysis and karyotype
analysis were performed. Additionally, we manipulated
SA-ncRNA to load into exosome using Exotic devise,
then investigated the biological roles of them.
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Results: We found that epigenetic de-regulation of
genomic DNA induces the aberrant expression of
non-coding RNA in senescent cells and SA-ncRNAs
are enriched in exosomes secreted from senescent
cells. Surprisingly, these exosomes cause anchorage-
independent growth of normal cells and change the
number of chromosomes. It is therefore possible that
the overexpression of SA-ncRNA in old mice may
eventually promotes tumorigenesis. These results indi-
cate that senescence-associated epigenetic dysregula-
tion is likely to contribute to tumour development
not only through SASP but also exosomes during
aging process.
Summary/Conclusion: Here we show a novel function
of exosomes secreted from senescent cells on chromo-
somal instability. These data suggest that senescence-
associated exosome secretion may contribute to age-
related increase of cancer incidence.
Funding: PRESTO, JST.
OF15.03
Orthotopic neuroblastoma tumour model generating GFP-labelled
extracellular vesicles (EV) reveals specific capture of GPF EV by
monocytes/macrophages and mesenchymal cells in liver and bone
marrow
Yves A. DeClercka, Laurence Blavierb and Rie Nakatac
aUniversity of Southern California, Los Angeles, CA, USA; bChildren’s
Hospital Los Angeles, LosAngeles, CA, USA; cChildren’s Hospital Los
Angeles, Los Angeles, CA, USA
Introduction: EV released by tumours reaches target
cells at distant sites. The study of their capture in vivo
has been limited by methods relying on intravenous
injection (i.v.) of EV isolated in vitro. Using human
tumour cells producing GFP-labelled EV, we have
examined the capture of tumour-derived EV in distant
organs in vivo.
Methods: Luciferase expressing NB cell lines (SK-N-BE
(2), CHLA-136, CHLA-255) were transduced with a
lentivector targeting the GFP protein to the exosomal
membrane (CMV-XP-GFP-EF1 aka XPack). The ana-
lysis of EV produced by XPack NB cells by differential
ultracentrifugation followed by OPDG confirmed the
presence of GFP in fractions containing exosomes.
Mice orthotopically implanted with XPack NB cells
were sacrificed at week 2, 4, 6 and 8, and the bone
marrow (BM), liver, lung, kidney, and spleen were
examined by FACS and immunofluorescence imaging
(BM and liver) for the presence of GFP+ cells. The
presence of the disialoganglioside 2 (GD2) was used to
distinguish positive tumour cells from host cells having
captured EV.
Results: Preliminary experiments with PKH67-stained
NB-derived EV injected i.v. showed that after 24 h 0.9–
1% of CD 45+cells in the BM, 6.7–20.3% of CD105
+ cells in the bone, and 0.2–8.2% of CD45+ in the liver
and lung contained green vesicles. In mice orthotopi-
cally implanted with NB cells producing GFP-labelled
EV, we observed an increasing amount of GD2- /GFP+
cells in the BM (0.2%) between week 2 and 6. The
expression of CD45, CD11b, and CD105 in these
GD2- cells suggests their myeloid, monocytic, and
mesenchymal origin. In the liver, a similar capture by
CD45+ and CD11b+ was observed (up to 0.2%). We
also observed an increasing amount of GD2- /GFP+
cells that were negative for CD45, CD11b, and CD105
at week 6–8. No GFP+ cells were detected in the lung,
spleen and kidney.
Summary/Conclusion: Tumour-derived exosomes are
specifically captured by a small percentage (within the
limits of FACS detection) of myeloid and stromal cells
in the BM and the liver in the early stages of tumour
development before NB cells home to these organs.
The data which used an orthotopic model rather i.v.
injection, support the concept that exosomes contri-
bute to the pre-metastatic niche.
Funding: RO1 CA 207983 from the National Institutes
of Health, USA.
OF15.04
ExoBow – a transgenic strategy to study CD63+extracellular vesicles
in vivo
Bárbara Adema, Nuno Bastosa, Carolina Ruivoa, Maxwell Goodrichb, Zhang
Xiaojingc, Barbara Seidlerd, David W Goodriche, Jose L Costaf, José
Machadof, Dieter Saurg, Dawen Caih and Sónia Melof
ai3S – Instituto de Investigação e Inovação em Saúde, Porto University,
Portugal; IPATIMUP – Instituto de Patologia e Imunologia Molecular da
Universidade do Porto; ICBAS – Instituto de Ciências Biomédicas Abel
Salazar da Universidade do Porto, Porto, Portugal; bDepartment of
Pharmacology & Therapeutics, Roswell Park Comprehensive Cancer Center,
New york, NY, USA; 34Department of Pharmacology & Therapeutics,
Roswell Park Comprehensive Cancer Center, New York, NY, USA;
dGerman Cancer Research Center (DKFZ) and German Cancer Consortium
(DKTK), Heidelberg, Germany, heidelberg, Germany; eDepartment of
Pharmacology & Therapeutics, Roswell Park Comprehensive Cancer Center,
New York, NY, USA; fi3S – Instituto de Investigação e Inovação em Saúde,
Porto University, Portugal; IPATIMUP – Instituto de Patologia e Imunologia
Molecular da Universidade do Porto; FMUP – Faculdade de Medicina da
Universidade do Porto, Porto, Portugal; gGerman Cancer Research Center
(DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany,
Heidelberg, Germany; hUniversity of Michigan Medical School, Ann Arbor,
MI, USA.
Introduction: The whereabouts of extracellular vesicles
(EVs) inside a multicellular organism following their
spontaneous natural flow and the identification of their
recipient cells is still elusive. A comprehensive map of
the network of communication established by EVs in
vivo requires the development of new tools.
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Methods: We have developed a CD63 multireporter
transgenic mouse model to determine the spatiotem-
poral biodistribution of tissue/cell specific derived
CD63-enriched EVs, exosomes, that we termed
ExoBow. Using organ-specific promoters we have
mapped the network of communication mediated by
pancreas and intestine derived exosomes within the
respective organ microenvironment, and also with
neighbour and distant organs. The ExoBow transgene
allows a stochastic Cre recombination that determines
the expression of one of the fusion proteins CD63-
mCherry, -phyYFP, -eGFP or -mTFP, and secrete col-
our-coded CD63+ EVs. We have used genetically engi-
neered mouse models of pancreatic cancer crossed with
our ExoBow to determine the flow of cancer exosomes
during disease progression.
Results: We demonstrate that communication from the
pancreas occurs more frequently upon cancer-asso-
ciated transformation when compared to a healthy
setting.
Summary/Conclusion: Our work is the first attempt to
dissect the spontaneous flow of exosomes in a multi-
cellular organism and to understand their involvement
in several processes that occur in non-pathological and
in pathological conditions. The ability of the ExoBow
model to conditionally label any unique organ/tissue/
cell within a mouse, opens an unprecedented opportu-
nity to determine the connectome established by the
flow of exosomes in vivo, unravelling their biological
significance in health and disease.
Funding: NORTE-01-0145-FEDER-000029. Fundacao
Ciencia Tecnologia: IF/00543/2013/CP1184/CT0004,
PTDC/BIM-ONC/2754/201, POCI01-0145-FEDER-
32189. FAZ Ciencia Astrazeneca
OF15.05
BMP2-dependent osteoblast differentiation is suppressed by multiple
myeloma-derived extracellular vesicles
Mariko Ikuoa,b, Kei Sugisakib, Jumpei Teramachib, Ryou-u Takahashia,
Masahiro Abeb, Kohji Itohb and Hidetoshi Taharaa
aHiroshima University, Hiroshima, Japan; bTokushima University, Tokushima,
Japan
Introduction: Multiple myeloma (MM) suppresses
osteoblast differentiation and destroys bones. Cancer-
derived extracellular vesicles (EVs) such as exosomes
control microenvironments, but little is known about
EVs and exosomes secreted from MM cells (MM-EV).
We examined whether and how MM-EV affects osteo-
blastic differentiation.
Methods: The mouse pre-osteoblast MC3T3-E1 cells
and human osteosarcoma SaOS-2 cells was stimulated
with bone morphogenic protein-2 (BMP2) to activate
BMP/Smad pathway and induce osteoblastic differen-
tiation. Alkaline phosphatase (ALP) induction and cal-
cium deposition were used as indicators of
differentiation. The promoter activities of Smad’s target
genes were quantified by luciferase reporter assays.
Results: In BMP2-treated MC3T3-E1, MM-EV
repressed ALP induction and calcium deposition.
MM-EV fractions were collected by Total Exosome
Isolation Reagent (Invitrogen) or ultracentrifugation.
The ALP suppression activity of the MM-EV collected
by the kit and MM-EV collected by ultracentrifugation
were correlated with the vesicle quantity and exosomal
marker protein quantity. The suppression of ALP
induction by MM-EV was inhibited by macropinocy-
tosis inhibitor 5-(N-Ethyl-N-isopropyl) amiloride. In
mouse cell MC3T3-E1 and human cell SaOS-2, MM-
EV did not suppress Smad signal transduction.
Contrary, these MM-EV inhibited promoter activation
of genes targeted by Smad. This suppression activity
required Smad binding elements (SBEs) of the promo-
ter sequence. On Smad target promoters, a transcrip-
tion factor X co-represses Smad’s activity and inhibit
osteoblast differentiation. The factor X was translo-
cated in the nucleus and its target genes’ expressions
were changed in the cells treated with MM-EV.
Summary/Conclusion: MM-EV suppresses osteoblast
differentiation by inhibiting promoter activation of
Smad. This finding will lead a novel drug development
strategy for the bone defects of MM.
Funding: Research Support Foundation of Tokushima
University and TAIHO Pharmaceutical Co., LTD, JSPS
Grant-in-Aid for Young Scientists (B) (ID 26860037),
and JSPS Grant-in-Aid for Early-Career Scientists (ID
18K15213).
OF15.06
Tumour-derived extracellular vesicles require β1 integrins to promote
anchorage-independent growth
Lucia R. Languino, Rachel DeRita, Aejaz Saeed, Vaughn Garcia, Shiv Ram
Krishn, Christopher Shields, Andrea Friedman and Srawasti Sarker
Thomas Jefferson University, Philadelphia, PA, USA
Introduction: While the significance of extracellular
vesicles (EVs) in disease progression is known, it is
not clear whether “tumour-derived” EVs are detectable
in vivo and are active. EVs contain different integrins;
the β1 integrins, which are expressed in different cell
types, contribute to cancer progression, and are known
to signal through endosomes. In this study, we inves-
tigated whether prostate cancer (PrCa) EVs affect
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anchorage-independent growth and whether β1 integ-
rins in EVs are required for this effect.
Methods: We used EVs separated by ultracentrifuga-
tion and density–gradient from TRAMP mice, which
develop PrCa (TRAMP, transgenic adenocarcinoma of
the mouse prostate). We also used a cell line-based
genetic rescue approach. For this study, we selected
EVs with 1.14g/ml density and 100nm mean size.
Results: We show that EVs from either cancer cells in
vitro or from blood of tumour-bearing TRAMP mice
promote anchorage-independent growth of PrCa cells.
In contrast, EVs from cultured cells harbouring a
shRNA to β1, from wild-type mice or from β1pc-/-
/TRAMP mice carrying a β1 conditional ablation in
the prostatic epithelium, do not. Additionally, we show
that genetic rescue of β1 restores the stimulatory func-
tion of secreted EVs on anchorage-independent
growth. We demonstrate that EVs isolated through
density–gradients from cancer cells or TRAMP blood,
are functional and co-express β1, src, as well as CD9,
CD63 and TSG101; in contrast, EVs from β1pc-/-
/TRAMP or wild-type mice lack β1 as well as the
other markers listed above.
Summary/Conclusion: In this study, we demonstrate
that tumour-derived epithelial EVs require β1 integ-
rins to stimulate anchorage-independent growth of
recipient cells. Overall, this study opens new perspec-
tives in cancer treatment based on inhibition of cir-
culating β1 integrin- containing EVs shed by cancer
cells.
Funding: This study was supported by NIH R01 CA-
224769, P01 CA-140043; Thomas Jefferson University
Dean’s Transformational Science Award. This project
is also funded, in part, under a Commonwealth
University Research Enhancement Program grant
with the Pennsylvania Department of Health (H.R.);
the Department specifically disclaims responsibility
for any analyses, interpretations or conclusions.
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Brain tissue-derived extracellular vesicles of Alzheimer’s disease
patients with different apolipoprotein E genotypes
Yiyao Huanga, Vasiliki Machairakib, Lesley Chengc, Olga Pletnikováa, Juan
Troncosoa, Andrew Hilld, Lei Zhenge and Kenneth W. Witwera
aJohns Hopkins University School of Medicine, Baltimore, USA; bJohns
Hopkins University, Baltimore, USA; cDepartment of Biochemistry and
Genetics, La Trobe Institute for Molecular Science, La Trobe University,
Melbourne, Australia; dThe Department of Biochemistry and Genetics, La
Trobe Institute for Molecular Science, La Trobe University, Bundoora,
Australia; eClinical Laboratory Department, Nanfang Hospital, Southern
Medical University, Guangzhou, China (People’s Republic)
Introduction: Sporadic Alzheimer’s disease (AD)
associates with Apolipoprotein E (APOE) genotype.
The ε4 allele is associated with increased risk vs. the
more common ε3, while ε2 is protective. Recently,
Vella, et al. (JEV, 2017) reported efficient enrichment
of EVs from brain by differential and gradient density
ultracentrifugation. Importantly, the method was care-
fully evaluated by levels of proteins presumed to be
depleted in EVs vs. artefacts of tissue processing, per
MISEV. Using a modification of this rigorous method,
we extracted brain-derived EVs (bdEVs) of AD
patients with different APOE alleles and non-AD
brain tissues for quantitive and qualitative evaluation
of EVs and their cargo.
Methods: Brain of AD patients with different APOE
genotypes [ε2/ε3 (n = 5), ε3/ ε3 (5), ε3/ε4 (6), ε4/ε4 (6)]
and non-AD controls (n = 7) was obtained from the
Johns Hopkins Alzheimer’s Disease Research Center.
Tissue was processed per Vella et al. (JEV, 2017)
through 10k x g centrifugation. Subsequently, SEC
was followed by UC to concentrate bdEVs. Protein
and particle concentration, morphology, and protein
markers were examined by BCA, nano-flow cytometry
(NanoFCM), TEM, and Western blotting. RNA and
protein from brain homogenate (BH), 10k x g large
EVs (lEVs) and small EVs (sEVs) were extracted for
proteomics and small RNA QC (Fragment Analyser)
and sequencing.
Results: bdEVs of acceptable purity were obtained
using the modified method. No remarkable differences
in bdEV morphology or size distribution were
observed between AD and non-AD material.
Similarly, no significant differences in particle counts
separated AD from non-AD controls. Stratifying by
APOE genotype several differences were observed. In
contrast with a recent report on APOE4, counts of ε4-
associated bdEVs were not lower than those of brains
with other genotypes. Indeed, liberated particle counts
were highest for ε4/ε4. Fragment Analyser revealed
abundant sRNAs in sEVs. Total RNA and miRNA
abundance from highest to lowest by source was: BH,
lEVs, and sEVs.
Summary/Conclusion: Our results suggest ε4/ε4 gen-
otype in AD associates with greater bdEV recovery
than for other genotypes or non-AD brain. Ongoing
evaluation of protein and RNA from these samples
may reveal correlates or mechanisms of EV release.
Funding: US NIH: NIA (AG057430), NIMH
(MH118164).
OF16.02
Murine CNS-Derived extracellular vesicles originate from astroctyes
and neurons and carry misfolded proteins
Judith Maxwell. Silverman, Sarah Fernando, Catherine Cowan, Luke
McAlary, Leonard Foster and Neil R. Cashman
University of British Columbia, Vancouver, Canada
Introduction: Extracellular vesicles (EVs) are secreted
by myriad cells in culture and unicellular organisms,
and their identification in mammalian biofluids sug-
gests that vesicle release occurs at the organism level
also. However, despite clear importance to the under-
standing of EVs in organismal biology, EVs in solid
tissues have received little attention. Amyotrophic lat-
eral sclerosis (ALS) is a fatal neurodegenerative disease
resulting in the progressive loss of motor neurons in
the brain, brainstem and spinal cord. The disease is
characterized by progressive propagation of pathology
spreading from the CNS foci in which symptoms first
appear.
Methods: To better understand to role of EVs in an
ALS-affected central nervous system, we employed a
method of whole tissue vesicle isolation. We applied a
protocol for primary neural cell culture and modified it
for the collection of EVs from frozen whole murine
and human neural tissues by serial centrifugation and
purification on a sucrose gradient.
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Results: Quantitative proteomics found that brain-
derived EVs contain canonical exosomal markers,
with enrichment in synaptic and RNA binding pro-
teins. The brain EVs contained numerous proteins
implicated in ALS, and SOD1G93A transgenic EVs
were significantly depleted in myelin-oligodendrocyte
glycoprotein compared to non-transgenic animals.
Brain and spinal cord EVs are positive for the astrocyte
marker GLAST and the synaptic marker SNAP25,
while CD11b, a microglial marker, was largely absent,
suggesting that microglia do not contribute to the
tissue EV population under these conditions. EVs
from SOD1G93A transgenic ALS mouse model brains
and spinal cords, as well as human SOD1 familial ALS
patient spinal cord, possess abundant misfolded and
non-native disulfide-crosslinked aggregated SOD1.
Summary/Conclusion: We established a phenotypic
profile of vesicles from whole mouse brains and spinal
cords, and investigated how model motor neuron dis-
ease modifies this phenotype. The data demonstrates
that intra-organ CNS-EVs from disease affected ani-
mals and humans contain pathogenic disease-causing
protein, and suggests that in the brain and spinal cord,
astrocytes and neurons, as opposed to microglia, are
the main source of EVs.
Funding: A Bernice Ramsay ALS Canada grant sup-
ported the work, along with funding from the Paul
Heller Memorial Fund for JMS.
OF16.03
Investigating microvesicle motion on neuron surface through optical
tweezers
Giulia D’Arrigoa, Martina Gabriellib, Dan Cojocc, Giuseppe Legnamed and
Claudia Verderioe
aInternational School for Advanced Studies of Trieste, Varese, Italy; bCNR
Institute of Neuroscience, Milano, Italy; cCNR – Institute of Materials,
Trieste, Italy; dInternational School for Advanced Studies of Trieste, Trieste,
Italy; eCNR Institute of Neuroscience, Trieste, Italy
Introduction: Microvesicles (MVs) play an essential
role in intercellular communication. Exposing adhe-
sion receptors, they can interact with target cells and
deliver complex signals. It has been shown that MVs
also cover a crucial role in the spreading of pathogens
in neurodegenerative disorders, but almost nothing is
known about how MVs can transport messages moving
in the extracellular microenvironment exploiting neu-
ronal connections.
Methods: In order to investigate the interaction of
MVs with the plasma membrane of neurons, MVs
released from cultured astrocytes and isolated by dif-
ferential centrifugation, were added to the medium of
cultured hippocampal neurons. Using optical
manipulation, single MVs in suspension were trapped
by an infra-red laser collimated into the optical path of
the microscope, and delivered to neuron surface. The
MV-neuron dynamics were monitored by collecting
bright-field images.
Results: Analysis of time-lapse recordings revealed that
MVs efficiently adhered to neurons and about 70%
showed a displacement along the surface of neurites.
Interestingly, the MVs velocity (143 nm/sec) is in the
same range of retrograde actin flow, which regulates
membrane diffusion of receptors linked to actin.
Accordingly, we found that MV movement is highly
dependent on neuron energy metabolism. Indeed, only
33% of MVs were able to move on energy depleted
neurons treated with rotenone. Moreover, inhibiting
neuron actin cytoskeleton rearrangements (polymeriza-
tion and depolymerization) with cytochalasin D, which
binds fast growing end of actin, the percentage of EVs
able to move on neuron surface was significantly
reduced from 79% to 54%, revealing that neuronal
actin cytoskeleton is involved in EV-neuron dynamics.
Unexpectedly, we found by cryo-electron micro-
scopy that a subpopulation of MVs contains actin fila-
ments, suggesting an intrinsic capacity of MVs to
move. To address this hypothesis, we inhibited actin
rearrangements in EVs with Cytochalasin D and
observed a significant decrease, from 71% to 45%, of
MVs able to drift on neuron surface.
Summary/Conclusion: Our data support two different
way of MV motion. In the first case, MV displacement
could be driven by the binding with neuronal receptors
linked to the actin cytoskeleton. In the second, actin
rearrangements inside MVs could drive the motion
along a gradient of molecules on neuron surface.
OF16.04
P2RX7 Inhibitor suppresses tau pathology and improves hippocampal
memory function in tauopathy mouse model
Seiko Ikezu, Zhi Ruan, Jean Christophe Delpech, Mina Botros, Alicia Van
Enoo, Srinidhi Venkatesan Kalavai, Katherine Wang, Lawrence Hu and
Tsuneya Ikezu
Boston University School of Medicine, Boston, USA
Introduction: Microglia, the innate immune cells in
the central nervous system, could spread pathogenic
tau protein via secretion of extracellular vesicles, such
as exosome. P2X7 receptor (P2RX7) is an ATP-gated
cation channel and highly expressed in microglia and
triggers exosome secretion. We hypothesize that
P2RX7 inhibitor could alleviate tauopathy in PS19 tau
transgenic mice by inhibiting the exosome secretion by
microglia.
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Methods: BV-2 murine microglial cell lines were trea-
ted with GSK1482160, a specific inhibitor of P2RX7,
prior to ATP stimulation. Exosomes were enriched
from the conditioned media and quantified using
Nanoparticle Tracking Analysis and CD9 ELISA.
Three-months old P301S Tau (PS19) and control
wild-type mice were treated with GSK1482160
(20 mg/kg) or vehicle by oral gavage for 30 days. The
animals were tested for hippocampal memory function.
The accumulation of pathogenic Tau was determined
by immunohistochemistry and ELISA.
Results: ATP stimulation of BV-2 cells significantly
increased secretion of exosomes (30–150 nm), which
was significantly inhibited by GSK1482160 treatment
in a dose-dependent manner. Daily administration of
GSK1482160 over 30 days had no effect on body weight
of PS19 mice. Interestingly, GSK1482160 treatment
enhanced spontaneous alteration in Y-maze and
improved prepulse inhibition as compared to vehicle-
treated group. In addition, pTau level in the hippocam-
pal tissue was significantly reduced in GSK1482160-
treated PS19 mice as compared to vehicle-treated
group as determined by neuropathology and ELISA.
Summary/Conclusion: GSK1482160 treatment sup-
presses ATP-induced exosome secretion from BV-2
cells. Its oral administration to PS19 mice improved
hippocampal memory function and reduced the accu-
mulation of pathogenic tau. These data demonstrate that
targeting P2RX7 is a novel target for suppressing the
exosomal spread of pathogenic tau protein by microglia,
which may be applicable to Alzheimer’s disease.
Funding: Grant/Other Support: NIH 1RF1AG054199-
01
Grant/Other Support: 1R01AG054672-01
Grant/Other Support: 1R56AG057469-01
Grant/Other Support: DVT-14–320835
Grant/Other Support: Cure Alzheimer’s Fund.
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Astrocyte-derived extracellular vesicles shed in response to IL-1beta
up-regulate amyloidogenic processing in neurons
Zhigang Lia, Raha Dastgheyba, Seung-Wan Yooa, Carlos Nogueras-Ortizb,
Dimitrios Kapogiannisb and Norman Haugheya
aJohns Hopkins University, Baltimore, MD, USA; bNational Institute on
Aging, Baltimore, MD, USA
Introduction: Chronic inflammation is thought to
contribute to the pathogenesis of Alzheimer’s disease
by upregulating amyloidogenic processing of APP.
Based on previous findings that inflammatory stimuli
modify the cargo of astrocyte derived extracellular
vesicles (ADEV), we sought to determine if ADEVs
released in response to IL-1β (ADEV-IL-1β) contain
cargo that regulate APP processing in neurons.
Methods: Neurons were stimulated with constitutively
released ADEV or ADEV-IL-1β. APP, and BACE1 co-
localization in membrane microdomains was measured
by immunofluorescence staining. APP and BACE1
protein and mRNA levels measured by western blot
and RT-QPCR. The binding of APP mRNA and het-
erogeneous nuclear ribonuclear protein C (hnRNP C)
was measured by immunoprecipitation. Casein kinase
1 (CK1) efficiency was blocked using pharmacological
inhibition and genetic knockdown. Isolation of human
plasma ADEV was achieved by GLAST-1 pull-down.
Results: Neurons exposed to ADEV-IL-1β promoted the
co-localization of APP and BACE1 into membrane
microdomains (p < 0.001), and increased production
of Aβ1-42. Protein expression of APP (p = 0.0051) but
not BACE1 was also increased. APP mRNA was not
increased following exposure of neurons to ADEV-IL-
1β, suggesting a post-translational event. APP transla-
tion is regulated by a competitive interaction of the
fragile X mental retardation protein (FMRP), and
hnRNP C with the APP coding region. hnRNP C can
displace FMRP and increase APP translation. The asso-
ciation of hnRNP C with APP mRNA increased follow-
ing exposure to ADEV-IL-1β. Compared with ADEV-
CR, ADEV-IL-1β selectively carried CK1. CK1 is known
to activate hnRPC. Knockdown of CK1 in astrocytes
reduced CK1 in ADEV-IL-1β (p = 0.0061), prevented
the upregulation of APP protein expression (p = 0.007),
and co-localization of APP with BACE1 (p < 0.001).
Overexpression of CK1 in astrocytes increased CK1 in
ADEV-IL-1β, increased APP protein expression
(p = 0.0026), and co-localization of APP with BACE1
(p = 0.0015). We confirmed in ADEVs isolated from
human plasma that AD patients, but not healthy age-
matched controls contain CK1 (p = 0.0467).
Summary/Conclusion: These data suggest that neu-
roinflammatory stimuli modify ADEV cargo to
enhance amyloidogenic processing of APP by deliver-
ing CK1 to regulate the association of hnRNPC with
APP mRNA.
OF16.06
The role of human choroid plexus-derived extracellular vesicles in
viral neuroinvasion
Bethany O’Hara, Jenna Morris-Love, Gretchen Gee, Walter Atwood and
Sheila Haley
Brown University, Providence, RI, USA
Introduction: The human polyomavirus JCPyV causes the
fatal disease progressive multifocal leukoencephalopathy
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(PML) in immunocompromised individuals and patients
undergoing immunomodulatory therapy. A critical ques-
tion in JCPyV pathogenesis is understanding how the virus
is transported from the periphery to the CNS to infect glial
cells and cause demyelination. An additional paradox is
that the target glial cells do not express known virus
receptors. Previously, we analysed JCPyV infection of the
choroid plexus (CPE), a functional barrier to the CSF and
showed CPE cells are permissive to JCPyV infection and
express viral attachment and entry receptors. Here, we
investigate the role of CPE-derived extracellular vesicles
in receptor-independent infection of glial cells by JCPyV.
Methods: In addition to analysing primary human CPE
cells, we also developed an immortalized human CPE
line. CPE were transformed using hTERT lentiviral
transduction and verified by STR profiling. EV from
both cell types were concentrated by differential cen-
trifugation and evaluated by transmission electron
microscopy, Western blot, nanoparticle tracking analy-
sis, infection, and qPCR for protected viral genomes.
Infection was evaluated by immunofluorescence analy-
sis with antibodies against the major viral capsid pro-
tein VP1. Uptake was evaluated by flow cytometric
analysis of PKH67 fluorescently labelled particles and
confocal imaging.
Results: EV from CPE cells display characteristic mar-
kers and morphology, contain intact JCPyV virions,
and are infectious to both CPE cells and human glial
cells. EV-mediated infection is receptor independent.
Infection and uptake of EV cannot be inhibited by
neutralizing antisera and internalization is via endocy-
tosis. EV from CPE contains significantly more VP1
than other glial cell lines.
Summary/Conclusion: Primary and transformed CPE
produce similar EVs that are able to deliver significant
amounts of JCPyV in a receptor independent manner
to target cells in the CNS. The choroid plexus may be
an entry point by which JCPyV accesses the brain
leading to the development of PML.
Funding: NIH RO1NS043097.
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Mesenchymal stem cell derived extracellular vesicles restore the
engraftment capacity of stem cells in radiation exposed mice
Sicheng Wena, Mark Doonerb, Laura Goldbergc, Elaine Papac, Michael Del
Tattoc, Mandy Pereirac, Yang Chenc, Theodor Borgovand and Peter
Quesenberryb
aBrown University/Rhode Island Hospital, Providence, RI, USA; bBrown
University Department of Hematology Oncology; Rhode Island Hospital,
Providence, RI, USA; cRhode Island Hospital, Providence, RI, USA; dRhode
Island Hospital/ Brown University, Providence, RI, USA
Introduction: We have shown that pretreated irra-
diated murine bone marrow stem cells (BMSCs) with
mesenchymal stem cells-extracellular vesicles (MSC-
EVs) in vitro, could significantly improve the engraft-
ment capacity of radiation damaged BMSCs with a
predominant reversal effect in later periods of post-
transplant from 12 weeks up to 36 weeks. This indi-
cates a long-term effect of MSC-EVs on reversal of
radiation damage of BMSCs.
Methods: In this study, we investigated the long-term
effect of MSC-EVs on the restoration of engraftment of
BMSCs in radiation-exposed mice in vivo up to
53 weeks. Moreover, the safety and toxicity of MSC-
EVs treatment were also evaluated.
Results: 500cGy radiated mice were injected with
human MSC-EVs by tail vein injection at 24, 48 and
72h post-radiation. We followed the peripheral blood
cell counts up to 53 weeks post-EV injection. There
was a significant RBC, HGB and platelet restoration in
EV treated radiated mice compared to untreated mice
in the early period (before day 35). For the evaluation
of reversal effect on BMSCs, bone marrow, harvested at
6, 12, 26 and 53 weeks. post-EV injection, were trans-
planted into 950 cGy exposed B6.SJL mice. The
engraftment was evaluated at 4 and 12 weeks post-
transplantation. In those transplanted mice at 6 weeks
post-EV injection, there was a slight increase in the
restoration of engraftment rate in EV treated mice
(17.58 ± 2.32%) compared to untreated mice
(13.80 ± 1.41%) after 1 month post-transplantation.
However, for those mice transplanted at 12, 26, and
53 weeks post-EV injection, there were significantly
higher restorations of engraftment in EV treated mice
(40.48 ± 6.03%, 33.93 ± 3.76%, and 56.62 ± 3.63) com-
pared to untreated mice (12.39 ± 1.30%, 15.14 ± 2.21%,
36.21 ± 3.63%) after 4 weeks transplantation, respec-
tively. The similar restorations of engraftment were
also seen in 12 weeks post-transplantation. These data
suggested that EVs have early and late mitigating
effects on peripheral blood cytopenias and BMSCs.
No toxic effect was observed in bone marrow, kidney,
liver, spleen, lung and heart up to 53 weeks post-EV
injection.
Summary/Conclusion: Our data suggest that there is a
long-term effect of MSC-EVs on the restoration of
engraftment of BMSCs in radiation-exposed mice,
and MSC-EV treatment is a safe therapeutic strategy.
Funding: NIH grants 5UH2TR000880 and
5T32HL116249.
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Connexin43-positive exosomes released by osteoarthritic
chondrocytes favours osteoarthritis progression by spreading
senescence and inflammatory mediators to nearby tissues
Marta Varela-Eirína, María D. Mayán Santosb, Adrián Varela-Vázqueza,
Amanda Guitián-Caamañoa, Susana B. Bravo-Lópezc, Carlos Paínod, Raquel
Largoe, Eduardo Fonsecaa, Mustapha Kandouzf, Trond Aaseng, Arantxa
Taberneroh, Alfonso Blancoi, José R. Caeiroj and María D. Mayána
aCellCOM research group. Instituto de Investigación Biomédica de A Coruña
(INIBIC), Servizo Galego de Saúde (SERGAS), A Coruña, Spain;
bTranslational Research in Cell Communication and Signalling (CellCOM),
Instituto de Investigación Biomédica de A Coruña (INIBIC), A Coruña,
Spain; cProteomics laboratory. Instituto de Investigación Sanitaria de
Santiago de Compostela (IDIS), Complexo Hospitalario Universitario de
Santiago de Compostela (CHUS), A Coruña, Spain; dUnit of Experimental
Neurology-Neurobiology., Madrid, Spain; eBone and Joint Research Unit,
Rheumatology Department, IIS-Fundación Jiménez Díaz UAM, Madrid,
Spain; fDepartment of Pathology, School of Medicine, Wayne State
University, Detroit, MI, USA; gTranslational Molecular Pathology research
group. Vall d’Hebron Research Institute (VHIR), Universitat Autònoma de
Barcelona, Barcelona, Spain; hDepartamento de Bioquímica y Biología
Molecular, Instituto de Neurociencias de Castilla y León (INCYL),
Universidad de Salamanca, Salamanca, Spain; iFlow Cytometry Core
Technologies, UCD Conway Institute, University College Dublin, Dublin,
Ireland; jDepartment of Orthopaedic Surgery and Traumatology, Complexo
Hospitalario Universitario de Santiago de Compostela (CHUS). Universidade
de Santiago de Compostela (USC), Santiago de Compostela, Spain
Introduction: Chondrocytes in articular cartilage
undergo phenotypic changes and senescence, restrict-
ing cartilage regeneration and favouring osteoarthritis
(OA) progression. Like other wound healing disorders,
chondrocytes from OA patients show a chronic
increase in the transmembrane channel protein con-
nexin43 (Cx43). Extracellular vesicles (EVs), including
exosomes, have been show to harbour connexin
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channels that allow the formation of gap junctions
between the exosome and the target cell. However,
the role of these vesicles and exosomal-Cx43 in OA
progression has not been studied yet. The objective of
this study was to investigate the role of EVs released by
osteoarthritic chondrocytes (OACs) in cellular plasti-
city and senescence of surrounding tissues.
Methods: EVs were isolated from OA/healthy chon-
drocytes by ultracentrifugation and their protein con-
tent was analysed by LC-MS/MS using 6600 triple
TOF. RNA levels, protein activity and cellular senes-
cence were analysed by RT-qPCR, western blot, immu-
nofluorescence and flow cytometry.
Results: Our results indicate that OACs contain
increased levels of Cx43 within their EVs in compar-
ison to the EVs isolated from healthy donors.
Overexpression of Cx43 in chondrocytes increased
senescence and the total content of Cx43 in the EVs.
The treatment of target cells with EVs containing Cx43
led to a significant increase in Cx43 mRNA and protein
levels. The increase of Cx43 lead to dedifferentiation in
the recipient cells via EMT by activation of Twist-1,
with increased levels of the mesenchymal markers
CD105 and CD166. The phenotypic changes detected
in OACs lead to a decrease in the main cartilage
markers Col2A1 and ACAN expression, and increased
the levels of cellular senescence and SASP in target cells
via p53/p16 and NF-kß. These results were corrobo-
rated by analysing the protein cargo of these Cx43
positive EVs, where we found enrichment in proteins
related with the catabolic, senescence and wound-heal-
ing pathways
Summary/Conclusion: Together, these results suggest
that Cx43-positive EVs released by OACs may be
involved in the spread of cellular senescence, inflam-
mation and reprogramming factors involved in wound
healing failure to neighbouring tissues in the joint.
Further understanding of the role of exosomal Cx43
in OA will help to halt the disease spread and
progression.
OF17.03
Extracellular vesicles in ageing: from skin to bone
Lucia Terlecki-Zaniewicza, Madhusudan Reddy Bobbilia, Matthias Hacklb,
Regina Grillaric, Ingo Lämmermanna, Vera Pilsd, Florian Grubere and
Johannes Grillarif
aBOKU – University of Natural Resources and Life Sciences Vienna, Vienna,
Austria; bTAmiRNA GmbH, Vienna, USA; cEvercyte GmbH, Vienna,
Austria; dBOKU – University of Natural Resources and Life Sciences
Vienna, Vienna, USA; eChristian Doppler Laboratory on Biotechnology of
Skin Aging; Medical University of Vienna, Vienna, USA; fChristian Doppler
Laboratory on Biotechnology of Skin Aging, University of Natural Resources
and Life Sciences, Vienna (BOKU), Vienna, Austria
Introduction: Cellular senescence has evolved from an
in vitro model system to study aging to a multifaceted
phenomenon of in vivo importance since senescent
cells in vivo have been identified and their removal
delays the onset of age-associated diseases in a mouse
model system. In order to understand how senescent
cells that accumulate within organisms with age nega-
tively impact on organ and tissue function, we have
started to characterize secreted miRNAs within extra-
cellular vesicles that are differentially expressed in early
passage versus senescent cells and their functional role
in the context of cellular and organismal aging.
Methods: We performed next generation sequencing as
well as qPCR on extracellular vesicles from senescent
versus control cells, after characterizing the EVs in
detail. In addition, open flow microperfusion experi-
ments were used to proof the presence of EVs in the
interstitial fluid of the skin.
Results: We identified extracellular vesicle contained
miRNAs as bona fide members of the senescence asso-
ciated secretory phenotype (SASP) that are transferred
from senescent cells to their microenvironment or even
the systemic environment. These miRNAs, among
them miR-23a-5p, are transported via extracellular
vesicles also in organotypic human skin equivalents
and recipient cells taking them up are altered in their
cell fate, including altered wound healing and apopto-
totic behaviour. In addition, miR-31 is transferred to
mesenchymal stem cells, inhibiting osteogenic
differentiation.
Summary/Conclusion: In summary, we present evi-
dence of the importance of specific miRNAs and high-
light their potential use as biomarkers of aging and age-
associated diseases, or even as therapeutic tools and
targets to prevent age-associated diseases.
Funding: This work was funded by the Christian
Doppler Society. The financial support by the
Austrian Federal Ministry of Economy, Family and
Youth; the National Foundation for Research,
Technology and Development is also gratefully
acknowledged, as is funding by the Austrian Science
Fund (FWF: I2514 to JG) and the PhD Programme
BioToP – “Biomolecular technolgy of proteins”.
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Human embryonic stem cells derived exosomes promote tissue
regeneration in aged mice by rejuvenating senescent endothelial
cells
Bi Chen, Liangzhi Gonga and Yang Wangb
aShanghai Jiaotong University Affiliated Sixth People’ Hospital, Shanghai,
China (People’s Republic); bShanghai Jiao Tong University Affiliated Sixth
People’s Hospital, Shanghai, China (People’s Republic)
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Introduction: Angiogenesis plays a crucial role in tis-
sue repair. This process is significantly impaired by
age-related dysfunction of vascular endothelial cells in
aged bodies. Exosomes from embryonic stem cells
(ESCs) contain primitive molecules (proteins, miRNA,
etc.) from their parent cells. Therefore, our hypothesis
is that ESCs derived exosomes (ES-Exos) would influ-
ence and rejuvenate aging endothelial cells and lead to
enhanced tissue repair in aged bodies.
Methods: Six- to eight-week-old C57BL/6 mice were
daily subcutaneous injection of D-gal (1000 mg/kg) to
establish aged mice model. Pressure ulcers were created
on the back of each mouse, followed by pipetting ES-
Exos (1*1011/mL) suspension or PBS one time per day.
Mice were sacrificed at 3, 7, 14, and 21 days after
intervention. In addition, a group of young mice with
pressure ulcer was also set. Samples from each mouse
were evaluated in the aspect of vascular formation and
aging condition. Furthermore, we induced HUVEC
senescence in vitro by D-gal treatment and investigate
the function and mechanism of ES-Exos in restoring
function and rejuvenation of senescent endothelial cells
by qRT-PCR, WB, and immunofluorescent staining.
Results: Our results showed that ES-Exos treated aged
mice exhibit faster repairing than PBS treated group.
The angiogenesis condition of ES-Exos treated group
was similar as that of young mice and was better than
PBS treated senescent mice. The number of SA-β-gal-
positive cells and the expression level of P16 and P21 in
ES-Exos treated group were significantly lower than
that in PBS treated group. In vtiro experiments showed
that ES-Exos could also downregulate senescent related
protein expressions and enhance tube formation of
senescent endothelial cells. In addition, our results
also showed that ES-Exos could greatly decreased the
expression level of MDA and increase the activity of
SAD, CAD, and GSH, molecules tightly related with
endogenous anti-oxidative condition. Further investi-
gation demonstrated that ES-Exos could activate NRf2
pathway by inhibiting Keap1, leading to rejuvenative
function on senescent endothelial cells.
Summary/Conclusion: We demonstrate that ES-Exos
can accelerate wound healing and promote angiogen-
esis in aged mice by rejuvenating endothelial
senescence.
Funding: NSFC Project No. 81871833 and 81672254.
OF17.05
Schwann cell derived exosomes regulate Schwann cell activation and
neuropathic pain related behaviours
Naoya Hirosawaa, HyoJun Kwonb, Haylie Romerob, John Kimb, Coralie
Brifaultc, Seiji Ohtorid and Wendy Campanae
aAnesthesiology and Program in Neuroscience, University of California, San
Diego, CA, USA; bDepartment of Anesthesiology, School of Medicine,
University of California, San Diego, CA, USA; cUniversity of California,
San Diego, San Diego, CA, USA; dDepartment of Orthopaedic Surgery,
Chiba University, Chiba, Japan; eDepartment of Anesthesiology and
Program in Neuroscience, School of Medicine, University of California, San
Diego, CA, USA
Introduction: Exosomes (Exs) are small extracellular
vesicles originally known to be secreted from multi-
vesicular endosomes in dendritic cells. We now know
that Exs are secreted from many cell types and are
essential for autocrine/paracrine communication. In
the peripheral nervous system (PNS), Exs derived
from primary Schwann cells (SC) appear to facilitate
axon growth after injury, however their effects on SC
physiology and pain outcomes are unknown.
Methods: Exs were purified from primary SC condi-
tioned media by ultracentrifugation (SC-Ex) and char-
acterized by immunoblotting and NanoSight In
cultures of SC, TNFa robustly activated proinflamma-
tory cell signalling and migration. SC-Ex (50–500 ng/
mL) were added to TNFa treated SC, and phosphoryla-
tion of p38MAPK and JNK1/2 were measured.
Transwells were used to evaluate SC migration. To
determine if SC-Ex regulate neuropathic pain, we per-
formed intraneural injections of SC-Ex (500–1500 ng)
or vehicle into sciatic nerves during partial nerve liga-
tion (PNL) surgeries in adult male rats (n = 12). Tactile
allodynia was assessed using von Frey filaments.
Results: Nanoparticle tracking of SC-Ex showed the
expected size distribution with a mean peak diameter
of 121 nm. Immunoblotting of SC-Ex revealed that
exosome markers, TSG101 and flotillin-1, and SC
marker, P0 protein, were expressed. The golgi marker,
GM130, and GFAP were not. In cultured SC, the SC-Ex
signalling response was distinguished from the cell
signalling signature elicited by TNF alone, which
robustly activated p38MAPK and JNK1/2 by > 6 and
4-fold (p < 0.01), respectively. When SC-Ex were
added, p38MAPK and JNK1/2 activation were dose
dependently and significantly inhibited (p < 0.05).
TNF increased SC migration 3-fold after 4 h that was
blocked by SC-Ex at low doses. Local injections of
SC-Ex modified tactile allodynia associated with PNL
compared to saline injected controls.
Summary/Conclusion: We demonstrated that SC uti-
lizes autocrine secretion of Exs for regulating SC sig-
nalling and migration. SC-Ex act as cell independent
entities, carrying bioactive substances capable of inhi-
biting pro-inflammatory signalling in SCs that may
contribute to the extent and magnitude of chronic
pain. Future studies will elucidate SC-Ex cargo driving
autocrine/paracrine activities after PNS injury.
Funding: VA.
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Urinary extracellular vesicles improve the recovery of renal function
in an Acute Tubular Injury model restoring Klotho levels
Elli Papadimitrioua, Benedetta Bussolatib, Cristina Grangec, Veronica
Dimuccioc and Giovanni Camussid
aDepartment of Molecular Biotechnology and Health Sciences; University of
Turin, Turin, Italy; bDepartment of Molecular Biotechnology and Health
Sciences, University of Turin, Turin, Italy; cUniversity of Turin, Turin,
Italy; dDepartment of Medical Sciences, University of Turin, Turin, Italy
Introduction: Extracellular vesicles present in urine
(uEVs), are considered a non-invasive source of infor-
mation regarding the pathophysiology of the whole
kidney. Mainly secreted by renal cells lining the
nephron, uEVs have been studied as biomarkers for
diagnosis of renal diseases. However, their possible
therapeutic use has not been addressed yet. In the
current study, we investigated the potential therapeutic
effect of uEVs, in a murine model of acute kidney
injury (AKI). While the beneficial effect of mesenchy-
mal stromal cell-derived EVs (MSC EVs) for AKI treat-
ment has been extensively described, we here tested the
possible therapeutic use of uEVs as more “renal com-
mitted” source.
Methods: uEVs were isolated by ultracentrifugation of
human urine provided by healthy subjects. AKI was
performed by intramuscular injection of 8 ml/kg
hypertonic glycerol. Next day, 2 × 108 uEVs /mouse
were intravenously injected and 48 h later mice were
sacrificed.
Results: Our data showed that administration of uEVs
in AKI mice resulted in the acceleration of renal recov-
ery in a MSC EV-treatment comparable manner.
Functional and histological abnormalities, observed
upon AKI, were alleviated, cell proliferation was stimu-
lated, while the expression of renal tissue injury and
inflammation markers was reduced. The analysis of
uEV miRNA cargo showed the presence of several
miRNAs possibly involved in tissue repair. miR-30
and miR-151, previously described present in MSC
EVs, were further found transferred in renal tissue of
uEV-injected mice. In addition, the reno-protective
factor Klotho, was found present in uEVs at both
protein and mRNA level. The administration of uEVs
in AKI mice resulted in the restoration of Klotho
protein levels in renal tissue, significantly lowered
upon damage. Of interest, ineffective fibroblast-derived
EVs loaded with recombinant Klotho exhibited a reno-
protective effect, suggesting a possible Klotho-mediated
mechanism in the amelioration of AKI.
Summary/Conclusion: Overall, our results reveal a
novel potential therapeutic approach for AKI treat-
ment, using renal cell-derived EVs present in urine
and indicate common, as well as unique, uEV and
MSC EV mechanisms of action.
Funding: FP7 NephroToolsproject and by Miur ex60%
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Increased levels of systemic LPS-positive bacterial extracellular
vesicles in patients with intestinal barrier dysfunction
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Introduction: Bacterial extracellular vesicles (EV) are
secreted by gut bacteria and contain nucleic acids,
proteins, metabolites and endotoxins. Consequently,
bacterial EV that enters the systemic circulation may
deliver and elicit a variety of immunological and meta-
bolic responses in different organs. However, the sys-
temic presence and activity of bacterial EV in patients
with intestinal barrier dysfunction have not been
investigated.
Methods: Size exclusion chromatography and density
gradient centrifugation were combined to fractionate
faeces and plasma in two dimensions separating bac-
terial EV-associated LPS from other LPS products and
eukaryotic EV. Bacterial EV-associated LPS levels of 49
subjects with a compromised or intact intestinal barrier
were measured by Limulus Amebocyte Lysate and Toll-
like receptor four reporter assays and confirmed by
immunoelectron microscopy. Plasma zonulin was mea-
sured to assess intestinal barrier integrity and Caco-2
transwell systems were used for in vitro validation
experiments.
Results: We calculate that the human gut harbours
approximately 100 trillion bacterial EV which may
serve as a substantial source of systemic pathogen-
associated molecular patterns (PAMP), evidenced by
proteomic analysis of faeces-derived bacterial EV. We
demonstrate that bacterial EV can translocate the
intestinal epithelial layer in a paracellular way. LPS-
positive bacterial EV levels are significantly increased
in plasma of patients diagnosed with HIV, inflamma-
tory bowel disease and cancer therapy-induced intest-
inal mucositis compared to respective controls (Mann-
Whitney U test, p < 0.01). These bacterial EV are able
to induce immune activation and significantly correlate
with impaired barrier integrity of the patient
(Spearman’s ρ = 0.4241, p = 0.0245).
Summary/Conclusion: Pathologies with an intestinal
barrier dysfunction open the door for bacterial EV to
enter the circulation and to induce immune activation.
Their systemic presence correlates with impaired gut
barrier integrity. These data deliver novel opportunities
to advance our knowledge of PAMP-induced systemic
reactions and biomarker development.
Funding: This work was supported by concerted
research action from Ghent University and Krediet
aan Navorsers from the Research Foundation
Flanders (FWO). JVD, EG, LV and AH are supported
by fellowships from FWO.
OF18.02
Milk exosomes accumulate in the intestinal mucosa and peripheral
tissues in wild-type pups nursed by exosome and cargo tracking
dams
Janos Zemplenia, Bijaya Upadhyayaa, Mengna Xiaa, Hideaki Moriyamaa and
Masato Ohtsukab
aUniversity of Nebraska-Lincoln, Lincoln, USA; bTokai University,
Kanagawa, USA
Introduction: Exosomes and their cargos may be
obtained from dietary sources such as milk.
Hypothesis: Milk exosomes accumulate in the intestinal
mucosa and peripheral tissues in suckling mice. Aims:
1) Develop an Exosome and Cargo Tracking (ECT)
mouse to assess the origin, destination and cargo of
exosomes. 2) Assess the bioavailability and distribution
of milk CD63-positive EVs (“exosomes”) labelled with
fluorescent proteins in suckling pups.
Methods: ECT mice were developed by random integra-
tion of an ECT plasmid. The plasmid encodes a fusion
protein of CD63 and green fluorescent protein (eGFP) plus
stop codon, flanked by two loxP sites (ORF-1). A second
ORF, coding for a CD63/near-infrared protein (iRFP)
fusion protein, follows downstream of ORF-1. A trans-
membrane domain is fused to the C-terminus of the iRFP
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to create an extra-exosomal C-terminus, followed by a
second iRFP and a stop codon. In the presence of Cre,
the CD63/eGFP/Stop insert is removed and the mice
switch from expressing eGFP-labeled exosomes to iRFP-
labeled exosomes, including an extra-exosomal iRFP for
collection with anti-iRFP and magnetic beads. Wild-type
(WT) pups were fostered to ECT dams to assess the
bioavailability of milk exosomes.
Results: ECT mice showed no disease phenotypes. In
the absence of Cre, the mice expressed eGFP-labeled
exosomes, whereas the offspring of mice mated with
Cre mice expressed iRFP-labelled exosomes. The same
patterns were obtained when HEK-293 cells were
transfected with the ECT plasmid in the absence of
presence of Cre plasmid. Fluorescent proteins localized
to exosomes but not to other complexes secreted by
HEK-293 cells. The particles had the size expected for
exosomes (131 ± 49 nm), stained positive for CD9, Alix
and TSG101, stained negative for histone H3, and were
captured by anti-CD63. When WT pups were nursed
by ECT dams for three weeks, exosomes accumulated
primarily in the intestinal mucosa, brain and kidneys.
Summary/Conclusion: We have developed a mouse
that permits tracking CD63-positive exosomes and
their cargos. CD63-positive exosomes are bioavailable
in suckling mice.
Funding: NIFA, NIH, Gates Foundation, Gerber
Foundation, USDA. JZ serves as consultant for
PureTech Health, Inc.
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Deciphering extracellular vesicle mediated host-pathogen interaction
in streptococcus pneumoniae
Saigopalakrishna Yernenia, Rory Eutseyb, Sarah Wernerb, Surya Aggarwalb,
Changjin Huangc, K. Jimmy Hsiac, Luisa Hillerb and Phil Campbelld
aDepartment of Biomedical Engineering, Carnegie Mellon University,
Pittsburgh, PA, USA; bDepartment of Biological Sciences, Carnegie Mellon
University, Pittsburgh, PA, USA; cSchool of Mechanical and Aerospace
Engineering, College of Engineering, Nanyang Technological University,
Singapore, Singapore; dDepartment of Biomedical Engineering and
Engineering Research Accelerator, Carnegie Mellon University, Pittsburgh,
PA, USA
Introduction: Extracellular vesicles (EVs) represent a
highly sophisticated cell-to-cell mailing system. Both
eukaryotic and prokaryotic cells selectively pack signal-
ling cargo into and onto EVs and deliver them to the
extracellular milieu. However, it was not until recently,
that Gram-positive bacteria including the major
respiratory pathogen Streptococcus pneumoniae (pneu-
mococcus), were shown to produce EVs, likely origi-
nating from the plasma membrane to be released into
the extracellular milieu. The role of Gram-positive EVs
in cell-to-cell communication, and their interactions
with the host immune system remain poorly under-
stood. Similarly, the interaction of eukaryotic immune
EVs with pneumococcus remains unexplored. In this
study, EVs from pneumococci and pneumococci-con-
ditioned macrophages were isolated and reciprocal
interaction between the host and the microbe was
explored.
Methods: EVs from pneumococci and pneumococci-
conditioned macrophages were isolated using size
exclusion chromatography and characterized by trans-
mission electron microscopy, dynamic light scattering,
tunable resistive pulse sensing and western blotting.
Effects of pneumococcal EVs on different immune
cell subsets were assessed using flow cytometry, wes-
tern blotting and immunostaining. Effects of EVs on S.
pneumoniae were assessed by evaluating their growth
kinetics and biofilm development.
Results: Pneumococcal EVs were internalized by var-
ious immune cells and conversely, eukaryotic EVs from
J774A.1 cells were taken up by both Gram-positive and
Gram-negative bacteria. In a reporter murine macro-
phage cell line (RAW 264.7), pneumococcal EVs
induced NF-kB expression in a dosage-dependent
manner and induced p65 nuclear translocation in
human primary macrophages. Pneumococcal EVs also
activated primary human CD4+ and CD8 + T cells as
evidenced by their CD69 upregulation in a dose and
time-dependent manner. Moreover, EVs secreted by S.
pneumoniae promoted their own planktonic growth
and biofilm development in a dose-dependent manner.
Summary/Conclusion: For the first time, we show that
eukaryotic EVs are taken up by Gram-positive bacteria.
Our data also indicate that pneumococcal EVs have
immunomodulatory effects on the host immune cells
and represents a sophisticated communication system
that needs further investigation.
OF18.04
Calpain carried by platelet-derived microparticles mediates protease-
activated receptor 1-dependent vascular inflammation in diabetes.
Anastasia Kyselova, Amro Elgheznawy, Ingrid Fleming and Voahanginirina
Randriamboavonjy
Goethe University, Frankfurt, Germany
Introduction: Diabetes mellitus is a major risk factor for
cardiovascular diseases and platelet hyperactivation in
diabetes is linked to the release of platelet-derived
microparticles (PMPs) that carry the Cab+-activated pro-
tease calpain 1 (CAPN1). Here we determined whether
CAPN1 could target proteins on the vascular wall that
could precipitate the development of vascular disease.
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Methods: Mass spectrometry and ELISA were used to
analyse proteins in the culture medium. Protein levels on
the surface of endothelial cells weremeasured by FACs and
en-face immunostaining was used to assess protein levels
on intact aorta. Diabetes was induced with streptozotocin.
Results: In vitro treatment of human endothelial cells
with PMPs or recombinant calpain 1(CAPN1) led to a
decrease in endothelial protein C receptor (EPCR) levels
on the cell surface and an increase in its levels in the
culture medium. In agreement, EPCR levels were
increased in plasma from diabetic patients. Also, dia-
betes induction in mice led to a similar increase in
plasma EPCR levels, an effect prevented by treatment
with the calpain inhibitor. At the molecular level,
CAPN1 did not directly target the EPCR but rather
cleaved the protease-activated receptor 1 (PAR-1), indu-
cing an intracellular signalling cascade i.e the phosphor-
ylation of protein kinase C (PKC) and the extracellular
regulated kinase (ERK) as well as the activation of the
tumour necrosis factor (TNF)- converting enzyme
(TACE). The latter was responsible of EPCR shedding
as well as of the increased local TNF- levels. TNF-
triggered the phosphorylation of the p65 subunit of
NFκB, increased ICAM-1 expression and enhanced
monocyte adhesion. The same phenomenon was evident
in vivo as en-face preparations of aortae from diabetic
mice revealed a loss of PAR-1 but induction of ICAM-1
which could be prevented by CAPN inhibitor or by
specific knocking out of CAPN1 in platelets (PF4-
Capn1-/-). All of the effects of PMPs or CAPN1 were
abolished in PAR-1-deficient endothelial cells.
Summary/Conclusion: These data demonstrate that pla-
telet-derived calpains contribute to diabetes-associated
vascular inflammation by targeting the PAR-1 receptor.
Funding: Deutsche Forschungsgemeinschaft RA 2435/
3-1.
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Plasma-derived extracellular vesicles from P. vivax patients increase
ICAM-1 expression of human spleen fibroblasts facilitating adherence
of infected reticulocytes
Haruka Todaa, Wanlapa Roobsoongb, Miriam Díaz-Varela1a, Barbara Baroc,
Marcus VG Lacerdad, Pilar Armengole, Jetsumon Sattabongkotb, Carmen
Fernandez-Becerraf and Hernando A del Portillog
aISGlobal Institute for Global Health, Hospital Clínic – Universitat de
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Tropical Medicine, Mahidol University, Bangkok, Thailand; cFundaçao de
Medicina Tropical Dr. Heitor Vieira Dourado (FMT-HVD), Manaus, Brazil;
dFundaçao de Medicina Tropical Dr. Heitor Vieira Dourado (FMT-HVD),
Manaus, Brazil, and Instituto Leônidas & Maria Deane (ILMD), Fiocruz,
Manaus, Amazonas, Brazil., Manaus, Brazil; eInstitut d’Investigació
Germans Trias i Pujol (IGTP), Badalona/Barcelona, Spain; 6ISGlobal
Institute for Global Health, Hospital Clínic – Universitat de Barcelona,
Barcelona, and Institut d’Investigació Germans Trias i Pujol (IGTP),
Badalona/Barcelona, Spain; 7ISGlobal Institute for Global Health, Hospital
Clínic – Universitat de Barcelona, Barcelona, and Institut d’Investigació
Germans Trias i Pujol (IGTP), Badalona/Barcelona, Spain, and Institució
Catalana de Recerca i Estudis Avançats (ICREA), Barcelo, Barcelona, Spain
Introduction: Using a reticulocyte-prone rodent
malaria model, resembling P. vivax, our group demon-
strated cytoadherence of infected reticulocytes to
spleen blood barrier cells of fibroblastic origin
(Martin-Jaular et al., 2011). Here, as extracellular vesi-
cles (EVs) play a role in intercellular communication,
we hypothesized that plasma-derived EVs from natural
vivax infections (PvEVs) signal human spleen fibro-
blasts facilitating adherence of P. vivax, a reticulocyte-
prone human malaria parasite.
Methods: Upregulation of ICAM1 and other targeted
genes upon uptake of PvEVs in human spleen fibro-
blasts (hSF) was determined by qRT-PCR. Expression of
ICAM1 was validated by FACS. NF-kB nuclear translo-
cation analysis was determined by confocal microscopy.
The binding capacity of P. vivax-infected reticulocytes
from infections upon uptake of PvEVs was tested after
maturation and purification of frozen estabilates of iso-
lates from Mae Sot (Thailand). P. vivax-infected reticu-
locytes were incubated with hSF previously stimulated
with PvEVs, hEVs or PBS, and the number of binding
parasites determined by microscopy.
Results: ICAM-1, a known receptor for binding of
malaria, was specifically upregulated by EVs from
infections in a dose-dependent manner at mRNA and
protein levels. NF-κ B was observed both in the cyto-
plasm and the nucleus on non-stimulated and hEVs-
stimulated hSF, whereas PvEVs stimulation induced
nuclear translocation of NF-κ B on hSF. By comparing
the binding of iRBCs to hSF, we last demonstrated
significant higher binding to the cells after uptaken of
exosomes from infections.
Summary/Conclusion: These results suggest that cir-
culating exosomes from vivax malaria infections have
spleen-tropism signalling spleen fibroblasts to induce
ICAM-1 through NF-kB and facilitate adherence of
infected reticulocytes. Thus, unveiling molecular
insights of cytoadherence in P. vivax infections.
Funding: Funded by Generalitat de Catalunya,
Ministerio Español de Economía y Competitividad,
REDiEX, and Fundación Ramón Areces. HT is recipi-
ent of an AGAUR PhD fellowship
OF18.06
Oxidative stress alert by extracellular vesicles, in vitro study in ocular
drainage system
Natalie Lernera, Sofia Schreiber-Avissara and Elie Beit-Yannaib
aClinical biochemistry and Pharmacology department, Ben-Gurion
University, Beer-Sheva, Israel; bBen-Gurion University, Beer-sheva, Israel
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Introduction: The ocular drainage system is chroni-
cally exposed to oxidative stress (OS) contributing to
cataract and primary open angle glaucoma (POAG)
development. Classical markers of OS were found in
patients ocular drainage tissues. The ability of EVs to
deliver OS alert messages between the aqueous humor
producing cells named non pigmented ciliary epithe-
lium (NPCE) end the Trabecular Meshwork (TM) cells
draining the aqueous humor was studied.
Methods: NPCE cells were exposed to OS and their
released EVs were collected (Ox-EV). Non-stressed
NPCE derived EVs (N-EV) were used as control. TM
cells exposed to the same OS were treated with Ox-EV
or N-EV and non-stressed TM cells were use as con-
trol. The EV treatment effect was measured by Nrf2-
Keap1 signaling pathway changes including Nrf2
expression, related antioxidant gene expression, SOD
and Catalase activity and TM cell antioxidant capacity.
Results: TM cells exposed to OS caused a significant
25% reduction in viability. When treated with Ox-EV
the viability decrease was abolished. This cell rescue
effect was not shown with N-EV treatment. Increase in
Nrf2 cytosolic and nucleic expression was found fol-
lowing TM oxidative stress. Some nucleic but not
cytosolic increase was found when N-EV treatment
was done. The most pronounced significant increase
cytosolic and nucleic expression was found following
Ox-EV treatment. Antioxidant gene expression showed
a significant increase following Ox-EV treatment in
SOD2, GPx, HOX1 and NRF2 an effect that was not
archived following N-EV treatment. SOD1 gene
expression decreased following N-EV treatment but
did not change when Ox-EV were used. Using the
DCF-DA analytical method for total antioxidant capa-
city of TM cells we found that OX-EV treatment
resulted in significantly higher antioxidant capacity vs
N-EV or untreated TM cells. The two major antioxi-
dant enzymes, SOD and Catalase activity was signifi-
cantly higher following OX-EV treatment.
Summary/Conclusion: EVs are capable of OS alert to
other cell resulting in a better antioxidant capacity.
This phenomenon is relevant probably for all cells,
can be the result of EVs cargo modification under OS
including proteins and miRNAs or/and oxidized pro-
teins, lipid and nucleic acids carried by the EVs as
cargo or on their surface.
Funding: ISRAEL SCIENCE FOUNDATION (grant
No. 1315/ 14).
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From adults to centenarians: characterization of T cell
immunosenescence markers on plasma extracellular vesicles and
their influence on T cell activation, viability and interleukin secretion
Ainhoa Alberroa, Iñaki Osorio-Querejetaa, Leire Iparraguirrea, Susana
Carregalb, Natalia Elguezabalc, Itziar Vergaraa, Adolfo López de Munaind,
Matías Sáenz-Cuestaa and David Otaeguia
aBiodonostia Health Research Institute, Donostia – San Sebastián, Spain;
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Derio, Spain; dDonostia University Hospital and Biodonostia Health
Research Institute, Donostia – San Sebastián, Spain
Introduction: Aging is a universal, complex and het-
erogeneous process that leads to reduced adaptation
capacity and increased vulnerability. Two of the hall-
marks of aging are cellular senescence and altered
intercellular communication. Specifically, the dysfunc-
tion and accumulation of senescent cells of the
immune system is called immunosenescence.
Regarding intercellular communication, the term
senescence-associated secretory phenotype (SASP) is
used and while inflammaging has been broadly studied,
the role of extracellular vesicles (EVs) remains unclear.
In the present work, we investigated the senescent
features of plasma EVs and their role in T cell activa-
tion, viability and interleukin (IL) secretion.
Methods: All participants (24–104 years) gave
informed consent and the study was approved by the
Donostia University Hospital Ethics Committee.
PBMCs were isolated with Ficoll-Hypaque method
and EVs by differential centrifugation as described
before by our group (Saenz-Cuesta et al., 2015). T
cells were characterized by flow cytometry (FC)
(FACSCanto II). Isolated EVs were detected by
cryoEM, NTA and FC. The immunosenescence mar-
kers of EVs were also assessed by FC (CytoFLEX).
Coculture experiments of PBMCs and EVs were per-
formed and activation of T cells was induced by PHA.
Cultured cells were evaluated by FC and the super-
natants by Luminex for IL measurement.
Results: Senescent T cells accumulate with age, and
CD8 cells are more affected than CD4 cells. Most of
isolated EVs are 100–200 nm. They carry characteristic
EV markers (CD63, CD81, CD9) as well as T cell
markers, but no accumulation of EVs with senescent
features was found with age. The co-culture of plasma
EVs with PBMCs influences diverse aspects of T cells.
They enhance cell viability. Besides, under PHA stimu-
lation, EVs influence T cell activation and interleukin
secretion. Interestingly, the effect of plasma EVs is
distinct depending on the age of the donor.
Summary/Conclusion: Plasma EVs bear characteristic
tetraspanins and T cell markers and can be detected by
FC. However, EVs with senescent features do not accu-
mulate with age. Moreover, EVs can influence T cell
viability activation and IL secretion in vitro.
Funding: AA, IOQ and LI are supported by a fellow-
ship from the Dept. of Education of the Basque
Government
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Profiling tetraspanin expression patterns on the surface of
retroviruses and extracellular vesicles by nanoscale flow cytometry
Vera Tang, Tyler Renner; Anna Fritzsche; Mariam Maltseva and Marc-André
Langlois
University of Ottawa, Ottawa, Canada
Introduction: Tetraspanins are membrane-associated
proteins with variable functions. Given that extracellu-
lar vesicles (EVs) bud from the membranous structures
of the cell, whether it be at the cell surface or through
the endosome, they serendipitously uptake these mem-
brane-spanning proteins, most notably CD9, CD63 and
CD81. Retroviruses share numerous biophysical and
biochemical features with EVs, and especially small
EVs in the 80 – 150nm size range. They also have a
membrane-derived envelope that captures tetraspanins,
as they too can egress from the cell surface and from
the endosomal pathway. Here we attempt to distin-
guish EVs from retroviruses according to their surface
tetraspanin expression profiles.
Methods: Using nanoscale flow cytometry (NFC), we
assessed the expression of tetraspanins CD9, CD63 and
CD81 by optimized antibody labelling on different
fluorescent retroviruses including murine leukemia
virus (MLV), avian leukosis virus (ALV), and the
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human immunodeficiency virus-1 (HIV-1). These ret-
roviruses were engineered to express either eGFP or
superfolder GFP (sfGFP) on their surface as a fusion
protein with the viral envelope glycoprotein. We also
analysed endogenous retroviruses released from mur-
ine T cell lines EL-4 and BW5147, and from primary
splenocytes from various mouse strains.
Results: Differential levels of CD9, CD63 and CD81
expression was observed among the retrovirus strains.
Also, the type of fluorescent reporter present influ-
enced tetraspanin capture on the surface of these
viruses. Overall, these expression patterns appear dis-
similar to those present on EVs released from unin-
fected cells. Analysis of murine T cells lines and
primary splenocytes also exhibit release of endogenous
retroviruses, which was confirmed by Western Blot
analysis of the p30 capsid protein.
Summary/Conclusion: Taken together, these findings
suggest that caution must be exercised in the use of
tetraspanins as identifying markers for EVs as they are
also highly expressed on retroviruses, which are known
to be prevalent in most animal species including birds,
mice and humans. Furthermore, mouse studies should
control for the presence of endogenous retroviruses,
which may contaminate EV sample preparations.
Funding: Natural Sciences and Engineering Research
Council of Canada (NSERC)
PF01.03
Isolation of EVs derived from human oral keratinocytes
Younggap Lim and Bong-Kyu Choi
Department of Oral Microbiology and Immunology, School of Dentistry,
Seoul National University, Jongno-gu, Seoul, Republic of Korea, Seoul,
Republic of Korea
Introduction: Oral keratinocytes are the first defense
line against external environments such as chemical
agents, microbes and physical factors. Stimulated oral
keratinocytes produce cytokines/chemokines to modu-
late local inflammatory status. Based on recent
researches, not only cytokines/chemokines but extra-
cellular vesicles (EVs) also regulate immune response.
Therefore, we hypothesized that oral keratinocytes
release EVs and those EVs could modulate immune
response in the gingival tissue.
Methods: EVs were isolated from human oral kerati-
nocytes (HOK-16B) by ultracentrifugation (UC) and
commercial EVs isolation kit and analysed by western
blotting and Nanoparticle Tracking Analysis (NTA).
Results: To exclude EVs originated from cell culture
medium, we compared three different keratinocyte cul-
ture media, then we chose medium that contained the
smallest number of particles. Two million HOK-16B
cells released 10 billion EVs for 24 h. The EVs
expressed general EV markers such as CD9, CD63,
Flotillin-1 and Alix. According to the NTA the EVs
were heterogeneous in size.
Summary/Conclusion: HOK-16B cells released EVs
that have general EV markers. The EVs derived from
HOK-16B infected with periodontopathogen need to
analyse and confirm the biological function to other
cells.
Funding: This work was supported by National Research
Foundation of Korea grants (No. NRF-2018R1A5A2
024418 and NRF-2018R1A2A2A05018558).
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Air pollution effects on the clinical course of autoimmune diseases:
the role of extracellular vesicles
Mirjam Hoxhaa, Tommaso Schioppob, Simona Iodicea, Laura Pergolia, Nicola
Ughib, Luca Ferraria, Francesca Ingegnolib and Valentina Bollatia
aUniversity of Milan, Department of Clinical Sciences and Community
Health, Milan, Italy; bDivision of Clinical Rheumatology, G. Pini Hospital,
Milano, Italy
Introduction: Autoimmune diseases (ADs) are charac-
terized by the body’s intolerance to self-antigens. The
cause of autoimmunity is still unknown. However, it is
generally accepted that ADs might be triggered by
environmental factors able to increase inflammation.
In recent years, extracellular vescicles (EVs) have been
described to play an important role both in ADs patho-
genesis and environmental toxicants, such as particu-
late matter (PM). The aim of our study is to evaluate
PM effects on EV release in ADs.
Methods: We recruited 24 patients with ADs (12
Rheumathoid Arthritis, RA and 12 Systemic Sclerosis,
SSc) and 12 patients with Osteoarthritis (OA), a non-
autoimmune inflammatory disease taken as control.
Plasma EVs were analysed by Nanosight and flow
cytometry after labelling with the following markers:
CD14+ (monocyte), CD61+ (platelet), CD25+ (T-reg),
ERVWE1+ (human endogenous retrovirus W), HLAG
+ (human leukocyte antigen G). PM10 and PM2.5
concentrations at the residency of each subject were
obtained from the regional air quality monitoring
network.
Results: The increase of PM2.5 led to a decrease of
MVs CD14+ (β = −0.13; p < 0.01) and CD61+
(β = −0.08; p = 0.05) in RA, of ERVWE1+ in both
SSc (β = −0.10; p = 0.01) and OA (β = −0.09; p = 0.01),
and of HLA+ (β = −0.12; p < 0.01) only in SSc. Similar
results were observed analyzing PM10 exposure.
Analysis of EVs concentration according to their
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dimensions showed a negative association in the size
range of exosomes (63–92 nm) in RA and SSc com-
pared to OA (p < 0.05). Finally, we observed a negative
association between exosomes and C-reactive protein
(β = −1.99; p = 0,03), and a positive association
between ERVWE1+ and Erythrocyte Sedimentation
Rate (ESR) (β = 0.53; p = 0,06) and HLA+ and ESR
(β = 0.29; p = 0,01).
Summary/Conclusion: Our findings showed that PM
exposure could be a further risk factor of autoimmu-
nity through a modulation of EV release.
PF01.05
The immunomodulatory effects of human umbilical cord perivascular
cell-derived extracellular vesicles on T lymphocyte differentiation
Ching-Po Huanga, Lianet Lopezb, Daniel Ngb, Ansar Khanb, Peter Szarazc,
Denis Gallagherb, Andrée Gauthier-Fisherb and Clifford Librachd
aCReATe Fertility Centre, Toronto, Ontario, Canada, National Yang Ming
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ON, Canada; dCReATe Fertility Centre, Toronto, ON, Canada. Department
of Obstetrics & Gynecology, University of Toronto, Toronto, Canada.
Institute of Medical Sciences, University of Toronto, Toronto, Canada
Introduction: We have characterized human umbilical
cord perivascular cells (HUCPVC) as a promising
source of mesenchymal stromal cells (MSC). Our pre-
vious data from in vitro and in vivo models of myo-
cardial infarction and neurovascular injury support
that HUCPVCs have potent immunomodulatory prop-
erty, and in many cases, are superior to bone marrow
MSCs. The immunomodulatory effects of HUCPVCs
are thought to be contributed by paracrine factors.
However, the role of HUCPVCs in immunomodula-
tion is still unknown. Here, we reveal the immunomo-
dulatory effects of HUCPVC-derived extracellular
vesicles (EV) on T cell differentiation in vitro.
Methods: Conditioned medium (CM) was obtained
from sub-confluent first trimester (FTM) and term
HUCPVCs cultured for 48 hrs in serum-free RPMI
medium with or without cytokines (10 ng/mL of IFN-
γ, 15 ng/mL of TNF-α). HUCPVC-derived EVs were
enriched from CM using the Qiagen exoEasy Maxi kit,
followed by a Vivaspin 100k MWCO buffer exchange.
Human peripheral blood mononuclear cells (PBMC)
were isolated by Ficoll gradient with written informed
consent from healthy donors. PBMCs stimulated with
anti-CD3/CD28 beads were co-culture with HUCPVCs
or their EVs for five days. T cell differentiation and
proliferation were analyzed by flow cytometry.
Results: HUCPVCs elicited an immunomodulatory
effect by increasing the T regulatory cells/T effector
cell (Treg/Teff) ratio in a paracrine manner, which
could be partially impaired by the endosomal pathway
inhibitor, GW4869. In the CD4+ population,
HUCPVC-derived EVs promoted both the prolifera-
tion of Treg and Teff. Notably, the ratio of proliferating
Treg/proliferating Teff is increased by HUCPVC-
derived EVs treatment when compared to no cell-CM
control isolation, which eventually resulted in an
increase of Treg/Teff ratio. In the CD8+ population,
administration of HUCPVC-derived EVs significantly
shifted the CD8+ population towards a CD8low popu-
lation. We found no significant difference in the effect
of EVs derived from inflammatory primed and
unprimed HUCPVCs.
Summary/Conclusion: HUCPVC-derived EVs demon-
strated immunomodulatory effects by increasing Treg/
Teff ratio in the CD4 T helper cells and shifting the
cytotoxic T cell phenotype towards CD8low. We suggest
that HUCPVC-derived EVs represent a promising cell-free
immunomodulatory therapy.
PF01.06
Cytokine and miRNA profiling of plasma extracellular vesicles in
individuals with myalgic encephalomyelitis/chronic fatigue syndrome
Ludovic Giloteauxa, Adam O’Neala, Jesus Castro-Marrerob, Jennifer Grenierc,
Maureen Hansona
aDepartment of Molecular Biology and Genetics, Cornell University, Ithaca,
USA; bCFS/ME Unit, Vall d’Hebron University Hospital Research Institute
(VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain, Barcelona,
Spain; cRNA Sequencing Core, Department of Biomedical Sciences, College
of Veterinary Medicine, Cornell University, Ithaca, USA
Introduction: Myalgic encephalomyelitis/chronic fati-
gue syndrome (ME/CFS) is a debilitating disease of
unknown aetiology lasting for 6 months or more,
with features including fatigue, cognitive impairment,
myalgias, postexertional malaise, and immune system
dysfunction. Given the possibility that abnormal pro-
tein signaling could be altering cellular function in ME/
CFS, we aimed to characterize the cytokine/chemokine
profile and miRNA content of blood-derived
Extracellular Vesicles (EVs) in ME/CFS individuals
and healthy controls.
Methods: We included 35 ME/CFS patients and 35
sedentary controls matched for age, sex and BMI.
EVs were enriched from plasma by precipitation and
characterized by NTA, TEM and western blotting. A
43-plex immunoassay was used to determine cytokine/
chemokine concentrations in both plasma and isolated
EVs. Total RNA was isolated from EVs and small RNA
libraries were prepared and sequenced for miRNA
profiling.
Results: ME/CFS patients had significantly higher
levels of EVs than controls and morphological analysis
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showed a homogeneous population of vesicles in both
groups. Comparison of cytokine concentrations in
plasma and isolated EV for cases and controls yielded
few significant results. Cases had higher plasma levels
of MCP-1 and IP-10 and lower levels of RANTES, EGF
and GROβ. In isolated EVs, EGF and GROβ were also
significantly lower in patients while concentrations of
IL-12p70, IL-2 and GM-CSF were higher. Correlations
analysis revealed that CD40L was a negative driver of
TRAIL and IP-10 in patients but had no inverse asso-
ciations with other cytokines within the control group.
We also generated on average over 800,000 miRNA-
mapped reads per EV sample. A total of 316 mature
miRNAs sequences were detected and no significant
differences between groups after multiple corrections
were found. PCA analysis of all ME/CFS and control
miRNAs revealed a separation of the groups based
on PC4.
Summary/Conclusion: Higher levels of pro-inflamma-
tory cytokines were found in plasma and EVs from
ME/CFS patients and inter-cytokine correlations
revealed unusual regulatory relationships among cyto-
kines in the ME/CFS group that were not apparent in
the control group. Studies with expanded cohorts are
needed to increase power of analysis.
Funding: This project was funded by NIH NIAID R01
AI107762.
PF01.08
Immunomodulatory exosomal signalling mediated by porous
templated scaffolds
Thomas Hady, Billanna Hwang and James Bryers
University of Washington, Seattle, USA
Introduction: Porous templated scaffolds (PTS) with
pores 40 µm in diameter drive healing upon implanta-
tion by reducing inflammation and foreign body rejec-
tion while increasing local angiogenesis. Macrophage
recruitment and polarization are known to play roles in
this phenomenon, but the mechanism driving this
healing response is poorly understood. We believe
40 µm PTS resident immune cells are releasing exo-
somes containing unique cargo that modulates healing
by influencing CD4+ T cell subsets.
Methods: We quantified the cellular origin and inter-
nal composition of exosomes isolated from explanted
40 µm and 100 µm PTS using a Cre-Lox double trans-
genic mouse model and qPCR, respectively. We then
quantified the cellular response to these exosomes in
vitro using qPCR, ELISA and cell proliferation assays.
Results: Our evidence shows that immortalized T cells
treated with exosomes isolated from explanted 40 µm
PTS significantly down regulate TNF-α expression
without other transcriptomic effects. Moreover, pri-
mary co-stimulated (CD3/CD28) T cells treated with
exosomes from macrophages (MØ) resident to 100 µm
PTS exhibited broad transcriptional upregulation and
significantly upregulated proportional expression of
several pro-inflammatory genes: TNFα, TBX21,
GATA3 and TGF-β1. When treated with exosomes
from MØ in 40 µm PTS, these T cells exhibited no
broad transcriptional upregulation but proportionally
upregulated immunomodulatory T cell phenotypic
markers FoxP3 and IL-10.
Summary/Conclusion: These data show that exosomal
signalling of PTS resident cells is controlled by pore
size, thus influencing T cell differentiation and host
response. Particularly, exosomes from cells in 100 µm
PTS proportionally upregulate T cell markers asso-
ciated with Th1, Th2 and Th3 T cell subpopulations
and transcriptomic stimulation, whereas exosomes
from 40 µm PTS induce a proportional upregulation
of T cell markers associated with immunomodulatory
Tregs, without broad transcriptomic stimulation. Our
next experiments will examine the ability of exosomes
generated in 40 µm PTS to recapitulate a healing
response in implants known to otherwise promote the
foreign body response.
PF01.09
Extracellular vesicles in systemic sclerosis as potential mediator for
pulmonary vascular disease
Federica Rotaa, Alessandro Albinib, Marco Vicenzib, Rosa Casellab,
Santaniello Alessandrob, Lorenzo Berettab, Jacopo Marianic, Laura
Cantonea, Laura Dionia, Valentina Bollatic and Federico Lombardib
aEPIGET LAB, Department of Clinical Sciences and Community Health,
Università degli Studi di Milano, Milan, Italy; bFondazione IRCCS Ca’
Granda Ospedale Maggiore Policlinico, Milan, Italy; cUniversity of Milan,
Department of Clinical Sciences and Community Health, Milan, Italy
Introduction: Pulmonary vascular disease (PVD) is
characterized by media muscular hypertrophy/hyper-
plasia. Recently, the deregulation of EVs in some forms
of pulmonary hypertension studies has been reported,
but data on pulmonary vascular disease are still lack-
ing. We investigated whether EVs from SSc patients
with or without established PVD can induce hypertro-
phy and/or hyperplasia in in vitro smooth muscle cells
and to study vesicular miRNAs expression.
Methods: We isolated plasma EVs from: 3 SSc-PAH
patients with established PVD under target therapy
[PH+]; 3 SSc patients with high clinical risk without
PVD [PH−]; 3 early SSc patients with low clinical risk
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[Ea]; and 3 healthy control subjects. Smooth muscle
cells were cultured in RPMI complete medium
enriched with EVs purified from each study subject.
Real-time cell growth was analysed with xCELLigence
RTCA. miRNAs from both plasma and medium cell
EVs were characterized and target prediction was per-
formed via Diana Tools mirPath 2.0.
Results: Real-time analysis of cellular growth showed a
brisker growth in every aliquot exposed to EVs with
respect to the control. The intergroup comparison
showed that EVs from controls induced an inferior
growth in terms of cell index and doubling time. PH−
showed the greatest effect on cell growth with respect
to Ea and PH+ treated subjects. The most deregulated
miRNA was miR-324-3p which was strongly downre-
gulated in PH−, weakly downregulated in PH+ and
upregulated in Ea. Bioinformatics prediction for 324-
3p showed it to target lipids synthesis and metabolism
pathways.
Summary/Conclusion: These results provide evidence
that EV content may predispose to PVD. The observed
miRNA is potentially linked with the effect on cellular
growth, suggestive of a role in subjects with high risk to
develop PVD. The potential implication of deregulated
miRNAs, especially 324-3p, on lipids metabolism indi-
cates that this pathway could be involved in the patho-
genesis of SSc-PVD.
PF01.10
Extracellular vesicles-associated cytokines in human pathologies
Leonid Margolis
Section of Intercellular Interactions, Eunice Kennedy Shriver National
Institute of Child Health and Human Development, National Institutes of
Health, Bethesda, MD, USA
Introduction: Many human diseases progress due to
low-level chronic immune activation associated with
the release of cytokines. Recently, we found that
many cytokines are released in association with extra-
cellular vesicles (EVs) rather than in the soluble form.
Here, we investigated these EV-associated cytokines in
three human diseases that are known to be facilitated
by improper immune activation.
Methods: Multiplexed bead-based assays of 33 free and
EV-associated cytokines in culture supernatants, plate-
let poor plasma and amniotic fluid.
Results: HIV disease: Infection of human lymphoid
tissue by HIV-1LAI.04 resulted in the increased release
of cytokines of which IL-7, IL-21, IFN-, MIP-1 and
RANTES were selectively increased in EV-associated
form. After 13 days of tissue treatment with combined
anti-retroviral therapy (ART) cytokines, in particular,
those that were associated with EVs, remain upregu-
lated in spite of complete suppression of HIV replica-
tion. Cardiovascular disease: Myocardial infarction
(STEMI) is associated with increased production of
various cytokines of which IL-2, IL-6, IL-18, Gro-α
and MIG were selectively increased in EV-associated
form. Logistic regression analysis of a cohort of 110
individuals demonstrated that healthy controls and
STEMI patients can be discriminated solely based on
the analysis of EV-associated cytokines with 82.3%
sensitivity and 85.4% specificity. Pregnancy complica-
tions: Amniotic fluid from pregnancies with intra-
amniotic infection (IAI) demonstrated significantly
increased concentrations of almost all cytokines in
EV-associated form, as well as an increase of cytokine
fraction released in EV-associated form.
Summary/Conclusion: The increase of EV-associated
cytokines is a common denominator for diverse human
diseases associated with chronic immune activation.
For three diverse human pathologies, we observed
increased cytokines packaging in EVs. In HIV infection
EV-associated cytokines failed to return to baseline
with ART, increases in STEMI allow for discrimination
from controls, and IAI increases EV-associated cyto-
kines. EV-associated cytokines may contribute to var-
ious disease progressions and can be developed into
diagnostic tools.
Funding: NIH/NICHD Intramural Program.
PF01.11
Isolation and characterization of serum exosomes from Cystic Fibrosis
patients receiving lung transplant
Ruying Chen, Billanna Hwang, Erika D. Lease, Ryan V. Abbaszadeh, James
Bryers, Michael S. Mulligan
University of Washington, Seattle, USA
Introduction: Lung transplantation is an important
therapeutic option for Cystic fibrosis (CF) patients
with end-stage lung diseases. Long-term survival has
been impaired by various post-transplant complica-
tions. There is a critical need for development of meth-
ods to noninvasively monitor and evaluate patient
recovery. Exosomes are the key mediator of intercellu-
lar communication, regulator of immune system and
have been considered a promising candidate for liquid
biopsy. Here, we developed imaging flow cytometry
method that enables easy quantification and character-
ization of the exosomes surface markers in clinical
samples. We profiled circulating exosome in serum
isolated from a cohort of CF lung transplant patients
with two macrophage and T cell-associated panels.
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Methods: Serum samples were acquired from 30 CF
patients 0, 1, 3, 6 and 12 months following lung trans-
plantation. Upon isolation, exosomes were labelled
with CFSE and a macrophage (CD68, CD86, CD163)
or T cell panel (CD3, CD4, CD8, CD45RO). Flow
cytometry analysis was carried out with Amnis
Imagestream X Mark II. Results were analysed with
patients’ clinical indicators including pulmonary func-
tion tests (PFTs) and chronic lung allograft dysfunction
(CLAD) diagnosis.
Results: Using optimized staining protocol, exosomes
isolated from a wide range of patient samples were
labelled consistently. All seven selected surface markers
were detected on circulating exosomes. Results indicate
that markers were selectively expressed on exosomes
and do not follow the classic immune cell subsets.
Results indicated that pan markers (CD68, CD3)
expressions were lower than some subset markers,
especially pro-inflammatory CD86. Patients diagnosed
with CLAD showed higher percentage of macrophage
surface markers consistently than the ones without
CLAD. Additionally, patients not diagnosed with
CLAD demonstrated a higher percentage of CD45RO
expressing exosomes than those with CLAD at
6 months.
Summary/Conclusion: Detection and profiling of
macrophage and T cell associated surface markers on
circulating exosomes provide additional insights into
patients’ recovery and immune processes. Imaging flow
cytometry-based exosome profiling represents a novel
and promising strategy in CF patients post-transplant
follow-up.
Funding: 265-2368 LTR Training Funds Mulligan (PI)
09/01/2010-12/1/2025.
PF01.12
Loss of TP53 modifies the quantity and protein load of extracellular
vesicles in leukemic B-cells
Elena Izquierdoa, Daniela Vorholtb, Janica Wiedersteinc, Liudmila
Lobastovab, Stuart Blakemoreb, Marcus Krügerc, Hinrich Peter Hasenb,
Michael Hallekd and Christian Pallaschb
aDepartment I for Internal Medicine and CECAD, University Hospital of
Cologne, Bonn, Germany; bDepartment I for Internal Medicine and CECAD,
University Hospital of Cologne, Köln, Germany; cGermany Institute for
Genetics and CECAD, Köln, Germany; dDepartment I of Internal Medicine,
University Hospital of Cologne, Center for Integrated Oncology Cologne-
Bonn, CECAD Center of Excellence on “Cellular Stress Responses in Aging-
Associated Diseases”,Center for Molecular Medicine Cologne, University,
Köln, Germany
Introduction: Macrophages are key effector cells of the
chemo-immunotherapy (CIT) response in B-cell malig-
nances. We have previously shown that loss of TP53 in
leukemic B-cells diminishes the anti-tumour capacity of
macrophages upon CIT. Here, we investigated the poten-
tial p53-dependent mechanisms in leukemic B-cells that
could alter the phagocytic capacity of macrophages
upon CIT.
Methods: The proteomic profile of control and TP53-
deficient leukemic B-cells, untreated or treated with
mafosfamide, was analysed by mass spectrometry.
EVs were isolated from control and TP53-deficient
leukemic B cells by differential ultracentrifugation and
their proteomic content was evaluated by mass spectro-
metry. Validation of protein expression was performed
by Western Blot and flow cytometry. The measure-
ments of exosomes concentration and size distribution
were performed by NanoSight NS300 and ZetaView.
Results: 244 of 5785 proteins were observed to be
significantly different between TP53-deficient and con-
trol leukemic B-cells, with 159 independent of mafos-
famide treatment, 147 associated to mafosfamide and
86 modifications shared between DMSO and mafosfa-
mide treatment. Enrichment analysis for GO terms
showed that TP53-deficient leukemic B-cells exhibited
mainly altered expression of proteins associated with
EVs. We confirmed that TP53-deficient leukemic B-
cells produced higher concentration of EVs and that
the EV-protein content differed from control leukemic
B-cells. Notably, 1239 of 2663 proteins were signifi-
cantly different between TP53-deficient and control
leukemic B-cells, 68 were exclusively detected in the
control-derived EVs and 128 proteins were only found
in the TP53-deficient-related EVs
Summary/Conclusion: The loss of TP53 drastically
modifies the proteomic profile of leukemic B-cells
and influences the protein expression of leukemic B-
cells upon mafosfamide treatment. Especially, the loss
of TP53 regulates the EV-related protein expression
and EV production in leukemic B-cells
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PF02.01
The effect of exosome purification method on the detection of
amyloid β in exosomes with Photooxidation-Induced Fluorescence
Amplification (PIFA)
Youhee Heoa, Min Cheol Parkb, SangYun Kimc, Kwanwoo Shind and Ji Yoon
Kange
aKorea Institute of Sceince and Technology, Seoul, Republic of Korea;
bIntekBio, seoul, Republic of Korea; cSeoul national university bundang
hospital, seoul, Republic of Korea; dsogang university, soeul, Republic of
Korea; eKorea Institute of Science and Technology, Seoul, Republic of Korea
Introduction: Blood-based diagnosis of disease using
exosomes sometimes demands a highly sensitive bioas-
say to detect rare protein biomarkers. New assay meth-
ods were suggested to overcome the limitations of a
conventional ELISA system such as digital ELISA or
plasmonic ELISA. However, these methods need a spe-
cial expensive equipment with the long process. We
have developed a photo-oxidation-induced fluores-
cence amplification (PIFA) that can measure less than
1 pg/mL by continuous irradiation on resorufin for the
photooxidation of chemi-fluorescent substrate amplex
red. This paper demonstrated it can identify
Alzheimer’s disease (AD) patient from normal control
(NC) by measuring a low level of amyloid beta(Aβ) in
the neuronal exosome from plasma samples.
Methods: The level of resorufin was measured by PIFA
to compare with conventional ELISA. The oligomer Aβ
was detected by same antibody system whose capture
antibody is same as detection antibody to exclude the
signals from monomer Aβ. We isolated exosomes from
plasma samples (AD:4, NC:4) by three methods: ultra-
centrifuge(UC), CD9 antibody-coated magnetic beads
(MB) and ExoQuick with agarose precipitation (EQ).
Exosomes were lysed with RIPA buffer and Aβ as a
cargo protein in exosomes were measured by PIFA.
ELISA was performed by an automated machine
using polypropylene tip. After removing the tip with
HRP-tagged detection antibody, the fluorescence was
measured continuously to amplify the fluorescence.
Results: The LOD of PIFA in measuring oligomer Aβ
was less than 100 fg/mL that was lower than 2 orders of
magnitude than commercialized ELISA kit. The
dynamic range of PIFA assay is more than 5 decades.
The volume of plasma sample was 150 uL and the final
volume of exosome was almost the same. The
concentrations of UC and EQ are 8.16 × 10^10 and
5.77 × 10^10 particles/mL. The AUC (area under
curve) in identifying AD was 1.0, 1.0, and 0.875 by
UC, MB and EQ, respectively. The result showed it
could clearly identify AD from NC.
Summary/Conclusion: Exosome isolations using the
magnetic beads, the exosomes can be extracted even
in a small amount of less than 50 μl. Therefore, it is
advantageous that the sample is used less and the
exosome can be isolated quickly. We believe that the
reliability of human samples will be improved by an
additional number of testing samples and optimization
of PIFA assay.
PF02.02
Bioinformatic and biochemical evidence for extracellular vesicle
remodelling in Huntington’s disease
Francesca Farinaa, françois-Xavier Lejeuneb, Satish Sasidharan Nairb, Frédéric
Parmentierb, Jessica Voisinb, Lorena Martin-Jaularc, Clotilde Theryc and
Christian Nerib
aSorbonnes Université, Centre National de la Recherche Scientifique,
Research Unit Biology of Adaptation and Aging, Team Brain-C, Paris,
France; bSorbonnes Université, Centre National de la Recherche
Scientifique, Research Unit Biology of Adaptation and Aging, Team Brain-
C, Paris, France; cInstitue Curie, Paris, France
Introduction: Intercellular communication mediated
by extracellular vesicles (EV) is emerging as a mechan-
ism that is important to neuronal development and
survival. Here, we investigated the features of EV sig-
nalling in response to Huntington’s disease (HD), a
neurodegenerative disease that is caused by CAG
expansion in the Huntingtin gene and that shows a
significant degree of clinical heterogeneity.
Methods: We applied an integrated approach in which
we combined bioinformatic analysis of public HD data-
sets and biological analysis in cellular models of HD
pathogenesis.
Results: Using network methods to integrate high-
dimensional HD transcriptomic data, we built a com-
putational model of the transition between different
phases of the HD process: from cell differentiation
(early phase) to dysfunctional striatum (intermediate
phase) and finally advanced neurodegeneration (late
phase). This model evidenced the deregulation of a
set of genes associated with the biology of EVs from
184 ISEV2019 ABSTRACT BOOK
the earliest to latest phases of the disease. To test this
hypothesis experimentally, we analysed EVs in mouse
and human neuronal cell models of HD pathogenesis.
To this end, we analysed different EV subtypes, testing
for changes in secreted level and protein cargo compo-
sition. The results suggest that EV subtypes, especially
small EVs, possibly including exosomes, may be altered
in these cells.
Summary/Conclusion: Collectively, these data point to
EV remodelling in the course of HD. Biological and
clinical implications will be discussed.
Funding: ANR, France
PF02.03
HIV-1 Tat-induced astrocytic extracellular vesicle miR-7 impairs
synaptic architecture
Guoku Hu, Fang Niu, Ke Liao and Shilpa Buch
University of Nebraska Medical Center, Omaha, USA
Introduction: Although combination antiretroviral ther-
apy (cART) has improved the health of millions of those
living with HIV, the penetration into the CNS of many
such therapies is limited, thereby resulting in residual
neurocognitive impairment, commonly referred to as
NeuroHIV. Additionally, although cART can successfully
suppress peripheral viremia, there is a continuous persis-
tence of the cytotoxic viral Transactivator of transcription
(Tat) protein in tissues such as the brain, thereby con-
tributing to neuronal injury.
Methods: Transmission electron microscopy, NanoSight
and western blot analyses were used to characterize astro-
cyte-derived EVs (ADEVs). Among the various dysregu-
lated miRs in the ADEV cargo, miR-7 levels were found
to be upregulated by real-time PCR. Uptake of ADEVs by
neurons was assessed by confocal microscopy. Rodent
hippocampal neurons were exposed to Tat-ADEVs and
assessed for inhibitory (GAD65 and gephyrin) and exci-
tatory (vGlut1 and PSD95) synapses by immunostaining
and confocal microscopy.
Results: Expression level of miR-7 was upregulated in
the astrocytes from SIV+/HIV+ brains. In addition,
Tat-stimulated astrocytes also demonstrated upregu-
lated expression and release of miR-7 in the EVs, that
were taken up by neurons, resulting in synaptic injury.
Furthermore, our results also demonstrated that expo-
sure of hippocampal neurons to Tat-ADEVs resulted in
decreased expression of neuronal NLGN2, which in
turn, led to loss of both excitatory and inhibitory
synaptic densities. Moreover, we also demonstrated a
neuroprotective role of PDGF-CC in rescuing Tat-
ADEV-mediated synaptic loss.
Summary/Conclusion: We demonstrate that exposure
of astrocytes to HIV protein Tat mediates the induc-
tion and release of EV-miR-7 that is taken up by
neurons, leading in turn, to downregulation of neuro-
nal NLGN2 and ensuing synaptic alterations.
Importantly, synaptic impairment could be reversed
by pretreatment of neurons with a neurotropic factor
PDGF-CC.
Funding: This work was supported by grants DA040397,
MH112848 (S.B.) and DA042704, DA046831 (G.H.) from
the National Institutes of Health. The support by Nebraska
Center for Substance Abuse Research is acknowledged.
PF02.04
The pericytes-derived extracellular vesicle-mimetic nanovesicles
rescues erectile function by enchancing penile neurovascular
regeneration in a mouse model of cavernous nerve injury.
Jiyeon Ocka, Guonan Yinb, Mi-Hye Kwona, Kang-Moon Songa, Kalyan
Ghataka, Nguyen Nhat Minha, Min-Ji Choic, Yong Song Ghod, Ji-Kan Ryua
and Jun-Kyu Suha
aNational Research Center for Sexual Medicine and Department of Urology,
Inha University School of Medicine, incheon, Republic of Korea; bNational
Research Center for Sexual Medicine and Department of Urology, Inha
University School of Medicine, Incheon, Republic of Korea; cinha university
urology, incheon, Republic of Korea; dDepartment of Life Sciences, Pohang
University of Science and Technology, Pohang, Republic of Korea
Introduction: Extracellular vesicles (EVs) contains var-
ious proteins, mRNA and miRNA, that have many
regulatory effects on recipient cells. However, most
mammalian cells release low quantities of EVs, there-
fore, we use bioengineered method and extract extra-
cellular vesicle-mimetic nanovesicles from mouse
cavernous pericyte. The aim of this study was to inves-
tigate effectiveness of pericytes-derived extracellular
vesicle-mimetic nanovesicles (PC-NVs) in restoring
erectile function in cavernous nerve injury (CNI) mice.
Methods: Twelve-week-old C57BL/6J mice were used
and divided into into groups (N = 5 per group): sham
operation group and bilateral cavernous nerve crushing
group receiving a single intracavernous injection of
PBS (20 µl) or PC-NVs (0.1 µg, 1 µg, 5 µg/20 µl,
respectively). One week later, erectile function was
measured by electrical stimulation of the cavernous
nerve (N = 5 per group). The penis was then harvested
and stained with antibodies to CD31, NG2 and βIII
tubulin. We also determined the neurotrophic and
angiogenic potential of PC-NVs in an ex vivo major
pelvic ganglion (MPG) culture experiment.
Results: The PC-NVs was extract and characterized by
several EVs markers, such as CD63, CD81 and TSG101.
Intracavernous injections of PC-NVs significantly
improved erectile function in CNI mice, which reached
up to 84% of control values. PC-NVs induced significant
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restoration of cavernous contents of endothelial cells,
pericytes, and neuronal cells in CNI condition.
Moreover, PC-NVs promoted major pelvic ganglion
neurite sprouting in ex vivo culture experiment.
Summary/Conclusion: In light of critical role of neu-
ropathy in the pathogenesis of radical prostatectomy-
induced ED, pericytes-derived extracellular vesicle-
mimetic nanovesicles successfully restored erectile
function in cavernous nerve injury mice. Further stu-
dies are needed to clarify mechanism by which PC-
NVs induces neuropathy repair.
Funding: This work was supported by the National
Research Foundation of Korea (NRF) grant funded by
the Korea government (MSIP) (Guo Nan Yin,
2018R1C1B6003829).
PF02.05
Neuronal EVs and microglial activation in hypoxia
Yvonne Couch and Kate Lambertsen
University of Oxford, Oxford, UK
Introduction: There is significant data suggesting that
EVs play a key role in CNS injuries such as stroke.
During these types of injury the penumbral tissue
around the core of the injured area is hypoxic and
inflammatory. Here, we aimed to test the hypothesis
that hypoxia affects EV production in cells of the
neurovascular unit.
Methods: Using endothelial cells, microglia and neu-
rons, we subjected cells to short periods of oxygen and
glucose deprivation (OGD) measuring both the EVs
released into the medium, and the downstream effects
of these EVs on cells.
Results: Brain-derived endothelial cells (b.END3) and
microglia (BV-2) do not produce significant numbers
of EVs in response to hypoxia. However, N2A neuronal
cells do, both under normal and differentiated condi-
tions. These EVs appear to be pro-inflammatory when
applied to microglia in culture.
Summary/Conclusion: Together, these data suggest
that EVs produce pro-inflammatory EVs during peri-
ods of hypoxia, capable of activating microglia.
Characterizing these neuronal EVs more fully may
enable us to determine whether they are also able to
escape the CNS during brain injury and activate per-
ipheral macrophage populations.
Funding: MRF University of Oxford, Rose Trees Trust
PF02.06
Comprehensive study of vesicular and non-vesicular-associated
miRNAs from a volume of cerebrospinal fluid compatible with the
clinical practice
Endika Prieto Fernándeza, Ana Maria Aransayb, Felix Royoc, Esperanza
Gonzalezc, Juan Jose Lozanod, Borja Santos-Zorrozuae, Nuria Macias-
Camarab, Monika Gonzalezb, Raquel Perez Garayf, Javier Benitog, Africa
Garcia-Orada and Juan Manuel Falcon-Perezc
aDepartment of Genetics, Physical Anthropology and Animal Physiology,
Faculty of Medicine and Nursery, University of The Basque Country (UPV/
EHU), Leioa, Spain; bGenome Analysis Platform, CIC bioGUNE, Derio,
Spain; cExosomes Lab, CIC bioGUNE, CIBERehd, Derio, Spain;
dBioinformatics Unit, Centre Esther Koplovitz (CEK), CIBERehd,
Barcelona, Spain; eDepartment of Genetics, Physical Anthropology and
Animal Physiology, Faculty of Medicine and Nursery, University of The
Basque Country (UPV/EHU), Leioa, Spain; fBiochemistry service, Cruces
University Hospital, Barakaldo, Spain; gDepartment of Pediatric Emergency,
Cruces University Hospital, Barakaldo, Spain
Introduction: Cerebrospinal fluid (CSF) miRNAs have
emerged as a potential low invasive diagnostic tool for
central nervous system malignancies. However, they
have not yet been implemented in the clinic since
there is no a reliable and simple method established
to analyse the limited amount of CSF obtained from
patients, especially from infants.
Methods: We have compared six existing protocols for
characterizing miRNAs from a clinically rational volume
(i.e. 200 µl) of CSF. Four of the methods incorporated an
extracellular vesicles (EVs) enrichment step and the other
two aimed to extract miRNAs directly from cleared CSF.
The efficiency of each method was assessed by real-time
PCR (qPCR) and smallRNA sequencing (smallRNAseq).
Additionally, by size-exclusion chromatography, we
determined the distribution of miRNAs among different
CSF components.
Results: We found that NOR and INV protocols were
the most efficient. According to our results, NOR was
very reproducible by qPCR, showed a good miRNA
levels correlation between techniques, and presented a
user-friendly protocol starting from low volumes of
CSF. In addition, we identified a set of microRNAs
enriched in CSF exosomes that are involved in neuro-
developmental pathways.
Summary/Conclusion: We found that different proto-
cols purify specific miRNAs subpopulations and CSF
exosomes isolated by size-exclusion chromatography
contain miRNAs involved in neurodevelopment.
Funding: This work was supported by the Basque
Government [IT989-16]; the Spanish Ministry of
Economy and Competitiveness MINECO (SAF2015-
66312), and the Ramon Areces Foundation (FRA-17-
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JMF). We also thank MINECO for the REDIEX (Spanish
Excellence Network in Exosomes) and the Severo Ochoa
Excellence Accreditation (SEV-2016-0644).
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Identifying plasma-derived extracellular vesicle (EV) contained
biomarkers in the development of chronic neuropathic pain
Natasha Sosanyaa, Raina Kumarb, John Cliffordc, Roger Chavezd, George
Dimitrove, Seshamalini Srinivasanf, Aarti Gautamg, Alex Trevinoa, Rasha
Hammamiehh, Bopaiah Cheppudirai, Robert Christya, Stephen Crimminsj
aUSAISR, San Antonio, USA; bUSACEHR/FNLCR, Fort Detrick, USA; cUS
Army Center for Environmental Health Research, Frederick, USA; dCo-
Author, Floresville, USA; eUSCEHR; FNLCR, Fort Detrick, USA; fUS Army
Medical Research and Materiel Command, USACEHR, Frederick, USA; gUS
Army Center For Environmental Health Research, Frederick, USA;
hUSACEHR, Frederick, USA; iUS Army Institute of Surgical Research, San
Antonio, USA; jUS Army Institute of Surgical Research, San Antonio, USA
Introduction: Over 100 million Americans suffer from
chronic pain. However, research into potentially novel
biomarkers and therapeutics for chronic pain is lack-
ing. microRNAs (miRNAs) are attractive candidates as
biomarkers due to their conservation across species,
stability in liquid biopsies, and variation that corre-
sponds to a pathologic state. miRNAs can be sorted
into extracellular vesicles (EVs) within the cell and
released from the site of injury. EVs transfer cargo
molecules between cells thus affecting key intercellular
signalling pathways. The focus of this study was to
determine the plasma-derived EV miRNA content in
a chronic neuropathic pain model.
Methods: Male Sprague-Dawley rats underwent either
spinal nerve ligation (SNL; n = 6) or sham (n = 6)
surgery, while under anaesthesia. Mechanical allodynia
(MA) was assessed and plasma-derived EV RNA was
isolated at baseline and days 3 and 15 post-injury
followed by small RNA sequencing. Differentially
expressed (DE) miRNAs and gene target enrichment/
signalling pathways analysis was performed using R
packages and TargetScan/IPA, respectively.
Results: SNL rats displayed a time-dependent increase
in MA from day 3 to day 15 post-injury. Our results
indicate that 22 miRNAs at day 3, 74 miRNAs on day
15, and 33 miRNAs at both day 3 and 15 were
uniquely differentially expressed between the SNL
and sham groups. The plasma-derived DE EV
miRNAs were also found to regulate processes impor-
tant in the development and maintenance of neuro-
pathic pain states.
Summary/Conclusion: The key findings from this pro-
posal include (1) the majority of the DE EV miRNAs,
which normally function to suppress inflammation,
were downregulated, and (2) twenty-one of the
plasma-derived DE EV miRNAs reflect previously
observed changes in the injured L5 nerve. This suggests
that the plasma-derived EVs can potentially serve as
key regulators, biomarkers and targets in the progres-
sion and treatment of neuropathic pain.
Funding: This research was supported by Congression-
ally Directed Medical Research Programs-Applied Pain
Research (MR157005C). Research was conducted in com-
pliance with the Animal Welfare Act, and all other
Federal requirements. The views expressed are those of
the authors and do not constitute endorsement by the U.
S. Army.
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A pilot study to evaluate serum miRNA from extracellular vesicles of
neural origin for insight into neurological disorders
Michelle M. Barnetta, Michael Geaghana, Ebrahim Mahmoudia, Judith
Weidenhoferb and Murray Cairnsc
aUniversity of Newcastle, Australia, Callaghan, Australia; bUniversity of
Newcastle, Australia, Ourimbah, Australia; cUniversity of Newcastle,
Callaghan, Australia
Introduction: miRNA are important regulators of gene
expression and can be informative biomarkers of dis-
ease state. Alteration of miRNA expression in the brain
has been observed in several neurological and psychia-
tric disorders postmortem, but they are almost impos-
sible to non-invasively biopsy. These molecules,
however, have been observed in serum and serum
vesicles and have application as trait biomarkers.
While it is possible that brain disorders also have
systemic changes that contribute to the serum profile
it is reasonable to suspect that extracellular vesicles
(EV) that originated in the brain would have more
specificity and relevance to the neuropathology. In
this pilot study we investigated strategies for capturing
and profiling the miRNA content from extracellular
vesicles derived from the brain using an immunoaffi-
nity approach.
Methods: Whole blood from a healthy male volunteer
was collected in serum separator tubes, immediately
processed and stored at −80°C. Antibody-coupled
magnetic beads were incubated with serum and cell
culture EV. Enriched and non-enriched fractions were
recovered using a commercial spin column kit for EV
purification and RNA extraction. Small RNA libraries
were prepared for 75 cycles of single end multiplex
sequencing. Raw reads were converted to fastq, adap-
tors trimmed, reads mapped, aligned and counted.
Results: miRNA were identified in both total human
serum and the neural fractions. Functional annotation
of the 37 miRNA present in the neural EV revealed
that neuron projection was the most enriched cellular
JOURNAL OF EXTRACELLULAR VESICLES 187
component in predicted targets, suggesting that they
may serve to augment the synaptic regulatory environ-
ment. In support of this hypothesis, we found over
representation of all four cytoplasmic polyadenylation
element binding proteins (CPEB1-4) among targets
predicted to be regulated by the most abundant
miRNA. CPEB proteins affect translation of mRNA
bearing polyadenylation element sequences and
alterations in the expression of these proteins have
been associated with synaptic plasticity, intellectual
disability and autism spectrum disorder.
Summary/Conclusion: Serum EV can be enriched for
those of neuronal origin and this strategy may provide
insight into the brain’s regulatory environment and
ultimately more sensitive biomarkers of neurological
and psychiatric disorders.
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Promotion of metastasis via alteration of vascular endothelium by
tumour exosome miRNA
Masahiro Morimotoa, Nako Maishia, Aya Matsudaa, Tetsuya Kitamuraa,
Fumihiro Higashinoa, Yoshimasa Kitagawab, Yasuhiro Hidac and Kyoko
Hidaa
aVascular Biology and Molecular Pathology, Hokkaido University Graduate
School of Dental Medicine, Sapporo, Japan; bOral Diagnosis and Medicine,
Hokkaido University Graduate School of Dental Medicine, Sapporo, Japan;
cCardiovascular and Thoracic Surgery, Hokkaido University Graduate School
of Medicine, Sapporo, Japan
Introduction: We have reported that tumour endothe-
lial cells acquire diversity by cancer secreting factors.
Cancer cells secrete exosomes to create a suitable envir-
onment for themselves. miRNA (miR) is transported
by exosome from cell to cell. We have identified miR-
1246 that is more abundant in high metastatic mela-
noma (A375SM) exosomes compared with in low
metastatic melanoma (A375) exosomes by miRNA
array analysis. In this study, we investigated the role
of miR-1246 in alteration of the character of endothe-
lial cells (ECs). In addition, we addressed the mechan-
ism of cancer metastasis induced by miR-1246.
Methods: We focused on the adhesion between ECs
and between cancer cells and ECs. Changes in adhesion
molecule expression and endothelial permeability were
examined. We analysed the effect of the administration
of A375SM exosome and miR-1246 knockdown on
lung metastasis in vivo. In addition, exosome miR-
1246 levels in blood of melanoma and oral cancer
patients were compared with healthy subjects.
Results: miR-1246 transfection in ECs increased the
expression of adhesion molecule, ICAM-1 via activa-
tion of STAT3, and increased the number of adherent
cancer cells to ECs. Furthremore, A375SM exosome
treatment enhanced endothelial permeability. Also,
the expression of VE-Cadherin, which is intracellular
adhesion molecule of EC and function as EC barrier,
was downregulated by miR-1246 transfection. The tar-
get gene prediction database and reporter assay showed
that VE-Cadherin is the target gene of miR-1246.
Intravenous administration of A375SM exosome-
induced cancer cell colonization in the lung, resulting
in establish of lung metastasis. In contrast, miR-1246
knockdown in A375SM caused in decrease of lung
metastasis in vivo model. Exosome miR-1246 levels in
blood of melanoma and oral cancer patients were sig-
nificantly higher than those in healthy subjects.
Summary/Conclusion: Thus, it was suggested that
miR-1246 in tumour-derived exosomes promotes lung
metastasis by inducing the adhesion of cancer cells to
ECs and destroying the EC barrier.
PF03.02
Patient-derived circulating exosomes enhance cancer and stemness
properties through polymeric immunoglobulin receptor in liver
cancer
Sze Keong Tey and Judy Yam
The University of Hong Kong, Hong Kong, Hong Kong
Introduction: Hepatocellular carcinoma (HCC) is a
primary malignancy of liver which often diagnosed at
an advanced stage accompanied by extrahepatic metas-
tasis. Emerging evidences have demonstrated cancer
cells derived exosomes play an important role in inter-
cellular communication in tumour microenvironment
during metastasis. Thus, exosome research may solve
the mystery of metastatic organotropism in HCC.
Methods: Exosomes were isolated from HCC patients.
The biological effects of exosomes were studied using
transwell and matrigel invasion assays. The in vivo
effect of exosomes were analysed in mice by intrave-
nous injection of exosomes together with hepatoma
cells. The in vivo lung pulmonary vasculature and
vascular leakiness were revealed by FITC-lectin stain
and presence of Texas Red-dextran, respectively. Stem-
like properties were examined by spheroid assay and
flow cytometry. Proteomic profiling and expression
level of exosomal proteins were analysed by mass spec-
trometry and enzyme-linked immunosorbent assay
(ELISA), respectively.
Results: We recruited representative individuals of dif-
ferent stages of HCC development for the collection of
circulating exosomes, namely, exosomes of healthy
individual (Normal-Exo), patient with cirrhosis
(Cirrhosis-Exo), HCC patients at early stage (E-HCC-
Exo) and late stage with distant metastasis to lungs (L-
HCC-Exo). Among these exosomes, L-HCC-Exo
exhibited the highest effect in promoting HCC cell
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migration and invasion in vitro and colonization of
hepatoma cells in lungs. L-HCC-Exo also modulated
tumour microenvironment by enhancing pulmonary
vascular permeability. Along with cancerous beha-
viours, L-HCC-Exo induced stem-like properties such
as increased self-renewal, expressions of hepatic CSC
markers and drug resistance. Elevated level and activity
of β-catenin were also detected in cells stimulated by L-
HCC-Exo. Proteomic profiling of exosomal proteins
identified polymeric immunoglobulin receptor (pIgR)
to be markedly upregulated in L-HCC-Exo when com-
pared with exosomes of other subjects.
Summary/Conclusion: HCC patient-derived circulat-
ing exosomes augment cancer and stemness properties
through the activation of β-catenin signalling by exo-
pIgR, leading to a more aggressive phenotype in HCC
tumourigenesis and metastasis.
PF03.03
Ectopic ATP synthase induces extracellular vesicle release for cell-to-
cell communications
Yi-Chun Kaoa, Nai-Wen Changb, Yi-Wen Changa, Charles P. Laic, Hsuan-
Cheng Huangd and Hsueh-Fen Juane
aDepartment of Life Science, National Taiwan University, Taipei, Taiwan
(Republic of China); bInstitute of Molecular and Cellular Biology, National
Taiwan University, Taipei, Taiwan (Republic of China); cInstitute of Atomic
and Molecular Sciences, Academia Sinica, Taipei, Taiwan (Republic of
China); dInstitute of Biomedical Informatics, National Yang-Ming
University, Taipei, Taiwan (Republic of China); eNational Taiwan
University, Taipei, Taiwan (Republic of China)
Introduction: Ectopic Adenosine triphosphate
synthase (eATP synthase) is defined as ATP synthase
located on cell surface instead of inner membrane of
mitochondria. Our previous studies showed eATP
synthase located on lung cancer cell surface and gen-
erated ATP to extracellular space. Recently, several
reports indicated that the subunits of ATP synthase
were identified in extracellular vesicles (EVs) using
proteomics approach. However, where does ATP
synthase in EVs come from and what are the functions
of it are still unclear. We proposed the hypothesis: ATP
synthase in EVs may be conveyed from cell surface for
cell-to-cell communications.
Methods: Here we used immunochemistry to detect
eATP synthases and serial high-speed centrifugation
to isolate EVs including apoptotic bodies, microvesicles
and exosomes which were further confirmed by trans-
mission electron microscopy (TEM) and nano tracking
analysis (NTA). Furthermore, we used quantitative
proteomics by dimethyl labelling to profile the pro-
teomes in extracellular vesicles, and dot blot analysis
to elucidate whether ATP synthase was localized on the
EV membrane.
Results: We identified 892, 311 and 331 proteins
including ATP synthase subunits in apoptotic bodies,
microvesicles and exosomes, respectively. We further
confirmed that ATP synthase was indeed localized on
EV membrane. Additionally, we observed the release of
these three subtypes of EVs was decreased after starva-
tion stress and an eATP synthase inhibitor citreoviridin
treatment. However, we did not measure the signifi-
cantly different ATP production between control and
citreoviridin treatment in apoptotic bodies, microvesi-
cles and exosomes, indicating that ATP synthase on the
EVs may not be for ATP synthesis. We observed that
eATP synthase was transferred from cancer cells to
normal cells via EVs, indicating eATP synthase plays
an important role for cell-to-cell communications and
eventually promotes cancer metastasis.
Summary/Conclusion: Our findings suggest that ATP
synthase indeed exists on the membrane of EVs and
enhances cancer cells to release EVs for cell-to-cell
communications.
Funding: Ministry of Science and Technology (MOST
106-2320-B-002-053-MY3) and National Health
Research Institutes. (NHRI-EX107-10709BI) in Taiwan.
PF03.04
Anesthesia-dependent changes in vesicular miRNA profiles during
colorectal cancer surgery
Dominik Buschmanna, Anja Lindemannb, Florian Brandesc, Gustav
Schellingc, Michael Pfaffld and Marlene Reithmaire
aTUM School of Life Sciences Weihenstephan, Division of Animal Physiology
and Immunology, Freising, Germany; bInstitute of Human Genetics,
University Hospital, LMU Munich, Germany, Munich, Germany;
cDepartment of Anesthesiology, University Hospital, Ludwig-Maximilians-
University Munich, Germany, München, Germany; dAnimal Physiology and
Immunology, School of Life Sciences Weihenstephan, Technical University of
Munich, Freising, Germany, Freising, Germany; eInstitute of Human
Genetics, University Hospital, Ludwig-Maximilians-University Munich,
Germany, München, Germany
Introduction: Colorectal cancer (CRC) is one of the
most common and most deadly cancer types world-
wide, leading to 50,000 annual deaths in the US alone.
Even though surgical resection presents the best chance
of survival for CRC patients, accumulating evidence
demonstrates that removal of primary tumours can
foster disease progression and metastasis. Recent out-
come-based studies described differential effects of the
type of anaesthesia used during CRC surgery on metas-
tasis as well as overall and recurrence-free survival. As
mechanistic data on how anaesthesia impacts cancer
progression are sparse, we assessed the potential invol-
vement of extracellular vesicles (EVs) in the process.
Methods: Serum was sampled from 18 CRC resection
patients before induction of anaesthesia (pre) using
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propofol (n = 8) or sevoflurane (n = 10) and after surgery
(post). EVs were precipitated from 1 ml serum, and
associated microRNAs (miRNAs) were profiled by
Next-Generation Sequencing. The anaesthesia-dependent
impact on miRNA profiles in paired EV samples was
assessed using DESeq2. Next, we performed pathway
analyses based on differentially regulated miRNAs.
Additionally, deregulated candidates selected from NGS
data were validated by RT-qPCR.
Results: NGS-based profiling of EVs resulted in
3.79E6 ± 1.58E6 (propofol pre), 3.09E6 ± 1.81E6 (propo-
fol post), 3.40E6 ± 1.65E6 (sevoflurane pre) and
3.34E6 ± 1.32E6 (sevoflurane post) mean miRNA reads
per sample. As evidenced by Principal Component
Analysis, samples from pre- and post-operative sera clus-
tered into distinct groups for both types of anaesthesia.
Differential expression analysis revealed 64 and 44
miRNAs significantly regulated by propofol and sevoflur-
ane, respectively. Despite substantial overlap in the
intraoperative miRNA changes, a set of 31 (propofol)
and 11 (sevoflurane) miRNAs specifically responsive to
either drug was also identified. In silico analyses indicated
a differential effect of anaesthesia-responsive miRNAs on
cancer-relevant pathways such as proliferation, apoptosis
and migration.
Summary/Conclusion: Previous studies have demon-
strated distinctive effects of propofol and sevoflurane
on tumour cells, host immunity and survival in CRC.
Anaesthesia-induced changes in circulating miRNAs
might mediate disease progression and impact post-
surgical outcome.
PF03.05
The role of hypoxia-derived exosomes in determining Neuroblastoma
dissemination and aggressiveness
Pina Fuscoa, Maria Rosaria Espositob, Giulia Borilec, Marcello Manfredid,
Emilio Marengod and Elisa Cimettaa
aDepartment of Industrial Engineering (DII), Padova University –
Fondazione Istituto di Ricerca Pediatrica Città della Speranza (IRP),
Padova, Italy; bDepartment of Industrial Engineering (DII), Padova
University – Fondazione Istituto di Ricerca Pediatrica Città della Speranza
(IRP), Padova, Italy; cUniversity of Padova, Department of Physics and
Astronomy, Padova, Italy; dUniversity of Piemonte Orientale, Department
of Science and Technological Innovation, Alessandria, Italy
Introduction: Neuroblastoma (NB) is a heterogeneous
paediatric malignancy of the sympathetic nervous sys-
tem accounting for up to 10% of childhood cancers
with a strong tendency to metastasize. Hypoxia is a key
feature of solid tumours and is specifically known to (i)
favour NB metastasis and dedifferentiation towards
immature stem cell-like phenotypes and to (ii) stimu-
late release of exosomes (EXO), facilitating intercellular
communication at distant sites. In this study, we
characterized the proteomic and miRNAs cargo of
EXO isolated from NB cell lines cultured at different
oxygen concentrations to identify an exosomal signa-
ture associated with NB metastatic dissemination.
Methods: SKNAS and SKNDZ NB cell lines were cul-
tured for 48 h in standard (20% O2) and hypoxic (1.5%
O2) conditions. EXO were purified from the media
using Ultra spin tubes 100K MWCO and characterized
by scanning electron microscopy (SEM) and qNANO.
Proteome and miRNA cargo profiles were analysed by
quantitative mass spectrometry and FirePlex Discovery
Panel (on 405 miRNAs), respectively, and surface mar-
kers were evaluated using MACSplex technology.
Results: SEM and qNANO size distribution analysis
gave populations of round particles within the expected
diameters (50–120 nm). Surface markers analysis
revealed that NB hypoxia-derived EXO express an
increase of proteins associated with angiogenesis, adhe-
sion, stemness and immune function such as CD105,
CD29, CD49e, SSEA4, HLA-DR and HLA-ABC. We
characterized the proteomic cargo of EXO isolated
from cultures in normal and hypoxic conditions reveal-
ing differential expression of about 90 proteins. These
preliminary results highlight relevant changes in the
expression of several markers of EXO derived from
cultures exposed to different oxygen concentrations.
Summary/Conclusion: We successfully isolated and
purified exosomes from NB cell lines and assessed
their protein composition. These promising results
are the starting point for the identification of predictive
biomarkers to be used to detect and monitor metastatic
spread in NB.
Funding: ERC Starting Grant 2017 to Elisa Cimetta.
PF03.06
HNSCC exosomes drive tumour angiogenesis via ephrin reverse
signalling
Shinya Sato and Alissa Weaver
Department of Cell and Developmental Biology, Vanderbilt University
School of Medicine, Nashville, USA
Introduction: Exosomes are small extracellular vesicles
(EVs) that are secreted upon fusion of multivesicular
endosomes (MVE) with the plasma membrane and
carry bioactive protein and RNA cargoes. A number
of studies have identified key roles for exosomes in
promoting tumour angiogenesis; however, the mechan-
isms are unclear. Our goal is to identify the role of head
and neck squamous cell carcinoma (HNSCC) exo-
somes in tumour angiogenesis.
Methods: EVs were collected from the conditioned
media of HNSCCs and purified through cushioned
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density gradient ultracentrifugation. An orthotopic
mouse model was used for the assessment of tumour
angiogenesis. Angiogenic potential of EVs was assessed
by tube formation assays with Human Umbilical Vein
Endothelial Cells (HUVECs).
Results: In HNSCC tumours, the microvessel density
correlated with exosome secretion rates of original
HNSCC lines. In vitro, CM and purified exosomes
but not exosome-depleted CM from HNSCC cells
drove tube formation of HUVECs and human lympha-
tic endothelial cells. Proteomics analysis of HNSCC
exosomes revealed multiple potential angiogenic pro-
teins, including EphB2 and EphB4. The addition of
purified HNSCC exosomes to HUVECs-induced
reverse ephrin-B signalling in endothelial cells, as
assessed by Western blot analysis. To test whether
reverse ephrin-B signalling might account for exo-
some-induced angiogenesis, we pre-incubated purified
exosomes with Fc-ephrin-B2 to block the interaction
between exosomal EphB2 and ephrin-B2 on endothe-
lial cells. We found that low concentrations of this
reagent had little effect on endothelial tube formation
in the absence of exosomes but blocked the pro-angio-
genic effect of the exosomes. In addition, EphB2-KD
HNSCC derived exosomes significantly reduced
endothelial tube formation compared to parental
HNSCC derived exosomes.
Summary/Conclusion: We find that HNSCC-derived
exosomes can induce reverse ephrin-B signalling and
angiogenesis. This mechanism may be important in the
HNSCC microenvironment.
Funding: This work was funded by the National
Institutes of Health grant R01CA163592.
PF03.07
Nanoparticle mediated inhibition of intercellular communication
between enzalutamide resistant prostate cancer cells and myeloid
cells
Stephen Henricha, Kaylin McMahona, Michael Plebanekb and C. Shad
Thaxtona
aNorthwestern University, Chicago, USA; bDuke University, Durham, USA
Introduction: Crosstalk between neoplastic cells and
myeloid cells has emerged as an axis of communication
which drives tumour progression and metastasis.
Recently, our group and others have shown that cancer
exosome-mediated intercellular signalling is depen-
dent, in part, upon target cell cholesterol homeostasis.
In this study, we investigated whether exosome signal-
ling between enzalutamide resistant (EnzR) prostate
cancer cells and myeloid cells could be effectively
inhibited by targeted reduction of myeloid cell
cholesterol using high density lipoprotein mimetic
nanoparticles (HDL NPs).
Methods: Exosomes were isolated via ultracentrifuga-
tion of conditioned media from EnzR CWR-R1 pros-
tate cancer cells. Murine bone marrow macrophages
were obtained by culturing total bone marrow in M-
CSF for 7 days. For in vitro experiments, cells were
treated with exosomes derived from EnzR CWR-R1
cells (1–10 ug/mL exosomal protein) with or without
HDL NPs (50–150 nM). For in vivo experiments, 10
ug exosomal protein were injected via tail vein with or
without HDL NPs (1 uM, 100 ul). Confocal micro-
scopy and flow cytometry were used for uptake
experiments. Osteoclast differentiation assays were
performed using a commercially available TRAP
staining kit (Sigma Aldrich). NF-kB activation assays
were performed using the human monocyte reporter
cell line, THP-1 Dual. HDL NPs were synthesized
using 5 nm gold nanoparticle templates, phospholi-
pids, and apolipoprotein A-1. Mechanistic studies
were performed using transgenic, SR-B1 knockout
mice.
Results: Results showed that myeloid cell uptake of
EnzR CWR-R1 exosomes was inhibited in vitro and
in vivo upon treatment with HDL NPs. Furthermore,
functional inhibition was observed via reduced osteo-
clast differentiation and reduced stimulation of NF-
kB signalling. Finally, experiments conducted using
SR-B1 knockout mice revealed that nanoparticle
inhibition is dependent upon the scavenger receptor,
SR-B1.
Summary/Conclusion: Our findings demonstrate that
exosome-mediated signalling between prostate cancer
cells and myeloid cells can be inhibited using HDL
NPs. Furthermore, our results strongly suggest that
exosome-mediated crosstalk between prostate cancer
cells and myeloid cells are dependent upon cholesterol
homeostasis.
Funding: This work was supported by the National
Institutes of Health and the Prostate Cancer
Foundation.
PF03.08
High-grade bladder cancer cells secrete extracellular vesicles
containing MiRNA-146a-5p and promotes angiogenesis
Marta Prieto Vilaa, Wataru Usubab, Nobuyoshi Kosakac, Fumitaka
Takeshitad, Hideo Sasakib, Tatsuya Chikaraishib and Takahiro Ochiyac
aDivision of Mollecular and Cellular Medicine, National Cancer Center
Research Institute, Japan, Tokyo, Japan; bSt. Marianna University, School of
medicine., Tokyo, Japan; cDepartment of Molecular and Cellular Medicine,
Institute of Medical Science, Tokyo Medical University, Shinjyuku-ku, Japan;
dDivision of functional analysis, National Cancer Center Research Institute,
Tokyo, Japan
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Introduction: High recurrence is one of the major
issues in bladder cancer (BCa). The classical method
for detecting recurrence is cystoscopy, a highly invasive
technique. Thus, novel methodologies with high relia-
bility and low-invasiveness are needed. To overcome
this problem, biomarkers in the urine such as
microRNA (miRNA) in extracellular vesicles (EVs)
are been proposed. We previously detected high urin-
ary levels of miR-146a-5p in patients with BCa related
to tumour grade. However, the function of this miRNA
in EVs from BCa had not been elucidated yet. Here, we
show that miRNA-146a-5p in EVs promoted angiogen-
esis in BCa.
Methods: High-grade BCa cell line, UMUC-3, with miR-
146a overexpression, was established and orthotopically
transplanted in SCID mice. Immunohistochemical analy-
sis was performed to evaluate angiogenesis. Cellular pro-
liferation, migration, and invasion were assessed in human
umbilical vein cell (HUVEC) after the addition of EVs
from BCa. The target gene of miR146-5p was identified
by microarray and in silico analyses, and downregulation
was further confirmed by qPCR and western blot.
Results: Urinary miR-146a-5p level was higher in
patients with high-grade BCa and the tumours pre-
sented high levels of angiogenesis. Similarly, miR-
146a overexpressed BCa cells orthotopically injected
into mice generated tumours with high levels of angio-
genesis. HUVEC cell proliferation was significantly
increased, both under transfection of miR-146a mimic
and treatment with miR-146a-enriched EVs. Moreover,
the target of miR-146a was found to be TET2, which
has been reported to regulate cell growth in other
malignancies. Consequently, TET2 was downregulated,
both at RNA and protein level, under miRNA-146a-
enriched EVs treatment.
Summary/Conclusion: Our findings indicate that EVs
containing miR-146a-5p from BCa, previously
described as BCa biomarker, promoted the prolifera-
tion of endothelial cells that supported tumour growth.
These results demonstrate that miRNAs in EVs may
become not only a diagnosis tool but also a target
molecule for cancer therapy.
PF03.09
Activated glial cells stimulated by breast cancer-derived exosomes
enhance proliferation of brain metastatic breast cancer cells
Dayi Jeonga, Oh Jinhyea, Dowon Hwangb and Dongsoo Leeb
aSeoul National University, Seoul, Republic of Korea; bSeoul National
University Hospital, Seoul, Republic of Korea
Introduction: Brain metastatic breast cancer cells have
been known to stimulate glial cells in the brain to
facilitate their brain metastasis. Long distance of pri-
mary breast cancer site to the brain may require the
communication mediator to deliver cancer favourable
information to the brain. However, the exact role of
breast cancer-derived exosome during brain metastasis
is not well understood. In this study, we observed the
phenomenon that breast cancer-derived exosomes
directly activate primary astrocytes and the co-culture
condition of these activated astrocytes with microglia
cells enhances cancer cell proliferation and invasion.
Methods: To trace the extracellular vesicle (EV) including
exosome movement, Palm-tandem dimer tdTomato
(Palm-tdTomato) lentiviral vector was transduced into
MDA-MB-luc-D3H2LN (D3H2LN) breast cancer cells.
EVs isolated from D3H2LN-Palm-tdTomato cell lines
showed the increased Palm-tdTomato fluorescence inten-
sity and were stably internalized into astrocytes. After
astrocytes were treated by the EVs, we checked the level
of Glial Fibrillar Acidic Protein (GFAP), vimentin, MCP-
1/CCL2 and IL-6 expression. Astrocytes and microglia
are co-cultured under the EVs containing media.
Results: We found that astrocytes taken up by cancer-
derived exosomes were activated, showing the increase
in GFAP, vimentin, MCP-1/CCL2 and IL-6 expression.
Also, we found that co-culture glial cells of astrocytes
and microglia significantly increased cytokine IL-6 pro-
duction. The co-cultured medium from cancer exo-
somes-stimulated astrocytes and microglia increases
invasion and proliferation of cancer cells and inhibits
tumour suppressor gene in breast cancer cells.
Summary/Conclusion: These results indicate that
breast cancer-derived exosomes participate in activat-
ing astrocytes and the activated astrocytes and micro-
glia induce breast cancer proliferation and invasion
during brain metastasis.
PF03.10
The glycosylation status affects the biodistribution of cancer
extracellular vesicles
Akiko Kogurea, Nao Nishida-Aokib, Naoomi Tominagac, Nobuyoshi Kosakad
and Takahiro Ochiyad
aDivision of Molecular and Cellular Medicine, National Cancer Center
Research Institute, Tokyo, Japan; bHuman Biology Division, Fred
Hutchinson Cancer Research Center, Seattle, USA; cDepartment of Biology,
Massachusetts Institute of Technology, Massachusetts, USA; dDepartment of
Molecular and Cellular Medicine, Institute of Medical Science, Tokyo
Medical University, Shinjyuku-ku, Japan
Introduction: It has been shown that extracellular
vesicles (EVs) from cancer cells delivered to the meta-
static site, and promoted metastasis by communicating
with microenvironmental cells, although molecules,
which are indispensable for cancer progression, has
been investigating yet. It is well known that aberrant
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glycosylation is a hallmark of cancer, and is related to
the cancer malignancy; however, the role of the glyco-
sylation of EV surface proteins in cancer progression
has not been clarified yet. In this study, we investigated
the role of glycosylation of the EVs from metastatic
cancer cells in the biodistribution.
Methods: We performed lectin blot analysis in order to
compare the glycan level of the EVs among metastatic
cancer cell lines and non-metastatic cancer cell lines.
Then, we investigated whether glycosylation of EVs
affects their incorporation rate to endothelial cells by
enzymatic deglycosylation in vitro. DiR-labelled EVs
were employed to analyse the location of EVs in vivo by
intravenous injection. After 24 h of injection, the
fluorescence intensities of each organ were measured in
order to determine the amount of the EVs remained at
the organs.
Results: We found that the glycosylation level of EVs
from metastatic cancer cells was higher than that from
non-metastatic cancer cells. Moreover, enzymatic
digestion of N- and O-linked glycans on EVs increased
their incorporation to the endothelial cells in vitro.
Furthermore, we found that the glycosylation status
of EVs from cancer cells influenced their direction to
the organs in mice.
Summary/Conclusion: These findings suggest that the
glycosylation of EVs from cancer cells involved in the
biodistribution of EVs.
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Preferential packaging of tRNA fragments into extracellular vesicles
released by protozoan parasite Trichomonas vaginalis
Anastasiia Artuyantsa, Anthony Phillipsb and Augusto Simoes-Barbosaa
aSchool of Biological Science, The University of Auckland, Auckland, New
Zealand; bDepartment of Surgery, Faculty of Medical and Health Sciences,
The University of Auckland, Auckland, New Zealand
Introduction: Extracellular vesicles (EVs) are impor-
tant mediators of cell-to-cell communication. Delivery
of EVs is known to modulate the response of the
recipient cells. EVs are produced by most if not all
organisms and are involved in communication between
host and pathogen. Trichomonas vaginalis is a unicel-
lular eukaryotic pathogen, known to produce EVs with
proteins and RNA cargo. This parasite colonizes the
mucosal surface of the human genitourinary track
extracellularly. In this study, we hypothesised that the
RNA cargo of parasite EVs is an important element of
this host-pathogen communication.
Methods: As the first step of this investigation, we
isolated and characterised EVs from T. vaginalis strain
B7RC2. Small RNAs present in these vesicles were
identified by deep-sequencing and specificity of these
molecules as EVs cargo was evaluated.
Results: Our results show that T. vaginalis releases
membrane-bound vesicles with an average size of
~100 nm that are taken up by host cells. These vesicles
are depleted of DNA but enriched with RNAs of small
size. These RNAs are physically protected from exo-
genous RNases. The population of small RNAs was
consistent among libraries, with tRNA being the most
abundant RNA biotype in all samples. We identified
individual sequences from the top 30 transcript clusters
as being mostly tRNA fragments, particularly 5’-tRNA
halves. The presence of the identified fragments was
validated and compared with total cells by digital dro-
plet PCR, showing the preferential packaging for these
tRNAs into EVs.
Summary/Conclusion: Our study indicates that tRNA
fragments from T. vaginalis EVs (particularly tRNA
halves) might play a role in communication with host
cells. Work to confirm their bioactivity continues.
PF04.02
The endothelial PlGF is upregulated by exosomes from activated
kidney fibroblast
Noritoshi Katoa, Fumitoshi Nishiob, Yoshio Funahashic, Hiroki Kitaic,
Shintaro Komatsuc and Shoichi Maruyamac
aNagoya University Graduate School of Medicine, Nagoya, Japan; bTushima
City Hospital, Tushima, Japan; cNagoya University Graduate School of
Medicine, Nagoya, USA
Introduction: It is well known that patients with
chronic kidney disease (CKD) are at risk of cardiovas-
cular diseases, but the mechanism of this distant organ
crosstalk is not fully understood. Recently, placental
growth factor (PlGF) received attention in pathogenesis
of cardio-renal syndrome (CRS). Under the hypothesis
that exosomes are involved in pathophysiology of CRS,
the aim of this study is to explore the role of exosomes
from kidney fibroblasts, which actively proliferate in
diseased kidney, on vascular endothelial cells.
Methods: Clinical samples; HUVECs were stimulated
by serum exosomes from stage G5 CKD patients and
healthy donor. Exosomes tracking; Primary culture of
activated kidney fibroblasts were obtained from experi-
mental renal fibrosis model mice. These exosomes were
labelled by microRNA of C. elegance (Cel-miR-39) then
labelled exosomes were injected to the mice through
tail vein. Effects of exosomes on endothelial cells; We
purified exosomes from culture media of TGF-b sti-
mulated kidney fibroblasts cell line (NRK-49f), and
then primary culture of vascular endothelial cells
(RAOEC) was stimulated using these exosomes. By
qPCR, we evaluated the expression of PlGF genes.
Results: (1) Not only the serum but also exosomes
from CKD stage G5 patients stimulated PlGF expres-
sion on HUVECs. (2) Injected labelled exosomes from
activated kidney fibroblast distributed mainly in lung,
liver and aorta. (3) RAOEC stimulated with exosomes
form TGF-b activated rat kidney fibroblast showed
higher expression of PlGF than control.
Summary/Conclusion: So far, CRS is considered to be
caused by uremic factor, RAS system, chronic inflam-
mation and so on. From this study, both serum and
exosomes from CKD patients stimulated PlGF
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transcription on endothelial cells. Exosomes from acti-
vated kidney fibroblast had same tendency. We specu-
lated that exosomes from diseased kidney have some
roles in atherosclerotic change by modulating the
expression of PlGF on endothelial cells. Farther studies
are needed to elucidate the degree of contribution
to CRS.
Funding: N/A.
PF04.03
The effect of in vivo irradiation on the extracellular vesicle’s cargo
and uptake
Tünde Szatmária, Dávid Kisa, Nikolett Sándora, Eszter Persab, Rita Hargitaia,
Enikő Kisa, Katalin Balázsa, Géza Sáfránya and Katalin Lumniczkya
aNational Public Health Center, Division of Radiobiology and Radiohygiene,
Department of Radiation Medicine, Budapest, Hungary; bNational Public
Health Center, Budapest, Hungary
Introduction: Recent studies suggest that ionizing
radiation (IR), as a stress agent, induces changes in
the release, uptake and composition of extracellular
vesicles (EVs). EVs were shown to play a role in radia-
tion-related signalling and radiation induced bystander
effects (RIBE). We have recently shown that EVs
released by bone marrow (BM) cells of mice irradiated
with X-rays mediate RIBE, such as DNA damages,
chromosomal aberrations or phenotypical changes in
certain cellular subpopulations of the BM. The aim of
this study is to investigate the mechanism of these
functional changes.
Methods: In order to follow the uptake of irradiated
EVs, we isolated EVs from BM of total-body irradiated
(TBI) mice, labelled them with a selective RNA stain
and co-incubated them in vitro for 3 h with BM cells
extracted from nonirradiated mice. We quantified the
uptake of EVs in different BM subpopulations by flow
cytometry and fluorescence microscopy. To test
whether in vivo irradiation affects the miRNA cargo
of EVs, total RNA was isolated from the same EVs,
subjected to miRNA profiling and assessed by bioin-
formatical tools. Significantly altered miRNAs were
validated by qRT-PCR in EVs, BM cells of EV donor
and recipient mice.
Results: There were differences in EV uptake capacity
of different BM cell subpopulations but irradiation did
not change the extent of EV uptake. We identified a
panel of miRNAs differentially expressed in the EVs
following TBI of mice with involvement in DNA
damage repair, immune system regulation and acute
leukaemia.
Summary/Conclusion: We proved that EVs transmit
certain radiation related signals; IR alters the miRNA
cargo of EVs, but does not affect their uptake. Our
study helps to disclose the radiation-related mechan-
isms involved in EV signalling and the role of EV
signalling in systemic response of organisms to IR.
Funding: The Euratom research and training pro-
gramme 2014–2018 (CONCERT, grant agreement
number 662287) and a Hungarian Scientific Research
Fund–OTKA (124879).
PF04.04
UVB induced-release of bioactive microvesicle particles in
keratinocytes carry platelet-activating factor
Ji Bihl, Langni Liu, Christine Rapp and Jeffrey Travers
Wright State University, Dayton, USA
Introduction: Ultraviolet B radiation (290–320 nm;
UVB) has profound effects upon skin and generates
systemic consequences. As UVB only penetrates the
epidermis, a major question in photobiology is how
UVB-treated skin sends systemic signals. Recent stu-
dies have indicated that small membrane-bound vesi-
cles known as microvesicle particles (MVP) released
from cells in response to various stressors can act as
potent signalling agents due to their ability to carry
nuclear and cytoplasmic components. Our lab has pre-
viously determined that UVB induces the production
of the lipid mediator, platelet-activating factor (PAF),
which is involved in mediating both acute pro-inflam-
matory and immunosuppressive UVB responses. More
recently, we discovered that UVB generates MVP
release (UVB-MVP) from epithelial cells and skin in a
PAF-PAFR dependent way. However, the contents of
UVB-MVP have not identified and whether UVB-MVP
carry PAF is not known.
Methods: In this study, we determined the kinetics of
PAF production in cell- vs. MVP over time. IL-8
release assay was further used to confirm the PAF-R-
agonist activity in KBP cells using PAF as positive
control. Moreover, we verified the PAF-R-agonist
activity in UVB-MVP in animal models.
Results: The kinetics of PAF agonist production fol-
lowing UVB suggest that PAF-R agonists generated in
response to UVB were cell-associated early, then, were
found predominantly in MVP. The PAF-R-agonist
activity found in MVP of HaCaT cells 2 h post UVB.
UVB-MVP contain approximately 20 ng of PAF activ-
ity per 1E+10 MVP. However, PAF agonistic activity
was not found in control MVP, and UVB-MVP did not
generate IL-8 release in PAFR- negative KBM cells.
Topical application of lipid extracts from UVB-MVP
derived from HaCaT cells onto ears of WT mice
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resulted in an increase in ear thickness at 2 h, however,
there was no effect on PAF-R Knock-out (KO) mice
Summary/Conclusion: This study suggests that UVB-
MVP contain bioactive PAF agonists involved in acute
UVB-induced inflammation. This is the first study
demonstrating that UVB-MVP carry PAF.
Funding: National Institutes of Health (NIH): R21
AR071110.
PF04.05
A mathematical model for extracellular vesicles, as a communication
tool between cells.
Anna Concetta Berardia and Andrea Collevecchiob
aospedale Santo Spirito Pescara, Pescara, Italy; bMonash University,
Melbourne, Australia
Introduction: The main goal of the present work is to
introduce a mathematical model for extracellular vesi-
cles (EV), as a communication tool between cells.
Methods: Our basic model has a graph theoretical
representation in terms of weighted graphs and sto-
chastic processes that take values on the vertices of the
graph, which play the role of cells. More specifically
consider a complete graph, where each vertex commu-
nicates with any other vertex. To each edge of the
graph associate a positive number, which might be
interpreted as the euclidean distance between cells. In
order to understand the main features of the model, it
is enough to isolate one designated cell, called the root,
and understand how effective is its communication
with the other cells.
Results: We regard the EV as signals sent to other cells.
At each stage the root sends a signal to another cell
chosen with probability proportional to the weight
associated to the connecting it to the root. Each time
an edge is traversed, its weight is updated. This allows
learning during the communication. In other words,
the root has preference in communicating with cells
that has been already contacted before. Each signal
contains a task. Once a cell receives a task, it will
activate in order to complete it. On the other hand,
the completion of the task has a random duration. If
during this time the cell is contacted too frequently by
the root cell (that is above a certain threshold), it will
abort the task.
Summary/Conclusion: Our goal is to understand
what are the phases transitions of this model with
respect to its parameters as the number of vertices
grow to infinity. In other words, if the threshold
associated to the abortion is large enough, we expect
to have a positive proportion of the cells to accom-
plish the task.
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PF05.01
Extracellular vesicles from KSHV-infected cells stimulate antiviral
immune response through mitochondrial DNA
Hyungtaek Jeon, Jisu Lee, Suhyuk Lee, Su-Kyung Kang, Sang June Park,
Seung-Min Yoo and Myung-Shin Lee
Eulji University School of Medicine, Daejeon, Republic of Korea
Introduction: Interferon-stimulated genes (ISGs) are
vital in controlling viral infections. As many antiviral
ISGs continue to be identified, their roles in viral
pathogenesis are also being explored in more detail.
Kaposi’s Sarcoma-associated herpesvirus (KSHV) is the
etiologic agent of Kaposi’s sarcoma, which is the most
common cancer in acquired immune deficiency syn-
drome patients. Because KSHV contains numerous
viral proteins that modulate antiviral response, type 1
Interferon response is strongly suppressed in KSHV-
infected cells. However, the antiviral effects of extra-
cellular vesicles (EVs) during de novo KSHV infection
have not been investigated to our best knowledge.
Methods: EVs were isolated from KSHV-infected cells
at 24 h of postinfection and characterized. The expres-
sion of ISGs in these EVs-treated human endothelial
cells was investigated and underlying mechanisms were
analysed.
Results: In this study, we showed that KSHV-infected
cells induce ISG response in uninfected bystander cells
using EVs. mRNA microarray analysis indicated that
ISGs and IRF-activating genes were prominently acti-
vated in EVs from KSHV-infected cells (KSHV EV)-
treated human endothelial cells, which were validated
by RT-qPCR. Mechanistically, mitochondrial DNA on
the surface of KSHV EVs was presumed to be asso-
ciated with ISG response via the cGAS-STING path-
way. In addition, KSHV EV-treated cells showed lower
infectivity for KSHV and viral replication activity than
mock EV-treated cells.
Summary/Conclusion: Our results indicated that EVs
from KSHV-infected cells would be an initiating factor
for the innate immune response against viral infection,
which would be helpful to expand our understanding
of the microenvironment of virus-infected cells.
Funding: This work was supported by the Basic Science
Research Program through the National Research
Foundation of Korea (NRF-2017R1A2B1006373, NRF-
2017R1A2B4002405).
PF05.02
Exosomes secreted by platelets infected with Hepatitis E virus can
mediate transmission of HEV
Lishan Chenga, Yu Liub, Ping Fuc, Bingting Wuc and Ling Kec
aChinese Academy of Medical Sciences and Peking Union Medical College,
Chengdu, China (People’s Republic); bChinese Academy of Medical Sciences
and Peking Union Medical College, 石家庄市, USA; cChinese Academy of
Medical Sciences and Peking Union Medical College, chengdu, China
(People’s Republic)
Introduction: Evidences suggested that exosomes can
transfer genetic material between cells, including viral
nucleic acids, proteins or miRNAs which can mediate
transmission of viruses such as HBV or HCV. It is
known that platelet-derived exosomes constitute the
major fraction in the circulating plasma which can
participate in haemostasis, immunity and development.
Whether the virus infected platelet-derived exosomes
can also promote the transmission of virus has not
been reported. The hepatitis E virus (HEV) is one of
the most common causes of acute hepatitis worldwide.
Recent studies have shown that the exosomes secreted
by HEV-infected cells were infectious. Our studies have
confirmed that HEV can infect platelets, thus we con-
ducted this study to prove if exosomes secreted by
platelets infected with HEV are also infectious, thereby
further promoting the transmission of HEV.
Methods: An in vitro model of HEV-infected platelets
were established by HEV-G3 virus strain and washed
human platelets and the exosomes were isolated from
HEV-infected and uninfected platelet by differential cen-
trifugation and magnetic bead separation. Exosomes were
characterized by Western Blot and TEM, and quantitated
by NTA. qRT-PCR and ELISA were used to detect HEV
RNA and proteins in exosomes. Positive exosomes were
used to infect PLC/PRF/5 cells, observing the changes of
HEV RNA and proteins within one month.
Results: The in vitro model of HEV-infected platelets
was successfully established. The concentration of exo-
somes secreted by HEV-infected platelets was higher
than uninfected platelets. Exosomes isolated from
HEV-infected platelets contained HEV RNA and
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proteins. HEV RNA and proteins were detected in cells
and supernatant of PLC/PRF/5 cells infected with posi-
tive exosomes, and the concentration of which
increased after the culture of one month.
Summary/Conclusion: Our study showed that HEV
can promote the secretion of platelet exosomes and
these vesicles can establish a productive infection
which suggested that the exosomes secreted by platelets
not only play a role in haemostasis, immunity and
development, but also play a non-negligible role in
the transmission of the virus.
Funding: 1.CAMS Innovation Fund for Medical
Sciences (CIFMS2016-I2M-1-018)
2. Supported by the Fundamental Research Funds for
the Central Universities(Item No:3332018125)
PF05.03
Multi organ association mediated by extracellular vesicles secreted
from HBV positive hepatocyte
Ai Kotania and Masatoshi Kakizakib
aTokai University, Isehara, Japan; bTokai University, School of Medicine,
Department of Gastroenterology, Iisehara, Japan
Introduction: Hepatitis B virus (HBV) infected hepa-
tocytes secreted extracellular vesicles such as virion,
exosome and incomplete virions such as hallow parti-
cles which have only HBs viral antigens but neither
capsid and HBV genome. We found that the EVs are
taken by monocyte/macrophage which upregulates PD-
L1, immune checkpoint molecule. (Kakizaki et al PLOS
one in press). It suggests that the EVs play critical roles
in viral immunology.
Methods: PKH labelled EVs are injected into mice then
those biodistribution are analysed by tissue sections
and confocal microscopy and flow cytometry then
multiorgan association are analysed by use of bone
marrow transplantation. The HBV hepatitis model
mice was established to analyse the significance of the
EVs on HBV hepatitis.
Results: In almost all the organs we analysed the PKH
signal were detected which suggest the biodistribution
of the EVs are systemic. Especially in the bone marrow
monocytes, PKH positive cells are abundant. Then the
bone marrow cells which were treated by PKH labelled
the EVs secreted from HBV infected hepatocytes were
transplanted. The organ where the most PKH positive
cells were detected was gut. These cells showed CD103
positive which suggest these cells are regulatory DCs.
The HBV hepatitis model mice treated by the EVs
showed persistent HBV infection.
Summary/Conclusion: Based on the results, the EVs
secreted from HBV infected hepatocytes have significant
roles in HBV hepatitis through the multiorgan association
of liver, bone marrow and gut.
Funding: AMED hepatitis grant.
PF05.04
HIV-1 Nef mediated Hck kinase activation triggers loading of TACE
into EVs in a ceramide-dependent manner
Zhe Zhao, Riku Fagerlund and Kalle Saksela
University of Helsinki, Helsinki, Finland
Introduction: TNF-α converting enzyme (TACE)
exists in circulating EVs collected from HIV-infected
individuals. In addition to its role in TNF-α shedding,
TACE is responsible for the proteolytic maturation of
numerous cytokines, cytokine receptors and extracellu-
lar matrix components involved in inflammation.
Thus, EV-associated TACE could be a key player in
the chronic immune activation that drives AIDS patho-
genesis and persistent viral replication. Although
uploading of TACE into EVs is promoted by the
HIV-1 pathogenicity factor Nef, the mechanism of
TACE secretion remains incompletely understood.
Methods: EVs were isolated by ultracentrifugation and
analysed by western blotting. Gene knock-out by
CRISPR was used to study TACE loading into
exosomes.
Results: We have previously shown that uploading of
TACE into EVs is promoted by HIV-1 pathogenicity
factor Nef via its interaction with cellular protein
kinases. Herein, we have studied the molecular
mechanisms of TACE loading into EVs in more
depth and show that active Src family tyrosine kinases
(SFKs) Lck, Hck, Lyn, Fyn and Fgr can trigger TACE
secretion. Among the SFKs Hck is unique by displaying
two isoforms p59 and p61. We found that only acti-
vated p59, but not p61, could trigger TACE secretion.
In contrast to the myristoylated and palmitoylated
SFKs and p59Hck the p61 isoform lacks the palmitoy-
lation signal and these differing signals have been
shown to direct p59 and p61 to the plasma membrane
and lysosomes, respectively. Our observations show
that catalytic activity and proper membrane association
domain of Hck is required for TACE secretion into
EVs. We characterized the origin of the EVs in Hck-
activated TACE secretion by nSmase2 knock-out, and
found that Hck-mediates the loading of TACE into
vesicles that similar to classical exosomes are generated
in a manner requiring nSmase2-mediated ceramide
synthesis.
Summary/Conclusion: We conclude that HIV-1 Nef
mediated Hck p59 kinase activation triggers the
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loading of TACE into exosome-like vesicles in a cer-
amide dependent manner.
Funding: Jane and Aatos Erkko Foundation
PF05.05
Role of Extracellular Vesicles in HIV and Methamphetamine induced
neurotoxicity
Sowmya V. Yelamanchilia, Dalia Moorea, Catherine DeMarinob, Farah
Shahjinc and Fatah Kashanchib
aDepartment of Pharmacology and Experimental Neuroscience, University of
Nebraska Medical Center, Omaha, USA; bGeorge Mason University,
Manassas, USA; cDepartment of Pharmacology and Experimental
Neuroscience, University of Nebraska Medical Center, OMAHA, USA
Introduction: The advent of combined antiretroviral
treatments (cART) has markedly decreased the preva-
lence of HIV-associated dementia. However, there
remains a high prevalence rate of the milder forms of
HIV-associated neurocognitive disorders (HAND).
Although many contributing factors have been studied,
the role of drugs of abuse has remained elusive.
Methamphetamine (Meth) and related amphetamine
compounds, which are potent psychostimulants, are
among the most commonly used illicit drugs. Long-
term Meth abuse is associated with a host of systemic
and neurological maladies. Neurologically, Meth abu-
sers exhibit cognitive and psychomotor impairment,
and have shown increased risk for HIV infection.
However, the mechanisms underlying Meth and HIV
neurotoxicity are still not known. This study focuses
extracellular vesicles (EVs) and their role in HIV infec-
tion and chronic Meth abuse. Our results presented
here, indicate that Meth can not only increase EV
biogenesis and release but also change the composition
of EV cargo.
Methods: EV isolations, EV quantification by
Nanoparticle tracking analysis, Immunoflurescence
and structural illumination microscopy, transmission
electron microscopy, Taqman RT-PCR, In situ hybri-
dization, in vitro primary macrophage cultures.
Results: Nanoparticle tracking analysis and transmis-
sion electron microscopy revealed that Meth changed
EV dynamics in uninfected and HIV infected macro-
phage cultures. Our investigation revealed that the
genes involved in the endosomal sorting complexes
required for transport (ESCRT) are responsible are
significantly increased upon Meth treatment. Further,
our data reveals that Meth increases the release of HIV
accessory protein, myristoylated Nef (Myr-Nef), that
plays a critical role in HIV/AIDS progression. Myr-
Nef is N-terminally myristoylated, which acts as a
membrane anchor. Furthermore, we also reveal that
gp120 is released in the EVs along with Myr-Nef. We
show that the release of gp120 is followed by the
increase in syncytia formation in the macrophage
cultures.
Summary/Conclusion: We conclude that chronic
Meth abuse interferes with EV biogenesis and cargo
release in HIV infected cells. These results can uncover
the role of chronic Meth abuse in progression of HIV
pathogenesis.
Funding: NIH/NIMH/NIDA
PF05.06
Extracellular vesicle-associated cytokines in HIV infected human
lymphoid tissue ex vivo
Vincenzo Mercurioa, Wendy Fitzgeraldb and Leonid Margolisc
aDepartment of Biomedical and Clinical Sciences ‘L. Sacco’, University of
Milan, Milan., Bethesda, USA; bSection of Intercellular Interactions, Eunice
Kennedy Shriver National Institute of Child Health and Human
Development, National Institutes of Health, Bethesda, MD, USA; cSection
of Intercellular Interactions, Eunice Kennedy Shriver National Institute of
Child Health and Human Development, National Institutes of Health,
Bethesda, MD, USA
Introduction: Cytokines play an important role in HIV
infection. Some of these cytokines are present on the
surface or encapsulated in extracellular vesicles (EVs).
We investigated the modulation of EV-associated cyto-
kines during HIV infection and antiretroviral therapy
(ART) in human ex vivo tonsils.
Methods: Ex vivo tonsils were infected with HIV-1
strains, X4-LAI04 or R5-SF162. HIV was either allowed
to replicate for 15 days, or tissues were treated with
ART (3TC and AZT) at day 2 post-infection. 33 cyto-
kines in soluble or EV-associated forms were evaluated
with multiplexed bead-based assays.
Results: Infection with HIV-1 led to increases in many
soluble cytokines, with the highest increases in IL-2, IL-
12, IL-15, IFN-γ, MIP-1α, MIP-1β and RANTES by
both viruses. These same, and additional, cytokines,
were elevated in EV-associated form, often increasing
in both EV surface and internal compartments.
Likewise, soluble cytokines unaffected by HIV infection
tended to also be unchanged in EVs.
ART treatment halted HIV-1 replication, but cyto-
kines increased by HIV infection remained elevated.
After 13 days of ART, five of the above seven soluble
cytokines remained high for X4, and 4 for R5. EV-
associated cytokines were less likely to be restored:
13 days after ART, for X4 all 10 of the most upregu-
lated cytokines remained high, and for R5 7 of 10.
Summary/Conclusion: Cytokine levels increased dur-
ing HIV infection in both soluble and EV-associated
forms; the same cytokine is often upregulated in both
forms. Many soluble cytokines upregulated by HIV did
200 ISEV2019 ABSTRACT BOOK
not decrease even after 13 days of ART, and EV-asso-
ciated cytokines were even less likely to decrease. X4
induced increases were less likely to return to control
levels. ART-treated infected human tissues provide a
new model to study tissue activation after HIV replica-
tion is suppressed, in particular, the role of EVs in this
phenomenon. These studies will assist in deciphering
mechanisms of pathologies that develop in ART-trea-
ted patients.
PF05.07
Circulating MiR-122 and let-7a may predict progression to
hepatocellular carcinoma in patients with chronic hepatitis C virus
infection
Yuki Ichikawaa, Masashi Sakakib and Hitoshi Yoshidac
aShowa University, Ito, Japan; bShowa University, Tokyo, Japan; cShowa
University, Tokyo, Japan
Introduction: At the bedside, circulating microRNAs
in human body liquids are noted as `liquid biopsy’ to
evaluate the disease stages, especially in Liver diseases,
`actual biopsy’ is used in patients because of its inva-
siveness. In chronic liver disease, many circulating
miRNAs are recently reported such as miR-122, miR-
192, miR-223 to diagnose HCC patients and HCV- or
HBV-infected patients, in this study. To identify the
miRNAs which can predict HCC (hepatocellular cell
carcinoma) development, we first focused on the
microRNAs associated with the liver fibrosis, because
liver fibrosis stages are one of the most important
factors to predict Hepatocellular cell carcinoma
(HCC) development and evaluated those predictable
ability among other noninvasive fibrosis markers to
clarify our hypothesis that those miRNAs are patholo-
gically related to carcinogenesis development.
Methods: Serum circulating miR-122 and let-7a were
retrospectively evaluated using RT-PCR in 35
patients with HCV-related chronic hepatitis and cir-
rhosis who undergone DAA treatment. HCC had
developed in 8 patients afterwards in the observation
period. Informed consent was obtained and the study
was approved by a recognized medical ethics com-
mittee in our hospital.
Results: Serum miRNA miR122and let-7a levels were
significantly higher in liver chirrosis than chronic
hepatitispatients. (miR122, p = 0.00836 let-7a
p = 0.01595). For the predictable ability of HCC,
AUROC of miR122 was 0.85606 and le1-7a was
0.76667,which showed highest ability compared with
other non-invasive fibrosis markers, such as APRI,
FIB-4. (AUROC = 0.5023, 0.66697, respectively)
Based on our ROC results to predict complicating
HCC, COF of miR122 was 0.04175 (sensitivity and
specificity of 86% and 75%, respectively) and COI of
let-7a was 0.0166 (sensitivity and specificity of 71% and
87%). The cumulative incidence rate of HCC was sig-
nificantly different miR-122 ≥ 0.04175 and > 0,04175
groups or let-7a ≥ 0.01666 (p = 0.050 and 0.00054)
Summary/Conclusion: Serum miR-122 and let-7a
values appear to have superior ability to predict HCC
development in patients with chronic HCV infection,
which implies the possibility that they have crucial role
in HCC development.
PF05.08=OWP2.07
Biogenesis of JC polyomavirus associated extracellular vesicles
depends on neutral sphingomyelinase 2
Jenna Morris-Lovea, Bethany O‘Haraa, Gretchen Geea, Aisling Duganb,
Benedetta Assettac, Sheila Haleya and Walter Atwooda
aBrown University, Providence, USA; bAssumption College, Worcester, USA;
cBrown Univerisity, Providence, USA
Introduction: JC polyomavirus is a non-enveloped
virus that causes progressive multifocal leukoencepha-
lopathy (PML) in immunocompromised patients.
JCPyV infects cells by first binding to the major attach-
ment receptor lactoseries tetrasaccharide C (LSTc), fol-
lowed by the serotonin receptor 5-hydroxytryptamine
type 2 required for entry. In PML, JCPyV undergoes
lytic infection in oligodendrocytes and astrocytes, both
of which have been shown to lack LSTc. Further, deep
sequencing has shown that viral quasispecies existing
in PML patients contain mutations in the sialic acid
binding pocket of the major viral capsid protein, ren-
dering these virions incapable of binding LSTc. We
have recently demonstrated that JCPyV is packaged
into extracellular vesicles (EV) that can spread the
virus, potentially overcoming this paradox. Here, we
begin to characterize the biogenesis of this EV-virus
association by examining endosomal sorting complexes
required for transport (ESCRT) proteins and neutral
sphingomyelinase 2 (nSMase2).
Methods: Cambinol was used to specifically target
nSMase2 activity. Knockdown cell lines were created
with shRNA targeted against ALIX, TSG101, or
SMPD3. SMPD3 was also targeted using CRISPR/
Cas9 genetic knockout in separate cell lines.
Knockdown was confirmed by qPCR and/or Western
blot, and knockout by next generation sequencing. EV
were concentrated by differential centrifugation and
evaluated by transmission electron microscopy,
Western blot, nanoparticle tracking analysis, infection,
and qPCR for protected viral genomes. Infection was
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scored by immunofluorescence analysis with antibodies
against the major viral capsid protein VP1.
Results: We found that depletion of nSMase2 by cam-
binol, genetic knockdown or knockout caused a reduc-
tion in spread of JCPyV over time. Knockdown and
knockout SMPD3 cell lines produced less infectious
EV. In the absence of nSMase2, cells produced more
EV but there were fewer protected genomes associated
with the EV. Knockdown of Alix or TSG101 had no
effect on the infectivity of EV or the production of EV.
Summary/conclusion: Overall, our studies found that
biogenesis of JCPyV associated extracellular vesicles
depends upon the enzymatic activity of nSMase2 and
not the ESCRT-related proteins Alix or TSG101.
Funding: NIH R01NS043097
PF05.09=OWP2.08
Exosomes mediate the anti-viral activity of interferon-β against zika
virus infection
Shuang Li, Shilin Li and Limin Chen
Provincial Key Laboratory for Transfusion-Transmitted Infectious Diseases,
Institute of Blood Transfusion, Chinese Academy of Medical Sciences and
Peking Union Medical College, Chengdu, Sichuan, 610052, China, Chengdu,
China (People‘s Republic)
Introduction: IFNβ-induced exosomes (Exo-IFNβ)
may impact on viral dissemination or antiviral immu-
nity and therefore involve in the pathogenesis of many
infectious pathogens. However, little is known about its
underlying mechanisms. To better understand how
Exo-IFNβ performs its anti-viral effect, we employed
RNA sequencing analysis to explore the exosomal
expression profiles of lncRNA and mRNA related to
viral infections. We hypothesized that exosomes can
regulate viral infection through transmitting enclosed
specific lncRNAs into neighbouring cells to inhibit
viral replication.
Methods: Exosomes were purified from A549 with/
without IFNβ treatment by serial centrifugation fol-
lowed by sucrose density gradient purification, and
characterized by TEM and Western Blot. ELISA assay
were performed on purified exosome fractions to
demonstrate that they are free of IFNβ. ZIKV replica-
tion was assayed by real-time PCR.
Results: ZIKV replication was significantly suppressed
in A549 cells pre-treated with Exo-IFNβ followed by
ZIKV infection. Moreover, we found that anti-ZIKV
effect of Exo-IFNβ is IFN-independent because ZIKV
replication was also decreased in U5A cells (IFN-α/β
receptor IFNAR deficient) pre-treated with Exo-IFNβ .
Similar results were observed in Dengue virus and
HCV infections. RNA sequencing analysis found sev-
eral lncRNAs and mRNAs were differentially expressed
and function annotation and pathway analysis demon-
strated that the differentially expressed genes were
involved in many functions and pathways, including
anti-viral infection. To validate the RNA sequencing
analysis results, some lncRNAs were selected to test
their expression levels by qPCR. We are in the process
of deciphering the mechanism employed by these exo-
somal lncRNAs in anti-viral activty independent of
inteferon.
Summary/conclusion: We believe that understanding
the anti-viral functional molecules wrapped in exo-
somes may help design exosomes as efficient vehicles
for antiviral therapy.
Funding: Chinese Academy of Medical Sciences
Innovation Fund for Medical Sciences (2016-12M-
3–025)
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PF06.01
Exosome quantification by ELISA and Flowcytometry using anti-CD9
antibody
Naoki Hataa, Hiroyuki Kogurea, Hikaru Sonodab and Chihiro Okadab
aLuminex corporation, Tokyo, Japan; bHakarel Inc, Osaka, Japan
Introduction: Quantifying and characterizing exo-
somes in a reproducible and reliable manner has been
challenging due to their small sizes, of which the ranges
are from 30 to 150 nm in diameter. The analysis used
to be mainly performed with either the electric micro-
scopy or the nanoparticle tracking analysis; however,
these techniques are low throughput and not enough
for the quantification especially in the large and het-
erogeneous populations. Also, attempts to analyse exo-
somes using traditional PMT-based flow cytometers
has been hampered by the limit of detection of such
small particles and low refractive index. Here, to over-
come these limitations, we used the highly qualified
and validated monoclonal antibodies for CD9 on the
surface of exosome to employ ELISA and the high
sensitive flow cytometry. In this study, we would like
to show and discuss more reliable and robust platforms
for the quantification of exosomes with use of ELISA
and flow cytometry.
Methods: Malignant cell line-derived exosome was
prepared by the ultracentrifugation
↓
Diluted the samples in PBS at 1:60, 1:120, 1:240, 1:480
and 1:960
↓
Measured the samples either by CD9-based ELISA
(Hakarel Inc) or Flow cytometer (CellStream,
Luminex Corporation)
Results: The quantifications of exosomes were per-
formed by ELISA and CellStream flow cytometer with
use of anti-CD9 monoclonal antibody
Summary/Conclusion: In this study, the quantifica-
tions of exosomes were performed by ELISA and
CellStream flow cytometer with use of anti-CD9 anti-
body. Tumour cell-derived exosomes were labelled
with CD9-PE. The average concentration of the exo-
somes was measured by CD9 ELISA whereas the mean
fluorescence intensity and the objects per microlitre for
the exosomes and control samples were shown by
CellStream flow cytometer. The robust sensitivity of
ELISA and CellStream flow cytometer with use of the
validated CD9 antibody would provide an informative
platform for measuring exosomes.
Funding: No fundings.
PF06.02
Characterizing the light-scatter sensitivity of the CytoFLEX flow
Cytometer
George Brittain, Sergei Gulnik and Yong Chen
Beckman Coulter Life Sciences, Miami, USA
Introduction: Extracellular vesicles (EVs) and other
biological nanoparticles (NPs) generally fall within the
optical noise of light-scatter-based detection methods,
and most flow cytometers are not sensitive enough to
effectively detect NPs less than 300 nm in diameter.
The CytoFLEX is a notable exception to this: it is so
sensitive that the SSC detector actually has an attenua-
tion filter to reduce 95% of the scatter signal, adjusting
it to a range useful for cells. As an alternative, the
Violet SSC (VSSC) signal is unfiltered and can be
used to bring the CytoFLEX sensitivity well into the
nanoparticle range. However, the added VSSC layer
can confuse individuals, and a few instrument compar-
isons have even been published by users unfamiliar
with the use of VSSC on the CytoFLEX.
Methods: In order to better characterize the biological
threshold sensitivity of the CytoFLEX using VSSC, we
analysed a variety of NPs of different compositions,
including viruses and purified plasma EVs. The plasma
EVs were prepared from fresh human blood using
centrifugation, size filtration, and column chromato-
graphy, followed by size characterization using DLS.
After acquisition on the CytoFLEX, we converted the
median scatter intensity for each sample to either their
size or refractive index (RI) using Mie theory
approximations.
Results: We found that the CytoFLEX could fully
resolve 70 nm polystyrene and 100 nm silica (Si) NPs,
including Si with a RI of 1.43 at 405 nm. We could fully
resolve both 110 nm MLV viruses and 90 nm
Adenoviruses with RIs of 1.47–1.50. And, we were
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able to detect plasma EVs at least as small as 80 nm in
diameter using only a VSSC trigger, though immuno-
fluorescence was necessary to fully resolve the smallest
of these EVs from noise.
Summary/Conclusion: Ultimately, the CytoFLEX is
highly sensitive for NP detection. Moreover, unlike
dedicated microparticle analysers, the CytoFLEX is a
full-fledged flow cytometer with a biological dynamic
range extending from approximately 80 nm–50 µm.
The CytoFLEX is for research use only. Individual
results may vary. The Beckman Coulter product and
service marks mentioned herein are trademarks or regis-
tered trademarks of Beckman Coulter, Inc. in the USA
and other countries.
PF06.03
Preparing a CytoFLEX for Nanoscale flow Cytometry
George Brittain, Sergei Gulnik and Yong Chen
Beckman Coulter Life Sciences, Miami, USA
Introduction: Built around semiconductor technology,
with a number of innovations to enhance light capture,
reduce noise and prevent signal losses, the CytoFLEX is
capable of detecting biological nanoparticles (NPs) as
small as 80 nm by light scatter, and has a linear fluores-
cence range that extends down into the single digits for
fluorophores like FITC. However, in order to properly
setup the CytoFLEX for NP analyses, a variety of con-
siderations need to be taken into account, some of which
are extraordinary to conventional flow cytometry.
Methods: In this poster, we will demonstrate how to
properly setup and clean a CytoFLEX flow cytometer
for NP analyses. First, we will explore the different
threshold options and sensitivity ranges. Next, we will
show how to clean the instrument and reduce noise.
And finally, we will discuss several important issues
that affect proper sample analyses.
Results: The three primary detection methods on the
CytoFLEX are FSC, SSC and Violet-SSC (VSSC). FSC
on the CytoFLEX utilizes comparative signal analyses
rather than traditional small-angle scatter, and is accu-
rate for sizing events from 500 nm to 50 µm, indepen-
dent of the refractive index or membrane integrity. The
biological threshold sensitivities for SSC and VSSC on
the CytoFLEX range roughly between 250 nm–20 µm
and 80 nm–2 µm, respectively. In order to take full
advantage of the lower end of these scatter ranges,
cleaning the instrument and thoughtful sample pre-
paration are very important.
Summary/Conclusion: Ultimately, the CytoFLEX is
one of the most sensitive flow cytometers on the
market. However, with such great power comes great
responsibility to properly prepare the instrument and
samples for effective nanoscale flow cytometry
experiments.
The CytoFLEX is for Research Use Only. Individual
results may vary. The Beckman Coulter product and
service marks mentioned herein are trademarks or regis-
tered trademarks of Beckman Coulter, Inc. in the USA
and other countries.
PF06.04
Improved scatter sensitivity of a flow cytometer for detection of
extracellular vesicles
Leonie de Ronda, Edwin van der Polb, Ludovic Monheimc, Ton van Leeuwend
and Frank Coumanse
aAmsterdam University Medical Centers, Amsterdam, USA; bAmsterdam
UMC, University of Amsterdam, Department of Biomedical Engineering
and Physics, Amsterdam, Netherlands; cBD Life Sciences, Erembodegem,
Belgium; ddAmsterdam UMC, University of Amsterdam, Department of
Biomedical Engineering and Physics, Amsterdam, Netherlands, ;
eAmsterdam UMC, University of Amsterdam, Laboratory of Experimental
Clinical Chemistry, Amsterdam, Netherlands,
Introduction: To investigate the biomarker potential of
extracellular vesicles (EVs), EV subtypes are studied by
flow cytometry. A flow cytometer detects fluorescence,
forward (FSC) and side scattered (SSC) light of single
EVs. However, the scatter intensities of the majority of
EVs are below the detection limit of common flow
cytometers because EVs are small and have a low
refractive index. We aim to improve the scatter sensi-
tivity of a common flow cytometer 450-fold for SSC
and 107-fold for FSC, which will allow detection of
100 nm EVs. Improved scatter sensitivity enables us
to derive the size of EVs from the scatter signal and to
increase the fraction of EVs that can be characterized
using immunofluorescence as well as scatter-based
sizing.
Methods: A FACSCanto (Becton Dickinson) was
adapted by replacing the 20 mW laser with a 20–
200 mW adjustable power laser (both 488 nm
Sapphire, Coherent). Confocal detection was achieved
by replacing the standard 1000 µm pinhole on SSC by a
200 µm pinhole, and the standard photodiode on FSC
by a 350 µm pinhole and PMT. The improvements in
scatter sensitivity were quantified by calculating the
scatter stain index (SI) (median intensity of a bead
minus median intensity of the noise divided by two
times the standard deviation of the noise) of a 500 nm
polystyrene bead and the robust coefficient of variation
(rCV) of a 100 nm polystyrene bead (both BioCytex).
Ideally the SI is as high as possible and rCV as low as
possible.
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Results: A 10-fold increase in laser power increased the
SI on SSC 2.9-fold and on FSC 20-fold, whereas the
rCV improved (reduced 0.67-fold and 0.97-fold,
respectively). The improved confocal detection
increased the SI on SSC 6.4-fold and on FSC 550-
fold, while the rCV slightly worsened (increased 1.1-
fold and 1.02-fold, respectively). Combining both
increased laser power and confocal detection resulted
in a 20-fold increase in SI for SSC and 2 · 10^4-fold for
FSC, and improved the rCV (reduced 0.39-fold and
0.24-fold, respectively).
Summary/Conclusion: Adaption of the optical config-
uration of the FACSCanto by increasing the laser
power and confocal detection improved the scatter
sensitivity 20-fold for SSC and 2 · 10^4-fold for FSC.
Next, we will evaluate the influence of increased mea-
surement time and reduction of the number of parti-
cles in the sheath on the scatter sensitivity.
Funding: NWO-TTW Perspectief CANCER-ID 14195
PF06.05
Lipoprotein particles can be detected by high-resolution flow
cytometry and potentially interfere with EV characterisation
Rikke Wehner Rasmussen, Jaco Botha, Mathilde Sanden and Aase Handberg
Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg,
Denmark, Aalborg, Denmark
Introduction: Lipoproteins co-isolate with EVs and are
potential confounders in EV characterisation. CD36 is
a membrane-bound scavenger receptor located on cells
and EVs capable of interacting with VLDL and LDL,
which could interfere with antibody-based phenotyp-
ing. Freezing and thawing samples was shown to
increase phosphatidylserine-positive (PS+) EVs while
other common phenotype markers were unchanged.
This could provide a method for disrupting lipopro-
teins and EVs. Thus, we aimed to investigate the
impact of lipoproteins on EV characterisation and
freezing/thawing samples on their dissociation from
EVs on a high-resolution flow cytometer (hFCM).
Methods: Plasma from 6 healthy individuals was sub-
jected to either 0, 2, 4 or 6 freeze-thaw (FT) cycles and
stained with a cocktail of lactadherin-FITC, anti-CD41-
BV510, anti-CD36-PE and anti-ApoB-APC or lactad-
herin-FITC and matched isotype controls. Samples
were analysed on an Apogee A60 Micro-PLUS hFCM.
Gating was performed as follows: size gates established
on silica reference beads; phenotype gates set on 99th
percentile of isotype control channel fluorescence.
Results: hFCM was able to detect both free apolipo-
protein B (ApoB) particles and ApoB bound to PS
+CD41+, PS+CD36+ and PS+CD41+ CD36+ EV
phenotypes. From 0–2 FT cycles, ApoB bound to PS
+CD41+ and PS+CD41+ CD36+ phenotypes tended to
decrease (p > 0.05). Moreover, ApoB bound to PS
+CD36+ increased 4.9-fold from 0–2 FT cycles for
(p < 0.05). Interestingly, this progression mirrored
that of PS+CD36+ (2.0–2.5-fold, p < 0.05), bulk CD36
+ (1.8–2.4-fold, p < 0.05) and ApoB+ (4.1–5.0-fold,
p < 0.01). Finally, in line with previous reports, PS+
tended to increase following FT (1.5-2.1-fold, p > 0.05).
Contrary to previous reports, certain EV phenotypes
decreased from 0–2 FT cycles (PS+CD41+ and PS
+CD41+ CD36+, both 2.6-fold, p < 0.05) suggesting
that EV phenotypes might perish following FT further
confirmed on bi-variable plots of data.
Summary/Conclusion: This study demonstrates that
ApoB can be detected on hFCM and thereby interfere
with EV characterisation. What further complicates
matters is that lipoproteins could carry markers tradi-
tionally associated with EVs including PS and CD36.
FT cycles did not consistently dissociate EVs and lipo-
proteins; however, FT affected certain EV populations.
Further studies are required to elucidate these findings.
PF06.06
Analysis of fluorescent labelling efficiency of extracellular vesicles
derived from different kingdoms of life with lipid-binding dyes via
nano-flow cytometry
Ye Tiana, Chen Chenb, Qian Niua, Shaobin Zhuc and Xiaomei Yand
aDepartment of Chemical Biology, College of Chemistry and Chemical
Engineering, Xiamen University, Xiamen, China, Xiamen, China (People’s
Republic); bInstitute for Chemical Research, Kyoto University, Uji, Japan;
cNanoFCM Inc., Xiamen, China (People’s Republic); dDepartment of
Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen
University, Xiamen, China, Xiamen, China (People’s Republic)
Introduction: In all domains of life – archaea, bacteria
and eukarya, cells produce and release extracellular
vesicles (EVs). The double-layered lipid membrane is
the most prominent feature of EVs, and fluorescent
labelling with lipid-binding dyes has been frequently
used to visualize and detect single EVs. For example,
most conventional flow cytometers rely on fluorescence
threshold triggering for single EV detection upon
membrane labelling with lipophilic dyes. However,
the labelling efficiency of EVs with these lipid-binding
dyes remains unknown. Here, we reported an approach
to quantitatively analyse the labelling efficiency of
lipid-binding dyes toward EVs by using a laboratory-
built nano-flow cytometer (nFCM) that enables light
scattering detection of individual EVs as small as
40 nm.
Methods: EVs were extracted from cultured medium of
HCT15 cells (colorectal cancer cell line), E. coli O157:
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H7 (gram-negative), S. aureus (gram-positive) and
Prochlorococcus (Pro., marine cyanobacteria) by differ-
ential ultracentrifugation. EVs isolated from E. coli
O157:H7 and S. aureus were further purified by floata-
tion in iodixanol density gradient. The purity of these
EV isolates was assessed by enumerating the particles
before and after the treatment with Triton X-100.
Subsequently, the labelling efficiency of several lipophi-
lic fluorescent dyes, such as PKH26, PKH67, DiI and
Di-8-Ane for EVs were evaluated by comparing with
their light scattering signals.
Results: The purity of EVs isolated from HCT15 cells,
E. coli O157:H7, S. aureus and Pro. were around 80%
to 90%. Compared with side scattering signals, we
found that almost all the EVs derived from E. coli
O157:H7, S. aureus and Pro. could be lightened up by
PKH26, PKH67, DiI and Di-8-Anepps. However, only
around 40% of EVs isolated from HCT15 cells could be
labelled by these dyes. Morphological study by cryo-
TEM indicates that some vesicles secreted by HCT15
cells had surface protrusions (electron-dense spikes
protruding from the membrane). We suspect this
structure may prevent these lipophilic dyes from inter-
calating with EV membrane.
Summary/Conclusion: The nFCM provides a straight-
forward platform to analyse the labelling efficiency of
EVs with different lipid-binding dyes, which will be
very helpful in guiding the development of efficient
vesicle-labelling strategies.
PF06.07
Evaluating the surface charge of yeast extracellular vesicles as a
function of environmental parameters
Nicholas M. Rogers, Meta Kuehn, Claudia Gunsch and Mark Wiesner
Duke University, Durham, USA
Introduction: Understanding the mechanisms of
extracellular vesicle (EV) fate and transport is critical
to predicting their targeting capabilities and delivery
efficiencies. Surface chemistry has been shown to be an
effective predictor of the fate of nanomaterials (which
include EVs) in complex environments. In particular,
ascertaining how surface charge changes based on sur-
rounding conditions provides a foundation for the
prediction of nanomaterial behaviour. Hence, the goal
of this study is to evaluate EV surface charge as a
function of environmental parameters to predict their
ultimate environmental fate.
Methods: EVs were isolated from yeast (S. cerevisiae)
cell culture via the ultracentrifugation/density gradient
purification method. Nanoparticle Tracking Analysis
(NTA), transmission electron microscopy (TEM) and
the Coomassie protein assay data collectively confirm
the presence of EVs. To evaluate the surface charge of
EVs, electrophoretic mobility was measured (Malvern
Zetasizer Nano ZS) at varied pHs, ionic strengths and
organic contents to simulate environmental solution
chemistry; values were then converted to zeta potential
estimates via the Smoluchowski approximation.
Results: Initial tests reveal EVs to have a predomi-
nantly negative charge, with a zeta potential of −5.4
mV in phosphate buffer. Higher ionic strengths desta-
bilize vesicles, causing aggregation by neutralizing the
surface charge.
Summary/Conclusion: We demonstrate an initial
understanding of the behaviour of how EV surface
charge is influenced by various environmental para-
meters; the effects of these changes are variable. This
implies that studying these trends mechanistically in
complex systems may be challenging. Changes to the
EV surface chemistry induced by alterations in the
surrounding environment often also causes aggrega-
tion, which has implications for fate and transport.
Further, work will be performed to probe the aggrega-
tion tendencies of EVs. The quantification of physico-
chemical parameters is a first step in parameterizing
future fate and transport models.
Funding: Funded by the National Science Foundation
(NSF) and the Environmental Protection Agency (EPA)
under NSF Cooperative Agreement EF-0830093 and DBI-
1266252, Center for the Environmental Implications of
NanoTechnology.
PF06.08
Isolation and characterization of bovine milk-derived EVs.
Saori Fukunagaa, Yuki Yamamotob and Hidetoshi Taharaa
aHiroshima University, Hiroshima, Japan; bHiroshima university, Hiroshima,
Japan
Introduction: Extracellular vesicles (EVs) are secreted
from various cells and known to contain DNA, RNA
and protein. Such inclusion is taken in other cells and
plays functionally. Since recent studies reported that
EVs are detected in food, such as fruits, vegetables
and bovine milk, we hypothesized that functional EVs
in food could contribute to human health. In the study,
we investigated whether the growth environment for
dairy cattle affected the contents and functions of EVs
from bovine milk.
Methods: Milk was warmed at 37ºC water bath for
10 min, then mixed with 1/100 volume of acetic acid
at room temperature for 5 min and centrifuged at
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10,000 x g at 4ºC for 10 min to remove milk fat and
debris. The supernatant was filtered with a 0.22 um
membrane and defined as whey. The whey was ultra-
centrifuged at 200,000 x g for 70 min at 4ºC. After PBS
wash was performed twice, the pellet of EVs was resus-
pended in PBS, and centrifuged at 10,000 x g for 5 min
at 4ºC. The supernatant was used as EV solution.
Particle size and concentration of EVs were measured
by qNano. Total RNA of EVs was isolated by
miRNeasy Mimi kitand the RNA concentration was
measured by Agilent 2100 Bioanalyzer. RNA sequence
was performed by Ion S5. The sequences data was
analysed by CLC Genomics.
Results: We compared two bovine milks, which were
collected from different farm. Milk A and milk B were
both from healthy cattle who grew up with nutrient-
filled pasture without giving stress, however, B was
raised under better conditions. Between milk A and
B, bovine milk-derived EVs were almost same particle
size and concentration. Then, amount of RNA contain-
ing EVs were same between milk A and B. However,
NGS data was revealed that EVs from milk B contained
more immune-related microRNAs than milk A.
Summary/Conclusion: This study revealed that the
better growth environment of dairy cattle increased
immune-related microRNAs in bovine milk-derived
EVs and so might be better for health.
PF06.09
Regulatory effect of apple-derived nanoparticle on intestinal organic
anion transporting polypeptide (OATP) 2B1
Daichi Fujitaa, Hisakazu Komoria, Yuma Shirasakia, Toshiki Araia, Yui
Iwamotoa, Tomohiko Wakayamab, Takeo Nakanishia and Ikumi Tamaia
aFaculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical and
Health Sciences, Kanazawa University, Kanazawa, Japan; bFaculty of Life
sciences, Kumamoto University., kumamoto, Japan
Introduction: Several studies have shown that plant-
derived nanoparticles (NPs) taken up by the intestinal
cells affect intestinal function. Food-derived NP is
known to facilitate delivery of proteins, nucleic acids
including microRNA (miRNA) and other large mole-
cules to intestinal tissues. Therefore, such large mole-
cules may affect gastrointestinal functions through
NPs. Accordingly, we investigated the effect of apple-
derived NP to intestinal transporters through contain-
ing cargos.
Methods: NP was prepared by ultracentrifugation.
Lipid membrane of NP and apple-derived nucleic
acid were labelled by fluorescents to examine uptake
in Caco-2 cells using microscope. Expressions of
mRNA and protein of transporters in Caco-2 cells
were evaluated by qRT-PCR and Western blotting.
Transport activity of OATP2B1 was evaluated by
uptake of oestrone sulphate. Apple miRNA targeting
OATP2B1 predicted by in silico analysis were detected
by RT-PCR. microRNA target sites for OATP2B1 were
evaluated by deletion assay and luciferase assay.
Results: Fluorescent labelled NP and nucleic acids were
observed in Caco-2 cells after 6 h exposure. NP sig-
nificantly decreased expression and transport activity
of OATP2B1 in Caco-2 cells. When NP were heat-
denatured or broken by sonication, their decreasing
effects were attenuated. In deletion assay, decrease of
OATP2B1 mRNA expression was observed in only
plasmid construct containing 3’ untranslated region
(3’UTR). Luciferase activity of pGL-OATP2B1-3’UTR
was reduced by NP exposure. Seven miRNAs which
predicted to bind to this region were detected in NP.
Moreover, decreased luciferase activity was inhibited
by some miRNA inhibitors for predicted miRNAs.
Summary/Conclusion: Apple NP reduced mRNA and
protein expressions and activity of OATP2B1, suggesting
that apple miRNA in NP is involved in drug food interac-
tion. Moreover, it was suggested that apple miRNA con-
tributes to drug disposition by regulation of drug
absorption mediated by OATP2B1 through NPs,
PF06.10
Fluorescent retroviruses as reference particles for Nanoscale flow
cytometry
Vera Tanga, Tyler Rennera, Anna Fritzschea, Dylan Burgera, Edwin van der
Polb and Marc-André Langloisa
aUniversity of Ottawa, Ottawa, Canada; bAmsterdam UMC, University of
Amsterdam, Department of Biomedical Engineering and Physics,
Amsterdam, Netherlands
Introduction: Nanoscale flow cytometry (NFC) is a
promising tool for phenotypic analysis of individual
small particles such as extracellular vesicles (EVs) and
viruses that are smaller than 500 nm in diameter.
However, since many small EVs are currently at the
limit of detection for commercial flow cytometers, suc-
cessful detection of EVs requires optimization of both
sample preparation and instrument settings. These
optimizations require reference particles reflecting
size, refractive index (RI), and fluorescence emission
intensity of the labelled EVs of interest. Murine leu-
kaemia virus (MLV) is a retrovirus ~114 nm in dia-
meter as measured by cryo-EM, with an estimated RI
of 1.5. Here we showcase the monodispersed nature of
these viruses and demonstrate their use as fluorescence
reference particles for NFC.
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Methods: We engineered MLVs to express its envelope
glycoprotein fused to green fluorescent proteins (eGFP
and sfGFP) on the viral surface. MLVs were character-
ized by NFC and by nanoparticle tracking analysis.
Because MLVs are monodispersed, we combined scat-
ter intensities and hydrodynamic diameter to obtain
the effective RI by solving the inverse light scattering
problem using Mie theory.
Results: We measured an antigen density of ~300
MESF of GFP per virion. In addition, we found that
antibody labelling of this virus-associated antigen with
different fluorophore conjugates (PE, BV421 and
AF647) modulates both scatter intensities and hydro-
dynamic diameter of the labelled virus. With regard to
the hydrodynamic diameter, we show that the effective
RI of the viruses could be tuned by using different
fluorophores.
Summary/Conclusion: MLVs are similar to small EVs in
size with equivalent surface area and comparable capacity
for antigen expression. Unlike synthetic beads, MLVs can
be genetically engineered to express protein antigens of
choice in biologically relevant and consistent levels to act as
internal positive controls for phenotypic studies of EV
surface marker expression. Moreover, MLVs are mono-
disperse and have tuneable RI. Collectively, these proper-
ties support that MLVs are strong candidates as
fluorescence reference particles for NFC.
Funding: Natural Sciences and Engineering Research
Council of Canada (NSERC)
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PF07.01
Proteomic profiling of outer membrane vesicles derived from MicA, a
small RNA from Escherichia coli
So Hee Leea, Yeong-Jun Parkb and Kwang-sun Kima
aPusan National University, Busan, Republic of Korea; bPusan National
University, Pusan, Republic of Korea
Introduction: Outer membrane vesicles (OMVs) pro-
duced by Gram-negative bacteria are utilized as vaccine
or drug delivery platforms in terms of their efficient
immune responses to host cells. In a previous report,
we identified that ectopic expression of MicA, a small
noncoding RNA from E. coli, produced a high produc-
tion of OMVs as a conserved manner in both E. coli
and Salmonella through both up- or down-regulation
of OmpC or OmpA level, respectively, in OMV frac-
tions. Moreover, MicA-derived OMVs showed the pro-
tective role against Salmonella challenge, suggesting
that OmpC-enrichment in OMVs is important for the
production and function of OMVs. However, MicA
overexpression in the knockout strain of ompA, a target
of MicA, still strongly induced the production of
OMVs, indicating that another underlying mechanism
of high production of OMV is presented.
Methods: Analysis of total and surface proteins from
control- and MicA-derived OMVs from E. coli was
performed using high-resolution mass spectrometry.
The OMVs were isolated from culture supernatants,
followed by characterization using Nanosight. We
then analysed proteins of OMVs by in-gel digestion
from SDS-PAGE, followed by nano LC-MS/MS analy-
sis. The functional analysis of candidate proteins on the
biogenesis of OMVs was performed by OMV prepara-
tion, BCA quantification, and protein analysis from
knockout strains of specific genes.
Results: We found that spherical OMVs were an aver-
age diameter of 84.7 ± 1.3 nm and 88.2 ± 2.4 nm for
MicA- or control-derived OMVs, respectively. Further,
we identified 1,102 (38) or 656 (40) proteins for MicA-
or control-derived OMVs in total (or surface) fractions
are presented. Among them the level of 84 or 15
proteins from total or surface fractions, respectively,
was decreased or absent compared to control sample.
Total 99 proteins were categorized into 19 functional
groups and found that 60 proteins are associated with
flagella, ribosome, and modification. Moreover, the
role of individual proteins on the biogenesis of OMVs
using knockout strains expressing proteins was
evaluated.
Summary/Conclusion: All our results enabled us to
elucidate the underlying mechanism of high produc-
tion of OMVs by MicA and the information will be
utilized as a vaccine platform for infectious diseases.
PF07.02
Dysfunction in an autophagy-lysosome degradation pathway
promotes secretion of ubiquitinated proteins via extracellular vesicles
Toshihide Takeuchi, Satoko Sakai, Harue Ando and Yoshitaka Nagai
Osaka University, Suita, Japan
Introduction: Autophagy-lysosome degradation is a
cellular protective mechanism that prevents aberrant
accumulation of cellular proteins, and thus, maintains
protein homeostasis. Recent studies have suggested that
autophagy impairment leads to an increase in secretion
of aggregation-prone proteins, such as proteins that are
associated with the neurodegenerative diseases,
although molecular mechanisms underlying such
secretion and its biological significance still remain
elucidated.
Methods: The extracellular vesicle (EV) fractions were
collected from the cell culture media by ultracentrifu-
gation, and analysed by Western blotting, electron
microscopy and nanoparticle tracking analysis.
Results: Here we show that perturbation of the autop-
hagy/lysosome pathway activates secretion of ubiquiti-
nated proteins via EVs. We found that treatment of
cells with autophagy inhibitors leads to an increase in
the amounts of ubiquitinated proteins, as well as
autophagy-related proteins including LC3 and p62, in
the EV fraction of the culture media. We also found
that inhibitor treatment facilitates secretion of EVs
distinct from exosomes in size, and that these EVs are
involved in secretion of ubiquitinated proteins.
Interestingly, analysis of knockout cells deficient for
autophagy-related proteins revealed that the factors in
the initiation step of autophagy are needed for EV-
mediated secretion of ubiquitinated proteins.
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Summary/Conclusion: These results indicate that
autophagy impairment promotes secretion of ubiquiti-
nated proteins via EVs. Our data provide the mechan-
istic link between the autophagy/lysosome pathway and
vesicle secretion. We propose that cells may use the
EV-mediated secretion as an alternative pathway to
maintain protein homeostasis when cellular proteosta-
sis machinery is functionally impaired.
Funding: This work was supported by JST; by KAKENHI
(18H02585); by The Asahi Grass Foundation and The
Tokyo Biochemical Research Foundation.
PF07.03
Identifying the miRNAs associated with EV Secretion from cancer cell
lines
Tomofumi Yamamotoa, Nobuyoshi Kosakab, Fumihiko Urabea, Yutaka
Hattoric and Takahiro Ochiyab
aDivision of Molecular and Cellular Medicine, National Cancer Center
Research Institute, Tokyo, Japan; bDepartment of Molecular and Cellular
Medicine, Institute of Medical Science, Tokyo Medical University,
Shinjyuku-ku, Japan; cClinical Physiology and Therapeutics, Keio University
Faculty of Pharmacy, Tokyo, Japan
Introduction: Extracellular vesicles (EVs) derived from
cancer cells contribute to their surrounding microenvir-
onmental cells for their benefit. Our group has previously
shown that inhibiting the EVs production attenuated the
angiogenesis in the tumour, resulting in the suppression
of metastasis. Thus, understanding the mechanisms of EV
secretion might contribute to the regulation of EV-
mediated cancer progression. However, the precise
mechanism of EV secretion in cancer cells remains
unclear. The purpose of this study is to elucidate the
unknown mechanisms of EV secretion in cancer cells.
To reveal this, microRNAs (miRNAs), which regulate
multiple genes, are employed.
Methods: To identify the EV secretion associated
miRNAs, miRNA-based screening method was estab-
lished. Combined with ExoScreen, which is ultra-sen-
sitive detection method of EV by measuring surface
protein of EVs, such as CD9 and CD63, miRNA-
based screening was performed in colorectal cancer
cell line, HCT116, and lung cancer cell line, A549.
The results of the screening were confirmed by the
nanoparticle tracking analysis. Candidate genes of
these miRNAs were chosen by in silico analysis.
Results: From the initial 1728 miRNAs, we identified
13 miRNAs which are associated with EV secretion in
each cell lines. Then, the target genes of these miRNAs
were identified and confirmed that EV secretion was
attenuated by siRNAs against candidate genes. From 6
miRNAs, 27 genes, which were associated with EV
secretion, were identified. Interestingly, among six
miRNAs, four miRNAs altered the EV secretion in
both cell lines, HCT116 and A549.
Summary/Conclusion: Some of these target genes have
reported as endosomal pathway associated protein and
shown the up-regulation in cancer cells. These findings
suggest that the identification of target genes of these
miRNAs provides the new insight into the cancer cell
communication with the microenvironmental cells,
which leads to a promising therapeutic approach
against cancer progression.
PF07.04
Ras Tumour microvesicles biogenesis and signalling in drosophila
Vakil Ahmad, Carson Broeker, Kayla Calandro and Yves Chiswili. Chabu
University of Missouri, Columbia, USA
Introduction: Tumour-derived exosomes and micro-
vesicles are increasingly implicated in cancers. Their
respective functional contributions to cancer progres-
sion and the related mechanisms remain poorly
defined. This is partly because current techniques, cen-
tered on differential centrifugation, do not permit ade-
quate and specific isolation of pure exosomes or MV
for targeted functional studies. More importantly, the
paucity of animal models to address mechanistic and
functional questions in tissues has further limited our
knowledge on the role of extracellular vesicles in cancer
biology
Methods: Using a Drosophila Ras tumour model, we
have identified a strategy to specifically label and
genetically manipulate tumour microvesicles in tissues
for mechanistic studies.
Results: We will discuss some of our preliminary
results on the dynamic of microvesicle biogenesis and
their role in Ras tumour-macrophage signalling
interaction.
Summary/Conclusion: Together with the power of
Drosophila genetics, this in vivo system will enable
novel insights into microvesicle biogenesis and func-
tion during tumour progression.
PF07.05
Src in endosomal membranes promotes exosome secretion and
cancer progression
Chitose Oneyama
Cancer Cell Regulation, Aichi Cancer Center Research Institute, Nagoya,
Japan
Introduction: c-Src is a membrane-associated tyrosine
kinase that has key roles in the signalling transduction
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that controls cell growth, adhesion and migration. In
the early stage of carcinogenesis, c-Src is activated
under the plasma membrane and transduces oncogenic
signals. Previous reports demonstrate that c-Src is loca-
lized to intracellular membranes, such as those of
endosomes. However, the functional significance of
endosomal c-Src in cancer is not well understood.
Methods: We examined intracellular localization of
active c-Src, and in intermediate sections we found c-
Src localized in perinuclear regions. In co-localization
experiments with organelle markers in Src-transformed
cells, active c-Src was present with the late endosome
markers, including CD9 and CD63, which are also
known as canonical exosome markers. We examined
exosome secretion in c-Src-transformed cells.
Results: Our results indicate that activated c-Src in the
endosomal membrane promoted the secretion of exo-
somes, in which c-Src was encapsulated. In addition,
the ESCRT-interacting molecule, Alix was identified as
a c-Src–interacting protein in exosomes. We revealed
that the interaction between the SH3 domain of c-Src
and the proline-rich region of Alix activates ESCRT-
mediated intra-luminal vesicle (ILV) formation, result-
ing in the upregulation of exosome secretion in c-Src–
transformed cells. We observed also a correlation
between malignant phenotypes and Alix–dependent
aberrant exosome secretion in c-Src–upregulated can-
cer cells.
Summary/Conclusion: Our findings indicate that c-
Src-mediated activation of Alix promotes ILV forma-
tion in MVB, resulting in increased exosome secretion
from various human cancer cells with activated c-Src.
These data suggest that dysfunctions of exosome secre-
tion suppress cell transformation, offering a novel sig-
nalling target and strategy for cancer therapeutics.
Funding: JST, PRESTO Grant Number JP1005457,
Japan.
PF07.06
Modulation of Sphingosine-1-phosphate lyase and its implication in
release of apoptotic exosome-like vesicle
Jihyo Kim, Jaehark Hur and Yong Joon Chwae
Introduction: Biogenesis of apoptotic exosome-like
vesicles (AEVs), which can function as damage-asso-
ciated molecular patterns, is reported to be regulated
by sphingosine-1-phosphate (S1P)/S1P receptor 1/3
signalling. Thus, cellular S1P levels could be key factors
in the biogenesis of AEVs. As is well-known, S1P is
synthesized from sphingosine by sphingosine kinase 1/
2-mediated phosphorylation and irreversibly degraded
into fatty aldehydes and phosphoethanolamine by the
enzyme, S1P lyase. In the present work, we investigated
the role of S1P lyase in biogenesis of the AEVs and its
molecular modulation in the apoptotic processes.
Methods: Preparation of AEVs: The conditioned med-
ium was centrifuged for 10 min at 200 × g and twice
for 20 min at 2,000 × g to remove cellular debris and
apoptotic bodies. The pellets were collected by over-
night incubation in 8% PEG6000 and 0.5 M NaCl, and
washed by ultracentrifugation at 100,000 × g for
70 min.
Results: S1P lyase was degraded caspases-dependently
in HeLa cells by apoptotic stimuli. Over-expression of
N-terminal 3X flag- and C-terminal HA-tagged S1P
lyase turned out that C-terminal region of S1P lyase
was degraded. However, S1P lyase was not a direct
target of caspases because mutations of Asp residues
at C-terminal regions did not block its degradation.
Possibly, S1P lyase might be a substrate of calpain in
that co-treatment of a calpain inhibitor, PD150606
with staurosporine inhibited the degradation of S1P
lyase. In consistent with this, knock-down of an endo-
genous inhibitor of calpain, calpastatin increased the
degradation of S1P lyase while knock-down of calpain
small subunit, CAPNS1 decreased the degradation of
S1P lyase. Functionally, mutant form of S1P lyase
deleted in C-terminal 21 amino acids showed decreased
enzyme activities as well as less inhibitory effect on
release of the AEVs when compared with wild type.
Summary/Conclusion: C-terminal degradation of S1P
lyase during apoptotic processes contribute to enhance-
ment of biogenesis of the AEVs, possibly through
decreasing enzymatic activities of S1P lyase and subse-
quent increment of S1P in ER region. Although degra-
dation of S1P lyase is caspases-dependent, S1P is not a
direct substrate of caspases. It would be probable that
S1P lyase was degraded by calpain, activated caspase-
dependently.
PF07.07
Super-repressor-IκB-loaded exosome improves survival in a mouse
model of sepsis and attenuates sepsis-induced inflammation
Youngeun Kima, Hojun Choib, Amin Mirzaaghasib, Eunsoo Kimc, Kyungsun
Choic and Chulhee Choic
aCellex LIfe Sciences Incorporated, Daejeon, Republic of Korea; bKorea
Advanced Institute of Science and Technology (KAIST), Daejeon, Republic
of Korea; cCellex Life Sciences Incorporated, Daejeon, Republic of Korea
Introduction: The nanoparticles referred as exosomes
play an active role in intercellular communication. The
ability of exosomes to travel between cells and deliver
their cargo, which includes proteins and nucleic acids,
makes them an appealing cell-free therapy option to
treat multiple diseases. Super-repressor IκB (srIkB)
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which is S32A and S36A mutant form of IκB can
continuously inhibit NF-κB because it is not phos-
phorylated by IκB Kinase and degraded by proteasome.
Therefore, it has the great potential as a treatment for
various inflammatory diseases. We have previously
developed an opto-genetically engineered exosome sys-
tem named exosomes for protein loading via optically
reversible protein–protein interaction (EXPLOR) that
can deliver soluble proteins via reversible protein–pro-
tein interactions. Here, we generated opto-genetically
engineered exosome system to load srIkB into newly
generated exosomes. Treatment with srIkB-loaded exo-
somes significantly reduced tumour necrosis factor-α-
induced translocation and DNA binding of the p65, a
subunit of NF-κB, in HeLa cells. Furthermore, srIkB-
loaded exosomes administration improved survival in
the cecal ligation and puncture (CLP)-induced sepsis
mouse model and attenuated lipopolysaccharide (LPS)-
induced systemic inflammation. In addition, in sepsis-
induced mice, exosomes accumulated in the spleen and
liver after intraperitoneal injection. This finding may
be helpful for understanding the mechanism about
how the administration of srIkB-loaded exosomes facil-
itates the recovery from sepsis. Taken together, these
results show that srIkB-loaded exosomes could poten-
tially be a novel anti-inflammatory and immunosup-
pressive cure in the treatment of sepsis and septic
shock.
Methods: ABC
Results: ABC
Summary/Conclusion: ABC
PF07.08
Efficient delivery of Glucocerebrosidase Lysosomal Enzyme via
EXPLOR technology for treatment of Gaucher’s disease
Yonghee Songa, Hojun Choib, Youngeun Kimc, Kyungsun Choia and Chulhee
Choia
aCellex Life Sciences Incorporated, Daejeon, Republic of Korea; bKorea
Advanced Institute of Science and Technology (KAIST), Daejeon, Republic
of Korea; cCellex LIfe Sciences Incorporated, Daejeon, Republic of Korea
Introduction: Many intracellular proteins with great
potential as biopharmaceutical drugs have been identi-
fied. However, numerous challenges associated with
intracellular protein delivery have yet to be solved.
Over the past years, extracellular vesicles including
exosome have been regarded as a new paradigm for
soluble protein delivery into cells or tissues. Because of
their biological functions and features, exosomes are
expected to be a novel treatment for diverse diseases,
such as cancer and rare genetic disorder diseases. We
have previously developed an opto-genetically
engineered exosome system named exosomes for pro-
tein loading via optically reversible protein–protein
interaction (EXPLOR) that can deliver soluble proteins
via reversible protein–protein interactions. Here, we
demonstrate the intracellular delivery of β -glucocereb-
rosidase (GBA) as functional proteins from the exo-
somes to the target cells. We generated opto-genetically
engineered exosome system to load GBA, which is an
enzyme deficient in Gaucher disease patients, into
newly generated exosomes. Treatment with GBA-
loaded exosomes showed the significant increase of
intracellular levels of cargo proteins and their function
in recipient cells in both time- and dose-dependent
manner. In the present study, we tested lysosomal
localization of GBA-loaded exosome in the target cells
and compared the the efficacy with an analogue of the
human GBA, VPRIV, to suggest it as a potential drug
candidate in Gaucher disease.
Methods: ABC
Results: ABC
Summary/Conclusion: ABC
PF07.09
Sequence-specific release of EV-associated RNAs
Christian Preußer, Marie Mosbach, Lee-Hsueh Hungand Albrecht Bindereif
Institute of Biochemistry, Justus Liebig University of Giessen, Giessen,
Germany
Introduction: Extracellular vesicles (EVs) contain differ-
ent classes of RNAs, such as mRNA, miRNAs and
circRNAs. As shown for miRNA and circular RNAs,
RNAs are selectively exported into vesicles [1–2].
However, the factors or mechanisms that contribute to
this specificity remain elusive. Thus, for example, a so-
called Exo-motif has been described for miRNAs, which,
however, cannot be transferred to all miRNAs classes, and
for circRNAs a possible size-dependent export was sug-
gested. In addition, only a few putative protein factors
involved in packaging have been described [2].
Methods: To determine the export signals for the
selective release of certain RNA species into EVs, we
designed a modified in vivo SELEX approach
(Systematic Evolution of Ligands by Exponential
Enrichment) for identifying putative RNA sequence
elements. We generated a random sequence pool
(N40), which was transfected and expressed into
HEK293 and HeLa cells. Moreover, several expression
constructs were used, which consist of either an RNA
Pol II or a Pol III promoter to analyze possible mod-
ification effects on the 5’-end of the RNA. Similarly, we
introduced transcription terminators at the 3’-end to
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prevent possible polyadenylation. EVs were isolated,
followed by RNA isolation, library preparation, RNA-
seq analysis and bioinformatic identification of
enriched RNA motifs.
Results: We developed a new SELEX-based approach
to identify enriched sequence motifs within EV-RNAs.
For this, we have generated constructs that express
long degenerate sequences but are still relatively small
in total (85 nts). In a first attempt, we analysed the
expression of the degenerated sequences and were able
to recover these sequences from EV-RNAs. Detailed
sequence and motif enrichment analyses are now in
progress.
Summary/Conclusion: Here we described a novel
approach to determine specific sequence motifs
required for selective loading of RNA into EVs. This
unbiased method should contribute to our understand-
ing of how RNAs are specifically packaged into EVs.
References: [1] Preußer et al. 2018, J Extracell Vesicles.; [2]
Villarroya-Beltri et al. 2013, Nat Commun.
PF07.10=OWP2.14
Isolation of extracellular vesicles from extracellular matrix based
hydrogel 3D cell cultures
Jens Luotoa, Lea Sistonenb and Eva Henrikssona
a1Cell Biology, Biosciences, Faculty of Science and Engineering, Åbo
Akademi University, FI-20520, Turku, Finland; 2Turku Centre for
Biotechnology, University of Turku and Åbo Akademi University, FI-20521,
Turku, Finland;, Turku, Finland; b1Cell Biology, Biosciences, Faculty of
Science and Engineering, Åbo Akademi University, FI-20520, Turku,
Finland; 2 Turku Centre for Biotechnology, University of Turku and Åbo
Akademi University, FI-20521, Turku, Finland;, Turku, Finland
Introduction: Cancer-derived extracellular vesicles
(EVs) are commonly studied and isolated from two-
dimensional (2D) cell cultures. Nevertheless, three-
dimensional (3D) culture systems with extracellular
matrix (ECM) provide physiologically more relevant
system to mimic in vivo tumour growth and progres-
sion of invasion. However, there are currently no
methods to efficiently isolate EVs from ECM-based
3D cultures. For that purpose, we established a proto-
col for isolating EVs from cancer cells growing in a 3D
ECM-based hydrogel.
Methods: Human prostate cancer PC3 cells were
grown in 3D to form spheroids in a commercially
available ECM-based hydrogel and the growth media
was collected every two days for a period of 14 days,
during which the spheroids grew invasive. The respec-
tive media were differentially centrifuged at 2K, 10K
and 100K g and the pellets were resuspended in PBS.
The EVs were analysed by western blotting (WB)
against the common EV markers CD81, CD63
and CD9.
Results: Our preliminary data shows a step-wise
increase of the EV markers in the media as the PC3
spheroids formed, expanded and invaded to the sur-
rounding 3D ECM. The EVs produced by non-invasive
or invasive spheroids are currently being characterized
with nano tracking analysis, electron microscopy
and WB.
Summary/conclusion: This study demonstrates that
EVs can be isolated from 3D ECM-based hydrogel
cell cultures, which recapitulate the tissue architecture
of solid tumours. Our results suggest that 3D cancer
cell cultures have dynamic EV secretion determined by
the phenotype of the spheroids. Taken together, we
present a novel protocol for EV isolation from a 3D
culture system and provide a platform to investigate
EVs from in vivo mimicking conditions.
Funding: This project is funded by Magnus Ehrnrooth
Foundation, K. Albin Johansson Foundation and Åbo
Akademi University.
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PF08.01
The role of adipocyte-derived extracellular vesicles in vimentin
mediated fibrosis
Sepideh Parvaniana,b, Fang Chengc,d,e, John Erikssonf,g, Jens Luotoh,i and
Peiru Yangf,g
aCell Biology, Biosciences, Faculty of Science and Engineering, Åbo Akademi
University, Turku, Finland; bTurku Centre for Biotechnology, University of
Turku and Åbo Akademi University, Turku, Finland; Turku, Finland; cCell
Biology, Biosciences, Faculty of Science and Engineering, Åbo Akademi
University, Turku, Finland; dTurku Centre for Biotechnology, University of
Turku and Åbo Akademi University, Turku, Finland; eSchool of
Pharmaceuticals, Turku, Finland; fCell Biology, Biosciences, Faculty of Science
and Engineering, Åbo Akademi University, Turku, Finland; gTurku Centre for
Biotechnology, University of Turku and Åbo Akademi University, Turku,
Finland; hCell Biology, Biosciences, Faculty of Science and Engineering, Åbo
Akademi University, Turku, Finland; iTurku Centre for Biotechnology,
University of Turku and Åbo Akademi University, Turku, Finland
Introduction: Vimentin is involved in wound healing
by mediating fibroblast proliferation, epithelial-
mesenchymal transition processing, and collagen accu-
mulation, but its functional contribution to this process
is not clear. Adipocyte-derived extracellular vesicles
(EVs) have the potential to promote wound healing
by controlling molecular processes on recipient cells.
Methods: Differential centrifugation was used for the
isolation of EVs from wilde-type (WT) and vimentin
knockout 3T3lt1 (VIM-/-) cells. Electron microscopy
and Western blot were used to characterize EVs from
the cell culture media. In vitro analysis of cell migration
and proliferation were performed using wound scratch
assay and cell-derived matrices (CDM) in response to
WT and VIM-/- EVs.
Results: Our preliminary data shows that Human Dermal
Fibroblasts (HDF) show different significant migration
responses in the presence of Adipose-derived Stem Cells
(ASCs) EVs. Especially, exosomes treatment inducedmore
migration compared to other EVs. Also, vimentin affected
the results of the exosome treatment in fibroblast prolif-
eration and migration assays.
Summary/Conclusion: This study is expected to reveal
novel mechanisms of ASCs-derived exosomes regulat-
ing fibroblast activities in physiological wound healing
and fibrosis.
Funding: This project was funded by Sigrid Juselius
Stiftelse and Åbo Akademi University.
PF08.02
Effect of exosomes from human adipose-derived stem cells on hair
growth
Hye-In Choia, Eun Wook Choib, Sang Won Yoonb and Byung-Soon Parkb
aR&D Center, PROSTEMICS, Seoul, Republic of Korea; bR&D Center,
PROSTEMICS, seoul, Republic of Korea
Introduction: Hair loss (alopecia) is a common
medical problem affecting both men and women,
and is caused by genetics, hormonal changes, med-
ical condition or medications. Adipose-derived stem
cells (ASCs) have been reported as an important
component of regenerative medicine and cell ther-
apy for hair loss. Recent studies have demonstrated
that exosomes from mesenchymal stem cells and
DPCs may regulate the hair follicle development
and hair growth. In this study, we investigated the
function of ASC secreted exosomes (ASC-exos) on
hair growth.
Methods: Exosomes were isolated from the condi-
tioned medium of human ASCs. The effects of ASC-
exos on hDPC proliferation were evaluated using CCK-
8 assays. The mRNA expression of growth factors was
investigated using real-time PCR. Additionally, anagen
induction was evaluated using an in vivo mice model.
Furthermore, we analyzed the profile of exosomal
microRNAs (exo-miRNAs) by microarray analysis,
which was isolated from ASC-exos.
Results: We found that the ASC-exo enhanced the cell
proliferation of DPCs. Also, quantitative real-time PCR
showed that the expression of genes related with hair
growth, such as transforming growth factor β-2, nog-
gin, was increased after being treated with ASC-exos.
Additionally, ASC-exos treatment accelerated the ana-
gen hair induction when topically applied to C57BL/6
mice. Based on this finding, we conducted microRNA
analysis and selected 12 miRNAs that contribute to
regulation of hair growth.
Summary/Conclusion: Our results show that the exo-
somes from ASCs have a potential to activate DPCs
and promotes hair growth in vivo and may use in
treatment of hair loss.
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PF08.03
Paracrine regenerative function of mesenchymal stem cells is not
affected by chronic kidney disease
Bas WM. van Balkoma, Femke van Rhijn-Brouwerb, Diana Papazovab, Dienty
Hazenbrinkb, Anke Meijerb, Arjan van Zuilena, Raechel Tooropa, Joost
Fledderusa, Hendrik Gremmelsa and Marianne Verhaara
aUMC Utrecht, Utrecht, Netherlands; bUMC Utrecht, Utrecht, USA
Introduction: Cell-based therapies have been devel-
oped to meet the need for curative therapy in chronic
kidney disease (CKD). Mesenchymal stromal cells
(MSCs) enhance tissue repair and induce neoangiogen-
esis through paracrine action of secreted proteins and
extracellular vesicles (EVs). Administration of allo-
geneic MSCs is less desirable in a patient population
likely to require a kidney transplant, but potency of
autologous MSCs should be confirmed, given previous
indications that CKD-included dysfunction is present.
While the immunomodulatory capacity of CKD MSCs
has been established, it is unknown whether CKD
affects wound healing and angiogenic potential of
MSC-derived CM and EVs.
Methods: MSCs were cultured from BM obtained from
kidney transplant recipients (N = 15) or kidney donors
(N = 17). Passage 3 MSCs were used for experiments
and collection of conditioned medium (CM). EVs were
isolated from passage 8 MSCs from 13 male partici-
pants. In vitro pro-migratory and pro-angiogenic capa-
city of bone marrow (BM) MSC-derived CM and EVs
was assessed using an in vitro scratch wound assay and
Matrigel angiogenesis assay. Our methods are in agree-
ment with the declaration of Helsinki and we obtained
written consent from bone marrow donors.
Results: Healthy and CKD MSCs exhibited similar
differentiation capacity, proliferation and senescence-
associated β-galactosidase activity. Scratch wound
migration was not significantly different between
healthy and CKD MSCs (p = 0.18). Healthy and CKD
CM induced similar tubule formation (p = 0.21). There
was also no difference in paracrine regenerative func-
tion of EVs (tubulogenesis: P = 0.46; scratch
wound: P = 0.6).
Summary/Conclusion: Our results indicate that CKD
does not affect the regenerative potential of CM and
EVs derived from CKD BM MSCs. This suggests that
autologous MSC-based therapy is a viable option
in CKD.
Funding: Netherlands Organisation for Scientific
Research (NWO)
PF08.04
Cell to cell interactions orchestrated by exosomal MiRNAs between
pathogenic- and Non-pathogenic corneal endothelial cells
Kazuko Asadaa, Junji Hamuroa, Morio Uenoa, Atsushi Mukaia, Munetoyo
Todab, Shigeru Kinoshitab and Chie Sotozonoa
aDepartment of Ophthalmology, Kyoto Prefectural University of Medicine,
Kyoto, Japan; bDepartment of Frontier Medical Science and Technology for
Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan
Introduction: Corneal endothelial dysfunction such as
bullous keratopathy (BK), Fuchs’ endothelial corneal
dystrophy (FECD) can be restored only with corneal
transplantation. We have recently developed a cell-
injection therapy using cultured human corneal
endothelial cells (cHCECs) (New Eng J Med.2018).
Cultured HCECs have an inclination towards cell-
state transition (CST). The expression of miRNAs is
essential in the regulation of many cellular processes
closely linked to CST in cHCECs. Here, we studied the
role of exosomal miRs in pathogenesis of BK and
FECD.
Methods: The composition of heterogeneous cHCEC
subpopulations (SPs) were verified in regard to their
surface cluster determinant (CD) markers. The profiles
of miRs in cells, culture supernatants (CS) and in fresh
corneal tissues were detected by 3D-Gene® Human
miRNA Oligo chip (Toray). Exosome surface markers
were measured either directly by Exo Screen or by WB
after ultracentrifugation. PKH-labelled exosome was
applied for the evaluation of the incorporated exo-
somes in cHCECs with distinct CD44 expression levels.
Results: MiR34a-5p and miR-378 family were detected
only intracellularly and were strikingly lowered in
pathogenic corneal endothelium. Candidate miRs in
CS to discriminate CD44- SPs from those with CD44
++~+++ phenotypes were miRs 23a-3p, 24-3p, 184,
1246, 1273 and 1285-3p. Among these miRs 23a-3p,
24-3p and 184 have a tendency to decrease in senes-
cence-disposed cHCECs, the inversely correlated
decrease with upregulated CD44. It is of note that
lowered expression of cellular miR-378 induced the
elevated gene expression of IL-8, MCP-1 and VEGF,
and the increased secretion of exosomal miRs 23a-3p /
24-3p / 184 / 1273e / 1285-3p. CD9+ exosomes were
more elevated in cHCEC CS with senescence-like CST
than those without CST, indicating the possible import
of these extracellular vesicles into cHCECs without
CST. Compared with non-CST, CST cHCECs have a
tendency to incorporate more exosomes.
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Summary/Conclusion: MiRNAs in exosomes serve as
an alternative tool to qualify cHCEC SPs. In this cur-
rent study, we present the first finding that the lowered
miRs in pathogenic tissues may induce the groups of
exosomal miRs reliant on the depolarized CD44++~++
+ HCECs.
PF08.05
Urinary CRK1 positive vesicles yield novel insight into microvesicular
signaling of the kidney
Fabian Brauna, Inka Homeyera, Valerie Oberübera, Victor Puelles Rodriguezb,
Sasha Shafikhanic and Tobias B. Hubera
aIII. Department of Medicine, University Medical Center Hamburg-
Eppendorf, Hamburg, Germany; bIII. Department of Medicine, University
Medical Center Hamburg-Eppendorf, Hamburg, Germany, Hamburg, USA;
cDepartment of Medicine, Division of Hematology/Oncology, Department of
Immunology and Microbiology, Rush University Medical Center,
Chicago, USA
Introduction: While specific functions of microvesicles
have been uncovered in many fields of biology and
medicine, very little is known about their role in kidney
health and disease. Recently, a new subgroup of micro-
vesicles was discovered in human and murine cell
culture as well as a model of glomerulonephritis.
These vesicles are shed upon apoptosis and trigger
proliferation in neighbouring cells, hence named apop-
totic compensatory proliferative signalling vesicles –
ACPSVs. As these vesicles could be isolated from kid-
ney tissue, we hypothesized that a fraction is shed into
the urine and can be isolated for further analyses.
Methods: We established a protocol of differential cen-
trifugation and filtration to isolate ACPSVs from urine
samples of healthy control subjects and patients suffer-
ing from different nephropathies. With western blot
analysis and immunofluorescence microscopy, we vali-
dated the presence of ACPSVs and investigated the
cellular origin of the vesicles. Whole lipid quantifica-
tion was used to determine vesicle amount and to
normalize the protein content. To identify the potential
of initiating proliferation, HeLa cells were counted 24 h
after treatment with freshly isolated urinary vesicles.
Results: The employed protocol lead to a robust isola-
tion of spherical vesicles ranging between 0.6–1.8 µm
containing the ACPSV marker protein CRK1. Further
protein analysis revealed the presence of Podocin and
Nephrin, pointing to a clear podocyte origin of a frac-
tion of these vesicles. Similar results could be obtained
for vesicles originating from the proximal tubulus and
the collecting duct.
Summary/Conclusion: Our study represents the first
analysis of urinary CRK1 containing vesicles. Taken
into account the presence of podocyte marker proteins
in the vesicle fraction isolated, we hypothesize, that
these are not only shed upon apoptosis, hence would
not call the isolated fraction urinary ACPSVs. Ongoing
studies aim to validate the potential to initiate prolif-
eration on different renal cell types, to further identify
the cellular origin as well as to determine differences in
their function and content in the state of renal diseases.
As these vesicles can be easily isolated in a high purity,
they also represent a valuable source for biomarker
research in various nephropathies.
PF08.06
Human adipose stem cells-derived vesicles improve pain and reduce
cartilage destruction in an osteoarthritis rat model
Sehee Kima, Jihye Leeb, Jinhee Parkb, Jieun Leeb, Soyeon Kimb, Hanlim
Moonb and Shingyu Baec
aMDimune, Seoul, Republic of Korea; bStem cell team, Seoul, Republic of
Korea; cMdimune corp., Seoul, Republic of Korea
Introduction: Human mesenchymal stem cells (hMSC)
release extracellular vesicles (EV) containing various
proteins and RNAs, which can act as regulatory signals
between cells. hMSC-EVs also have provided signifi-
cant beneficial effects in various disease models.
However, most mammalian cells secret small amount
of EV, which is a limitation for development of ther-
apeutics. Therefore, the next generation of EV-mimetic
vesicles produced by serial extrusion of cells produces
higher number of vesicles, and may be easier to scale
up for therapeutic developments. In this study we
aimed to test the efficacy of EV-mimetic vesicles
derived from human adipose-derived stem cells
(hASCs) on rat osteoarthritis (OA) model.
Methods: hASC-derived EV-mimetic vesicles (CDV) were
produced by serial extrusions of cells through filters. The
CDVs were characterized by transmission electron micro-
scopy (TEM), nanoparticle analysis system (NTA), and
western blot and flow cytometry. CDVs were injected
into the joints in a MIA-induced osteoarthritis (OA) rat
model. Improvement of pain after CDV injections was
assessed by paw withdrawal threshold and weight bearing,
whereas the joint destruction was evaluated by histology.
We also estimated the effects of CDV on proliferation and
migration of human chondrocytes in vitro by cell-counting
and scratch assays.
Results: The CDV were 50–150 nm in diameter and
carried multiple EV-associated tetraspanins (CD63,
CD9, CD81). CDV-treated OA mice had reduced paw
withdrawal and was more weight bearing 17 days after
treatment than PBS-treated. Further, histology showed
reduced joint defects at 24 days. CDV-treated OA
models displayed significant improvement in paw
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withdrawal behaviour and weight bearing analysis.
Similarly, chondrocyte migration and proliferation
were enhanced by CDV in a dose-dependent manner.
Summary/Conclusion: This study demonstrates for
the first time the efficacy of hASC EV-mimetic vesicles
in OA model. Most interestingly we have confirmed
that hASC EV-mimetic vesicles can improve pain and
regenerate defected cartilage. These results support the
concept that a potential application of hASC EV-
mimetic is osteoarthritis, by giving CDV locally into
affected joints.
PF08.07
Natural and synthetic biomaterial mediated delivery of Mesenchymal
Stem Cell derived exosomes
Chun-Chieh Huanga, Miya Kanazawab, Praveen Gajendrareddyc and Sriram
Ravindrana
aUniversity of Illinois at Chicago, Chicago, IL, USA; bUIC College of
Dentistry, Oral Biology, Chicago, IL, USA; cUniversity of Illinois, Chicago,
Chicago, IL, USA
Introduction: Mesenchymal stem cell (MSC) derived
exosomes are versatile agents that possess immunomo-
dulatory and regenerative properties. However, sys-
temic delivery of natural or engineered MSC
exosomes lacks site-specificity and can trigger ectopic
effects. Therefore, biomaterial-mediated site-specific
delivery of exosomes is important. As exosomal mem-
branes are subsets of the plasma membrane. We
hypothesized that MSC exosomes can bound to extra-
cellular matrix proteins and the property can be used as
a delivery technique.
Methods: To test this hypothesis, we evaluated the
binding and delivery kinetics of MSC exosomes to
and from fibronectin, type I collagen and their deriva-
tive peptides followed by in vitro and in vivo evaluation
of their efficiency when delivered using this approach.
Results: Results indicated that MSC exosomes bound
dose-dependently and saturably to fibronectin, type I
collagen and their derivative peptides in an integrin
mediated fashion. The presence of integrins on the
exosomal membrane was verified by immuno electron
microscopy and immunoblotting. Finally, exosomes
bound to 3D hydrogels containing these motifs were
able to promote differentiation of naive MSC in vitro
and bone regeneration in a valvaria defect model in
vivo.
Summary/Conclusion: Overall, this study shows that
MSC exosomes can be tethered to natural and synthetic
biomaterials for site-specific delivery to aid repair and
regeneration of tissues.
Funding: This project is sponsored by NIH grant
R01DE027404 and The Osteology Foundation Advanced
Researcher award.
PF08.08
Exosomes secreted during chondrogenic differentiation of human
adipose-derived stem cells for osteoarthritis treatment
Ye eun Yuna, Woo Sung Kima, Hyun-A Parkb, Su Yeon Kimb and Yong Woo
Choc
aDepartment of Chemical Engineering, Hanyang University, Ansan, Republic
of Korea; bExostemtech,Inc., Ansan, Republic of Korea; cHanyang University,
Ansan, Republic of Korea
Introduction: Osteoarthritis (OA) is a chronic degen-
erative joint disease and the most common form of
arthritis. Most of the current treatments focus on
pain management and treatment options for repair
and regeneration of damaged articular cartilage are
limited. In recent years, stem cell-derived exosomes
have been the spotlight as a therapeutic candidate due
to their regenerative and immunomodulatory capabil-
ities. In this study, we hypothesized that exosomes
(Chondro-EXOs) secreted during chondrogenic differ-
entiation of human adipose-derived stem cells (hASCs)
may contain specific biochemical cues that promote the
regeneration of damaged cartilage in OA animal
model.
Methods: Chondro-EXOs were isolated from condi-
tioned media during chondrogenic differentiation by
pre-filtration in 0.2 μm, followed by tangential flow
filtration (TFF) system (300 kDa MWCO). The isolated
Chondro-EXOs were characterized using transmission
electron microscopy (TEM), nanoparticle tracking ana-
lysis (NTA), flow cytometry, western blot, and cytokine
arrays. To evaluate the therapeutic efficacy of Chon-
EXO, we injected a mixture of Chondro-EXOs (1×108
particles) and hyaluronic acid hydrogel (1%) once a
week for 3 weeks at intra-articular site of MIA-induced
subacute OA models. Knee joints were harvested at
four weeks after MIA injection and analysed histologi-
cally by safranin O-fast green and haematoxylin and
eosin (H&E).
Results: Chondro-EXOs were approximately 50-
120 nm in diameter and expressed exosomal markers
such as CD9, CD63, and CD81. Various soluble factors
related to anti-inflammatory and cartilage regeneration
were contained in Chondro-EXOs. In vivo studies
demonstrated that Chondro-EXOs significant pre-
vented proteoglycan degradation and attenuated the
cartilage destruction in the damaged articular cartilage.
Summary/Conclusion: Our findings suggest that
Chondro-EXOs act as a biological cue for cartilage
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repair and provide a new therapeutic approach for
osteoarthritis treatment.
PF08.09
hucMSC exosomes delayed diabetic kidney diseases by transported
kinase ubiquitin system promoted YAP ubiquitination degradation
Si Qi Yina, Cheng Jib, Hui Qianc and Jia Hui Zhangd
aJiangsu university, Zhen jiang, China (People’s Republic); bZhengjiang,
China (People’s Republic); czhen jiang, China (People’s Republic); 4Zhen
jiang, China (People’s Republic)
Introduction: Diabetes mellitus (DM) is a type of
metabolic disease. Diabetic kidney disease (DKD) is
the important microvascular complications of DM,
the leading cause of end-stage renal disease (ESRD).
Human umbilical cord mesenchymal stem cell exo-
somes (hucMSC-Exosomes) can participated in a vari-
ety of tissue damage repair. In this study, we
demonstrated that the mechanism which hucMSC-
Exosomes delayed the progression of DKD.
Methods: The DKD rat model established by 45%
high-fat diet combined with streptozotocin (STZ,
35 mg/kg,iv). DKD group (n = 12) and hucMSC-exo-
somes group (n = 12), control group (n = 6). Blood
glucose, body weight and 24 h urinary albumin clear-
ance were measured at 16 and 24 weeks. HE, PAS
staining used to observed pathological of renal tissue,
Sirius red staining to detected renal interstitial fibrosis.
YAP protein in renal tissues with time. Confocal
microscopy observed YAP in cytoplasm and nucleus
location. The CO-IP showed that the ubiquitin bound
by YAP protein was significantly increased. LC-MS/MS
and west bolt confirmed CK1δ/β-TRCP existed in the
exospores. Used the adenovirus shRNA experiment
knockdown CK1δ/β-TRCP.
Results: hucMSC-exosomes can migrated to renal
injury site and regulated blood glucose in tissues.
hucMSC-exosomes intervention delayed the progres-
sion of DKD. Maintained rat weight, reduced serum
urea nitrogen, the degree of interstitial fibrosis signifi-
cantly weakened. Sustained high glucose stimulated
activation of YAP. The YAP increased significantly
with time which increased degree of interstitial fibrosis.
hucMSC-exosomes transported CK1δ/β-TRCP
repaired kinase ubiquitin system imbalance inhibited
YAP activity that attenuated interstitial fibrosis of
DKD. Our experiments confirmed that hucMSC-exo-
somes carried CK1δ/β-TRCP promoted YAP ubiquiti-
nation degradation.
Summary/Conclusion: hucMSC exosomes delayed
diabetic kidney diseases by transported CK1δ/β-TRCP
promoted YAP ubiquitination degradation reduced
renal interstitial fibrosis.
Funding: National Natural Science Foundation of
China: (81871496)
Zhenjiang Key Laboratory of Exosomes Foundation
and Transformation Application High-tech Research,
China: (ss2018003)
PF08.11
Neutrophil extracellular vesicles protect from joint breakdown in
inflammatory arthritis
Bethan Lynne. Thomasa, Lucy Norlingb, Francesco Dell’Acciob and Mauro
Perrettib
aWilliam Harvey Research Institute, Queen Mary University London,
London, UK; bWilliam Harvey Research institute, Queen Mary University
of London, London, UK
Introduction: Rheumatoid arthritis (RA) is a chronic
autoimmune, inflammatory disease. Recently our
understanding of the inflammatory component has
progressed tremendously, however, even after the con-
trol of inflammation, joint damage, in particular carti-
lage breakdown, continues to progress leading to
secondary osteoarthritis and patient disability.
Extracellular vesicles (EVs), with their roles in cell-to-
cell communication, present a novel opportunity for
treatment within difficult to target joint tissues like
cartilage. Neutrophil EVs are remarkable in their bio-
actions and are abundant within the joints of RA
patients. Here we report the role of Neutrophil EVs
in RA and their effect on cartilage breakdown.
Methods: EVs were generated from human neutrophils
stimulated with TNF (20 ng/ml; 20 min), and tested in
the K/BxN murine model of inflammatory arthritis.
Results: In murine inflammatory arthritis, intra-articu-
lar injection of neutrophil EVs (30–300x103 per joint),
reduced knee swelling and displayed cartilage protec-
tive effects, measured as reduced loss of proteoglycans
and improved structural integrity in the treated joints.
Cartilage in EV-treated joints also maintained a higher
content of Collagen type2, an important component of
healthy cartilage, and contained fewer hypertrophic
chondrocytes, abundant in diseased cartilage. Of great
translational importance, this effect lasted at least
28 days, suggesting that administration of these EVs
enacted positive circuits of protection characterized by
a phenotypic change within the tissue, resulting in long
lasting protective effects even after the EVs themselves
have been cleared. In vitro, neutrophil EVs inhibited
IL-1-induced cartilage breakdown and restored basal
expression of cartilage specific genes.
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Summary/Conclusion: Neutrophil EVs exert powerful
and long lasting protective bioactions in inflammatory
arthritis, modulating the ongoing joint inflammation
while also protecting from cartilage breakdown.
Funding: Medical Research Council (MRC)
Regenerative medicine research grant
PF08.12
Role of small extracellular vesicles in ageing
Juan Antonio Fafian Labora, Ana O’Loghlen, Paula Carpintero-Fernandez
and Olga Eleftheriadou
Epigenetics & Cellular Senescence Group, Blizard Institute, Barts and The
London School of Medicine and Dentistry, Queen Mary University of
London, London, UK
Introduction: Ageing is a major risk factor for many
human diseases. It is a complex process that progres-
sively compromises most of the biological functions of
the organisms, resulting in an increased susceptibility
to disease and death. Hutchinson-Gilford progeria syn-
drome (HGPS) and normal aging share many cellular
phenotypes: abnormal nuclear shape, dysregulated of
epigenetic markers, increased DNA damage.
Remarkably, partial reprogramming extended the life-
span of the progeric mice with remodelling of the
epigenetic markers. The alteration in intercellular com-
munication with age has been demonstrated to be due
to senescent cells developing a senescence-associated
secretory phenotype (SASP).
Methods: In this study, we have a characterization of
small extracellular vesicles (sEVs) using in vitro normal
and premature ageing models and the rejuvenation
capacity of sEVs from young donors and iPSCs in old
and progeria recipients.
Results: Firstly, we performed the evaluation of pro-
duction of sEVs using Nanoparticle Tracking Analysis
(NTA) and characterization of positive CD63/CD81
sEVs by flow cytometry. Then, we evaluated the reju-
venation potential of sEVs from young and iPSCs
donors on old and progeria fibroblasts. We found an
increment of sEVs production with the age and the
capacity of sEVs from young and iPSCs donors to
recover the proliferation capacity (BrdU) and epige-
netic marker (H3K9me3) in fibroblasts from progeria
and old donors.
Summary/Conclusion: These findings are important
to the understanding about influence of the ageing on
sEVs and the development sEV-based therapies in age-
related diseases.
Funding: BBSRC (BB/P000223/1) and The Royal
Society (RG170399) awarded to AOL. JFL and PCF
are funded by the Xunta de Galicia Fellowships (Spain).
PF08.13
Rab27a dependent exosome secretion from tubular epithelial cell
promotes albumin-induced tubulointerstitial inflammation
Ye Fenga, Linli Lvb and Bi-Cheng Liua
aInstitute of Nephrology, Southeast University, Nanjing, China (People’s
Republic); bInstitute of Nephrology, Zhongda Hospital, Southeast
University, Nanjing, China (People’s Republic)
Introduction: Tubular epithelial cells (TECs) secrete
increasing exosomes under with proteinuric toxicity.
However, the mechanism through which exosomes
are produced and the effect on tubular cell haemostasis
and tubulointerstitial inflammation are unknown.
Methods: Proteinuric renal disease model was induced by
adriamycin (ADR) administration through tail vein.
Urinary albumin was determined at 0, 7, 14, 21 and
23 days after ADR injection. For in vitro studies, TECs
were treated with albumin. Exosomes were purified from
isolated tubules of kidney and cell culture supernatant for
characterization and functional study.
Results: Urinary albumin was significantly increased in
ADR-treated mice 2 weeks after injection compared with
controls. Exosome production was increased significantly in
kidneys and tubules ofADRmice and inTECswith albumin
exposure, confirmed by electron microscopy, western blot-
ting analysis of exosome markers and EXOCET.
Interestingly, we showed increasing levels of Rab27a
mRNA and protein both in the tubules of ADR-injected
mice and in BSA-treatedTECs in a dose dependentmanner.
Furthermore, the increased exosomeproductionwas depen-
dent on Rab27a up-regulation since silencing of Rab27a
reversed the exosomes secretion. Importantly, albumin was
present in TEC-derived exosomes after BSA exposure.
Impressively, lysosomal degradation of albumin was
increased while the mRNA expression of inflammatory
cytokines was reduced after inhibition of exosome secretion
by Rab27a silencing in TECs treated with BSA. To explore
the effect of TEC exosome production under albumin expo-
sure, TEC-exosomes were purified and added to naïve TEC.
Up-regulation of inflammatory cytokines were found in
receipt TECs. Lentivirus Rab27a-inhibitor intrarenal injec-
tion reversed tubulointerstitial inflammation and increased
survival of ADR-induced mice through stably inhibiting
Rab27a expression. Clinically, high levels of Rab27a were
found in tubules and correlated with the magnitude of
urinary exosomes in patients with chronic kidney disease.
Summary/Conclusion: These results suggest that Rab27a-
dependent exosomes secretion drive albumin escaping
degradation and secreting into extracellular fluid may
exacerbate TECs injury by enhancing inflammatory
response and consequently leading to tubulointerstitial
inflammation.
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PF09.01
Extracellular vesicle (EV) extraction and characterisation in amniotic
fluid (AF)
Natalia Gebaraa, Corinne Lampietrob, Benedetta Bussolatic, Chiara
Benedettod and Luca Marozioe
aUniversity of Torino, Torino, Italy; bDepartment of Molecular
Biotechnology and Health Sciences, University of Torino, Torino, Italy;
cDepartment of Molecular Biotechnology and Health Sciences, University of
Turin, Turin, Italy, Turin, Italy; dDepartment of Surgical Sciences, Obstetrics
and Gynecology, Torino, IL, USA; eDepartment of Surgical Sciences,
Obstetrics and Gynecology, Torino, Italy
Introduction: During pregnancy, placental-derived
EVs have been identified in maternal blood and AF
thus are implicated in cell-to-cell communication. We
hypothesize that placental-derived EVs released in
amniotic fluid may possess angio-modulating proper-
ties that could be relevant in placental angiogenesis and
that these characteristics may be altered in pre-eclamp-
sia (PE), a pregnancy complication characterised by
hypertension and proteinuria causing neonatal mor-
bidity and perinatal mortality.
Methods: The amniotic fluid was obtained from nor-
mal pregnancies during caesarean sections. The physio-
chemical characteristics were tested by Nanosight tech-
nology (NTA) and characterization of exosomal mar-
kers was carried through FACS using microspheres and
MASPlex exosome kit. MASPlex kit simultaneously
detects 37 exosome surface epitopes.
Results: We set up a method for EV isolation from AF
based on subsequent dilution with PBS; first centrifu-
gation at 10,000 g for 30 min at 4°C, filtration through
a 0.45 µM filter and ultracentrifugation at 100,000 g for
2 h in 4°C. The averages EV concentration was
4.34×1011 particles/ml with a mean peak of
240.45 nm, measured by NTA. FACS analysis showed
presence of angiogenic markers VEGFR 1,2,3 and
CD105, immunological markers HLA ABC, HLA DR,
exosome specific markers CD81 and CD63 also CD133,
which indicates kidney origin. By using the MASPlex
kit, we set up a semiquantitative method for detection
of 37 different potential AF-EV surface markers in one
sample simultaneously. We confirmed the heterogenic
characteristics of AF-EVs, including expression of
immune system markers CD209, CD62P, CD11c,
CD20 and endothelial markers CD146 and CD41b.
Summary/Conclusion: The characterisation of the AF-
EVs with NTA and FACS demonstrates the composi-
tion and size as well as presence of markers of different
origin including kidney, immune system and endothe-
lium. The investigation of EV properties in healthy and
diseased placenta could prove useful in the future as a
diagnostic tool to understand and diagnose pregnancy-
associated diseases.
Funding: This work was supported by the iPlacenta
project founded by the European Union’s Horizon
2020 research and innovation programme under the
Marie Skłodowska-Curie grant agreement No. 765274
PF09.02
Evaluation of non-invasive biomarkers for monitoring functional
status of endometrium
Mattia Criscuolia, Gaia Papinia, Davide Zoccob, Alice Luddic, Valentina
Pavonec, Paola Piombonic and Nataša Zarovnid
aExosomics Siena – University of Siena, Siena, Italy; bExosomics Siena, Siena,
USA; cUniversity of Siena, Siena, Italy; dExosomics, Siena, Italy
Introduction: Endometrium is a complex tissue with
self-renewing properties, normally undergoing cyclic
modifications regulated by ovarian steroids divided
into proliferative and secretory phase. The transcrip-
tomic profile of the endometrium is influenced by
other endometrial cell types (glandular epithelial and
stromal) in both physiological and pathological condi-
tions. These cells have mutual paracrine effects par-
tially mediated by EVs, and they grow in a cycle-
dependent manner. To assess the endometrium status,
several invasive or expensive techniques are currently
employed, including immunohistochemistry (IHC) on
tissue biopsy, cytology and imaging. Development of
protocols for the isolation of EVs from novel biological
sources is an extremely attractive means to surrogate
endometrial biopsies. These novel protocols may
enable the identification and sensitive detection of spe-
cific endometrial EV biomarkers for diagnostic solu-
tions in reproductive medicine, endometriosis or
cancer.
Methods: Samples: primary endometrial cultures, urine
from healthy donors in secretory phase; Differential
centrifugation, size exclusion chromatography (SEC),
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immunobeads for EV isolation; Nanoparticle Tracking
Analysis (NTA), BCA assay, ELISA, HS Qubit, ddPCR,
SPR, FACS for EVs and EV markers quantification and
characterization.
Results: We provide new evidence that urine is a
surrogate biofluid suitable for the detection of endo-
metrial EV biomarkers. Using pre-selected antibody
panels, we identify specific endometrium EV binding
antibodies in relevant in vitro models. Coupling
immune-isolation to pre-analytical protocols for urine
processing and sample quality testing enables detection
of a panel of endometrial genes in urine-recov-
ered EVs.
Summary/Conclusion: Overall, the study provides a
tool for non-invasive monitoring of the functional sta-
tus of the endometrium, supporting biomedical niches
such as assisted fertilization and diagnosis of
endometriosis.
Funding: ENDEvor POR Region Tuscany (identifica-
tion of the project) and Exosomics R&D Programme
PF09.03
Unveiling autologous blood doping: comparative analysis of different
purification strategies for urinary extracellular vesicles pioneering
miRNA biomarker research
Veronika Mussacka, Georg Wittmannb and Michael Pfafflc
aTUM School of Life Sciences Weihenstephan, Division of Animal Physiology
and Immunology, Freising, Germany, Freising, Germany; bDepartment for
Transfusion Medicine, Cell therapeutics and Haemostaseology, University
Hospital LMU, Munich, Germany, München, Germany; cAnimal Physiology
and Immunology, School of Life Sciences Weihenstephan, Technical
University of Munich, Freising, Germany, Freising, Germany
Introduction: Autologous blood doping (ABD)
increases the oxygen capacity via re-infusion of a per-
son’s autologous red blood cells. It is therefore used by
endurance athletes with a high level of unreported
cases, especially since reliable methods for unequivocal
detection are still lacking. To support the Worldwide
Anti-Doping Agency (WADA) in protecting the ath-
letes’ healthiness and ensuring harmonization, herein-
after extracellular vesicles (EVs) and their conveyed
cargo were used as potential biomarkers. Since
degraded red blood cells and their content are elimi-
nated via the kidney and urine, the urinary EV popula-
tion and their microRNA (miRNA) profile were
particularly focused.
Methods: After study approval by the local ethics com-
mittee, written informed consent was obtained of 30
healthy men undergoing different ABD intensities and
several sampling time points. Consistent compliance
with the “Declaration of Helsinki” was assured. Due
to a lack of standardization in urinary EV purification,
five different isolation strategies were evaluated: ultra-
centrifugation, membrane affinity, spin column chro-
matography, immunoaffinity and precipitation. After
EV characterization by nanoparticle tracking analysis,
western blotting, and transmission electron micro-
scopy, total RNA was isolated and a library for small
RNA sequencing was prepared. The resultant success-
ful strategy was then applied to all the collected sam-
ples which were equally analysed regarding their EV
distribution and miRNA content.
Results: The comparative analysis disclosed huge dis-
crepancies with respect to EV yield, population, and
purity, as well as RNA yield and detected miRNAs. By
applying the best performing strategy, which was based
on immunoaffinity, significantly higher amounts of
urinary EVs and several significantly differentially
regulated miRNAs were observed after ABD.
Summary/Conclusion: Urinary EVs and their miRNA
profile hold indeed promising attempts for the clear
separation of ABD and non-doped athletes. Moreover,
the included complex comparative methodological ana-
lysis contributes enormously to future standardization
and comparability of urinary EV research.
Funding: The current project has been financially sup-
ported by the WADA.
PF09.04
Extracellular vesicles as graft biomarkers to address lung
transplantation outcome
Mario Barilania, Ilaria Righib, Giuseppe Buonoc, Lorenzo Rossod, Mario
Nosottie and Lorenza Lazzaric
aUnit of Regenerative Medicine – Cell Factory, Department of Transfusional
Medicine and Hematology, Fondazione IRCCS Ca’ Granda Ospedale
Maggiore Policlinico, Milano (MI), Italy; Università degli Studi di Milano,
Milan, Italy; bThoracic Surgery and Lung Transplant Unit, Fondazione
IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (MI), Italy,
Milano, Italy; cUnit of Regenerative Medicine – Cell Factory, Department
of Transfusional Medicine and Hematology, Fondazione IRCCS Ca’ Granda
Ospedale Maggiore Policlinico, Milano (MI), Italy, Milano, Italy; dUniversità
degli Studi di Milano, Milano (MI), Italy, Milano, Italy
Introduction: In the medical practice, lung transplan-
tation is the last therapeutic option for end-stage pul-
monary failure, when other treatments are no longer
effective. Yet, only 15-20% of the multi-organ donors
have suitable lungs. Furthermore, clinical complica-
tions may rise after organ retrieval following ische-
mia–reperfusion lung injury, such as primary grafts
dysfunction or chronic lung allograft dysfunction.
Currently, clinical parameters implemented to assess
the quality of the graft have failed to evaluate tissue
damage at the cellular level and to predict transplanta-
tion outcome. Therefore, we focused our attention on
extracellular vesicles (EV) as innovative, non-invasive
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biomarkers urgently needed to assess lung quality and
monitor organ engraftment.
Methods: Research activities involving human subjects
complied the Declaration of Helsinki. Informed con-
sent and local ethics committee approval were
obtained. Size and concentration analysis were per-
formed by nanoparticle tracking analysis (Nanosight
NS300, Malvern).
Results: Preliminary results showed the presence of EV
of different sizes in bronchoalveolar lavage (BAL) and
plasma of both donors and recipients. EV presented
highly polydispersed size distributions in a 50–
1000 nm range. Different EV production kinetics
were observed in the recipients (10E08-10E10 parti-
cles/mL range): BAL samples showed concentration
peaks within 72 h post-transplant and a subsequent
decreasing trend, whereas plasma samples showed a
slightly increasing trend. EV samples will be analysed
for RNA content and antigen expression, and correla-
tion with lung transplantation outcome will be evalu-
ated at the conclusion of the follow-up.
Summary/Conclusion: The identification of specific
EV kinetics patterns and RNA signatures represents a
promising approach to define biomarkers useful for
thoracic surgeons who want to manage in advance
complications associated with lung transplantation.
PF09.05
Expression profile analysis of miRNAs in serumal exosomes as
sensitive biomarkers before and after hematopoietic stem cell
transplantation
Daming Wanga, Lei Zhengb and Taixue Anc
aShenzhen, China (People’s Republic); bClinical Laboratory Department,
Nanfang Hospital, Southern Medical University, Guangzhou, China
(People’s Republic); cNan Fang Hospital, Southern Medical University,
Guangzhou, China (People’s Republic)
Introduction: To investigate the differential expression
of miRNAs of candidate genes in peripheral blood
serum of patients with acute graft-versus-host disease
(aGVHD) after allogeneic hematopoietic stem cell
transplantation (allo-HSCT).
Methods: There were a total of 30 patients with
aGVHD and without aGVHD within 100 days after
allogeneic hematopoietic stem cell transplantation in
leukaemia; serumal exosome and RNA were extracted
before and after the transplantation; image acquisition
and data analysis were performed after hybridization of
gene chips; candidate genes associated with the occur-
rence of aGVHD were screened out based on the
differential expression of miRNAs.
Results: The expression profile of miRNAs after hybri-
dization of gene chips showed increasing or decreasing
tendency of miRNAs before and after the transplanta-
tion. Compared with the control group, for the
miRNAs whose signal fold multiples greater than 10
folds, there were 11 miRNAs increased and 26
decreased in the aGVHD group. The expression of
hsa-miR-3976, hsa-miR-122-5p, hsa-miR-3125 were
significantly up-regulated and the expression of hsa-
miR-4687-5p, hsa-miR-941, hsa-miR-4769-5p were
down-regulated; these six miRNAs were listed as can-
didate miRNA gene sensitive biomarkers in peripheral
serum.
Summary/Conclusion: Through Go, pathway and tar-
get gene analysis, candidate genes participate in regulat-
ing water-soluble vitamin metabolism, mitochondrial
apoptosis and other biological processes, regulating cell
membrane and organelle synthesis. The specific
mechanism will be further studied.
Funding: Natural Science Foundation of Guangdong
Province (2015–2018)
Free application project of Shenzhen Science and
Technology Innovation Committee (2017–2020)
PF09.07
Circulating cancer-associated extracellular vesicles as early detection
and recurrence biomarkers for pancreatic ductal adenocarcinoma
Yusuke Yoshiokaa, Tetsuya Nakatsurab and Takahiro Ochiyac
aTokyo Medical University, Shinjyuku-ku, Japan; bDivision of Cancer
Immunotherapy, Exploratory Oncology Research and Clinical Trial Center,
National Cancer Center, Kashiwa, Japan; cDepartment of Molecular and
Cellular Medicine, Institute of Medical Science, Tokyo Medical University,
Shinjyuku-ku, Japan
Introduction: Pancreatic ductal adenocarcinoma
(PDAC) is usually found at an advanced stage,
although diagnosis at an early stage is unequivocally
associated with better long-term survival. Therefore,
there is an urgent need to develop early detection
methods to improve these outcomes. Extracellular vesi-
cles (EVs) attract much attention as potential biomar-
ker because tumour cells have been shown to release
EVs into circulation which mirror their cellular origin.
Detection of cancer-associated EVs in body fluids from
patients could serve as a non-invasive liquid biopsy for
diagnosis and monitoring of cancer. The main objec-
tive of this study is the identification and detection of
PDAC-specific EVs in patient-derived serum.
Methods: Total EV proteins were purified from three
different stages of PDAC (stage II, III and IV, each
group: six patient sera pooled) and healthy donors.
Mass spectrometry was performed with purified EV
proteins, and biomarker candidates were validated by
immunoblotting in PDAC patient blood samples.
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Results: Proteomics analysis identified over 500 pro-
teins in each pooled samples, and we identified nine
membrane proteins, which were detected in only
PDAC patients, not in healthy donors. We focused on
two proteins and performed immunoblotting for the
validation of potential biomarkers in three stages of
PDAC blood samples. As a result, these proteins were
detected exclusively in EVs of PDAC patient sera
including stage II. Moreover, we analysed a total of
33 samples from 11 PDAC patients who performed
surgery at three time points; before surgery, after sur-
gery and recurrence as an early stage model. As a
result, these proteins were detected in EVs derived
from preoperative samples and recurrence samples.
Summary/Conclusion: This study using unique recur-
rence samples as an early stage model shows that the
identified EV-associated proteins have potential as
early detection makers and warrant further
investigation.
Funding: This work was supported in part by a Grant-
in-Aid from the Japan Science and Technology Agency
(JST) through the Center of Open Innovation Network
for Smart Health (COINS) and a Grant-in-Aid from
the Japan Agency for Medical Research and
Development (AMED) through Project for Cancer
Research and Therapeutic Evolution (P-CREATE:
JP18cm0106402).
PF09.08
Exosome-encapsulated miRNA in urine as a non-invasive biomarker
for prostate cancer
Zhuo Li, La-Xiu Li, Yanjun Diao, Yue-yan Ma and Xiaoke Hao
Department of Clinical Laboratory Medicine, Xijing Hospital, Air Force
Medical University, Xi’an, China (People’s Republic)
Introduction: Prostate cancer (PCa) is the most com-
mon malignant tumours in male urinary system. Novel
and non-invasive biomarker with higher sensitivity and
specificity for the diagnosis of PCa are urgently needed.
Exosomal microRNAs in circulating fluids have
recently been reported to augment diagnosis and man-
agement of certain diseases, including cancer. The pur-
pose of this study is to explore the diagnostic value of
urinary exosomal miRNAs for PCa.
Methods: A urinary exosomal microRNA expression
profiling was performed by next-generation sequencing
using urine samples. Then, candidate miRNAs were
selected and validated by qRT-PCR in 3 cohorts con-
sisting of PCa patients, healthy controls and patients
with benign prostatic hyperplasia (BPH). Receiver
operator characteristic (ROC) analysis was used to
evaluate the diagnostic and prognostic value of urinary
exosomal miRNA in PCa.
Results: Five candidate miRNAs were found by NGS.
Significant downregulation of urinary exosomal miR-
375 was observed in PCa patients comparing with
healthy controls, while miR-451a, miR-486-3p and
miR-486-5p were found significantly upregulated.
However, no significant difference was found for
miR-16-2-3p. The expression level of urinary exosomal
miR-375 showed significant correlation with clinical
stage and bone metastasis of the patients with PCa
(p < 0.05). ROC analysis demonstrated that the urinary
exosomal miR-375, miR-451a, miR-486-3p and miR-
486-5p are able to differentiate PCa patients from
healthy controls, with the AUC of 0.788, 0.757, 0.704
and 0.796, respectively. The urinary exosomal miR-375
was found superior in discriminating localized PCa
from metastatic PCa, with an AUC of 0.806.
Additionally, PCa patients can be distinguished from
BPH patients by using a panel combining urinary exo-
somal miR-375 and miR-451a, with an AUC of 0.726.
Summary/Conclusion: These findings demonstrate
that the urinary exosomal miRNA can serve as a
novel and non-invasive biomarker for diagnosing and
predicting the progression of PCa.
Funding: Shaanxi Health and Family Planning
Commission Foundation Project (2016D020), Xi’an
Science and Technology Bureau Foundation Project
(2017121SF/YX015) and Shaanxi Natural Science
Foundation Project (2018JQ8010).
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Unlocking the secret of salivary exosomes derived from HPV-driven
oropharyngeal cancer
Kai D Tanga, Yunxia Wana, Natalie Bozyka, Xi Zhanga, Liz Kennyb and
Chamindie Punyadeeraa
aThe School of Biomedical Sciences, Institute of Health and Biomedical
Innovation, Queensland University of Technology and The Translational
Research Institute, Queensland, Australia., Brisbane, Australia; bSchool of
Medicine, University of Queensland; Royal Brisbane and Women’s
Hospital, Brisbane; Central Integrated Regional Cancer Service, Queensland
Health, Queensland, Australia., Brisbane, Australia
Introduction: There has been a significant rise in the
incidence of oropharyngeal cancer (OPC) associated
with high-risk human papillomavirus (HPV), predomi-
nantly HPV-16 infections in high-income countries,
especially when compared to HPV-negative head and
neck cancer (HNC). Growing evidence supports the
concept that exosomes (30–150 nm) loaded with
unique bio-components (DNA, RNA and protein)
play a salient role in cancer development and
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progression. However, the role of exosomes in saliva
obtained from HPV-driven OPC is still far from clear.
Methods: Morphology and molecular features of exo-
somes derived from three different saliva sampling meth-
ods: unstimulated saliva, acid-stimulated saliva and
salivary oral rinses were examined using transmission
electron microscopy (TEM), nanoparticle tracking
(NTA) andwestern blot analysis. HPV-16DNAdetection
in salivary exosome was determined using qPCRmethod.
Proteome profile of salivary exosomes derived from both
cancer-free controls and HPV-driven OPC patients was
characterized using mass spectrometry analysis.
Results: Here, we showed that unstimulated saliva had the
greater abundance of exosomes when compared to the
other saliva sampling methods. In fact, the three common
exosome markers (CD9, CD63 and CD81) were higher in
unstimulated saliva method. Nevertheless, no appreciable
difference in exosome morphology was found among the
three different sampling methods. Furthermore, only sali-
vary exosome derived from HPV-driven OPC had a
detectable level of HPV-16 DNA. Intriguingly, the proteo-
mic signature of salivary exosome was significantly differ-
ent between cancer-free controls and HPV-driven OPC.
Summary/Conclusion: Taken together, our results
showed that unstimulated saliva is an optimum sam-
pling method for exosome characterization. More
importantly, the development of a low cost non-inva-
sive saliva-based test (salivary exosomal DNA and pro-
tein) will offer an opportunity to detect HPV-driven
OPC, thereby opening new avenues in the future for
clinical and commercial translation.
Funding: N/A
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Determination of the protein cargo of colon cancer tissue-derived
extracellular vesicles
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and Jan Lötvalld
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cDepartment of Surgery, Institute of Clinical Sciences, Sahlgrenska
Academy at the University of Gothenburg, Sahlgrenska University Hospital,
Gothenburg, Sweden; d1 Krefting Research Centre, Dept of Internal medicine
and clinical nutrition, Institute of Medicine, University of Gothenburg,
Gothenburg, Sweden
Introduction: Colorectal cancer (CC) is the third most
common cancer to affect both men and women, and
the third-leading cause of cancer-related mortality. In
order to be curable, CC has to be diagnosed and treated
by surgery before the tumour cells have started to
metastasize. In order to find CC at an early stage,
more sensitive biomarkers need to be developed.
Extracellular vesicles (EVs) have in the last decade
been recognized as major players in cancer biology
but it’s only in recent years that isolation protocols
have reached enough sophistication for a truly mean-
ingful proteomic analysis.
Methods: Tumour and non-tumour tissue (approx.
10 cm from tumour) were excised from 10 CC patients.
The tissue was sliced into approximately 1 mm 3 pieces
and partially digested with DNase and Collagenase in
cell culture medium for 30 min at 37°C. Digested tissue
was filtered through a 70 µm filter to remove tissue
pieces and large fragments. Vesicles were isolated from
the media with an isolation process consisting of dif-
ferential ultracentrifugation and density gradient floa-
tation aimed at isolating EVs. Isolates were then lysed,
tryptically digested and Tandem Mass Tag labelled
before analysis by mass spectrometry. The samples, 20
in total, were analysed in two rounds as “Set 1” and
“Set 2”, with each set containing EVs derived from five
tumour tissues and five non-tumour tissues.
Results: In total, approximately 4000 proteins were
identified and quantified, with 2567 and 3742 proteins
identified in Set 1 and Set 2 respectively with an over-
lap of 2271 proteins between the sets. Proteins which
after a t-test had a p-value lower than 0.05 and a fold
change of at least two were considered as being differ-
ently expressed in tumour tissue EVs as compared to
normal tissue EVs. 299 and 592 such proteins were
identified in Set 1 and Set 2 respectively, with 125
meeting these requirements in both Sets.
Summary/Conclusion: EVs isolated directly from the
tumour tissue microenvironment differ in their protein
cargo from that of EVs resident in equivalent non-
tumour tissue. Proteins carried by tumour derived
EVs could potentially play a role in tumour biology
by mediating signalling to neighbouring cells.
Furthermore, these differentially expressed proteins
could potentially function as biomarker candidates.
PF09.13
Characterization of small extracellular vesicles secreted by dermal
fibroblasts
Marijana Jevtića and Sarah Hetrichb
aMaster of Pharmacy – Medical Biochemist, Berlin, Germany; bProf. Dr,
Berlin, Germany
Introduction: Dermal fibroblasts play a key role in epider-
mal proliferation and differentiation. They communicate
with other cell types, playing a crucial role in the regulation
of the skin (patho)physiology. Extracellular vesicles (EVs)
are smallmembrane-enclosed vesicles (30-150 nm) that are
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released from all cell types into the extracellular space and
represent an important mode of cell-to-cell communica-
tion. Emerging data indicate that they play key roles in
many (patho)physiological processes. However, there is
currently very little information about the content and
the function of EVs from dermal fibroblasts. Therefore,
we aimed to isolate and characterize EVs secreted by der-
mal fibroblasts.
Methods: Dermal fibroblasts were isolated from juvenile
foreskin and cultivated inDMEM supplementedwith 7.5%
FBS and 2 mM L-glutamine. On day 5 of cultivation,
dermal fibroblasts were washed with PBS and further cul-
tured in EV-depletedmedium for 24h before collecting the
medium. To elucidate the characteristics of EVs, EVs were
isolated from conditioned medium by several ultracentri-
fugation and filtration steps. To verify the presence of EVs,
nanoparticle tracking analysis (NTA), transmission elec-
tron microscopy (TEM) and flow cytometry (FACS) were
performed on the dermal fibroblasts-derived EVs.
Results: With FACS analysis of dermal fibroblasts, we
proved that more than 95% of the cells were alive in the
culture, what provide that we isolated pure EVs
released by live cells. NTA and TEM analyses proved
the presence of EVs, cup-shaped structure and size
smaller than 150 nm. With FACS analysis of EVs, we
proved that EVs are enriched with cytosolic protein
present in EVs, Tsg101.
Summary/Conclusion: Here we present characteriza-
tion of EVs secreted by dermal fibroblasts in terms of
size, shape and cytosolic proteins present in EVs. In
next steps, we plan mass spectrometry of the proteome
of dermal fibroblasts and EVs secreted by dermal fibro-
blasts. EVs are able to interact with cells located nearby
or distantly and EVs can be a way for carrying infor-
mation from cell to cell. These findings may lead to
identification of new signalling pathways in between
dermal fibroblasts and other cells present in the skin,
what could help us to understand the regulation of the
skin physiology.
Funding: S.H. acknowledges financial support by the
German Research Foundation (DFG HE 7440/4–1).
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Efficient clearance of lipoproteins from anti-coagulated and native
blood-derived products to yield pure extracellular vesicle
preparations
Alexander Otahala, Olga Kutenb, Andrea De Lunab, Zsombor Laczac and
Stefan Nehrerb
aDanube University Krems, Krems An Der Donau, Austria; bDanube
University Krems, Vienna, Austria; cOrthosera, Vienna, Austria
Introduction: Extracellular vesicles (EVs) increasingly
gain focus in regenerative medicine for promoting
tissue repair and alleviating inflammation. However,
there are no standards for EV isolation from patient
blood nor for quality assessment owing to lack of
knowledge about active components or mechanisms
of action. It is known that high, low and very low
density lipoproteins (HDL, LDL, VLDL) as well as
chylomicrons copurify with EVs during isolation
from various body fluids including blood via ultracen-
trifugation (UC) or size exclusion chromatography
(SEC). The aim of our study was to develop an isola-
tion strategy to purify EVs from blood derived pro-
ducts which are already in clinical use. Therefore, we
analysed EV preparations from citrate-anticoagulated
platelet-rich plasma (CPRP) and hypACT™ serum.
Methods: Particle concentrations after UC, SEC or a
combination of both were assessed via nanoparticle
tracking analysis (NTA). EVs were labelled with
annexin V (AnnV), CD63 as well as CD41 and ana-
lysed by flow cytometry (FC). LDL and HDL content
was determined in EV preparations by labelling of
Apolipoprotein A1 (ApoA1) and Apolipoprotein
B100/48 (ApoB-100) by FC as well as detection via
Western Blot. Presence of EVs was confirmed by cryo
electron microscopy.
Results: NTA revealed 100-fold higher particle concen-
trations after SEC than after UC or UC+SEC in both,
CPRP and hypACT(TM) serum. AnnV, CD63 as well
as CD41 were detected on EVs via FC. It also revealed
efficient clearance of ApoB-100 bearing particles by
UC, while ApoA1-positive particles persisted. SEC
alone removed ApoA1-positive particles, but failed to
remove ApoB-100 bearing particles. The combination
of enrichment via UC and purification via SEC enabled
efficient clearance of both lipoprotein species (ApoA1
as well as ApoB-100). These findings are also supported
by Western Blot analysis.
Summary/Conclusion: EV preparations are commonly
contaminated with lipoproteins due to their similar size
and density. The coupling of UC to separate EVs from
lipoproteins by density and SEC to yield separation by
size enabled efficient clearance of lipoproteins from
CPRP or hypACT(TM) serum and obtaining pure EV
preparations.
Funding: The work was funded by the
Wissenschaftsfonds of Lower Austria (NÖ) together with
the European Fund for Regional Development (EFRE).
PF10.02
Proteomic and Lipidomic Analysis of Extracellular Vesicles from
Human Plasma and Urine Purified by Asymmetrical Flow Field-Flow
Fractionation
Fuquan Yang
Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
(People’s Republic)
Introduction: Extracellular vesicles (EVs) are com-
posed of lipid bilayer membranes and they are a
group of heterogeneous, nano-sized structures vesicles
enriched with nucleic acids, proteins and lipids. EVs
can be released by normal and cancer cells to their
surrounding environments and they are also found in
diverse body fluids, including blood, urine, saliva, cer-
ebrospinal fluid, breast milk, seminal fluid. EVs play
many important roles in numerous physiological and
pathological processes.
In recent years, various studies on EVs have been
conducted in the clinical research. EVs are rich in
disease related biomarkers, and can protect the
wrapped parent cells derived materials due to their
double layer membrane structures and target the spe-
cific cells or tissues. EVs have promising potential for
diagnostic and therapeutic applications, and can serve
as biomarkers and targeting drug delivery systems.
Omics studies of EVs have been used for the dis-
covery of biomarkers. The isolation of EVs are the key
step for the omics studies on EVs.
Methods: Field-flow fractionation (FFF) technique was
first invented in 1966 by J. Calvin Giddings. FFF has
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unique properties enabling separation and characteri-
zation of macromolecules, polymers, proteins, colloids,
cells and vesicles from 1 nm to 100 m at high resolu-
tion. AF4 has been reported to purify EVs from the
supernatant of cell culture. In this study, we have
developed AF4 based mothed for isolation of EVs
from human plasma and urine. The proteomic and
lipidomic analysis was performed using LC-MS/MS.
Results: EVs in human plasma were isolated from
HDL and LDL with good resolution by an optimized
AF4 conditions. EVs in human urine were also isolated
from the high abundant protein uromodulin by opti-
mized AF4 conditions after treatment with DTT reduc-
tion. Transmission electron microscopy (TEM), SDS-
PAGE, Western Blot, proteomics and lipidomics are
further applied for the studies on purified EVs from
human plasma and urine.
Summary/Conclusion: The results reveal that AF4-
based separation method for EVs is of high reproduci-
bility, purity, recovery and continuous preparation and
separation ability. The specific proteins and lipids have
been identified from human plasma and urine EVs
compared with the whole components in human
plasma and urine
PF10.03
A centrifugation model to predict the behaviour of tumour
biomarkers in liquid biopsies
Linda Rikkerta, Edwin van der Polb, Ton van Leeuwenc, Rienk Nieuwlandd,
Leon Terstappene and Frank Coumansd
aAmsterdam UMC, location AMC, Amsterdam, Netherlands; bAmsterdam
UMC, University of Amsterdam, Department of Biomedical Engineering and
Physics, Amsterdam, Netherlands, Amsterdam, Netherlands; cdAmsterdam
UMC, University of Amsterdam, Department of Biomedical Engineering and
Physics, Amsterdam, Netherlands, Amsterdam, Netherlands; dAmsterdam
UMC, University of Amsterdam, Laboratory of Experimental Clinical
Chemistry, Amsterdam, Netherlands, Amsterdam, Netherlands; eMedical
Cell Biophysics, University of Twente, Enschede, Netherlands
Introduction: Biomarkers in blood of cancer patients
include circulating tumour cells (CTCs), tumour-edu-
cated platelets (TEPs), tumour-derived extracellular
vesicles (tdEVs), EV-associated miRNA (EV-miRNA),
and circulating cell-free DNA (ccfDNA). Because the
size and density of biomarkers differ, blood is centri-
fuged to isolate or concentrate the biomarker of inter-
est. Here, we applied a model to predict the effect of
centrifugation on the purity of a biomarker according
to published protocols.
Methods: The model is based on the Stokes equation
and was validated using polystyrene beads in buffer
and plasma. Next, the model was applied to predict
the biomarker behaviour during centrifugation. The
result was expressed as recovery of CTCs, TEPs,
tdEVs in three size ranges (1–8 µm, 0.2-1 µm, and
0.05–0.2 µm), EV-miRNA and ccfDNA.
Results: Bead recovery was predicted with errors <18%.
Most notable cofounders are the 22% contamination of
1–8 µm tdEVs for TEPs, and 50–82% of tdEVs
<200 nm for ccfDNA. Based on our model, none of
the evaluated protocols produces a pure biomarker.
Thus, care should be taken in interpretation of
obtained results, as, for example, results from TEPs
may originate from co-isolated large tdEVs, and
ccfDNA may originate from DNA enclosed in
tdEVs <1 µm.
Summary/Conclusion: The Stokes model can be
applied to predict the behaviour of biomarkers –
including EVs- during isolation or concentration to
other body fluids, which may facilitate the comparison
of such protocols in e.g. EV-TRACK, further standar-
dization of protocols, and develop optimal bioreposi-
tory conditions.
Funding: This work is supported by the Netherlands
Organisation for Scientific Research – Domain Applied
and Engineering Sciences (NOW-TTW), research pro-
grams VENI 13681 (Frank Coumans), Perspectief
CANCER-ID 14198 (Linda Rikkert), and VENI 15924
(Edwin van der Pol).
PF10.04
Effects of lipoprotein destabilization on isolation and analysis of
plasma-derived extracellular vesicles
Danilo Mladenovića, Paolo Guazzib, Elina Aleksejevab, Antonio Chiesib, Kairi
Koorta, Davide Zoccoc, Triin Ojab and Nataša Zarovnid
aTallinn University, School of Natural Sciences and Health, Tallinn, Estonia;
bHansaBioMed Life Sciences, Tallinn, Estonia; cExosomics Siena, Siena, USA;
dExosomics, Siena, Italy
Introduction: Plasma is one of the most commonly
used sources of EVs since it is easy to access and is
extensively used in clinical research and diagnostics.
Isolation of pure EVs from such a complex biofluid is
hard to accomplish due to presence of many contami-
nants (lipoproteins, soluble proteins and protein aggre-
gates) that affect downstream application. Here, we are
exploring effects of plasma acidification on isolation,
purification and detection of EVs, as stand-alone or
combined with other pre-analytical steps: lipoprotein
lipase (LPL) and low-density lipoprotein receptor
(LDLR) treatment, in line with further purification
and analytical methods.
Methods: Plasma preclearing and EV isolation: differ-
ential centrifugation, tangential flow filtration (TFF),
size exclusion chromatography (SEC), enzyme-coupled
and affinity magnetic beads.
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Quantification and characterization of EVs: ELISA,
NTA (Nanoparticle Tracking Analysis), BCA assay,
Western Blot, total RNA extraction and quantification.
Results: Preliminary results reveal 3–5 fold increase of
EV protein signal in EV-enriched SEC fractions after
plasma acidification, although lipoprotein profile in
same fractions, as well as NTA counts and protein
content, stay mostly unchanged compared to normal
pH (control) samples. Additional steps aimed at
separation of lipoproteins from vesicles, after lipopro-
tein destabilization through combination of size focus-
ing, enzymatic digestion and ligand specific-depletion/
selection, are described.
Summary/Conclusion: Our experiments are addres-
sing the issue of plasma EV purification in attempt to
deplete lipoprotein particles using different preanalyti-
cal approaches. Acidification, along with LPL and
LDLR incubation, hold potential for lipoprotein
removal.
Funding: This research is part of TRAIN-EV project,
funded by EU grant under the Horizon2020 Marie
Sklodowska Curie Innovative Training Network
(MSCA-ITN) programme.
PF10.05
The stability of placental extracellular vesicles in different short-term
storage conditions
Qi Chena, Yunhui Tangb, Chunlin Sub, Michelle Wisea and Larry Chamleya
aThe University of Auckland, Auckland, New Zealand; bFudan University of
China, Shanghai, China (People’s Republic)
Introduction: Extracellular vesicles (EVs) are attract-
ing considerable attention from a wide range of
researchers because of their signalling capacity of rele-
vance to health and many diseases. EVs are classified to
macro-, micro-, and nano-EVs based on their size and
carry complex cargos of RNAs, protein, DNA and
lipids that can change the behaviour of target cells.
Given the unique characteristics of EVs and that they
are challenging to isolate in large quantities for use in
experiments especially in vivo experiments it is impor-
tant to be able to store EVs and maintain their quality.
In this study we began to investigate the stability of
human placental EVs which were extruded from first
trimester placentae.
Methods: EVs were isolated from first trimester pla-
cental explants (range from 8 to 12 weeks of gestation,
n = 8) and separated into micro- and nano-EVs by
differential centrifugation. EVs were then individually
stored in PBS at room temperature, 4°C or −20oC for
up to 2 weeks. The concentration and the size of each
type of EVs were measured by Nanoparticle Tracking
Analysis at day 0, day 3, day 7 and day 14.
Results: The concentration of micro-EVs or nano-EVs
which were stored at 4oC or room temperature was not
significantly different between days 0, 3, 7 or 14. In
contrast, the concentration of micro-EVs which were
stored at −20°C was significantly reduced at both days
7 (p = 0.001) and 14, compared with the concentration
of micro-EVs at day 0. The concentration of nano-EVs
stored at −20°C was significantly reduced at day 14
(p = 0.04), compared with the concentration of nano-
EVs at day 0. In addition, there was no difference in
the modal (or mean) size of either micro- or nano-EVs
regardless of the storage conditions at any time point.
Summary/Conclusion: we found that, at least in terms
of concentration and size, short/medium-term storage
of placental EVs at 4°C or room temperature was
preferable to freezing. Further work is required to
determine optimal storage conditions to maintain EV
function.
PF10.06
Only a portion of the T cell-released exosomes has a capacity to
destruct mesenchymal tumour stroma
Naohiro Seoa, Tsuguhiro Kanedaa, Junko Nakamuraa, Fumiyasu Momosea,
Kazunari Akiyoshib and Hiroshi Shikua
aMie University Graduate School of Medicine, Mie, Japan; bKyoto University,
Kyoto, Japan
Introduction: Exosomes (Exo) released from single
cells have been thought to be diverse populations in
membrane structures, membrane charges and bioactive
substances. We have reported that CD8 + T cell Exo
can deplete mesenchymal tumour stromal cells and
suppress tumour invasion and metastasis (Nat.
Commun. 9: 435, 2018). In this study, we examined
the diversity of CD8 + T cell Exo and destruction of
mesenchymal tumour stroma.
Methods: H-2Kd-restricted and mutated (m) ERK2
136–144 peptide-specific TCR gene-transfected
DUC18 mice were used in this study. DUC18 spleno-
cytes were cultured for 7 days with mERK2 peptide,
and obtained culture supernatant (sup) was used as a
source of CD8 + T cell (CTL) Exo. Ultrafiltration (UF)
of DUC18 culture sup was performed by tangential
flow filtration system (KrosFlo TIFF system) using
mPES MidiKros Filter Modules (MWCO 500 kDa or
750 kDa: Spectrum) at the entrance flow rate of
approximately 50 mL/min. DEAE-sepharose Fast
Flow (GE) was used as a carrier of cationic ion-
exchange chromatography. DEAE-sepharose column
(bed volume 8 cm3) was equilibrated with 10 mM
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Tris-HCl (pH7.5) containing 0.15 M NaCl. DUC18 Exo
concentrated with UF was loaded on the column, and
washed with TBS at over three column volumes. Exo
bound with DEAE-sepharose were eluted by linear
gradient of NaCl.
Results: By UF with 750 kDa MWCO mPES filter,
CD8 + T cell Exo can be effectively concentrated
more than 20 times without leaking. The concentrated
CD8 + T cell Exo was adsorbed on a DEAE column
and eluted with NaCl gradient of 0.15 M to 0.8 M. As a
result, the various Exo fractions could be obtained
from the difference of the levels of CD9 expression,
CD90 expression, Granzyme B content, the Tsg101
content, and engulfment by mesenchymal stem cells.
Interestingly, capacity of destruction of mesenchymal
stroma was found only in Exo fraction eluted about
0.25 M NaCl, indicating that a part of CD8 + T cell Exo
exerts a biological function.
Summary/Conclusion: We establish a novel method
for Exo preparation according to the negative charge.
Exo released from single cells are diverse populations
with different physical properties, some of which exhi-
bit biological significance.
Funding: This work was supported by a grant from the
JST CREST (JPMJCR17H2).
PF10.07
Evaluation of the effects of acidification on isolation of extracellular
vesicles from bovine milk
Md. Matiur Rahmana, Kaori Shimizub, Marika Yamauchic, Ayaka Okadab
and Yasuo Inoshimab
aThe United Graduate School of Veterinary Sciences, Gifu University, Gifu,
Japan; bGifu University, Gifu, Japan; cGifu University, Gifu, USA
Introduction: Acidification has shown potential for
separating casein from raw bovine milk to facilitate
isolation and purification of extracellular vesicles
(EVs). The purpose of this study was to evaluate the
effects of different acidification treatments on the yield
and surface marker proteins of EVs from raw bovine
milk.
Methods: Fresh raw bulk milk was collected from
healthy dairy cows. Casein was separated from the
raw milk by ultracentrifugation (UC), treatment with
hydrochloric acid, or treatment with acetic acid, fol-
lowed by filtration and preparation of the whey. The
protein concentration of the whey was determined by
spectrophotometry, and the size and concentration of
EVs were measured by tunable resistive pulse sensing
analysis. Surface marker proteins of EVs were detected
by western blot (WB) analysis using the primary
antibodies anti-CD9, anti-CD63, anti-CD81 and anti-
MFG-E8.
Results: The UC method yielded a higher concentra-
tion of proteins in the whey than did acidification.
However, both acidification treatments yielded higher
amounts of EVs than UC. WB analysis revealed that
acidification had partially degraded the surface marker
proteins CD9 and CD81 but not CD63 or MFG-E8.
Summary/Conclusion: Acidification was likely favour-
able to the removal of casein and the rapid, efficient
isolation of milk EVs. A higher amount of EVs were
purified by acidification, but this treatment degraded
partially some of the surface marker proteins of the
EVs. Our results suggest that appropriate surface mar-
ker antigens should be used for evaluation of EVs from
bovine milk after acidification in the following EVs
experiments.
Funding: This study was partly supported by a research
project for Improving Animal Disease Prevention
Technologies to Combat Antimicrobial Resistance 2017–
2021 FY of the Ministry of Agriculture, Forestry and
Fisheries of Japan. This study was also supported in part
by the OGAWA Science and Technology Foundation and
the Morinaga Foundation for Health and Nutrition.
PF10.08
Comparison of isolating method for obtaining extracellular vesicles
from cow’s milk
Mai Morozumia, Hirohisa Izumib, Muneya Tsudac, Takashi Shimizua and
Yasuhiro Takedaa
aMorinaga Milk Industry Co., Ltd., Zama-City, Japan; bMorinaga Milk
Industry Co., Ltd., Zama-city, Japan; cMorinaga Milk Industry Co., Ltd.,
Zama, Japan
Introduction: MicroRNAs (miRNAs) are present in
many foods including milk, which could be involved
in various bioactivities when taken orally. Milk consists
mainly of two fractions, i.e. casein and whey, and most
of the milk miRNAs are thought to be included in
extracellular vesicles (EVs) in whey fraction.
Biological roles of milk miRNAs are not fully eluci-
dated and thus require further investigation. However,
procedures for isolating milk-derived EVs (M-EVs)
have not fully established. The aim of this study was
to compare methods for isolating M-EVs.
Methods: Aiming to minimize the contamination of
casein in whey fraction, which is the great obstacle to
determining M-EVs purity, whey fraction was sepa-
rated from milk (defatted) by centrifugation only,
acetic acid precipitation, or EDTA precipitation
(n = 3). M-EVs were then isolated from each whey
fraction by ultracentrifugation, an exoEasy Maxi kit
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(Qiagen), a qEV kit (Izon Science) or an EVSecondL70
kit (GL Sciences). The number of M-EVs particles was
measured using NanoSight (Malvern Instruments).
Results: Acetic acid precipitation prevented casein con-
tamination to greater extents. Three combinations,
such as “acetic acid precipitation and qEV”, “acetic
acid precipitation and EVSeocondL70” and “EDTA
precipitation and qEV” were able to collect larger
numbers of total M-EVs particles than the other com-
binations. Among the three combinations, “EDTA pre-
cipitation and qEV” achieved collecting the largest
number of M-EVs but “acetic acid precipitation and
EVSeocondL70” was able to obtain M-EVs fractions
with high concentration.
Summary/Conclusion: The combination of “EDTA
precipitation and qEV” is suited to collect the largest
amount of M-EVs. The combination of “acetic acid
precipitation and EVSeocondL70” is capable of obtain-
ing M-EVs fractions with high concentration.
PF10.09
Generating, characterizing and testing recombinant extracellular
vesicles as biological reference material
An Hendrix; Edward Geeurickx; Olivier De Wever
Laboratory of Experimental Cancer Research, Department of Human
Structure and Repair, Ghent University, Ghent, Belgium
Introduction: Recent years have seen a tremendous
increase in the study of extracellular vesicles (EV)
geared towards biological understanding, diagnostics
and therapy. Concurrently EV data interpretation
remains challenging owing to the complexity of bio-
fluids and the technical variation introduced during EV
sample preparation and analysis.
Methods: To understand and mitigate these limitations
we have developed a standard operating procedure to
generate trackable recombinant EV (rEV).
Results: Employing complementary characterization
methods we demonstrate that rEV are stable, commu-
table and share both physical and biochemical charac-
teristics with sample EV. rEV can be accurately
measured using fluorescence-, RNA and protein-
based technologies. Implementation of rEV reduces
intra-method and inter-user variability of EV sample
preparation and analysis, and improves the sensitivity
of EV enumeration in biofluids.
Summary/Conclusion: The informed use of rEV will
aid method development, instrument calibration, data
normalization and routine evaluation of EV sample
preparation and analysis in various research and bio-
medical applications.
PF10.10
ExtraSome: method for exosome isolation based on polyethylene
glycol
Jihye Kima and Jihye Choib
aYonsei University, Seoul, Republic of Korea; bYonsei University College of
Medicine, Seoul, Republic of Korea
Introduction: Exosome sized 30-120 nm secreted from
cells and present in blood, urine and cell media. It con-
tains biomarkers that play important roles cell–cell com-
munication. Therefore, it is important to isolate exosome
in stable and effectively eliminate these contaminants.
Extant method to isolate exosome include ultracentrifu-
gation, immunoisolation and precipitation in polymeric
solution. Ultracentrifugation is the most conventional
method due to its reliability but it has the demerits of
lengthy and laborious centrifugation, requirement for
expensive equipment and low yield. Immunoisolation
which uses beads conjugated with an antibody to isolate
EVs; this method has high specificity but the EVs are
hard to detach from beads, and detachment methods may
reduce the functionality of the surface protein.
Methods: Exosomes were isolate from Fetal Bovine
serum (FBS): After centrifugation at 2000g for
30 min, 5 mL of FBS were combined with PEG buffer
solution, resulting in 2–30% final PEG concentration.
The sample were carefully mixed and incubated at 4 C
overnight. Then the samples were pun down at 11,000
rpm for 1 h. The supernatant was discarded, and the
exosome pellet was resuspended in PBS and the num-
ber of exosomes was quantified on a Nanosight LM10
instrument.
Results: We isolate exosome from FBS using PEG buffer
solution varied molecular weight (1000, 6000, 8000,
10,000, 20,000) at various concentration (2–30 w%). We
confirm the size, morphology, chemical structure and
biological marker (CD63, CD81) of the exosome. As a
result, we verify the optimal isolation condition of exo-
some for efficient system.
Summary/Conclusion: In summary, we have devel-
oped a new method for the determination of the
critical PEG value of exosome, which was proven to
be very convenient and reliable. We believe that this
method is highly effective and economical and has
great potential to be further used for the selective
separation of exosome.
Funding: This work was supported by a National
Research Foundation (NRF) grant funded by the
Korean government, Ministry of Education and
Science Technology (NRF-2017M2A2A6A01071157,
NRF-2018R1C1B6008799).
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Aqueous two-phase system to isolate extracellular vesicles for
prostate cancer diagnosis
Hyunwoo Shina, Jiyoon Kima, Mee Young Kimb, Yong Hyun Parkb, Yong
Goo Kimc, Ji Youl Leeb and Jaesung Parkd
aPOSTECH, Pohang, Republic of Korea; bDepartment of Urology, Seoul St.
Mary’s Hospital, The Catholic University of Korea, Seoul, Republic of Korea,
Seoul, Republic of Korea; cDepartment of Laboratory Medicine, Mary’s
Hospital, The Catholic University of Korea, Seoul, Republic of Korea,
Seoul, Republic of Korea; dDepartment of Mechanical Engineering,
POSTECH, Pohang, Republic of Korea, Pohang, Republic of Korea
Introduction: Analyzing extracellular vesicles (EVs) is
an attractive means in prostate cancer diagnosis.
However, existing methods of EVs isolation have low
efficiency, purity and long process time, which induce
low diagnostic ability. To approach the problems, we
adapt a two-phase system to diagnose prostate cancer
by isolating EVs from patients’ urine. Using the two-
phase system, prostate hyperplasia (BPH) patients and
prostate cancer (PCA) patients were diagnosed, and the
diagnostic ability was compared with conventional
diagnostic methods.
Methods: Forty-two prostate cancer (PCA) patients
and 20 benign prostate hyperplasia (BPH) patients’
urine, plasma, saliva was collected and used for identi-
fying EVs isolation ability of aqueous two-phase system
(ATPS) and for comparing diagnostic ability of ATPS
with conventional diagnosis.
Results: With an optimized ATPS, EVs were isolated
with an efficiency of approximately 90%. In addition,
the EV-isolation time was within approximately 30
min, and the purity of EVs in ATPS was approximately
two times better than achieved with a conventional
methods, ultracentrifugation and polymeric precipita-
tion. After the ATPS isolated EVs from patients’ body
fluid, PCR and ELISA were utilized to detect EVs
derived from prostate cancer cells. The expression
levels of RNA and protein markers of prostate cancer
were compared, and the relationship between expres-
sion levels and clinical data was analysed. The results
demonstrated that diagnostic ability based on ATPS
was better than other conventional methods (serum
PSA and sediments). Moreover, sensitivity increased
by at least 10%, and specificity was improved by at
least 20% compared to conventional methods.
Summary/conclusion: High quality and quantity of
EVs can be obtained from patients’ body fluid using
ATPS. Using the abundant sources, which contain
cancer-related proteins and genes, we can perform a
diagnosis with high specificity and sensitivity.
Therefore, ATPS offers a powerful tool for more spe-
cific and sensitive diagnosis.
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Therapeutic effect of plant sap-derived nanovesicles on cancer cells
Kim Kimina, Yeon Ju Hunb, Yoo Hye Jua and Ruri Leea
aUniversity of brain education, Cheon-an, Republic of Korea; bUniversity of
British Columbia, cheonan, Republic of Korea
Introduction: Most of the chemical agents are toxic to
both malignant and normal cells. The new anticancer
agents with debilitating side effects are highly demand.
Various plant sap have known to possess therapeutic
effects like anticancer traditionally. Plant-derived
nanovesicles play critical roles in intercellular and
inter-species communications to transfer plant compo-
nents to mammalian cells. Plant sap-derived nanovesi-
cles successfully delivered contained components into
cells with high efficiency.
Methods: We extracted plant sap-derived nanovesicles
from four endemic plants: Dendropanax morbifera
(DM), Pinus densiflora (PD), Chamaecyparis obtusa
(CO) and Thuja occidentalis (TO), and investigated
endocytosis pathway of nanovesicles to malignant and
benign cells. We assessed their anti-cancer effects on
breast, skin, colon and melanoma cancer cells of nor-
mal, benign and malignant origins.
Results: We found that different endocytosis pathway
between malignant and benign cells, DM-derived exo-
some-like nanovesicles (DM-ENVs) showed anticancer
effect especially on malignant breast cancer cells, while
no cytotoxic effects were exhibited against benign cells.
PD-ENVs showed the cytotoxic effect on malignant
skin cancer cells but not on Fibroblasts. TO-ENVs
and CO-ENVs showed no cytotoxic effect on most
malignant cancer cells. We also found the synergistic
effect of the DMNVs and PDNVs on malignant breast
and skin cancer cells. We identified that combination
of DM-ENVs and PD-ENVs make enhancement in the
cytotoxicity against malignant cells than normal and
benign cells.
Summary/Conclusion: We confirm that DM-ENVs
have anticancer effects against malignant breast and
skin cancer cells than benign breast and skin cancer
cells. We also found synergistic effects according to the
combination of DM-ENVs and PD-ENVs on malig-
nant cells. These results provide that plant sap-derived
ENVs can be a new source for specific cancer
therapeutics.
Funding: This work was supported by the Basic
Science Research Program through the National
Research Foundation of Korea (NRF) funded by the
ministry of Education, Science and Technology (NRF-
2016R1C1B2013345) and Samsung Research Funding
Center of Samsung Electronics under Project Number
SRFC-IT1701-00
PF11.02
Amniotic fluid stem cell extracellular vesicles derived from different
species contain evolutionarily conserved microRNAs: valuable
resources for regenerative medicine.
Lina Antounians and Augusto Zani
The Hospital for Sick Children, Toronto, Canada
Introduction: Amniotic fluid stem cells (AFSCs) are a
population of multipotent cells that have been reported
to hold broad regenerative potential. This regenerative
capacity has been linked to a paracrine mechanism
mediated by microRNAs (miRNAs) contained in AFSC
extracellular vesicles (EVs). Herein, we investigated the
miRNA content of AFSC-EVs from multiple species to
identify commonly shared and evolutionarily conserved
miRNAs that may be responsible for AFSC beneficial
effects.
Methods: In this study, we combined data from the
literature and from our laboratory.
Literature review: Using a defined strategy, we con-
ducted a systematic review searching for studies report-
ing on AFSC-EVs and we extracted available miRNA
sequencing data.
Our study: Rat AFSCs were subjected to exosome-
depleted FBS in minimal essential media for 18 h.
Conditioned medium was collected, cleared of cells
and debris, filtered through a 0.22 µm syringe filter,
and ultracentrifuged for 14 h at 100,000g. EVs were
assessed for size (nanoparticle tracking analysis), mor-
phology (transmission electron microscopy) and
expression of canonical protein markers CD63,
Hsp70, Flo-1 and TSG101 (Western). AFSC-EV RNA
was isolated using SeraMir, constructed into libraries
(CleanTag Small RNA) and sequenced on NextSeq
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High Output single-end sequencing run. TargetScan
was used to identify species-specific and evolutionarily
conserved miRNA using seed sequences across all three
species. Pathway enrichment analysis was conducted
using miR-path.
Results: Overall, data on AFSC-EVs from three species
(n = 2 human, n = 2 mouse, n = 1 rat) were included.
Four miRNAs (miR-21, miR-24, miR-100 and miR-
145) were found in AFSC-EVs from all three species
and were reported to exert beneficial effects on lung,
muscle and kidney regeneration. These miRNAs were
enriched in signalling pathways that involve TGF-β
(p = 0.004) and TNF-α (p = 0.03) and the maintenance
of stem cell pluripotency (p = 0.0001). We also
observed species-specific miRNAs (n = 15 human,
n = 6 mouse, n = 6 rat) contained in AFSC-EVs.
Summary/Conclusion: AFSC-EVs isolated from differ-
ent species have some miRNAs that are shared and
evolutionarily conserved. These miRNAs may have a
specific role in the regenerative effects that AFSC-EVs
exert in different diseases.
Funding: CIHR-SickKids Foundation
PF11.03
Extra-cellular vesicles in human platelet lysates for clinical use and
human cell in vitro propagation
Liling Delilaa, Yu-Wen Wua, Ming-Li Choub, David Devosc and Thierry
Burnoufd
aCollege of Biomedical Engineering, Taipei Medical University, Taipei,
Taiwan (Republic of China); bCentre de Recherche Saint-Antoine (CRSA) –
INSERM UMRS 938, Taoyuan, Taiwan (Republic of China); cPharmacologie
Médicale & Neurologie, University of Lille, University hospital center,
INSERM U-1171, Lille, France; dCollege of Biomedical Engineering, Taipei
Medical University, Taipei City, Taiwan (Republic of China)
Introduction: Human platelet lysates (HPLs) are
increasingly used in regenerative medicine and cell ther-
apy. The functional activity of HPLs to regenerate tissues
in vivo and to expand cells in vitro is believed to be due to
their richness in a plethora of growth factors. However,
little is known about the presence and content of extra-
cellular vesicles (EVs) in HPLs, as well as their potential
functional activity, biological impact and involvement in
tissue repair. We aim to characterize the number, the size
and the biological functions of EVs present in HPLs in
order to develop dedicated preparations best suitable for
specific clinical applications
Methods: Clinical grade of platelet concentrates were pro-
cessed into different fractions of HPLs: platelet pellet lysate
(PPL); heat-treated PPL ; serum-converted platelet lysate
(SCPL) using calcium chloride/glass bead treatment; and
heat-treated SCPL (HSCPL). EVs in HPLs were isolated
using size exclusion chromatography column. The number
and the size distribution were determined by dynamic light
scattering (DLS), nanoparticle tracking analysis (NTA)
and transmission electron microscopy (TEM). EVs func-
tional activity was assessed for the expression of tissue
factor and phosphatidylserine (PS) activity. In addition,
the HPLs were tested for their thrombin and plasmin
activity, anti-oxidative property and thrombin generation
capacity
Results: Abundant number of EVs (1010 ~ 1012/mL)
was found in all HPLs fractions. DLS analysis showed
that isolated EVs in PPL, HPPL, SCPL and HSCPL
have size distribution approximately ranging as follows:
100 ~ 250 nm; 45 ~ 210 nm; 145 ~ 230 nm and
55 ~ 180 nm, respectively, these data being confirmed
by NTA and TEM. None of the HPLs were found to
have detectable TF-expressing EVs but some significant
differences in PS-expressing EVs, as well as thrombin,
plasmin and anti-oxidative activity were found, possi-
bly linked to their EVs composition
Summary/Conclusion: This study establishes that all
HPLs evaluated have a high content of EVs. Differences
in functional activity were also unveiled supporting the
need for further studies of the physiological functions
of HPL-derived EVs in cell-based and preclinical ani-
mal models
PF11.04
EV-mediated delivery of enzymatically fabricated size-controllable
functional DNA/RNA microstructures for therapeutic applications
Hyejin Kim, Dajeong Kim and Jong Bum Lee
Department of Chemical Engineering, University of Seoul, Seoul, Republic of
Korea
Introduction: Nucleic acids have been widely investi-
gated as a generic material with the advantage of their
wide range of biological functions, predictable molecu-
lar structure, programmability and reversibility of base-
paring. Here, the following enzymatically fabricated
multiscale functional nucleic acid-based structures are
introduced: bubbled RNA-based cargoes (BRCs), mes-
senger RNA nanoparticles (mRNA-NPs) and CpG
incorporated DNA microparticles (CpG DNA-MPs).
Methods: Primer DNA and long linear DNA bearing
complementary sequences to functional DNA or RNA
were prepared for the synthesis of circular DNA for
the BRCs and CpG DNA-MPs. For mRNA-NPs, plas-
mid DNA bearing T7 promoter region, ribosome
binding site and ORF was prepared. T7 RNA poly-
merase or Phi29 DNA polymerase were used to
induce self-assembly of DNA or RNA-based struc-
tures, respectively.
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Results: Adaptation and modification of rolling circle
replication (RCR) approach has enabled generating
these functional structures with desired sizes for
demonstration of regulation of biological processes.
The BRCs were designed to down-regulate the target
gene upon introducing to cells by bearing specific
cleavage sites for Dicer to generate functional siRNAs.
Furthermore, manipulating template DNA to polymer-
ase ratio in the modified RCR reaction enabled size-
modulable synthesis of BRCs. We also adapted plasmid
DNA as template DNA in RCR to fabricate mRNA-
NPs for up-regulation of target gene expression. While
the two studies were geared towards regulation of gene
expression, we also demonstrated the fabrication of
CpG DMA-MPs for boosting immune response by
improving efficiency of antigen presentation in
macrophages.
Summary/Conclusion: Since the pre-assembled struc-
tures have high cargo capacity without any condensation,
loading extracellular vesicles (EVs) with the DNA/RNA-
based nanostructures would greatly enhance therapeutic
potential of nucleic acid-based therapeutics. Together with
the nature of EVs being safe and effective delivery agent,
we envision that the exploitation of EVs in the field of
nucleic acid engineering would provide a way of next-
generation gene therapy.
Funding: This research was supported by the Bio &
Medical Technology Development Program of the
National Research Foundation of Korea (NRF) funded by
the Korean Government (NRF-2016M3A9C6917402).
PF11.05
VES4US: Extracellular vesicles from a natural source for tailor-made
nanomaterials
Daniele Romancinoa, Mauro Mannob, Antonella Cusimanoa, Sabrina
Picciottoa, Samuele Raccostab, Vincenzo Martoranab, Rosina Notob, Rita
Carrottab, Elia Di Schiavic, Giovanna L. Liguorid, Annamaria Kisslingere,
Katharina Landfesterf, Blanca Rodriguezg, Svenja Morsbachh, Ales Iglici,
Veronika Iglici, Laura Corcuerah, Paolo Arosioj, Gabriella Pocsfalvik,
Nicolas Touzetl and Antonella Bongiovannia
aNational Research Council (CNR), Institute of Biomedicine and Molecular
Immunology (IBIM), Palermo, Italy; bInstitute of Biophysics, Palermo, Italy;
cNational Research Council of Italy (CNR) – Institute of Biosciences and
BioResources, IBBR, Napoli, Italy; dNational Research Council of Italy (CNR) –
Institute of Genetics and Biophysics, Palermo, Italy; eNational Research Council –
Institute of Experimental Endocrinology and Oncology (IEOS), Napoli, Italy;
fMax-Planck Institute for Polymer Research, Mainz, Germany; gZabala
Innovation Consulting, Navarra, Spain; hFaculty of Health Sciences, University
of Ljubljana, Ljubljana, Slovenia; iETH Zurich Institute for Chemical and
Bioengineering, Zurich, Switzerland; jExtracellular Vesicles and Mass
Spetrometry Group, Institute of Bioscience and BioResosrces (IBBR) – CNR,
Naples, Italy; kInstitute of Technology Sligo – ITSligo, Sligo, Ireland
Introduction: VES4US is a new European project
funded by the Horizon 2020-Future and Emerging
Technology Open programme, which aims to develop
an innovative platform for the efficient production of
extracellular vesicles (EVs) from a renewable biosource,
enabling their exploitation as tailor-made products in
the fields of nanomedicine, cosmetics and nutraceutics
(https://ves4us.eu). A core aspect of the project is to
focus on an identified natural source to constitute a
cost-effective and sustainable source of EVs. The pro-
ject will run for the next three years with six organiza-
tions from six European countries.
Methods: In the first phase, the focus will be the selec-
tion of the natural source and the optimization of
culture condition at pre-industrial scale. Then, the iso-
lation and physiochemical characterization of the EVs
will be realized. In the second phase, the functionaliza-
tion and load of the EVs will be approached. Finally,
the biological activity of the EVs will be explored both
in vitro and in vivo.
Results: The selection of the best EV-producing nat-
ural source strain/s is ongoing and it will get to the
production of the EVs needed to develop the natural
nanocarriers. Before that happens, it exists the need of
applying good research practices that include personnel
training on Standard Operating Procedures to control
major experimental activities for harvesting, manipu-
lating, storing, characterizing and treating EVs, as well
as for key related activities.
Summary/Conclusion: Safe, efficient and specific
nano-delivery systems are essential to current thera-
peutic medicine, cosmetic and nutraceutics sectors.
The ability to optimize the bioavailability, stability
and targeted cellular uptake of a bioactive molecule
while mitigating toxicity, immunogenicity and off-tar-
get/side effects is of the utmost priority. VES4US aims
at creating a fundamentally new bioprocessing
approach to generate and functionalize EVs from a
renewable biological source.
Funding: This project has received funding from the
European Union’s Horizon 2020 research and innova-
tion programme under grant agreement No 801338.
PF11.07
Therapeutic effects of mesenchymal stem cell exosomes in
myocardial ischemia/reperfusion injury in a porcine model
Max Silvisa, Vince de Hoogb, Sai Kiang Limc, Dominique de Kleijnd and Leo
Timmerse
aUMC Utrecht, Cardiology, Nijmegen, Netherlands; bUMC Utrecht, Utrecht,
USA; cInstitute of Medical Biology, Agency for Science, Technology and
Research, Singapore, Singapore, Singapore; dUMCU, Utrecht, Netherlands;
eSt. Antonius Nieuwegein, Utrecht, USA
Introduction: After an acute myocardial infarction,
restoration of the blood flow to the ischemic myocardium
(reperfusion) is the standard and most effective treatment
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for reducing the infarct size and improving clinical out-
come. The process of reperfusion, however, can induce
injury as well. Studies in animal models suggest that this
“reperfusion injury” accounts for up to 50% of the final size
of a myocardial infarct and in these models a number of
strategies have been shown to ameliorate lethal reperfusion
injury.
Our laboratory previously showed that human ESC-
derived mesenchymal stem cell-derived exosomes med-
iate cardio protection during myocardial ischemia/
reperfusion injury in a mouse model.
However, the therapeutic efficacy of these exosomes
in a large-animal model remain to be addressed.
In the current study, we therefore hypothesized that
infusion of MSC exosomes reduces infarct size and
preserves cardiac function in a large-animal model.
Methods: Thirty female landrace pigs were subjected to
60 min transluminal balloon occlusion and treated with
a combination of intravenous (1 mg) and intracoronary
(1 mg) MSC exosomes (n = 15) or placebo (n = 15) in a
randomized, blinded fashion. At baseline and prior to
termination 3D transesophageal echocardiography was
performed to assess cardiac function. Infarct size will
be calculated as the percentage of the area at risk using
Evans blue/TTC double staining.
Results: This is an ongoing study and no major results
are available yet. However, pilot studies in an open
chest LCx ligation model revealed that 1 mg of MSC
exosomes (200 μg i.v. 5 min before reperfusion and 800
μg intracoronary immediately after reperfusion)
resulted in a significant reduction of infarct size com-
pared to saline injection (infarct size as a percentage of
the area at risk 22% vs 46%, p = 0.01).
Summary/Conclusion: In this study, we will investi-
gate whether MSC exosomes are capable of reducing
infarct size and preserving cardiac function in a highly
translational large-animal model.
The main goal is to establish a clinically applicable
protocol for MSC exosomes to be used as a therapeutic
tool for the treatment of acute MI.
Funding: Dutch Heart Foundation
PF11.08
The therapeutic potential of MSC-derived extracellular vesicles for
stroke
Ji Hee Sunga, Eun Kyoung Shinb, Jeong Pyo Sonc, Yeon Hee Choa, Dong Hee
Kimd, Mi Jeong Ohb, Eun Hee Kimb, Jae Min Chae, Oh Young Bangf
aSamsung medical center, seoul, Republic of Korea; bSamsung medical center,
Seoul, Republic of Korea; cSungkyunkwan University, Seoul, Republic of Korea;
dSungkyunkwan University, seoul, Republic of Korea; eDepartment of
Mechatronics, College of Engineering, Incheon National University, Incheon,
Republic of Korea; fSamsung medical center, Seoul, Republic of Korea
Introduction: Adult stem cell therapy is an excellent
treatment for a variety of ischemic diseases including
ischemic heart disease, limb ischemia and stroke.
Mesenchymal stem cells (MSCs) exert their therapeutic
capability via extracellular vesicles (EVs) in infarcted
tissue. Therefore, we hypothesized that MSC-derived
EVs (MSC-EVs) possess the equivalent sets of thera-
peutic molecules to MSCs.
Methods: EVs were isolated from 3D cultures of
Wharton’s Jelly MSC (WJ-MSC) using tangential flow
filtration system and characterized by nanoparticle
tracking analysis. We investigated the therapeutic effi-
cacy of WJ-MSC derived EVs (does tested: 0.3 × 1010,
1.5 × 1010, 3 × 1010 EVs/rat) in a rat stroke model.
Results: The infarct size did not decrease, but the
ladder walking test showed a greater improvement in
behaviour in all EV groups than in the control group.
Immunohistochemical analysis was performed using
ki-67 (proliferating cells), DCX (immature progenitor
neurons) and collagen IV (angiogenesis) of ipsilateral.
EVs groups showed significantly increased co-expres-
sion of ki-67 and DCX in the subventricular zone.
Enhanced expression of collagen IV in the ischemic
boarder zone was more found in the EV groups than
in the control group. Diffusion tensor imaging was
used to examine the regeneration of nerve fibre bun-
dles, and nerve fibre bundles were also increased in the
EV groups.
Summary/Conclusion: Our study shows that WJ-MSC
derived EVs from 3D culture system promotes the
neurogenesis, angiogenesis and recovery of nerve fibre
bundles in rat stroke models. These results suggest that
an effective MSC-derived EV can be used ideally for
the treatment of stroke.
Funding: This study was supported by a grant from the
Korean Healthcare Technology R&D Project, Ministry
of Health & Welfare (HI17C1256) and Basic Science
Research Program, the Ministry of Science, ICT and
Future Planning (2018M3A9H1023675).
PF11.10
Exosomes from human urine-derived stem cells promote
neurogenesis via histone deacetylase6 regulation in ischemic stroke
Xiaozheng Linga, Zhang Guoweia, Qingwei Zhua, Hu Guowena, Yang Wangb
and Zhifeng Denga
aShanghai Jiao Tong University Affliated Sixth People’s Hospital, Shanghai,
China (People’s Republic); bShanghai Jiao Tong University Affiliated Sixth
People’s Hospital, Shanghai, China (People’s Republic)
Introduction: Human urine-derived stem cells (USCs)
are receiving much more attention in tissue regenera-
tion and injury repair. Exosomes derived from USCs
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(USCs-Exo) have recently been suggested to mediate
the restorative effects of USCs. However, whether
USCs-Exo play a protective role in stroke remains
unknown.
Methods: Therapeutic effect of USCs-Exo in vivo was
evaluated by cerebral infarction and neurological beha-
viour. The proliferation and differentiation of neural
stem cells (NSCs) was determined by double immu-
noﬂuorescent staining. The viability, apoptosis, prolif-
eration, and differentiation of NSCs subjected to
oxygen glucose deprivation/reoxygenation (OGD/R)
were assessed, respectively. The protein expression
and activity of HDAC6, and the expression levels of
miRNAs both in vivo and in vitro were assessed to
detect the possible mechanism.
Results: We found that intravenous injection of USCs-
Exo reduced brain infarct volume and improved func-
tional recovery by enhancing the proliferation and
differentiation of NSCs in ischemic rats. The in vitro
results suggested that USCs-Exo increase viability,
reduce apoptosis, and promote the proliferation and
neuronal differentiation of NSCs after OGD/R. We
further found that miR-206 contained in USCs-Exo is
associated with the therapeutic efficacy for neurogen-
esis through the inhibition of histone deacetylase6
(HDAC6).
Summary/Conclusion: Our study demonstrates that
USCs-Exo can improve neurological function recovery
by promoting neurogenesis, which is attributed to
miR-206-mediated HDAC6 inhibition. Our research
suggests that the use of USCs-Exo represents a novel
therapeutic strategy for stroke recovery.
Funding: This work was funded by National Natural
Science Foundation of China (Numbers 81671209,
81471243 and 81472152).
PF11.11
Protective effect of extracellular vesicles released from the neural
stem cells on 6-hydroxydopamine induced pathological condition of
Parkinson’s disease
Eun Ji Leea, Dowon Hwangb and Dong Soo Leea
aDepartment of Nuclear Medicine, Seoul National University Hospital, Seoul,
Republic of Korea; bSeoul National University Hospital, Seoul, Republic of
Korea
Introduction: Parkinson’s disease (PD) is a neuro-
degenerative disease characterized by bradykinesia,
resting tremors and postural instability. A key
symptom of PD is the loss of the nigral dopaminer-
gic neurons and subsequent dopamine deficit in the
brain. However, the precise mechanism is still
unknown. While neural stem cells (NSCs) are
potential therapeutic resources for PD, NSC-
secreted extracellular vesicles (EVs) including exo-
somes are key mediators of positive paracrine
effects. Direct evidence for neuronal protective
effects of EVs is essential for developing new PD
therapeutics.
Methods: To trace EV movement, a lentivirus contain-
ing Palm-tandem dimer tdTomato (Palm-td) was
transduced into F3 NSCs. EVs isolated from Palm-td-
infected F3 cells showed high tdTomato fluorescence
intensity enough to visualize their functional actions
such as secretion, migration and engulfment between
cells. We found that pretreatment with EVs dramati-
cally prevented 6-OHDA-induced toxicity by reducing
intracellular reactive oxygen species (ROS), percentage
of apoptotic cells and caspase-3/7 activity.
Results: These results indicate that NSC-derived EVs
have neuroprotective effects against the cell damage,
possibly through antioxidant and anti-apoptotic action.
Specifically, F3-derived EVs effectively prevents 6-
OHDA-induced the production of ROS, NSC-EVs
that inhibit ROS production might be applied as an
important therapeutic agent for neuroprotection. EV-
mediated neuroprotection likely acts by inhibiting the
generation of caspase-3/7, leading to reduce apoptosis
induction caused by 6-OHDA neurotoxicity.
Summary/Conclusion: In summary, this study demon-
strates that NSC-derived EVs protected dopaminergic
cells from oxidative insults. While 6-OHDA-induced
cell death in SH-SY5Y cells occurs by the generation of
ROS, the neurotoxin-mediated cell death was sup-
pressed by F3-derived EVs via their protective effects
on ROS-induced cell damage. We therefore expect that
further investigations into the therapeutic applications
of NSC-derived EVs will reveal additional advantages
for EV-based PD therapies in comparison to cell
transplantation.
PF11.12
The function of extracellular vesicles secreted by human-induced
pluripotent stem cell-derived mesenchymal stem cells on a cellular
ischemic stroke model
Gang Lu, Man Sze Wong, Xian Wei Su, Rui Can Cao, Hoi Hung Cheung and
Wai Yee Chan
CUHK-SDU joint laboratory on reproductive genetics, School of Biomedical
Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong
Introduction: Stroke is the second leading cause of
death and the primary cause of long-term disability,
but yet lack of effective treatment. Studies suggested
the transplantation of mesenchymal stem cells
(MSCs) improved recovery from stroke in animal
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models, similar therapeutic effect was found with
the injection of MSCs medium. MSCs medium was
found enriched with extracellular vesicles, hence
leads to the focus on utilizing extracellular vesicles
to treat neurological diseases, due to the evidence
that extracellular vesicles are able to penetrate the
blood–brain barrier. This project aims to develop a
product with enriched extracellular vesicles and to
evaluate its therapeutic efficacy in ischemic stroke.
Methods: MSCs, with same passage number, were derived
from human-induced pluripotent stem cells-MSCs for the
isolation of extracellular vesicles. The derived MSCs were
then confirmed by the adherence to plastic, multipotent
differentiation potential and surface antigen expressions.
Three methods (ultracentrifugation, ultrafiltration and
polyethylene glycol) were used to extract extracellular
vesicles, which were further analysed by the expression of
surface proteins, electron microscopy, ribosomal RNA
detection and oxygen–glucose deprivation (OGD) in
vitro stroke model.
Results: Differentiated MSCs exhibited adherence to
plastic, ability to differentiate into osteoblasts, adipocytes
and chondroblasts, and ≥95% population expressed
CD105, CD73 and CD90, and lack of CD45, CD34
and HLA class II. The isolated extracellular vesicles
expressed CD9, CD63 and CD81, with the size between
30 and 200 nm and contained RNA with a peak
between 25 and 200 nucleotides. Products from ultrafil-
tration were found to increase cell viability in vitro
stroke model most significantly.
Summary/Conclusion: Extracellular vesicles were
able to increase the viability of neuronal cell
(HT22) in oxygen–glucose deprivation in vitro
stroke model, indicating the potential use of extra-
cellular vesicles injection as an alternative therapy
for ischemic stroke.
Funding: Innovation and Technology Fund ITS-053–
17FX, the Government of the Hong Kong Special
Administrative Region.
PF11.13
Endosomal escape enhancing compounds facilitate functional
delivery of EV cargo
Nikki Heatha, Xabier Osteikoetxeab, Taiana Mia de Oliveirac, Elisa Lázaro-
Ibáñezd, Olga Shatnyevae, Christina Schindlerf, Natalie Tiguef, Lorenz Mayrg,
Niek Dekkerh, Ross Overmanb and Rick Daviesb
aAstraZeneca, Vancouver, Canada; bAstraZeneca, Macclesfield, UK; cAstraZeneca,
Cambridge, UK; dAstraZeneca, Molndal, Sweden; eAstraZeneca, Molndal,
Sweden; fMedImmune, Cambridge, UK; gAstraZeneca, Cambridge, USA;
hAstraZeneca, Mölndal, Sweden
Introduction: Extracellular vesicles (EVs) are desirable
carriers and delivery vehicles for therapeutic cargoes. We
aimed to load EVs with Cre recombinase (Cre) as a model
protein cargo and determine whether functional delivery
to cells could be improved by using uptake-enhancing
compounds.
Methods: Expi293F cell line was used for isolating Cre
loaded EVs by differential centrifugation after trans-
fecting releasing cells with constructs for protein
expression. EVs were then analysed by nanoparticle
tracking analysis, western blotting, RT-qPCR and
cryo-electron microscopy including detergent and
nuclease digestion controls. Uptake of Cre loaded
EVs was assessed using modified Hek293T cells
expressing a fluorescent reporter cassette consisting
of LoxP – GFP – LoxP – RFP.
Results: Endosomal escape enhancers chloroquine and
Unc10217939 increased TATcre functional delivery by
≥50%. CreFRB protein was loaded into EVs by rapalog-
induced dimerisation to CD81FKBP. Cells treated with
20 µg/mL CreFRB loaded EVs showed functional Cre
activity only in the presence of 25 µM chloroquine or
2 µM unc10217939.
Summary/Conclusion: Passively loaded protein and
mRNA was effectively delivered to recipient Hek293T
fluorescent Cre reporter cells in the presence of endo-
somal escape enhancing compounds. This finding
shows that endosomal escape enhancing compounds
may have a place in the clinic to improve delivery
efficiency of nanoparticle-based therapies.
PF11.14=OWP1.02
MSC exosome works through a multifaceted mechanism of action in
joint repair
Shipin Zhanga, Yedan Wangb, Francis Keng Lin Wongc, Ming Wangb, Ruenn
Chai Laid, James Hoi Po Huib, Sai Kiang Limd and Wei Seong Toha
aFaculty of Dentistry, National University of Singapore, Singapore, Singapore,
Singapore; bDepartment of Orthopaedic Surgery, Yong Loo Lin School of
Medicine, National University of Singapore, Singapore, Singapore;
cDepartment of Orthopaedic Surgery, Sengkang General Hospital,
Singhealth, Singapore, Singapore, Singapore; dInstitute of Medical Biology,
Agency for Science, Technology and Research, Singapore, Singapore,
Singapore
Introduction: Mesenchymal stem cell (MSC) exosome
is increasingly accepted as the principal agent that
underpins the therapeutic efficacy of MSC in tissue
repair. Here, we aim to elucidate the mechanism of
action of MSC exosome in immunocompetent rat
models of osteochondral defect and osteoarthri-
tis (OA).
Methods: Exosomes were purified from conditioned
medium of human MSCs by size fractionation.
Osteochondral defect creation or anterior cruciate liga-
ment transection to induce OA were performed in 72
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adult rats. Thereafter, weekly 100 µl intra-articular
injections of 100 µg exosome or PBS vehicle were
given. Analysis included weight distribution, histology,
immunohistochemistry and cytokine assay. Cellular
assays using chondrocytes were performed to deter-
mine the exosome-activated cellular processes and sig-
nalling pathways.
Results: We observed that exosome-mediated repair of
osteochondral defects was characterized by increased
cellular infiltration and proliferation, enhanced matrix
synthesis, together with a regenerative M2 macrophage
phenotype and a reduction in pro-inflammatory cyto-
kines IL-1β and TNF-α. In OA joints, MSC exosome
mediated an early suppression of pain and degenera-
tion with reduced inflammation, followed by sustained
proliferation and matrix restoration that led to cartilage
and subchondral bone regeneration. Using chondro-
cyte cultures, we could attribute some of these cellular
activities during exosome-mediated joint repair to exo-
somal CD73-mediated adenosine activation of AKT
and ERK signalling. These effects were partially abro-
gated by wortmannin or U0126, which inhibited AKT
and ERK phosphorylation, respectively. The role of
exosomal CD73 was confirmed using CD73 inhibitor
and theophylline that showed inhibition of exosome-
induced AKT and ERK phosphorylation.
Summary/conclusion: Our observations suggest that
MSC exosome works through a multifaceted MoA
that involved multiple cellular processes to restore
joint homeostasis and promote regeneration.
Funding: National Medical Research Council
Singapore (NMRC/CNIG/1168/2017 and NMRC/
CIRG/1480/2017).
PF11.15=OWP1.04
Exosome-mediated enhancement of cellular therapy in acute
myelogenous leukemia (AML)
Theo Borgovana, Peter Quesenberryb, Mike Deltatto; Sicheng Wenb, Mark
Doonerb
aBrown University Department of Hematology Oncology; Rhode Island
Hospital, Pawtucket, USA; bBrown University Department of Hematology
Oncology; Rhode Island Hospital, Providence, USA
Introduction: Of the acute myelogenous leukemia
(AML) patients able to tolerate curative therapy with
chemotherapy and stem cell transplant, many are chal-
lenged by treatment related toxicities as well as graft
versus host disease. There is novel work exploring the
utility of haploidentical cellular therapy infusion in
order to incite purposeful recipient immune response
and subsequent cytokine storm to treat refractory
AML. Our group has demonstrated the healing poten-
tial of bone marrow-derived mesenchymal stem cell
extracellular vesicles (MSC-EVs) across multiple dis-
ease states, most recently demonstrating the pro-apop-
toic signalling imparted by these nanoparticles on
nascent leukemic cells in vivo; as well as the potentiat-
ing effects of MSC-EVs when used as an adjunct to
standard cytarabine chemotherapy. We have also
shown the protective role of HMSC EV on radiated
BM and stem cell recovery.
Methods: Kasumi AML cells lines were seeded with
MSC-derived EVs. Vesicles were isolated using an
established differential centrifugation technique, and
were co-cultured with Kasumi cells for various time
points. To study cellular viability, we used a fluores-
cence-based method for quantifying viable cells.
We also explored various modes of death EVs may
illicit via a tri-dye Abcam assay designed to simulta-
neously monitor apoptotic, necrotic and healthy cells.
Both assays were used to measure viability and apop-
tosis in similar experiments employing cytarabine
Results: AML cell proliferation decreased after 1
−6 days of co-culture with hMSC-derived EVs.
Apoptosis is the primary mode of death induced.
AML cell Proliferation Decreased synergistic after 1–
6 days of co-culture with hMSC-derived EVs ±
Cytarabine.
Summary/conclusion: MSCs inhibits the proliferation
of the AML cell line in vitro and work synergistically
with cytarabine chemotherapy to promote apoptotic
death in AML cell lines. Our prior work has shown
that MSC-EVs can abate the effects of toxic chemo/
radiation and serve to protect stem cell allowing for
quicker recover in cell blood counts.
Based on the innate ability of MSC-EV to directly alter
the cellular machinery of abnormal leukemic cell and
of nascent immune cells our corollary hypothesis is
that BM-derived MSC-EVs may serve as suitable alter-
native to conditioning chemo/radiation in the AML
setting and will enhance the effects seen by cellular
therapy infusion.
Funding: t32
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Tumor driver TGFBR2-dependent microRNA profiles in colorectal
cancer cells and their EVs
Fabia Frickea, Veronika Mussackb, Dominik Buschmannb, Michael Pfafflc,
Jürgen Kopitzd and Johannes Gebertd
aDepartment Applied Tumor Biology, University Hospital Heidelberg,
German Cancer Research Center (DKFZ), Heidelberg, Germany; bTUM
School of Life Sciences Weihenstephan, Division of Animal Physiology and
Immunology, Freising, Germany; cAnimal Physiology and Immunology,
School of Life Sciences Weihenstephan, Technical University of Munich,
Freising, Germany; dApplied Tumor Biology, University Hospital
Heidelberg, Heidelberg, Germany
Introduction: Microsatellite unstable (MSI) colorectal
cancers accumulate frameshift mutations at short repe-
titive DNA sequences (microsatellites). MSI-specific
mutation patterns in tumour driver genes such as
Transforming Beta Receptor Type 2 (TGFBR2) were
found to be reflected in the cargo of MSI cell line-
derived extracellular vesicles (EVs). In previous work,
we have shown that TGFBR2 reprograms the protein
content of MSI tumour cells and small EVs derived
thereof. Here, we report on TGFBR2-dependent altera-
tions of miRNA expression in small EVs and their
corresponding parental MSI tumour cells.
Methods: To identify TGFBR2-regulated miRNAs in
an isogenic background, the established doxycycline
(dox)-inducible MSI model HCT116-TGFBR2 was
used. RNA was isolated from four biological replicates
of TGFBR2-proficient (+dox) and TGFBR2-deficient
(-dox) cells and their EVs. EVs were isolated by differ-
ential centrifugation, ultrafiltration, and precipitation
and characterized by electron microscopy, Western
blot, and nanoparticle tracking. RNA quality and con-
centration were determined by capillary electrophor-
esis. cDNA libraries for small RNA fractions were
generated and RNA sequencing was performed.
TGFBR2-regulated miRNA expression was assessed
by DESeq2 and validated by RT-qPCR.
Results: From 471 identified miRNAs, the majority
(n = 263) was unaffected by TGFBR2 expression and
shared by small EVs and parental MSI cells. In addi-
tion, we detected specific miRNAs exclusively present
in EVs from TGFBR2-deficient (n = 4) or TGFBR2-
proficient (n = 14) MSI cells. Differential expression
analysis revealed TGFBR2-regulated miRNAs in EVs
(n = 10) and MSI donor cells (n = 15). Three
candidates (miR-381-3p, −889-3p, −323a-3p) were
found to be upregulated in both TGFBR2-proficient
EVs and parental cells.
Summary/Conclusion: Our results emphasize a broad
overlap of miRNAs between EVs and their parental
cells but also highlight the impact of the recurrent
MSI tumour driver TGFBR2 on aberrant miRNA sig-
natures in MSI cancer cells and their small EVs.
Funding: This work was supported by intramural
funding from the Technical University Munich (MP)
and the University Hospital Heidelberg (JG, JK).
PF12.02
Orthologous grouping and comparison of prokaryotic and eukaryotic
EV proteomes
Tae-Young Roha, Seokjin Hamb, Dae-Kyum Kimc, Jaewook Leec and Yong
Song Ghod
aDiv. of IBB, Department of Life Sciences, Pohang University of Science and
Technology (POSTECH), Pohang, Republic of Korea; bDepartment of Life
Sciences, Pohang University of Science and Technology (POSTECH),
Pohang, Republic of Korea; cDepartment of Life Sciences, Pohang
University of Science and Technology (POSTECH), Pohang, Republic of
Korea; dDepartment of Life Sciences, Pohang University of Science and
Technology, Pohang, Republic of Korea
Introduction: Most prokaryotic and eukaryotic cells
secrete extracellular vesicles (EVs) with bioactive mole-
cules, including proteins and nucleic acid. Protein car-
gos important for EV biogenesis and/or biological
functions can be found using proteomic analyses.
Methods: To analyse the similarity and difference
between prokaryotic and eukaryotic EVs, EV pro-
tein databases was obtained from EVPedia (http://
evpedia.info), regardless of EV sources and analys-
ing platforms. EV proteins were catalogued into
orthologous groups and annotated these groups
using eggNOG database. Gene set enrichment ana-
lysis (GSEA) was employed to determine how much
the orthologous groups are enriched in EVs of pro-
karyotic or eukaryotic species. The core network of
prokaryotic and eukaryotic EV orthologous groups
were explored by Generalized HotNet analysis. Only
hot clusters with more than four orthologous
groups were visualized by Cytoscape.
Results: A total of 6634 proteomic orthologous groups
were identified from 33 prokaryotes and 22 and
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separated into two distinct groups. Each orthologous
group was annotated with gene symbols, GO terms, as
well as functional interactions. Frequently detected
orthologous groups were related with mainly mem-
brane-associated compartments. The GSEA analysis
showed some common and specific proteins to prokar-
yote or eukaryote in the categories of biological process
and cellular component. The correlation network ana-
lysis clearly provided a domain-specific terms such as
intracellular organelle cilium, cytoplasm ribosome, and
ribosome proteasome complex for eukaryotes, and
cytoplasm envelope, extracellular exosome and cell
outer membrane for prokayrotes.
Summary/Conclusion: Our comprehensive EV pro-
teome analysis could provide a functional modules
related with characteristic biological mechanisms in
prokayrotes and eukaryotes. This analytical strategy
will also provide a new integrative method to investi-
gate EV proteins and propose an evolutionary protein
repertoire of EV.
PF12.03
Quantitative proteomic analysis of trypsin-treated extracellular
vesicles to evaluate the real-vesicular proteins
Gyeongyun Goa, Dong-Sic Choia, Dae-Kyum Kima, Jaewook Leea and Yong
Song Ghob
aDepartment of Life Sciences, Pohang University of Science and Technology
(POSTECH), Pohang, Republic of Korea; bDepartment of Life Sciences,
Pohang University of Science and Technology, Pohang, Republic of Korea
Introduction: Extracellular vesicles (EVs) are nano-
sized vesicles surrounded by a lipid bilayer and released
into the extracellular milieu by most of cells. Up to
date, various isolation methods of EVs have been estab-
lished. However, most of the current methods isolate
EVs with the contaminated extravesicular proteins,
which are co-isolated proteins or non-specifically
bound proteins. Since it is difficult to isolate EVs with-
out any contaminations, the evaluation of the real-
vesicular proteins could be valuable for the quality
control of EVs.
Methods: SW480 EVs were isolated from the condi-
tioned medium by sucrose cushion and iodixanol
buoyant density gradient ultracentrifugation. The iso-
lated EVs were treated with trypsin or control for 6 h
and then pelleted by ultracentrifugation, before under-
going LC-MS/MS.
Results: Trypsin treatment could digest the contami-
nated extravesicular proteins without influencing the
intravesicular (luminal) proteins, as well as size and
morphology of EVs. By the quantitative proteomic
analyses between vesicular proteins with and without
trypsin treatment, we classified the vesicular proteins
into 363 candidate real-vesicular proteins and 151 con-
taminated extravesicular proteins. Protein interaction
network analyses showed that candidate real-vesicular
proteome is composed of proteins derived from plasma
membrane (46.8%), cytosol (36.6%), cytoskeleton
(8.0%) and extracellular region (2.5%). On the other
hand, most of the identified proteins derived from
other cellular organelles including nucleus, Golgi appa-
ratus, endoplasmic reticulum and mitochondria were
considered as the contaminated extravesicular proteins.
In addition, protein complexes, including ribosome
and T-complex proteins, were classified as the con-
taminated extravesicular proteins.
Summary/Conclusion: Taken together, this trypsin
treatment to EVs with large-scale quantitative proteo-
mics allows the evaluation of the real-vesicular proteins
in isolated EVs as well as the sub-vesicular localization
of identified proteins. Therefore, our results provide
the applicable approach to identify the reliable diag-
nostic markers of EVs.
PF12.04
Characterization of sweat extracellular vesicles
Genevieve Barta, Anatoliy Samoylenkoa, Daniel Fischerb, Anna Kaisanlahtic,
Artem Zhyvolozhnyia, Marko Suokasd, Prateek Singha, Justus Reunanenc
and Seppo Vainiod
aUniversity of Oulu, Biocenter Oulu, Laboratory of developmental Biology,
Oulu, Finland; bNatural Resources Institute Finland (Luke), Animal
Genomics, Jokioinen, Finland; cUniversity of Oulu, Biocenter Oulu, Cancer
and Translational Medicine Research Unit, Oulu, Finland; dUniversity of
Oulu, Biocenter Oulu, Department of Biology, Oulu, Finland; eUniversity of
Oulu, Biocenter Oulu, Laboratory of Developmental Biology, Oulu, Finland
Introduction: The view that human beings are more
complex than originally thought and could be described
as a mixture of human and microorganism is gaining
momentum and even biofluids which had always been
considered sterile have now been shown to contain bac-
teria originating molecules and, in some cases, bacteria.
Healthy human skin is populated by many species of
unicellular organisms, a number of which are known to
secrete extracellular vesicles (EVs). Our study of sweat EV
cargo using omics is aiming to shed some light on these
complex interactions.
Methods: We have collected sweat from the upper body
of exercising individuals (men and women) and isolated
EVs and EV RNA using concentration and filtration. EVs
were checked by TEM and NTA then subjected to pro-
teomics analysis. For RNA extraction EVs were directly
lyzed on filter. 1–10 ng of RNA was used to make
libraries for sequencing. Filtered and trimmed reads
were aligned to human genome using Bowtie.
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Unmapped reads were blasted against the EMBL database
to identify and classify metagenomics reads.
Results: A few hundred human proteins were iden-
tified but also a number of bacterial proteins. In the
case of RNA the number of unmapped reads was
larger than is usually observed with extracellular
small RNA sequencing. Metagenomic analysis pro-
vided information about species but only a certain
number of reads could be assigned, probably due to
the lack of available genome data. There is also an
uncertainty about the precise species as we can only
identify with any precision taxonomy at the level of
order.
Summary/Conclusion: Sweat EVs are amixture of human
andmicrobe-derived EVs and their complete characteriza-
tionwill depend on the availability of genomic information
including for difficult to cultivate strains.
Funding: Academy of Finland Biofuture2025
PF12.05
Proteomic signature of mesenchymal stromal cell-derived small
extracellular vesicles.
Bas WM. van Balkoma, Hendrik Gremmelsa, Bernd Giebelb and Sai Kiang
Limc
aUMC Utrecht, Utrecht, Netherlands; bUniversitatsklinikum Essen, Essen,
Germany; cInstitute of Medical Biology, Agency for Science, Technology
and Research, Singapore, Singapore, Singapore
Introduction: Small extracellular vesicles (EVs) are 50–
200 nm vesicles secreted bymost cells. They are considered
as mediators of intercellular communication, and EVs
from specific cell types, in particular mesenchymal stem/
stromal cells (MSCs), offer powerful therapeutic potential,
and could provide a novel therapeutic strategy. They
appear promising and safe (as EVs are non-self-replicat-
ing), and eventually MSC-derived EVs (MSC-EVs) may be
developed to standardized, off-the-shelf allogeneic regen-
erative and immunomodulatory therapeutics. Promising
preclinical data have been achieved using MSCs from
different sources as EV-producing cells. Similarly, a variety
EV isolation and characterization methods have been
applied. Interestingly, MSC-EVs obtained from different
sources and prepared with different methods show in vitro
and in vivo therapeutic effects, indicating that isolated EVs
share a common potential.
Methods: We analysed published MSC-EV proteomics
datasets to identify a unique and robust proteomics
signature.
Results: Here, we compare well-characterized and con-
trolled publicly available proteome profiles of MSC-EVs to
identify a common MSC-EV protein signature that might
be coupled to the MSC-EVs’ common therapeutic
potential.
Summary/Conclusion: This protein signature may
be helpful in developing MSC-EV quality control
platforms required to confirm the identity and test
for the purity of potential therapeutic MSC-EVs.
PF12.06
Comparative analysis of stool extracellular vesicles between germ-
free, bifidobacteria-di-associated and SPF mice
Hirohisa Izumia, Tatsuya Eharab, Mai Morozumib, Fuuka Tabatab, Yosuke
Komatsub, Takashi Shimizub and Yasuhiro Takedab
aMorinaga Milk Industry Co., Ltd., Zama-city, Japan; bMorinaga Milk
Industry Co., Ltd., Zama-City, Japan
Introduction: Gut microbiota is closely related to
host immune and metabolic functions. Recently,
microRNA (miRNA) in extracellular vesicles (EVs)
produced by host intestinal epithelial cells partici-
pate in shaping the gut microbiota. However, effects
of microbiota on host gut EVs and miRNAs are not
fully elucidated. In this study, we investigated the
effects of microbiota on host stool EVs and miRNAs
using germ-free (GF), bifidobacteria-di-associated,
and specific pathogen free (SPF) mice.
Methods: GF mice and SPF mice (11 week, male) were
obtained. At 12-week-old age, part of GF mice were
inoculated with Bifidobacterium longum BB536 and B.
breve M-16V (1109 each) once, and maintained with 5%
fructooligosaccharides (bifidobacteria-di-associated
mice). Mice were sacrificed at 15-week-old age by deep
anaesthesia with sevoflurane, and tissue samples and
stool samples were harvested. Stool EVs were purified
using exoEasy Maxi Kit, and were analysed by
NanoSight LM10. Total RNAs were purified from stool
EVs using miRNeasy, and were analysed by microarray.
Results: NanoSight analyses revealed that mean EV
size of GF stool was significantly smaller than that of
SPF stool, and EV quanity of bifidobacteria-di-asso-
ciated stool was tend to be increased than that of GF
stool. Moreover, microarray analysis revealed that
microbiota could change miRNA expression profiles
of stool EVs.
Summary/Conclusion: Microbiota might affect host
gut function via alterations of EVs’ characteristics.
PF12.07=OWP3.07
Shed microvesicles released from human primary and metastatic
colorectal cancer cell lines contain key cancer progression proteins
and RNA species
Wittaya Suwakulsiria, Alin Raia, Rong Xua, Maoshan Chena, David Greeningb
and Richard Simpsona
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aDepartment of Biochemistry and Genetics, La Trobe Institute for Molecular
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Institute for Molecular Science, La Trobe University, VIC, Australia,
Melbourne, Australia
Introduction: Extracellular vesicles (EVs) function in
bidirectional cell–cell communication and contribute
to the sustained growth, invasion, and metastasis of
cancer cells within the tumour microenvironment
(TME). EVs comprise two main classes – exosomes
and shed microvesicles (sMVs, also termed micropar-
ticles and ectosomes) – with distinct modes of biogen-
esis. Within each EV class, subtypes exist that can be
distinguished by their distinct protein/RNA signatures.
Whilst much is known about exosome cargo content
and functionality, sMVs are poorly understood.
Methods: Here, we compare protein/RNA profiles and
functionality of sMVs and exosomes secreted from
human primary (SW480) and metastatic (SW620) col-
orectal cancer cell lines. Milligram amounts of EVs
were purified from cell culture media using a combina-
tion of differential ultracentrifugation/isopycnic iodix-
anol density centrifugation. Label-free quantitative
mass spectrometry was performed to obtain protein
profiles for SW480-derived and SW620-derived sMVs.
Results: We show that sMVs, unlike exosomes, are
ALIX-, TSG101-, CD63- and CD9- and contain a dif-
ferent suite of key cancer progression modulators.
Protein/RNA signatures for SW480-derived sMVs and
exosomes differ from each other and also from their
SW620-derived counterparts. SW480-derived sMVs are
enriched in ITGA/B, ANXA1, CLDN7, CD44 and
EGFR/NOTCH signalling networks, while SW620-
derived sMVs are enriched in PRKCA, MACC1,
FGFR4 and MTOR/MARCKS signalling networks.
Fibroblast invasion capabilities of SW480-derived and
SW620-derived sMVs are comparable.
Summary/conclusion: Furthermore, we report for the
first time a comprehensive biochemical/functional ana-
lysis of a hitherto undescribed subpopulation of sMVs.
We anticipate our in-vitro findings will be a starting
point for more sophisticated studies aimed at elucidat-
ing the biochemical and functional properties of EV
subtypes in vivo. The emerging roles of specific EV
subtypes in the TME we believe will alter our view of
cancer biology and might present new targets for ther-
apeutic intervention.
Funding: Funding support from La Trobe University,
Melbourne, Australia.
PF12.08=OWP3.08
Mass spectrometry analysis of small extracellular vesicles isolated
from ovarian cancer ascites
Anna Kotrbováa, Kristina Gomoryovaa, David Potesilb, Vit Weinbergerc, Igor
Crhac, Eva Jandakovad, Lubos Minarc, Zbynek Zdrahalb, Vítězslav Bryjaa and
Vendula Pospíchalovaa
aDepartment of Experimental Biology, Faculty of Science, Masaryk
University, Brno, Czech Republic; bCore Facility Proteomics, Central
European Institute of Technology, Masaryk University, Brno, Czech
Republic; cDepartment of Obstetrics and Gynecology, Faculty Hospital
Brno, Brno, Czech Republic; dDepartment of Pathology, University Hospital
Brno, Brno, Czech Republic
Introduction: High-grade serous carcinoma (HGSC)
of the ovaries, fallopian tube and peritoneum is the
deadliest gynaecological malignancy with 5-year survi-
val rate below 30%. HGSC is frequently accompanied
by ascites, a pathological accumulation of fluid in the
peritoneum, which can be exploited as a liquid biopsy
containing not only cancer cells but also the tumour
microenvironment including extracellular vesicles
(EVs). Tumour cells produce substantially more EVs
than healthy cells, thus malignant ascites is the source
of enriched pool of EVs of HGSC origin.
Methods: Ascitic fluids depleted of cells were frac-
tioned using size-exclusion chromatography and two
fractions – containing and not containing EVs – were
further analysed. In parallel, small EVs were also iso-
lated from ascitic fluids using differential ultracentrifu-
gation followed by purification step in sucrose/D2O
cushion. In total, 24 malignant ascites and 5 non-
malignant ascites were used for EV isolation and
further analysed using high resolution hybrid mass
spectrometer Orbitrap Fusion Lumos Tribrid. The sub-
sequent data visualization and statistical analyses were
performed using in-house developed pipelines in
KNIME environment.
Results: We identified 2441 proteins in total in the EVs
from the ascites among which 21 were present in all 29
EV samples and not in non-vesicular fractions. Several
of these proteins were specifically enriched in small
EVs in malignant ascites in comparison with non-
malignant ascites. These proteins are now being eval-
uated as biomarkers.
Summary/conclusion: Using advanced mass spectro-
metry, we identified candidate proteins which are spe-
cifically enriched in small EVs of HGSC. These
proteins warrant further investigation as they may act
as important players in HGSC progression as well as
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serve as potential prognostic/diagnostic/screening bio-
markers of HGSC.
Funding: Czech Science Foundation, Grant No. GJ17-
11776Y
PF12.09=OWP1.05
Extracellular vesicles derived from amniotic fluid stem cells rescue
impaired foetal lung development via the release of microRNAs
Lina Antounians, Vincenzo Catania, Benjamin Liu, Areti Tzanetakis, Louise
Montalva and Augusto Zani
The Hospital for Sick Children, Toronto, Canada
Introduction: Incomplete lung development, also
known as pulmonary hypoplasia (PH), is a recognized
cause of neonatal death. To date, there is no effective
treatment that promotes foetal lung growth and
maturation. Herein, we describe a stem cell based
approach that enhances foetal lung development via
the administration of extracellular vesicles (EVs)
derived from amniotic fluid stem cells (AFSCs) in rat
models of PH. Moreover, we report the microRNAs
present in AFSC-EVs that are responsible for these
beneficial effects.
Methods: AFSC-EVs were isolated by ultracentrifuga-
tion from conditioned medium (CM) of c-Kit+ rat
AFSC that were grown in exosome-depleted FBS for
18 h. AFSC-EVs were assessed for size (nanoparticle
tracking analysis), morphology (TEM), and expression
of CD63, Hsp70, Flo-1 and TSG101 (Western).
Ex vivo: Pregnant dams were gavaged nitrogen at E9.5
to induce foetal PH. At E14.5, foetal lungs were har-
vested, and incubated with culture medium alone,
AFSC-CM, or AFSC-EVs. Foetal lungs from untreated
dams served as control. Lungs were compared for
terminal bud density and surface area at 72 h, by two
independent investigators.
In vitro: Foetal rat lung organoids were generated with
epithelial cells from normal and hypoplastic lungs.
Organoids were cultured for 10 days in either medium
alone or medium supplemented with AFSC-EVs. Lung
organoids from untreated normal pups served as con-
trol. Organoids were assessed for proliferation (Ki67)
and markers of epithelial cell differentiation via
immunofluorescence.
RNA-sequencing: RNA was isolated using SeraMir,
constructed into libraries (CleanTag Small RNA), and
sequenced on NextSeq High Output single-end sequen-
cing run.
Results: Administration of AFSC-EVs increased term-
inal bud density and surface area of lung explants back
to control levels and promoted lung epithelial cell
differentiation in lung organoids (increased SPC and
CC10 expression). AFSC-EVs contain 901 microRNAs,
some of which are crucial for foetal lung development,
such as miR17 ~ 92 cluster.
Summary/conclusion: Administration of AFSC-EVs
rescues impaired foetal lung development in experi-
mental models of PH. AFSC-EV regenerative ability is
exerted via the release of miRNAs some of which
regulate genes involved in foetal lung development.
AFSC-EVs represent a promising therapeutic strategy
for PH in foetuses.
Funding: CIHR-SickKids Foundation
PF12.10=OWP2.10
HIV-specific antibody-mediated targeting of ENV+ tissues by
exosomes
Zou Xue, Yuan M’eng, Zheng Nan and Wu Zhiwei
Nanjing University, Nanjing, China (People’s Republic)
Introduction: ART (Antiretroviral Therapy) can effec-
tively suppress HIV replication in the peripheral blood
to an undetectable level. However, efforts to eradicate
the latent virus in reservoirs remain a challenge and are
a major obstacle in the treatment of HIV patients.
Exosomes exhibit huge promise as an endogenous
drug delivery nanosystem for delivering drugs to reser-
voir tissues given their unique properties, including
low immunogenicity, innate stability, high delivery effi-
ciency and mostly importantly the ability to penetrate
solid tissues due to their lipophilic properties.
Methods: In this study, we engineered and expressed
the ScFv of a high affinity HIV-specific monoclonal
antibody, 10E8, on exosome surface. Exosomes from
293T cells were loaded with curcumin via saponin,
with efficient up to 34%. 10E8ScFv-expressing exo-
somes (10E8-Exo) showed highly efficient targeting of
and curcumin delivery to CHO cell that expresses a
trimeric gp140 on its surface (ENV+ cells) in vitro as
demonstrated by confocal imaging and flow cytometry.
We showed that 10E8-Exo could effectively bind to
CHO cell that expresses a trimeric gp140 on its surface.
The exosomes loaded with curcumin, a chemical that
was shown to kill HIV-infected cells, showed specific
killing of the trimeric gp140-expressing CHO cells. In
an NCG mouse model that was grafted with the
tumourigenic gp140-CHO cells and developed solid
tissue tumours intravenously injected 10E8-Exo tar-
geted the ENV-expressing tissues and delivered curcu-
min to induce a strong suppression of the ENV+
tumour growth with a low toxicity.
Results: Our results demonstrated that engineered exo-
somes can deliver anti-HIV agents to solid tissues by
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specifically targeting cells expressing viral ENV and
induce cell killings.
Summary/conclusion: It suggesting that such an
approach can be developed for eradicating virus-
infected cells in tissue reservoir
Funding: This study was supported by The National
Key Research and Development Program of China
(2016YFC1201000), Nature Science Foundation of
Jiangsu Province (BY2015069-02) and National
Nature Science Foundation of China (81672020). The
funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the
manuscript.
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Exosomes from LNCaP cells promote the activity of osteoblasts
through the transfer of mir-375
Yun Yea and Su-liang Lib
aProstate Cancer, Xi’an, China (People’s Republic); bCancer, Xi’an, China
(People’s Republic)
Introduction: Studies have shown that exosomes influ-
ence tumour metastasis, diagnosis and treatment. It has
been found that exosomal miRNAs are closely linked
to the metastatic microenvironment. However, the reg-
ulatory role of exosomes from prostate cancer (PCa)
cells in bone metastasis remains poorly understood.
Methods: We isolated and purified exosomes by ultracen-
trifugation, isolated total RNA from cells and total miRNA
from exosomes, and analysed the level of miR-375 by RT-
PCR. Exosome libraries from LNCaP cells and RWPE-1
cells were sequenced and filtered with an Illumina
HiSeqTM 2500 system. The activity of alkaline phospha-
tase, the extent of extracellular matrix mineralization and
the expression of osteoblast activity-related marker genes
were measured to evaluate osteoblast activity.
Results: Morphological observation, particle size analysis
and molecular phenotyping confirmed that the isolated
extracts contained exosomes. Differential expression ana-
lysis confirmed the high expression of miR-375 in LNCaP
cell-derived exosomes. We further determined which exo-
somes could enter osteoblasts and increase their miR-375
level. In addition, exosomal miR-375 could significantly
promote the activity of osteoblasts.
Summary/conclusion: This study lays the foundation
for further investigations on the function of exosomal
miR-375 in the activation and differentiation of osteo-
blasts and the mechanism of bone metastasis in PCa.
Funding: none
LBF01.02=OWP1.13
Colorectal cancer cell-derived exosome enhances microenvironmental
angiogenesis through modulation of intracellular metabolism
Atsushi Ikedaa, Satoshi Nagayamab and Koji Uedac
aCancer proteomics group, Cancer Precision Medicine Center, Japanese
Foundation for Cancer Research, Tokyo, Japan; bDepartment of
Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation
for Cancer Research, Tokyo, Japan; cCancer Proteomics Group, Cancer
Precision Medicine Center, Japanese Foundation for Cancer Research,
Tokyo, Japan
Introduction: For improvement of prognosis of color-
ectal cancer (CRC), detection at an earlier stage of CRC
is essential. Exosomes are nanovesicles secreted from
plasma membrane, and have potential to be served as
biomarker carriers. In this study, we performed pro-
teomic profiling of exosomes secreted from viable CRC
tissues.
Methods: To identify early detection biomarkers for
CRC, we performed comprehensive proteome analysis
of tissue-exudative extracellular vesicles (Te-EVs),
which were obtained from culture media of freshly
resected viable CRC tissue or adjacent normal mucosa
(n = 17). Among the identified Te-EV proteins, we
narrowed down the biomarker candidate by selecting
proteins which are statistically upregulated (p < .05,
fold change > 5.0) in Te-EVs from CRC tissues than
those from adjacent normal tissues. Then we per-
formed functional analysis of the biomarker candidate
specifically.
Results: Comprehensive LC/MS analysis identified
6149 Te-EV proteins, in which 641 proteins showed
significant upregulation in Te-EVs from CRC tissues
(p < . 05, fold change > 5. 0) compared to those from
adjacent normal mucosa. We focused especially on
GAM (p = 7.0 × 10–5, fold change = 7.4) as a novel
biomarker candidate. GAM protein was significantly
overexpressed in CRC tissues compared with adjacent
normal mucosa. In EV-sandwich ELISA assay, the
expression level of GAM on plasma EVs from CRC
patients was significantly higher than that from
healthy donors in EV-sandwich ELISA assay
(n = 133, p = 4.0 × 10–7). In addition, the uptake of
GAM-overexpressing EVs enhanced vascular endothe-
lial cell growth and angiogenesis through modulation
of nitric oxide metabolism.
Summary/conclusion: EV-GAM might have great
potential as a target for both CRC diagnosis and ther-
apy. Our strategy for identification of exosomal bio-
marker by proteomic profiling of Te-EV proteins can
be applied to other cancers.
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Augmentation of Exosome secretion in Ha-RasV12-induced cell
softening and multilayer cellular aggregates in Madin-Darby canine
kidney cells
Ming Jer Tang and Hsi Hui Lin
Deaprtment of Physiology, National Cheng Kung University Medical College,
Tainan, Taiwan (Republic of China)
Introduction: Ha-RasV12 overexpression-induced cell
softening and multilayer cellular aggregates (cell
clumping) during confluence in MK4 cells (inducible
Ras harbouring MDCK cells). We have demonstrated
that Ha-RasV12-induced cell softening and transforma-
tion required Cav-1 downregulation and augmented
secretion of Wnt-5a containing exosome. Here, we
explored the role of exosome secretion and cell soft-
ening in Ha-RasV12-induced cell clumping.
Methods: We employed MK4 cells (inducible Ha-Ras-
harbouring MDCK cells). Cell stiffness was measured
by atomic force microscope (Biowizard II, JPK) and
cell aggregates were examined under confocal micro-
scope. Quantitation of exosome secretion in culture
media was assessed by Nanoparticle analysis.
Results: We found that Induction of Ha-RasV12-trig-
gered YAP nuclear translocation and subsequently
YAP-targeted gene expression. However, verteporfin,
a YAP/TEAD binding inhibitor, failed to prevent Ha-
RasV12-induced multilayer cellular aggregates.
Overexpression of Cav1 inhibited Ha-RasV12-induced
YAP activation and multicellular cell aggregates,
whereas knockdown of Cav1 in MDCK cells resulted
in activation of YAP, but not cellular aggregates and
cellular transformation. Activities of Rac and RhoA,
both associated with cell extrusion, were increased in
Ha-RasV12-overexpressed MK4 cells. EHT1864 (Rac
inhibitor) abolished multilayer cellular aggregates in
Ha-RasV12-overexpressed MK4 cells, whereas Y27632
(ROCK inhibitor) induced multilayer cellular aggre-
gates in MK4 cells. However, neither EHT1864 nor
Y27632 inhibited Ha-RasV12-induced YAP nuclear
localization. Finally, Ha-RasV12-overexpression
induced a marked increase in exosome secretion and
cell softening, which preceded cell clumping.
Summary/conclusion: Taken these data together, our
results indicate that Cav-1 downregulation is required
for Ha-RasV12-induced YAP activation and cellular
transformation. However, only Cav1 downregulation
and Rac activation, but not YAP activation, are
required for Ha-RasV12-induced multilayer cellular
aggregate.
Funding: This work was partially funded by MOST
107-3017-F-006-002 to MJ Tang.
LBF01.04
Longitudinal analysis of serum-derived extracellular RNA for
monitoring of treatment response to targeted therapy in
glioblastomas
Leonora Balaja, Rob Kitchenb, Bob Carterc, Xandra Breakefieldc and Johan
Skogd
aMassachusetts General Hospital, Boston, USA; bExosome Diagnostics,
Waltham, USA; cMGH, Boston, USA; dExosome Diagnostics, Inc.,
Waltham, Massachusetts, USA, Waltham, USA
Introduction: We performed longitudinal whole-tran-
scriptome profiling of serum exosomes from patients
suffering from recurrent glioblastoma (GBM) enrolled
in a clinical trial to assess response to Dacomitinib, a
second-generation irreversible EGFR tyrosine kinase
inhibitor. All patients had failed standard of care ther-
apy and had tumours amplified for EGFR. They under-
went daily oral administration of Dacomitinib and
blood serum samples were collected immediately
prior to first treatment and monthly thereafter.
Methods: Deep sequencing of exosomal RNA
(exRNA), derived from just 2 ml of patient serum,
revealed robust signatures of treatment response, as
defined by >6-month progression-free survival.
Results: Non-responders were found to have signifi-
cantly elevated levels of a number of transcripts includ-
ing colony stimulating factor 1, which regulates the
proliferation, differentiation, and survival of macro-
phages and microglia. We further identified robust
signatures of treatment response in post-treatment
serum samples, including the suppression of DNA
methyltransferase 3 alpha, an important player in
DNA methyl transfer for de-novo methylation, as well
as Adenosine A2B receptor, a member of the G pro-
tein-coupled receptor superfamily which is overex-
pressed in a variety of cancers and has been shown to
play a role in tumour progression via increased angio-
genesis and metastasis. Furthermore, we identified gen-
eral decreases in oncogene abundance following
Dacomitinib treatment, including tumour protein p53
and Ovo-like transcriptional repressor 1, a zinc finger-
containing transcription factor, shown to be a critical
inducer of epithelial-to-mesenchymal transition in can-
cer. Finally, in comparison to healthy control serum,
we find hundreds of transcripts exhibiting differential
abundance in pretreatment GBM patients that may
serve as general non-invasive biomarkers for this
devastating disease.
Summary/conclusion: This study is unique because it
represents the first longitudinal profiling of the exoso-
mal transcriptome in a cohort of genomically selected
GBM patients. These findings are a tantalizing step
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towards exosome-based biomarkers for the detection of
GBM, as well as patient stratification and monitoring.
Funding: CA069246 CA230697 TR000931
LBF01.05
Lung cancer exosome specific protein 1 (LESP-1) is increased in the
plasma of non-small cell lung cancer patients
Byeonghyeon Choia, Yu Hua Quanb, Jiyun Rhob, Hyesun Jeongc, Jik Han
Jungd, Sunghoi Hongc, Ji-Ho Parkd, Yeonho Choie, Yong Parkf, Kook Nam
Hang, Young Ho Choig and Hyun Koo Kimg
aKorea university, Seoul, Republic of Korea; bDepartment of Biomedical
Sciences, College of Medicine, Korea University, Gurogu, Republic of
Korea; cSchool of Biosystem and Biomedical Science, Korea University,
seongbuk-gu, Republic of Korea; dDepartment of Bio and Brain
Bioengineering, Korea Advanced Institute of Science and Technology
(KAIST), Daejeon, Republic of Korea; eDepartment of Bioconvergence
Engineering, Korea University, seongbuk-gu, Republic of Korea; fDivision
of Hematology-Oncology, Department of Internal medicine, Korea
University Anam Hospital, seongbuk-gu, Republic of Korea; gDepartment
of Thoracic and Cardiovascular Surgery, Korea University Guro Hospital,
Korea University College of Medicine, Gurogu, Republic of Korea
Introduction: Lung cancer remains to be the leading
cause of cancer-related mortality worldwide. Finding
new non-invasive biomarkers for lung cancer is still a
significant challenge. Exosomes are endosome-derived,
nano-sized (30–150 nm), extracellular microvesicles
released from many cell types, and that play a key
role for in cell-to-cell communication. Use of exosomes
as biomarkers in of lung cancer, in a liquid biopsy, is a
rising emerging field in nanotechnology in a liquid
biopsy. This research work focused on identifying exo-
some-specific proteins (LESP) of in non-small cell lung
cancer (NSCLC) by using proteomics and assessed
their concentration efficacy within exosomes derived
from the plasma of normal and NSCLC patients.
Methods: Proteomics analysis was performed to inves-
tigate lung cancer-specific proteins within exosomes
isolated from five NSCLC (H522, A549, H1299,
H1650, PC9) and one normal lung alveolar cell lines
(Human pulmonary alveolar epithelial cell), using size
exclusion chromatography. We then isolated plasma
exosomes from healthy controls and NSCLC patients
(17 controls and 54 patients) using dual size exclusion
chromatography. ELISA and Western blot were utilized
to validate the proteomic results in NSCLC patients
and compare with healthy controls.
Results: Using proteomics analysis, we identified
LESP-1 in the exosomes from NSCLC cells, but not
in those from normal cells. LESP-1 concentration was
higher in lung cancer patients compared to the healthy
controls (p < .01), and increased according to the grade
of lung cancer, in peripheral blood (p < .01). Moreover,
Western blot results confirmed the increase in LESP-1
in NSCLC patients, with band intensity increasing with
the grade of lung cancer, compared to healthy controls.
Summary/conclusion: LESP-1 in exosomes was highly
expressed in the blood plasma of lung cancer patients,
which suggests that LESP-1 could serve as a potential
biomarker for diagnosis of NSCLC.
Funding: This research was supported by the Korea
Health Technology R&D Project (No. HR14C0007)
funded by the Ministry of Health & Welfare, Republic
of Korea.
LBF01.06
Chloride intracellular channel protein 4 (CLIC4) is a serological cancer
biomarker released from tumour epithelial cells via extracellular
vesicles and required for metastasis
Vanesa C. Sanchez, Alayna Craig-Lucas, Ji Lou; Kent Hunter and Stuart
Yuspa
National Institutes of Health (NIH), Bethesda, USA
Introduction: Chloride intracellular channel protein 4
(CLIC4) is a highly conserved metamorphic protein
originally described as an ion channel. It translocates
to the nucleus serving as an integral component of
TGF-β signalling. In multiple cancers, CLIC4 is a
tumour suppressor, excluded from the nucleus and
lost from the cytoplasm of progressing cancer cells. In
contrast, CLIC4 is upregulated in the tumour stroma
acting as a tumour promoter. Recent reports indicate
that CLIC4 is detected in the circulation of cancer
patients serving as possible biomarker and has been
detected in extracellular vesicles (EVs).
Methods: EVs from multiple sources were isolated by
differential centrifugation, following ultracentrifuga-
tion and Optiprep density gradients. EV size distribu-
tion and concentration were analysed by NTA and
TEM. The presence of prototypical markers and
CLIC4 were analysed by immunoblot and by tissue
staining.
Results: CLIC4 was present in EVs released from pri-
mary normal and multiple breast tumour cell lines and
increased in EVs from TGF-β-induced myofibroblasts.
In vivo, in two different orthotopic syngeneic mouse
breast cancer models, CLIC4 levels in EVs isolated
from plasma increased with tumour burden and lung
metastatic load. Moreover, CLIC4 levels in EVs isolated
from plasma of breast cancer patient was elevated when
compared to healthy age and race matched controls. To
dissect the contribution of stromal vs tumour epithelial
compartments as the source of the CLIC4-high EVs,
CLIC4 was either deleted in tumour cells lines by
CRISPR/Cas9 or CLIC4 KO females were implanted
CLIC4 WT tumour cells. CLIC4 is reduced in
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circulating EVs from CLIC4 KO tumour bearing mice
when compared to WT and it is present in circulating
EVs from CLIC4 KO females bearing WT tumours,
indicating that the major contribution of CLIC4 into
circulation is from tumour epithelium. Additionally,
CLIC4 KO females display no difference in primary
tumour size and a significant reduction in both size
and number of lung metastases.
Summary/conclusion: CLIC4 levels in EVs from bio-
logical fluids may have value as a cancer biomarker, in
conjunction with other markers, to detect or analyse
tumour progression or recurrence. The low lung
metastasis frequency in CLIC4 KO females may due
to a defect in lung tissue to recruit neutrophils and to
induce neovasculature.
Funding: National Institutes of Health
LBF01.07
Comparative proteomic analysis of exosomes and whole cells from
NSCLC cell lines: focus on gefitinib resistance
Mi young Lee, Ye-Eun Jeong and A-Reum Ryu
Soonchunhyang University, Asan, Republic of Korea
Introduction: Overexpression of epidermal growth
factor receptor (EGFR) is a typical feature of approxi-
mately 90% of NSCLC patients. EGFR mutations
induce excessive activation of tyrosine kinase domain
of EGFR, eventually inducing oncogenic alterations.
Thus, EGFR has become a therapeutic target for
NSCLC patients harbouring activating EGFR muta-
tions with tyrosine kinase inhibitor (TKI) such as gefi-
tinib. However, more than 50% of patients with
NSCLC receiving gefitinib showed resistance to gefiti-
nib. Thus, acquired resistance to EGFR TKI is a major
challenge in the lung cancer treatment. Although sev-
eral mechanisms have been attributable to acquired
resistance, the information on exosomal studies on
EGFR-TKIs resistance of NSCLC is limited.
Methods: In this study, comparative proteomic analy-
sis of exosomes and whole cells from EGFR mutant
gefitinib-sensitive NSCLC cell lines (PC9) and gefiti-
nib-resistant cell line (PC9/GR) were conducted by
quantitative proteomics. The significant protein
expression changes observed in each analysis, and the
differences of gefitinib resistance-related proteins from
exosomes and whole cells were examined.
Results: Biological processes, molecular functions and
cellular components associated with gefitinib resistance
and key pathways related with gefitinib resistance have
been identified in exosomes and whole cell lysates from
PC9 and PC9/GR cells. The results also revealed the
similarities and differences between gefitinib-resistance
of exosomes and whole cells, through pathway analysis
of the core functional proteins.
Summary/conclusion: The results might suggest that
functional exosomal proteins secreted from gefitinib
resistant lung cancer cells contain specific signatures
via horizontal transfer from whole cells of NSCLC
Funding: This work was supported by the Industrial
Strategic Technology Development Program
(10077559) funded by the Ministry of Trade, Industry
& Energy (MOTIE, Korea).
LBF01.08
Extracellular vesicles derived from bone marrow stromal cells
promote evasion of multiple myeloma cells from natural killer cell
antitumour activity
Tomohiro Umezua, Chiaki Kawanaa, Satoshi Imanishib, Junko Ohyashikia
and Kazuma Ohyashikia
aTokyo Medical University, Tokyo, Japan; bTokyo University of Science,
Tokyo, Japan
Introduction: Natural killer (NK) cells are a major
component of the antitumour immune response. NK
cell dysfunctions have been reported in various haema-
tologic malignancies, including multiple myeloma
(MM). In the bone marrow of MM patients, bone
marrow stromal cells (BMSCs) interact with MM
cells, and also create a permissive microenvironment
for MM cell survival and immunosuppression. In this
study, we investigated the biological property of the
extracellular vesicles (EVs) and EV-miRNAs of
BMSCs derived from MM patients (MM-BMSCs), aim-
ing to clarify the involvement of EVs derived from
MM-BMSCs in tumour immune microenvironment.
Methods: BM samples were obtained from MM
patients (age 68–79, n = 6) in accordance with the
Declaration of Helsinki and using protocols approved
by the research Ethics Committee of Tokyo Medical
University (IRB No. 2648), and BMSCs derived from
MM patients (MM-BMSCs) were isolated by the clas-
sical adhesion method. BMSCs from healthy donors
(Normal-BMSCs) were purchased from Lonza Inc.
The EVs were isolated from conditioned medium of
BMSCs using Exoquick-TC Reagent (System
Biosciences). EV-miRNA profiling was done using a
TaqMan low-density array (Applied Biosystems). A
rapid flow cytometry assay for quantifying target cell
killing after CellVue (Sigma)-labelled MM cell lines
(RPMI8226, U266) prior to co-incubation with NK
cells (Biotherapy Institute of Japan, Inc.).
Results: There were no significant differences in size
and amount of EVs among Normal-BMSCs and MM-
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BMSCs. We found that the expression of some
miRNAs, including miR-146a, in the EVs derived
from MM-BMSCs were higher than that of Normal-
BMSCs. Furthermore, miR-146a in MM-BMSC-EVs
was significantly up-regulated by co-culturing with
MM cell lines (RPMI8226, U266). Functionally, when
the miR-146a-enriched MM-BMSC-EVs was added to
the NK cell-MM cell co-culture system, RPMI8226
become less sensitive to NK cell killing compared
with adding the Normal-BMSC-EVs.
Summary/conclusion: These results indicated that
MM-BMSC-EVs, including miR-146a, may function
as immune regulator to inhibit NK cell function against
tumours, therefore providing a new therapeutic target
for tumour treatment.
LBF01.09
Exosomal long noncoding RNA NBR2 facilitates the
immunosuppression of MDSCs by enhancing the phosphorylation of
signal transducers and activators of transcription 3
Xinyu Tiana and lI Zhiyangb
aNanjing Drum Tower Hospital & the affiliated Hospital of Nanjing
University Medical School, Nanjing, China (People’s Republic); bNanjing
Drum Tower Hospital Clinical College, Nanjing, China (People’s Republic)
Introduction: The immunosuppression induced by
myeloid-derived suppressor cells (MDSCs) plays a cru-
cial role in tumour escape. And long noncoding RNA
(lncRNA) has been indicated as a core regulator of
tumour immunity. However, the effect and regulatory
mechanism of lncRNA on the immunosuppressive
function of MDSCs remain unclear. Exosomes are
cell-derived vesicles which are present in high abun-
dance in the tumour microenvironment where they
transfer information between cells.
Methods: Ultracentrifugation was used to isolate exo-
somes from cancer cells. MDSCs and T cells were
sorted from the spleen of tumour-bearing mice and
wild type mice, respectively, with immunomagnetic
beads. CFSE was performed to estimate the influence
of MDSCs on the proliferation of T cells. And real-time
fluorescence quantification PCR (qRT-PCR) was used
to detect the expression of lncRNA NBR2, while wes-
tern-blot was used to confirm the phosphorylation of
signal transducers and activators of transcription 3
(STAT3).
Results: Herein, we found that tumour-derived exo-
somes (TEXs) could enhance the development and
immunosuppression of MDSCs. Furthermore, it was
indicated that the regulation of TEXs to the develop-
ment and immunosuppression of MDSCs depending
on the transportation of lncRNA NBR2 from cancer
cells to MDSCs. Besides that, lncRNA NBR2 conveyed
by TEXs induced the development and suppressive
function of MDSCs by interacting with STAT3 and
enhancing its phosphorylation.
Summary/conclusion: Thus, this present study indi-
cates that exosomal lncRNA NBR2 can increase the
immunosuppression of MDSCs by regulating the phos-
phorylation of STAT3, which will provide sufficient
scientific basis for the immunotherapy of cancer.
LBF01.10
In vivo imaging of natural killer cells labelled with fluorophore-
loaded extracellular vesicle mimetics
Hye Sun Parka, Gyeongyun Gob, Yong Song Ghob and Kwan Soo Hongc
aKorea Basic Science Institute, Cheongju-si, Republic of Korea; bDepartment
of Life Sciences, Pohang University of Science and Technology, Pohang,
Republic of Korea; cBioimaging Research Team, Korea Basic Science
Institute, Cheongju, Republic of Korea
Introduction: In the field of cancer immunotherapy,
in-vivo biodistribution of immunotherapeutic moiety
has emerged as important issue as well as its therapeu-
tic efficacy. This is because it plays an important role in
assessing the pharmacokinetic aspects associated with
the bio-toxicity of the immunotherapeutic moieties
injected in vivo and evaluating the therapeutic effects
associated with homing to lesion sites. Natural killer
(NK) cells have non-specific antitumour activity, and
have been employed to treat tumours. Unlike other
immune cells, NK cells cannot perform phagocytosis
sufficiently, so it is difficult to label NK cells with
imaging materials such as nanoparticles. Difficulty in
labelling NK cells makes it difficult to validate the
distribution and antitumour activity of NK cells in
vivo.
Methods: In this study, we tried to develop NK cell
labelling technology using exosome mimetics, based on
the fact that exosome mimetics can deliver their cargos
to target cells via receptor-mediated endocytosis. We
analysed cell adhesion molecules that were overex-
pressed in NK cells and produced the cell line that
overexpress them using cell transformation techniques.
We also labelled NK cells with exosome-mimetic nano-
vesicles loaded with magnetic nanoparticles and fluor-
ophores, and evaluated biomedical imaging and
therapeutic effects of the NK cells using mouse tumour
models.
Results: We analysed cell adhesion molecules
expressed in NK cells and constructed cell lines that
overexpress counter receptors. We succeeded in label-
ling NK cells with a fluorophore-loaded exosome
mimetics and also quantitatively evaluated the
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biomedical imaging and therapeutic effects of the
labelled NK cells.
Summary/conclusion: We produced and characterized
NK cell-targeting exosome-mimetic nanovesicles.
Exosome mimetics-based cell labelling technology
developed in this study will overcome the limitations
of current technology and can be widely applied to in
vivo image-tracking of immune cells in cancer
immunotherapy.
LBF01.11
Comparison of MMP-13-containing extracellular vesicles with
metastatic ability in human osteosarcoma cells
Ryo Sasakia, Mitsuhiko Osakib and Futoshi Okadab
aDivision of Pathological Biochemistry, Department of Biomedical Sciences,
Faculty of Medicine, Tottori University, Yonago, Japan; bDivision of
Pathological Biochemistry, Department of Biomedical Sciences, Faculty of
Medicine, Tottori University, Yonago, Japan
Introduction: Osteosarcoma commonly develops from
bone and mainly affects children and adolescents.
Although therapy for primary osteosarcoma, such as
adjuvant chemotherapy combined with surgical wide
resection, is being improved, 30–40% of osteosarcoma
patients die of lung metastasis. Therefore, it is impor-
tant to elucidate the mechanism of lung metastasis to
establish specific new therapies based on the mechan-
ism. We previously reported that the down-regulation
of miR-143 promotes cellular invasion of 143B cells, a
human osteosarcoma cell line, and that intravenous
injection of miR-143 significantly suppresses lung
metastasis of osteosarcoma cells in mice. In addition,
matrix metalloproteinase-13 (MMP-13) was identified
as one of the miR-143 target genes, and knockdown of
MMP-13 was able to suppress the invasion of 143B
(metastatic osteosarcoma cell line) cells in vitro.
Methods: These data motivated us to examine whether
MMP-13 concentration in extracellular vesicles (EVs)
secreted by 143B was higher than in that secreted by
HOS (non-metastatic cell line). In this study, we exam-
ined the number of secreted EVs and MMP-13 con-
centration in the EVs of two human osteosarcoma cell
lines-143B and HOS.
Results: The number of EVs secreted by 143B was four
times higher than those secreted by HOS. Moreover,
Western blot analysis revealed that MMP-13 concen-
tration per 3 µg of EVs was increased 2.5 times in EVs
derived from 143B in comparison to those derived
from HOS.
Summary/conclusion: These data suggest that the
number of secreted EVs and/or the concentration of
MMP-13 in EVs play an important role in the meta-
static ability of human osteosarcoma cells.
LBF01.13
Exosomal long noncoding RNA NBR2 induces the autophagy of lung
cancer cells by interacting with high-mobility group box 1
Ting Wanga and Xinyu Tianb
aJiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The
Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China
(People’s Republic); bNanjing Drum Tower Hospital, Nanjing, China
(People’s Republic)
Introduction: Lung cancer has become the leading
cause of disease-related death worldwide. It has been
confirmed that high-mobility group box 1 (HMGB1) is
closely correlated with the progression of lung cancer.
However, it still remains unclear about the accurate
mechanisms of regulating the expression and secretion
of HMGB1 in lung cancer cells. Exosomes are cell-
derived vesicles which are present in high abundance
in the tumour microenvironment where they transfer
information between cells.
Methods: Exosomes from cultivate supernatant of lung
cancer cells were isolated with ultracentrifugation.
Western-blot and immunofluorescence were per-
formed to confirm the expression of HMGB1 in lung
cancer cells, and ELISA was used to detect the secreted
HMGB1. The expression of long noncoding RNA
(lncRNA) NBR2 was detected with real-time fluores-
cence quantitative fluorescence (qRT-PCR). Western-
blot and transmission electron microscope were used
to make sure the autophagy of lung cancer cells.
Results: Herein, we demonstrated that exosomes from
lung cancer cells could promote the both the expres-
sion and secretion of HMGB1, and therefore induce
the autophagy of lung cancer cells. Besides that, it was
also demonstrated that exosomes from lung cancer
cells promoted the expression and release of HMGB1
by conveying lncRNA NBR2 which could interact with
HMGB1 protein and enhance its stability. Moreover,
high level of HMGB1 facilitated the autophagy of lung
cancer cells via activating RAGE-Erk1/2 pathway, and
accelerated the progression of lung cancer.
Summary/conclusion: Taken together, our study indi-
cates that exosomal lncRNA NBR2 induces the autop-
hagy of lung cancer cells and accelerates the tumour
progression by interacting with HMGB1.
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Morphology of tissue disruption at the sites of high-grade tumour
Mousumi Chaudhury
GIM foundation, Little Rock, USA
Introduction: Invasive cancers originating from diverse
organs like breast, ovary and lung metastasize to distant
sites. However, the structural changes at the primary site of
these high-grade tumours have not been well character-
ized. In this observational study using images of hematox-
ylin-eosin stained human tumour tissues, it is reported that
intriguingly, the morphology of the tissues at the meta-
static front or at the primary site appears similar, irrespec-
tive of the organ of origin of the primary tumour. These
structures appear as a bulb-like projection, emanating
from the tumour cell membrane. Mostly, they appear
similar as a ball and stick bulge. Although structures are
not exactly similar in their dimension, there is a conserved
bulb like morphological protrusion in all tumours. Earlier
studies have described in in vitro or mouse models of
similar structures as invadopodia, invadosome or podo-
some, but their morphology has not been well character-
ized and examined in detail.
Methods: Web pathology website of H&E-stained
human tumour slides were used. Cases have been
studied based on the H&E-stained slides and on their
diagnosis available for each case. Each organ and tissue
specific tumours were selected after systematically
browsing all seminars. Control cases were chosen
based on their diagnosis notes as non-invasive benign
tumour condition. In this study, image J was used for
its different potentials. It was used to prepare the
figures to show boundary, measure the perimeter, mak-
ing efficient colour contrast figures.
Results: The preliminary observations reported in this
study suggest that there may be excessive force acting
in the periphery of the cell, which likely leads to this
cytosol enclosed membrane protrusions, likely to con-
tain the nuclei. Some of these protrusions have nuclei
and others do not. Also, there is clear evidence of
enhanced membrane synthesis in high-grade tumour
tissues.
Summary/conclusion: This study suggests that there is
a possible final common pathway of mechanical force
generation, likely via cytoskeleton remodelling, which
may arise irrespective of organ-specific genomic mod-
ulation related to the primary disease process. These
observations provide visual evidence of epithelial-
mesenchymal transition during tumour metastasis.
Funding: none
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Type-2 transglutaminase affects calcium homeostasis in neurons and
is released in association with astrocytes-derived exosomes
Elisa Tonolia, Ilaria Pradab, Claudia Verderioc and Elisabetta Verderioa
aNottingham Trent University, Nottingham, United Kingdom; bCNR
Institute of Neuroscience, Milan, Italy., Milan, Italy; cCNR Institute of
Neuroscience, Milan, Italy, Milan, Italy
Introduction: Type-2 transglutaminase (TG2) has been
linked to calcium (Ca2+) dysregulation in conditions
such as neurodegeneration. Recent evidences suggest
that extracellular vesicles (EVs) contribute to the onset
and progression of neurological diseases, and we have
recently shown that TG2 is a cargo of EVs in biological
fluids. Here, we hypothesise that TG2 could be released
by EVs, interact with neurons and affect neuronal Ca2
+ homeostasis.
Methods: Primary hippocampal neurons were estab-
lished from E18 rat embryos. Extracellular TG2 was
modulated in neurons either by lipofectamine transfec-
tion of a TG2-EGFP construct or by addition of pur-
ified TG2. Intracellular Ca2+ concentration ([Ca2+]i)
was assessed by live imaging in fura-2/AM-loaded neu-
rons. EVs were isolated from primary astrocytes (60
DIV) by serial centrifugation, characterized by Western
blotting (flotillin-2 and alix) and nanoparticle tracking
analysis (ZetaView). Experiments to assess TG2 influ-
ence on exosomes-to-neural cells interactions, using a
Renilla sensor based on miR-146a-5p-transfer, are still
ongoing.
Results: Increase of extracellular TG2 levels in neurons
induced an influx of extracellular Ca2+ ions, leading to
a significant raise in basal [Ca2+]i both in normal
conditions (ΔF340/380 = 0.126 ± 0.014; N = 23;
p < 10–5) and with inhibited synaptic transmission
(tetrodotoxin) (ΔF340/380 = 0.058 ± 0.005; N = 33;
p < 10–5). Nifedipine, a blocker of L-type voltage-oper-
ated Ca2+ channels (VOCCs), partially prevented TG2-
dependent Ca2+ response (average inhibition 36%;
N = 21; p < 10–5), suggesting that Ca2+ influx may
occur through L-type VOCCs. To identify the source of
extracellular TG2, we analysed EVs isolated from rat
primary astrocytes, previously reported to release TG2
into the matrix especially in inflammatory conditions.
TG2 was detected in astrocytic exosomes (but not in
ectosomes) only upon LPS stimulus, and not in the
EVs-free medium, suggesting that TG2 is a cargo of
exosomes during neuroinflammation.
Summary/conclusion: TG2 is externalized through
astrocyte-derived exosomes upon neuroinflammatory
stimuli. Extracellular TG2 mediates the opening of L-
type VOCCs in neurons and sets basal [Ca2+]i at
higher levels, which could have a significant impact
on neuronal activity in neuroinflammation.
Funding: John Turland PhD bursary (NTU) and IBRO
travel fund.
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Plasma exosomes regulate proliferation and migration of vascular
smooth muscle cells
Kosuke Otania, Mai Yokoyab, Muneyoshi Okadac and Hideyuki Yamawakib
aLaboratory of Veterinary Pharmacology, School of Veterinary Medicine,
Kitasato University, Towada, Japan; bKitasato University, Towada, Japan;
cKitasato University, School of Veterinary Medicine, Laboratory of
Veterinary Pharmacology, Towada, Japan
Introduction: We previously reported that systolic
blood pressure in spontaneously hypertensive rats, an
animal model of essential hypertension, was partly
modulated by circulating exosomes (BBRC 2018).
Vascular wall remodelling regulated by proliferation
and migration of vascular smooth muscle cells
(VSMCs) mediates development of hypertension. We
aimed to clarify the effects of plasma exosomes derived
from SHR and control Wistar Kyoto Rats (WKY) on
proliferation and migration of VSMCs.
Methods: Exosomes were isolated from rat plasma by
an ultracentrifuge method, and identified through
measurement of particle size distribution by a tunable
resistance pulse sensing. For exploring exosome inter-
nalization in VSMCs, the isolated exosomes were
labelled with PKH67 dye and observed by a fluores-
cence microscopy. Proliferation and migration of
SMCs were determined by a bromodeoxyuridine incor-
poration and Boyden chamber assay, respectively.
Actin cytoskeleton was visualized by a rhodamine-
phalloidin staining. Expression of protein and
microRNA in exosomes was determined by Western
blotting and microarray, respectively.
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Results: There was no difference in size and concen-
tration of plasma exosomes between WKY and SHR.
Exosomes were incorporated into VSMCs, while the
internalization of SHR exosomes was significantly
lower than WKY exosomes. Both WKY and SHR exo-
somes similarly stimulated proliferation, migration and
cytoskeletal changes such as formation of filopodia and
lamellipodia in VSMCs. Heparin, an inhibitor of exo-
some internalization, completely blocked the migration
and proliferation. Protein expression of CD9 and
CD63, an exosomal marker, was significantly higher
in exosomes from WKY than SHR. The expression of
several microRNAs in SHR exosomes changed com-
pared with WKY exosomes.
Summary/conclusion: These results suggest that
plasma exosomes play physiological, but not patholo-
gical, role on VSMCs irrespective of their origin (nor-
motensive or hypertensive rats). Further research is
required for determining whether the changes in mole-
cular profiles of circulating exosomes mediate the
development of high blood pressure in SHR.
LBF02.03
Exosomes containing HIV protein Nef reorganize lipid rafts inducing
inflammatory responses of immune cells and increasing their
susceptibility to HIV infection
Dmitri Sviridova and Michael Bukrinskyb
aBaker Heart and Diabetes Institute, Melbourne, Australia; bGeorge
Washington University School of Medicine, Washington, USA
Introduction: HIV disease is associated with co-mor-
bidities, which persist even after successful application
of antiretroviral therapy. One important factor respon-
sible for these effects is exosomes containing the main
HIV pathogenic factor, Nef, which can be found in
blood of HIV subjects with undetectable HIV load. In
this study, we investigated the effect of Nef-containing
exosomes on uninfected macrophages and T cells.
Methods: Exosomes were purified by differential cen-
trifugation from HEK293 cells transfected with Nef-
expressing or empty vector, monocyte-derived human
macrophages infected with Nef-positive or Nef-defi-
cient HIV-1, or plasma of uninfected subjects or
patients infected with wild-type or Nef-deficient HIV-
1. Exosomes were adjusted by protein content and
added to cells at 0.2 ng/ml of Nef protein. Mice were
injected with Nef exosomes IP (2 μg per injection) 3
times a week for 2 weeks.
Results: Exosomes containing HIV protein Nef (exNef)
are internalized by macrophages altering cholesterol
metabolism and causing sharp increase in the abun-
dance of lipid rafts through reduced activation of small
GTPase Cdc42 and decreased actin polymerization.
ExNef increased susceptibility of MDM to fusion with
HIV. These changes resulted in activation of NLRP3
inflammasome and increased secretion of pro-inflam-
matory cytokines. The effects of exNef were reversed
by overexpression of a constitutively active mutant of
Cdc42. The findings were validated with exosomes
produced by HIV-infected cells and with exosomes
isolated from plasma of HIV-infected subjects, but
not from ΔNef-HIV-infected subjects. Mice injected
with exNef displayed altered cholesterol metabolism,
monocytosis, increased raft abundance and augmented
inflammation.
Summary/Conclusion: Nef containing exosomes
potentiate pro-inflammatory responses by impairing
cholesterol metabolism and reorganizing lipid rafts,
increasing cell susceptibility to HIV infection and con-
tributing to co-morbidities of HIV disease.
Funding: Grants from NIH (HL131473, AI055019),
American Heart Association (17GRNT33630163), and
NHMRC (GNT1036352).
LBF02.04
Exosomes derived from human mesenchymal stem cells ameliorates
autistic-like behaviours in BTBR and Shank3 mice models of autism
Nisim Peretsa, Ehud Maromb, Yona Geffenc, Uri Danond, Oded Orone, Evan
Eliote and Daniel Offenf
aSagol School of neuroscience, Tel Aviv University, Israel, Tel aviv, Israel;
bStem Cell Medicine LTD, Jerusalem, Israel., Jerusalem, Israel; cStem Cell-
Medicine LTD, Jerusalem, Israel., Jerusalem, USA; dStem Cell Medicine LTD,
Jerusalem, Israel, Jerusalem, Israel; eFaculty medicine, Bar-Ilan University,
Israel, Ramat Gan, Israel; fSagol School of neuroscience, Tel Aviv University,
Israel, Sacklar school of medicine, department of human genetics and bio-
chemistry Tel Aviv University, Israel., Tel Aviv, USA
Introduction: Autism spectrum disorders (ASD) are
neurodevelopmental disorders characterized by three
core symptoms that include severe impairment of
social interaction and communication skills, increased
repetitive behaviours and cognitive inflexibility. Rate of
ASD is steadily increasing in children over the past
several years, with no effective treatment.
Methods: BTBR and Shank3 are accepted mouse mod-
els used for evaluating autistic-like behaviours as it
presents all core symptoms and genetic human muta-
tion of ASD. We have previously shown that transplan-
tation of human bone marrow mesenchymal stem cells
(MSCs) to the lateral ventricles of BTBR mice results in
long lasting improvement in their autistic behavioural
phenotypes. Recent studies point of exosomes as the
main mediators of the therapeutic effect of MSCs.
Results: Here we show that intranasal administration
of exosomes derived from bone marrow or adipose
tissue MSCs, ameliorate autistic-like behaviour in
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BTBR and Shank3 mice. Including significant increase
of social interaction and ultrasonic vocalizations,
reduced repetitive behaviours and improve maternal
behaviours of pup retrieval. No negative safety symp-
toms were detected following exosomes intranasal
treatments in mice.
Summary/conclusion: The beneficial effects of the
exosomes treatment in mice models may be translated
to a novel, easy to administer, therapeutic strategy to
reduce the symptoms of ASD.
Funding: Partially by Stem Cell Medicine LTD and
Kamin
LBF02.05
The use of artificially produced bacterial vesicles as an
immunotherapeutic vaccine against Pseudomonas aeruginosa
pneumonia
Kyong-su Parka and Jan Lötvallb
aKrefting Research Centre, University of Gothenburg, Gothenburg, Sweden;
bKrefting Research Centre, Institute of Medicine at the Sahlgrenska Academy,
University of Gothenburg, Göteborg, Sweden, Gothenburg, Sweden
Introduction: Pseudomonas aeruginosa is an opportu-
nistic pathogen which is involved in pneumonia and
cystic fibrosis. Immunization with outer membrane
vesicles (OMVs), which has naturally budded off
from bacteria, is an evolving field in infectious diseases
due to their highly immunogenic properties. However,
OMVs are difficult to produce naturally in large quan-
tities with high purity. This study aims to develop an
artificial OMVs (aOMVs) isolation method, and to
investigate the protective effects of aOMVs against P.
aeruginosa-induced pneumonia.
Methods: Outer membranes were obtained from P.
aeruginosa by lysozyme and detergent treatment, fol-
lowed by ionic stress and applied mild energy to gen-
erate aOMVs. The yield and purity of aOMVs were
analysed by nanoparticle tracking analysis and trans-
mission electron microscopy. The protein and RNA
contents were examined by label-free quantitative
mass spectrometry and bioanalyzer. Inflammation was
evaluated in lung macrophages by measuring cytokine
release. Naturally produced OMVs or aOMVs were
weekly injected in mice for 3 weeks, and then blood
and spleen were obtained for antibody titer and sple-
nocyte cytokine study. Lung inflammation by P. aeru-
ginosa challenge was assessed in H&E stained lungs.
Results: The aOMVs were isolated in higher yield
(fivefold) compared to OMVs. They had similar sphe-
rical shape and size as OMVs, but had better purity.
Outer membrane components were more enriched in
aOMVs, and cytosolic protein and RNA contents were
almost completely removed. Especially, aOMVs were
observed to induce less inflammation in macrophages
compared to OMVs. In addition, immunization with
aOMVs induced strong IgG antibody response to the
bacterial proteins, and a greater increase in IFN-
gamma from CD4+ T cells compared to OMVs.
Moreover, aOMV-immunized mice showed dramati-
cally reduced lung inflammation caused by bacterial
challenge.
Summary/conclusion: This study shows that aOMVs
can be produced in a large amount with high purity,
and have protective effect against P. aeruginosa-
induced pneumonia through a balanced humoral and
cellular immune response, suggesting that aOMVs may
be novel bacterial vesicle-mimetics to clinically applic-
able to infectious diseases.
Funding: This work was supported by Swedish Heart-
Lung Foundation (20150588).
LBF02.06
Herpesvirus infection of infant tonsil mucosal epithelia containing
intravesicular Human Immunodeficiency Virus induces release of HIV
from epithelial cells
Rossana Herrera, Kristina Rose and Sharof M. Tugizov
University of California San Francisco, San Francisco, USA
Introduction: Mother-to-child transmission (MTCT)
of HIV is an important pathway for the spread of the
virus from mother to child; however, the molecular
mechanisms of HIV MTCT are poorly understood.
Our recent work showed that >90% of virions inter-
nalized into polarized infant tonsil epithelium were
sequestered, that is, trapped in the endosomes, includ-
ing multivesicular bodies (MVBs) and vacuoles of
epithelial cells, for up to 9 days. The primary goal of
this work was to investigate the role of common oral
viral pathogens herpes simplex virus-1 (HSV-1),
human cytomegalovirus (HCMV), and Epstein-Barr
virus (EBV) in the release of endosomal HIV, which
may play a role in HIV MTCT.
Methods: Polarized tonsil epithelial cells were incu-
bated with HIV-1. After 4 h, the extracellular virus
was removed, and cells were maintained for 3 days.
Cells were then infected with HSV-1, HCMV, and
EBV. AP and BL medium was independently collected
after herpesvirus infection and HIV release was exam-
ined by p24 ELISA assay.
Results: Our data showed that the infection of HSV-1,
HCMV and EBV in tonsil epithelial cells containing
intravesicular HIV-1 led to the release of HIV virions,
which were infectious for peripheral blood mononuc-
lear cells. HIV release was correlated with the reduction
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of TER in HSV-1-, HCMV- and EBV-infected polar-
ized epithelial cells; that is, herpesvirus-induced depo-
larization of epithelial cells was critical for HIV release.
HSV-1 and HCMV infection in tonsil epithelial cells
substantially increased the expression of GTPases
Rab27a and Rab27b, which may regulate the movement
of MVBs and vacuoles to the plasma membrane and
their fusion with the epithelial cell membrane.
Summary/conclusion: HSV-1- and HCMV-induced
activation of Rab27a and Rab27b in epithelial cells
containing intravesicular HIV may promote virus
release, that is, exocytosis of virions. HSV-1-, HCMV-
and EBV-induced depolarization of tonsil epithelial
cells also may play critical in the release of endosomal
HIV. Herpesvirus interaction with infant tonsil epithe-
lial cells containing HIV may lead to the release and
spread of HIV into CD4+T lymphocytes, macrophages
and Langerhans/dendritic cells, leading to HIV MTCT.
Funding: R01DE028129, NATIONAL INSTITUTE OF
DENTAL & CRANIOFACIAL RESEARCH
LBF02.07
Syntenin regulates Hepatitis C virus sensitivity to neutralizing
antibody by promoting E2 secretion through exosomes
Libin Deng and Gang Long
Institut Pasteur of Shanghai, Shanghai, China (People’s Republic)
Introduction: Hepatitis C virus (HCV) is a major
cause of chronic liver disease, infecting approximately
71 million people worldwide. Assembly of infectious
HCV particles involves host lipoproteins, giving rise to
unique lipo-viro-particles (LVPs), but proteome studies
suggest that additional cellular proteins are associated
with HCV virions or other particles containing the
viral envelope glycoprotein E2. Many of these host
cell proteins are common markers of exosomes, most
notably the intracellular adaptor protein syntenin
required exosome biogenesis. These observations sug-
gest that E2 might be a component of both LVPs and
exosomes produced from HCV infected cells.
Methods: Using HCVcc in both hepatoma cells and
primary human hepatocytes (PHHs), we studied bio-
genesis and function of E2-coated exosomes.
Results: Knockout of syntenin had negligible impact
on HCV replication and virus production whereas
ectopic expression of syntenin at physiological level
reduced intracellular E2 abundance concomitant with
increased secretion of E2-coated exosomes.
Importantly, cells expressing syntenin and HCV struc-
tural proteins efficiently released exosomes containing
E2 but lacking the core protein. Furthermore,
infectivity of HCV released from syntenin expressing
hepatoma cell and PHHs was more resistant to neu-
tralization by E2-specific antibodies and chronic-phase
patient serum. Last, high E2/syntenin levels in sera
correlates to lower serum neutralization capability.
Summary/conclusion: E2- and syntenin-containing
exosomes is a major type of particles released from
cells high expressing syntenin. Efficient production of
E2-coated exosomes in hepatoma cells and PHHs ren-
ders HCV infectivity less susceptible to antibody
neutralization.
Funding: This work was supported by from the strate-
gic priority research program of the Chinese Academy
of Sciences (XDB29010000), the National Science and
Technology Major Project of the Ministry of Science
and Technology of China (2015CB554300 and
2016YFC1200400) and the National Nature Science
Foundation of China (81761138046). Work by R.B.
was supported by the Deutsche
Forschungsgemeinschaft, collaborative research center
(TRR) 179, TP9.
LBF02.08
Lipidomics profiles of plasma microvesicles differ in experimental
cerebral malaria, compared to malaria without neurological
complications
Amani M. Batarseha, Elham Hosseini-Beheshtib, Alex Chenc, Amy Cohenb,
Annette Juillardd, Michael Marianie and Georges Graub
aBCAL Dx, Eveleigh, NSW, Australia 2015, Eveleigh, Australia; bVascular
Immunology Unit, Faculty of Medicine & Health, University of Sydney,
Camperdown, NSW, Australia 2050, Camperdown, Australia; cThermo
Fisher Scientific, Scoresby, VIC, Australia 3179, Scoresby, Australia;
dVascular Immunology Unit, Faculty of Medicine & Health, University of
Sydney, Camperdown, NSW, Australia 2050, Sydney, Australia; eThermo
Fisher Scientific, North Ryde, NSW, Australia 2113, North Ryde, Australia
Introduction: Cerebral malaria (CM), a fatal complica-
tion of Plasmodium infection affecting children in sub-
Saharan Africa and adults in South-East Asia, results
from incompletely understood pathogenetic mechan-
isms, which include sequestration of infected erythro-
cytes, cytokine overproduction, accumulation of
inflammatory cells, and excessive release of microvesi-
cles (MV). Plasma MV levels are elevated in CM
patients and in the experimental mouse model. Here,
MV lipidomics profile was studied in relation to the
development of cerebral complications.
Methods: Plasma MV was enriched using differential
centrifugation (El-Assaad 2014). Lipids were extracted
according to Matyash et al. (2008), loaded on a C30
Acclaim column using a Vanquish liquid chromatogra-
phy (LC) system and analysed using a Fusion mass
spectrometer (MS). LipidSearch software was used for
lipid species annotation and quantification.
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Results: We compared lipid profiles in circulating MV
purified from CBA mice with P. berghei ANKA (PbA),
which causes CM, to those from P. yoelii (Py), which
does not. Plasma MV produced at the time of CM
dramatically differed from those from non-CM mice,
in spite of identical levels of parasitaemia: using high-
resolution LCMS, we identified over 200 lipid species
within 12 lipid classes. Total phosphatidylethanolamine
(PE) levels were significantly higher in MV from PbA
mice compared to those from uninfected control and
Py. Using fragmentation MS, we identified that this PE
increase is due at least in part to PE (16:0_22:6), PE
(18:0_22:6) and PE (18:1_22:6) species identified in
PbA vs Py and uninfected control. Total phosphatidyl-
serine (PS) was significantly higher in both PbA and Py
compared to uninfected control. Conversely total lyso-
phosphatidylcholine (LPC) and lysophosphatidyletha-
nolamine (LPE) were significantly lower in PbA
compared to uninfected mice, while they were
unchanged in Py MV.
Summary/conclusion: These results suggest, for the
time, that experimental CM is characterized by specific
changes in lipid composition of circulating MV, point-
ing towards PE subsets, LPC and LPE as potential
important players in CM pathogenesis.
Funding: NHMRC Project grant APP1099920 to GG.
LBF02.09
Compound extracted from cinnamomum osmophloeum leaves
reduced exosomes release from hepG2 cells
Wei-chi Kua, Shu-yu Yangb, Jen Ying Lib and Meng-Jen Leec
aFu Jen Catholic University, New Taipei, USA; bTsu-chi Hospital, Taichung,
Taiwan (Republic of China); cDepartment of applied chemistry,
Taichung, USA
Introduction: Cinnamomum osmophloeum belongs to
the genus of Cinnamon, the same genus as the species
used for commercially sold cinnamon. Compounds of
the extracted Cinnamomum osmophloeum leaves have
good potential to be developed into new drugs.
Further, usage of the leaves of the tree is much more
sustainable and cost effective than the bark. ABL006 is
a major compound isolated from Cinnamomum
osmophloeum that previously known for insulin
mimetick effect. For fear of side effect of pro-inflam-
matory effect to the central nervous system, we tested
using proteomic approach to study differential protein
expression after ABL006 treatment in astrocytic cells.
Methods: We used dimethyl labelling on the peptide
level and LC-MS/MS to select differentially expressed
proteins. The selection criterion was based on
significant up- or down-regulation in both biological
samples.
Results: We were able to quantitate 13,013 peptides,
which corresponds to 1264 proteins from two biologi-
cal replicates. Thirty-two differentially expressed pro-
teins were shortlisted, among them some are nuclear
protein and protein relevant to lipid metabolism.
Further pursuing this, we treat hepG2 with ABL006,
and study the differential protein expression in the
conditioned medium, hoping to understand further
the lipid regulating action of ABL006. The differentially
expressed proteins between treated and non-treated
were short-listed to 33 proteins. These proteins were
checked against the 100 top expressing proteins
secreted by the exosomes (Exocarta, http://exocarta.
org/index.html). Out of 33 most significantly regulated
proteins, 8 were exosomal markers, and almost all were
down-regulated upon ABL006 treatment.
Summary/conclusion: This suggested that exosomes
release from hepG2 is reduced upon ABL006
treatment.
Funding: MOST 107-2632-B-324-001.
LBF02.10
Placental cells function as environmental sensors that respond to
changes in the extracellular milieu via extracellular vesicles
Carlos Palmaa and Carlos Salomonb
aExosome Biology Laboratory, Centre for Clinical Diagnostics, University of
Queensland Centre for Clinical Research, Royal Brisbane and Women’s
Hospital, The University of Queensland, Brisbane QLD 4029, Australia,
Brisbane, Australia; bExosome Biology Laboratory, Centre for Clinical
Diagnostics, University of Queensland Centre for Clinical Research, Royal
Brisbane and Women’s Hospital, The University of Queensland, Brisbane
QLD 4029, Australia., Brisbane, Australia
Introduction: Placenta-derived extracellular vesicles
(PdEVs) are present in maternal circulation as early
as 6 weeks of gestation. Changes in the concentration
of PdEVs are found in gestational diabetes, preeclamp-
sia and preterm birth. The aim of this study was to
characterize the release and biogenesis of EVs from
placental cells in response to extracellular glucose,
insulin, lipopolysaccharide (LPS) and tumour necrosis
factor a (TNF-a) in vitro.
Methods: Bewo cells were used as a placental model.
Cells were incubated with forskolin for 24 h to stimu-
late syncytium formation in vitro. After syncytializa-
tion, cells were incubated in the presence of forskolin
with D-glucose (5 mM or 25 mM), insulin (1 nM), LPS
(0–10 μg/ml) and TNF-a (0–20 ng/ml) for 48 h. EVs
were isolated from cell-conditioned media by differen-
tial centrifugation and characterized by their size dis-
tribution, protein abundance and morphology using
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nanoparticle tracking analysis, Western blot and elec-
tron microscopy, respectively. The effect of the extra-
cellular milieu on the release of PdEVs was evaluated in
four different subpopulations according to size; <50,
50–150, 150–200 and >200 nm.
Results: Differential changes in the release of PdEVs
subpopulations in response to glucose, insulin, LPS and
TNF-a were observed. High glucose induced the release
of EVs <50 nm, and >200 nm although this effect was
abolished by insulin. High glucose and insulin
decreased the release of EVs 150–200 nm and EVs
50–150 nm, respectively. The effect of LPS on the
release of PdEVs was size-dependent with the greatest
effect on EVs of >200 nm. Finally, TNF-a increased the
release of EVs in size and concentration-dependent
manner with a maximum effect on EVs >200 nm and
2 ng/ml. Changes in the release of exosomes were
associated with a differential abundance of proteins
associated with ESCRT machinery.
Summary/conclusion: The effect of the extracellular
milieu on PdEVs release may be recapitulated and is
of clinical relevance in vivo in association with hyper-
glycaemia (glucose and insulin), infection (LPS) and
inflammatory (TNF-a) conditions.
Funding: Lions Medical Research Foundation,
National Health and Medical Research Council
(NHMRC; 1114013), Fondo Nacional de Desarrollo
Científico y Tecnológico (FONDECYT 1170809), and
CONICYT PFCHA/DOCTORADO BECAS CHILE/
2018-72190513
LBF02.11
Association of cytokines with circulating populations of extracellular
vesicles at early gestation
Katherin Scholz-Romeroa, Andrew Laia, Carlos Palmaa, Gregory Duncombea,
Gregory Ricea and Carlos Salomonb
aExosome Biology Laboratory, Centre for Clinical Diagnostics, University of
Queensland Centre for Clinical Research, Royal Brisbane and Women’s
Hospital, The University of Queensland, Brisbane QLD 4029, Australia,
Brisbane, Australia; bExosome Biology Laboratory, Centre for Clinical
Diagnostics, University of Queensland Centre for Clinical Research, Royal
Brisbane and Women’s Hospital, The University of Queensland, Brisbane
QLD 4029, Australia., Brisbane, Australia
Introduction: Cytokines have several roles across
gestation, including implantation, placentation and
immune response, which are all essential for the con-
tinuation of pregnancy. The aim of this study was to
isolate and characterize different populations of extra-
cellular vesicles (EVs) from maternal plasma at the first
trimester of pregnancy, and quantify the levels of inter-
leukin 10 (IL-10), 6 (IL-6), Interferon gamma (IFN-γ),
and tumour necrosis factor a (TNF-a), associated
with EVs.
Methods: Plasma samples were collected from preg-
nant women during the first trimester of pregnancy
(n = 10). EVs were isolated through differential centri-
fugation, at 2000g for 30 min (pellet 1); 12,000g for
45 min (pellet 2) and at 100,000g for 120 min (pellet 3).
The supernatant after the last centrifugation was
termed “soluble fractions”. EVs were characterized by
size distribution, abundance of proteins associated with
EVs (i.e. CD63, Flotilin-1 and TSG101), negative con-
trol for Grp94, and morphology, according to the
recommendations of the International Society of
Extracellular Vesicles, using Nanoparticle Tracking
Analysis (NTA), Western blot analysis and electron
microscopy, respectively. The concentration of IL-10,
IL-6, IFN-γ and TNF-a in the EVs and the soluble
fractions were established by cytokine array analysis
(Bioplex-200).
Results: Specific changes in the levels of cytokines, in
the different population of vesicles, and in the soluble
fractions were identified. The levels of IL-10, IL-6, IFN-
γ and TNF-a were significantly higher (p < .05) in the
exosome fraction (pellet 3) compared to the values
observed in pellet 1 and pellet 2 (macro and micro-
vesicles fractions). The levels of IL-10, IFN-γ and TNF-
a were significantly higher (p < .05) in the soluble
fractions compared with the exosomal fraction. No
significant difference in the level of IL-6 in the exoso-
mal and soluble fraction was observed.
Summary/conclusion: This study established that cyto-
kines are packaged within EVs (in which these mole-
cules are protected), suggesting a novel mechanism of
action through which cytokines via EVs can lead to
distal interactions.
Funding: Lions Medical Research Foundation,
National Health and Medical Research Council
(NHMRC; 1114013), and Fondo Nacional de
Desarrollo Científico y Tecnológico (FONDECYT
1170809).
LBF02.12
Mesenchymal stem cell-derived exosomes attenuate inflammation
and protect ischemic neuronal damage
May-Jywan Tsaia, Dann-Ying Lioub and Henrich Chengb
aNeurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan
(Republic of China); bNeurological Institute, Taipei Veterans General
Hospital, Taiwan, Taipei, Taiwan (Republic of China)
Introduction: Bone marrow mesenchymal stem cells
(BM-MSC) are the most extensively used stem cells in
tissue engineering due to their easy access, rapid ex
vivo expansion and poor immunogenicity. MSCs
secrete various factors that can modulate a hostile
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environment, which is called the paracrine effect.
MSCs have a strong capacity for secretion of exosomes
which are suspected to participate in paracrine cellular
communication.
Methods: We compare the effects of BM-MSC condi-
tioned medium (MSCcm) and MSC-derived exosomes
(MSCexo) in neuron-glial cultures as well as in spinal
cord injured (SCI) rat model.
Results: We found that both MSCcm and MSCexo
were effective in reducing LPS stimulation and oxygen
glucose deprivation, an in vitro stroke model, damage
in neuron-glial cultures. Further comparison of the
beneficial effects of MSCcm and MSCexo will be con-
ducted in in vivo SCI rats via vascular administration.
Summary/conclusion: This cell-free therapy, avoiding
the risks associated with direct MSC transplantation,
may improve nerve regrowth and functional recovery
after SCI.
Funding: Research grant (V107C-087) from the Taipei
Veterans General Hospital in Taiwan, and grants (106-
2314-B-075-023 & 107-2314-B-075-021) from the
Ministry of Science and Technology in Taiwan.
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OF19.01
Distinct extracellular RNA cargo types associate with specific vesicular
and non-vesicular RNA carriers across human biofluids
Aleksandar Milosavljevic
Department of Molecular and Human Genetics, Baylor College of Medicine,
Houston, USA
Introduction: The Extracellular RNA Communication
Consortium (ERCC) has developed the ExRNA Atlas, a
reference catalogue of exRNAs present in human bio-
fluids. A computational deconvolution analysis identi-
fied six RNA cargo types (CT1, CT2, CT3A, CT3B,
CT3C, CT4) present across human biofluids repre-
sented within the Atlas. Extensive experimental ana-
lyses by the ERCC show association of these cargo
types with specific vesicular and non-vesicular (lipo-
protein, RNP particle) carriers.
Methods: To identify carriers for the six CTs, we
performed: cushioned density gradient ultracentrifuga-
tion of serum and plasma using the OptiPrep density
gradient, RNA-seq, western blot and mass spectrome-
try analysis of the density fractions; RNA-seq profiling
of ultracentrifugation products, of size fractionation
using nanoscale deterministic lateral displacement
(nano-DLD) arrays; of lipoprotein fractions; and of
AGO-1 immuno-pulldowns. We also carried out
RNA-seq of a shared pool of human plasma and
serum samples processed using 10 widely used RNA
isolation methods.
Results: CT1 correlates with RNA-seq profiles of car-
riers of exosomal size and density (OptiPrep fractions
4–7 that are CD9 and Flotillin positive). CT2 correlates
with the exRNA profiles of lipoprotein carriers (HDL,
LDL, VLDL, Chylomicron); the carrier shows HDL
density (OptiPrep fractions 9–12) and is APOA1 posi-
tive. CT3A and B show high miRNA content and
correlate with RNA-seq profiles of AGO2 immuno-
pulldowns. CT4 correlates with the RNA-seq profiles
of both low-density vesicles (OptiPrep fractions 1-3)
and HMC-1 cell-line derived vesicles of higher-density.
The 10 widely used commercial RNA isolation kits
show distinct preferences for specific CT subsets. On
average, across all kits, CT4 was captured at highest
and CT3B at second-highest relative abundance.
Summary/Conclusion: The heterogeneity of exRNA
cargo types exceeds the capabilities of current experi-
mental methods to reproducibly isolate defined carrier
subpopulations from human biofluids. While this pro-
blem calls for the development of new carrier isolation
methods, we have now demonstrated the power of
computational deconvolution to complement and
enhance current isolation methods and have created
the first comprehensive survey of exRNA cargo types
and their carriers in human biofluids.
Funding: Common Fund of the NIH (5U54
DA036134).
OF19.02
Heparan sulphate glycosaminoglycans on the extracellular vesicle
surface bind a variety of proteins
Sara Veigaa, Alex Shepharda, Alex Cocksa, Aled Claytona and Jason Webberb
aTissue Microenvironment Group, Division of Cancer and Genetics, School
of Medicine, Cardiff University, Cardiff, UK; bCardiff University, Cardiff, UK
Introduction: Cancers develop in complex tissue
environments, comprising multiple cell types that con-
tribute to tumour growth, invasion and metastasis. Our
group has previously demonstrated that prostate cancer
derived EVs mediate the delivery of TGFβ, via heparan
sulphate (HS) glycosaminoglycans on the EV surface
and stimulate fibroblast to myofibroblast differentia-
tion. Given the potential capacity for HS to bind
other “soluble” factors we have herein explored the
repertoire of proteins associated vesicular HS.
Methods: EVs were isolated from DU145 prostate can-
cer cells by differential centrifugation followed by
ultra-centrifugation on a sucrose cushion and washed
with PBS. Specific removal of Heparan sulphate side
chains from the vesicle was performed by enzymatic
digestion using heparinase III (HEPIII). Differences in
proteins with vs. without digestion were identified by a
sensitive multiplex proximity extension assay and select
targets validated by ELISA.
Results: Protein profiles identified approximately 60
factors that were significantly differentially expressed
on control versus HS-deficient EV’s. Some but not all
of these have been previously identified as HS-asso-
ciated factors. Gene ontology analysis points to
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functional relationships with angiogenesis, invasion
and immune regulation. Using ELISA, we have been
able to quantify six selected candidates on wild type
vesicles, some of these are lost following HS-digestion.
We went on to examine functional consequences of
HS-deficiency in relation to cell-uptake, and angiogenic
responses.
Summary/Conclusion: These data demonstrate a
diverse repertoire of proteins that are bound to the
surface of exosomes via HS glycosaminoglycans. We
anticipate that removal of EV-associated HS will result
in attenuated delivery of multiple factors to recipient
cells, and this will have major implications on EV
functions and their ability to modulate tissue
environments.
Funding: Cancer Research Wales.
OF19.03
Membrane lipid saturation modifies the lipid signature of
extracellular vesicles released by HuH7 hepatocarcinoma cells
Eva Costanzia, Yuta Shimanakab, Lorena Urbanellic, Krizia Saginic, Stefano
Giovagnolid, Hiroyuki Araie, Carla Emilianic and Sandra Burattac
aDepartment of Chemistry, Biology and Biotechnology (University of
Perugia), Foligno, Italy; bGraduate School of Pharmaceutical Sciences
(University of Tokyo), Tokyo, Japan; cDepartment of Chemistry, Biology
and Biotechnology (University of Perugia), Perugia, Italy; dDepartment of
Pharmaceutical Sciences (University of Perugia), Perugia, Italy; eGraduate
School of Pharmaceutical Sciences (University of Tokyo), Perugia, Italy
Introduction: Extracellular vesicles (EVs) are mem-
brane-limited particles released by cells during physio-
logical and pathological conditions involved in cell
communication. An increased ceramide-enriched pro-
inflammatory EV release has been demonstrated in in
vitro lipotoxic conditions and in non-alcoholic steatohe-
patitis mouse models and patients. So far, lipid profile
changes in EVs released under lipotoxic conditions have
not been investigated, despite the evidence that EVs
shuttle many membrane-derived bioactive lipids playing
crucial role in several processes, including inflammation.
In this study, we carried out a comprehensive lipidomic
analysis of EVs released by HuH7 cells under membrane
lipid saturation conditions induced by lipotoxic palmi-
tate (PA) or Δ9 desaturase inhibition (SCD1i). Since
membrane lipid saturation induces ER stress, HuH7
cells were also treated with Thapsigargin (Tg), a con-
ventional ER stress inducer, and with oleate (OA), a
nontoxic monounsaturated fatty acid.
Methods: EVs were isolated from culture media of
HuH7 cells treated for 16 h with fatty acids (400 μM),
or Tg (2.5 nM), or SCD1i (CAY 10566, 5 μM). All
treatments were performed in serum-free medium con-
taining 0.1% free fatty acids-BSA. EVs were recovered
by differential centrifugation and characterized by SEM
and immunoblotting. Total lipids from EVs and their
parental cells were analysed by LC/MS-MS.
Results: EVs released by HuH7 cells expressed positive
markers (Alix and CD63), whose levels were higher in
PA-EVs. SEM images showed vesicles with the typical
cup-shaped morphology and size, not altered by the
various treatments. Lipid composition comparison of
EVs released by treated- and control cells showed a
higher content of all phospholipid subclasses, in PA-
EVs, except for phosphatidic acid and phosphatidyli-
nositol, whereas no differences were observed in EVs
released by OA-, Tg- or SCD1i-treated cells. Specific
differences have been observed in the levels of numer-
ous phospholipid molecular species in PA-EVs as com-
pared to other treatments.
Summary/Conclusion: In HuH7 cells, the most rele-
vant changes in lipid composition were observed in
PA-EVs, even if all treatments, except OA, induced
ER stress. These results suggest that the increase of
membrane phospholipid saturation is crucial to deter-
mine which lipids discarded via EVs.
OF19.04
Deconvolution analysis of small RNAseq data from exRNAs isolated
using different methods reveals multiple carrier subclasses and
identifies optimal methods for isolation of total and EV-specific
exRNA
Srimeenakshi Srinivasana, Ashish Yerib, Pike See Cheahc, Kirsty M.
Danielsond, Peter DeHoffa, Justyna Filante, Anu Paulf, Ravi Shahb, Bridget
Simonsonb, Irene Yang, Cuong Trana, Xuan Zhangc, Leonora Balajh, Xandra
Breakefieldi, Roopali Gandhif, Jodi Lapidusj, Eric Londink, Tushar Patelg,
Robert Raffail, Anil Soode, Saumya Dasb and Louise Laurentm
aUCSD, San Diego, USA; bCardiovascular Research Center, Massachusetts
General Hospital, Harvard Medical School, Boston, USA; cNeuology and
Radiology Services and program in Neuroscience, Harvard Medical School,
Massachusetts General Hospital, Boston, USA; dUniversity of Otago,
Wellington, Wellington, New Zealand; eThe University of Texas MD
Anderson Cancer Center (MDACC), Houston, USA; fCenter for Neurologic
Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston,
USA; gMayo Clinic Florida, Jacksonville, USA; hMassachusetts General
Hospital, Boston, USA; iNeurology and Radiology Services and program in
Neuroscience, Harvard Medical School, Massachusetts General Hospital,
Charlestown, USA; jBiostatistics & Design Program, Oregon Health and
Science University, Oregon Health & Science University – Portland State
University School of Public Health, Portland, USA; kSidney Kimmel College
of Medicine, Thomas Jefferson University, Philadelphia, USA; lUniversity of
California & VA Medical Center, San Francisco, San Fransisco, USA;
mUCSD, La Jolla, USA
Introduction: Reproducibility has been a major chal-
lenge in extracellular RNA (exRNA) research both due
to low concentration and heterogeneity of exRNA car-
riers in biofluids, such as EVs, RNPs and LPPs. Lack of
knowledge regarding the efficiency/reproducibility of
different isolation methods in accessing the exRNAs
in different carriers has hindered rational selection of
standardized methods.
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Methods: Using small RNAseq, we compared the per-
formance of 10 exRNA isolation methods on standar-
dized samples of five biofluids across multiple
laboratories. We found that the read depth required
to maximize miRNA complexity in each biofluid was
different: 1 million in Bile (~200 detected miRNAs), 0.5
million in Cell culture supernatant (~300), 2 million in
Plasma/Serum (~450), and 50,000 in Urine (~100).
While the miRNA profiles varied greatly among
exRNA isolation methods in Plasma, Serum, and Bile,
Cell culture supernatant and Urine showed similar
profiles for all tested methods.
Results: We performed small RNAseq on purified
exRNA carriers from Plasma and Serum; and used
the resulting carrier-specific miRNA signatures to
computationally deconvolute the miRNA profiles
from each of the isolation methods. We found that
ExoRNeasy, ME, and Ultracentrifugation purified
miRNAs that were predominantly carried in EVs,
while Exiqon, ExoQuick, and Norgen isolated both
EV- and AGO2+ RNP-associated miRNAs.
Summary/Conclusion: Our studies identified several
factors that contribute to difficulties with reproducibil-
ity in exRNA studies, like inefficient and variable
exRNA isolation for many of the available methods,
differences in accessibility of miRNA cargo associated
with different carriers among methods, and insufficient
sequencing depth. To help investigators select an opti-
mal method, we developed an interactive web-based
application, miRDaR, that will provide a ranked list
of tested exRNA isolation methods by complexity/
expression level and reproducibility, specific to their
biofluid and miRNA of interest.
Funding: This study was supported by the Extracellular
RNA Communication Consortium funded by the NIH
Common Fund.
OF19.05
Novel angiogenic extracellular vesicles induced by StemRegenin1
Yen-Michael Sheng Hsua, Jae-Hung Shiehb, Taojunfeng Suc, Zhen Zhaoa
aDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine,
New York, USA; bDepartment of Medicine, Weill Cornell Medicine, New
York, NY, USA; cProteomics&Metabolomics Core Facility, Weill Cornell
Medicine, New York, NY, USA
Introduction: Aryl hydrocarbon receptor antagonists,
such as StemRegenin1 (SR1), have been recently shown
to enhance expansion of hematopoietic stem progeni-
tor cells (HSPCs). Our preliminary data showed that
SR1 enhances endothelial cells (EC) to promote HSPC
expansion possibly via direct and indirect intercellular
interactions, including extracellular vesicle (EV)
production. However, the direct effect of SR1 on EC
biology and EV production is largely unknown.
Methods: Human umbilical vein EC (HUVEC) and
HSPC were obtained per approved IRB protocol. EC
culture and EC-HSPC in vitro co-culture was performed
as described previously. EC-EV harvest was collected in
serum free medium. The effect of SR1 on HUVEC
growth was evaluated by EC-colony-forming cell (EC-
CFC) assay. HSPC population analysis was done by
FACS. EV was purified by ultracentrifugation. EV pro-
teins were identified by LC-MS/MS. Student t-test was
performed with p < 0.05 for statistically significance.
Results: HSPC co-cultured with HUVEC in the pre-
sence of SR1 results in a ~ 2-fold increase of more
primitive HSPC subpopulation compared to the con-
trol group. SR1 treated HUVEC leads to a significant
>2-fold increase in EC-CFC numbers and >67%
increases in the colony diameter. A total of 327 pro-
teins were detected in ECs derived from HUVEC. As a
quality control, many commonly reported “EV-
enriched” proteins per “ISEV position statement”
were identified. A small fraction of proteins recovered
from the EV fraction (<2%) is found on EC membrane.
Among the 327 proteins, 46 of them showed a signifi-
cant change with SR1 treatment. Functional annotation
by DAVID bioinformatics enrichment tools classified
three EV proteins associated with enhanced angiogen-
esis signalling pathways.
Summary/Conclusion: SR1 differentially regulates
angiogenic EV production that associates with
increased robustness in endothelial growth and
enhanced haematopoiesis. Future investigations on
the biological effects of HUVEC EV differentially pro-
duced by SR1 are in progress and needed.
OF19.06
Evaluation of circulating extracellular vesicles derived miRNAs as
biomarkers of early colon cancer: a comparison with plasma total
miRNAs
Li Mina, Shengtao Zhua, Lei Chena, Xiang Liub, Rui Weia, Libo Zhaob, Yuqing
Yangb, Guanyi Kongb, Peng Lic and Shutian Zhangc
aDepartment of Gastroenterology, Beijing Friendship Hospital, Capital
Medical University, Beijing, China (People’s Republic); bEcho Biotech Co.,
Ltd, Beijing, China (People’s Republic); cDepartment of Gastroenterology,
Beijing Friendship Hospital, Capital Medical University, Beijing, P. R. China
Introduction: Early diagnosis of colon cancer (CC) is
clinically important, as it can significantly improve
patients’ survival rate and quality of life. Although the
potential role for small extracellular vesicles (sEVs) in
early detection of many diseases has been repeatedly
mentioned, systematic screening of plasma sEVs
derived early CC biomarkers has not yet been reported.
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Methods: Plasma sEVs were derived from 15 early
stage CC patients and 10 normal controls (NC) and
characterized according to MISV2014 standard. The
total circulating sEVs derived microRNA (miRNA)
expression profile of all participants was investigated
by next-generation sequencing (NGS). Selected
miRNA candidates were further verified in both
plasma-derived sEV miRNA and plasma total
miRNA of an independent cohort consisting of 134
participants.
Results: RNA sequencing identified a total number of
95 sEVs miRNA with differential expression between
CC and NC, most of which (60/95) was in well accor-
dance with tissue results in the Cancer Genome Atlas
(TCGA) dataset. Among those miRNAs, we selected
let-7b-3p, miR-139-3p, miR-145-3p, and miR-150-3p
for further validation in an independent cohort
consisting of 134 participants (58 CC and 76 NC). In
the validation cohort, the AUC of 4 individual miRNAs
ranged from 0.680 to 0.792. A logistic model combin-
ing two miRNA (i.e. let-7b-3p and miR-145-3p)
achieved an AUC of 0.901. Adding the 3rd miRNA
(miR-139-3p) into this model can further increase the
AUC to 0.927. Side by side comparison revealed that
sEVs miRNA profile outperformed cell-free plasma
miRNA in the diagnosis of early CC.
Summary/Conclusion: Circulating sEVs have a dis-
tinct miRNA profile in CC patients, and sEVs derived
miRNA could be used as a promising biomarker to
detect CC at an early stage.
Funding: This work was supported by grants from the
National Natural Science Foundation of China
(81702314).
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Nano-Ghosts: mesenchymal stem cells derived nanoparticles as a
novel approach for cartilage regeneration.
Domenico D’Atria, Joao Garciab, Laura Creemersc and Marcelle Machlufd
aTechnion Israel Institute of Technology, Haifa, Israel; bUMC Utrecht,
Utrecht, Netherlands; cDept Orthopaedics, University Medical Centre
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Introduction: Osteoarthritis is the most common
inflammatory disease of the joints which is character-
ized by cartilage degeneration and bony overgrowth.
Mesenchymal stem cells (MSCs) play an essential role
in inflammation, due to their aptitude to home to
inflamed tissues and modulate the process. We
designed a new kind of particles termed Nano-Ghosts
(NGs), derived from the cytoplasmic membrane of the
MSCs. Retaining MSCs’ surface properties, NGs are
expected to target inflamed tissue and modulate
inflammation. In this study, we demonstrate NGs’ abil-
ity to target human articular chondrocytes (hACs) and
cartilage explants while reducing inflammation.
Methods: Targeting was evaluated by flow cytometry
and confocal microscopy. NGs’ anti-inflammatory
properties were studied in vitro on TNF-stimulated
and non-stimulated hACs and, ex vivo, on cartilage
explants. qPCR and ELISA of various markers assessed
anti-inflammatory effect. Smooth muscle cell (SMC)-
NGs were used as a non-MSC control.
Results: Flow cytometry showed that NGs can target
hACs’ 2 times more efficiently compared to SMC-NGs.
Moreover, NGs showed 4 times higher targeting to
TNF-stimulated hACs. Targeting was confirmed by
confocal microscopy and imaging flow cytometry
which showed that NGs bound the membrane and
were taken up by the cells. Similar results were
achieved in human explants where the particles showed
4 times higher binding to TNF-stimulated explants. To
test the anti-inflammatory effect, different markers
such as NO2, IL6, PGE2 and MMP13 were analysed.
Our data showed that NGs reduce inflammation by
more than 50% both at the protein and RNA level.
Summary/Conclusion: Here we provide a proof-of-
concept for the utility of NGs with intrinsic capabilities
for targeted cartilage regeneration, either as a
standalone biological or as a carrier for the targeted
delivery of therapeutics, such as anti-inflammatory
agents and growth factors. Ongoing in vivo studies
are focusing on confirming the NGs’ targeting and
anti-inflammatory capacity.
Funding: This project has received funding from the
European Union’s Horizon 2020 research and innova-
tion programme under Marie Sklodowska-Curie grant
agreement No 642414
OF20.02
Combining virus-based therapeutics and EV therapy for the
treatment of pancreatic cancer
Marie-Ève Wedge and Carolina Ilkow
Ottawa Hospital Research Institute, Ottawa, Canada
Introduction: Pancreatic cancer (PC) is a highly
aggressive disease with unmet therapeutic needs.
Recent advances in the use of cancer killing oncolytic
viruses (OVs) as cancer therapeutic agents bring new
hope to fight the notorious disease that is PC.
Although OVs have shown promising results in cer-
tain cancers, some tumours remain resistant to OV
therapy due to their inherent residual antiviral
mechanisms. We hypothesized that the use of OV-
encoded artificial microRNAs (amiRs) could help
target the cellular antiviral components associated
with the observed OV resistance and could also
sensitize neighbouring tumour cells to OV therapy
and small molecule inhibitors through the secretion
of amiR-containing extracellular vesicles (EVs) from
infected cells.
Methods: To find such amiRs, we passaged a viral
library encoding ~16,000 unique amiRs in several PC
cell lines and patient-derived xenograft samples to
enrich for sequences that could enhance OV
replication.
Results: We identified an amiR that improves PC cell
killing (amiR-PC) when expressed from an OV.
Target identification of amiR-PC revealed ARID1A
as a key player in resistance to OV therapy in PCs.
This target is of particular interest since its down-
regulation acts in a synthetic lethal fashion with inhi-
bition of the EZH2 methyltransferase. Combining an
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amiR-PC-expressing OV with a small molecule inhi-
bitor of EZH2 enhances PC cell death. Moreover, we
have shown that amiR-PC is packaged in cancer cell-
secreted EVs which have the ability to reach neigh-
bouring naïve cells to sensitize them to EZH2 inhibi-
tion-mediated cell death and to spread the OV-
mediated tumour killing effect throughout the
tumour. These results translate into an impressive
improvement in tumour debulking and survival in
animal models of highly aggressive PC.
Summary/Conclusion: This work not only broadens
our knowledge on the resistance of select tumours to
oncolytic virotherapy and the EV-mediated bystander
killing effect in OV-infected tumours, but it also pro-
vides new hope for a cure to the grim disease that
is PC.
OF20.03
CD47, a “don’t eat me signal” expression in ovarian cancer cells were
regulated by circulating exosomes – the therapeutic potential of
targeting exosomes by inhibiting immune evasion
Aasa Shimizua, Kenjiro Sawadab, Masaki Kobayashib, Mayuko Miyamotob
and Tadashi Kimurab
aOsaka University, Sjuita, Japan; bOsaka University, Suita, Japan
Introduction: CD47, a “don’t eat me” signal, is over-
expressed on the surface of various tumours to allows
tumour immune evasion. However, the role and reg-
ulation of CD47 in high grade serous ovarian carci-
noma (HGSOC) remains undetermined. CD47 is
known to be present on exosomes. Herein, we tested
the following hypothesis that CD47 present on exo-
somes mediates immune evasion of cancer cells from
macrophages.
Methods: Prognostic significances of CD47 expression in
HGSOCs were examined using a public database includ-
ing 1656 HGSOC patients (Kaplan-Meier Plotter; http://
kmplot.com/analysis) and validated with 80 HGSCOs
treated at Osaka University Hospital between 2013 and
2017. CD47 expression in exosomes derived from several
HGSOC cell lines were examined by western blot. The
effect of exosomal CD47 in HGSOCs was examined by
inhibiting exosome secretion with GW4869, or by inhi-
biting exosome uptake with E1PA. Further, the co-culture
experiments of HGSOCs with THP-1-derived macro-
phage were performed and the effect of exosomal CD47
on phagocytosis was analysed.
Results: High CD-47 expression was correlated with poor
prognoses of HGSOC patients compared with low CD-47
expression (19.0months vs. 23.6months in overall survival
(OS)). Exosomes derived from SKOV3ip1, OVCAR3 and
A2780 cell lines showed strong CD47 expression. The
inhibition of exosome secretion and uptake by GW4869
and E1PA inhibited CD47 expression in ovarian cancer
cells, suggesting that CD47 is released from cells via exo-
somes and thereafter recycled via pinocytosis. The co-
culture assay revealed that the inhibition of exosomal
CD47 enhanced the phagocytosis of macrophage-like
cells against cancer cells, which may lead to cancer cell
survival in vivo.
Summary/Conclusion: CD47 expression was corre-
lated with poor OS in HGSOC patients, suggesting
the importance of immune evasion. CD47 was
expressed on exosomes and the inhibition of exosome
recycling enhanced the phagocytosis of macrophage-
like cells against cancer cell through the down-regula-
tion of CD47 expression in cancer cells. Our data
indicates that cancer derived exosomes can be con-
sidered as a therapeutic target of HGSOCs.
OF20.04
The impact of in vitro ageing on the release of extracellular vesicles
from human mesenchymal stem cells
Xiaoqin Wanga, Jincy Philipa, Forugh Vazirisanib, Chrysoula Tsirigotia, Peter
Thomsenb and Karin Ekströma
aDepartment of Biomaterials, Institute of Clinical Sciences, Sahlgrenska
Academy, University of Gothenburg, Gothenburg, USA; bDepartment of
Biomaterials, Institute of Clinical Sciences, Sahlgrenska Academy,
University of Gothenburg, Gothenburg, Sweden
Introduction: Ageing increases the risk of bone degen-
erative diseases, which are partially caused by ageing-
related changes in mesenchymal stem cells (MSCs).
Both in vitro ageing (reflected by the passage number
in culture) and ageing (donor age) reflect a loss of
regenerative capacity in terms of the proliferation and
osteogenic differentiation of MSCs. Extracellular vesi-
cles (EVs) secreted from MSCs have been shown to
exert therapeutic effects that contribute to the regen-
eration of various tissues, but there is scarce informa-
tion on whether ageing, particularly in vitro ageing,
influences the release of EVs by MSCs.
Methods: An in vitro ageing model in which low- and
high-passage cells (LP and HP MSCs, respectively)
represent “young” and “aged” cells, respectively, was
utilized. Both LP and HP EVs were characterized by
NTA and WB. The EV protein contents were further
explored and the functions of LP and HP EVs on the
survival and proliferation of MSCs were investigated.
Results: The results showed that in vitro ageing
retained the phenotypic signature of MSCs but resulted
in morphological changes and decreases in the prolif-
eration and osteogenic differentiation capacity of the
cells. Both LP and HP MSCs secreted EVs with similar
characteristics in terms of size and typical exosomal
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protein markers, but HP MSCs secreted more EVs than
LP MSCs. The global proteome of the LP and HP EVs
revealed that the vast majority of the identified proteins
were in fact associated with EVs. The most abundant
proteins in LP and HP EVs shared similar but not
identical functional characteristics, and the proteins
showing significant differential expression between
HP and LP EVs were predicted to be enriched in
Gene Ontology biological process terms mainly related
to transport and secretion and to pathways regulating
cellular morphology, growth/proliferation and develop-
ment. Both LP and HP EVs promoted MSC survival
and proliferation in autocrine and paracrine manners,
and the degree of proliferation was dependent on the
applied EV dose and associated with the characteristics
of the recipient cells.
Summary/conclusion: The above-described results
demonstrate that in vitro ageing influences the secre-
tion of EVs by MSCs, particularly the number and
protein cargoes of the EVs.
OF20.05
Novel role of BCR-ABL-containing leukemic extracellular vesicles in
controlling the function of regulatory T cells
Julian Swatlera, Wioleta Dudka-Ruszkowskaa, Lukasz Bugajskib, Ewa
Kozlowskac and Katarzyna Piwockaa
aLaboratory of Cytometry, Nencki Institute of Experimental Biology, Polish
Academy of Sciences, Warsaw, Poland; bLaboratory of Cytometry, Nencki
Institute of Experimental Biology, Polish Academy of Science, Warsaw,
Poland; cDepartment of Immunology, Faculty of Biology, University of
Warsaw, Warsaw, Poland
Introduction: BCR-ABL-positive chronic myeloid leu-
kemia (CML) has only recently been recognized as a
malignancy associated with an immunosuppressive
microenvironment, which includes increased amount
of Foxp3+ regulatory T cells (Treg). However, mechan-
isms driving Treg differentiation and function in CML
are mostly unknown. We hypothesize that extracellular
vesicles (EVs) released by leukemic cells may be
engaged in this phenomenon and mediate immuno-
suppression both inside and outside the CML bone
marrow niche.
Methods: We isolated EVs from murine BCR-ABL-
expressing progenitor cells, using differential centrifu-
gation. EVs were characterized using TEM, Western
blotting, Nanosight analysis and uptake of EVs by
lymphocytes was analysed by flow cytometry.
Influence of CML-derived EVs on Treg was analysed
in different ex vivo settings, such as an in vitro suppres-
sion assay and differentiation of Treg on dendritic cells.
To precisely analyse Foxp3 expression in Treg, we have
used cells from B6.Cg-Foxp3tm2Tch mice that co-
express Foxp3 and EGFP. Treg in blood of CML
patients were analysed using 13-colour flow cytometry.
Results: Leukemic EVs potentiate suppressive function
of regulatory T cells. This effect is driven by EV-
mediated upregulation of Foxp3 – a transcription fac-
tor responsible for Treg suppressive phenotype.
Proteomic analyses revealed that CML-derived EVs
contain BCR-ABL oncoprotein. Interestingly, further
functional studies revealed that inhibition of kinase
activity of BCR-ABL in EVs has abolished the increase
in Foxp3 level in EVs-treated Treg. Similarly to our in
vitro findings, also Treg in CML patients seem to have
more suppressive phenotype, as demonstrated by e.g.
larger amount of highly suppressive CD39+ Tregs.
Summary/conclusion: CML-derived EVs seem to
modulate immunosuppression in leukemia, by increas-
ing suppressive activity of regulatory T cells. This effect
is largely driven by BCR-ABL contained in leukemic
EVs. However, precise mechanism of this regulatory
pathway is yet to be dissected.
Funding: Grants from National Science Centre: 2013/
10/E/NZ3/00673 to KP, 2018/29/N/NZ3/01754 to JS
and Foundation for Polish Science grant TEAM
TECH Core Facility Plus/2017-2/2 to KP.
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Immunomodulatory function of human mesenchymal stromal cells
(MSC)-derived extracellular vesicles (EVs) on type-i interferon
response in human plasmacytoid dendritic cells (pDCs) and its
therapeutic effect on murine lupus model
Lin Kuia, Godfrey Chanb and Pamela PW Leea
aDepartment of Paediatrics and Adolescent Medicine, LKS Faculty of
Medicine, The University of Hong Kong, Hong Kong, Hong Kong; bThe
University of Hong Kong, Hong Kong, Hong Kong
Introduction: Immunoregulatory effect of mesenchy-
mal stem cell (MSC) is attributed to extracellular vesi-
cles (EVs) secretion. Given its effectiveness in
preclinical studies of autoimmune disease, no one has
examined its effect on SLE pathogenesis, signify by
excessive type-I IFN production by plasmacytoid den-
dritic cells (pDCs) and animal models.
Objective: To investigate the effect of MSC and MSC-
EVs on regulating cytokines production in pDCs, and
the immunomodulatory role of MSC-EV in NZB/
W F1.
Methods: htMSC (immortalized human MSCs), was
cultured in CDPF medium for 48 h. EV were isolated
by ultracentrifugation at 100,000g, 3 h, 4°C and char-
acterized. Comparison of immunosuppressive function
between htMSC-EV and TSG-6 knockdown htMSC on
TLR9-mediated cytokine production in pDC was deter-
mined with GEN2.2, a human pDC cell-line, following
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activation by CpG-A, and analysis by qPCR and ELISA.
Finally, we compared the survival, pDC IFN-α intra-
cellular expression and serum IgG autoantibodies
expression of htMSC-EV-treated NZB W/F1 mice
with those that received htMSC cellular treatment,
and PBS control-group.
Results: Upon activation of TLR9 by CpG-A, IL-1ß,
TNF-α and IFN-α transcription was upregulated in
GEN2.2. Such response was reduced when CpG-A-
primed GEN2.2 were co-cultured with htMSC.
Knockdown of TSG-6 in htMSC dampened its capacity
to suppress IL-1ß, TNF-α, IFN-α and IRF7 transcrip-
tion in GEN2.2. To find out whether MSC exert its
immunosuppressive effect by means of EV, we isolated
EVs from hTERT MSCs and found htMSC-EV con-
tained TSG-6 protein. Co-culture of htMSC-EV with
CpG-A-primed GEN2.2 resulted in downregulation of
IFN-α transcription and protein expression, mediated
via reduction in total and phospho-IRF7. NZB/W F1
mice treated with htMSC-EV resulted in improved
survival, followed by reduction in splenic pDC IFN-α
expression, and IgG autoantibodies in serum.
Summary/conclusion: We showed that MSC downre-
gulated TLR9 activation in human pDCs, in a TSG-6
dependent manner. Furthermore, htMSC-EV contains
TSG-6 and suppress IFN-α response in CpG-A-acti-
vated pDCs through reducing total and phospho-IRF7.
Finally, htMSC-EV treatment improved survival, and
modulated pDCs and serum IgG autoantibodies
expression in NZB/W F1 mice.
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Targeting Rab27a in pancreatic cancer
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Cancer Center, University of Texas, Texas, USA, Texas, USA; ei3S –
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Introduction: Pancreatic ductal adenocarcinoma
(PDAC) is one of the most lethal cancers with very
limited therapeutic options. PDAC lesions are unique
due to their extensive desmoplastic reaction and sparse
cancer cells, highlighting the potential role of cell com-
munication in PDAC progression. Despite cell com-
munication being intrinsically involved in tumour
progression, this process of tumorigenesis is still off
the cancer therapy landscape. Exosomes have emerged
as crucial mediators of intercellular communication in
cancer. Rab27a and −27b have been described as key
players in cancer exosomes release.
Methods: Therefore we decided to evaluate if inhibi-
tion of cancer exosomes communication could repre-
sent a novel therapeutic strategy in PDAC.
Results: We demonstrate that Rab27a, but not Rab27b,
expression correlates with poor survival in patients
with metastatic PDAC, but the same is not true for
early stage PDAC. We further demonstrate that Rab27a
knockout in pancreatic cancer cells is lethal, further
stressing the crucial role of Rab27a for cancer cells
survival. When using an inducible TetON knockdown
system for Rab27a, downregulation of this protein
impairs tumour growth in orthotopic models and,
most strikingly, inhibits liver metastatic colonization.
Next we evaluated Rab27a, −27b, −5 and −7 expression
during disease progression in a genetically engineered
mouse model (GEMM) that spontaneously develops
PDAC (KPC) and reflects the human disease. Rabs
expression is dynamic during the different stages of
disease progression, but only Rab27a shows an
increased expression in metastatic lesions. Using a
Rab27a small molecule inhibitor in KPC mice we see
a decrease in the number of liver macro-metastasis and
increase in overall survival. In addition, we developed a
conditional and inducible Rab27aKO mouse and show
that pancreas conditional KO of Rab27a does not affect
the normal development and physiology of the
pancreas.
Summary/Conclusion: We are currently assessing the
effects of Rab27a conditional KO in PDAC GEMMs.
Funding: Project NORTE-01–0145-FEDER-000029 from
NORTE 2020. IF/00543/2013/CP1184/CT0004, PTDC/
BIM-ONC/2754/201 and, POCI01-0145-FEDER-32189
from FCT – Foundation for Science and Technology.
FAZ Ciencia Award from Astrazeneca Foundation.
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Roles of lysyl oxidase like 2 (LOXL2) in exosomal fraction on lymph
node metastasis of head and neck squamous cell carcinoma
Hajime Yano, Afsana Islam, Teppei Kaminota, Reina Tanimoto, Naohito
Hato and Junya Tanaka
Graduate School of Ehime University Medical School, To-on, Japan
Introduction: The secretory enzyme lysyl oxidase like
2 (LOXL2) is assumed to contribute to tumour pro-
gression through participation in cellular events
including remodelling extracellular matrix and epithe-
lial-mesenchymal transition. In a previous study, we
identified elevated expression of LOXL2 in human
head and neck squamous cell carcinoma (HNSCC)
lymph node metastases, and localization of LOXL2 in
exosomal fraction of a metastatic HNSCC cell. Here we
assessed the significance of LOXL2 in the metastasis
and of liquid biopsies for detecting HNSCCs and their
risk of the metastasis.
Methods: A mouse model of lymph node metastasis of
HNSCC was established to assess metastatic activity
and responsible factors for the metastasis. LOXL2 pro-
tein expression as well as lysyl oxidase enzyme activity
were assessed in exosomal fraction of human meta-
static HNSCC cell. Effects of LOXL2 knockdown on
the metastasis was assessed in the mouse model.
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LOXL2 levels were assessed in immunohistochemistry
and immunoblotting in HNSCC tissues as well as
serum from patients. Exosomal LOXL2 levels from
further 38 serum samples from HNSCC patients were
subjected to statistical analysis.
Results: LOXL2 localization was identified in exosome
from metastatic HNSCC cell but not in non-metastatic
cancer cell. Knockdown of LOXL2 attenuated the
lymph node metastasis. Immunoblot analyses revealed
that LOXL2 was present in human serum exosomal
fractions, and the mean LOXL2 level was approxi-
mately three-fold higher in patients than healthy
volunteers. Immunohistochemical LOXL2 staining
was detected in HNSCC cells in a human tongue
HNSCC sample. Further measurements of exosomal
LOXL2 showed higher LOXL2 levels in patients.
Summary/Conclusion: Elevated serum exosomal
LOXL2 levels can be an indicator of HNSCC. A fol-
low-up clinical study will be required to determine the
clinical utility of using LOXL2 to diagnose HNSCC
and/or determine the risk of metastasis.
Funding: This study was supported in part by grants
from Ehime University (#0101010010, #0101050003,
and #0101390003), Daiwa Securities Health Care
Foundation (#14–23), and the Ministry of Education,
Culture, Sports, Science, and Technology of Japan
(15K10809 and 18K09379).
OF21.03
Growing old disgracefully – a novel role of extracellular vesicles in
bone invasion
Areeg A. Elmusrati, Daniel Lambert and Syed Ali Khurram
The University of Sheffield, Sheffield, UK
Introduction: Bone invasion is a common feature of
oral squamous cell carcinoma (OSCC) and is associated
with poor prognosis. The mechanism of OSCC bone
invasion remains unclear, but our recent work indi-
cated a key role for cancer-associated fibroblasts (CAF)
Methods: In this study we sought to investigate
whether senescent fibroblasts and derived extracellular
vesicles (EV) play a role in bone invasion in OSCC.
Immunohistochemistry (IHC) for senescence markers
p16INK4a and dipeptidyl peptidase 4 (DPP4) was car-
ried out on bone resection cases with cortical and
medullary OSCC invasion. Senescence in normal oral
fibroblasts (NOF) was experimentally induced through
replicative mitotic exhaustion, as well as exposure of
NOF at low passage to hydrogen peroxide, and the
chemotherapeutic drug cisplatin. Senescence-associated
beta-galactosidase (SA-βgal) activity was monitored to
confirm senescence induction. Receptor activator of
nuclear factor kappa-Β ligand (RANKL), a key pro-
osteoclastogenic factor, and p16INK4a transcript abun-
dance was assessed by qPCR. Conditioned media was
collected and an enzyme-linked immunosorbent assay
used to detect soluble RANKL protein secretion.
Furthermore, osteoclastogenesis and pit formation on
a synthetic bone substrate was assessed in response to
proliferating and senescent NOF-derived EV condi-
tioned media.
Results: Readily detectable p16INK4a and DPP4
expression was observed in fibroblastic stroma adjacent
to bone, indicative of the presence of senescent fibro-
blasts. A significant increase in RANKL and p16INK4a
expression was observed following 15 days of senes-
cence induction. RANKL secretion by NOFs was sig-
nificantly upregulated following in vitro induction of
senescence. Conditioned media from senescent oral
fibroblasts provoked a marked increase in osteoclasto-
genesis, shown by an increase in tartrate resistant acid
phosphatase activity, multinucleation and osteoclastic
resorption/pit formation.
Summary/Conclusion: Here we provide novel evi-
dence that senescent oral fibroblasts and derived EVs
play an active role in OSCC bone invasion. The ability
of senescent fibroblast-derived factors to promote
osteoclastogenesis may have implications more broadly
for age-related bone pathologies, and this is the focus
of our ongoing investigations.
OF21.04
The multifaceted role of breast cancer-derived extracellular vesicles
in brain metastasis
Golnaz Morada, Christopher Carmanb and Marsha Mosesc
aHarvard Graduate School of Arts and Sciences, Boston Children’s Hospital,
Boston, USA; bMolecular and Integrative Physiological Sciences Program,
Harvard T.H. Chan School of Public Health, Boston, USA; cVascular
Biology Program, Boston Children’s Hospital; Department of Surgery,
Harvard Medical School and Boston Children’s Hospital, Boston, USA
Introduction: Breast cancer brain metastasis is often
associated with a dismal prognosis. Elucidation of the
early events that lead to brain metastasis will pave the
way to identifying potential diagnostic and therapeutic
targets for early intervention. We have previously
shown that extracellular vesicles (EVs) derived from
the brain-seeking MDA-MB-231 breast cancer cell
line can increase brain metastasis growth. To investi-
gate the mechanisms underlying the EV-induced facil-
itation of brain metastasis, we studied the mechanisms
with which EVs interact with and modulate the blood
brain barrier (BBB), as an initial niche for tumour cell
growth.
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Methods: EVs were isolated from the parental MDA-
MB-231 breast cancer cell line (P-EVs) and its brain-
seeking variant (Br-EVs). Through retro-orbital and
intracardiac injection of EVs in mouse and zebrafish
models, we studied the distribution of EVs to the brain.
A combination of in vitro and in vivo BBB models was
used to study the mechanisms with which EVs interact
with an intact BBB. We next conducted continuous in
vitro and in vivo treatment with EVs to elucidate the
effects of EVs on the behaviour of the luminal and
abluminal components of the BBB.
Results: Our distribution studies demonstrated that
breast cancer-derived EVs could enter the brain parench-
yma via an intact BBB. Using state-of-the-art models of
the BBB and high-resolution microscopy, we have identi-
fied, for the first time, the mechanisms with which Br-Ex
interact with the endocytic pathway in brain endothelial
cells to cross the endothelium. Interestingly, our mechan-
istic studies showed that through transferring miRNAs,
Br-EVs could modulate the endothelial endocytic path-
way to decrease EV degradation. Moreover, we have
shown that following their transport across the brain
endothelium, Br-EVs can exclusively alter the expression
profile of astrocytes to provide a suitable environment for
metastatic growth.
Summary/Conclusion: These findings indicate that EVs
derived from a brain-seeking subpopulation of breast
cancer cells can exclusively modify the physiological
regulation of the BBB at multiple levels to accelerate
metastatic growth in the brain microenvironment.
Funding: This work was supported by the Breast
Cancer Research Foundation and NIH R01CA185530.
OF21.05
Exposed aminophospholipids enriched in a subtype of small
extracellular vesicles from tumour cell lines
Sachiko Matsumuraa, Tamiko Minamisawab, Kanako Sugac and Kiyotaka
Shibad
aJapaese Foundation for Cancer Research, Koto-ku, Japan; bJapanese
Foundation for Cancer Research, Tokyo, Japan; cJapanese Foundation for
Cancer Research, Tokyo, Japan; dJapaese Foundation for Cancer Research,
Tokyo, Japan
Abstract: Aminophospholipids such as phosphatidyl-
serine (PS) and phosphatidylethanolamine (PE) nor-
mally exist in the inner leaflet of the plasma
membrane. Tumour cells, however, expose PS on
their surfaces and release the extracellular vesicles
(EVs) enriched with the exposed PS, which have been
proposed to play an important role in communication
between tumour cells and other surrounding or distal
cells. We have recently identified a subtype of small
EVs (sEVs) from tumour cell lines that were enriched
with exposed PS; this subtype has lower density, larger
size, more negative zeta potentials and lower abun-
dance of exosomal proteins. Because PS and PE have
often been reported to change their membrane locali-
zation in a closely associated manner, in this study, we
aimed to examine if PE is also present in this subtype
of sEVs.
Methods: An sEV fraction was prepared from a con-
ditioned medium of tumour cell lines (HT-29 and HT-
1080) that were propagated in a serum-free medium
for approximately 68 h. After differential centrifuga-
tions (10,000g for 30 min and 160,000g for 70 min) and
filtration with a 0.22-µm pore filter, the sEVs were
further differentiated by continuous density-gradient
centrifugation (8–40% iodixanol, 100,000g, 17 h) into
10 fractions. Thereafter, the fractions were washed with
phosphate-buffered saline and analysed by Western
blotting, silver staining, nanoparticle tracking and
atomic force microscopy (AFM). To detect PS or PE
on the surfaces of the vesicles, sEVs were labelled with
gold nanoparticles (GNPs) using MFG-E8 or duramy-
cin, respectively, followed by AFM observation.
Results: Continuous density-gradient centrifugation
showed two subtypes of sEVs. One subtype was
enriched with canonical exosome markers, including
CD63, CD81, Alix and Tsg101, and had a density of
1.10 g/ml. The other subtype, however, was scarce for
these markers and had a lower density of 1.04 g/ml.
The estimation of the amounts of exposed PS and PE
by GNP in AFM showed that the second subtype of
sEVs had exposed PE as well as PS.
Summary/conclusion: The subtype of sEVs with lower
density and fewer canonical exosome markers in den-
sity-gradient centrifugation contained not only exposed
PS but also PE, which defined a new subtype of sEVs
from tumour cells.
Funding: This work was supported by JSPS KAKENHI
Grant Numbers 16K07152 to SM and 17H06255 to KS.
OF21.06
Mesenchymal stem cells-derived exosomes present natural migration
and homing abilities to specific neuropathological areas
Nisim Peretsa, Oshra Betzerb, Ronit Shapirac, Shmuel Berensteind, Areil
Angele, Tamar Sadanb,Uri Asheryf, Rachela Popovtzerb and Daniel Offeng
aSagol School of neuroscience, Tel Aviv University, Israel, Tel Aviv, Israel;
bFaculty of Engineering and the Institute of Nanotechnology & Advanced
Materials, Bar-Ilan University, Israel, Ramat Gan, USA; cSchool of
Neurobiology, Biochemistry and Biophysics, Life sciences faculty, Tel Aviv
University, Israel, Tel Aviv, Israel; dSacklar School of medicine, department of
human genetics and biochemistry Tel Aviv University, Israel, Petah Tikva,
Israel; eSacklar School of Medicine, Department of Human Genetics and
Biochemistry Tel Aviv University, Israel, Petah Tikva, USA; fSagol School
of neuroscience, Tel Aviv University, Israel. School of Neurobiology,
Biochemistry and Biophysics, Life Sciences Faculty, Tel Aviv University,
Israel, Tel Aviv, Israel; gSagol School of Neuroscience, Tel Aviv University,
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Israel, Sacklar School of Medicine, Department of Human Genetics and
Biochemistry Tel Aviv University, Israel, Tel Aviv, USA
Introduction: Though exosoemes have been found to
cross the blood–brain barrier, their migration and
homing abilities within the brain remain unstudied.
We have recently developed a method for longitudinal
and quantitative in vivo neuroimaging of exosomes,
based on the superior visualization abilities of CT,
combined with gold nanoparticles as labelling agents.
Here, we used this technique to track the migration
and homing patterns of intranasally administrated exo-
somes derived from bone marrow mesenchymal stem
cells (MSC-exo) in different brain pathologies, includ-
ing stroke, autism, Parkinson’s disease and Alzheimer’s
disease. We found that MSC-exo specifically targeted
and accumulated in pathologically-relevant murine
models brains regions up to 96 h post administration,
while in healthy controls they evacuated. The neuro-
inflammatory signal in pathological brains was highly
correlated with MSC-exo accumulation. In addition,
MSC-exo were selectively uptaken by neuronal cells
in the pathological regions.
Methods: Exosomes were extracted from human bone
marrow mesenchymal stem cells. They were loaded
with glucose-conjugated gold nanoparticles and were
given via intranasal administration to mice with differ-
ent pathologies. All mice were scanned with CT 1, 24
and 96 h post administration. Moreover, using PKH26
MSC-exo were labelled and were visualized with whole
brain florescence.
Results: Altogether, our DATA suggests that MSC-exo
present distinct neurodistribution which is pathology-
specific in each of the mice models visualized both in
vivo and ex-vivo.
In both the induced stroke and Parkinson’s models, the
MSC-exo were visualized mainly in the damaged tissue
(Striatum). In Alzheimer’s model, they were visualized
mainly in the hippocampus, and in the Autism mice
model, they were visualized both in the prefrontal
cortex and the cerebellum. Interestingly, in healthy
mice the exosomes did not home to any specific loca-
tion and the signal was lost 24 h post administration
both in vivo and ex vivo. In the damaged tissue, the
MSC-exo were found mainly in the neurons and not in
other cells.
Summary/conclusion: Taken together, these findings
can significantly promote the application of exosomes
for therapy and targeted drug delivery in various brain
pathologies via intranasal administration.
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OF22.01
Biolayer interferometry – extracellular vesicles (BLIEV) platform for
liquid biopsy of ovarian cancer
Tatu Rojalina, Randy Carneya and Kit Lamb
aUC Davis, Davis, USA; bUniversity of California, Davis, Sacramento, USA
Introduction: Rigorous efforts are being addressed to
tackle the hurdles in extracellular vesicle (EV)-based
cancer diagnostics – in particular liquid biopsies. We
introduce a promising optical platform, biolayer inter-
ferometry – EV (BLIEV) for EV-based liquid biopsies.
BLIEV utilizes “dip-and-read” optical fibre biosensors
without any microfluidics that can be clogged by crude
and complex sample matrices.
Methods: A ForteBio Octet RED384 System and SSA
Streptavidin sensor tips were used for the BLI. EVs
were collected from the serum of 16 ovarian cancer
(OvCan) patients and 16 healthy (H) individuals. A
group of 16 test samples was also prepared by spik-
ing-in several concentrations of OvCan EVs into
healthy human plasma. The sensor tips were functio-
nalized with biotinylated CD9 or CD63. Bulk EVs from
OvCan and H preparations were captured by the
BLIEV-CD9 or BLIEV-CD63 biosensors. The same
procedure was repeated for the spiked-in clinical test
samples. Cancer-specific signals were acquired by dip-
ping the EV-containing BLIEV biosensors to the solu-
tion of an in-house cyclic reporter peptide, LXY30,
which has been demonstrated to bind the α3β1 integrin
overexpressed on OvCan cells and EVs.
Results: The EV capturing efficiency of BLIEV-CD9 and
BLIEV-CD63 sensors was very high, enabling the sub-
sequent detection with LXY30. Regardless the used bio-
sensor type, high signals were recorded in the bulk-
capturing phase for OvCan EV preparations while the
healthy EV samples gave negligible signals. Titration of
the prepared spiked-in clinical test samples yielded
remarkably high OvCan detection specificity (>90%),
and the sensitivity reaching as low as < 1500 EVs/µL.
Our integrin-binding reporter peptide LXY30 enabled
significant detection specificity towards the OvCan EVs.
Summary/Conclusion: We have developed a robust,
sensitive, label-free, cost-effective, and high-throughput
BLIEV platform for EV-based liquid biopsies. Up to 16
clinical EV samples can be analysed in parallel and
total 384 samples in one run. Processing 16 EV samples
required less than 2 min. To our knowledge, this is the
first time BLI has been used as a diagnostic tool. We
strongly believe that the remarkable sensitivity and
specificity of our BLIEV platform exhibit clinical sig-
nificance for the next-generation cancer diagnostics.
Funding: Sigrid Juselius Foundation, Finland.
OF22.02
Enhanced detection and visualization of exosomes with
interferometric reflectance imaging
M. Selim Ünlüa, Ayca Yalcin Ozkumura, Celalettin Yurdakula, Marcella
Chiarib, Lei Tiana, Fulya Ekiz Kanika, Nese Lortlar Unlua and Elisa Chiodic
aBoston University, Boston, USA; bConsiglio Nazionale delle Ricerche (CNR),
Istituto di Chimica del Riconoscimento Molecolare (ICRM), Milano, Italy;
cCNR, Milano, Milano, Italy
Introduction: Biological sensors that detect whole
viruses and exosomes with high specificity, yet without
chemical labelling, are promising because they generally
reduce the amount and complexity of sample prepara-
tion required by molecular amplification methods and
may improve measurement quality by retaining infor-
mation about nanoscale biological structure. We devel-
oped an optical sensing technology, Interferometric
Reflectance Imaging Sensor (IRIS), a multifunctional
platform for quantitative, label-free and dynamic detec-
tion. In high-magnification modality, Single-Particle
Interferometric Reflactance Imaging (SPIRI) has the
ability to detect and characterize individual biological
nanoparticles. We have recently improved the contrast
and spatial resolution of SPIRI by pupil function engi-
neering and computational imaging.
Methods: In SPIRI, the interference of light reflected from
the sensor surface is modified by the presence of particles
producing a distinct signal that reveals the size of the
particle that is not otherwise visible under a conventional
microscope. Using this instrument platform, we have
demonstrated label-free identification and visualization of
various viruses in multiplexed format in complex samples
in a disposable cartridge. Recently, our technology was
applied to detection of exosomes and commercialized by
Nanoview Biosciences for quantified measurement of exo-
somes on dry sensor chips. We are currently focusing on
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various in-liquid detection as well as further improvement
of the technique using pupil function engineering.
Results: By acquiring multiple images with a parti-
tioned pupil (resulting in structured illumination) and
computational imaging, we have demonstrated signifi-
cant improvement in visibility of low-index nanoparti-
cles in liquid. Furthermore, spatial resolution has been
improved beyond the diffraction limit approaching
100 nm in the visible microscopy. We have developed
compact and inexpensive sensor chips and microfluidic
cartridges allowing for study of biological particles
(exosomes and other extracellular vesicles) directly in
the bodily fluids without labels.
Summary/Conclusion: In summary, we have demon-
strated improved visibility of exosomes in SPIRI using
pupil function engineering.
Funding: EU-INDEX
OF22.03
Proximity assays for detection and characterization of exosomes
Masood Kamali-Moghaddam, Ehsan Manouchehri, Alireza Azimi, Qiujin
Shen, Radiosa Gallini and Claudia Fredolini
Uppsala University, Uppsala, Sweden
Introduction: Exosomes receive an increased attention
in basic biology as well as in medicine. They are shown
to be involved in many biological processes, and are
proven to hold great potentials as diagnostic and ther-
apeutic tools. However, there is an unmet need for new
and improved technologies for quantitative and quali-
tative characterization of exosomes to meet challenges
related to these vesicles, such as low concentrations in
body fluids, the small size of the exosomes or the low
copy numbers of antigens present on the surface of the
exosomes.
Methods: We have developed a large number of affi-
nity-based proximity assays for single- and multiplex
detection of proteins and large complexes with high
specificity and sensitivity. Several of these technologies,
such as proximity ligation assay combined with flow
cytometry readout, multiplex proximity extension
assays and proximity barcoding assays, are used for
sensitive detection and characterization of individual
exosomes.
Results: Commonly, in these assays the exosomes are
recognized by several affinity binders, each equipped
with a DNA oligonucleotide. Upon binding of the
target exosomes by the affinity probes, the DNA oligo-
nucleotides are brought in proximity, subjected to
enzymatic ligation or polymerization, which results in
formation of an amplifiable reporting molecule. The
use of multiple recognition events in combination with
signal amplification allows detection of exosomes with
high specificity and sensitivity.
Summary/Conclusion: Here, we discuss the applica-
tion of proximity assays for sensitive detection of exo-
somes in body fluids, to visualize the uptake of
exosomes by cells, and the potential of such approach
to be used to better understand the biology of the
exosomes and to identify exosomes as disease
biomarkers.
OF22.04
A 96 well plate format lipid quantification assay with improved
sensitivity for standardization of experiments with extracellular
vesicles
Tamas Visnovitza, Xabier Osteikoetxeab, Barbara W. Sódarc, Judith Mihalyd,
Péter Lőrincze, Krisztina V. Vukmana, Eszter Ágnes Tótha, Anna Koncza,
Inna Székácsf, Robert Horváthf, Zoltan Vargag and Edit I Buzásc
aSemmelweis University, Dept. of Genetics, Cell- and Immunobiology,
Budapest, Hungary; bAstraZeneca, Macclesfield, UK; cSemmelweis
University, Budapest, Hungary; dRCNS HAS, Budapest, Hungary;
eDepartment of Anatomy, Cell and Developmental Biology, Eötvös Loránd
University, Budapest, Hungary; fNanobiosensorics Laboratory MTA-EK-
MFA, Budapest, Hungary; gResearch Centre for Natural Sciences,
Hungarian Academy of Sciences, Budapest, Hungary
Introduction: Current EV studies usually standardize
EV samples on the basis of their protein content,
particle number or both. Even with this latter approach
may lead to inaccuracy and overestimation of the EV
concentration. Lipid bilayers are defining components
of EVs. Therefore, a lipid-based quantification, espe-
cially in combination with protein content and/or par-
ticle count determination, appears to be a
straightforward approach for quantification of EVs.
Here we set the goal to improve the sensitivity of the
previously reported sulfo-phospho-vanillin (SPV) lipid
assay.
Methods: We to replace the traditional purified lipid
standards (diluted in organic solvents) with an aqueous
phase liposome standard (DOPC), and we optimized
the concentration of the vanillin reagent of the assay.
Results of the lipid assay were compared with the
previously described ATR-FTIR spectroscopy-based
lipid quantification approach. The assay was validated
with EPIC biosensor system, qNano, commercially
available lipid assay and commercial LDL. Using the
optimized lipid assay, we tested liposomes of known
composition as well as EVs secreted by four different
cell lines. EV markers were documented by immune
electron microscopy.
Results: Elimination of organic solvents from the reac-
tion mixture abolished the background colour that
previously interfered with the assay. Comparison of
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the optimized assay with a commercial lipid kit (also
based on the original SPV lipid assay) showed an
increase of sensitivity by approximately one order of
magnitude, and the lipid-based quantification of EV
samples have clearly increased the reliability of the
experiments.
Summary/Conclusion: The optimized lipid assay with
improved sensitivity provides a fast, reliable and sensi-
tive test that addresses an existing need in EV standar-
dization. This optimized lipid assay for EV lipid
measurements can be as easy as a simple BCA test for
protein determination.
Funding: NVKP_16-1-2016-0017, OTKA11958, OTKA1
20237, OTKA PD112085, VEKOP-2.3.2-16-2016-00002
and VEKOP-2.3.3-15-2016-00016, KH_17 grant, ERC hu
and Lendület, Institutional Higher Education Excellence
Program of theMinistry of HumanResources in the theme
“Therapeutic development”. János Bolyai Research
Fellowship of HAS.
OF22.05
Characterization of exosomes-based on their unique dielectric
properties by a novel electrical impedance measurement system
Yuqian Zhanga, Esam Salemb, Takahisa Nakamurac and Leyla Esfandiard
aUniversity of Cincinnati, Non-hispanic or Latino, USA; bCincinnati
Children’s Hospital Medical Center, Cincinnati, USA; cCincinnati
Children’s Hospiltal Medical Center, Cincinnati, USA; dUniversity of
Cincinnati, Cincinnati, USA
Introduction: Exosomes are composed of a lipid
bilayer membrane containing nucleic acids, proteins
and lipids in the lumen and their compositions reflect
their cell of origin. Thus, when the secreting cells are in
abnormal microenvironments, the exosomes undergo
the compositional changes. We have developed a new
class of electrical impedance measurement system to
non-invasively characterize exosomes based on their
unique dielectric properties. Although, the biophysical
properties of exosomes such as size, density and shape
have been characterized before, their dielectric proper-
ties have not been investigated.
Methods: An electrokinetic-based system has been
developed to characterize the dielectric properties of
exosomes extracted from human hepatocellular carci-
noma (HuH-7) cells under different culture conditions.
Extracted exosomes were initially trapped with dielec-
trophoresis and further characterized by their dielectric
properties as 0.2Vpp was swept from 1 kHz to 50 MHz.
Results: The principle of the impedance measurement
was adapted from the Maxwell’s mixing theory applied
to analyse the dielectric behaviour of cells. Opacity was
defined as the ratio of impedance magnitude at high
frequency (>1 MHz) to the low frequency (e.g.
500 kHz), which provided a parameter independent of
the number of vesicles, reflecting the changes in dielectric
properties including their membrane capacitance and
cytosolic conductance. Extracted exosomes from different
cell of origins were measured five times and the result
showed the changes in opacity measurements at the
intermediate and high frequency ranges which represents
the difference between the membrane composition and
cytosolic conductance of the exosomes.
Summary/Conclusion: A new class of electrical impe-
dance measurement system was developed with the
capability to characterize and distinguish exosomes
based on their unique dielectric properties as their
biogenesis was subjected to systematic changes under
different culture conditions. This technique can be
further utilized for classification of exosomes based
on their cell of origin and can be evolved as a diag-
nostic tool for characterizing the pathogenic exosomes.
Funding: UC Faculty Development Fund.
OF22.06
A snorkel-tag based method for in vivo isolation of recombinant
extracellular vesicles
Madhusudhan Reddy Bobbilia, Stefan Vogtb, Severin Muehlederc, Carolina
Patriolid, Samir Barbariab, Markus Schossererb, Wolfgang Holnthonee, Heinz
Redle, André Görgensf, Samir El Andaloussig and Johannes Grillarih
aUniversity of Natural Resources and Life Sciences Vienna (BOKU), Vienna,
Austria; bUniversity of Natural Resources and Life Sciences, Vienna (BOKU),
Vienna, Austria; cLudwig Boltzmann Institute for Experimental and Clinical
Traumatology, vienna, Austria; dUniversity of Natural Resources and Life
Sciences, Vienna (BOKU), vienna, Austria; eLudwig Boltzmann Institute for
Experimental and Clinical Traumatology, Vienna, Austria; fKarolinska
Institutet, Department of Laboratory Medicine, Stockholm, Sweden;
gDepartment of Laboratory Medicine, Clinical Research Center, Karolinska
Institutet, Sweden., Stockholm, Sweden; hChristian Doppler Laboratory on
Biotechnology of Skin Aging, University of Natural Resources and Life
Sciences, Vienna (BOKU), Vienna, Austria
Introduction: Extracellular vesicles (EVs) emerged as
an important mode of cell-to-cell communication in
both normal and pathological conditions by transfer-
ring the cargo from donor cell to recipient cell. It is
their apparent natural ability to transfer cargo from
donor cell to recipient cell and thus regulating via
paracrine or endocrine mode. Over a decade, lot of
research has been done to understand the omics,
mode of secretion and uptake mechanisms. However,
trafficking of EVs in vivo is still poorly understood.
Methods: We used recombinant tetraspanin (tetraspa-
nin with C-terminus snorkel tag (1)) as a tool to under-
stand trafficking of EVs in vivo. As a first step we
established a method for isolating functional EVs car-
rying recombinant tetraspanins from stably expressing
cells in vitro. The presence of snorkel-tagged
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tetraspanins on EVs are not affecting the surface
protein signature (2). This method uses a combination
of anti-HA (hemagglutinin) affinity matrix and
Prescission protease to isolate EVs from cell culture
supernatants without damaging the integrity of the
EV membrane.
Results: EVs isolated by this method are further char-
acterized by using multiplex bead-based flow cytometry
assay and electron microscopy. The multiplex bead-
based assay results showed us that we are able to pull
out EVs carrying only snorkel tag from a mixture of
different EVs from different sources. Furthermore, we
plan to spike in human recombinant EVs into mouse
plasma and isolate recombinant EVs from this complex
matrix using this method and confirm by multiplex
bead-based assay. In addition, to determine the func-
tionality of recombinant EVs, we used CRE-LoxP
method (3) to confirm the recombinant EV uptake in
recipient cells.
Summary/Conclusion: Ultimately, we are comparing
the RNA content of recombinant EVs isolated by snor-
kel-tag to CD81+ affinity purified EVs with the total
EV population in order to investigate the specific RNA
loading by RNA seq.
Funding: This work supported by the FWF Doctoral
Program BioToP [W1224]
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piRNA biogenesis and functions in drosophila
Mikiko C. SIOMI
University of Tokyo, Tokyo, Japan
PIWI-interacting RNAs (piRNAs) are small non-cod-
ing RNAs enriched in animal gonads where they arm
race with transposons to maintain germline genome
integrity. Although transposons are powerful agents
contributing to evolution, they are also regarded as
selfish DNA parasites. Indeed, loss of piRNAs causes
derepression of transposons, leading to DNA damage
and failure in gonadal development and fertility. Thus,
piRNA-mediated transposon silencing is indispensable
for animals that undergo obligate sexual production,
including humans. Since the discovery of piRNAs, stu-
dies have intensively been conducted worldwide and
fundamental features of the pathway have emerged. We
now know that piRNAs are primarily produced from
piRNA clusters, discrete intergenic elements composed
of transposon remnants, and loaded onto PIWI pro-
teins to form piRISCs. Cytoplasmic piRISCs silence
transposons post-transcriptionally while piRISCs in
the nucleus repress target genes co-transcriptionally.
However, the molecular mechanism is not yet fully
understood. To solve the problem, we have use
Drosophila and Bombyx as model systems, particularly
their cultured cell lines where piRNAs are fully
functional in repressing transposons. The details of
our new findings will be presented at the meeting.
EV as a novel therapeutic target for cancer metastasis
Takahiro Ochiya, Ph.D., Chief and professor
National Cancer Center, Tokyo and Tokyo Medical University
Extracellular vesicles, known as exosomes and micro-
vesicles, serve as versatile intercellular communication
tools. Increasing evidence has suggested that cancer
cell-derived exosomes carry pathogenic components.
Exosomal transfer of cancer pathogenic components
enable long-distance-crosstalk between cancer cells
and target organs and tissues, resulting in the promo-
tion of the initial steps for pre-metastatic niche forma-
tion. Furthermore, the circulating exosome have also
been of interest as a source for liquid biopsies.
Circulating exosome in body fluids provides a reliable
source of miRNAs, mRNAs, DNAs, proteins and onco-
metabolites for cancer biomarkers. We also suggest our
current knowledge on the tumour-specific DNA
methylome in exosomes effectively provide various
messages on the physiological and pathological status
of cancer patients. In this talk, we provide an overview
of current research on exosomes in cancer. We also
propose new therapeutic strategies by targeting cancer-
specific exosomes to inhibit tumour metastasis.
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A novel CRISPR/Cas9-based reporter system enables detection of EV-
mediated functional transfer of RNAs on a single-cell level
Olivier G. de Jonga, Dan E. Murphyb, Imre Mägerc, Eduard Willmsc, Sander
A.A. Kooijmansb, Raymond Schiffelersb, Samir El Andaloussid, Matthew J. A.
Woodc and Pieter Vaderb
aDepartment of Physiology, Anatomy and Genetics, University of Oxford,
UK, Utrecht, Netherlands; bLaboratory of Clinical Chemistry and
Hematology, University Medical Center Utrecht, The Netherlands, Utrecht,
Netherlands; cDepartment of Physiology, Anatomy and Genetics, University
of Oxford, UK, Oxford, UK; dDepartment of Laboratory Medicine, Clinical
Research Center, Karolinska Institutet, Sweden., Stockholm, Sweden
Introduction: In recent years, multiple studies have
shown that extracellular vesicles (EVs) play a role in
intercellular communication through transfer of RNAs.
Unfortunately, our understanding of the mechanisms
regulating EV-mediated RNA delivery and processing
is lacking, due to the absence of suitable readout sys-
tems for functional RNA transfer. Here, we describe a
novel highly-sensitive CRISPR/Cas9-based reporter
system that, for the first time, allows direct functional
study of EV-mediated transfer of small non-coding
RNA molecules on a single-cell level.
Methods: We generated a CRISPR/Cas9-based stop-
light reporter system, in which eGFP expression is
activated upon functional delivery of targeting single-
guide RNAs (T-sgRNAs). Donor cell lines were gener-
ated stably expressing either T-sgRNAs or non-target-
ing sgRNAs (NT-sgRNAs). Intercellular functional
RNA transfer was assessed by measuring eGFP expres-
sion in reporter cells after direct co-culture, transwell
co-culture, and upon addition of isolated EVs, using
fluorescence microscopy and flow cytometry. The role
of potential regulators of EV-mediated RNA transfer
was assessed after RNAi-mediated target knockdown in
reporter cells, prior to co-culture experiments.
Results: Expression of sgRNAs in donor cells and EVs
was confirmed by RT-PCR. A significant activation of
eGFP expression was observed in reporter cells after
direct co-culture and transwell co-culture with donor
cells expressing T-sgRNAs, but not NT-sgRNAs.
Addition of EVs from cells expressing T-sgRNAs, and
not NT-sgRNAs, also resulted in significant reporter
activation. Reporter activation was substantially
decreased after blocking EV production through addi-
tion of GW4869 or Rab27A knockdown in donor cells.
Knockdown of multiple targets in endocytosis and/or
intracellular membrane trafficking in reporter cells sig-
nificantly decreased reporter activation, suggesting vital
roles for these processes in EV-mediated RNA transfer.
Summary/Conclusion: Here we demonstrate a
CRISPR/Cas9-based reporter system that for the first
time allows the study of functional delivery of small
non-coding RNAs with single-cell resolution. This
novel approach allows the study of EV cargo proces-
sing in the context of functional RNA delivery, and
may help to increase our understanding of the regula-
tory pathways that dictate the underlying processes.
FA2.02
From nanoscale to organisms: a multi-resolution imaging system of
endogenously released extracellular vesicles with bioluminescence
resonance energy transfer
Anthony Yan-Tang Wua, Yun-Chieh Sungb, John Jun-Sheng Koc, Alan Ling
Yangd, Vanessa Guoe, Yunching Chenf and Charles P. Laie
aDepartment and Graduate Institute of Pharmacology, National Taiwan
University, Taipei, Taiwan (Republic of China); bDepartment of Chemical
Engineering, National Tsing Hua University, Hsinchu, Taiwan (Republic of
China); cInstitute of Biomedical Engineering, National Tsing Hua University,
Zuoying, Taiwan (Republic of China); dInstitute of Atomic and Molecular
Sciences, Taoyuan, Taiwan (Republic of China); eInstitute of Atomic and
Molecular Sciences, Academia Sinica, Taipei, Taiwan (Republic of China);
fNational Tsing-Hua University, Hsinchu, Taiwan (Republic of China)
Introduction: Accurate visualization and monitor-
ing of EVs is paramount to the understanding of its
biological mechanism. However, EV labelling with
organic dyes such as DiI and PKH have an extended
half-life (e.g. PKH26: >100 days) and self-assemble
into micelles, which may lead to inaccurate inter-
pretation of EV spatiotemporal properties.
Furthermore, reporters which fuse EV and fluores-
cent proteins (e.g. CD63-GFP) may only detect spe-
cific EV subpopulations.
Methods: To overcome these limitations, here we
developed a next-generation reporter to enable EV
imaging from organismal to super-resolutions by engi-
neering enhanced green fluorescent protein fused to a
palmitoylation signal and nanoluciferase, termed
PalmGp. HEK293T and HCA-1 cells were lentivirally
transduced to stably expressed PalmGp as EV donor
cells. In vivo EV and nanoscopic imaging were
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achieved by in vivo imaging system (IVIS) and super-
resolution radial fluctuations nanoscopy, respectively.
Results: PalmGp predominantly labels EV inner mem-
brane, and exhibited a robust bioluminescent and
BRET-GFP signals for EV imaging upon addition of
its substrate, furimazine. IVIS imaging of liver cancer
HCA1-PalmGp bearing mice showed sustained biolu-
minescent and fluorescent signals at the primary and
metastatic sites, indicating the high sensitivity of
PalmGp to enable biodistribution and clearance of
endogenously released EVs. PalmGp-EVs could further
be visualized at super-resolution (50–150 nm) to moni-
tor EV subcellular trafficking.
Summary/Conclusion: To our knowledge, this is the
first report of a multi-resolution reporter strategy that
enables EV imaging. Efforts are currently underway in
employing the PalmGp EV reporter to elucidate the
spatiotemporal property and mechanism(s) of cancer
EVs during disease progression.
Funding: Ministry of Science and Technology (MOST)
grants104-2320-B-007–005-MY2 (C.P.L.), 106–2320-B-
007–004-MY3 (C.P.L.), and Academia Sinica Innovative
Materials and Analysis Technology Exploration (i-MATE)
Program AS-iMATE-107–33 (C.P.L.)
JOURNAL OF EXTRACELLULAR VESICLES 277
Symposium Session 23: EV Engineering II
Chairs: Cherie Blenkiron; Thomas Kislinger
Location: Level 3, Hall B
13:00–14:00
OS23.01
exoTOPE: loading bioactive molecules into exosomes using a short-
peptide fusion
Russell McConnell, Madeleine Youniss, Ke Xu, Kevin Dooley, Bryan Choi,
Rane Harrison, Sonya Haupt, Damian Houde, Nuruddeen Lewis, Shelly
Martin, Chang Ling Sia and Sriram Sathyanarayanan
Codiak BioSciences, Cambridge, USA
Introduction: Exosomes represent a promising thera-
peutic platform for the selective delivery of diverse
classes of payloads; however, loading exosomes with
non-native cargo molecules has historically been a sig-
nificant barrier to unlocking this potential. We rea-
soned that it would be possible to load therapeutically
relevant proteins into exosomes by identifying and co-
opting peptide sequences that natively enrich proteins
in exosomes.
Methods: Differential and density gradient ultracentri-
fugation were used to purify exosomes from cell cul-
ture supernatant. LC-MS/MS was used to identify
proteins present in purified exosomes, the amino acid
sequences of highly abundant proteins were analysed
for common sequence features, and plasmids encoding
candidate peptide sequences fused to cargo proteins
were expressed in stably selected cells. The enrichment
of fusion proteins in purified exosomes was assessed
using biochemical, flow cytometric and functional
analyses.
Results: Among the most abundant native exosomal pro-
teins identified by LC/MS-MS were three members of the
MARCKS family. All three MARCKS family members
were found to strongly localize to purified exosomes
when overexpressed as GFP fusions. Using truncated and
point mutant versions of sequences derived from these
proteins, we identified a seven amino acid consensus pep-
tide sequence that is able to load non-native cargo proteins
into the exosome lumen at extremely high levels, compris-
ing up to ~10% of the total exosomal protein. Sequences
containing this seven amino acid “exoTOPE” tag were
used to load exosomes with cytosolic cargos such as fluor-
escent proteins, RNA-binding proteins and mRNA, Cas9,
antigenic peptides and proteins, and the type 2 transmem-
brane protein CD40 ligand (CD40L). Exosomes carrying
exoTOPE-CD40L activated antigen presenting cells in
PBMCassays with similar EC50 values as free recombinant
CD40L.
Summary/Conclusion: We have identified and refined
a short peptide, exoTOPE, that can be used to load
exosomes with diverse classes of cargos, including pro-
teins and nucleic acids. The small size of this peptide
tag makes this system readily adaptable to a wide
variety of applications and represents a significant
advance in our ability to engineer exosomes with bio-
logically active cargos.
Funding: Funded by Codiak Biosciences.
OS23.02
Retrograde dicer-independent AGO-loading of extracellular single
stranded miRNA in recipient human cells
Bartika Ghoshala and Suvendra N. Bhattacharyyab
aCSIR_Indian Institute of Chemical Biology, Kolkata, India, Kolkata, India;
bMolecular Genetics Division, CSIR-Indian Institute of Chemical Biology,
Kolkata, India
Introduction: microRNAs are tiny regulator of gene
expression that can be transferred between neighbour-
ing cells in mammalian tissue to control the expression
of genes in both donor and recipient cells. How the
extracellular vesicle (EV)-derived miRNAs are getting
internalized and become functional in target cells is an
unresolved question.
Methods:We used mammalian cells in culture to study
the EV-mediated miRNA delivery to target cells. Using
miR-122 negative HeLa cells as recipient cells and miR-
122 containing exososmes isolated from miR-122 posi-
tive cells, we have delineated the mechanistic detail of
the import process.
Results: We have identified that, through a unique
mechanism, the EV-associated miRNAs that are primar-
ily single stranded can get loaded with the Ago proteins
present in the target cells to become functional there. The
loading of EV-derivedmiRNAs to host cells Ago proteins
is not dependent on the Dicer1 that otherwise required
for the loading of the Ago proteins with double stranded
miRNAs before one strand get cleaved and dislodged
from Ago2. The EV-derived miRNA loading of Ago2
happens on the endosomal membrane where the pH
dependent fusion of the internalized EV membrane
with endosomal membrane releases the miRNAs that
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get loaded with unloaded Ago2 present on the endosomal
membrane. This process is depenent on memebrane
dynamics and restriction of memebrane dynamics either
due to mitochondrial depolarization or other ways affects
the loading of EV-derived miRNAs with Ago2.
Leishmania donovani, a protozoan parasite affect mem-
brane dynamics in infected macrophage cells and thus it
restrict the internalization of miR-122 containing EVs
that otherwise cause an inflammatory response in mam-
malian macrophage-a process detrimental for the
pathogen.
Summary/Conclusion: therefore we conclude that
Leishmania donovani Restricts Retrograde Dicer-
Independent Loading of Extracellular Single Stranded
miR-122 in Host Cell Agos to Prevent Inflammatory
Response.
Funding: SERB, Dept of Science and Technology,
Govt. of India and Swarnajayanti Fellowship Fund,
Dept of Science and Technology, Govt. of India.
OS23.03
Engineering of extracellular vesicles for surface display of targeting
ligands
Elisa Lázaro-Ibáñeza, Anders Gunnarssonb, Gwen O´Driscollb, Olga
Shatnyevac, Xabier Osteikoetxead and Niek Dekkerb
aAstraZeneca, molndal, Sweden; bAstraZeneca, Mölndal, Sweden;
cAstraZeneca, Molndal, Sweden; dAstraZeneca, Macclesfield, UK
Introduction: Cell engineering is one of the most com-
mon strategies to modify extracellular vesicles (EVs) for
therapeutic drug delivery. Engineering can be applied to
optimize cell tropism, targeting, and cargo loading. In this
study, we screened several EV proteins fused with EGFP to
evaluate the surface display of the EV-associated cargo. In
addition, we screened for EV proteins that could efficiently
traffic cargo proteins into the lumen of EVs. We also
developed a novel technology to quantify the number of
EGFP molecules per vesicle using total internal reflection
(TIRF) microscopy for single-molecule investigation.
Methods: Human Expi293F cells were transiently
transfected with DNA constructs coding for EGFP
fused to the N- or C-terminal of EV proteins (e.g.,
CD63, CD47, Syntenin-1, Lamp2b, Tspan14). 48 h
after transfection, cells were analysed by flow cytome-
try and confocal microscopy for EGFP expression and
EVs were isolated by differential centrifugation fol-
lowed by separation using iodixanol density gradients.
EVs were characterized by nanoparticle tracking ana-
lysis, western blotting, and transmission electron
microscopy. Single-molecule TIRF microscopy was
used to determine the protein number per vesicle at a
single particle level, using monomeric EGFP as a
reference.
Results: The screening of EGFP fused to the N- or C-
terminal of EV proteins served as a quantitative
method to identify protein candidates for the surface
display of EV-associated cargo. Fusions to CD47 and
luminal EV proteins with a snorkel domain allowed the
display of EGFP at the surface of EVs, with CD47 as
good candidate for surface display. Alternatively,
fusions of EGFP to EV proteins with either C- or N-
in topology like Tspan14 and CD63 allowed for loading
of EGFP within the EV lumen. Single EV analysis using
TIRF microscopy enabled the quantification of the
average number of EGFP molecules per single engi-
neered vesicle, which was between 15 and 136 EGFP/
EV depending on the fusion protein.
Summary/Conclusion: The screening of EGFP-fusions
to EV proteins revealed several protein candidates for
both surface display and intra-luminal cargo loading in
EVs. These results contribute to the understanding of
EV biogenesis and are relevant for exploiting the
potential of engineered EVs as drug delivery systems.
OS23.04
Endogenous drug loading of extracellular vesicles using microbubble-
assisted ultrasound
Yuana Yuanaa, Kim van der Wurff-Jacobsa, Banuja Balachandrana, Linglei
Jiangb and Raymond Schiffelersc
aDivision Imaging, UMC Utrecht, The Netherlands, Utrecht, Netherlands;
bDepartment of Clinical Chemistry and Haematology, UMC Utrecht, The
Netherlands; cLaboratory of Clinical Chemistry and Hematology, University
Medical Center Utrecht, Utrecht, Netherlands
Introduction: Development of extracellular vesicles (EVs)
as nanocarriers for drug delivery relies on loading a
substantial amount of drug into EVs. Loading has been
done from the simplest way by co-incubating the drug
with EVs or producer cells until using physical/chemical
methods (e.g. electroporation, extrusion, and EV surface
functionalization). We use physical method combining
gas-filled microbubbles with ultrasound known as sono-
poration (USMB) to pre-load drug in the producer cells,
which are eventually loaded into EVs.
Methods: Cells were grown overnight in 0.01% poly-L-
lysine coated cell culture cassette. Prior to USMB, cells
were starved for 4 h. Treatment medium containing
microbubbles and 250 µg BSA-Alexa Fluor 488 as a
model drug was added to the cells grown in the cas-
sette. Cells were exposed directly to pulsed ultrasound
(10% duty cycle, 1 kHz pulse repetition frequency, and
100 μs pulse duration) with up to 845 kPa acoustic
pressure. After USMB, cells were incubated for
30 min and then treatment medium was removed.
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Cells were washed and incubated in the culture med-
ium for 2 h. Afterward, EVs in the conditioned med-
ium were collected and measured.
Results: Cells took up BSA-Alexa Fluor 488 after
USMB treatment as measured by flow cytometry.
These cells released EVs in the conditioned medium
which were captured by anti-CD9 magnetic beads.
About 5% of the CD9-positive EVs contained BSA-
Alexa Fluor 488. The presence of CD9-positive EVs
containing BSA also were confirmed by immunogold
electron microscopy.
Summary/Conclusion: USMB serves as a tool to pre-
load the model drug, BSA-Alexa Fluor 488, endogen-
ously and to produce EVs loaded with this model drug.
USMB setup, incubation time, and type of drugs will be
investigated to further optimize the production of
drug-loaded EVs and to explore possible application
for in situ drug delivery system.
Funding: This research is funded by Focused
Ultrasound Foundation.
OS23.05
Extracellular Vesicles for new Molecular Insight to Biomolecular
Interactions
Tamas Beke-Somfaia, Priyanka Singhv, Imola Szigyarto and Zoltan Vargac
aPI, Budapest, Hungary; bMs, Budapest, Hungary; cResearch Centre for
Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary
Introduction: The potential of extracellular vesicles
(EVs) to revolutionize the diagnosis and therapy of
various diseases has been realized and thus it is an
extensively studied direction. However, EVs are also
in the size range suitable for membrane biophysics,
while they preserve the complex composition of a
biological bilayer. Consequently, they are optimal for
monitoring the structure, orientation and function of
biomolecules associated to EVs.
Methods: The investigated red blood cell-derived vesicles
(REVs) were isolated from blood using a standard protocol
and purified using size-exclusion chromatography. REVs
were subjected to IR, CD and flow-Linear Dichroism
spectroscopy, freeze-fracture Transmission Electron
Microscopy as well as Dynamic Light Scattering.
Results: Here we demonstrate that polarized light spectro-
scopy techniques can provide important information on
REVs and molecules inserting into their bilayer. Flow-
linear dichroism (flow-LD) measurements show that EVs
can be oriented by shear force, insight into properties of
orientedmacromolecules in the vesicles. The Soret-band of
the LD spectra demonstrates that hemoglobin molecules
are oriented and associated to the lipid bilayer in freshly
released REVs [1].
Further on, we selected three different antimicrobial
peptides (AMPs), CM15, melittin and gramicidin and
investigated their interactions with REVs using a
diverse set of techniques. The peptide-membrane inter-
actions reveal several novel function of AMPs, includ-
ing their ability to remove associated proteins from the
surface of REVs (Figure 1).
[1] I. Cs. Szigyártó, R. Deák, J. Mihály, S. Rocha, F.
Zsila, Z. Varga, T. Beke-Somfai. Flow-alignment of
extracellular vesicles: structure and orientation of
membrane associated biomacromolecules studied with
polarized light. ChemBioChem. 2018;19:545–551
Summary/Conclusion: In conclusion, EVs provide excel-
lent opportunities to better understand the function and
mechanism of natural membrane active biomolecues.
Funding: This work was funded by the Momentum
programme (LP2016-2), by the National Competiti-
veness and Excellence Program (NVKP_16-1-2016-
0007) and BIONANO_GINOP-2.3.2-15-2016-00017.
The János Bolyai Research Scholarship (Z.V.) is greatly
acknowledged.
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OS24.01
State of the art microscopy for live cell study of the extracellular
vesicle-mediated drug delivery
Ekaterina Lisitsynaa, Kaisa Rautaniemia, Heikki Saarib, Timo Laaksonena,
Marjo Yliperttulab and Elina Vuorimaa-Laukkanena
aLaboratory of Chemistry and Bioengineering, Tampere University of
Technology, Tampere, Finland; bDivision of Pharmaceutical Biosciences
and Drug Research Program, Faculty of Pharmacy, University of Helsinki,
Helsinki, Finland
Introduction: Extracellular vesicles (EVs) provide a
compelling alternative for targeted drug delivery due
to the unique set of their properties: (1) natural
protection of EV content from degradation in the
circulation; (2) EVs’ intrinsic cell targeting proper-
ties and (3) innate biocompatibility. However, their
mechanisms of interacting with living cells are
poorly understood.
Methods: Microvesicles (MVs) and exosomes (EXOs)
derived from prostate cancer cells were studied. The
EVs were passively loaded with the conjugate of cancer
drug Paclitaxel (Ptx) and fluorescent probe Oregon
Green (OG). Ptx-OG EVs were applied to the cells
autologously and imaged by fluorescence lifetime
microscopy (FLIM). Simultaneous labelling of cell
organelles with the FRET pairs to OG was done to
utilize FLIM in combination with Foerster resonance
energy transfer (FLIM-FRET). Time-resolved fluores-
cence anisotropy imaging (TR-FAIM) was applied for
the first time to study the EV-based drug delivery.
Confocal microscopy was used as a standard method
of live cell imaging.
Results: By FLIM, we show distinct cellular uptake
mechanisms for EXOs and MVs loaded with the
drug-dye conjugate Ptx-OG. We demonstrate differ-
ences in intracellular behaviour and drug release
profiles of Ptx-containing EVs in correlation with
the intracellular position. Based on FLIM and con-
focal data we suggest that EXOs deliver the drug
mostly by endocytosis while MVs enter the cells by
both endocytosis and fusion with the cell mem-
brane. TR-FAIM shows that Ptx-OG binds some
intracellular target inside the cell that is in accor-
dance with the known fact that Ptx interacts with
microtubules network.
Summary/Conclusion: This research offers new real-
time methods to investigate EV kinetics with living
cells and complements the existing techniques. The
findings of the study improve the current knowledge
in exploiting EVs as drug delivery systems.
Funding: The research is funded by Academy of
Finland projects 311362 and 258114.
OS24.02
Fusion of extracellular vesicles (EVs) and delivery of internal EV
cargos to host cells is dependent upon circulating or endogenous
viral envelope proteins
Zach A. Troyera, Aiman Haqqanib and John Tiltonb
aCase Western Reserve University, Shaker Heights, USA; bCase Western
Reserve University, Cleveland, USA
Introduction: Extracellular vesicles (EVs) contain pro-
teins and small RNAs that are posited to mediate cell-
to-cell communication; however, the precise molecular
mechanisms of EV fusion to host cells and delivery of
internal cargos remains poorly defined. Delivery of
internal EV cargos to target cells requires fusion
between the EV and cell membranes; otherwise, the
EV and its contents are degraded by lysosomal
enzymes. In this study, we probed the molecular
mechanisms of EV fusion by adapting and employing
a validated and powerful viral fusion assay.
Methods: EVs were produced in HEK 293T cells and
labelled with beta-lactamase (BlaM) by overexpression
or with BlaM-CD9/CD63/CD81 chimeric proteins. In
some conditions, the HEK 293T cells were also trans-
fected with plasmids encoding viral envelope glycopro-
tein (Env) proteins. EVs were isolated by
ultracentrifugation and size exclusion chromatography,
characterized by TEM imaging, and titered with
microBCA assay. To test EV fusion, EVs were added
to target cells containing CCF2-AM FRET dye. Fusion
was measured by flow-cytometric evaluation of CCF2-
AM dye cleavage by BlaM.
Results: EVs produced in the absence of viral Env
showed no evidence of fusion with target cells. In
contrast, EVs produced in cells co-transfected with
vesicular stomatitis virus Env (VSV-G) were highly
fusogenic even at low doses. EV fusion was dependent
on the presence of functional viral Env machinery,
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either from actively circulating viruses – including
VSV-G, rabies, influenza, and mokola viruses – or
from human endogenous retroviruses (HERVs) Env
proteins – such as syncytin-1.
Summary/Conclusion: EVs produced in the
absence of viral Env machinery are poorly fusogenic
and are unlikely to be efficient mediators of cell-to-
cell communication via the delivery of EV contents
to the cytoplasm. In contrast, viral Env proteins
significantly enhance EV fusogenicity, suggesting
that EV fusion and communication may occur and
play a significant role during viral infections.
Furthermore, cells expressing the HERV Env syncy-
tin-1 – including many human cancers – also give
rise to fusogenic EVs that may contribute to tumour
establishment, growth, and metastasis. These find-
ings suggest that blocking syncytin-mediated EV
fusion may be an effective strategy to block EV
communication in human cancers.
OS24.03
Preferential accumulation of copper-free click chemistry-modified
exosomes to own pancreatic xenograft in vivo
Lizhou Xua, Revadee Liam-Orb, Farid N. Faruqub, Omar Abedc, Danyang Lib,
Julie Wangb and Khuloud Al-Jamalb
aSchool of Cancer and Pharmaceutical Sciences, King’s College London,
London, UK; bKing’s College London, London, UK; cKing’s College
London, London, UK
Introduction: Pancreatic cancer (PC) is one of the
deadliest malignancy with few effective approaches
available for early diagnosis or therapy. Exosomes
(Exo) as one type of extracellular vesicles are cur-
rently being investigated as potential theragnostic
tools in cancer. However, it is not yet well-under-
stood how Exo are taken up by PC cells. This work
aims to study the Exo dosimetry and preferential
Exo-cell affinity in PC cells in vitro and in vivo for
exploitation of Exo-based delivery of therapeutics.
Methods: Exo are isolated by sucrose cushion ultra-
centrifugation and characterized for exosomal marker
expression, number, purity and shape. Exo were fluor-
escently labelled by copper-free click chemistry to
enable uptake quantification in cells using the Design
of Experiments (DoE) approach. Cellular uptake of Exo
was investigated using flow cytometry and confocal
microscopy. Factors studied are donor Exo source,
dose, receipt cell type, and incubation time.
Responses identified are Exo “Taken up numbers”
and “Percentage uptake” per cell. Candidate PC Exo
uptake was then assessed in vivo and compared
between PC and melanoma xenograft models in NSG
mice following intravenous administration.
Results: Cellular uptake of Exo was time- and dose-
dependent profiles. PC derived PANC-1 Exo showed
significantly higher and not saturable uptake in PANC-
1 cells compared to B16-F10 Exo (cancer-derived) and
HEK-293 Exo (non-cancer derived) which showed
lower and saturable uptake profile at 24 h. In vivo
biodistribution studies of PANC-1 Exo in subcuta-
neous PC xenograft further confirmed that PANC-1
Exo favoured accumulation in PC tumours over mela-
noma (B16-F10) tumours.
Summary/Conclusion: A simple and highly efficient
surface modification approach via click chemistry was
developed enabling both in vitro and in vivo tracking of
Exo. DoE modelling predicted PC cells’ preference to
PC-derived Exo which was confirmed also in vivo. This
Exo dosimetry study could facilitate a rationalized
approach in Exo-based therapeutics for treatment of
cancer in pre-clinical studies.
Funding: The K. C. Wong Education Foundation and
The Marie Skłodowska-Curie actions, European
Commission “Horizon 2020”, EU (H2020-MSCA-IF-
2016)
OS24.04
Specific transfer of hollow gold nanoparticles within exosomes is
determined by the exosome origin
Maria Sancho-Alberoa, Nuria Navascuésb, Gracia Mendozab, Victor
Sebastiana, Manuel Arrueboa, Pilar Martin-Duquec and Jesus Santamariaa
aDepartment of Chemical Engineering, Aragon Institute of Nanoscience
(INA), University of Zaragoza, Campus Río Ebro- Edificio I+D, C/
Mariano Esquillor S/N, 5018- Zaragoza, Spain.///Networking Research
Center on Bioengineering, biomaterials and Nano, Zaragoza, Spain;
bDepartment of Chemical Engineering, Aragon Institute of Nanoscience
(INA), University of Zaragoza, Campus Río Ebro- Edificio I+D, C/
Mariano Esquillor S/N, 5018- Zaragoza, Spain, Zaragoza, Spain; cInstituto
Aragonés de Ciencias de la Salud/ IIS Aragón// Fundación Araid, Zaragoza,
Spain
Introduction: Exosomes are considered key elements
for communication between cells but very little is
known about the mechanisms and selectivity of the
transference processes involving exosomes released
from different cells.
Methods: In this study we have investigated the trans-
fer of hollow gold nanoparticles (HGNs) between dif-
ferent cells when these HGNs were loaded within
exosomes secreted by human placental mesenchymal
stem cells (MSCs). These HGNs were successfully
incorporated in the MSCs exosome biogenesis pathway
and released as HGNs-loaded exosomes, by using time-
lapse microscopy and atomic emission spectroscopy
Results: Those studies allowed us to demonstrate the
selective transfer of the secreted exosomes only to the
cell type of origin when studying different cell types
282 ISEV2019 ABSTRACT BOOK
including cancer, metastatic, stem or immunological
cells.
Summary/Conclusion: In this study we demonstrate
the selectivity of in vitro exosomal transfer between
certain cell types and how this phenomenon can be
exploited to develop new specific vectors for advanced
therapies. We show how this preferential uptake can be
leveraged to selectively induce cell death by light-
induced hyperthermia only in cells of the same type
as those producing the corresponding loaded exo-
somes. We describe how the exosomes are preferen-
tially transferred to some cell types but not to others,
thus providing a better understanding to design selec-
tive therapies for different diseases.
Funding: We thank the ERC Consolidator Grant pro-
gram (ERC-2013- CoG-614715, NANOHEDONISM)
for the financial support, and CIBER-BBN, financed
by the Instituto de Salud Carlos III.
OS24.05
A high-throughput screen for functional extracellular vesicles
Shu Liua, André Hossingera, Philip Dennera and Ina Vorbergb
aGerman Center for Neurodegenerative Diseases Bonn (DZNE e.V.), Bonn,
Germany, Bonn, Germany; bGerman Center for Neurodegenerative Diseases
Bonn (DZNE e.V.), Bonn, Germany / Rheinische Friedrich-Wilhelms-
Universität Bonn, Bonn, Germany, Bonn, Germany
Introduction: Prions are infectious protein aggregates
that self-propagate and infect naïve cells by direct cell
contact or via secreted vesicles. Several lines of evi-
dence argue that also protein aggregates associated
with common neurodegenerative diseases can intercel-
lularly propagate their aggregated states in a prion-like
manner. Thus, targeting extracellular vesicles (EVs) has
potential clinical implications for neurodegenerative
diseases. We have developed a mouse neuroblastoma
cell-based assay to identify compounds that modulate
exosome uptake and subsequent protein aggregate for-
mation in recipient cells. In this novel cell-based assay,
we take advantage of the non-toxic Saccharomyces
cerevisiae prion domain Sup35NM that forms self-tem-
plating protein aggregates in mammalian cells capable
of spreading through cell cultures. The addition of
fibrils produced from bacterially expressed Sup35NM
to cells expressing soluble NM efficiently induces
appearance of NM aggregates which are faithfully
inherited by daughter cells. Importantly, EVs released
from donor cells containing NM aggregates are infec-
tious and induce the aggregation of soluble NM-GFP in
recipient cells after 12 h incubation time. We here
introduce a high throughput assay to screen for func-
tional EVs that trigger NM reporter protein aggrega-
tion in target cells.
Methods: We have developed a quantitative high-
throughput screen assay to identify modulators (inhi-
bitors and activators) on exosome uptake. The read-out
of this functional EV assay is the percentage of recipi-
ent cells with induced NM-GFP aggregates.
Results: A total of 4135 small molecules were screened
from three well-defined compound libraries (LOPAC,
TOCRIS and SELLECKCHEM). Thirty-three inhibitors
and 35 activators were found to decrease or increase
the EV-mediated aggregate induction in recipient cells,
respectively. Lead compounds identified in this screen
affect active and selective EV uptake in recipient cells.
Summary/Conclusion: We successively developed a
cell-based assay for functional extracellular vesicles
and performed high-throughput screening to identify
the mechanisms of active extracellular vesicle uptake. I
will present some interesting findings out of the screen.
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OS25.01
Circulating extracellular vesicles of astrocytic origin carry neurotoxic
complement in Alzheimer’s disease
Carlos Nogueras-Ortiza, Francheska Delgrado-Perezab, Vasiliki Machairakib
and Dimitrios Kapogiannisa
aNational Institute on Aging, Baltimore, USA; bJohns Hopkins University,
Baltimore, USA
Introduction: Recent research has documented the
role of reactive astrocytes in neuroinflammation in
Alzheimer’s disease (AD), and of Extracellular vesi-
cles (EVs) in the transneuronal propagation and
seeding of Aβ, tau and other pathogenic protein
mediators. However, the mechanisms underlying
the initial induction and propagation of neurodegen-
eration in AD remain elusive. In our Lab, we have
pioneered the isolation of neuronal- and astrocytic-
derived EVs (NDEVs, ADEVs) from peripheral
blood and have found that, in AD patients, NDEVs
contain pathogenic Aβ and tau, whereas ADEVs
contain high levels of potentially toxic complement.
Based on these observations we hypothesized that
ADEVs and/or NDEVs circulating in the plasma of
AD patients are neurotoxic.
Methods: We isolated plasma ADEVs, NDEVs and
CD81+ EVs from patients with sporadic AD and age-
matched controls. To assess their ability to induce
neurotoxicity, we used them to incubate cultures of
rat cortical neurons and human iPSC-derived neu-
rons. We studied neuronal viability using the MTT
assay and neurite density quantification; necrosis
using fluorescent detection of EthD-1; and apoptosis
using caspase 3/7 assays in vitro. We used the phy-
siologic inhibitor of the terminal complement path-
way CD59 in rescue experiments. In evolving vivo
experiments, we perform hippocampal injections in
rats and study neurodegeneration and induction of
Aβ and tau pathology.
Results: Neurons incubated with NDEVs and ADEVs
from AD patients exhibited significantly decreased
neurite density, cell viability, and increased necrotic
and apoptotic cell death, compared to neurons treated
with control EV subpopulations (CD81+, total EVs)
from patients or ADEVs or NDEVs from control
participants. Blocking the formation of the comple-
ment Membrane Attack complex with CD59 rescues
the toxicity.
Summary/Conclusion: This is the first demonstration
that blood-borne EVs from AD patients are neurotoxic
through a complement-mediated mechanism. These
findings indicate a novel mechanism for induction
and perhaps propagation of neurodegeneration in AD
through circulating EVs with important therapeutic
implications.
Funding: This research was supported entirely by the
Intramural Research Program of the National Institute
on Aging, NIH.
OS25.02
Platelet extracellular vesicles as first liquid biopsy biomarkers to
diagnose acute ischaemic stroke
Aleksandra Gaseckaa, Ceren Eyiletenb, Edwin van der Polc, Rienk
Nieuwlandd, Krzysztof J. Filipiake and Marek Postulab
a1st Chair and Department of Cardiology, Medical University of Warsaw,
Warsaw, Poland; bDepartment of Experimental and Clinical Pharmacology,
Centre for Preclinical Research and Technology, Warsaw Poland, Warsaw,
USA; cAmsterdam UMC, University of Amsterdam, Department of
Biomedical Engineering and Physics, Amsterdam, Netherlands, Amsterdam,
Netherlands; dAmsterdam UMC, University of Amsterdam, Laboratory of
Experimental Clinical Chemistry, Amsterdam, Netherlands, Amsterdam,
Netherlands; e1st Chair and Department of Cardiology, Medical University
of Warsaw, Poland, Warsaw, USA
Introduction: Acute ischemic stroke is the second
most common cause of death in Europe, accounting
for almost 1.1 million deaths annually. Diagnosis of
stroke relies on neurologic deficits and brain imaging.
Because time is brain, stroke is preferably already diag-
nosed in the ambulance, which requires a liquid biopsy
biomarker. Our aim is to determine whether EVs from
platelets, leukocytes and endothelial cells can be used as
biomarker to diagnose stroke.
Methods: The study was approved by the medical
ethics committee. Venous blood was collected at days
1 (acute phase) and 7 (late phase) after the onset of
stroke from fasting patients (n = 19, mean age
53.8 ± 5.4 years, 55% male) and controls (patients
with Parkinson or Alzheimer disease, n = 9, mean age
57.1 ± 3.2 years, 53% male). Flow cytometry (Apogee
A60 Micro) was used to determine plasma
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concentrations of EVs labelled with antibodies for acti-
vated platelets (CD61, CD62p; PEVs), leukocytes
(CD45; LEVs) and endothelial cells (CD146; EEVs).
Flow cytometry data files were processed using in-
house developed, automated software (MATLAB
R2018a), enabling flow rate stabilization, diameter
and refractive index determination, MESF calibration,
fluorescent gate determination and application, and
statistics reporting. To standardize and differentiate
EVs from small platelets and lipoproteins, only events
between 200 and 700 nm and with a refractive index
<1.42 were included.
Results: Concentrations of PEV were elevated in stroke
patients compared to controls, both at day 1 and day 7
(p = 0.035, p = 0.059, respectively). Concentrations of
LEVs were comparable at day 1 (p = 0.83) and
decreased at day 7 (p = 0.059), whereas concentrations
of EEVs decreased at day 1 (p = 0.048) and normalized
to control levels at day 7 (p = 0.91).
Summary/Conclusion: Concentrations of platelet EVs
are elevated in patients with stroke both at day 1 and
day 7, compared to controls. In follow-up studies, we
are going to validate platelet EVs as the first liquid
biopsy biomarker to diagnose ischemic stroke.
Concentrations of LEVs and EEVs fluctuate between
day 1 and day 7 after stroke, likely reflecting activation
of immune system and endothelium following brain
damage.
Funding: Polish National Science Centre (2017/25/N/
NZ5/00545)
OS25.03
Circulating extracellular vesicles as a novel source of biomarkers for
diagnosis and monitoring of neurological diseases
Silvia Picciolinia, Alice Gualerzia, Cristiano Carlomagnoa, Andrea Sguasseroa,
Massimo Masserinib and Marzia Bedonia
aIRCCS Fondazione Don Carlo Gnocchi, Milan, Italy; bNanomedicine Center
NANOMIB, Monza, Italy
Introduction: One of the main hurdle in clinical
approach to neurological diseases is the lack of
easily accessible and sensitive biomarkers. Brain-
derived extracellular vesicles (EVs) circulate in
blood, cross the blood–brain barrier and are
involved in the onset and progression of neurologi-
cal disorders, but reliable, sensitive and reproduci-
ble methods that can cope with their nanoscale
dimensions are still lacking.
We propose to validate brain-derived EVs as new
biomarkers of Stroke, Alzheimer’s disease (AD) and
Parkinson’s disease (PD) by using biophotonics-based
techniques as Surface Plasmon Resonance imaging
(SPRi) and Raman Spectroscopy (RS).
Methods: EVs were isolated by size exclusion chro-
matography and ultracentrifugation from plasma
and serum of Stroke, AD and PD patients and
healthy controls recruited according to a protocol
approved by the medical Ethics Committee. We
developed an SPRi antibody array to separate and
characterize plasma EVs of different neural origins.
In parallel, RS was applied to serum EVs in order to
obtain a snapshot of their biochemical profiling.
Statistical analysis was applied for the comparison
of SPRi and Raman data from healthy subjects and
neurological patients.
Results: After the successful SPRi detection of EVs
from neurons, oligodendrocytes, astrocytes and
microglia, the quantification of specific surface
molecules related to pathological or recovery pro-
cesses has revealed variations of EVs specific con-
tent during a disease. Moreover, the bulk
characterization of EVs by RS demonstrated the
presence of EVs loaded with atypical cargoes when
compared to healthy controls.
Summary/Conclusion: Our results provide support for
using EVs as biomarkers for monitoring the progres-
sion of Stroke, AD and PD, suggesting the possibility to
use the SPRi-biosensor and Raman fingerprint to iden-
tify and verify the neuro-pathological or recovery pro-
cesses ongoing in neurological patients.
Funding: This study was supported by the Italian
Ministry of Health.
OS25.04
Extracellular vesicles of Alzheimer’s disease patients as a biomarker
for disease progression
Anat Aharona, Polina Spectorb, Rwan Sayed Ahmedc, Nizar Horranyd, Anni
Sabache, Benjamin Brennerf and Judith Aharon-Peretzg
aTel Aviv Sourasky Medical Center, Tel Aviv, Israel; bCognitive
Neurology Unit, Rambam Health Care Campus, Haifa, Israel;
cDepartment of Hematology, Tel Aviv Sourasky Medical Center, Tel-
Aviv, Israel; dCognitive Neurology Unit, Rambam Health Care Campus,
Haifa, Israel; eDepartment of Hematology and Bone Marrow
Transplantation, Rambam Health Care Campus, Haifa, Israel; fBruce
Rappaport Faculty of Medicine, Technion-Israel Institute of
Technology, Haifa, Israel; gBruce Rappaport Faculty of Medicine,
Technion-Israel Institute of Technology, Haifa, Israel
Introduction: Introduction: Alzheimer’s disease
(AD) is progressive irreversible neurodegenerative
pathology and the most common cause of degenera-
tive dementia. AD becomes symptomatic only after
brain changes occur over years.Accumulating evi-
dence suggests that extracellular vesicles (EVs) that
contain cytokines and microRNA are involved in the
regulation of inflammation. The current study aimed
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to characterize the EVs of AD patients as a biomar-
ker for disease progression.
Methods: Blood samples were collected after
obtaining signed informed consent (No. 0462-14-
RMB) from 39 AD patients at three stages of disease
severity and from 14 healthy controls (HC).
Cerebrospinal fluid was collected from five patients
and three HC. EV size and concentration were
studied by Nano-tracking analysis. Membrane anti-
gens were characterized by their cell origin as
defined by flow cytometry. EV protein contents
were screened by protein array, and miRNA content
was screened by Nano-string technology and vali-
dated by RT-PCR.
Results: The AD patients’ EVs were significantly smal-
ler and the levels of neural cell markers were higher
than EVs obtained from HC. Moderate or severe AD
patients’ EVs had a significantly higher level of the
Myelin oligodendrocyte glycoprotein (MOG), com-
pared to the EVs obtained from patients with mild
AD (P = 0.0002 and P = 0.036). Levels of the EVs
that expressed the axonal glycoprotein CD171 were
significantly higher in the patients with severe AD
compared to HC (P = 0.0066), possibly indicating
injured apoptotic neural cells. There was also a signifi-
cant increase in EVs originating from endothelial cells
(labelled with CD31+ CD41-, P = 0.0115 and with
CD144, P = 0.0276) in patients with moderate AD
compared EVs obtained from the HC. A >2-fold
increase was measured in the content of inflammatory
cytokines (TNFα, IL8, IL-2, IFNγ) as was a >50%
reduction in growth factors (FGF, EGF VEGF) and
their receptors in the EVs of moderate AD patients.
miR-146a-5p and several other miRNAs obtained from
the EVs of severe AD patients had significantly low
levels compared to HC.
Summary/Conclusion: The neural and endothelial
damage severity as reflected by AD patients’ EVs (anti-
gen profiles cytokine and miRNA) may serve as a
biomarker for disease dynamics.
OS25.05
Novel Blood-derived Extracellular Vesicle-based Biomarkers in
Alzheimer’s Disease by the Proximity Extension Assay
Jonas E. Nielsena, Kamilla Pedersenb, Karsten Vestergårdc, Søren Kristensena
and Shona Pedersena
aDepartment of Clinical Biochemistry, Aalborg University Hospital, Aalborg,
Denmark; bBioXpedia A/S, Aarhus, Denmark; cDepartment of Neurology,
Aalborg University Hospital, Aalborg, Denmark
Introduction: Biomarkers capable of identifying complex
pathways contributing to neuropathological development,
especially in the early stages of Alzheimer’s disease (AD),
are lacking. Such biomarkers could be present in easily
available fluids, such as blood, due to the breakdown of
the blood–brain barrier (BBB) early in AD. However, the
identification of specific and sensitive blood-based bio-
markers is a challenging task. Therefore, extracellular
vesicles (EVs) may provide a window into AD etiology
and therapeutic targets, as brain-derived EVs have been
shown to cross the BBB and are present in blood. As
biomarkers, proteins are a potential source of relevant
information relating to biological function. Thus, we
investigated a subset of proteins hypothesized to be
involved in neurological processes in plasma and EV
samples using the Proximity Extension Assay (PEA).
Methods: EVs were isolated from platelet poor plasma
from 10 healthy controls (HC), 10 patients with Mild
Cognitive Impairment (MCI) and 10 patients with
mild/moderate AD. Isolation was performed using cen-
trifugation at 20.000 xg, 1 h, 4°C with a subsequent
washing of the pellet at the same g-force. For the
characterization of the EV isolates, Nanosight and wes-
tern blotting (CD9) are performed. A neurology panel
of 92 biomarkers were assessed in plasma and EVs
using the PEA. Written informed consent was obtained
from all study participants and the study was approved
by The North Denmark Region Committee on Health
Research Ethics (N-20150010).
Results: PEA showed no significant difference of pro-
tein levels comparing the three groups for the plasma
samples. Interestingly, EV samples showed four statis-
tically significant proteins; Siglec-9, CLM-1, CLM-6
and CD38, which were less expressed in the MCI and
AD groups compared with the HC group with a false
discovery rate adjusted p-values of 0.014, 0.024, 0.035
and 0.031, respectively. These proteins have been docu-
mented to be involved in neurotoxicity protection and
inflammatory regulation.
Summary/Conclusion: Our preliminary results
demonstrate that EVs, compared to plasma, hold
potential as candidate diagnostic biomarkers in AD.
OS25.06
Proteomic and transcriptomic profiting of extracellular vesicles
isolated from immune-stimulated human primary astrocytes
Tsuneya Ikezua, Yang Youa, Kathleen Borgmannb, Satomi Stacyb and Anuja
Ghorpadeb
aBoston University School of Medicine, Boston, USA; bUniversity of North
Texas Health Science Center, Fortworth, USA
Introduction: Astrocytes are abundant glial cells in the
central nervous system that provide supportive neuro-
nal functions. They have critical roles in regulating
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neuronal activities in response to pro-inflammatory
factors in neurodegenerative diseases. Exosomes, typi-
cally 50–150 nm in size extracellular microvesicles, are
known to carry a large diversity of molecules such as
proteins and RNA species that can modify the physiol-
ogy of recipient cells. Here, we hypothesized that astro-
cyte-derived exosomal proteins are regulated when
exposure to pro-inflammatory factors, thus transported
to control neuronal function and plasticity.
Methods: We performed a quantitative proteomic
and transcriptomic analysis of exosomes purified
from human primary astrocytes with or without
interleukin 1-β (IL1-β) stimulation in vitro.
Exosome-enriched fractions were purified by size-
exclusion columns. The total proteins isolated from
the EVs were run on 1D SDS-PAGE and mass
spectrometry. miRNA was isolated from EVs and
subjected to Affymetrix miRNA 4.0 Array. The
data are subjected to bioinformatic analysis and
validation for select molecules.
Results: A total of 539 common proteins were iden-
tified. IL1-β-stimulated astrocytes enhanced the
cargo load of proteins in the EVs. IL-1b stimulation
induced activation of immune response and modula-
tion of cell adhesions. The EVs from resting astro-
cytes play a role in protein metabolism, cell growth
and maintenance. Finally, similar proteomic results
were also obtained from exosomes derived from
astrocytes cultured in serum-free media with IL1-β
stimulation, further validating the alteration of exo-
somal proteins in activated astrocytes which can be
transferred to control neuronal function and
plasticity.
Summary/Conclusion: Our finding will be helpful to
elucidate the pathophysiological functions of astrocyte-
derived exosomes in regulating neuronal networks and
provide new insights into the diagnostics and thera-
peutics of inflammatory diseases.
Funding: NIH 1R01AG054672, 1R56AG057469 and
1RF1AG054199 (TI), 5R24HD0008836
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PS01.01
Targeting prostate cancer via PSMA-peptide decorated exosome-
mimetics
Maja Severic, Guanglong Ma, Hatem Hassan, Sara Pereira, Calvin Cheung
and Wafa AL-Jamal
Queen’s University Belfast, Belfast, UK
Introduction: Prostate cancer (PC) is the most
common type of cancer and the second cause of
death in men worldwide. A range of effective antic-
ancer drugs have been used to treat advanced PC,
however, their systemic toxicity has limited their
clinical use. Therefore, there is an unmet need to
develop novel strategies to deliver cancer therapeu-
tics to PC tissues. Exosomes are nanosized, cell-
derived vesicles that carry proteins and RNAs for
intercellular communication. They could also deli-
ver their cargo across the plasma membrane and
delay premature drug transformation and elimina-
tion. Exosomes have shown an intrinsic homing
ability to a wide range of cells. Furthermore, a
new approach has been proposed to combine the
intrinsic homing ability of exosomes with active
targeting to enhance their tumour accumulation.
In the present work, we report the development of
novel prostate-specific membrane antigen (PSMA)-
targeted exosome-mimetics (EMs) for advanced PC.
Methods: Stably transfected PSMA-peptide expressing
monocytes U937 cell line was established. PSMA-tar-
geted EMs were prepared by serial extrusion of the
transfected U937 monocytes. The PSMA-targeted
EMs were characterized by dynamic light scattering,
nanoparticle tracking analysis, transmission electron
microscopy, bicinchoninic acid assay and western blot-
ting. Furthermore, the binding of the PSMA-targeted
EMs to the recombinant human PSMA protein was
confirmed by ELISA. Their drug loading capability
was assessed by loading doxorubicin and its derivatives.
Next, in vivo biodistribution and safety studies of tar-
geted EMs were carried out in C4-2B and PC3-
tumour-bearing mice.
Results: The engineered EMs exhibited high protein
yield, good drug loading and exosome markers
expression. The expression of PSMA targeting peptide
and its binding to PSMA receptors was confirmed in
vitro. Finally, successful tumour accumulation of
PSMA-targeted EMs was achieved in vivo with the
absence of in vivo toxicity.
Summary/Conclusion: Our engineered PSMA-tar-
geted EMs, could offer a promising drug delivery sys-
tem for PC, based on its drug loading capacity, tumour
targeting and safety in vivo.
Funding: Rosetrees Trust studentship (A1108), PCUK
(CDF-12-002 Fellowship) and EPSRC (EP/M008657/1).
PS01.02
Improved loading of plasma-derived extracellular vesicles to
encapsulate antitumour miRNAs
Margherita A. C. Pomattoa, Benedetta Bussolatib, Sergio D’Anticoc, Sara
Ghiottoc, Ciro Tettad, Maria Felice Brizzia and Giovanni Camussia
aDepartment of Medical Sciences, University of Turin, Turin, Italy;
bDepartment of Molecular Biotechnology and Health Sciences, University
of Turin, Turin, Italy; cBlood Bank, A.O.U. Città della Salute e della
Scienza, Turin, Italy; dUnicyte srl, Turin, Italy
Introduction: Extracellular vesicles (EVs) are particles
released by cells that carry a complex cargo of mole-
cules and mediate intercellular communication.
Recently, they have raised great interest as drug deliv-
ery systems and several engineering methods are cur-
rently under investigation. Numerous factors, however,
influence the transfection yield, including protocol
variability and EV damage.
Methods: The electroporation was investigated as
method to directly load miRNAs in plasma-derived
EVs. Different parameters (voltage and number of
pulses) were compared for their effect on EV mor-
phology and loading capacity of a synthetic miRNA,
cel-39, including miRNA enrichment in EVs and its
transfer to target cells. Next, analyses were per-
formed to evaluated the transfection effect on EV
endogenous cargo and the exogenous miRNA pro-
tection from RNAse degradation. Then, EVs were
loaded with antitumour miRNAs and their pro-
apoptotic effect was evaluated on a cell line of
hepatocellular carcinoma, HepG2 cells.
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Results: The comparison of different electropora-
tion settings demonstrated the importance of choos-
ing the more appropriate protocol parameters to
obtain an efficient EV transfection yield, under-
stood as both molecules loading and EV damage.
In particular, we observed the superiority of one
electroporation protocol (using 750 Volt and 10
pulses) that allowed the most efficient miRNA
packaging and transfer to target cells, without struc-
turally damaging EVs. The most efficient electro-
poration protocol was also proven to allow a more
efficient miRNA loading in respect to incubation,
better protecting miRNA from enzymatic digestion.
In addition, our findings suggested that electropora-
tion preserved the naïve EV cargo, including RNAs
and proteins, and did not alter their uptake in cells.
EVs engineered with antitumor miRNAs (miR-31
and miR-451a) successfully promoted the apoptosis
of HepG2 cells, downregulating their target genes
related to apoptotic pathways.
Summary/Conclusion: In conclusion, our findings
indicate an efficient and functional miRNA encapsula-
tion in plasma-derived EVs following an electropora-
tion protocol that preserves EV integrity.
Funding: Associazione Italiana per la Ricerca sul
Cancro (A.I.R.C.), Unicyte AG (Switzerland)
PS01.04
Development of a platform for exosome engineering using a novel
and selective scaffold protein for surface display
Kevin Dooley, Ke Xu, Sonya Haupt, Shelly Martin, Russell McConnell,
Nuruddeen Lewis, Christine McCoy, Chang Ling Sia, Jorge Sanchez-Salazar,
Nikki Ross, Rane Harrison, Bryan Choi, Damian Houde, John Kulman and
Sriram Sathyanarayanan
Codiak BioSciences, Cambridge, USA
Introduction: Membrane proteins preferentially parti-
tioned into exosomes can be co-opted to display phar-
macologically active molecules on the exosome surface,
which is an important strategy for maximizing the
potential of therapeutic exosomes. Previously published
approaches have relied on “canonical” scaffolds includ-
ing multi-pass transmembrane tetraspanins (CD9/
CD63/CD81), LAMP2B, or non-exosomal domains
such as pDisplay or GPI anchors. We sought to identify
novel scaffolds that enable more uniform, higher den-
sity surface display of structurally and biologically
diverse molecules.
Methods: Proteomic analysis of stringently purified
exosomes led to the identification of highly abundant
and unique exosomal proteins, including a single-pass
transmembrane glycoprotein (Protein X, PrX) belong-
ing to the immunoglobulin superfamily. Protein X and
fragments thereof were expressed in a cell line and the
minimum PrX domain requirements for exosomal
enrichment were determined. Leveraging PrX as a scaf-
fold for exosome surface display, we developed our
engEx platform to generate engineered exosomes func-
tionalized with a variety of pharmacologic payloads
including enzymes, antibodies, type I cytokines and
TNF superfamily members. Biological activity of these
engineered exosomes was assessed in an array of in
vitro assays and compared to previously described
scaffolds.
Results: Stable expression of PrX in an exosome
producing cell line resulted in 200-fold enrichment
of PrX on secreted exosomes. Interestingly, over-
expression of PrX structural paralogs did not result
in similar levels of enrichment, suggesting PrX is
unique. Exosomes expressing PrX-GFP exhibited
100-fold increase in relative fluorescence compared
to LAMP2B and pDisplay GFP fusions. Similar
levels of high-density expression were achieved
with a variety of topologically diverse therapeutic
proteins fused to full-length or truncated forms of
PrX. Exosomes engineered to display IL7, CD40
ligand, IL12 and antibody fragments via PrX fusion
exhibited up to 1500-fold improvement in potency
compared to previously described scaffolds.
Summary/Conclusion: This work demonstrates the
potential of our engEx platform to generate novel exo-
some therapeutics, specifically through high density
surface display mediated by PrX.
PS01.05
Leptin-loaded macrophage-derived exosome: high-efficiency loading
method and its properties
Ryo Kojima, Elena Batrakova and Alexander Kabanov
University of North Carolina at Chapel Hill, Chapel Hill, USA
Introduction: Exosome, one of extracellular vesi-
cles, is considered to be an important player in
intercellular communication. Application of exo-
some to drug delivery system is expected to target
specific cells. Especially macrophage-derived exo-
some is known to cross blood–brain barrier (BBB)
and deliver its cargo after intravenous administra-
tion. Leptin is hormone to regulate energy balance
by inhibiting hunger, and leptin receptor is located
on neurons of hypothalamus. Drug delivery system
of leptin to brain is anticipated because leptin trans-
porter at BBB is known to be impaired in obesity
models. However, it has been challenging to load
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enough amount of protein drugs into exosome
without changing its original properties.
Purposes of this research are to develop leptin-
loading method into exosome with high efficiency
and to evaluate its physicochemical and biological
characteristics.
Methods: Exosome was isolated from IC-21 (mouse
macrophage) cells by an ultracentrifuge method.
Particle-size distribution of the exosome was measured
by Nanoparticle Tracking Analysis. Expression of exo-
some-marker protein was confirmed by Simple
Western. Leptin was loaded into the exosome by
using a probe sonicator, and free leptin was removed
by gel filtration chromatography. Loaded amount of
leptin was measured by ELISA. Release profile of leptin
from the exosome was evaluated in mouse serum at 37°
C. In order to evaluate protection ability of exosome
formulation against protease, the leptin-loaded exo-
some was treated with pronase and remained leptin
was quantified. Stability of the exosome was also
investigated.
Results: IC-21 derived exosome had 100–110 nm of
mean size and contained exosomal markers, such as
Alix and Rab11A. Size distribution and exosomal
marker level of the leptin-loaded exosome prepared
under optimized condition were similar to those of
bare exosome. Drug-loading efficiency was 7% in
this condition. Although ~50% of leptin burst
from the exosome after release study and ~70% of
leptin was degraded by protease challenge test, the
other leptin was considered to be retained in the
exosome. Particle-size distribution and leptin con-
centration of the exosome were stable at 4°C for
1 month.
Summary/Conclusion: This methodology to load pro-
tein drugs into exosome is promising strategy for its
drug delivery application.
PS01.06
Characterization and in vivo imaging of mesenchymal stem cells
derived extracellular vesicle
Cheng-Hsiu Lu, Yi-An Chen, Chien-Chih Ke and Ren-Shyan Liu
National Yang-Ming university, Taipei, Taiwan (Republic of China)
Introduction: Mesenchymal stem cells (MSCs) are
multipotent stromal cells which show the great poten-
tial in tissue engineering, regenerative medicine and
the treatment of various diseases. Deep into mechan-
isms, paracrine effect has been reported to be the major
role in MSC therapy. Further, extracellular vesicles
(EVs) are reportedly the major player mediating the
therapeutic and paracrine effects of MSCs. With the
rapid increase of attention and being of great potential
as a future medical regimen for human disease, the
information of fate and behaviour of EVs in the living
subject should be urgently gathered. However, investi-
gators still have not developed an effective method to
monitor the in vivo behaviour of EVs. Therefore, here
in our study, EVs derived from Wharton’s jelly MSCs
were isolated, characterized and radiolabeled with
111In-oxine followed by biodistribution study and in
vivo SPECT/CT imaging.
Methods: Conditioned medium was collected fol-
lowed by exosome isolation using Exo-Prep kit
(Hansa BioMed) followed by purification with PD-
10 columns and 100 kDa concentration. Expression
of EVs specific proteins CD63 and HSP70 was ver-
ified by western blot. Morphology and size were
characterized by transmission electron microscopy
nanoparticle tracking analysis (NTA). For radiola-
beling, EVs were incubated with 111In-oxine in PBS
at 37oc for 1 h followed by purification and further
characterization. Biodistribution and in vivo
SPECT/CT imaging of 111In-oxine- labelled EVs
were performed at 1, 3, 6 and 24 h after intravenous
injection into C57BL/6 mice.
Results: CD63 and HSP70 expression were observed
on EVs as well as 111In-oxine-EVs. Radiochemical
purity of 111In-oxine-EVs as higher than 90% and
remained stable for at least 48 h. Result of biodistribu-
tion showed that 111In-oxine-labelled EVs accumu-
lated in liver, spleen, bone marrow and cleared
rapidly from the circulation. In vivo SPECT/CT ima-
ging of 111In-oxine-labelled EVs showed high accumu-
lation in liver, bone, spleen and liver, but not in brain
and circulation.
Summary/Conclusion: In this study, we have pre-
liminarily demonstrated the feasibility of in vivo
tracking of MSC- derived EVs labelled with 111In-
oxine. Further investigation is still needed and
underway to monitor the in vivo fate and behaviour
of EVs.
PS01.07
EVs as siRNA delivery vehicles for functional knockdown in cells
Senny Nordmeier, Victoria Portnoy and Frank Hsiung
System Biosciences, Palo Alto, USA
Introduction: Extracellular vesicles (EVs) mediate cell-
to-cell communication by delivering cargo, composed
of nucleic acids, proteins and various other molecules,
from secreting cells to specific tissues and recipient
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cells. This method of cellular delivery has generated
great interest in targeted delivery of therapeutics, such
as chemical probes, proteins and RNA. In particular,
EV RNA has gained increasing attention not only in
biomarker development but also in the regulation of
gene expression in cells. The delivery of siRNA by EVs
is one method to induce gene silencing. Here we devel-
oped and optimized a method of loading EVs with
siRNA using a chemical transfection reagent.
Methods: Isolated EVs from tissue culture media
were loaded with siRNA using a chemical transfec-
tion reagent. Various compositions of the chemical,
as well as molar ratio between the chemical and
siRNA, temperatures and EV concentrations were
examined to determine optimal conditions. The
transfected EVs were added onto cells and incu-
bated for 24–48 hrs. After the incubation period,
the cells were imaged for fluorescence and cell
morphology changes. Then, the cells were har-
vested, lysed and analysed by Western blot (protein
level). Additionally, cell lysates RNA was isolated
and analysed by RT-qPCR.
Results: Fluorescent imaging showed a dose-depen-
dent incorporation of control Cy3-labelled siRNA
into cells. The cell nuclear morphology was
examined after delivery of ECT2 and TOR1AIP1
siRNA. In addition, RT-qPCR and Western blotting
analyses were used to measure the level of knock-
down of the housekeeping gene, HPRT. CCK8
assay was used to determine cell viability after
delivery of EVs loaded with control siRNA and
other siRNAs.
Summary/Conclusion: Our results provide a specific
and efficient approach for loading siRNA directly
into EVs for the implementation of targeted gene
silencing.
PS01.08
Development of an in vivo extracellular vesicle-based peptide library
screening tool
Masako Harada
Institute for Quantitative Health Science and Engineering (IQ), Michigan
State University, East Lansing, USA
Introduction: Extracellular vesicles (EVs) including
exosomes and microvesicles are heterogenous popula-
tion of membrane-bound vesicles with cargos includ-
ing protein, lipids and nucleic acids of DNA and RNA
species. Recently, EVs have gained attention as a deliv-
ery vehicle for targeted delivery of oligo nucleotide
drugs. Previous reports suggest that particles coated
with targeting peptide can be delivered to selected
cells and tissues. However, the biocompatible system
for screening combinational libraries have not been
described. The goal of this project is to develop a
biocompatible system for peptide screening using EV-
peptide display library.
Methods: Homologous recombination cloning using
regenerative oligos are used to create peptide library
plasmids where peptide sequences are fused to the
phosphatidylserine binding domain (C1C2) of human
lactadherin for peptide display to the vesicle surface.
Fluorescent reporter gene was cloned with C1C2
domain for imaging purposes. Plasmid DNA was trans-
fected to HEK293FT cells and EVs were harvested by
ultracentrifugation followed by differential centrifuga-
tion. DNA sequence was recovered from EV by direct
PCR amplification.
Results: Homologous recombination cloning was suc-
cessfully used for EV library construction. Chimeric
protein expression on EVs was determined by
Western blot analysis and that of reporters was verified
fluorescent microscopy. Direct detection of plasmid
DNA was verified from isolated EVs and the targeting
with known targeting peptide is in progress.
Summary/Conclusion: In this study, our current pro-
gress on developing in vivo peptide screening strategy
using degenerative oligonucleotide library EVs will be
discussed. The success of this approach may provide a
novel biocompatible system for peptide screening both
in vitro and in vivo.
Funding: Michigan State University Startup funding
PS01.09
The construction of nanogel/exosome hybrid by exosome surface
polymer engineering
Shin-ichi Sawadaa, Yuko T. Satob, Riku Kawasakib, Yoshihiro Sasakia and
Kazunari Akiyoshia
aKyoto University, Kyoto, Japan; bKyoto University, Kyoto-shi, Japan
Introduction: Extracellular vesicles secreted by var-
ious cells have attracted attention as a new system
in cell-to-cell communication. We focus on the uti-
lization of exosomes as biological molecule delivery
systems. However, it is not always easy to control
the delivery and internalization of exosomes to var-
ious cells. We propose here a new strategy for the
effective delivery of exosomes into cells using func-
tional macromolecular carriers such as amphiphilic
nanogels. Surface polymer engineering was applied
with a carrier of exosomes, namely, amphiphilic
cationic CHP (cCHP) nanogel, to improve the
delivery of exosome content by forming complexes
with the exosomes. In this study, we developed the
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preparation method of exosome hybrids with nano-
gel, and the hybrids were evaluated the character-
istics and the biological functions.
Methods: Mouse macrophage cells were used to pro-
duce the exosomes, which were then mixed with cCHP
nanogel to form a hybrid. Various characteristics of
these hybrid particles were examined by TEM observa-
tion, nanoparticle tracking analysis to determine their
size, measurements of their ζ-potential. The interac-
tions between the hybrids and cells were evaluated by
confocal scanning laser microscopy and flow
cytometry.
Results: TEM revealed that the surface of each
exosome was coated by cCHP nanogel particles.
Flow cytometry also showed significant uptake of
this exosome/nanogel hybrid by cells, with the main
mechanism behind this internalization being endo-
cytosis. A range of different molecules that inhibit
different types of endocytosis were also applied to
determine the particular pathway involved, with a
caveola-mediated endocytosis inhibitor being
revealed to markedly affect hybrid uptake. Next,
we evaluated revealing the functional efficacy of
this approach, we showed that the nanogel system
could successfully deliver functional exosome into
cells as indicated by its ability to induce neuron-like
cell differentiation in the recipient cells.
Summary/Conclusion: These results indicate that the
newly developed cationic nanogel systems for exosome
delivery are powerful tools to investigate the biological
functions of exosomes.
PS01.10
Human telomerized cells for production of extracellular vesicles
Regina Grillaria, Susanne Neubertb, Matthias Wiesera and Johannes Grillarib
aEvercyte GmbH, Vienna, Austria; bChristian Doppler Laboratory on
Biotechnology of Skin Aging, University of Natural Resources and Life
Sciences, Vienna (BOKU), Vienna, Austria
Introduction: Human cells are of ever increasing
importance as in vitro test system to represent the
in vivo situation. Additionally, highly differentiated
cells are also essential production systems for com-
plex biopharmaceuticals. However, the use of such
cell systems are limited due to the fact that the cells
enter replicative life span and therefore can only be
propagated for a limited number of population dou-
blings in vitro, which limited standardization of
experiments as well as production processes.
Moreover, reports have shown that the number of
secreted vesicles significantly reduced with increas-
ing age of normal cells.
Methods: Human telomerase overexpression immorta-
lizes cells while keeping primary like characteristics
intact. Ectopic overexpression and charcterization of
mesenchymal stem cells was used to establish produc-
tion cell lines.
Results: Here we describe the development of human
continuously growing cell lines from various tissues
that show a high potential as innovative production
systems for extracellular vesicles with use for clinical
applications.
Summary/Conclusion: These cell lines will be used for
the production of standardized EV preparation.
PS01.11=OWP1.06
Extracellular vesicles from Fat-laden hypoxic hepatocytes activates
pro-fibrogenic signals in Hepatic Stellate Cells
Alejandra Hernandeza, Yana Gengb, Daniel Cabrerac, Nancy Solisd, Han
Moshagee and Marco Arresed
aPontificia Universidad Católica de Chile; University Medical Center of
Groningen, Groningen, Netherlands; bUMCG, Groningen, Netherlands;
cPontificia Universidad Católica de Chile/Universidad Bernardo O´Higgins,
SANTIAGO, Chile; dPontificia Universidad Católica de Chile, Santiago,
Chile; eUniversity Medical Center Groningen, Groningen, Netherlands
Introduction: Background: Transition from isolated
steatosis (IS) to non-alcoholic steatohepatitis (NASH)
is a key issue in non-alcoholic fatty liver disease
(NAFLD). Recent observations in patients with
obstructive sleep apnea syndrome (OSAS), suggest
that hypoxia may contribute to disease progression
mainly through activation of hypoxia inducible factor
1α (HIF-1α)-related pathways. Release of extracellular
vesicles (EV) by injured hepatocytes may be involved
in NAFLD progression.
Aim: To explore whether hypoxia modulates the
release of EV from free fatty acid (FFA)-exposed hepa-
tocytes and assess cellular crosstalk between hepato-
cytes and LX-2 cells (human hepatic stellate cell line).
Methods: HepG2 cells were treated with FFAs (250 μM
palmitic acid + 500 μM oleic acid) and chemical
hypoxia (CH) was induced with Cobalt (II) Chloride,
which is an inducer of HIF-1α. Induction of CH was
confirmed by Western blot (WB) of HIF-1α. EV isola-
tion and quantification was performed by ultracentri-
fugation and nanoparticle tracking analysis
respectively. EV characterization was performed by
electron microscopy and WB of CD-81 marker. LX-2
cells were treated with 15 μg/ml of EV from hepato-
cytes obtained from different groups and markers of
pro-fibrogenic signalling were determined by quantita-
tive PCR (qPCR), WB and immunofluorescence (IF).
Results: FFA and CH-treatment of HepG2 cells
increased gene expression of IL-1β and TGF-β1 in
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HepG2 cells and increased the release of EV compared
to non-treated HepG2 cells. Treatment of LX-2 cells
with EV from FFA-treated hypoxic HepG2 cells
increased gene expression of TGF-β1, CTGF, α-SMA
and Collagen1A1 compared to LX-2 cells treated with
EV from non-treated hepatocytes or LX-2 cells exposed
to EV-free supernatant from FFA-treated hypoxic
HepG2 cells. Moreover, EV from FFA-treated hypoxic
HepG2 cells increased Collagen1A1 and α-SMA pro-
tein levels.
Summary/conclusion: CH promotes EV release from
HepG2 cells. EV from hypoxic FFA-treated HepG2
cells evoke pro-fibrotic responses in LX-2 cells.
Further genomic and proteomic characterization of
EV released by steatotic cells under hypoxia are neces-
sary to further delineate their role in the crosstalk
between hepatocytes and stellate cells in the setting of
NAFLD and OSAS.
Funding: FONDECYT 1150327-1150311.
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PS02.01
Host:pathogen interactions and host cell internalization of
Trichomonas vaginalis exosomes
Patricia J. Johnsona and Anand Raib
aUniversity of California, Los Angeles, Los Angeles, USA; bUCLA, Los
Angeles, USA
Introduction: The parasite Trichomonas vaginalis is the
causative pathogen of the sexually transmitted infection
trichomoniasis. Depending on the parasite strain and host,
infections can vary from asymptomatic to highly inflam-
matory. We previously reported that T. vaginalis generates
and secretes vesicles with physical and biochemical proper-
ties similar to mammalian exosomes that deliver their
contents to human host cells. T. vaginalis exosomes mod-
ulate host cell immune responses and likely assist in para-
site colonization of the host.
Methods: In our current study, we are optimizing
methods to study the uptake of T. vaginalis exosomes
into the host cells.
Results: The data obtained from our studies show that
exosome uptake is a time-dependent process, regulated
by many factors such as temperature, etc. Our findings
also suggest that exosome uptake is mediated by endo-
cytosis, with specific host cell lipids playing a critical
role in this process. We have also identified target
molecules present on the surface of T. vaginalis exo-
somes that induce exosome uptake into the host cell.
Summary/Conclusion: This work expands our general
knowledge of exosome uptake by target cells and our
understanding of the mechanisms used by exosomes to
mediate T. vaginalis host-pathogen interactions.
Funding: National Institutes of Health
PS02.02
Coating filter membranes with bacterial derived vesicles to study the
permeation of anti-infectives across the Gram-negative cell envelope
Robert Richtera, Adriely Goesb, Marcus Kochc, Gregor Fuhrmannd, Nicole
Schneider-Daume and Claus-Michael Lehre
aDepartment of Drug Delivery (DDEL), Helmholtz-Institute for
Pharmaceutical Research Saarland, Saarbrücken, Germany; bBiogenic
Nanotherapeutics (BION), Helmholtz Institute for Pharmaceutical Research
Saarland, Saarbrücken, Germany; cLeibniz Institute for New Materials (INM),
Saarbrücken, Germany; dHelmholtz-Institut for Pharmaceutical Research
Saarland (HIPS), Saarbrücken, Germany; eDepartment of Drug Delivery
(DDEL), Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS),
Saarbrücken, Germany
Introduction: Less and less novel anti-infectives
against diseases caused by Gram-negative bacteria
reach the market while bacterial resistance is steadily
increasing. Among the many hurdles of an antibiotic
on its way from development to clinical use, the Gram-
negative cell envelope is one crucial factor strongly
delimiting access to inner bacterial targets and thus
decreasing efficacy. As a model to study and optimize
the permeation of anti-infectives, outer membrane
vesicles (OMV) were selected to create an in vitro
membrane model on a 96-well filter plate.
Methods: E. coli BL21 were cultured in Luria-Bertani
medium until stationary phase. Bacteria were separated
by centrifugation (15 min, 9500g) and filtration (0.2 or
0.45 µm membrane pore size). OMV’s were isolated by
adding 33% (w/w) PEG 8000 solution to the filtrate (ratio
4:1), shaking and overnight incubation at 4°C. The pre-
cipitate was centrifuged (30 min, 16,233g) and the pellet
resuspended in 100 µl filtered PBS. This suspension was
characterized by nanoparticle tracking analysis and coated
onto 96-well filter plates using a vacuum oven (15min, 37°
C, 100 mbar). Coating morphology was imaged by scan-
ning electron microscopy and confocal laser scanning
microscopy. For permeation studies the OMV coating
was covered with 0.5% (w/v) agarose gel before adding
solutions of different antibiotics to the donor compartment
and determining the concentration time course in the
acceptor compartment using UV-spectroscopy.
Results: The filtration through 0.2 and 0.45 µm pores
led in both cases to sterile filtrates, whereas 0.45 µm
pores led to larger vesicles and higher yield.
The applied microscopy methods indicated that a
complete and homogenuous OMV coating was
achieved. Preliminary permeation studies revealed
kinetic differences between antibiotics.
Summary/Conclusion: The OMV isolation and purifi-
cation protocol allowed for a yield sufficient to coat 96-
well filter supports. The measured permeated amounts
allow to distinguish the permeability of different anti-
biotics. Compared to artificial phospholipid membrane
models, fluxes across OMV derived membranes were
significantly higher, facilitating faster analytics. An
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involvement of outer membrane proteins in this model
is subject of ongoing investigations.
PS02.03
Quality markers for microbial EVs
Simon Swifta, Jiwon Honga, Zachary Devereuxa, Priscila Dauros Singorenkoa,
Cherie Blenkironb and Anthony Phillipsc
aUniversity of Auckland, Auckland, New Zealand; bThe University of
Auckland, Auckland, New Zealand; cDepartment of Surgery, Faculty of
Medical and Health Sciences, The University of Auckland, Auckland, New
Zealand
Introduction: Microbial EVs have potentially impor-
tant roles in interactions with cells in populations of
the same species, with other microbial species and with
eukaryotic cells. To investigate the effect of these inter-
actions in target cells it is important to define the EVs
under test.
Methods: Pathogenic Escherichia coli 536 and 2348/69 and
probiotic Nissle 1917 were cultured in RPMI 1640 ± FeCl3.
Candida albicans and C. auris were cultured in YPD broth.
Microbial EVs were separated from cells by centrifugation,
filtration (0.2 μm for bacteria or 0.45 μm for yeast) fol-
lowed by concentration (100,000 kDa cut-off filter) and
ultracentrifugation. EVs were further enriched by either
density gradient centrifugation (DGC, bacterial samples)
or size exclusion chromatography (SEC, bacterial and yeast
samples). An iTRAQ proteomic approach was used to
identify proteins from bacterial cells, crude EV pellets
and DGC and SEC fractions. Yeast proteins were fractio-
nated by SDS/PAGE and proteins in EV-enriched and
non-EV fractions were identified using mass spectrometry
techniques.
Results: A number of outer membrane proteins were
identified in E. coli EVs, but with some variation
between strains and media used. Cytoplasmic protein
GroEL was also common. There were no obvious pro-
teins removed by the purification of EVs and the major
differences in proteome were due to changes in envir-
onmental growth conditions. For Candida, a clear set
of EV-associated envelope proteins were identified. In
addition, a series of proteins removed from the crude
EV prepartion by further enrichment were identified
for Candida species that may represent non-EV
contaminants.
Summary/Conclusion: A number of possible markers
for E. coli and Candida species have been identified,
which now need verification by alternative techniques
and the screening of a range of pathogenic and non-
pathogenic isolates grown in different conditions.
These findings offer promising new markers for
isolation of microbial EVs from both laboratory cul-
tures and from clinical samples.
Funding: School of Medicine Performance-Based
Research Fund; Maurice and Phyllis Paykel Trust
Project Grant [8.1.17]; Lottery Health Research Grant
[326702]; Health Research Council, Explorer Grant
[14/805]; Ministry of Business, Innovation and
Enterprise, Smart Ideas Grant [UOAX1507].
PS02.04
Akt and CD9 in urine exosomes as potential markers for urinary tract
infection
Kosuke Mizutania, Kyojiro Kawakamib, Kengo Horiea, Yasunori Fujitab, Koji
Kameyamac, Taku Katoa, Keita Nakanec, Tomohiro Tuchiyad, Mitsuru
Yasudac, Koichi Masunagae, Yutaka Kasuyae, Yoshishige Masudae, Takashi
Deguchif, Takuya Koiec, Masafumi Itob
aDepartment of Urology, Gifu University Graduate School of Medicine, Gifu,
Japan; bResearch Team for Mechanism of Aging, Tokyo Metropolitan
Institute of Gerontology, Itabashi-ku, Japan; cGifu University Graduate
School of Medicine, Gifu, Japan; dGifu University Graduate School of
Medicine, Gifu, Japan; eDepartment of Urology, Tokyo Metropolitan
Geriatric Hospital, Tokyo, Japan; fTokyo Metropolitan Geriatric Hospital,
Tokyo, Japan; gDepartment of Urology, Kizawa Memorial Hospital,
Minokamo, Japan
Introduction: Urinary tract infections (UTI) is one of
the most common bacterial infections. UTI is treated
with antibacterial agents, but asymptomatic bacteriuria
(ABU) that is diagnosed by bacteriuria without any
urinary tract symptoms should not be treated except
pregnant women and patients who will undergo trau-
matic urologic interventions. However, there has been
no clinically available biomarker to distinguish UTI
from ABU. Exosomes are 40–150 nm sized membrane
vesicles containing proteins and nucleic acids that are
present within cells from which they are released and
thus have the potential as biomarkers for various dis-
eases. It is likely that urine may contain exosomes
released from uroepithelial cells and white blood cells.
In the present study, we aimed to identify urinary
exosomal markers that are useful to discriminate
between UTI and ABU.
Methods: Exosomes were collected by ultracentrifugation
from the culture medium of SV-HUC-1 (immortalized
uroepithelial cell line) and THP-1 (acute monocytic leu-
kaemia cell line) co-cultured with or without Escherichia
coli or treated with or without LPS. The protein expression
was examined by western blot analysis. Urinary exosomes
were isolated from urine by Tim4-conjugated magnetic
beads. Expression of Akt and CD9 in isolated exosomes
was analysed by ELISA and CLEIA, respectively.
Results: Expression of Akt, ERK and NF-κB was
increased in exosomes isolated from SV-HUC-1 and
THP-1 cells co-cultured with E. coli or treated with LPS
compared to without co-culture or treatment. The
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levels of Akt and CD9 in urinary exosomes from
patients with UTI were higher than those from ABU
patients.
Summary/Conclusion: Our results suggest that intra-
cellular signalling molecule Akt and cell surface-resi-
dent exosomal marker CD9 in urinary exosomes have
the potential to discriminate UTI from ABU, thus
providing novel objective markers for their differential
diagnosis, which will allow better diagnosis and treat-
ment of UTI and ABU patients.
Funding: JSPS KAKENHI Grant Number JP18K09190,
GSK Japan Research Grant 2015
PS02.05
Different protein profile and host immune response induced by
extracellular vesicles from Enterococcus faecium cultured with or
without antibiotics
Mi Hyun Kima, Se Yeon Kima, Seung Il Kimb, Joo Hee Sona and Je chul Leec
aDepartment of Microbiology, School of Medicine, Kyungpook National
University, Daegu, Republic of Korea; bDrug & Disease Target Team, Korea
Basic Science Institute, Ochang, Republic of Korea; cDepartment of
Microbiology, School of Medicine, Kyungpook National University, Daegu,
Republic of Korea
Introduction: Vancomycin-resistant Enterococcus fae-
cium is of medical importance associated with multi-
drug resistance and opportunistic infection. E. faecium
produces extracellular vesicles (EVs), but EV produc-
tion in E. faecium under antibiotic stress condition and
their pathogenic roles have not been determined yet.
This study investigated the production of EVs in van-
comycin-resistant E. faecium strain cultured with or
without the sub-minimum inhibitory concentrations
(MICs) of vancomycin and linezolid, and determined
the pathogenic roles of EVs in colon epithelial Caco-2
cells.
Methods: The EVs were purified from vancomycin-
resistant E. faecium ATCC 700221 cultured with or
without the 1/2 sub-MICs of vancomycin and linezolid.
Caco-2 cells were incubated with E. faecium EVs and
then analysed for cytotoxicity and pro-inflammatory
cytokine gene expression.
Results: E. faecium ATCC 700221 produced EVs dur-
ing in vitro culture. E. faecium cultured with 1/2 sub-
MIC of vancomycin and linezolid produced 4.5 and 2
times more EV proteins than bacteria cultured without
antibiotics, respectively. A total of 438, 461 and 513
proteins were identified in the EVs isolated from E.
faecium cultured in brain heart infusion (BHI) broth
(EVs/BHI), EVs from E. faecium in BHI broth with 1/2
sub-MIC of vancomycin (EVs/VAN) and EVs from E.
faecium in BHI broth with 1/2 sub-MIC of linezolid
(EVs/LIN), respectively. EVs/BHI induced cytotoxicity
and stimulated the expression of pro-inflammatory
cytokine and chemokine genes in Caco-2 cells in a
dose-dependent manner. Moreover, EVs/LIN were
more cytotoxic towards Caco-2 cells than EVs/BHI
and EVs/VAN, whereas EVs/VAN induced more pro-
inflammatory cytokine and chemokine gene expression
in Caco-2 cells than EVs/BHI and EVs/LIN.
Summary/Conclusion: The sublethal dose of antibio-
tics modulates the EV biogenesis in E. faecium. EVs
produced by E. faecium under different antibiotic stress
condition show different host cell responses, which
plays a role in bacterial pathogenesis.
Funding: This work was supported by the National
Research Foundation of Korea (NRF) grant funded by
the Korea government (NRF-2017R1A2A2A05001014).
PS02.06
The RNA profile of extracellular vesicles released from Trypanosoma
brucei
Christian Preußera, Lee-Hsueh Hungb and Albrecht Bindereifb
aJustus Liebig University of Giessen, Institute of Biochemistry, Giessen,
Germany; bJustus Liebig University of Giessen, Institute of Biochemistry,
Giessen, Germany
Introduction: Trypanosomes are unicellular eukar-
yotes, which are vector-borne ubiquitous parasites of
vertebrates and have a high impact on global health.
The well-known Trypanosoma brucei for instance is the
causative agent of the human African trypanosomiasis,
a lethal tropical disease, and the nagana-cattle disease
in domestic livestocks in sub-Saharan Africa. Besides
this, trypanosomes have become an important model
organism, because of various biochemical and cellular
characteristics such as trans spliced mRNAs. As other
parasites, trypanosomes produce extracellular vesicles
(EVs), which contribute to parasite-host interactions.
Here we analysed for the first time the RNA profile
from EVs produced by parasitic T. brucei.
Methods: We isolated EVs released from two different life
cycle stages (procylic and bloodstream) ofT. brucei, using a
combination of differential centrifugation, size exclusion
chromatography and ultracentrifugation. Subsequently we
performed RNA-seq analysis of long RNAs (>200 nts) and
small RNAs (<200 nts), followed by bioinformatic identi-
fication; validation of trypanosome and EV-associated
RNAs was based on quantitative RT-PCR.
Results: Our analysis of RNAs revealed different RNA
species in trypanosome-derived vesicles. Interestingly,
we observed specific release of fragments from certain
mRNAs into the vesicles, whereas metabolically impor-
tant mRNAs were retained in the parasite, suggesting a
role in RNA disposal. We are currently comparing the
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mammalian- and insect-specific life cycle stages of the
parasites, which should further clarify a potential func-
tional role of vesicle-mediated host-parasite interac-
tions.
Summary/Conclusion: Trypanosome-derived extracel-
lular vesicles contain several RNA species, which are
selectively released, representing a class of diagnostic
biomarkers for diseases caused by these parasites.
Funding: LOEWE Center DRUID (Novel Drug Targets
against Poverty-Related and Neglected Tropical
Infectious Diseases).
PS02.07
Host immune response induced by outer membrane vesicles derived
from Burkholderia cepacia cultured with different antibiotics
Se Yeon Kima, Mi Hyun Kima, Joo Hee Sona, Seung Il Kimb and Je chul Leec
aDepartment of Microbiology, School of Medicine, Kyungpook National
University, Daegu, Republic of Korea; bDrug & Disease Target Team, Korea
Basic Science Institute, Ochang, Republic of Korea; cDepartment of
Microbiology, School of Medicine, Kyungpook National University, Daegu,
Republic of Korea
Introduction: Burkholderia cepacia is an opportunistic
pathogen that usually infects the patients with cystic
fibrosis or indwelling hardware. This study investigated
the production of outer membrane vesicles (OMVs) in
B. cepacia strain cultured with the sub-minimal inhibi-
tory concentrations (MICs) of antibiotics and their
pathogenic roles in vitro and in vivo.
Methods: OMVs were purified from the culture super-
natants of B. cepacia ATCC 25416 cultured with the 1/
4 sub-MICs of ceftazidime (CAZ), trimethoprim/sulfa-
methoxazole (SXT) or meropenem (MEM). A549 cells
were incubated with B. cepacia OMVs and then ana-
lysed for cytotoxicity and pro-inflammatory cytokine
gene expression. Mice were treated with B. cepacia
OMVs intratracheally, and lung pathology was
evaluated.
Results: B. cepacia produced OMVs during in vitro
culture. A total of 265 proteins were identified in
OMVs isolated from B. cepacia cultured in Luria-
Bertani broth (OMVs/LB) using proteomic analysis.
OMVs/LB induced cytotoxicity and stimulated the
expression of pro-inflammatory cytokine genes in
lung epithelial A549 cells in a dose-dependent manner.
B. cepacia produced more OMVs under antibiotic
stress condition than under no antibiotic condition.
Host cell cytotoxicity and pro-inflammatory response
were significantly higher in A549 cells treated with
OMVs from B. cepacia cultured with 1/4 sub-MIC of
CAZ (OMVs/CAZ) than in the cells treated with
OMVs/LB, OMVs from B. cepacia cultured with 1/4
sub-MIC of SXT (OMVs/SXT) or OMVs from B.
cepacia cultured with 1/4 sub-MIC of MEM (OMVs/
MEM). Intratracheal injection of OMVs/LB, OMVs/
MEM, and OMVs/CAZ induced histopathology and
pro-inflammatory responses in the mouse lung, but
OMVs/SXT did not induce pro-inflammatory
responses in the mouse lung. The expression of the
interleukin-1β and GRO-α genes was significantly
higher in the mice treated with OMVs/CAZ than the
mice treated with other OMVs.
Summary/Conclusion: OMVs produced by B. cepacia
exposed to different antibiotics represent different host
cell responses, which may modulate influence on the
bacterial pathogenesis.
Funding: This work was supported by the National
Research Foundation of Korea (NRF) grant funded by
the Korea government (NRF-2017R1A2A2A05001014).
PS02.08
Thymol suppresses the inflammatory responses induced by
Staphylococcus aureus-derived extracellular vesicles in cultured
keratinocytes
Joo Hee Sona, Se Yeon Kima, Mi Hyun Kima, Sang Hyun Kimb and Je chul
Leec
aDepartment of Microbiology, School of Medicine, Kyungpook National
University, Daegu, Republic of Korea; bDepartment of Pharmacology,
Kyungpook National University, School of Medicine, Daegu, Republic of
Korea; cDepartment of Microbiology, School of Medicine, Kyungpook
National University, Daegu, Republic of Korea
Introduction: Staphylococcus aureus-derived extracel-
lular vesicles (EVs) deliver effector molecules to host
cells and induce host cell pathology. This study inves-
tigated whether thymol could disrupt S. aureus EVs
and suppress the pathology of the keratinocytes
induced by S. aureus EVs.
Methods: Membrane disruption of the S. aureus EVs
treated with thymol was determined using transmis-
sion electron microscopy. Human keratinocyte HaCaT
cells were incubated with either intact or thymol-trea-
ted S. aureus EVs and then analysed for cytotoxicity
and pro-inflammatory cytokine gene expression.
Results: Thymol inhibited the growth of S. aureus
strains and disrupted the membranes of the S. aureus
EVs. Thymol-treated S. aureus EVs inhibited the cyto-
toxicity of HaCaT cells when compared to intact S.
aureus EVs; however, the cytoprotective activity dif-
fered between the EVs derived from S. aureus strains.
Intact S. aureus EVs stimulated the expression of the
pro-inflammatory cytokine and chemokine genes in
keratinocytes. The expression levels of the cytokine
genes differed between thymol-treated EVs from dif-
ferent S. aureus strains, but thymol-treated S. aureus
EVs suppressed the expression of these genes. Thymol-
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treated S. aureus EVs delivered lesser amounts of the
EV component to host cells than intact EVs.
Summary/Conclusion: Our results suggest that the thy-
mol-induced disruption of the S. aureus EVs inhibits the
delivery of effector molecules to host cells, resulting in
the suppression of cytotoxicity and inflammatory
responses in keratinocytes. Thymol may attenuate the
host cell pathology induced by an S. aureus infection via
both the antimicrobial activity against the bacteria and
the disruption of the secreted EVs.
Funding: This work was supported by the National
Research Foundation of Korea (NRF) grant funded by
the Korea government (NRF-2017R1A2A2A0500
1014).
PS02.09= OWP2.09
Deciphering the role of extracellular vesicles on the blood–brain
barrier during Zika virus infection
Antonios Fikatas, Sam Noppen, Peter Vervaeke, Jordi Doijen, Mohammed
Benkheil, Christophe Pannecouque and Dominique Schols
Laboratory of Virology and Chemotherapy, Rega Institute, KU Leuven,
Belgium, Leuven, Belgium
Introduction: The association of Zika virus (ZIKV)
with severe neurological disorders has gained increased
interest over the last decade. However, the mechanism
by which ZIKV crosses the blood–brain barrier (BBB)
and reaches the brain remains to be elucidated. It is
known that viruses incorporate viral material in extra-
cellular vesicles (EVs) as a spreading strategy. These
membrane-enclosed vesicles play a vital role in inter-
cellular communication. Currently, there is a lack of
knowledge on the possible involvement of EVs in
ZIKV pathogenesis. Our study aims to unravel the
role of EVs in ZIKV RNA transmission to the brain,
via the BBB.
Methods: Human brain microvascular endothelial cells
(HBMEC/D3) were used in our study since they repre-
sent the BBB in vitro. Three different EV isolation
methods (precipitation kit, density gradient and size
exclusion chromatography combined with the density
gradient) were performed. Western blot, Transmission
electron microscopy and Nanosight tracking analysis
confirmed the presence of EVs in the supernatant of
HBMEC/D3 cells. The presence of ZIKV RNA in
infected-EVs (IEVs) was evaluated by immunofluores-
cence and qPCR. In addition, the effect of IEVs on the
BBB was assessed using a label-free impedance-based
biosensor (ECIS, Applied BioPhysics).
Results: We confirmed the presence of viral compo-
nents in our IEVs, including the NS1 and E proteins of
ZIKV. The obtained IEVs were able to re-infect
susceptible cells, even after being pretreated with
RNase A. This indicates that the viral RNA resides
inside the IEVs. Using impedance measurements on
HBMEC/D3 cell monolayers, we observed that IEVs,
as well as virus control caused similar and temporal
disturbances on the monolayer’s integrity within
30 min post infection. No disturbances were seen
upon addition of non-infected EVs.
Summary/conclusion: Our study demonstrates that
EVs-derived from ZIKV-infected cells are able to trans-
fer proteins and viral RNA to recipient cells. Since both
IEVs and viral particles can induce similar changes on
barrier’s integrity it is possible that IEVs are involved
in an alternative mechanism of ZIKV transmission.
PS02.10=OWP2.11
In vivo testing of OMV-based vaccine prototypes against
Gallibacterium anatis
Fabio Antenuccia, Homa Arakb, Jianyang Gaob, Toloe Allahghadryb, Ida
Thøfnerb and Anders Miki Bojesenc
aUniversity of Copenhagen, København S, Denmark; bUniversity of
Copenhagen, Copenhagen, Denmark; cUniversity of Copenhagen,
Copenhagen, USA
Introduction: Outer membrane vesicles (OMVs) are
produced by the majority of Gram-negative bacteria.
Thanks to the antigenic similarity between OMVs and
the bacterial outer membrane, OMVs have proven to
be promising for the development of novel vaccines
against bacterial pathogens. In this work, we describe
the testing of OMV-based vaccine prototypes against
Gallibacterium anatis, a Gram-negative pathogen of
great veterinary interest.
Methods: OMVs were isolated from a G. anatis hyper-
vesiculating mutant using a modified version of the
Hydrostatic Filtration protocol described by Musante
et al. (2014). 120 16-week-old Lohmann-Brown chick-
ens were divided in six groups and immunized twice
intramuscularly with different combinations of buffer
(controls), OMVs and selected recombinant immuno-
gens. Two weeks after second immunization, the effec-
tiveness of the immunization regimes adopted was
tested by challenging the animals intraperitoneally
with live CFUs from a heterologous G. anatis strain.
One week post-challenge, the animals were sacrificed
and an established lesion score model was used during
necropsy to evaluate the clinical outcome of infection.
Results: Statistical analysis of the recorded lesion
scores showed that the group immunized with G. ana-
tis OMVs presented an average total score of 2.95, as
opposed to an average total score of 8.77 in the control
group. The approximately threefold reduction in total
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average lesion score observed demonstrates that immu-
nization with G. anatis OMVs is able to effectively
decrease the morbidity of G. anatis infection in the
immunized animals.
Summary/conclusion: Our results show that G. anatis
OMVs represent a promising candidate for the devel-
opment of cost-effective vaccination strategies for the
prevention of G. anatis infections in a cross-serovar
manner. Accordingly, we hypothesize that dose/
response optimization and the enrichment of G. anatis
OMVs with selected immunogens should result in an
improvement of the effectiveness of the vaccination
regime proposed.
Funding: This research project is being funded by a
grant from Huvepharma (https://www.huvepharma.
com/).
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Serum exosome mediates chronic intermittent hypoxia-associated
endothelial dysfunction through regulating miR-144, −27a/Nrf2
pathway
Huina Zhang
Beijing An Zhen Hospital, Capital Medical University, Beijing, China
(People’s Republic)
Introduction: Endothelial dysfunction plays a crucial
role in the development of OSAHS-related vasculopa-
thy, but the mechanisms are not fully understood.
Exosomes, abundant in blood, deliver various mole-
cules to recipient cells. However, whether serum exo-
somes (SExos) are involved in chronic intermittent
hypoxia (CIH)-associated vasculopathy is largely
unknown.
Methods: SExo was purified by ultracentrifugation.
TEM and NTS were used to evaluate the purity of
exosome. Myograph was used to detect endothelial
function. Western blotting and quantitative polymerase
chain reaction (qPCR) were used to measure the
expression of protein or miRNA respectively.
Confocal microscopy was used to detect the signal of
exosome or oxygen free radical in endothelial cells.
Results: Endothelial dysfunction caused by CIH was
related with oxidative stress. Furthermore, SExos from
CIH mouse (CIH SExos) severely impaired endothelial
function and enhanced the oxygen free radical in
endothelial cells from normal C57BL/6 mice. Western
blotting showed that the expression of antioxidant
transcription factor Nrf2 and its downstream target
catalase were significantly decreased in CIH SExos-
treated endothelial cells ex vivo or in vitro. qPCR
assay showed significant increasement of exosomal
miR-27a and miR-144 under CIH status.
Correspondingly, silencing miR-144 and miR-27a
with CIH SExo-packaged antagomiR-27a and
antagomiR-144 confirmed the pivotal role of SExo
miR-27a and miR-144 in CIH SExo-inhibited Nrf2
expression, CIH SExo-induced endothelial dysfunction
and the excess oxygen free radical generation in
endothelial cells.
Summary/Conclusion: This study demonstrates the
adverse effect of CIH SExo on endothelial cells, repre-
senting a novel cellular mechanism of exosomal miR-
27a, −144/Nrf2 pathway that mediates the development
of CIH-associated endothelial dysfunction.
Funding: This study was supported by National
Natural Science Foundation of China (No.81471082,
31741064 and 81470567)
PS03.02
Influence of cardiovascular risk markers on numbers and
characterization of circulating extracellular vesicles
Ruihan Zhou, Dionne Tannetta, Plinio Ferreira; Esra Bozbas, Jon Gibbins,
Chris Jones and Parveen Yaqoob
University of Reading, Reading, UK
Introduction: Extracellular vesicles (EVs) are small
plasma membrane-derived vesicles released from var-
ious cells, which potentially affect many pathophysio-
logical processes involved in cardiovascular diseases
(CVDs). However, there is little information about
the relationship between gender, CVD risk markers
(Body Mass Index (BMI), blood pressure (BP), trigly-
ceride level, cholesterol level and HDL level), CVD risk
score and circulating EVs.
Methods: Subjects (n = 27) aged 40–70 years with
moderate risk of CVDs (QRISK2 score) were recruited
and assessed for BMI, BP and blood lipid profile. EVs
were isolated from platelet-free plasma by size exclu-
sion chromatography and analysed by nanoparticle
tracking analysis (NTA) and flow cytometry (FCM).
NTA measured the concentration and size distribution
of EVs, and EVs were phenotyped by FCM via a 3-
colour panel, including Annexin V (for the majority of
circulating EVs), CD41 (for platelet-derived EVs) and
CD105 (for endothelial-derived EVs).
Results: • Subjects unexpectedly fell into two clear
groups: high EVs group (total EV numbers: 4*10^10/
mL blood ~ 8*10^10/mL blood, n = 9 or Annexin V
+ EV numbers: 2.6*10^7/mL blood ~ 5*10^7/mL
blood, n = 17) and low EVs group (total EV numbers:
1*10^10/mL blood ~ 3.9*10^10/mL blood, n = 18 or
Annexin V+ EV numbers: 9*10^6/mL blood ~
2.5*10^7/mL blood, n = 10).
• Males accounted for 78% of the subjects in high total
EVs group. Overweight subjects (BMI ≥ 24.9 kg/m^2)
contributed to 89% of the subjects with high total EV
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numbers, while 93% of the subjects with normal weight
were classified into low EVs group. The high Annexin
V+ EVs group had significantly higher diastolic BP
levels (p = 0.02) and higher cholesterol levels
(p = 0.03) than those with low EV numbers. Those
with higher total EV numbers had a higher average
CVD risk score (p = 0.02).
• Overweight subjects had a significantly higher num-
ber of endothelial-derived EVs than subjects with nor-
mal weight (p = 0.02).
Summary/Conclusion: The majority of subjects with
high total EV numbers were male. Overweight contrib-
uted to the elevation of total EV and endothelial-
derived EV numbers. Higher BP level, cholesterol
level and CVD risk score were associated with higher
numbers of circulating EVs.
Funding: This project is supported by Biotechnology
and Biological Sciences Research Council (BBSRC)–
Diet and Health Research Industry Club in UK
PS03.03
Changes in exosome release in ageing: a pilot study in a human
model of ischemia reperfusion
Ying Qiu Zhoua, Liem Nguyena, Michael Madanib, Victor Pretoriusb, Hemal
Patelb and David Rotha
aUniversity of California, San Diego, USA; bUniversity of California, San
Diego, La Jolla, USA
Introduction: The growing aged population necessi-
tates better understanding of cellular and physiological
changes in ageing to improve future healthcare delivery
and cost. The role of exosomes, extracellular vesicles
carrying biologically active cargo secreted by almost all
cells, may have major impacts on perioperative care
and monitoring. Deep hypothermic circulatory arrest
(DHCA) is a profound perioperative stress event invol-
ving hypothermia, arrest of circulation to major organ
systems and whole body ischaemia reperfusion. DHCA
is used during pulmonary thromboendarterectomy, for
which the University of California, San Diego, USA,
serves as a leading centre. With a patient age range of
14–80 years old, we use DHCA as a model of whole
body ischaemia reperfusion to test the novel hypothesis
that DHCA alters the amount of exosome release,
content and ability of exosomes to affect cellular meta-
bolism and function in an age-dependent manner.
Methods: Plasma was obtained from patients under-
going DHCA: after induction of anaesthesia (baseline),
at initiation of cardiopulmonary bypass (CPB), com-
pletion of cooling, after circulatory arrests and at chest
closure. Exosomes were isolated with ExoQuick.
Nanoparticle tracking analysis (NTA) measured
particle concentration. Immunoblotting and electron
microscopy confirm the presence of exosomes.
Samples were stored for proteomic, microRNA and in
vitro analysis.
Results: Mean particle sizes at each time point were
within the known size distribution of exosomes.
Particle concentration at the completion of cooling
was decreased from baseline. Thereafter, particle con-
centration showed an increase after DHCA and a
further increase during chest closure at the conclusion
of the surgery.
Summary/Conclusion: Our data show that cooling can
decrease exosome levels in blood, while whole body
ischaemia reperfusion associated with DHCA in
patients may be a stimulus for exosome release. As
more samples are collected, we will assess changes in
the proteome and microRNA content of exosomes
before and after DHCA as a function of age. This
model also lends itself well to further detailed investi-
gation of tissue and organ-specific responses to ischae-
mia reperfusion in young and aged patients.
Funding: This work was funded by the National
Institutes of Health, USA.
PS03.04
Intracardiac extracellular vesicle release in post-infarction diabetic
hearts
Stephane Mazlana, Vincent Duvala, Cecile Devuea, Michael Robillarda,
Chantal Boulangerb, Jean-Sebastien Silvestrea and Xavier Loyera
aINSERM, Paris, France; bINSERM ‘ParCC’ Paris-Cariovascular Research
Center, Hôpital Européen Georges Pompidou, Assistance Publique-
Hôpitaux de Paris, and Université Sorbonne, Paris, France
Introduction: Cardiovascular disease (CVD) is the
main cause of death in non-communicable diseases.
In response to myocardial infarction (MI), extracellular
vesicles (EVs), including large (lEVs) and small (sEVs),
are released within and from the heart to facilitate
intercellular communication and maintain cardiac
homeostasis. As diabetes increases the risk of CVD,
the purpose of the study was to investigate how dia-
betes influences the release of intracardiac EVs
after MI.
Methods: C57BL/6J male mice were fed normal chow
diet or high-fat diet (HFD) for 3 months. HFD-fed
mice were glucose intolerant as attested by the measure
of GTT above 200 mg/mL. Mice were then subjected to
MI by permanent ligation of the left anterior descend-
ing artery, and sham animals underwent similar surgi-
cal procedure without ligation. Left ventricles from
sham or MI mice were then harvested at either 15,
24, 48 or 72 h after surgery (n = 5 per group at each
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time point) and processed for EV extraction by differ-
ential centrifugation. lEVs and sEVs were then quanti-
fied and analysed via Tunable Resistive Pulse Sensing
Technology (TRPS), flow cytometry and Western blot.
Results: In chow diet-fed mice, release of both lEVs
and sEVs was increased at 24 h post-surgery when
compared to shams. These findings were in agreement
with previous data obtained in younger control ani-
mals. In diabetic mice, lEVs peaked at 24 h post-MI
and this increase was slightly greater than that
observed in chow diet-fed animals. However, there
were no differences in sEV release between sham and
MI diabetic mice. TRPS analysis revealed that diabetes
does not change EV size (diameter) and population.
Furthermore, both control and diabetic-derived EVs
harboured cardiomyocyte marker (Troponin T) as
revealed by Western blot.
Summary/Conclusion: Our results thus show that dia-
betes modulates the release of both large and small
intracardiac EVs after MI. Further work will be needed
to fully investigate the functional impact of cardiac EVs
in the diabetic heart after MI.
Funding: INSERM and ANR-16-CE92-0032-02
PS03.05
Exosomal low-density lipoprotein receptor (LDLR) as a potential
biomarker in patients with coronary artery disease
Dapi Meng Lin. Chianga, Liv Weichien Chenb, Michael Pfafflc and Chin-
Sheng Linb
aBiovesicle, Taipei, Taiwan (Republic of China); bDivision of Cardiology, Tri-
Service General Hospital, Taiwan & National Defense Medical Center, Taipei
City, Taiwan (Republic of China); cAnimal Physiology and Immunology,
School of Life Sciences Weihenstephan, Technical University of Munich,
Freising, Germany
Introduction: Atherosclerosis is one of the key factors
contributing to cardiovascular disease. Exosomes have
been documented to be associated with atherosclerosis
pathogenesis. However, the potential exosome-related
biomarkers in atherosclerosis patients has not been
analysed and characterized yet. In this study, we
aimed for assessing the potential biomarker in serum
exosome for coronary artery disease (CAD).
Methods: Plasma samples were collected from patients
undergoing coronary angiography. To assess exosomal
low-density lipoprotein receptor (LDLR) and ATP-
binding cassette transporter A1 (ABCA1) expression,
we isolated exosome by incubating glycan recognition
beads, EXÖBead (Biovesicle) with 250 µL pre-cleared
plasma from healthy donors (n = 28) and CAD patients
(CADs, n = 26) as manufacturer’s protocol. To confirm
the purity of our isolation, we used NTA and TEM to
demonstrate exosome morphology and size
distribution, according to the MISEV guidelines.
Exosomal LDLR and ABCA1 protein expressions
were analysed by flow cytometry, FACS. Furthermore,
the exosome specific markers CD9, CD63 and CD81
were simultaneously detected in exosome-EXÖBead
complexes by multiple fluorescent antibody staining
and FACS. We incorporated 10% exosome-free “foetal
bovine serum” in PBS as the antibody staining negative
control.
Results: The exosome size distribution and morphol-
ogy were similar between the plasma sample from
healthy and CAD groups. The geometric mean fluor-
escence intensity, MFI of CD9, CD63, CD81, LDLR
and ABCA1 were not different between these two
groups. However, the corrected MFI ratio of LDLR/
CD9 in healthy donors was significantly higher com-
pared to CAD patients (p = 0.044). Similar significant
changes in ratio of LDLR/CD63 (p = 0.026) and LDLR/
CD81 (p = 0.027) were also observed. Besides, there is
no significant change in exosomal ABCA1 between
healthy donors and CAD patients.
Summary/Conclusion: Declined expressions of LDLR/
exosome in patients with CAD were observed in our
study. These results may be an essential clue for explor-
ing the function of exosomal LDLR in lipid metabolism
and atherosclerosis. Further approaches regarding cell-
to-cell communication of exosomal LDLR will be
addressed in the future.
PS03.06
Therapeutic EV rescue a deficient hypoxic response in pulmonary
arterial hypertension
David Marciano, Rebecca Harper, Vignesh Viswanathan, Marlene
Rabinovitch and Michael Snyder
Stanford University, Stanford, USA
Introduction: Complex gene-environment interactions
can determine the penetrance of a genetic mutation
leading to disease. Pulmonary arterial hypertension
(PAH) is a lethal disease that is highly associated with
loss-of-function bone morphogenetic protein receptor
II (BMPR2) mutations and persistent hypoxic stress.
While these genetic and environmental determinants of
PAH are clearly defined, little is known about how they
are interconnected to potentiate disease.
Methods: Pulmonary arterial endothelial cells (PAEC)
were exposed to hypoxia (0.5% O2) for 24 h and
culture media collected. Extracellular vesicles (EVs)
were isolated using differential ultracentrifugation and
characterized with electron microscopy and nanoparti-
cle analysis. qPCR analysis after RNAse digestion was
performed to identify packaged mRNA. EV treatment
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of mice was administered via tail-vein injection. In vivo
biodistribution was visualized by Gallium-68 labelling
coupled with positron emission tomography (PET)
imaging.
Results: Here we report that BMPR2 is induced by
hypoxia in PAEC, and loss of BMPR2 partially blocks
the release of extracellular vesicles under these condi-
tions. EVs derived from hypoxic PAEC are enriched
with BMPR2 mRNA and can restore abnormal pheno-
types in BMPR2 mutant cells in vitro. BMPR2 knock-
out mice exposed to intermittent hypoxia develop PAH
phenotypes that are prevented by treatment with
hypoxic PAEC derived EV.
Summary/Conclusion: These results show that PAEC-
derived EVs are critical for the maintenance of vascular
homeostasis, loss of this signal due to BMPR2 dysfunc-
tion contributes to PAH pathogenesis, and replacement
with exogenous EV has therapeutic potential in PAH.
Funding: F32 HL 132452, NIH NHLBI
PS03.07
Role of extracellular vesicles in cardiovascular toxicity induced by
BCR-ABL tyrosine kinase inhibitors
Dakota D. Gustafsona, Nazanin Aghelb, Jason Fishc, Diego Delgadob and Jeff
Liptond
aDepartment of Laboratory Medicine and Pathobiology, University of
Toronto, Toronto, ON, Canada; bPeter Munk Cardiac Centre, Toronto,
Canada; cToronto General Hospital Research Institute, University Health
Network, Toronto, ON, Canada; dPrincess Margaret Cancer Centre,
Toronto, Canada
Introduction: Despite their efficacy as an anti-cancer
therapeutic against chronic myelogenous leukaemia
(CML), tyrosine kinase inhibitors (TKIs) can be asso-
ciated with deleterious cardiovascular effects.
Considerable progress has been made in identifying
the excess risk of cardiovascular events related to TKI
exposure; however, the data on the underlying
mechanisms and possible predictive biomarkers are
currently inadequate. To this end, we sought to exam-
ine EV-associated miRNAs as a means of elucidating
their potential as effectors and biomarkers of TKI-
induced cardiovascular toxicity in CML.
Methods: We obtained informed consent and recruited
24 age- and sex-matched response stable CML patients
either off-TKI (median 32.26 months, n = 6) or on
long-term treatment with imatinib, nilotinib or pona-
tinib (median 79.01 months, n = 6/group), and assayed
plasma-derived EV-associated miRNAs using the
nCounter® Analysis System. Concurrently, in vitro stu-
dies were conducted to examine the responses of iPSC-
derived human cardiomyocytes to plasma-derived EVs
using BNP as a surrogate marker of the cardiovascular
stress response. Consent was obtained by the
University Health Network Research Ethics Board.
Results: We identified selective dysregulation in each
treatment group associated with CML and as well as
specific cardiovascular pathophysiology, e.g. miR-let-
7e-5p, miR-502-5p and miR-548a-5p (p < 0.05). In
vitro, we identified a surprising cardioprotective action
of ponatinib-patient EVs on cardiomyocytes, indicated
by a significant decrease in free BNP in the media of
cardiomyocytes treated with EVs compared to other
treatment arms (p < 0.01).
Summary/Conclusion: This study represents a novel
approach investigating the utility of EVs and their
associated miRNAs as biomarkers and effectors of
TKI-induced cardiovascular toxicity. Our results high-
light a distinct profile of miRNAs associated with TKI
treatment. Understanding the complex role of EVs in
TKI therapy will elucidate the complexities of cardio-
vascular toxicity and aid in tailoring the risk manage-
ment of individual patients.
Funding: This project was funded by the Princess
Margaret Cancer Centre.
PS03.08
Extracellular vesicles derived from genetically modified human
induced pluripotent stem cells enhance cardiomyogenesis and
angiogenesis in vitro and in vivo
Katarzyna Kmiotek-Wasylewska, Sylwia Bobis-Wozowicz, Anna Labedz-
Maslowska, Elzbieta Karnas, Zbigniew Madeja and Ewa Zuba-Surma
Department of Cell Biology, Faculty of Biochemistry, Biophysics and
Biotechnology, Jagiellonian University, Krakow, Poland
Introduction: Extracellular vesicles (EVs) represent
population of small circular membrane vesicles
secreted by most cells including stem cells (SCs). It
has been reported that EVs may carry bioactive cargo
including proteins, microRNAs and mRNAs. They also
play a crucial role in cell-to-cell communication in
both physiological and pathological conditions.
The aim of this study was to verify the impact of
EVs derived from human induced pluripotent stem
(iPS) cells (hiPS-EVs) overexpressing procardiomyo-
genic miR1 or miR199a, or proangiogenic miR126, on
various properties of human cardiac and endothelial
cells.
Methods: hiPS-EVs were isolated from conditioned
hiPS culture media by differential centrifugation
including ultracentifugation. Cardiac cells and
endothelial cells were used as target cells in vitro, and
their functional properties were evaluated after hiPS-
EVs treatment. The regenerative capacity of hiPS-EVs
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was also examined in vivo – in murine model of acute
limb ischaemia (LI).
Results: Our data indicate that hiPS-EVs carrying pro-
cardio- and proangiogenic miRNAs may protect car-
diac cell types from apoptosis as well as enhance their
proliferation, metabolic activity, migration and cardio-
myogenic differentiation. The hiPS-EVs enhanced also
proangiogenic capacity, migration and metabolic activ-
ity of HCAEC cells in vitro. The vesicles also promoted
angiogenesis and increased blood flow recovery in
murine ischaemic limb injury model in vivo.
Summary/Conclusion: These results may indicate (i)
feasibility of genetic modifications of EVs enforcing
their regenerative proprieties as well as (ii) enhanced
activity of EVs from hiPS cells overexpressing miR1,
miR199a and miR126 in regeneration of ischaemic
tissues. We conclude that EVs from genetically mod-
ified hiPS cells may represent new safe tool for tissue
repair alternative to whole-cell therapies in vivo.
Funding: This study was funded by NCN and NCBR
grants: SONATA BIS-3 (UMO-2013/10/E/NZ3/
007500) and STRATEGMED III (STRATEGMED3/
303570/7/NCBR/2017) to EZS and PRELUDIUM-11
(UMO-2016/21/N/NZ3/00363) to KKW.
PS03.09
Cardioprotective and proangiogenic potential of small extracellular
vesicles secreted from amniotic fluid stem cells
Kaloyan Takova, Filipa Vlahovab, Pascale Guillotb, Derek Yellona and Sean
Davidsona
aThe Hatter Cardiovascular Institute, University College London, London,
UK; bInstitute for Women’s Health, University College London, London, UK
Introduction: Mesenchymal stem cells (MSCs) exhibit
antiapoptotic and proangiogenic functions in models
of myocardial infarction, a common cause of death and
disability. These effects are partially mediated by
secreted small extracellular vesicles (sEVs). Amniotic
fluid stem cells (AFSCs) are foetal MSCs with superior
functional potential to adult MSCs. We hypothesized
that sEVs released by AFSCs are cardioprotective and
proangiogenic.
Methods: Human AFSC sEVs were isolated from
serum-free conditioned medium by size-exclusion
chromatography and characterized using nanoparticle
tracking, dot blots, protein and immunoassays, electron
microscopy and protein arrays. Their cardioprotective
potential was examined in models of hypoxia/reoxy-
genation- and reactive oxygen species-induced death of
primary adult rat cardiomyocytes in vitro. AFSC sEV
effects on human endothelial cell migration, prolifera-
tion and signalling pathway activation were also
investigated (using Boyden’s Chamber assay, MTT
assay and western blot analysis/phosphokinase arrays,
respectively).
Results: Isolated AFSC sEVs were CD9/CD63/CD81-
positive and of high purity (up to 1.2x10^10 particles/
µg protein). These vesicles were not cardioprotective in
models of simulated ischaemia/reperfusion injury in
primary cardiomyocytes in vitro. Nevertheless, AFSC
sEVs carried promigratory cytokines and angiogenic
factors (e.g. SDF-1, MIF, PTX3) and promoted
endothelial cell migration and proliferation in vitro.
Pharmacological inhibition of PI3K (a promigratory
signalling pathway) in target endothelial cells reduced
sEV-stimulated migration by 54 ± 15% (p < 0.001).
However, sEVs did not induce phosphorylation of
downstream PI3K targets, indicating that sEV effects
may be multifactorial and may involve multiple
pathways.
Summary/Conclusion: AFSC sEVs did not have direct
protective effects on cardiomyocytes in vitro but pos-
sessed proangiogenic potential which requires, but is
not solely dependent on, PI3K signalling. Ongoing
experiments include analyses of the sEV proteome,
their cardioprotective properties in a model of rat
myocardial ischaemia/reperfusion injury in vivo and
their role in capillary sprouting from rat aortic
explants. Together, these data will define the potential
for using AFSC sEVs as cardioprotective and proangio-
genic therapy.
Funding: BHF
PS03.10
CystatinC and CD14 in plasma extracellular vesicles are associated
with both renal dysfunction and heart failure in patients presenting
with dyspnoea
Mirthe Dekkera, Farahnaz Waissib, Laura Verbree, Irwani Ibrahim, Shirley
Ooi, Jiong-Wei Wangc, Win Kuand, Siew Chanc, Linda Peelene, Diederick
Grobbee, A. Mark Richards, Carolyn Lam, Ya-Nan Zhang, Muhammad I
Mazlan, Dominique de Kleijnf
aUMC Utrecht, Utrecht, Netherlands; bUMC Utrecht, Utrecht, Netherlands;
cNational University of Singapore, Singapore; dNational University Hospital,
Singapore; eJulius Center for Health Sciences and Primary Care UMC
Utrecht, Utrecht, Netherlands; fUMCU, Utrecht, Netherlands
Introduction: Heart failure and renal failure com-
monly coexist: heart failure patients have higher chance
of developing renal failure and vice versa.1,2 Declines in
renal function are associated with the development of
ventricular dysfunction and worsen prognosis in heart
failure.3,4 However, underlying pathophysiological
mechanisms in cardiac-renal cross talk are not fully
understood1. The role of plasma extracellular vesicles
(EVs) in combined organ failure such as cardiorenal
syndrome has not been investigated. The primary aim
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of this study is to investigate if the extracellular vesicle
proteins CystatinC, CD14, SerpinG1 and SerpinF2 that
have been associated with heart failure are also asso-
ciated with renal dysfunction in patients with acute
dyspnoea.
Methods: Blood samples were prospectively collected
in 404 patients presenting with breathlessness at the
emergency department at National University Hospital,
Singapore. Renal dysfunction was defined as estimated
glomerular filtration rate below 60 mL/min/1.73m2.
The presence of heart failure was independently adju-
dicated by two clinicians. EVs were precipitated in 3
sub-fractions from the plasma using dextrane sulphate
for the LDL and HDL plasma-subfractions or
ExoQuick. After precipitation, the EVs were lysed and
the four selected proteins were measured quantitatively
using immunobead assays and tested for their associa-
tions with renal dysfunction, heart failure and the
concurrence of both conditions using multinomial
regression analysis.
Results: CystatinC was associated with renal dysfunc-
tion, heart failure and their combination in all three
EV-sub-fractions and in plasma. CD14 was associated
with both renal dysfunction and the combined renal
dysfunction and heart failure in all EV-sub-fractions,
and with the presence of heart failure in the HDL-sub-
fraction but these associations were only seen in the EV
subfractions and not in plasma.
Summary/Conclusion: We provide the first data showing
that EV CystatinC and CD14 are associated with both
renal dysfunction and heart failure in patients presenting
with acute dyspnoea. These data suggest that extracellular
vesicle proteins may be involved in the combined organ
failure of the cardiorenal syndrome, and represent possi-
ble targets for prevention or treatment.
PS03.11=OWP1.03
Identification of extracellular vesicles as biomarkers for myocardial
infraction by flow cytometry and automated data processing
Aleksandra Gasecka1; Edwin van der Pol2; Frank Coumans3; Kinga Pluta4;
Grzegorz Opolski4; Krzysztof J. Filipiak5; Rienk Nieuwland3
11st Chair and Department of Cardiology, Medical University of Warsaw,
Warsaw, Poland; 2Amsterdam UMC, University of Amsterdam, Department
of Biomedical Engineering and Physics, Amsterdam, Netherlands, Amsterdam,
Netherlands; 3Amsterdam UMC, University of Amsterdam, Laboratory of
Experimental Clinical Chemistry, Amsterdam, Netherlands, Amsterdam,
Netherlands; 41st Chair and Department of Cardiology, Medical University of
Warsaw, Poland, Warsaw, Poland; 51st Chair and Department of Cardiology,
Medical University of Warsaw, Poland, Warsaw, USA
Introduction: Acute myocardial infarction (AMI) is a
major cause of death. To diagnose AMI, measuring
troponin concentration is the gold standard. Since tro-
ponin is unspecific for AMI, novel biomarkers for AMI
are urgently needed. After the onset of AMI, platelets,
endothelial cells and blood cells release specific extra-
cellular vesicles (EVs). Our aim is to identify these EVs
as biomarkers for AMI diagnosis and treatment
monitoring.
Methods: The study was approved by the medical
ethics committee. Venous blood was collected 24
hours, 72 hours and 6 months after AMI from fasting
patients (n=60, 64.5±10.8 years, 68% male) and healthy
controls (n=30, 57.7±6.6 years, 62% male). Flow cyto-
metry (Apogee A60 Micro) was used to determine
plasma concentrations of EVs labelled with antibodies
for activated platelets (CD61, CD62p; PEVs), endothe-
lial cells (CD146; EEVs) and red blood cells (CD235a;
RBC-EVs). Processing of 1,224 flow cytometry data
files was performed using in-house developed, auto-
mated software (MATLAB R2018a), enabling flow
rate stabilization, diameter and refractive index deter-
mination, MESF calibration, fluorescent gate determi-
nation and statistics reporting.
Results: Between AMI patients and controls, PEV con-
centrations in plasma were comparable (p=ns), EEV
concentrations increased (p<0.0001), and RBC-EV
concentrations decreased (p<0.0001). Antiplatelet
drug ticagrelor decreased concentrations of PEVs
(p=0.03), compared to less potent clopidogrel, but did
not affect EEVs and RBC-EVs. In turn, concentrations
of EEVs, but not PEVs and RBC-EVs, positively corre-
lated with the dose of atorvastatin (p<0.001). The anti-
oxidative β-blocker carvedilol increased concentrations
of RBC-EVs, compared to nebivolol (p=0.05), but did
not affect PEVs and EEVs.
Summary/Conclusion: Flow cytometry and automated
data processing were used to find biomarkers for AMI
based on EVs in plasma. During treatment, ticagrelor
decreased PEV concentrations, atorvastatin increased
EEV concentrations, and carvedilol increased RBC-EV
concentrations, suggesting that EVs might be used to
monitor AMI treatment. AMI patients differed from
controls regarding EEV and RBC-EV concentrations,
but not PEVs, likely because blood was collected 24
hours after the start of antiplatelet therapy. In follow-
up studies, it is crucial to collect blood prior to
treatment.
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Isolation of extracellular vesicles from small volume of plasma by
microfluidic aqueous two phase system
Bohoon Hana, Sumi Kima, Yeseong Choia, Seok Chungb and Ji Yoon Kanga
aKorea Institute of Science and Technology, Seoul, Republic of Korea; bKorea
University, Seoul, Republic of Korea
Introduction: Isolation of extracellular vesicles (EVs)
from small volume of sample is a major issue of point-
of-care testing and it leads to great attention in micro-
fluidic device. However, previous microfluidic immu-
noaffinity approach has possibility of the loss of EVs
that might have more useful information due to het-
erogeneity of EVs. In the case of microfluidic device
applying external forces, has drawback in complicated
fabrication process and possibility in deformation of
EVs. Therefore, this paper suggests a microfluidic aqu-
eous two phase system (ATPS) in isolation of EVs from
stable laminar two phase flow with just simple design
of chip.
Methods: EV-protein mixture was tested to investigate
the partitioning behaviour. EVs were isolated by ultra-
centrifuge from human plasma, then bovine serum
albumin was added to prepare EV-protein mixture.
Polyethylene glycol (PEG, 3.5 wt%) dissolved in phos-
phate-buffered saline was injected to top and bottom
inlet. Dextran (DEX, 1.5 wt%) dissolved in sample was
injected to middle inlet. Fluorescence intensities of EV
and albumin were imaged to investigate the partition-
ing behaviour in real time from EV-protein mixture.
Concentrations of collected EV and albumin were mea-
sured to confirm the fluorescence imaging. Also, same
experiment was performed with only PEG without
dextran to investigate the effect of ATPS. EV isolation
from human plasma was also performed and charac-
terized by western blot and atomic force microscopy.
Results: Most of green EVs were remained in middle
phase where red BSA seems almost fully diffused out
for the equilibrium state in fluorescence experiment.
Microfluidic ATPS could isolate the EV with 83.43% of
recovery efficiency and protein removal of 65.46%
from EV-protein mixture. Microfluidic without ATPS
could isolate the EV with recovery rate of 67.14%. Also,
EVs were successfully isolated from human plasma
with almost same recovery rate.
Summary/Conclusion: The difference of diffusion
velocity in laminar flow was dominant factor in separ-
ating proteins from EVs in our microfluidic ATPS.
Other body fluids will be tested with our modified
system. We expect that our device will provide more
useful application in isolation of EVs.
PS04.02
Extracellular vesicle-associated microRNAs show stronger correlations
with cardiovascular disease protein biomarkers than cell-free
microRNAs in human plasma
Shi Chena, Shu-Chu Shieshb, Gwo-Bin Leec and Chihchen Chena
aInstitution of NanoEngineering and MicroSystems, National Tsing Hua
University, Hsinchu, Taiwan (Republic of China); bDepartment of Medical
Laboratory Science and Biotechnology, National Cheng Kung University,
Tainan, Taiwan (Republic of China); cDepartment of Power Mechanical
Engineering, National Tsing Hua University, Hsinchu, Taiwan (Republic of
China)
Introduction: This abstract presents a high-efficiency
method utilizing two sets of magnetic beads to isolate
extracellular vesicles (EVs) and EV-associated
microRNAs (EV-miRNAs) from human platelet-poor
plasma samples. Our goal is to develop a platform for
risk assessment of cardiovascular diseases (CVDs) and
compare the expression levels of circulating cell-free
miRNAs and EV-miRNAs. In contrast to the rapid
peaking and falling of cardiac troponin I (cTN-I), a
conventional CVD biomarker, the level of circulating
miR-126 remains downregulated even one week after
the onset of acute myocardial infarction (AMI).
Methods: In this study, we first used anti-CD63 anti-
body-coated magnetic beads to separate CD63+ EVs.
EV-miRNAs were released after EV lysis and subse-
quently extracted by using oligonucleotide-conjugated
magnetic beads. Expression levels of cell-free and EV-
associated microRNAs in six clinical plasma samples
were quantified using quantitative reverse transcription
polymerase chain reaction (RT-qPCR) with a spike-in
exogenous cel-miR-238 control.
Results: Experimental results showed the levels of
miRNAs in CD63+ EVs were ~74% of cell-free
miRNAs in plasma, whereas the miRNA extraction
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efficiency was >87% and exhibited no apparent depen-
dence on the concentration of miRNA and the medium
evaluated. Compared with the levels of conventional
CVD protein biomarkers, EV-derived miR-126 levels
were negatively correlated with N-terminal pro-b-type
natriuretic peptide (NTproBNP) and cTN-I levels with
R^2 = 0.70 and R^2 = 0.61, respectively. In contrast,
circulating total miR-126 levels were only weakly cor-
related with these biomarkers (R^2 = 0.14, R^2 = 0.02,
respectively).
Summary/Conclusion: We have developed methods to
isolate EVs from human plasma samples, and subse-
quently to extract miRNAs carried by EVs by using two
sets of magnetic beads. Our preliminary results suggest
that EV-associated miR-126 may serve as a better bio-
marker than the total circulating miR-126. More clin-
ical samples are currently being investigated.
Funding: Taiwan Ministry of Science & Technology
(MOST 106–2221-E-007–003-, MOST 105–2221-E-
007–009-, and MOST 106–2221-E-007–002-) and the
Taiwan Ministry of Education (Higher Education
Sprout Project: grant no. 107Q2713E1).
PS04.03
Effective separation of exosomes based on its surface sugar chains
using a macroporous spongy monolith
Takuya Kubo, Raga Ishikawa, Seiya Kato, Toyohiro Naito, Yoshihiro Sasaki,
Kazunari Akiyoshi and Koji Otsuka
Kyoto University, Kyoto, Japan
Introduction: The surface sugar chains on exosomes
contribute the communication among cells. But, in the
present separation procedures, the effective separations
of exosomes based on the differences of sugar chains
have never reported. We focus on a lectin affinity
chromatography (LAC) with a macroporous spongy
monolith (1), which is suitable for a high throughput
and selective separations for biomolecules. In this
study, we prepared a few lectin-immobilized spongy-
monolithic columns and evaluated for typical LAC
analyses. Additionally, the columns were applied for
the separation of exomes to determine the fundamental
adsorption/desorption conditions.
Methods: Poly(ethylene-co-glycidylmethacrylate) (PE
GM)-based spongy monolith (PEGM-SPM) was packed
into columns, and then concanavalin A (ConA) or
Sambucus sieboldiana agglutinin (SSA) was immobilized.
Additionally, bovine serum albumin or insulin (Ins) was
further immobilized to block the hydrophobic surface of
PEGM-SPM. The obtained columns were simply analysed
by LAC and applied for the separation of exosomes.
Results: As results of LAC evaluations, both ConA-
SPM and SSA-SPM showed selective lectin affinity for
the glycoproteins, only the glycoproteins associated to
each lectin were selectively separated from the mixture
samples. Additionally, an Ins-SPM allowed the effective
permeability against liposome and exosome. This
means that the protein-immobilized SPM was suitable
for the separation media of nanometer sized particles
without any non-specific adsorption. Finally, we
demonstrated the selective separation of exosome due
to lectin affinity. As a result, SSA-SPM provided the
effective adsorption of exosome based on the interac-
tion between SSA and sialic acid on exosome.
Summary/Conclusion: According to these results, the
newly developed lectin-SPMs can be used for the
separation of exosomes based on the difference of the
surface sugar chains. We believe that the increase of
number of lectin-SPMs and other affinity-SPMs will
lead to the detailed classification of exosomes due to
its surface chemistry.
(1) Kubota, K.; Kubo, T.; Tanigawa, T; Naito, T.;
Otsuka, K. Sci. Rep. 2017, 7, 178.
PS04.04
A microfluidic module for extracellular vesicle separation coupled to
microarray-based phenotyping
Marina Creticha, Dario Brambillaa, Alessandro Romanatoa, Maria Teresa
Odinolfia, Stephanie Descroixb, Lucile Alexandreb, Laura Trapiellab, M.
Selim Ünlüc, Natasa Zarovnid and Marcella Chiaria
aConsiglio Nazionale delle Ricerche (CNR), Istituto di Chimica del
Riconoscimento Molecolare (ICRM), Milano, Italy; bCurie Institute, Paris,
France; cBoston University, Boston, USA; dHansaBioMed Life Sciences Ltd,
Tallin, Estonia
Introduction: Standard approaches to characterize EVs
are usually either low-throughput, laborious or based
on sophisticated equipment not applicable to clinical
routines. An integrated microfluidic platform that iso-
lates and characterizes EVs available in bodily fluids by
combining capture, release and phenotyping of bio-
nanoparticles would significantly accelerate the transi-
tion of EV-based research to real clinical utility. The
realization of such a system is the goal of INDEX, a
project recently funded in the frame of Horizon 2020
FET-OPEN programs.
Methods: The platform consists of two modules, one
for the extraction of EVs in complex samples and one
for the interferometric label-free identification and
visualization in a disposable cartridge. In order to
integrate the two modules, a new approach for the
reversible capture of EVs from serum was developed
and demonstrated using the so called magnetic flui-
dized bed technology recently developed by Pereiro et
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al. (Lab Chip, 2017, 17, 1603–1615). This technology is
based on the use of functionalized magnetic particles to
perform a solid phase extraction step. We report on the
progress of the optimization of the technology itself
and how it can be used to recover intact EVs.
Results: In the optimization of the magnetic fluidized
bed system as tool for the isolation and pre-concentra-
tion of EVs in plasma/serum patient samples, several
steps/issues have been evaluated including the immo-
bilization chemistry of antibodies on the surface of
magnetic particles for increased EV recovery, the
dimensions of the chip, the flow rate and sample
volume. Capture and release efficiency were evaluated
by direct on-chip monitoring of the fluorescence when
working with fluorescent samples or by ELISA test.
Capturing and release steps were also monitored on
anti-tetraspanins antibody microarrays by fluorescence
and interferometric detection.
Summary/Conclusion: In summary, we have demon-
strated that intact EVs can be released from the first
module of the sensing platform and transferred to the
second module devoted to nanoparticle sizing and
phenotyping
Funding: This project has received funding from the
European Union’s Horizon 2020 research and innova-
tion programme under grant agreement no. 766466.
INDEX.
PS04.05
Comparison of extracellular vesicles detection by microfluidic
plasmonics of gold nano-island and nanocomposite platforms
Muthukumaran Packirisamya, Srinivas Bathinia, Simona Badilescub,
Duraichelvan Rajua, Anirban Ghoshc and Rodney J Ouellettec
aConcordia University, Montreal, Canada; bConcordia University Montreal,
Montreal, Canada; cAtlantic Cancer Research Institute (ACRI), Moncton,
Canada
Introduction: Extracellular vesicles (EVs) are groups of
nanoscale extracellular communication organelles in
the order of 30–100 nm, which can be used as disease
biomarkers for cancer. In this work, we have developed
different platforms for the detection and characteriza-
tion of EVs by using a localized surface plasmon reso-
nance (LSPR) method based on the sensitivity of the
gold plasmon band to the environment of gold
nanoparticles.
Methods: EVs from breast cancer cell line (MCF7) are
detected and characterized by using a gold nanoparti-
cle-based plasmonic platforms. Here, two different
platforms have been developed, a gold nano-island
platform on glass substrate and a gold poly(dimethyl)
siloxane (Au-PDMS) nanocomposite. A plasmonic
sensing protocol is established and carried out by
using the two platforms and, subsequently, the proce-
dure is transferred in a microfluidic environment. Gold
nanoparticles are first deposited on glass substrates and
annealed to form gold nano-islands, whereas the gold
nanoparticles were in-situ synthesized in a PDMS
matrix by the immersion method. EVs are affinity
captured by a peptide (Vn96) in this protocol. The
two platforms were individually bonded to a PDMS
sample having a channel to form a microfluidic device.
The entities involved in the biosensing protocol are
flown through the channel, and the absorption spec-
trum is measured after each step.
Results: A graph showing the LSPR shift of the gold
plasmon band for different concentrations of EVs is
plotted for the two platforms. The exosomes from
breast cancer cell line (MCF7)-conditioned media
have been grown in a small bioreactor. Comparable
results in terms of sensitivity have been found for the
two platforms.
Summary/Conclusion: Compared to the macro detec-
tion method, the microfluidic detection of EVs proved
to be highly reproducible and more sensitive as very
small amount of chemicals and EVs are necessary for
the analysis.
PS04.06
Dielectrophoretic nanovesicle sorter
Yong-Sang Ryua, Avijit Barikb, Nathan J. Wittenbergb, Daniel A. Mohrb and
Sang-Hyun Oh3
aSensor System Research Center, Seoul, Republic of Korea; bUniversity of
Minnesota, Minneapolis, USA; cUniversity of Minnesota, Minneapolis,
Minneapolis, USA
Introduction: Extracellular vesicles are membrane-
bound particles that play important roles in cellular
communications, packaging of genetic material and
waste management. An important category of extracel-
lular vesicles, exosomes, are only 30-100 nm in size. To
investigate the biological functions of these extracellu-
lar vesicles and to use them for applications in diag-
nostics and drug delivery, rapid isolation with high
collection efficiency and selectivity is of great impor-
tance. Small unilamellar vesicles (SUVs), as a model
type of exosomes, have been extensively exploited to
characterize the role of extracellular vesicles during the
processes.
Methods: 2.1. Fabrication of 10 nm-width-gap elec-
trode device
2.2. SUV preparation and size characterization
2.3. Dielectrophoresis on nanogap electrodes
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Results: Here we demonstrated that dielectrophoresis
(DEP) can be used to collect and sort sub-100 nm
SUVs, a model of exosomes, based on their size and
the electrical properties of their cargo. The DEP plat-
form is based on a 0.8 mm-long, 10 nm-wide gap
between gold electrodes, capable of generating ultra-
high electric field gradients with low voltages. We
determine the DEP trapping threshold voltages as a
function of vesicle size for the selective capture.
Furthermore, SUVs with different internal conductiv-
ities can be sorted by varying DEP frequency.
3. 1. Dielectrophoretic trapping of SUV and size-
dependent sorting
3.2. SUV sorting based on internal conductivity.
Summary/Conclusion: Such differential DEP
responses may allow the isolation of membrane-free
macromolecular aggregates in the presence of empty
vesicles down to size ranges of d ≤ 100 nm without
labelling processes required for detection methods used
with other separation techniques. Our electronic DEP
sorter can readily be applied to diverse biological mate-
rials including viruses, proteoliposomes, functionalized
nanobeads, DNA molecules and other biomolecules.
Funding: This research was supported by grants from
the Minnesota Partnership for Biotechnology and
Medical Genomics, MnDrive Research Initiative, NSF
through the National Nanotechnology Coordinated
Infrastructure (NNCI) program, and internal project
of KIST.
PS04.07
A novel capture-and-release platform to isolate extracellular vesicle
subpopulations reveals functional heterogeneity among EVs with
different surface markers
Olivier G. de Jonga, Mark Tielemansb, Raymond Schiffelersc, Pieter Vaderc
and Sander A. A. Kooijmansc
aDepartment of Physiology, Anatomy and Genetics, University of Oxford,
Utrecht, Netherlands; bDepartment of Clinical Chemistry and Haematology,
University Medical Center Utrecht, Utrecht, Netherlands; cLaboratory of
Clinical Chemistry and Hematology, University Medical Center Utrecht,
Utrecht, Netherlands
Introduction: Extracellular vesicles (EVs) are hetero-
geneous in terms of size and molecular composition,
which may also reflect functional differences. For
example, given that the EV surface dictates interactions
with their environment, EVs with different surface
profiles may be taken up and processed by target cells
in different ways. Unfortunately, tools to isolate and
functionally compare EV subpopulations based on
their surface marker expression are currently not avail-
able. Here, we describe a novel capture-and-release
platform to separate intact EVs based on specific sur-
face signatures and compare their properties.
Methods: EVs were isolated from MDA-MB-231 cells
using size exclusion chromatography. EV subpopula-
tions expressing specific surface markers were captured
on magnetic beads and released using a novel release
protocol. Released EVs were characterized by western
blotting, nanoparticle tracking analysis (NTA) and
transmission electron microscopy (TEM). Uptake of
fluorescently labelled EV subpopulations by various
cell types was examined using flow cytometry.
Results: Isolated MDA-MB-231 EVs showed typical
EV properties, including the presence of EV marker
proteins, heterogeneous size distribution (mode size of
120 nm) by NTA and intact, “cup-shaped” morphology
as visualized by TEM. When these EVs were subjected
to the capture-and-release platform, EV subpopula-
tions with different properties were obtained.
Released subpopulations appeared intact as demon-
strated by TEM, but differed in their size distribution.
Furthermore, EV subpopulations showed different
enrichment/depletion patterns of canonical EV pro-
teins as shown by western blot. Lastly, uptake of EVs
by target cells differed between EV subpopulations and
between target cell types.
Summary/Conclusion: In this work we showcase a
novel capture-and-release platform to separate intact
EV subpopulations based on their expression of speci-
fic surface markers. Using a small panel of antibodies
against EV surface markers, we show differences
between EV subpopulations in terms of protein com-
position, size distribution and cellular uptake by target
cells. We anticipate that this tool can help to clarify
relationships between the surface signature of EVs and
their functionality, and facilitate the enrichment of EVs
with desirable characteristics for therapeutic purposes.
PS04.08
Nanopillar and nanochannel fabrication via mixed lithography
Sung-Wook Nama, Sun-Woong Leea and Moon-Chang Baekb
aSchool of Medicine, Kyungpook National University, Daegu, Republic of
Korea; bSchool of medicine, Kyungpook National University, Daegu,
Republic of Korea
Introduction: Extracellular vesicle (EV) sorting and
separating by nanostructure is essential to achieve a
size-dependent analysis of protein and miRNA inside
the vesicles. In this regard, implementation of lab-on-a-
chip devices having the EV sorting functionality has
been pursued by utilizing the physical properties of the
particles.
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Methods: Nanopillar array is a useful template for
sorting and separating EVs. We report a method of
fabricating nanopillar array coupled with large-scale
fluidic structures. To do this, we introduce mixed
lithography by which both nanometer-scale functional
features and large-scale guiding structures are gener-
ated in the same level upon 200 mm silicon wafers.
Results: Upon 200 mm silicon wafer, nanometer fea-
tures are firstly produced by electron beam lithography
(EBL) in the extremely localized area which is subse-
quently connected by the micrometer structures pro-
duced by photolithography. By introducing hard-
masking oxide layer, we can create the coupled geome-
try in the same level structure. For the nanometer
fluidic channels, we examine wetting of a liquid solu-
tion containing fluorescent polystyrene particles.
Summary/Conclusion: We demonstrate EV sorting
devices by implementing nanostructures in lab-on-a-
chip structure. Our method may offer a way to produce
biochips that have versatile functions including sorting
and separating EVs.
Funding: This research was supported by the Bio &
Medical Technology Development Program of the
National Research Foundation (NRF) funded by the
Ministry of Science & ICT (2017M3A9G8083382).
PS04.09
Towards on-chip EVs separation: a lab-on-chip approach
Lyne Pillemont, Daniel Guneysu, Celine Elie-Caillea, Wilfrid Boireaub and
Anne-Marie Guec
aFEMTO-ST Institute, Besançon, France; bFEMTO-ST Institute, UBFC,
CNRS, Besançon, France; cCNRS, Toulouse, France
Introduction: Owing to their complexity in size, ori-
gin, membrane markers, there is currently no ideal
technology available to relate cell-derived microvesicles
(EVs) structure and functions. All currently available
methods (flow-cytometry, DLS, TRPS, etc.) have limits
in their ability to capture the whole diversity of EVs
populations and are not amenable to automation and
large-scale analysis of numerous samples. In that con-
text, the overall objective of this study is to develop a
miniaturized platform allowing the isolation, fractiona-
tion and qualification of microvesicles in µL volume.
Methods: Based on previous works (1), we propose a
lab-on-chip coupling a hydrodynamic separation mod-
ule enabling EVs separation according to their size to
an affinity-trapping chamber compatible with subse-
quent SPR and AFM characterization. We designed
and fabricated 2.5 × 2.5cm chips enabling the separa-
tion of vesicles at tunable cut-off (150-900nm). The
proof-of-concept was done using fluorescent
calibration particles (polystyrene and melanin resin
nanoparticles) biofunctionalized with proteins and
mimicking EVs in buffer solution.
Results: Sample was introduced into the chip using a
syringe pump or a pressure generator and the filtered
sample was simply collected at the chip outlet and
redirected towards a biodetection chamber designed
as an array of gold plots functionalized with antibodies.
We demonstrated the high quality separation of 490
nm nanoparticles from 920 nm particles in concen-
trated solution (2.109 to 2.1011 particles/µL).
Following sorting step, biosynthetic particles were
immunocaptured in a miniaturized module of the
NBA platform (2, 3) for their subsequent analysis.
Summary/Conclusion: We did the proof-of-concept of
on-chip nanoparticles separation and capture demon-
strating the ability of miniaturized systems to perform
sample fractionation. The tunable properties of the
device open the way to a versatile tool for pre-analy-
tical steps of EVs, including sorting and concentration,
even in complex media.
Funding: ANR: Agence Nationale de la Recherche
PS04.10
Acoustophoretic-based microfluidic platform for sorting extracellular
vesicles
Erfan Taatizadeha, Arash Dalilib, Nishat Tasnima, Cathie Garnisc, Mads
Daugaardd, Isaac Lie, Mina Hoorfarf
aUniversity of British Columbia Okanagan, Kelowna, Canada; bUniversity of
British Columbia Okanagan, Kelowna, Canada; cAssociate Professor, Faculty
of Medicine, Department of Surgery, Division of Otolaryngology, University
of British Columbia Senior Scientist, Genetics Unit, Integrative Oncology
Department, BC Cancer Research Centre, Vancouver, Canada; dVancouver
Prostate Centre Head, Molecular Pathology & Cell Imaging Core Facility,
Vancouver Prostate Centre Assistant Professor, Department of Urologic
Sciences, University of British Columbia, Vancouver, Canada; eDepartment
of Chemistry, University of British Columbia Okanagan, Kelowna, Canada;
fUniversity of British Columbia, Kelowna, Canada
Introduction: Conventional methods used for isolation
of extracellular vesicles (EVs) are time-consuming,
produce low purity samples and may change the struc-
ture of EVs. To address these problems, microfluidics-
based EV isolation methods have been introduced. In
particular, acoustic-based cell isolation (functioning
based on size, density and compressibility differences
of bioparticles and medium) have shown potentials.
However, the geometrical and operational parameters
of such a platform still need to be optimized to produce
high throughput and reproducible results. This study
focuses on the optimization of an acoustophoretic-
based microfluidic platform using first colloidal parti-
cles following by EVs isolated from culture media from
cancer cell lines. The results are compared against the
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conventional method to show high yield and purity of
the proposed platform.
Methods: The acoustic pressure field can be generated
inside a microchannel by applying a voltage to pat-
terned interdigital transducers fingers on the surface
of piezoelectric materials. Due to such a field, biopar-
ticles are deflected (and hence sorted) at different
points along the microchannel depending on their
volumes. Soft lithography and etching processes are
used for fabrication of microchannel and transducers
of the platform.
Results: To optimize the geometry and operational
parameters of the platform, polystyrene (PS) particles
are first used as they have similar size, density and
compressibility of the components in the body fluid
samples. The results showed that 90% of PS particles
are deflected at a frequency of 26.5 MHz and the input
voltage of 10 Vpp. Using these parameters, we are then
able to sort EVs from cell culture media into size
ranges between 500–1000 nm. The size of each sorted
vial is characterized by nanoparticle tracking analysis
and shown a size separation resolution of 500 nm and a
throughput of 4 uL/min.
Summary/Conclusion: Acoustofluidics-based separa-
tion results show the size separation resolution of
500 nm and a throughput of 4 uL/min, indicating the
protentional of such a technique as a non-invasive,
label-free and effective EV purification method.
Funding: This work was supported by the University
of British Columbia Eminence fund.
PS04.11
Proteomic and miRNA analysis of highly purified extracellular vesicles
recovery using immunoaffinity purification and ultracentrifugation
from serum, plasma and urine
Ayako Kurimoto, Yuki Kawasaki and Tatsutoshi Inuzuka
Miraca Research Institute G.K., Hachioji-shi, Japan
Introduction: Exosomes, one of extracellular vesicles,
are secreted into extracellular fluids from all types of
cells via endosomal pathway and found in most body
fluids including blood and urine. Exosomes are report-
edly associated with various disease conditions includ-
ing cancer metastasis and vascularization. Although
exosomes seem to be promising biomarkers, methods
to isolate and quantify exosomes still remain contro-
versial. Conventionally used methods include ultracen-
trifugation (UC), polymer precipitation and
immunoaffinity purification (IP) using surface marker
antibodies. In addition, obtained exosomes from cer-
tain types of specimens, urine in particular, is extre-
mely difficult.
In this study, we aimed to establish a method to effi-
ciently recover exosomes from serum, plasma and
urine using IP and UC method, considering practical
use at the clinical site.
Methods: Antibodies against tetraspanins and IP con-
dition were established and used to isolate exosomes
from serum, plasma and urine. Obtained exosomes
were subjected to immunoblotting, nanoparticle track-
ing analysis (NTA), proteomic analysis, internalization
assay and 3D-Gene miRNA microarray.
Results: Immunoblotting and NTA revealed the recov-
ery of highly pure exosomes from serum and plasma
with increased efficiency by our IP method. Our
method was successful in recovering exosomes from
urine specimens, whereas commercialized antibodies
failed to do so. Internalization assay showed that
uptake rate of exosomes isolated from conditioned
medium using our method were similar to that of
exosomes isolated using conventional method.
Number of identified proteins has increased, whereas
the detection of nonspecific proteins decreased by our
method. Expression profiles of miRNAs from our
obtained exosomes differed from that obtained by con-
ventional isolation method.
Summary/Conclusion: Our established exosome pur-
ification methods are capable of efficiently recovering
exosomes from serum and plasma in addition to urine
specimens. Our approach can be readily automated to
isolate exosomes from specimens, which could contri-
bute to therapeutic application of exosomes and bio-
marker detection.
PS04.12
Capture and release of extracellular vesicles in tens of μL samples for
ocular neuroprotection studies
Yi-Hsun Chena, Rong-Kung Tsaib and Chihchen Chena
aInstitution of NanoEngineering and MicroSystems, National Tsing Hua
University, Hsinchu, Taiwan (Republic of China); bInstitute of Eye
Research, Buddhist Tzu Chi General Hospital, Hualien, Taiwan (Republic
of China)
Introduction: The incidence of eye diseases is on the
rise with increasing longevity and use of 3C products.
However, treatments for several eye diseases, such as
vision-threatening glaucoma and age-related macular
lesions, offer only symptomatic control with no cura-
tive options. Extracellular vesicles (EVs) are cell-
derived vesicles that have been shown to play a role
in intercellular communication, immune regulation,
extracellular matrix turnover, stem cell division/differ-
entiation, neovascularization and cellular waste
removal. At present, ocular EV studies remain rare
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mainly due to the challenges associated with accessing
and processing minute ocular samples.
Methods: In this work, we collected EVs from Sprague
Dawley rat intraocular samples after non-arteritic ante-
rior ischaemic optic neuropathy (NAION) induction.
30 μL ocular fluid collected at day 0, 0.25, 1, 3 and 7
after NAION induction was applied to each paper-
based device. Long-wavelength UV light (360 nm)
was utilized to break the photolabile crosslinker and
release captured EVs for subsequent analyses.
Results: RNA molecules contained in captured CD63
+ EVs were extracted, and the next generation
sequencing (NGS) results showed that more anti-
inflammatory M2 miRNAs were present in NAION
samples than in sham controls. In addition, we have
identified 53 miRNAs that showed more than two-
fold changes in expression during the natural course
of recovery after NAION. These miRNAs included
pro-inflammatory M1-related miRNAs (miR-184,
miR-3473, let-7c-5p, miR-124, miR-125a-5p, miR-
210-3p) and anti-inflammatory M2-related miRNAs
(miR-31a-5p, miR-99a-5p, let-7i-5p, miR-204-5p,
miR-16-5p). Interestingly, M1-related miRNAs exhib-
ited a biphasic expression that peaked at day 1 and
then elevated again at day 7, whereas M2-related
miRNAs were upregulated at day 7 from NAION to
achieve putative neuroprotection effects.
Summary/Conclusion: We have developed an easy and
fast method capable of collecting and releasing EVs
from low-volume samples. The quantity and quality
of miRNA extracted is enough for NGS analysis.
Funding: Taiwan Ministry of Science & Technology
(MOST 106–2628-E-007–010-MY3) and the Taiwan
Ministry of Education (Higher Education Sprout
Project: Grant No. 107Q2713E1).
PS04.13=OWP3.04
An integrated microfluidic device for selective exosome isolation
from human plasma
Hogyeong Gwaka, Junmoo Kimb, Leila Kashefi-Kheyrabadib, Seung-Il Kimb,
Kyung-A Hyunb and Hyo-Il Jungb
aSchool of Mechanical Engineering, Yonsei University, Seoul, Republic of
Korea; bYonsei University, Seoul, Republic of Korea
Introduction: Extracellular vesicles released by many
cell types circulate in blood vessel and play a key role in
intercellular communication. Exosomes are 30–150 nm
membrane vesicles and are also shed by both normal
and cancer cells. Cancer cells are known as very het-
erogeneous, so exosomes are also heterogeneous and
have different surface expression markers. Cancer-
derived exosomes contain unique cargo determined
by the molecular characteristics of cancer cells.
Therefore, it is very important to selectively separate
exosomes depending on surface expression for down-
stream analysis. We designed an integrated microflui-
dic chip for selective exosome isolation. The
microfluidic chip consists of Hoof Structure (HS) for
mixing exosomes and two different sized aptamer-
coated particles and Multi-Orifice Flow Fractionation
(MOFF) for separating each particle.
Methods: Biotinylated EpCAM aptamer was immobi-
lized on the surface of 7 μm streptavidin-coated poly-
styrene particle and HER2 on 15 μm. The HS has the
circular expansion channel on the 1st layer to generate
expansion vortices and the two curvature channels on
the 2nd layer to make chaotic advection. It makes
transverse flow and mixes two particles without parti-
cle focusing phenomenon. The 100-nm (exosome), 7-
μm and 15-μm fluorescence particles were used to test
mixing performance between exosomes and particles in
the HS. The MOFF was designed by a series of con-
traction/expansion microchannels for continuous size-
based separation. Separation performance was tested by
using the 7-μm and 15-μm fluorescence microparticles
in the MOFF.
Results: The mixing efficiency was the highest at the
flow rate 150 μl/min. Each exosome was continuously
captured by aptamer-conjugated particle in the HS
channel. The capture efficiency of EpCAM positive
exosome was 96.9% and HER 2 was 68.09%. Two
particles were separated in the integrated microfluidic
device at the same flow rate. 96.26% of 15 μm micro-
particles were positioned into the centre of the channel,
and 89.48% of 7 μm microparticles were separated on
both sides of the channel.
Summary/conclusion: Each exosome was continuously
captured by mixing aptamer-conjugated particle in the
HS. Exosome-conjugated microparticles were success-
fully separated by inertial force in MOFF. This analysis
of each exosome will shed light on diagnosis and ther-
apy of cancers.
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Caveolin-1 reduces in extracellular vesicles derived from lung cancer
tissue and plasma and associates with cancer cell migration
Taixue Ana, Lei Zhengb, Han Zhangc and Yiyao Huangc
aNan Fang Hospital, Southern Medical University, Guangzhou, China
(People’s Republic); bClinical Laboratory Department, Nanfang Hospital,
Southern Medical University, Guangzhou, China (People’s Republic); cNan
Fang Hospital, Southern Medical University, Guangzhou, China (People’s
Republic)
Introduction: Early diagnosis is of significance mean-
ing for lung cancer. Extracellular vesicles (EVs) are a
new kind of diagnostic biomarkers with great potential.
However, the discovery of biomarkers based on EVs
remains disturbed by EVs from cells disassociated with
lung cancer. If biomarkers, we suggest, can be screened
based on EVs from cancer tissue and validated in
plasma, discovered biomarkers may combine good spe-
cificity and practicability in clinical practice.
Methods: Thirteen Lung cancer tissues and 71 plasma
samples (47 early stage lung cancer patients, 9
advanced stage lung cancer patients and 15 healthy
controls) were collected from Nang Fang Hospital.
Our research was approved and supervised by the
Medical Ethics Committee of Nan Fang Hospital. EVs
were purified from lung cancer tissues and paracancer-
ous tissues and characterized by LC MS/MS; protein
profiles of two groups were compared and Caveolin-1
was picked out in differentially expressed proteins.
With high-sensitivity flow cytometry, the diagnostic
performance of Caveolin-1 was validated in 79 plasma
samples. In cell line experiments, Caveolin-1 on EVs
was blocked by antibody, and the migration of EVs
stimulating cancer cells was evaluated by transwell.
Results: We determined profiles of EVs in lung cancer
tissue and paracancerous tissue separately. Combined
bioinformatics analysis and western blotting verifica-
tion, Caveolin-1 was chosen as candidate biomarker
and verified by western blotting in six plasma samples.
Subsequently, Caveolin-1 was evaluated in 79 plasma
samples. Caveolin-1 was significantly decreased in lung
cancer patients and the area under curve of ROC
reached 0.958 in diagnosis of cancer patients and
healthy controls. Furthermore, we observed the biolo-
gical function of Caveolin-1 on EVs with cell line.
When cancer cells were co-cultured with EVs, the
movement of cancer cells stimulated by antibody-
blocked EVs was increased.
Summary/Conclusion: Our study indicated Caveolin-1
on EVs can inhibit cancer cell movement. Cancer cells
promote the movement of other cells by reducing
Caveolin-1 on EVs. Caveolin-1 significantly decreased
in cancer tissues and patients’ plasma. Caveolin-1 may
serve as a potential marker for the diagnosis in lung
cancer diagnosis.
Funding: This study was supported by grants from the
National Natural Science Foundation of China
(81371901).
PS05.04
DNA assembly assisting magnetic fluorescence nanosensor based on
aggregation-induced emission probe/graphene oxide for cancerous
exosome analysis
Bo Li, Chunchen Liu, Weilun Pan and Lei Zheng
Clinical Laboratory Department, Nanfang Hospital, Southern Medical
University, Guangzhou, China (People’s Republic)
Introduction: Exosomes are emerging as non-invasive
diagnostic biomarkers of cancer because they carry
biomolecules that include proteins and nucleic acids
for intercellular communication. Assessing special exo-
some surface proteins provides a powerful means of
identifying the origins of their cancerous parental cells.
Glypican-1 (GPC-1), an exosomal membrane protein,
was discovered to have much higher expression on the
cancerous exosomes than the noncancerous for the
early diagnosis of pancreatic, breast and colorectal
cancer. However, quantification of low concentrations
of specific exosomes present in very small volumes of
clinical samples remains a challenge.
Methods: Herein, we proposed a magnetic fluorescence
nanosensor based on GPC-1 antibody-functionalized
magnetic microcarriers for GPC-1(+) exosome subpo-
pulation isolation and detection. And the recognition
signal was transformed into the formation of free-state
DNA nanostructure by the trigger containing CD63
aptamer. To increase the sensitivity of this method, a
“Y” shape DNA self-assembly nanostructure amplifica-
tion strategy was adapted to assist aggregation-induced
emission probe/graphene oxide (AIE/GO) “turn-on”
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fluorescence reporting system to realize the label-free
and ultracentrifugation-free quantitative analysis of
GPC-1(+) exosome subpopulation of breast cancer in
a homogeneous.
Results: We optimized the reaction conditions and
evaluated the detection performance of the method,
such as specificity, sensitivity and linear range. Under
optimal conditions, the results show that this magnetic
fluorescence nanosensor could distinguish breast can-
cer exosomes from five other types of cancerous exo-
somes, and the linear range of detection for breast
cancer exosomes is estimated to be 7.8 × 104–
3.9 × 109 exosomes/µL with a detection of limit
(LOD) of 6.56 × 104 exosomes/µL. We demonstrated
the application of the magnetic fluorescence nanosen-
sor in quantitative detection of exosomes in plasma
samples directly from breast cancer patients.
Summary/Conclusion: This magnetic fluorescence
nanosensor is expected to become a powerful tool for
rapid and simple cancer liquid biopsy.
Funding: This study was financed by grants from the
National Natural Science Foundation of China
(81371901, 81702100) and the Science and
Technology Planning Project of Guangdong Province
(2017A020215123)
PS05.05
Quantitative multiparameter analysis of individual urinary
extracellular vesicles via a laboratory-built nano-flow cytometer
Haisheng Liua, Ye Tianb, Shaobin Zhuc and Xiaomei Yana
aDepartment of Chemical Biology, College of Chemistry and Chemical
Engineering, Xiamen University, Xiamen, China (People’s Republic);
bDepartment of Chemical Biology, College of Chemistry and Chemical
Engineering, Xiamen University, Xiamen, China (People’s Republic);
cNanoFCM Inc., Xiamen, China (People’s Republic)
Introduction: Urinary extracellular vesicles (uEVs)
have attracted much attention as a source of non-inva-
sive biomarkers. To exploit their prominent potential
in the diagnosis of urinary tract diseases including
urinary cancers, an in-depth study of uEVs at the
single-particle level is important. Employing a labora-
tory-built nano-flow cytometer (nFCM) that facilitates
multiparameter analysis of single EVs as small as
40 nm, here we report quantitative measurement of
size distribution, particle concentration, purity, lipid
membrane, nucleic acids and surface proteins of uEVs.
Methods: uEVs were isolated from mid-stream urine
samples collected from healthy donors via differential
ultracentrifugation (UC). Monodisperse silica nanopar-
ticles were used as the size reference standards for the
size distribution measurement of uEVs via light scat-
tering detection. By using fluorescent silica
nanoparticles of known particle concentration as the
internal standard, particle concentration of uEVs was
measured via single particle enumeration. The purity of
uEVs in the isolates was examined by measuring the
particle concentration before and after Triton X-100
treatment. Lipid-membrane was labelled with PKH26
and PKH67. Subpopulation of uEVs expressing specific
surface proteins were analysed via immunofluorescent
staining. SYTO 16, a cell-permeant stain, was used to
stain the nucleic acids of uEVs before and after DNase
I treatment.
Results: The concentration of uEVs was determined
around 10^9 particles/mL in urine, and the purity of
isolated uEVs via UC was above 90%. Comparing with
the light scattering signal of single EVs, the lipid dye
labelling efficiency was found to be around 90%.
Considering the purity of EVs, we conclude that almost
all the uEVs can be stained by lipid dyes. We also
found that ~30% of uEVs expressing CD9, CD63,
CD81 or TSG101 on their surface. The ratio of uEVs
lightened up by SYTO 16 decreased from 16% to 10%
after DNase I treatment, which indicates that part of
the DNA resides on the outer membrane surface of
uEVs.
Summary/Conclusion: The laboratory-built nFCM is
applicable to the multiparameter biochemical analysis
of individual uEVs via protein, lipid and nucleic acid
staining. We expect nFCM will facilitate more in-depth
studies of uEVs and aid the development of clinical
diagnosis with uEVs.
PS05.06
Proteomic profiling of urinary exosomes for potential predictors of
albuminuria in subjects with diabetes
Rajni Sharma, Manju Kumari, Bhuvnesh Rai, Aradhana Mohan and Swasti
Tiwari
Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India
Introduction: Albuminuria is considered to be an
important clinical hallmark for renal diseases.
However, it has limited ability to predict the earliest
stages of diabetic nephropathy. Early biomarker poten-
tial of urinary exosomes (UE) for renal disease has
been highlighted by us and others. We carried out
proteomic profiling of UE followed by a longitudinal
follow-up study to determine potential predictors of
albuminuria in subjects with type-1 diabetes (T1D).
Methods: In study-1, proteomic profiling of UE from
T1D with or without albuminuria (urine albumin to
creatinine ratio between 30–300 mg/g, n = 3/group)
was performed using two-dimensional differential gel
electrophoresis (2D-DIGE). Diagnostic potential of one
314 ISEV2019 ABSTRACT BOOK
of the identified UE protein to predict incidence of
microalbuminuria was determined. For this, 29 T1D
subjects without albuminuria were followed for
~4.5 years (study-2). Urine microalbumin, serum crea-
tinine and HbA1C were analysed.
Results: 2D-DIGE revealed a total number of 592 dif-
ferential protein spots between T1D subjects with or
without albuminuria. The MASCOT search for 26
selected spots revealed 14 proteins associated with
nephropathy, including Wilms’ tumour 1 (WT1) pro-
tein. At the end of 4.5 years of follow-up, 9 subjects
(out of total 19) progressed to albuminuria in WT1-
positive group (presence of WT-1 in UE at the time of
recruitment) as opposed to 1 in WT1 negative group.
Both groups had statistically similar diabetes duration,
age, % HbA1c and estimated GFR at the baseline.
Summary/Conclusion: Urinary exosomal protein
could help in categorizing diabetic subjects that may
go on to develop nephropathy.
Funding: Funded by intramural, DST, Govt. of India.
PS05.07
Identification of exosomal biomarkers in urine for human prostate
cancer
Duojia Wu, Ying Zhu, Jie Ni, Julia Beretov, Paul Cozzi, Mark Willcox, Valerie
Wasinger, Bairen Pang, Xupeng Bai, Peter Graham and Yong Li
UNSW (The University of New South Wales), Sydney, Australia
Introduction: Prostate cancer (CaP) is the second lead-
ing cause of cancer-related death in males.
Identification of novel biomarkers is important for
the early detection of CaP. Exosomes are small mem-
brane-bound vesicles released from most cell types
including cancer cells. Exosomes play a key role in
intercellular signalling and potentially play a role in
tumorigenesis and cancer progression. In this study,
we investigated differential urinary exosomal proteins
in CaP patients compared to healthy controls by mass
spectrometry.
Methods: Midstream spot urine samples from CaP
(n = 20) and benign prostatic hyperplasia (BPH;
n = 10) patients were obtained, as well as urine from
age- and sex-matched controls (n = 10). Urinary exo-
somes were isolated using the Total Exosome Isolation
Reagent (invitrogen). The presence of exosomes was
evaluated by transmission electron microscopy (TEM)
and nanoparticle tracking analysis (NTA). Exosomal
markers including TSG101, CD9, CD63 and CD81
were validated by western blotting (WB) and flow
cytometry (FC). High-throughput LC-MS/MS-based
label-free quantification was performed on Q Exactive
to identify proteins in the exosomes. Three biomarker
candidates VCAM1, IL18BP and S100A6 were selected
for further validation in urine exosome samples from a
separate cohort of CaP patients and CaP cell lines
by WB.
Results: We successfully isolated exosomes from
human urine, which were further validated by TEM,
NTA, WB and FC. In total, 1330 proteins were identi-
fied through LC-MS/MS. Among them, 596 proteins
were differentially expressed between CaP and normal
controls. According to statistical analysis, a focus list of
37 proteins, including 17 upregulated and 20 down-
regulated proteins was revealed as dysregulated candi-
dates in urinary exosomes for CaP. The validation of
potential biomarkers including VCAM1, IL18BP and
S100A6 showed that the levels of these proteins were
higher in CaP cell lines including PC-3, PC-3M,
DU145 and LNCaP compared to the normal prostate
cell line RWPE-1. In addition, the expression level of
IL18BP was higher in urinary exosomes from CaP
patients compared to healthy controls.
Summary/Conclusion: Urinary exosomes harbour
informative proteins that might be used for the early
detection of CaP or monitoring its progression through
a non-invasive way.
Funding: ARC-Linkage Grant
PS05.09
Optimization of exosome isolation and ELISA method for
identification of novel cancer biomarkers
Ju-Hyun Baea, Hee-Kyung Jangb, Eun-Ju Imc, Chan-Hyeong Leec and Moon-
Chang Baekc
aSchool of Medicine, Kyungpook National University, Daegu, Republic of
Korea; bSchool of medicine, KyungPook National University, Daegu,
Republic of Korea; cSchool of medicine, Kyungpook National University,
Daegu, Republic of Korea
Introduction: Exosomes are a type of extracellular
vesicles with diameter of 30–150 nm secreted by cell
and circulate in blood abundantly. Especially, cancer-
cell-derived exosomes contain oncogenic molecules
that can be novel biomarker for cancer diagnosis.
Recent compelling issue of cancer patients is the
immune system that is negatively regulated by cancer-
cell-derived exosomes. Therefore, first we have to opti-
mize exosome isolation methods and ELISA methods
to analyse exosome’s constituents precisely. Through
this method, we can screen several candidates which
contain in cancer-cell-derived exosomes to identify
novel biomarkers for cancer prediction.
Methods: Exosomes were isolated from cancer patients’
plasma using serial centrifugation method. For western
blot analysis, we loaded exosomes to observe existence
and difference in the expression of protein between
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cancer patients’ and healthy controls’. And using exo-
somes each well in 96-well plate, sandwich ELISA was
performed to measure protein level of exosomes from
cancer patients’ and healthy controls’. We also made
mouse xenograft models to find the correlation between
exosomal protein level and tumour burden.
Results: We optimized isolation method to purify exo-
somes and to minimize sample variation, and we opti-
mized ELISA method using well-known exosomal
surface biomarkers and confirmed assay stability. By
optimization of exosome isolation and ELISA method,
we built finding system for novel cancer biomarker
which is expected significantly overexpressed in exo-
somes from cancer patients‘ plasma compared to
healthy controls’. In addition, we checked the level of
exosomal surface protein’s correlation with tumour
burden, therefore prove possibility as novel cancer
biomarkers.
Summary/Conclusion: Based on our results, we opti-
mized our own finding system and identified novel
cancer biomarkers.
Funding: This research was supported by the Bio &
Medical Technology Development Program of the
National Research Foundation (NRF) funded by the
Ministry of Science & ICT (2017M3A9G8083382)
and by the National Research Foundation of Korea
(NRF) grant funded by the Korea government
(2014R1A5A2009242).
PS05.10
Thyrotropin receptor-positive exosomes alleviate autoantibody-
mediated stimulation of cAMP production
Naoki Edoa, Kyojiro Kawakamib, Yasunori Fujitab, Koji Moritaa, Kenji Unoa,
Kazuhisa Tsukamotoa, Hiroyuki Onosec, Toshio Ishikawaa, Masafumi Itob
aDepartment of Internal Medicine, Teikyo University School of Medicine,
Tokyo, Japan; bResearch Team for Mechanism of Aging, Tokyo Metropolitan
Institute of Gerontology, Itabashi-ku, Japan; cDepartment of Internal
Medicine, Kanaji Hospital, Tokyo, Japan
Introduction: Exosomes or extracellular vesicles
secreted from cells play a variety of roles in both
physiological and pathological processes. In Graves’
disease (GD), autoantibodies bind to thyrotropin
receptor (TSHR) on thyroid follicular epithelial cells,
stimulating thyroid growth and thyroid hormone
synthesis and secretion through cAMP production. In
this study, we examined if exosomes expressing TSHR
are secreted from thyroid cells and defined their roles
in GD.
Methods: Exosomes by differential centrifugation from
the culture medium of NTHY-ori 3-1 human thyroid
follicular epithelial cell line and 8305C, 8505C and
FTC133 thyroid carcinoma cell lines. Western blot
analysis was performed to detect TSHR in cell lysates
and exosomes. Human embryonic kidney HEK293
cells (HEK) overexpressing TSHR (HEK/TSHR) were
established for the functional analysis of TSHR exo-
somes. Using exosomes isolated from HEK and HEK/
TSHR cells, in vitro binding capacity of a human
monoclonal autoantibody (M22) to TSHR exosomes
and their effect on M22-mediated stimulation of intra-
cellular cAMP production in HEK/TSHR cells were
studied. Human recombinant TSHR chimera capable
of binding to M22 was used as a positive control.
Results: TSHR was detected in exosomes from cancer
cells as well as normal epithelial cells. The binding
assay demonstrated that M22 dose-dependently
bound to TSHR exosomes. M22 stimulated intracellu-
lar cAMP production in HEK/TSHR cells in a dose-
dependent manner. Exosomes from HEK/TSHR cells
but not those from HEK cells significantly reduced
cAMP production activated by M22 in HEK/TSHR
cells. A similar inhibitory effect was observed for
human recombinant TSHR chimera.
Summary/Conclusion: Our results suggest that TSHR
exosomes may be secreted from normal and cancerous
thyroid epithelial cells. In the thyroid gland of patients
with GD, TSHR exosomes may exert a decoy effect by
sequestering M22, alleviating autoantibody-stimulated
cAMP production.
Funding: There is nothing to disclose.
PS05.11=OWP3.06
In vitro and in vivo investigation of extracellular vesicles (EVs) as
biomarker carriers in the diagnosis of early Alzheimer’s disease
Soraya Moradi-Bachillera, Miriam Cianib, Roberta Zanardinib, Luisa Benussib,
Roberta Ghidonib, J. Mark Cooperc, Gianluigi Forlonia and Diego Albania
aDepartment of Neurosciences, Mario Negri Institute for Pharmacological
Research IRCCS, Milan, Italy; bMolecular Markers Laboratory, IRCCS
Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy;
cDepartment of Clinical Neurosciences, Faculty of Brain Sciences,
University College London – Institute of Neurology, London, United
Kingdom
Introduction: Extracellular vesicles (EVs) represent an
ideal source of biomarkers due to their role in cellular
communication and their ability to carry protein aggre-
gates. The most investigated EVs are exosomes, active
entities secreted from cells and able to cross the blood–
brain barrier. Several neurodegeneration-involved
molecules may undergo intercellular spreading through
exosome release. In Alzheimer’s disease (AD), before
clinical signs appear, several proteins implicated in
exo- and endocytic pathways are altered. In this sce-
nario, the identification of a correlation between
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variations in proteins carried by EVs and the progres-
sion of AD is the main aim of our project.
Methods: We performed exosome isolation and char-
acterization from H4-SW glioma cells (a cell model
featuring mutated β-amyloid overexpression), as well
as in mouse- (triple-transgenic mouse model for famil-
ial AD) and human-plasma samples (Mild Cognitive
Impairment (MCI) and AD subjects). In every case a
differential centrifugation protocol was applied and
exosomes were then characterized using Nanoparticle
Tracking Analysis with the NanoSight. We then
explored exosome content, specifically Amyloid
Precursor Protein (APP) and its proteolytic fragments,
Microtubule Associated Protein Tau (tau), Progranulin
(PGRN protein), Soluble Triggering Receptor
Expressed on Myeloid Cells 2 (sTREM2) and α-synu-
clein (α-syn), using Western blot and ELISA. L1CAM
and CD63 were evaluated to define the neural-derived
exosomes amount in human samples.
All the samples were collected after ethical committee
approval respecting Helsinki’s declaration. Informed
consents were provided by all the subjects.
Results: Our preliminary results show that APP,
PGRN, sTREM2 are carried by H4- and human
plasma-derived EVs. H4-SW cell-culture medium and
3Tg mouse plasma had a decrease in the EVs number
release (≈1*10e8 EVs/ml) in comparison to control
(≈7*10e8 EVs/ml). This decrease was not found in
human plasma samples.
Summary/conclusion: EVs purified from H4-glioma
cellular AD model, 3xTg mouse-, MCI- and AD-
plasma samples carry proteins relevant for neurodegen-
erative diseases (NDs). EVs release is reduced in cellu-
lar and animal AD-models.
Funding: Horizon 2020 Marie Sklodowska-Curie
Innovative Training Networks – Blood Biomarker-
based Diagnostic Tools for Early Stage Alzheimer’s
Disease.
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PS06.01
AR-V7 in urinary EVs of patients with prostate cancer
Hyun-Kyung Wooa, Juhee Parkb, Ja Yoon Kuc, Chan Ho Leed, Vijaya
Sunkaraa, Hong Koo Hac and Yoon-Kyoung Choa
aUlsan national institute of science and technology (UNIST), South Korea,
Ulsan, Republic of Korea; bCenter for soft and living matter, institute for
basic science (IBS), South Korea, Ulsan, Republic of Korea; cPusan National
University Hospital (PNUH), South Korea, Busan, Republic of Korea;
dDepartment of Urology, Inje University Busan Paik Hospital, South Korea,
Busan, Republic of Korea
Introduction: Prostate cancer is the most common
cancer affecting men and a leading cause of cancer
deaths. Almost all patients initially respond to andro-
gen deprivation therapy but inevitably progress to a
lethal stage of disease, termed castration-resistant pros-
tate cancer (CRPC). Androgen-receptor splice variant
(AR-V7) is associated with CRPC and resistance to
anti-androgen therapy. Despite its clinical importance,
the lack of efficient methods for AR-V7 analysis
remains a challenge for broader use of this marker in
routine clinical practice. Here we suggest a practical
and non-invasive liquid biopsy method for analysis of
AR-V7 in the RNA of urine-derived extracellular vesi-
cles (EVs) without the need for blood withdrawal.
Methods: Urine samples were collected from patients
at Pusan National University Hospital (PNUH). The
study protocol was reviewed and approved by the
Institutional Review Board of PNUH and UNIST, and
written informed consent was obtained from all sub-
jects. All patients that progressed to CRPC underwent
docetaxel-based chemotherapy. Using a newly
upgraded centrifugal microfluidic device for size-
based EV isolation, rapid enrichment of EVs (<
30 min) from each 4 mL of urine was accomplished.
Followed by mRNA extraction, and AR-V7 and andro-
gen-receptor full-length (AR-FL) mRNA levels were
quantified by droplet digital polymerase chain reaction
(ddPCR). Furthermore, protein and mRNA expression
of EVs isolated from blood plasma are compared
together.
Results: Higher AR-V7 and lower AR-FL expression
were detected in urine-derived EVs from 14 patients
with CRPC (0–217.0 and 12.9–562.5 copies/mL,
respectively) than in those from 22 patients with hor-
mone-sensitive prostate cancer (HSPC, 0–24.1 and 6.2–
9053.6 copies/mL, respectively). Also, we found that
AR-V7 transcript levels and the AR-V7/AR-FL ratio
in urinary EVs were higher in patients with advanced
prostate cancer.
Summary/Conclusion: This study demonstrates that
mRNA of urine-derived EVs is a reliable source for
AR-V7 expression analysis, suggesting a simple and
promising approach to liquid biopsy with a great
potential for therapeutic impact on prostate cancer.
Funding: This study is funded by Ministry of Health
and Welfare (HI12C1845) and Institute for Basic
Science (IBS-R020-D1), Republic of Korea.
PS06.02
Microvesicles are absorbed on the surface of extracorporeal
membrane oxygenation circuit tubing
Yoichi Ikia, Shotaro Matsumotob, Michiko Abea, Kieran O’Deac, Hidenobu
Shigemitsub, Masao Takatac and Kenji Wakabayashia
aDepartment of Intensive Care Medicine, Tokyo Medical and Dental
University, Tokyo, Japan; bDepartment of Intensive Care Medicine, Tokyo
Medical and Dental University, Tokyo, Japan; cSection of Anaesthetics, Pain
Medicine, and Intensive Care, Imperial College London, London, UK
Introduction: There is an increasing interest in poten-
tial role of microvesicles (MVs) as non-invasive bio-
markers for acute critical care diseases. Clinically,
extracorporeal membrane oxygenation (ECMO) draws
attention in critical care, and MVs are considered to be
involved in the development of adverse events in criti-
cally ill patients. However, the dynamics of MVs within
ECMO circuit, in particular MV absorption on the
biomaterial, has not been systematically studied. The
purpose of this study was to explore whether MVs are
absorbed by ECMO circuit tubing.
Methods: Granulocytes were isolated from healthy
volunteer blood using density-gradient centrifugation.
MV production was induced by treatment with cal-
cium ionophore for 20 min, and MVs were quantified
on flow cytometry (FACS) based on their size and
surface expression of CD11b and CD66b. MVs were
then purified by differential centrifugation and dis-
solved with DMEM. Thereafter, 0.5 to 1.0 × 107 MVs
were administered to either ECMO circuit tubing
(material group) or Eppendorf tubes (control group)
with their lid removed and re-sealed with paraffin film.
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MV solution was rotated for 6 h, and small volume of
sample was regularly taken in 1–2 h interval for MV
quantification by FACS.
Results: The number of MVs in the material group was
significantly decreased over time, compared to the con-
trol group (64% reduction vs. 22% reduction at 6 h.
Significant interaction (n = 3, p < 0.05) between time
and treatment by 2-way repeated measures ANOVA).
Summary/Conclusion: ECMO circuit is known to
absorb bioactive drugs and mediators, and our results
showed that ECMO circuit also impacts on the
dynamics of circulating MVs. Further investigation
should explore the effects and mechanisms of MV
absorption/production induced by the biomaterial-cell
interaction.
PS06.03
Measurement of physical properties of exosome by atomic force
microscope
Akinori Kogurea, Noriyuki Motohashib, Satoshi Otsukab, Yurika Sawac,
Nobuyoshi Kosakad and Takahiro Ochiyad
aShimadzu Techno-Research, INC, Hadano, Japan; bShimadzu Corporation,
Chiyodaku, Japan; cDepartment of Molecular and Cellular Medicine, Institute
of Medical Science, Tokyo Medical University, Tokyo, Japan; dDepartment of
Molecular and Cellular Medicine, Institute of Medical Science, Tokyo
Medical University, Shinjyuku-ku, Japan
Introduction: It has been shown that exoxome can be
used as a drug delivery system (DDS), and exosome in
blood / body fluid has been studied as a new diagnosis
method for various diseases. The existence of various
proteins and sugar chains such as CD antigen, integrin
and ligand has been confirmed in the membrane of
exosome. However, physical properties of exosome and
their contribution for exosome-mediated phenomenon
have not been clarified yet. There are many reports
showing the morphology of exosomes by electron
microscopy; however, it is necessary for chemical fixa-
tion of sample and vacuum environment. Therefore,
the form of exosome by electron microscopic observa-
tion and the form of exosome in liquid may be differ-
ent. The AFM is an equipment that can observe
exosome in liquid (physiological saline, culture liquid).
In recent years, biomolecular property measurement by
AFM has been increasing (Kogure et al., BPS, 2018).
Methods: We used SPM-9700HT (Shimadzu
Corporation) for AFM measurement. Measurement
mode is dynamic mode and force curve mapping mea-
surement. Exosomes were isolated from human breast
cancer cell line (MDA-MB-231) and mouse breast can-
cer cell line (4T1) (Kosaka et al., JBC, 2013) by
ultracentrifugation.
Results: Physical properties of exosome were measured
using AFM observation and force curve measurement.
Exosomes derived from low metastatic strains derived
from human breast cancer cell lines showed a relatively
smooth surface. Exosomes derived from highly meta-
static strains have layers or chain-like substances hav-
ing a thickness of 10–20 nm. In addition, its physical
property was soft. Furthermore, it was found that exo-
somes derived from nSMase2 knock-down 4T1 cells
are harder than exosome from wild type or nSMase2
over-expressing 4T1 cells.
Summary/Conclusion: Now, we are investigating how
these properties are related to exosome characteristics
in cancer malignancy.
PS06.04
Stability of human salivary extracellular vesicles under
gastrointestinal tract conditions
Yuko Ogawaa, Mamoru Ikemotoa, Yoshihiro Akimotob, Hayato Kawakamic
and Ryohei Yanoshitaa
aTeikyo Heisei University, Tokyo, Japan; bKyorin University, Tokyo, Japan;
cKyorin University, Tokyo, Japan
Introduction: Human saliva plays an important role as
front-line of body defence. Extracellular vesicles (EVs)
are secreted from various types of cells and it is recog-
nized that they are involved in intercellular commu-
nication via delivering their contents. We have isolated
EVs with dipeptidyl peptidase IV (DPP IV) from
human whole saliva, whereas little is currently known
about the fate of secreted salivary EVs. In the present
study, we investigated morphological stability of sali-
vary EVs and chemical stability of proteins associated
with the EVs in simulated gastrointestinal (GI) fluids.
Methods: Human whole saliva was collected from
healthy volunteers. Salivary EVs were separated by
size-exclusion chromatography. For simulated gastric
fluids or intestinal fluids treatment, indicated concen-
tration of pepsin (pH3.0) or pancreatin (pH7.4) was
added to EV samples, respectively. For bile acid treat-
ment, sodium cholate (pH7.4) was added. After the
incubation, the treated samples were then subjected to
SDS-PAGE, western blot analysis, DPP IV activity
measurement, dynamic light scattering study or obser-
vation by a transmission electron microscope.
Results: Salivary EVs were morphologically stable
under simulated gastric fluids with pepsin and simu-
lated intestinal environment using pancreatin. While
some proteins associated with surface of the EVs,
such as mucin 5B and CD9, were digested with these
treatments, inside components such as Alix and
TSG101 were resistant. Even though DPP IV is
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oriented outside, it was not digested and retained its
enzymatic activity. Thus, membrane integrity was
intact and internal components were retained in diges-
tive enzymes. Morphological changes and solubiliza-
tion of proteins in the EVs scarcely occurred after
treatment with physiological concentration of sodium
cholate. Membrane integrity was destroyed with
increasing concentration of sodium cholate. However,
components of the vesicles were not completely solu-
bilized at higher concentration of sodium cholate.
Summary/Conclusion: These results suggest that sali-
vary EVs are stable and functional in GI tract. This
study would help to elucidate their potential pathophy-
siological roles in GI tract.
Funding: This work was supported by Japan Society
for the Promotion of Science (JSPS) KAKENHI Grant
Number 16K08348.
PS06.05
The factor affecting to the accuracy of extracellular small non-coding
RNA biomarkers
Yukie Nishiyama, Yumiko Koi, Genki Nishimura, Eri Kojima, Morihito
Okada and Hidetoshi Tahara
Hiroshima University, Hiroshima, Japan
Introduction: Extracellular small non-coding RNAs
(ncRNAs), such as microRNAs (miRNAs), isoforms
of microRNAs (isomiRs), tRNA-derived fragments
(tRFs) and others, are known as regulator of gene
expression for cell metabolism. They are released into
body fluid from various cells with extracellular vesicles
(EVs) including exosomes. In recent studies, some
extracellular miRNAs and tRFs in blood were reported
as novel biomarkers for diseases. In this study, we
investigated the factor affecting to the accuracy of
extracellular small ncRNA biomarkers such as
miRNA and tRFs for next generation sequencing
(NGS)-based detection.
Methods: Blood was collected from the patients who
provided written informed consent to participate in the
study (approved by IRB of Hiroshima University).
Serum were isolated and stored at –80°C. EVs in the
cell culture supernatant were collected after culture in
DMEM with FBS followed by one-day additional cul-
ture without FBS. Total small RNAs were purified by
using miRNeasy Mini Kit (Qiagen). EVs, including
exosomes, were isolated by using Total Exosome
Isolation Kit (Thermo Fisher Scientific). NGS was per-
formed by using Ion S5 (Thermo Fisher Scientific). We
analysed the sequence data of small ncRNAs (15-55 nt)
with software, CLC Genomics and JMP.
Results: We found that most of the extracellular small
ncRNAs in serum consisted of miRNA, isomiRs and
tRFs. Especially, most of ncRNAs in EVs were tRFs.
Several isomiRs and tRFs were expressed specifically in
serum from cancer patients. Some of them were also
observed in EVs from cultured cancer cell lines. EV-
free ncRNAs were decreased, and ncRNAs with EVs
were increased in blood during long 4°C storage after
blood sampling.
Summary/Conclusion: The expression profile of the
extracellular small ncRNAs is changed during storage
at 4°C after blood sampling. It may affect the accuracy
of extracellular small non-coding RNA biomarkers.
Funding: This research is partially supported by the
“Development program of microRNA measurement
technology foundation in body fluid” from Japan
Agency for Medical Research and development,
AMED.
PS06.06
Generation of reference material for flow cytometric detection of
extracellular vesicles
Anna Nowocin
NIBSC, London, UK
Introduction: Extracellular vesicle (EV)-related tech-
nologies have been developing rapidly over the past
few years and substantial growth is expected for the
market as they get integrated into the fields of liquid
biopsy, precision and regenerative medicine. NIBSC as
a designated WHO standardization laboratory is
actively developing methods that in the future may
allow the production of diagnostic and therapeutic
EV reference material for clinical and pre-clinical use.
As flow cytometry enables characterization of EV
populations down to single-event level, it has been
adapted as a meaningful tool in characterizing EV
isolates. High-throughput and multiparameter analysis
of EV are crucial to further advance the ability to
characterize these particles.
Methods: EVs from plasma samples were isolated
using several methods and their morphology and mole-
cular content was assessed. The effects of freeze-drying
were investigated to explore a possibility of long-term
storage of EV-reference material that has been labelled
in that way for flow cytometric analysis.
Results: The populations of submicron EVs could be
detected using commercially available flow cytometers
only when fluorescence and not light scatter triggered
detection was used. The labelling with 5-(and-6)-car-
boxyfluorescein diacetate succinimidyl ester followed
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by removal of unbound dye was efficient enough to
robustly label single EVs without generating label-asso-
ciated artefacts. Freeze-drying process had some effects
on morphology but not molecular content of EV
preperations.
Summary/Conclusion: Efficient labelling and preser-
vation of pure populations of EVs present a viable
option for the development of a stable monodispersed
reference material that can be used as positive control
or calibrant of flow cytometers used for analysing sub-
micron populations.
PS06.07
Comparison of serum and plasma as a source of blood extracellular
vesicles reveals possible contamination of serum with platelet-
derived particles produced during coagulation
Xiaoman Zhanga, Toshihide Takeuchib and Yoshitaka Nagaib
aDepartment of Neurotherapeutics, Osaka University Rraduate School of
Medicine, Osaka, Japan; bOsaka University, Suita, Japan
Introduction: Extracellular vesicles (EVs), including
exosomes and microvesicles, are released from cells to
extracellular environment, and can be found in several
biological fluids, such as blood, cerebrospinal fluid and
urine. Among them, blood-derived EVs are expected to
offer a more efficient and faster diagnostic method for
neurologic diseases than conventional diagnosis.
Although serum and plasma are utilized as a source
of blood EVs, it still remains unknown whether there
are differences in EVs derived from serum and plasma.
In this study, we performed a series of experiments to
see the differences between serum and plasma EVs.
Methods: Whole blood was obtained from 9-week-old
mice. Serum was collected from the supernatant of the
clotted blood. Plasma was collected from the blood
treated with EDTA. EVs were isolated from serum
and plasma using ultracentrifugation method. The
morphology of EVs was analysed by electron micro-
scopy, and the particle numbers and the diameter were
measured by nanoparticle tracking analysis (NTA). The
protein contents of EVs were analysed by LC-MS/MS
and western blotting.
Results: NTA measurement revealed that the particle
numbers in the EV fraction isolated from serum are
~2-fold larger than those derived from plasma
(p < 0.01, Student’s t-test), while the particle diameter
showed no difference between serum and plasma EVs.
LC-MS/MS analysis of EVs identified total 520 pro-
teins, of which 317 proteins were detected in both
serum- and plasma-derived EVs, while 189 proteins
and 14 proteins were detected only in serum- and
plasma-derived EVs, respectively. Interestingly,
platelet-associated proteins were specifically detected
in serum-derived EVs.
Summary/Conclusion: We found that serum has the
larger number of EVs than plasma, despite of the same
volume of blood. The existence of the platelet-specific
proteins detected in serum-derived EVs implies that
serum may be contaminated with platelet-derived
nanoparticles, which are reported to be produced dur-
ing coagulation.
PS06.08
Evaluation of stability maintenance of extracellular vesicles upon
storage temperature and period
Eun Kyoung Shina, Jae Min Chab, Mi Jeong Oha, Eun Hee Kima and Oh
Young Bangc
aSamsung medical center, Seoul, Republic of Korea; bDepartment of
Mechatronics, College of Engineering, Incheon National University,
Incheon, Republic of Korea; cSamsung medical center, Seoul, Republic of
Korea
Introduction: Extracellular vesicles (EVs) secreted
from stem cells are bilipid-layered and nano-sized,
retaining medicinal potency equivalent to that of stem
cells. As much interest in clinical use of therapeutic
EVs has been increasingly gained in the fields, how-
ever, few studies have been conducted regarding opti-
mal storage and shipping conditions for EVs, which are
critical to commercialize EVs as a medicinal product.
In this study, we tested the maintenance efficiency of
EVs in terms of physical stability and proteomic/geno-
mic contents of EVs in the following storage condi-
tions: (1) 4°C during the 28-day of short-term period
and (2) −80°C during the one-year of long-term period.
Methods: Comprehensively characterized stem cell-
derived EVs were stored at 4°C for 28 days and −80°
C for one year. During given periods, preserved density
and differing sizes of EVs were evaluated by nanopar-
ticle tracking analysis (NTA) along with quantitative
measurement of variations in total protein and RNA
concentrations.
Results: At the 4°C storage condition, concentration
and size of EVs were relatively unvarying for 28 days.
In terms of total protein and RNA concentrations,
about 3–40% of decreasing rates were shown during
the first week of period, but rest of the amounts were
stably preserved until day 28. At −80°C, EV concentra-
tion decreased about 10% from the initial level during
the first two weeks, but rest of the amounts were stably
preserved for one year. Size of EVs was not changing
during the long-term period. In terms of total protein
and RNA concentrations, about 50% of decreasing
rates were shown during the first two weeks, but rest
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of the amounts were stably preserved during the one
year of period.
Summary/Conclusion: While a variety of studies are
actively ongoing to reach effective cell-free treatments
using EVs, the information of EV storage provided by
our study would support safe and reliable use of EVs in
clinic
Funding: This study was supported by a grant from the
Korean Healthcare Technology R&D Project, Ministry
of Health & Welfare (HI17C1256) and Basic Science
Research Program, the Ministry of Science, ICT and
Future Planning (2018M3A9H1023675).
PS06.09
Questioning the purity of the media – extracellular small non-coding
RNA contaminants in foetal bovine serum and serum-free media
Bettina I. Mannerströma, Riku Paananenb, Ahmed Abu-Shahbac, Riitta
Seppänen-Kaijansinkkoa and Sippy Kaura
aDepartment of Oral and Maxillofacial Diseases, University of Helsinki and
Helsinki University Hospital, Helsinki, Finland; bHelsinki Eye Lab,
Ophthalmology, University of Helsinki and Helsinki University Hospital,
Helsinki, Finland; cDepartment of Oral and Maxillofacial Diseases,
University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Introduction: Extracellular vesicles (EVs) behave as
paracrine effectors as they are released from cells to
deliver signals to other cells. They control a diverse
range of biological processes by transferring proteins,
lipids and nucleic acids between cells and are secreted
by a wide spectrum of cell types and are found in
various biological fluids. In the research field of EV
research, the use of EV-depleted foetal bovine serum
(FBS) for in vitro studies is crucial to eliminate the
confounding effects of media-derived EVs. The current
methods to deplete culture media of EVs are lacking as
they do not guarantee an RNA-free preparation.
Methods: In this study we have addressed the RNA
contamination issue of EVs in FBS, ultracentrifugation
EV-depleted FBS, commercially available EV-depleted
FBS, and in our recently developed filtration-based EV-
depleted FBS. Commercially available serum-free,
xeno-free defined media were also screened for RNA
contamination.
Results: Our small non-coding (nc) RNA sequencing
data emphasized that all EV-depleted media contained
RNA contaminants. Additionally, defined media con-
tained miRNAs and other small RNAs, albeit at a much
lower level than in serum preparations. Out of the
different FBS preparations studied, our ultrafiltration
EV-depleted FBS performed the best in depleting
miRNAs. Certain miRNAs, such as miR-122 and
miR-203a, proved difficult to remove and were present
in all media. As compared to miRNAs, other small
RNAs (snRNA, Y RNA, snoRNA and piRNA) were
difficult to eliminate from the media.
Summary/Conclusion: Our study showed that even
defined media contained trace amounts of small ncRNA.
Therefore, in order to screen for baseline RNA contamina-
tion in culturing media, RNA sequencing data should be
carefully controlled by adding a media sample as a control.
This should be a mandatory step before performing cell
culture experiments in order to eliminate the confounding
effects of media.
Funding: This research was supported by University of
Helsinki project funding, Helsinki University Hospital
State funding for university-level health research, the
Finnish Dental Society Apollonia, Business Finland grant.
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Chairs: Quan Lu; Nobuyoshi Kosaka
Location: Level 3, Hall A
15:00–16:00
PS07.01
A tunable system to visualize retrofusion, a major pathway for
exosome uptake
Priscillia C. Perrina, Lennert Janssena, Daphne van Elslandb and Jacques
Neefjesc
aLeiden University Medical Center, Leiden, Netherlands; bLeiden University
Medical Center, Leiden, Netherlands; cLeiden University Medical Center,
Leiden, Netherlands
Introduction: Exosomes constitute a crucial mode of
intercellular communication, as they can travel through
extracellular space to transfer various cellular compo-
nents from one cell to another. While we understand,
to some extent, how exosomal contents can affect reci-
pient cells, the molecular mechanisms governing exo-
some uptake are yet to be unravelled. Upon encounter
with a target cell, exosomes may be internalized and
transported to late multivesicular compartments. To
avoid imminent degradation in lysosomes, exosomes
must escape the endocytic pathway and fuse back to
the limiting membrane of multivesicular bodies (MVB)
through a process referred to as “back-fusion” or “ret-
rofusion”. Within MVBs, retrofusion of intraluminal
vesicles (ILV) can notably allow recycling of membrane
proteins and also lead to cytoplasmic release of endo-
cytosed viruses. As retrofusion is poorly understood,
deciphering its workings would help unfold a major
pathway for exosome uptake.
Methods: To enable exploration of this process and
ultimately reveal the molecules responsible, we created
an inducible system allowing quantification of retro-
fusion in real time. CD63, a tetraspanin protein loca-
lized on both the limiting (LM) and intraluminal
membranes (ILM) of late endosomes, was fused to
GFP and stably expressed in MelJuso cells, along with
two inactive fragments of the tobacco etch virus (TEV)
protease. Upon addition of “dimerizer” to the cells, the
TEV protease regains activity and cleaves the GFP off
of CD63 exposed on the cytosolic side of the LM. A
nuclear localization signal then directs this newly lib-
erated GFP to the nucleus. When retrofusion occurs,
intraluminal GFP-CD63 repopulates the LM from ILV
stores and becomes accessible for TEV protease clea-
vage, resulting in the increase of nuclear GFP fluores-
cence over time. Concomitant labelling of acidic
vesicles with a fluorescent dye allows for quantification
of GFP signal decay specifically from those
compartments.
Results: Using this chemically tuneable system, we
found that knocking out the lysosomal integral mem-
brane protein Limp2 partially hampers retrofusion,
suggesting that Limp2 may be a major player in this
process.
Summary/Conclusion: We further aim to identify
other proteins implicated in retrofusion in order to
propose a suitable mechanistic model.
PS07.02
Uptake of EVs derived from cervical cancer patients with
precancerous induces HeLa cell proliferation
Piyatida Molikaa and Raphatphorn Navakanitworakulb
aFaculty of Medicine. Department of Biomedical Science. Prince of Songkhla
University, Maung, Thailand; bFaculty of Medicine. Department of
Biomedical Science. Prince of Songkhla University, Hat Yai, Thailand
Introduction: Precancerous lesion is defined as early
biological effects of cells which occur prior to invasive
carcinomas. The lesion is not cancerous and exhibits
variations at the cellular and molecular levels in the
pathway leading to cancer. Current evidence indicates
that extracellular vesicles (EVs) can release from most
of the cell types and affect adjacent or distant cells by
circulating in all bodily fluids.
Methods: We collected serum of healthy persons and
cervical cancer patients with precancerous lesions,
stage I, stage II and stage III and then counted con-
centration and size distribution of the EVs using nano-
particle tracking analysis (NTA). Differential
ultracentrifugation incorporated with size exclusion
chromatography was used to isolate and purify EVs
from pooled serum of each sample groups. Moreover,
isolated EVs were investigated their characteristic
based on morphology using transmission electron
microscope (TEM) and the expression of CD63,
CD81, CD9, and Alix protein markers using western
blot analysis. Live cell imaging machine was used to
monitor uptake of EVs derived from pooled serum of
healthy persons or precancerous lesion on HeLa cells.
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Results: NTA shows that the concentration of EVs is
increased in patients with precancerous lesion and
stage I, and declined in the later stages. We also
found that EVs isolated from serum of healthy and
precancerous group are capable of uptake into the
cells within 4 h. Nonetheless, only EVs isolated from
precancerous can stimulate HeLa cell proliferation
compared to those isolated from healthy and no EVs
treatment group.
Summary/Conclusion: This induction would associate
with the biomolecules inside of EVs. Our further study
is addressing to find out both proteins and regulatory
molecules which contribute to cancer progression.
Funding: This work was financially supported by
Faculty of Medicine, Prince of Songkhla University
and TRF research grant for new scholar.
PS07.03
Optimized protocol for the quantification of amino acid
concentrations in exosomes
Hidehiro Nakamura, Satoko Ueno and Asami Hagiwara
Ajinomoto Co., Inc., Kawasaki-shi, Japan
Introduction: Exosomes contain parent cell-derived
molecules including nucleic acids and metabolites,
which are useful as potential biomarkers serving as
surrogates of their cells of origin. Accurate quantifica-
tion of these molecules in exosomes requires to mini-
mize the carryover contamination of residual condition
medium (CM) or biological fluids, as they also contain
these molecules in high amount. Here, we developed a
method for accurate quantification of amino acids
(AAs) in exosomes by optimizing pre-analytical sample
preparation and applying highly sensitive analytical
system. The method enabled us to evaluate the AA
profiles of exosomes in comparison with those of CM
and cell extracts or biological fluids.
Methods: Exosomes were isolated from CM of human
pancreatic cancer cell line, PANC-1, or rat serum by
combination of ultrafiltration and ultracentrifugation.
AAs were extracted by methanol and analysed by LC-
MSMS after pre-column derivatization. AAs concentra-
tion and profile were compared among exosomes, CM
and parental cells or serum.
Results: Ultrafiltration was introduced to minimize the
effect of carryover contamination of residual AAs from
CM or serum. A minimal amount of exosomes
required for AAs quantification was determined. AA
profiles of exosome were different from those of CM
and parental cells or serum. In contrast, some changes
of intracellular AA concentrations were reflected in
exosomes.
Summary/Conclusion: We developed the optimized
pre-analytical method for AA quantification in exo-
somes. This method would be applicable to metabolo-
mics approaches to identify disease biomarkers or
surrogate biomarkers for the metabolic status of cells
of origin.
PS07.04
Metabolome analysis of pancreatic cancer-derived extracellular
vesicles
Ryosuke Hayasaka, Akiyoshi Hirayama, Sho Tabata, Tomoyoshi Soga and
Masaru Tomita
Keio university, Tsuruoka, Japan
Introduction: Extracellular vesicles (EVs) are facilitators
of cell-to-cell communication. Cancer-derived EVs con-
tribute to cancer progressions such as distant metastasis,
angiogenesis and immunosuppression. EVs contain
functional cellular components including DNA,
mRNA, microRNA and protein. However, metabolome
profiling in cancer-derived EVs remains largely unex-
plored. The purpose of this study is to explain compre-
hensive metabolite profiling of pancreatic cancer-
derived EVs. As a model for studying cancer metabo-
lism, we evaluate the difference between metabolomic
profiles in EVs obtained from cancer cells cultured in
normoxic or hypoxic conditions.
Methods: Pancreatic cancer cell line Panc-1 was culti-
vated under normoxic (20% O2) and hypoxic (1% O2)
conditions. Cells were sampled using methanol, and
EVs were isolated from conditioned medium using
ultracentrifugation. The amount of EVs was deter-
mined by nanoparticle tracking analysis, and the pro-
tein level of the CD9 exosomal marker was measured
using enzyme-linked immunosorbent assay (ELISA).
Metabolomic analysis was performed by using capillary
ion chromatography-mass spectrometry and liquid
chromatography-mass spectrometry.
Results: We identified more than 180 kinds of meta-
bolites in pancreatic cancer-derived EVs. Principal
component analysis (PCA) of metabolites in EVs
showed somewhat differentiated results between nor-
moxia and hypoxia. Further, the metabolite profiles
contained in the cells and EVs may be different.
Summary/Conclusion: In conclusion, we optimized
the collection protocol of EVs from cultured cell sam-
ples for metabolomic analysis. Our results suggested
that the metabolic character in EVs may vary that in
cells.
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Funding: This study was supported by the Japan
Society for the Promotion of Science KAKENHI
Grants and research funds from the Yamagata
Prefecture Government and Tsuruoka City.
PS07.05
Exosomal miR-141-3p regulates osteoblast activity to promote the
osteoblastic metastasis of prostate cancer
Yun Ye
The First Affiliated Hospital of Xi’an Medical University, Xi’an, China
(People’s Republic)
Introduction: Exosomes from cancer cells, which con-
tain microRNA and reach metastasis loci prior to can-
cer cells, stimulate the formation of a metastatic
microenvironment. Previous studies have shown that
exosomal miR-141-3p is associated with metastatic
prostate cancer (PCa). However, the role and regula-
tory mechanism of miR-141-3p in the microenviron-
ment of bone metastases require further study.
Methods: In this study, we performed a series of
experiments in vivo and in vitro to determine whether
exosomal miR-141-3p from MDA PCa 2b cells regu-
lates osteoblast activity to promote osteoblastic
metastasis.
Results: We demonstrate that extracts obtained from
cell culture supernatants contained exosomes and that
miR-141-3p levels were significantly higher in MDA
PCa 2b cell exosomes. Via confocal imaging, numerous
MDA PCa 2 bexosomes were observed to enter osteo-
blasts, and miR-141-3p was transferred to osteoblasts
through MDA PCa 2b exosomes in vitro. Exosomal
miR-141-3p from MDA PCa 2b promoted osteoblast
activity and increased osteoprotegerin OPG expression.
miR-141-3p suppressed the protein levels of the target
gene DLC1, indicating its functional significance in
activating the p38MAPK pathway. In animal experi-
ments, exosomal miR-141-3p had bone-target specifi-
city and promoted osteoblast activity. Mice injected
with miR-141-3p-mimics exosomes developed appar-
ent osteoblastic bone metastasis.
Summary/Conclusion: Exosomal miR-141-3p from
MDA PCa 2b cells promoted osteoblast activity and
regulated the microenvironment of bone metastases,
which plays an important role in the formation of
bone metastases and osteogenesis damage in PCa.
Clarifying the specific mechanism of bone metastasis
will help generate new possibilities for the treatment
of PCa.
PS07.06
Unrevealed mystery of cell dust: extracellular vesicles and tumour
derived exosomes
Deanna Ayupovaa, Thomas Nannb and Renee Gorehamc
aThe MacDiarmid Institute for Advanced Materials and Nanotechnology,
Victoria University of Wellington, Wellington, New Zealand; bThe
Univeristy of Newcastle, Callaghan, Australia; cVictoria University of
Wellington, Wellington, New Zealand
Introduction: Binding exosomes to their target cells is
more likely to be determined by specific interaction(s) of
protein(s) enriched in membrane of extracellular vesicles
(EVs) including tumour-derived exosomes (TEX) and cel-
lular proteins. Although the exact mechanism of EVs
action is not fully understood, several studies reported
that TEX can modify tumour microenvironment by trans-
ferring non-coding RNAs and miRNA (particularly
miRNA-21 and −29) to target cells. Several studies have
showed comparative proteomic analyses of exosomes and
circulating EVs from different biological fluids validating
their respective role as novel biomarkers offering an early,
non-invasive method for cancer diagnosis. Protein profil-
ing and detection conducted by label-free quantification
will contribute to understanding the contents of healthy
and tumour-derived exosomes by identifying their con-
centration, size distribution, population and composition
enabling characterization of peptide peak intensity.
Collected data combined into a protein library for early
diagnosis will result in the improvement of cancer immu-
notherapy and new therapeutic targets.
Methods: AB; SEC; IF; NTA;LC-MS; TEM; Flow
Results: According to cell viability assay, exosomes
increase cell proliferation after 24 h of treatment for
both cell lines: MCF 10 A and A549 for all concentra-
tions of exosomes (0.125, 0.25, 05, 1 mg/mL). Annexin
V/ PI assay was used to define the percentage of necro-
tic and apoptotic cell death after treating cancerous and
non-tumorigenic cell lines. Interestingly, the higher
percentage of necrotic death (6.45%) was recorded for
THP-1 exosomes conditioned with MCF 10 A, while
the smallest number of necrotic death was noticed for
A549 exosomes condition with the same cell line A549
(1.99%). The TEM analysis showed roughly same size
(40–50 nm) of exosomes for all various types of exo-
somes used in this study (THP-1, MCF 10 A and A549
exosomes).
Summary/Conclusion: In summary, we can conclude
that extracellular vesicles (including exosomes) derived
from mammalian cell including cancerous and non-
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tumorigenic cell line increase cell proliferation. That
being said, cancerous cell line secrets quiet a larger
amount of extracellular vesicles compared to non-
tumorigenic cell line.
Funding: No external fundings.
PS07.07
Surface glycan profiling of extracellular vesicles by lectin array
system for biomarker discovery
Asako Shimodaa, Shin-ichi Sawadab, Yoshihiro Sasakib and Kazunari
Akiyoshib
aKyoto Univerisity, Kyoto, Japan; bKyoto University, Kyoto, Japan
Introduction: Extracellular vesicles (EVs) are known
as cellular communicators that carry their contents
including proteins, lipids and nucleic acids. Since
cells handover their biological information to EVs,
they can be applicable to cell biomarkers. We showed
that glycans on mesenchymal stem cells (MSCs)-
derived EVs play important roles in cellular recogni-
tion using an evanescent-field fluorescence-assisted
lectin array system [1]. Most remarkable feature of
this method is that simple, sensitive and real-time
detection of surface glycan patterns on intact EVs.
In this study, surface glycan profiling on EVs from
many types of cells was analysed using the lectin array
system.
Methods: EVs were isolated from various kinds of
mouse and human cells including cancer cells, undif-
ferentiated and differentiated MSCs, and immune cells
by differential ultracentrifugation. Cy3-labelled EVs
and their originating cell membranes (CMs) were
applied to a glass slide with 45 lectins, and fluorescence
intensities were detected using an evanescent-field
fluorescence scanner.
Results: Most types of EVs showed higher binding to
sialic acids-recognizing lectins and weaker binding to
mannose-binding lectin as compared with their origi-
nating CMs. Hierarchical clustering analysis and prin-
cipal component analysis were performed to evaluate
whether surface glycans on EVs have their cell specific
patterns. The results indicated that glycan profiling of
EVs can be used to classify cell types (normal or can-
cer) and they can be further divided into each type of
cancer, MSC sources and cell lineages, indicating that
surface glycans on EVs may act as potential biomarkers
of cell state.
Summary/Conclusion: In conclusion, a lectin array
method is a powerful tool for comprehensively glycan
analysis of EVs towards biomarker discovery.
PS07.08
Tomato fruit-derived vesicles: isolation, biocargo characterization
and the dissection of different vesicle types
Ramesh Bokkaa;, Gabriella Pocsfalvia, Teresa Silvestrea, Immacolata Fiumea,
Lilla Turiakb and Tamás Csizmadiac
aExtracellular Vesicles and Mass Spetrometry Group, Institute of Bioscience
and BioResosrces (IBBR) – CNR, Naples, Italy; bHungarian Academy of
Sciences, Research Centre for Natural Sciences, Budapest, Hungary; cEötvös
Loránd University, Budapest, Hungary
Introduction: Plant-derived vesicles are receiving con-
siderable attention due to their potential applications as
vectors for the delivery of biologically active substances
in the nutraceutical, cosmetic and pharmaceutical
fields. Here, in the first time, we report the in depth
characterization of micro (MVs) and nanovesicles
(NVs) enriched fractions isolated from the pericarp
tissue of Solarium lycopersicum with the aim to develop
a new generation, natural vesicles-based delivery vec-
tors. This includes the setup of a novel GC-MS/MS
platform suitable for the characterization of vesicles’
metabolites.
Methods: MV and NV fractions were isolated by dif-
ferential centrifugation. NVs were further purified by
sucrose gradient ultracentrifugation method. Isolation
of NVs resulted to be troublesome due to the co-pur-
ifying pectin substances. Physiochemical properties of
the vesicles were analysed by TEM and DLS, while
biocargo composition was studied by mass spectrome-
try-based proteomic and metabolomics workflows.
Functional annotation and data mining were per-
formed using Blast2Go software package including
InterPro, enzyme codes, KEGG pathways and GOSlim
functions.
Results: The isolation method was improved by differ-
ential solubilization using 0.1M phosphate 10 mM
EDTA buffer pH 8, to keep pectin substances in solu-
tion allowing by the efficient purification of NVs. In
each sample, approximately 600–800 proteins and
approximately 50 metabolites could be identified. A
novel method based on GC-MS/MS metabolomic pro-
filing of plant-derived vesicles has been developed.
Summary/Conclusion: Protein biocargo of tomato
pericarp tissue-derived vesicles reveals heterogeneous
transport and extracellular vesicle subpopulations.
More than 340 enzymes comprising 43 antioxidants
identified in tomato nanovesicles may count for its
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health-promoting effects in the diet, i.e. protection
against cancer, maintenance of healthy blood pressure
and reduction of blood glucose in diabetic patients.
Funding: This project has received funding from the
European Union’s Horizon 2020 research and
innovation programme under the Marie Skłodowska-
Curie grant agreement number 798576 and FET Open
grant agreement number 801338.
JOURNAL OF EXTRACELLULAR VESICLES 327
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Chairs: Cecilia Lässer; Li Min
Location: Level 3, Hall A
15:00–16:00
PS08.01
Taxonomy of individual EVs by nanomechanics
Andrea Ridolfia, Marco Brucaleb, Lucia Paolinic, Costanza Montisd, Debora
Bertid, Francesco Valleb and Paolo Bergesee
aISMN-CNR and CSGI; Department of Chemistry, University of Florence,
Firenze, Italy; bISMN-CNR and CSGI, Bologna, Italy; cDepartment of
Molecular and Translational Medicine and CSGI, Università degli Studi di
Brescia, ITALY, Firenze, Italy; dDepartment of Chemistry and CSGI,
University of Florence, Firenze, Italy; eDepartment of Molecular and
Translational Medicine and CSGI, Università degli Studi di Brescia, ITALY,
Brescia, Italy
Introduction: Probing and understanding the physical
properties of individual EVs – as a whole and of their
separate components – are fundamental aspects in EV
research that still need to be addressed. We will present
our latest results regarding the nanomechanical char-
acterization of individual EVs via Atomic Force
Microscopy-based Force Spectroscopy (AFM-FS) and
discuss their significance and perspectives.
Methods: Our experimental approach entails adsorp-
tion of EVs (separated from cell culture media) on
inorganic substrates with controlled surface properties.
The response of each individual EV to an applied
mechanical deformation in physiological buffer is
then sampled via liquid AFM-FS. The obtained force
curves are finally quantitatively analysed by dedicated
models to obtain the EV “nanomechanical fingerprint”.
Results: The reversible elastic deformation behaviour
of an EV in response to the AFM tip indentation
resulted to be the convolution of several characteristics
of the EV. We found that the overall apparent stiffness
of an intact EV effectively recapitulates its mechanical
behaviour. We also found first evidences that this
property can be exploited to sort single EVs and that
it relates them to other organic envelopes of similar
size and composition, such as viruses and synthetic
liposomes.
Summary/Conclusion: These results proof that a
nanomechanics-based taxonomy might be an impor-
tant tool for advancing characterization and under-
standing of EVs at the single vesicle level.
Funding: This research has received funding from the
Horizon 2020 Framework Programme under the grant
FETOPEN-801,367 evFOUNDRY.
PS08.02
Electrical characterization of individual exosomes secreted from
amyloid beta-treated neuroblastoma cells via electrostatic force
microscopy
Yeseong Choia, Sumi Kima, Dae Sung Yoonb and Ji Yoon Kanga
aKorea Institute of Science and Technology, Seoul, Republic of Korea; bSchool
of Biomedical Engineering, Korea University, Seoul, Republic of Korea
Introduction: Exosomes are cell-derived nanovesicles
known to provide information about the state of parent
cells. Recently, it has been found that the pathogenic
amyloid beta oligomers (oAβs), known as a biomarker
of Alzheimer’s disease (AD), can be propagated
between neighbouring neurons through exosomes. At
the same time, there is an increasing need to introduce
a new technique for the characterization of individual
exosomes because of their diversity. In this paper, we
used electrostatic force microscopy (EFM) to demon-
strate the effect of oAβ on electrical properties of
individual exosomes.
Methods: Different concentrations (30, 150, 750 nM)
of oAβs were treated to mouse neuroblastoma (N2a)
cells, and exosomes were harvested from cell culture
media through ultracentrifugation. The electrical prop-
erties of exosomes were investigated by using EFM. For
EFM experiment, the 10 μL of each exosome solution
was deposited on a fresh mica substrate for 15 min,
washed in PBS and DW order and dried under pure
nitrogen gas.
Results: EFM can visualize the electrostatic force gra-
dient corresponding to the surface potential of single
exosomes. The scatter plot resulted from EFM data
analysis showed a correlation between the size and
the charge of exosomes. Moreover, charge density
values, which excludes the influence of size by dividing
the charge value by height, decreased by up to four
times depending on the concentration when compared
with the control (−5.95 μV/nm at control, −9.17, −11.1,
−23.85 μV/nm at 30, 150, 750 nM, respectively). It
implies that exosomes from oAβ-treated N2a cells
have significantly higher negative surface potential
than those from untreated N2a cells.
Summary/Conclusion: This paper proposes a new
nano-electrical characterization to differentiate neuro-
nal exosomes treated by oAβs from untreated ones. It is
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possible to use EFM as imaging and analysis tool for
single exosome characterization. Furthermore, it is
expected that exosomes associated with AD are isolated
from plasma in the diagnosis of AD according to a
surface potential of exosome.
PS08.03
Hybrid plasmonic biomaterial nanofilter scaffold for cancer EV
diagnostics based on surface-enhanced Raman scattering (SERS)
Randy Carneya, Tatu Rojalina and Sebastian Wachsmann Hogiub
aUC Davis, Davis, USA; bMcGill University, Montreal, Canada
Introduction: New analytical approaches are needed
that account for the vast molecular heterogeneity of
nanoscale extracellular vesicles (EVs). Raman spec-
troscopy is an attractive technology capable of sensi-
tive molecular fingerprinting of chemical changes
associated with disease. Surface-enhanced Raman
Spectroscopy (SERS) overcomes the inherent weak
nature of spontaneous Raman scattering and is prov-
ing to be a promising tool for next-generation clin-
ical diagnostics. The principle of SERS is based on
amplification of Raman scattering using metal sur-
faces that have a nanoscale roughness with features
of ~20–200 nm. We introduce an inexpensive and
flexible SERS substrate based on a novel biosilica
plasmonic nanocomposite that acts as a simulta-
neous nanofilter and detection platform for sensitive
characterization of tumour-associated EVs.
Methods: A porous biosilica scaffold doped with plas-
monic silver nanoparticles can be simply and easily
prepared on office-grade adhesive tape. This nanocom-
posite deposition requires no chemical modification of
the raw materials. Particles larger than ~100 nm con-
centrate on the top surface in close proximity to clus-
ters of plasmonic nanoparticles, affording usability as a
SERS-based sensing platform.
Results: We tested our platform with dozens of sam-
ples of tumour-associated EVs enriched from ovarian
cancer patients and healthy controls to demonstrate
that SERS imaging can sensitively detect and identify
disease profiles. We found enhancement factors of
more than 10^8-fold compared to spontaneous
Raman signatures. Sensitivity and specificity exceeding
90% was found for human clinical samples using less
than 1 μL of minimally processed plasma, all in just a
few seconds using a commercial Raman imaging
system.
Summary/Conclusion: We introduce a simple plasmo-
nic composite using readily available biomaterials and
metallic nanoparticles, and demonstrate its efficacy for
label-free sensing of EVs. High chemical specificity
afforded by Raman spectroscopy rapidly identified
tumour EVs from healthy controls in clinical samples.
Our nanocomposites are inexpensive, reusable, stable
and suitable for low resource environments, with high
potential for translational application of clinical diag-
nostics using EVs.
Funding: The authors acknowledge funding from the
Ovarian Cancer Education and Research Network
(OCERN).
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Electrochemical quantification of EVs at physiological concentrations
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Introduction: Tumour-derived extracellular vesicles
(tdEVs) are promising markers for cancer patient man-
agement. An advantage of tdEVs over circulating
tumour cells is their higher concentration in patient
blood by 3–4 orders of magnitude (∽103–105 tdEVs
/ml), giving more robust information while requiring
smaller sample sizes. However, their small size and
complex composition of blood samples require sensi-
tive and selective detection methods. Here, we report
electrochemical detection of tdEVs using a nano-inter-
digitated electrode array (nIDE) functionalized with
cancer-specific antibodies and an antifouling coating.
The detection mechanism is based on enzymatic con-
version of aminophenyl phosphate (APP) by alkaline
phosphatase (ALP) followed by redox cycling of the
cleaved substrate, yielding a double signal amplifica-
tion. The proposed sensing scheme is 10 times more
sensitive than state-of-the-art detection approaches,
giving a physiologically relevant limit of detection
(LOD) of 10 EVs/μl.
Methods: nIDEs (120 nm width, 80 nm spacing, 75 nm
height) were functionalized with an amino-undeca-
nethiol monolayer, and reacted with poly(ethylene gly-
col) diglycidyl ether. Anti-EpCAM antibodies were
next immobilized to subsequently capture tdEVs.
Anti-EpCAM-alkaline phosphatase conjugates were
then introduced to yield ALP-tagged tdEVs. The non-
electroactive pAPP was finally used to quantify the
ALP concentration.
Results: With increasing tdEV concentration, an
increase in redox current was measured, from 0.35
nA for 10 tdEV/μl to 12.5 nA for 10^5 tdEV/μl (avg.,
n = 3). Current is produced by the electroactive
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cleavage product of APP, which redox cycles between
electrodes. The short migration distance in our nanoe-
lectrode array yielded a factor ∽8 improvement com-
pared to micro-electrodes (3 μm width, spacing). As a
negative control, the experiment was performed with
incubation of platelet derived EVs, whereby the signal
did not significantly increase (background current
∽0.15 nA).
Summary/Conclusion: A sensitive sensor was devel-
oped for the detection of EVs at unprecedented low
concentrations. With an LOD of 10 tdEVs/μl and high
selectivity towards tdEVs, our platform opens new
avenues for screening patient blood samples.
Funding: Funded by NWO Perspectief
PS08.05
The Importance of Orthogonal Techniques in EV Quantification
Jean-Luc Fraikina, Franklin Monzonb, Lew Brownb, Mac Baileyb and
Ngoc Dob
aSpectradyne LLC, Torrance, USA; bSpectradyne, Torrance, USA
Introduction: As EV research matures, so must mea-
surement technologies. Two simple experiments are
reported that expose a critical failure mode of
Nanoparticle Tracking Analysis (NTA) for quantifying
EVs: NTA’s small size limit of detection (LOD)
depends strongly on the composition of the sample,
causing 10,000-fold errors within the EV size range
relative to Microfluidic Resistive Pulse Sensing
(MRPS) and Tunnelling Electron Microscopy (TEM).
Results show orthogonal methods for EV quantifica-
tion are critical.
Methods: Experiment 1: Three sizes of polystyrene
particles – 94, 150 and 208 nm diameters – were
measured by NTA and MRPS separately and after
mixing in equal parts. The relative concentration accu-
racy of NTA and MRPS was assessed as a function of
size, and the LOD evaluated for each sample.
Experiment 2: The striking implications of
Experiment 1 were demonstrated in a real-world sam-
ple. Urinary exosomes were measured by NTA, MRPS
and the gold standard, Tunnelling Electron Microscopy
(TEM). The accuracy of relative concentration mea-
surements was assessed for each method.
Results: Experiment 1: Polystyrene standards were
accurately quantified by MRPS: Each component was
clearly detected, and the relative concentrations of all
were measured to be approximately equal as intended.
NTA showed similar results for the separate compo-
nents. However, NTA was unable to detect the 94 nm
particles in the mixture and showed quantification
errors at 150 nm diameter.
Experiment 2: MRPS showed the particle size dis-
tribution expected: Concentration increased with
decreasing particle size with an approximate power-
law dependence on diameter reported elsewhere in
the literature. MRPS was in excellent agreement with
TEM. NTA reported misleading results: A loss of
counting efficiency was apparent as high as 200 nm
diameter, and led to a 10,000-fold discrepancy by
65 nm. Critically, NTA reported a prominent peak
that does not in fact exist.
Summary/Conclusion: These experiments expose a
critical failure mode of NTA: Its LOD depends strongly
on the composition of the sample, with enormous
impact for EV measurements. Critically, a researcher
could be severely led astray by the NTA results in
isolation, without an orthogonal technique for
reference.
PS08.06
Fourier-transform Infrared Spectroscopy (FT-IR) to fingerprint EV
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Annalisa Radeghierid, Ivano Alessandrie and Paolo Bergesef
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Introduction: Characterizing EV subpopulations
remains a challenge, which up-to-date has been tackled
through analysis that assess for a single biochemical or
biophysical component of the target subpopulation.
However, these approaches may be unsuitable to
describe EV subpopulations defined by higher level of
heterogeneity. In our contribution, we will discuss how
Fourier-transform Infrared Spectroscopy (FT-IR)
allows to fingerprint EV subpopulations as a whole,
presenting itself as a promising complement/alternative
to describe EV subpopulations
Methods: Medium from murine prostate cancer
(TRAMP-C2) and skin melanoma (B16) cell lines
were processed with serial centrifugation: 800g 30’ to
enrich large EVs (LEVs), 16,000g 45’ to enrich medium
EVs (MEVs) and 100,000g for 4 h to enrich small EVs
(SEVs). LEVs, MEVs and SEVs were characterized for
size, purity and EV markers with Atomic Force
Microscopy, colloidal nanoplasmonic assay and
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Western Blot, respectively. FT-IR measurements were
performed on LEVs, MEVs and SEVs re-suspended in
milliQ water and deposited onto a diamond cell.
Spectral regions between 3100–2800 cm-1 and 1880–
900 cm-1, corresponding to lipids and proteins, respec-
tively, were considered, and processed by Principal
Component Analysis (PCA)
Results: PCA was applied to data set of FT-IR spectra
(five replicates for each EV subpopulations) collected
for TRAMP and B16 cell line and visualized with scores
plots. LEVs, MEVs and SEVs resulted grouped sepa-
rately for both considered cell lines. Moreover, spectra
from the same subpopulation, but from different cells
are reported in two distinct groups
Summary/Conclusion: EV subpopulations of differ-
ent sizes and cellular origin are characterized by spe-
cific FT-IR fingerprint. This offers a proof of concept
that FT-IR could be effectively translated in real sce-
narios to characterize EVs with different content and
origin
Funding: LP acknowledges the BIOMANE grant
(University of Brescia) and evFOUNDRY grant
(H2020-FETOPEN-2016–2017 – Project ID: 801367)
for the financial support
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Exploration of the surface modification of outer membrane vesicles
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Introduction: Introducing bacteria-binding small
molecules to the surface of outer membrane vesicles
(OMVs) could greatly improve their potential for anti-
microbial drug delivery to difficult to treat bacteria.
Among the small number of studies on surface mod-
ification of OMVs, very few deal with small molecules.
The aim of the present study is to evaluate different
methods of introducing bacteria-specific targeting moi-
eties to OMVs. We assessed the modification of surface
proteins using N-hydroxysuccinimide (NHS) esters,
well established for mammalian extracellular vesicles
(EVs), cholesterol insertion, mainly applied for lipo-
somes and the novel application of diazo-transfer fol-
lowed by click-chemistry.
Methods: OMVs were obtained from model
Myxobacteria by differential ultracentrifugation (UC)
followed by size exclusion chromatography (SEC). For
cholesterol insertion and NHS ester-modification,
purified OMVs were incubated with either cholesteryl
PEG 2000 FITC or sulpho cyanine7 NHS ester. For
diazo transfer the pellet after UC was incubated with a
diazo transfer agent and the OMVs subsequently con-
jugated with DBCO-AF594. Unincorporated dye was
removed by SEC. Liposomes were composed of DMPC
and DPPC in 2:3 molar ratio. Results represent corre-
lated fluorescence intensity and particle number.
Results: Treatment with sulpho cyanine7 NHS ester led
to the modification with 547 ± 163 molecules per
OMVs, compared to 18 ± 1 for the control using
sulpho cyanine7 acid. Cholesterol insertion introduced
4 ± 1 molecules per OMV, compared to 101 ± 23 for
liposomes. First results for the diazo-transfer showed
71 dye-molecules per OMV, with 32 for the control.
Summary/conclusion: Of the three methods, NHS
ester-modification displayed the highest efficiency,
similar to published results for mammalian EVs. In
comparison, diazo transfer only yielded ~13% of the
dye-molecules per particle. However, there are still
many parameters to be optimized for this method,
including OMV concentration and incubation period.
Cholesterol insertion was unsuccessful for OMVs,
probably owing to their membrane structure. In this
study, we aim to get important insights into the mod-
ification of OMVs for bacterial targeting and EV-sur-
face engineering in general.
Funding: This project was funded by Studienstiftung
des Deutschen Volkes and Bundesministerium fuer
Bildung und Forschung.
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Identification of common EV markers in plasma using high-resolution
flow cytometry
Anders Askelanda, Jaco Bothab, Rikke Wehner Rasmussenb and Aase
Handbergb
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Introduction: Recent advancements in flow cytometry
(FCM) have led to the development of high-resolution
FCMs dedicated to the analysis of small particles
(hFCM). hFCM studies have predominantly focused
on the analysis of EVs expressing phosphatidylserine
(PS). PS is enriched in microvesicles (MVs), wherein it
is involved in lipid rearrangements responsible for MV
budding. While PS also is expressed on exosomes, it is
unknown whether it can be used as a universal marker
for smaller EVs. In this study, we attempted to char-
acterize proteins enriched in smaller EVs (CD9, CD63,
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CD81 and ADAM 10) and the relative co-expression of
PS with each of these markers.
Methods: Flow cytometry analysis was performed on
an Apogee A60 Micro-PLUS. In brief, platelet-poor
plasma (PPP) from healthy individuals was stained
with lactadherin-FITC (PS+) and one of several EV
surface markers enriched in smaller EVs. To evaluate
the precise differences in PS and specific EV marker
expression, the analysis was performed twice, (1) trig-
gering on lactadherin and (2) each EV marker (CD9-
PE, CD81-PE, CD63-PE, ADAM10-PE), separately. All
antibodies were matched with appropriate isotope con-
trols and centrifuged at 17,000g for 10 min. prior to
antibody labelling. EVs were defined as lactadherin or
EV surface marker positive events ≤1000 nm.
Results: Initial results indicate that CD9 is highly
expressed on EVs and is not universally associated to
PS. Triggering on PS revealed that 34.7% of all events
were CD9 positive (CD9+|PS+). Conversely, triggering
on CD9 resulted in a 2.1-fold increase in total events,
where 17.0% of events were PS+ (CD9+|PS+). Inferring
size from silica nanospheres, it appeared that popula-
tions containing CD9 (CD9+|PS+ and CD9+|PS-) were
smaller (94.4–99.7% <180 nm) compared to popula-
tions that did not (PS+|CD9-; 85.6% <180 nm & 95.2%
<300 nm). Interestingly, we did not detect CD81, CD63
or ADAM10 on EVs. We hypothesize that this is due to
a low abundance of these markers in PPP from healthy
individuals.
Summary/conclusion: Our findings demonstrate that
hFCM can be used for the characterization of smaller
EVs in PPP. Furthermore, we find that CD9+ EVs does
not universally express PS. From this point on, we plan
to study enrichment of these EV phenotypes following
a number of EV purification protocols and determine
whether EV isolation enable a more extensive charac-
terization of smaller EVs.
PS08.09=OWP2.02
Software to automate calibration and processing of flow cytometry
data in clinical studies
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Introduction: In search of new biomarkers, flow cyt-
ometers are used in clinical studies to measure the
concentration of specific extracellular vesicles (EVs).
Flow cytometers measure light scattering and fluores-
cence of single EVs in a fluid stream. However, to
realize data interpretation and comparison, light scat-
tering and fluorescence signals and the flow rate
require calibration. Moreover, flow cytometers gener-
ate large datasets. For example, a clinical study invol-
ving 60 patients, 30 controls and 8 antibody labels
covers 1224 data files, >33 gigabytes of data and >0.3
billion events. To manually calibrate and analyse such a
dataset would take days if not weeks and is prone to
human mistakes. Therefore, an urgent need exists for
software to automate calibration and processing of flow
cytometry data.
Methods: We have developed software (MATLAB
R2018a) to automatically process multiple .fcs files
and (1) relate two scatter signals to the diameter in
nm and refractive index (RI) of EVs, (2) express fluor-
escence signals in terms of molecules of equivalent
soluble fluorochrome (MESF), (3) export calibrated
channels to new .fcs files, (4) recognize unstable flow
rates, (5) determine fluorescence thresholds, (6) apply
gates, (7) create PDFs with scatter plots and (8) report
statistics. We are using clinical studies to validate and
apply the software.
Results: Compared to manual thresholding, automatic
thresholding results in a systematic decrease in counts
of 10% and a maximum difference of 14% (n = 5).
Using a high-end laptop, data processing takes typically
a minute or several seconds per .fcs file with or without
PDF reporting, respectively. Flow rate monitoring is
useful for 61% of the data. The platelet marker CD61
stains 7% of the events with an RI>1.42, which are
lipoproteins, and the concentration of these lipopro-
teins differed 4000-fold between individuals.
Summary/conclusion: We have developed software to
automate calibration and processing of flow cytometry
data in clinical studies, thereby reducing analyses time,
preventing human mistakes and providing new
insights. For example, non-specific labelling of antibo-
dies to lipoproteins together with variations in lipopro-
tein concentrations emphasize the relevance of fasting
before venipuncture. Our next step is to extend the
software with machine learning.
Funding: NWO-TTW VENI 15924
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Conventional, high-resolution and imaging flow cytometry:
potentials, pitfalls and solutions for EV characterization
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Denmark, Aalborg, Denmark
Introduction: Flow cytometry (FCM) has long been a
preferred method for characterizing EVs, however their
small size have limited the applicability of conventional
FCM to some extent. Thus, high-resolution and ima-
ging FCMs have been developed but not yet system-
atically evaluated. The aim of this presentation is to
describe the applicability of high-resolution and ima-
ging FCM in the context of EV characterization and
the most significant pitfalls potentially influencing data
interpretation.
Methods: First, we present a side-by-side comparison
of three different cytometry platforms on characteriz-
ing EVs from blood plasma regarding sensitivity, reso-
lution and reproducibility: a conventional FCM, a
high-resolution FCM and an imaging FCM. Next, we
demonstrate how different pitfalls can influence the
interpretation of results on the different cytometry
platforms. Finally, we propose controls, solutions or
workarounds for understanding and limiting the influ-
ence of each of these pitfalls.
Results: (1) High-resolution FCM and imaging FCM
displayed greater sensitivity and resolution compared
to conventional FCM when measuring a mixture of
nanospheres. Equally, both methods could detect larger
concentrations of specific EV phenotypes than conven-
tional FCM, where imaging FCM outperformed high-
resolution FCM. Within day variability (n = 20 ali-
quots) was similar for conventional and high-resolu-
tion FCM, while imaging FCM had a markedly larger
variability. Between day variability (n = 5 × 5 aliquots)
was similar for all three platforms. (2) The three most
substantial pitfalls variably influencing interpretation
of results on the three platforms are non-specific bind-
ing of labels, antibody aggregates and entities in the
sample (i.e. lipoproteins) binding EV-defining dyes. (3)
The most important strategies for circumventing these
pitfalls are stringent matching, gating and comparison
of antibodies and isotype controls, high-speed centri-
fugation of antibodies and labels prior to staining, and
the use and interpretation of stained buffer controls
and detergent-treated samples.
Summary/conclusion: High-resolution and imaging
FCM hold great potential for EV characterization.
However, increased sensitivity also leads to new arte-
facts and pitfalls. The solutions proposed in this
presentation provide useful strategies for circumvent-
ing these.
PS08.11=OWP2.04
Convolutional neural networks for classification of tumour derived
extracellular vesicles
Wooje Leea, Aufried Lenferinka, Cees Ottob and Herman Offerhausa
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Introduction: Raman spectroscopy probes molecular
vibration and thus reveals chemical information of a
sample without labelling. This optical technique can be
used to study the chemical composition of diverse EVs
subtypes. EVs have a complex chemical structure and
heterogeneous nature so that we need a smart way to
analyse/classify the obtained Raman spectra. Machine
learning (ML) can be a solution for this problem. ML is
a widely used strategy in the field of computer vision. It
is used for recognizing patterns and images as well as
classifying data. In this research, we applied ML to
classify the EVs’ Raman spectra.
Methods: With Raman optical tweezers, we obtained
Raman spectra from four EV subtypes – red blood cell,
platelet, PC3 and LNCaP – derived EVs. To classify
them by their origin, we used a convolutional neural
network (CNN). We adapted the CNN to one dimen-
sional spectral data for this application.
The ML algorithm is a data hungry model. The model
requires a lot of training data for accurate prediction.
To further increase our substantial dataset, we per-
formed data augmentation by adding randomly gener-
ated Gaussian white noise.
The model has three convolutional layers and fully
connected layers with five hidden layers. The Leaky
rectified linear unit and the hyperbolic tangent are
used as activation functions for the convolutional
layer and fully connected layer, respectively.
Results: In previous research, we classified EV Raman
spectra using principal component analysis (PCA).
PCA was not able to classify raw Raman data, but it
can classify preprocessed data. CNN can classify both
raw and preprocessed data with an accuracy of 93% or
higher. It allows to skip the data preprocessing and
avoids artefacts and (unintentional) data biasing by
data processing.
Summary/conclusion: We performed Raman experi-
ments on four different EV subtypes. Because of its
complexity, we applied a machine learning technique
to classify EV spectra by their cellular origin. As a
result of this approach, we were able to classify EVs
by cellular origin with a classification accuracy of 93%.
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[Cancer-ID] with project number [14197] which is
financed by the Netherlands Organization for
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PS08.12=OWP2.05
Microfluidic electrochemical aptasensor for detection of breast
cancer-derived exosomes in biofluids
Leila Kashefi-Kheyrabadi, Sudesna Chakravarty, Junmoo Kim, Kyung-A
Hyun, Seung-Il Kim and Hyo-Il Jung
Yonsei University, Seoul, Republic of Korea
Introduction: Exosomes are nanosized extracellular
vesicles, which are emerging as potential non-invasive
biomarkers for early diagnosis of cancer. However, the
small size and heterogeneity of the exosomes remain
significant challenges to their quantification in the bio-
fluids. In the present research, a microfluidic electro-
chemical biosensing system (MEBS) is introduced to
detect ultra-low levels of breast cancer cell-derived
exosomes (BCE).
Methods: Fabrication procedure of MEBS comprises
three main steps: first, biosensing surface was prepared
by immobilizing EPCAM binding aptamer (EBA) on a
nanostructured carbon electrode. The nanostructured
surface (NS) consists of 2D nanomaterials including
MoS2 nano-sheets, graphene nano-platelets and a
well-ordered layer of electrodeposited gold nanoparti-
cles. The NS was well characterized with FESEM and
EDX. FESEM analysis showed a well-ordered gold
nano-structuring for 50 nM of gold solution.
Furthermore, EDAX analysis confirmed >60% coverage
of gold nanoparticles on nano-structured surface com-
pared to bare carbon electrode. At the second step, a
herringbone structured microfluidic channel, which is
able to enrich BCE was designed and fabricated.
Finally, microfluidic channel was integrated to biosen-
sing surface. Different concentrations of exosome solu-
tions was introduced and enriched to biosensing
surface (SPCE/NS/GNP/EBA) using microchannel.
After capturing BCEs on the sensing surface a second-
ary aptamer labelled with silver nanoparticles (SNPs) as
redox reporter was introduced to the sensing surface.
Results: Direct electro-oxidation of SNPs was moni-
tored as analytical signal. The unique design of micro-
channel in combining with high-specific interaction
between BCE and EBA provided a high-sensitive detec-
tion of BCE as low as ~100 exosomes/μl.
Summary/conclusion: The unique design of MEBS
provides a highly sensitive accurate platform for detec-
tion of ultra-low levels of cancer-derived exosomes.
This tool holds great potential for early cancer diagno-
sis in clinical applications.
PS08.13=OWP2.06
A software suite allowing standardized analysis and reporting of
fluorescent and scatter measurements from flow cytometers
Joshua Welsh and Jennifer C. Jones
Translational Nanobiology Section, Laboratory of Pathology, National Cancer
Institute, National Institutes of Health, Bethesda, USA
Introduction: Single vesicle analysis using flow cyto-
metry is an extremely powerful technique to allow
identification of unique proteins in biological samples,
as well as enumerating the changes in concentrations.
While small particle analysis (for viruses and large
microparticles) using flow cytometry has been con-
ducted for several decades, there is no comprehensive
method for standardization of such studies. Therefore,
we developed a suite of flow cytometry post-acquisition
analysis software (FCMPASS) tools that enable the
conversion of scatter and fluorescent axes to standar-
dized units using appropriate controls, writing standar-
dized units to .fcs files for sharing upon publication
with open repositories, and exporting templates of
obtained data.
Methods: Standalone software packages for scatter and
fluorescent standardization were built using MATLAB.
The scatter software is based upon Mie modelling and
is capable of predicting the optical collection angle of
the instrumentation and reporting the Mie modelling
criteria in a standardized way, making it possible to
reproduce the models and flow cytometry settings.
Fluorescent standardization data uses least-squares lin-
ear regression to enable conversions of arbitrary unit
scales to molecules of equivalent soluble fluorophore
(MESF) using MESF calibration beads.
Results: The FCMPASS software converts arbitrary
fluorescence units to MESF units and writes them to
data files for clearer reporting and sharing of data.
FCMPASS also converts arbitrary scatter units to a
measurement of scattering cross-section using model-
ling software that predicts the collection angle of the
instruments and normalizes the data automatically.
Summary/conclusion: Utilization of our FCMPASS
software can help the EV flow cytometry more easily
implement standardization into their experimental
analysis and the use of the output templates can make
reporting more consistent. While currently available
MESF controls can be further optimized for small
particles, we believe their utilization along with the
other controls and can bring a new era to the reporting
of EV research using flow cytometry. This will be
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particularly useful for future comparison and valida-
tion of translational studies and will enable better
understanding and utilization of EVs across a broad
range of disciplines.
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Introduction: Research on extracellular vesicles (EVs),
which include exosomes and microvesicles, has wit-
nessed an exponential increase in the past decade.
EVs are membrane-derived vesicles, which play vital
role in transporting functional molecules to nearby or
distant cells, thus being involved in the intercellular
communications. Developing a reliable and quantita-
tive method for confirming a nanoparticle as an EV is
still challenging. Nanoparticles carry a net surface
charge due to the nature of their surface molecules.
We have hypothesized that EVs, which normally carry
a negative zeta potential (ZP), can be identified by the
change of net surface charge when bound to EV-spe-
cific antibodies.
Methods: ZP measurements were performed on EVs
collected from the conditioned medium of human
choriocarcinoma (JAr) cells grown in EV-depleted
media. EVs were purified using size exclusion chroma-
tography. EV populations were incubated with EV sur-
face membrane-specific antibodies and the change in
the electrokinetic mobility upon the binding of surface
EV proteome with an antibody was measured using
nanoparticle tracking analysis (Zetaview;
Particlemetrix, Inning, Germany).
Results: The mean+SEM ZP was −22.1 ± 0.8 mV and
−20.5 ± 0.8 mV for non-treated JAr EVs and immu-
noglobulin G isotype antibody (control)-treated EVs,
respectively, indicating the absence of influence of
nonspecific binding. Whereas the ZP distribution of
EVs incubated with surface exosomal marker antibo-
dies showed a significant positive shift in the measured
values compared to EVs incubated with control anti-
body. The mean+SEM ZP values of EVs bound with
CD63 and CD81 were 17.2 ± 1.1 mV and −17.8 ± 0.9
mV respectively (N = 3 biological replicates of mini-
mum 1000 particles measured in each replicate).
Western blot analysis showed particles carrying EV-
specific surface markers. Furthermore, we investigated
the other factors that may have a potential effect on the
changes in EV’s electrokinetic mobility such as the
concentration of particles and concentration of the
antibody.
Summary/conclusion: The measured antibody-specific
changes in ZP values provide an insight into the nature
of the nanoparticle surface antigens in a biological
sample. ZP measurement is a simple, cost-effective
and reliable method for profiling EV surface
composition.
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Extracellular vesicles secreted from ganglioside GD3-expressing
cancer cell lines contain high levels of integrins: Roles of lipid rafts
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Introduction: Cancer-associated glycosphingolipids
have been utilized as tumour markers and targets of
cancer therapy. We have analysed functions of gang-
liosides in cancers, and reported that cancer-associated
gangliosides enhance malignant properties of cells by
forming complexes with various membrane molecules.
In this study, we have examined contents of extracel-
lular vesicles (ECVs) secreted from ganglioside GD3-
expressing cancer cells to investigate roles of ganglio-
sides in the regulation of ECVs, leading to the induc-
tion of cancer microenvironments and metastasis.
Methods: GD3-positive cells as well as GD3-negative
control cells were established by transfection of GD3
synthase (ST8SIA1) cDNA into melanoma, glioma and
small cell lung cancer (SCLC) cell lines. ECVs were
collected from culture supernatants by repeated ultra-
centrifugation. Contents in ECVs were analysed by
Western blotting. Roles of lipid rafts were analysed by
treating cells with 1 mM methyl β-cyclodextrin.
Results: In ECVs from GD3-positive melanoma cells,
GD3 and ST8SIA1 mRNA were detected in TLC and
by RT-qPCR, respectively. In Western blotting,
increased levels of integrin families were detected in
ECVs from GD3-positive melanoma cells compared
with those from GD3-negative cells. Similar increase
of integrins was also found in glioma and SCLC cells.
This was contrastive with integrin levels in cell lysates
from GD3-positive and – negative cells, showing
almost equivalent levels of integrins regardless of
GD3 expression. Particularly in melanoma cells, levels
of integrin α2, β1 and β2 showed marked increase in
GD3-positive cell-derived ECVs. Treatment of GD3-
positive melanoma cells by 1 mM methyl β-
cyclodextrin resulted in marked reduction of exosomes
and TSG101 in them.
Summary/Conclusion: GD3 expression in cancer cells
resulted in increased levels of integrins in ECVs, sug-
gesting that GD3 and integrins play roles in the malig-
nant properties of cancers by forming molecular
complexes on ECVs. Lipid rafts may play roles as
sites for the complex formation.
Funding: Grants-in-aid from the Ministry of
Education, Culture, Sports, Science and Technology
of Japan
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Amniotic Epithelial Exosomes Result In Reversal of Epithelial to
Mesenchymal Transition in Hepatocellular Carcinoma Cell Lines
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Introduction: Mesenchymal type hepatocellular carci-
noma (HCC) with epithelial to mesenchymal transition
(EMT) constitutes the most aggressive HCC. Our work
has shown that exosomes from amniotic epithelial cells
(AECs), an intriguing cell from the epiblast which can
switch between epithelial and mesenchymal phenotype,
contain a myriad of growth and signalling factors that
regulate cell differentiation and has immunomodula-
tory and antiproliferative properties. We hypothesize
that modulation of HCC differentiation into more dif-
ferentiated epithelial phenotype via amniotic epithelial
cell exosomes will abrogate aggressive biology.
Methods: Size exclusion chromatography via the use of
qEV columns was used to separate AEC media into
exosome (less than 100 nm) and non-exosome frac-
tions (more than 100 nm). Using the MACSPlex exo-
some kit, we showed the abundant expression of CD63,
CD9 and CD81 in these AEC exosomes. HUH-7, SK
Hep-1 and HLF cell lines were seeded into plates trea-
ted with exosomes, non-exosome fractions and control
daily. Proliferation and migration were assessed over
72 h by Alamar blue, Glo and wound healing assays.
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Immunofluorescence for vimentin, E cadherin, KDR
and EPCAM were performed to assess for epithelial
to mesenchymal transition (EMT).
Results: The proliferation of all three cell lines were
significantly reduced in the exosome and non-exosome
arms compared with control, on both Alamar Blue
stain and Glo assay (all p < 0.05). Wound healing was
reduced significantly in the exosome arm vs. control in
Sk-Hep1 and HLF (p = 0.016 and 0.004, respectively),
but not in HUH-7 (p = 0.156).
On immunofluorescence, there was upregulation of
the epithelial marker E cadherin in the exosome and
non-exosome arms in SK-Hep1 and HUH7, but it was
not expressed in the control arm. E cadherin was
upregulated in the cells treated with exosomes com-
pared to non-exosomes in SK-Hep1 and HUH7. There
was downregulation of the mesenchymal marker
vimentin in the HLF cells treated with exosomes and
non-exosomes as compared to control.
Summary/Conclusion: Exosomes have the ability to
modulate HCC tumour biology, possibly by pushing
HCC cell lines into mesenchymal epithelial transition
to become less proliferative and motile.
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Extracellular vesicles miRNA in mediating EGFR-TKI sensitivity in
heterogeneous EGFR-mutant NSCLC
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Introduction: Tumour heterogeneity has impacts on
targeted drug resistance. At lung cancer, the discor-
dance rates of EGFR mutation implying tumour het-
erogeneity in metachronous and synchronous settings
were 14.3% and 9.1%, respectively. Extracellular vesi-
cles (EVs) serve as the transporter of bioactive mole-
cules between cells and become one of the major
mechanisms contributing intratumoural heterogeneity
via transferring genetic information. Since most
patients harbouring EGFR mutation showed excellent
response, we hypothesized that EVs mediate the cross-
talk between EGFR mutant cell and EGFR wild type
cell contributing the change of sensitivity of EGFR wild
type cell to EGFR-TKI in heterogeneous NSCLC
Methods: We used ultrafiltration (UF) method to iso-
late the EV. To mimic tumour heterogeneity, we next
tested the significance of EV on EGFRTKI sensitivity of
CL1-5 (EGFR-wild) in co-culture system with PC9
(EGFR-mutant) pretreatment with or without
GW4869. To further evaluate the role of EV in gefitinib
resistance, we harvested EV from PC9 cells and eval-
uated their effect on gefitinib sensitivity of CL1-5 in
orthopedic animal model. We further compared the
EV miRNAs from PC9 to those from CL1-5 and iden-
tified a panel of discriminative miRNAs.
Results: The CL1-5 uptake of PKH26 labelled exo-
somes derived from PC9 cell can be recorded by
time-lapse microscope. And the EGFRDel19 DNA
and specific protein can be detected in recipient wild-
type EGFR cells by digital PCR and Western blotting
respectively. We demonstrated that wild-type EGFR
lung cancer cell became sensitive to EGFR-TKI after
co-culture with PC9 cell for 48 h and then subjected to
gefitinib for 72 h. However, the pretreatment with
GW4869 for 48 h reversed the sensitivity to EGFR-
TKI in co-culture system with PC9. In CL1-5 animal
model, neither gefitinib nor exosome treatment alone
inhibited tumour growth compared to control group.
Only combination treatment with exosome and gefiti-
nib delayed tumour growth. Some miRNA among the
panel such as miR-200 family have been identified
associated with resistance to EGFR-TKI
Summary/Conclusion: Our study proposed that in
heterogeneous EGFR-mutant NSCLC, tumour cells
share biomolecules such as through local and systemic
transfer of EVs, which may affect cell sensitivity.
Funding: MOST-107-2314-B-006 −069 -
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Senescent cells-derived extracellular vesicles repress tumour growth
by transferring miR-127-3p and miR-134-5p.
Megumi Okadaa, Kimiyoshi Yanoa, Shigeyuki Teranishib, Mariko Ikuoc and
Hidetoshi Taharac
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Introduction: The mechanism called cellular senescence
avoids tumourigenesis by arresting DNA-damaged cells
growth. The microRNAs are about 20-nt non-coding
RNAs. MiRNAs complementary bind to target mRNA
and suppress their translations and/or stabilities. Cellular
miRNAs play important roles in cellular senescence
induction, and termed as senescence associated
miRNAs. MicroRNAs are transferred by extracellular
vesicles (EVs), and regulate phenotypes of recipient
cells. However, the roles of EV-miRNAs secreted from
senescent cells are still unclear. In this study, we examined
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whether EVs and EV-miRNAs secreted from senescent
cells regulate cancer cell’s activities.
Methods: The normal fibroblast TIG-3 was continu-
ously cultured to establish replicative senescent cells.
EVs were collected by ultracentrifugation. Particle
numbers and their size distributions were analysed by
a tunable resistive pulse sensing instrument (qNano;
IZON Science). The expressions of exosomal marker
proteins were analysed by western blot. MicroRNA
expression profiles were analysed by next-generation
sequencing. MicroRNA and mRNA expressions were
quantified by quantitative reverse transcription poly-
merase chain reaction.
Results: EV secretion was elaborated in replicative
senescent TIG-3 cells. Senescent cell-derived EVs (S-
EVs) treatment repressed growth of breast cancer cell
line MDA-MB-231. The expression of miR-127-3p and
miR-134-5p were enriched in S-EVs. Mir-127-3p and
miR-134-5p expressions were increased in S-EVs trea-
ted cancer cells. Growth arrest activity of S-EVs was
inhibited by pretreatment of LNA-miRNA inhibitor for
miR-127-3p and miR-134-5p in MDA-MB-231.
Summary/Conclusion: Senescence cell-derived extra-
cellular vesicles inhibited tumour growth by transfer-
ring miR-127-3p and miR-134-5p.
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Potential roles of cancer derived extracellular vesicles in lung cancer
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Wei-Lun Huanga and Wu-Chou Sub
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Introduction: Cells release different types of nano-
metre sized extracellular vesicles (EVs) of endosomal
and plasma membrane origin consisting into the extra-
cellular environment to mediate intercellular commu-
nication. EVs have been shown to play important roles
in many diseases including tumour. However, the role
of EVs in lung cancer is still not fully understood. In
this study, we tried to find out the biological functions
of EVs in lung cancer.
Methods: EVs were isolated from culture supernatants,
serum, and malignant pleural effusion (MPE) using
ultra-centrifugation (UC) and ultra-filtration (UF)
and then evaluated by TEM, cryo-EM, and Nanosight.
The biological functions of EVs were analysed in both
in vitro cell line model and in vivo animal model.
Results: EVs were isolated from culture supernatants
from both cell lines and ex vivo cultured cancer
associated cells, and clinical biofluids using the classical
ultra-centrifugation (UC) method and alternative ultra-
filtration (UF) method. The EVs could be uptake by
lung cancer cells and trigger oncogenic signals such as
Stat3 and Akt. Previously, we have shown that IL-6/
Stat3/tissue factor (TF)/VEGF pathway plays an impor-
tant role in lung cancer angiogenesis and metastasis.
Here, we showed that EVs from lung cancer samples
carried high level of VEGF and TF and triggered vas-
cular permeability changes in both in vitro and in vivo
models.
Summary/Conclusion: Using the UC as well as the UF
methods, we isolated EVs not only from culture super-
natants but also lung cancer associated clinical samples
and showed that the EVs triggered oncogenic signals in
an autocrine/paracrine fashion and increased vascular
permeability. These results may help the understanding
of potential roles of cancer derived extracellular vesicles
in lung cancer metastasis and progression.
Funding: This work was financially supported by the
Centre of Applied Nanomedicine from The Featured
Areas Research Centre Program within the framework
of the Higher Education Sprout Project by the Ministry
of Education in Taiwan, MOHW 106-TDU-B-211–
144004 and MOHW 105-TDU-B-211–133016 from
the Ministry of Health and Welfare in Taiwan, MOST
106–2314-B-006–040-MY2, and MOST 104-2314-B-
006-046-MY3 from the Ministry of Science and
Technology in Taiwan.
PS09.07
Whole transcriptome and miRNome profiling of plasma-derived
extracellular vesicles cargo in haematological malignancies.
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Introduction: Extracellular vesicles (EVs) role in
patients with haematological malignancies has not
been investigate as extensively as in solid cancers. In
this study, the overall composition of RNA species
content of plasma derived EVs isolated from lymphoid
and myeloid malignancies (B-cell chronic lymphocytic
– CLL, acute myeloid – AML, acute lymphoid – ALL
leukemia, monoclonal B-cell lymphocytosis – MBL,
myelodisplastic syndrome – MDS, myeloproliferative
neoplasms – MPN) was investigated.
Methods: Participants gave written informed consent in
accordance with the Declaration of Helsinki. EVs were
isolated with ExoquickTM (System Biosciences) from
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plasma collected from patients and then analysed with
Nanosight. Whole transcriptome (WTS) and small RNA
sequencing were performed respectively on 123 and 256
samples. TruSeq stranded mRNA library preparation kit
(Illumina) was used to detect coding and long non-coding
RNAs. Small RNA libraries were prepared using the
NebNext kit (NEB). Differential expression (DE) analysis
of RNA species was done with EdgeR Bioconductor pack-
age (ANOVA-like) and DESeq2 implemented in docker4-
seq package using as reference the expression values
detected in HD.
Results: The analysed EVs have size ranging between 80
and 250 nm. WTS generated, on average, more than 10
millionmapped reads/samples. TheRNAcargowasmainly
composed of protein coding genes (95%), and the remain-
ing fraction by lincRNAs and processed pseudogenes. 48
RNAs were detected as DE comparing diseases to HD.
Among them 14 were mitochondrial pseudogenes over-
expressed in all diseases with respect to HD and their
expression is higher in chronic versus acute diseases.
Small-RNA seq generated at least 100,000 mapped reads/
samples. Sets of miRNAs able discriminate each disease
from HD were also detected. Further, analysis to detect
disease-specific and disease-predictive signatures are in
progress.
Summary/Conclusion: This study gives an overview of
plasma derived EVs RNAs cargo in haematological
diseases. The analysis of the common/unique RNA
biotypes and the evaluation of their expression levels
among samples, can guide the identification of patients’
stratification markers. Moreover, this study provides a
collection of EVs-associated RNAs/miRNAs to be used
as reference in different applications in liquid biopsy
research.
Funding: FP7 NGS-PTL European grant
PS09.08
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Introduction:
Background: Head and neck squamous cell carcinoma
(HNSCC) has a high recurrence and metastatic rate with
an unknown mechanism of cancer spread. Tumour
inflammation is the most critical processes of cancer
onset, growth and metastasis. By inflammation, tumour
cells can establish an immunosuppressive microenviron-
ment to induce cancer progression.
Hypothesis: We hypothesize that the release of extracel-
lular vesicles (EVs) by tumour endothelial cells (TEC)
induce reprogramming of immune cells as well as stromal
cells to create an immunosuppressive microenvironment
that favour tumour spread. We call this mechanism as
non-metastatic contagious carcinogenesis.
Methods: EVs were collected from primary HNSCC-
derived endothelial cells (TEC-EVs) and were used for
stimulation of peripheral blood mononuclear cells
(PBMC) and primary adipose mesenchymal stem cells
(ASCs). Regulation of ASC gene expression was inves-
tigated by RNA sequencing and protein array. PBMC
stimulated with TEC-EVs were analysed by ELISA and
FACS. The effect of ASCs or PBMC, treated with TEC-
EVs, we demonstrated on tumour cells using various in
vitro assays, such as invasion, adhesion or proliferation.
Results: We found and confirmed that TEC-EVs were
able to change ASC inflammatory gene expression
within 24–48 h. TEC-EVs were also able to enhance
the secretion of TGFb1 and IL-10 by PBMC and to
increase T regulatory cell (Treg) expansion. TEC-EV
carries specific proteins and RNAs relevant for Treg
differentiation and immune suppression. ASCs and
PBMC, treated with TEC-EVs, enhanced proliferation
of tumour cells, their adhesion, and invasion, therefore
driving non-metastatic cancer spread.
Summary/Conclusion: Conclusions. These data indi-
cate that TEC-EVs are a mechanism of non-metastatic
contagious carcinogenesis that regulates tumour micro-
environment and reprogrammes immune cells to sus-
tain tumour growth and progression.
Funding: NIH fund R21DE025398, Grants from the
Associazione Italiana per la Ricerca sul Cancro
(AIRC) projects IG 2015.16973 and IG 2015.17630
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Exosomes from mitotic slippage-induced senescent cells stimulate
inflammatory response
Rekha Jakhar, Joycelyn Teo and Karen Crasta
Nanyang Technological University Singapore, Singapore, Singapore
Introduction: Microtubule-targeting drugs are the
most-commonly used first-line chemotherapy. We pre-
viously showed nocadazole treatment can lead to para-
crine pro-tumorigenic effects via mitotic slippage-
induced senescence. Senescent cells exosomes, which
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role in non-cell autonomous cell-cell communication.
The aim of this study was to decripher effect of exo-
somes released from senescent-inflammatory breast can-
cer cells post-slippage on recipient normal breast cells.
Methods: MDA-MB-231 and MCF-10A breast cancer
cell lines treated with Noc (100 ng/µl) for 72 h.
Conditioned media (CM) was prepared after Noc and
DMSO treatment by incubating cells in growth media
containing exosome-depleted FBS for 72 h. CM was
then collected and centrifuged at 500 ×g 10 min,
2000 ×g 30 min and 15,000 ×g 30 min at 4°C to remove
cells and large debris. Supernatant was filtered, exo-
somes pelleted at 120,000 ×g, 2 h, 4°C, washed with
PBS, centrifugation at 100,000 ×g,1 h, 4°C. Exosomes
were dissolved in PBS for whole exosome experiments
or processed for total RNA, miRNA and protein isola-
tion for microRNA profiling, RNA-seq and mass spec.
Results: Mitotic-slippage-induced senescent (MIS) cells
activate NFκB pathway and increase exosome production,
assessed via immunoblots of cytoplasmic and nuclear pro-
tein fraction, and IF for p65 localization. We characterized
exosomal proteins using TMT labelling and detected sig-
nificant upregulation of caveolin-1 in Noc treated exo-
somes. Exosomal microRNA also showed significant
upregulation of inflammatory pathway-related genes
upon Noc-treatment. Exosomes were transferred from
MDA-MB-231 cells after Noc treatment to the recipient
MCF-10A cells. Uptake of MIS-derived exosomes resulted
in transfer of NFκB response in recipient cells.
Summary/Conclusion: Noc treatment leads to MIS
and inflammation in MDA-MB-231 cells. Exosomes
released from senescent-inflammatory breast cancer
cells contribute to transfer of soluble factors which
activate inflammatory pathway in recipient cells.
Hence, senescence-induced exosomes can transfer
therapy-induced immune signalling via non-cell auton-
omous mechanisms.
Funding: National Research Foundation Fellowship
Singapore MOE AcRF Tier 2015-T1-002-046-01.
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Extracellular vesicles from breast cancer cells deliver microRNA-125b
to activate cancer-associated fibroblasts
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Introduction: Extracellular vesicles (EVs) are often
released by tumour cells for intercellular communica-
tion with other cell types in the tumour niches.
However, it is unclear which cell type is the most
frequent recipient of tumour EVs in vivo.
Methods: To analyse the cell types taking up EVs from
tumour cells, we created breast cancer cell lines secreting
fluorescent EVs, with CD63-GFP fusion protein or with
surface mCherry. The cells were implanted in the mouse
mammary fat pad or tail vein and the uptake of EVs were
analysed in different cell populations of the tumours and
the lungs using FACS. We then purified EVs from breast
cancer cells using ultracentrifugation and profiled
miRNAs using sequencing. The abundance of miR-125b
was validated in size exclusion chromatography -purified
EVs. The function of miR-125b was analysed by knock-
down or overexpression experiments.
Results: We found that fluorescent EVs from tumour
cells are taken up most robustly by fibroblasts in the
tumours or the metastatic lungs. Our RNA sequencing
data revealed that miR-125b is one of the most abun-
dant microRNAs in the EVs from mouse 4T1 and
4TO7 cells. Treatment with 4T1 EVs promotes fibro-
blast activation in isogenic 4TO7 tumours. This is
rescued by knocking down miR-125b in 4T1 EVs;
therefore, miR-125b transfer by EVs is responsible for
the fibroblast activation. Similarly, we found that miR-
125b is abundant in EVs from human breast cancer
cells. The uptake of EVs from human breast cancer
cells increases cellular levels of miR-125b in the resi-
dent fibroblasts hence upregulates several markers of
cancer-associated fibroblasts in vivo. miR-125b over-
expression also upregulates alpha-SMA and promotes
invasion of isolated fibroblasts in vitro. We further
identified Tp53 and Tp53inp1 as the targets of miR-
125b that are responsible for the phenotype.
Summary/Conclusion: In summary, our study shows
that the delivery of miR-125b in EVs from breast
cancer cells to resident fibroblasts promotes the devel-
opment of cancer-associated fibroblasts in the tumour
microenvironment.
Funding: This study is supported by City University of
Hong Kong (grant 9610343, 9667133 and 7200475), the
Hong Kong Health and Medical Research Fund
(03141186), the Hong Kong Research Grants Council
(21106616) and the National Natural Science
Foundation of China (81602514 and 81773246).
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Carnitine palmitoyltransferase 1 regulates proliferation of prostate
cancer cells under hypoxia via extracellular vesicles-mediated
removal of oxidized proteins
Gagan Deep, Leslimar Rios-Colon, Gati Panigrahi, Yixin Su, Kiran Kumar
Solingapuram Sai, Isabel Schlaepfer, Jingyun Lee, Cristina Furdui and Deepak
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Introduction: Prostate cancer (PCa) is the most com-
mon cancer in men with 164,690 new cases and 29,430
deaths estimated in the USA in 2018. Studies have
shown that hypoxia determines PCa aggressiveness,
and poor outcome. We have recently reported that
increased extracellular vesicle (EV) secretion under
hypoxia promotes survival of aggressive PCa cells;
here, we focused on underlying molecular mechan-
ism/s.
Methods: PCa cells were cultured under normoxia
(~21% O2) or hypoxia (1% O2), and EVs (exosomes)
isolated from the conditioned media by ultracentrifu-
gation. β-oxidation was measured using a novel PET
tracer (18[F]Fluoro-4-thia-oleate), reactive oxygen spe-
cies (ROS) levels measured by DCF-DA staining, and
oxidized proteins in PCa cells and EVs were measured
using an oxidative stress sensor (BP1:biotin-1,3-cyclo-
pentanedione) followed by immunoblotting and mass
spectrometry (MS). CPT1 knock-down and overex-
pressing PCa cells were generated using lentiviral
particles.
Results: We identified PCa cell lines (E006AA-hT,
MDA PCa 2b, 22Rv1 and WFCB17) with higher pro-
liferation under hypoxia compared to normoxia. These
cells showed increased lipid uptake and β-oxidation
under hypoxia. CPT1 is the main regulator of β-oxida-
tion, and CPT1 knock-down in PCa cells significantly
reduced the viability, clonogenicity and stemness under
hypoxia; while CPT1 overexpression increased the PCa
cells proliferation, clonogenicity and stemness. Both
hypoxia and β-oxidation are known to promote oxida-
tive stress, and we also observed high ROS levels in
PCa cells under hypoxia. We also observed higher
amount of oxidized proteins in hypoxic PCa cells,
measured by BP1 labelling and immunoblotting. MS
analyses identified the signature of oxidized proteins
that were altered in PCa cells under hypoxia.
Interestingly, PCa cells proliferating under hypoxia
secreted increased concentration of EVs, loaded with
high amount of oxidized proteins; while treatment with
either exosomes biogenesis inhibitors (GW4869 and
DMA) or antioxidants (N-acetylcysteine and ascorbic
acid) strongly reduced the growth of PCa cells under
hypoxia.
Summary/Conclusion: PCa cells could proliferate under
hypoxia through CPT1-mediated increased β-oxidation
and via managing high intracellular oxidative stress
through EV-mediated removal of oxidized proteins.
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Prostate cancer cells promote bone metastasis through extracellular
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Introduction: Bone metastasis (BM) is one of the
major concerns that causes skeletal-related events and
increases mortality in prostate cancer (PCa) patients.
Vicious cycle paradigm has been proposed to describe
how PCa cells educate osteoblasts and osteoclasts
(OCs) to benefit the survival and growth of the PCa
cells in the metastatic site. However, the underlying
mechanisms of BM in PCa remain obscure. Here, we
show that extracellular vesicles (EVs) from PCa cells
(PCa-EVs) are involved in the vicious cycle, and con-
tribute to the progression of BM.
Methods: PCa-EVs and normal prostatic epithelial cell
(NPE)-derived EVs (NPE-EVs) were isolated by ultra-
centrifugation and evaluated their effect on OC differ-
entiation by Tartrate-resistant acid phosphatase
(TRAP) stain. PCa-EVs and NPE-EVs were analyzed
using LC-MS/MS to identify candidate proteins which
promote OC differentiation. Then, a small-scale
screening was conducted using siRNA in PCa cells to
determine proteins essential for osteoclastogenesis. The
expression level of the specific molecule on EVs was
evaluated in clinical samples.
Results: We found that PCa-EVs promoted OC differ-
entiation in the presence of RANKL. In addition, RNA
sequence analyses confirmed the drastic change of gene
expression essential for osteoclastogenesis in OC pre-
cursors. Moreover, we found a specific molecule on
EVs which promote OC differentiation. Elimination
of the molecule on PCa-EVs led to the attenuation of
OC differentiation. In addition, overexpression of this
molecule promoted OC differentiation. Finally, we
found the molecule on EVs was specifically detected
in plasma-derived exosomes from PCa patients with
bone metastasis compared to non-metastatic PCa
patients.
Summary/Conclusion: PCa-EVs synergistically acti-
vate osteoclastogenesis with RANKL. PCa-EVs will be
the novel diagnostic and therapeutic target for BM in
PCa, leading the great improvement of quality of life in
PCa patients.
PS10.02
Novel Exosomal miRNAs-891-5p as an Indicator of Chemoresistance in
Ovarian Cancer
Mona G. Alharbia, Carlos Salomona, Dominic Guanzona, Andrew Laib, Alexis
Salasc, Carlos Palmab, Katherin Scholz-Romerob, Yaowu Hed, Felipe Zunigae,
Lewis Perrinf and John Hooperf
aExosome Biology Laboratory, Centre for Clinical Diagnostics, University of
Queensland Centre for Clinical Research, Royal Brisbane and Women’s
Hospital, The University of Queensland, Brisbane, Australia; bExosome
Biology Laboratory, Centre for Clinical Diagnostics, University of
Queensland Centre for Clinical Research, Royal Brisbane and Women’s
Hospital, The University of Queensland, Brisbane, Australia; cFaculty of
Biological Science, Department of Pharmacology, Universidad de
Concepción, Concepción, Chile; dMater Research Institute-University of
Queensland, Translational Research Institute, Woolloongabba, Australia;
eDepartment of Clinical Biochemistry and Immunology, Faculty of
Pharmacy, University of Concepción, Concepción, Chile; fMater Health
Services, South Brisbane, Australia
Introduction: Ovarian cancer patients usually have a
poor prognosis and low five year’s survival rate because
it predominantly presents at late stages of the disease.
New approaches are required to develop more effective
early detection strategies and real-time response mon-
itoring to the available treatments. Thus, this study
aimed to identify an exosomal signature which can be
used to determine a patient’s response to the
chemotherapy.
Methods: A panel of ovarian cancer cell lines were
used in this study. Cell migration, proliferation and
apoptosis in response to different concentrations of
carboplatin (0-100 µM) were evaluated using a real-
time monitoring system (Incucyte). The miRNA profile
was determined using TruSeq® SmallRNA Library
(Illumina). Hierarchical clustering and principal com-
ponent analysis (PCA) were used for multi-omics ana-
lyses. Subsequently, candidate miRNAs inducing
chemoresistance was confirmed in cells and their exo-
somes. Candidate miRNAs (mimic) were incubated on
sensitive ovarian cancer cells (CAOV-3) and cells
response to carboplatin was determined. Finally, a set
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of miRNAs were validated in circulating exosomes
obtained from a small cohort of patients who experi-
ence cancer relapse.
Results: The migration capacity of these cells were
associated with cell apoptosis in response to carbopla-
tin with EC50 (concentration of a drug that gives half-
maximal response) of 12.1 ± 2.6, 9.4 ± 2.2, 4.4 ± 1.5,
4.1 ± 1.6, 4.0 ± 1.9, 2.8 ± 0.9, 1.5 ± 0.6, 0.9 ± 0.2 and
0.7 ± 0.1 for HEY, SKOV-3, OVACR-429, OV90,
OVTOKO, OVCAR-420, OVCAR-3, CAOV-3 and
TOVII-2D, respectively. In contrast, the proliferation
of these cells was inversely correlated (p < 0.005) with
their migration and EC50. Based on migration, prolif-
eration and response to carboplatin PCA separated into
four distinct groups. Using miRNA approach, we suc-
cessfully identified miR-21-5p, 3p and miR-891-5p that
were enriched in resistant cells and their exosomes.
Transfected CAOV-3 cells (sensitive cells) with
miRNAs showed a reduction in cells sensitivity to
carboplatin. Finally, we were able to confirm the
expression of these miRNAs in plasma from ovarian
cancer patients.
Summary/Conclusion: We suggest that exosomal
cargo may be used as prognostic biomarkers to moni-
tor the response to treatments in patients with ovarian
cancer.
PS10.03
Functional analysis of exosomes in cancer metastasis
Yoshiki Kodamaa, Yuhsuke Ohmib, Zhang Qingc, Satoko Yamamotod, Keiko
Furukawad and Koichi Furukawad
aDepartment of Biomedical Sciences, College of Life and Health Sciences,
Chubu University, Kasugai, Japan; bDepartment of Biochemical Sciences,
College of Life and Health Sciences, Chubu University, Kasugai, Japan;
cDepartment of Biochemistry II, Nagoya University Graduate School of
Medicine, Tokyo, Japan; dKanazawa Medical University, Uchinada, Japan;
eDepartment of Biomedical Sciences, College of Life and Health Sciences,
Chubu University, Nagoya, Japan
Introduction: The development of metastasis is a cause
of death in many human cancers. Mechanisms for the
acquisition of metastatic potential remain unknown.
Recently, it has been reported that exosomes are a
trigger of cancer metastasis. Exosomes are small vesi-
cles that are secreted from cells and have been found to
mediate signal transduction between neighbouring or
distant cells. They have the tendency to specifically
interact with target cells. In the future, it may be
possible that exosomes can be used as biomarkers to
predict the metastatic destination.
Methods: Established mouse Lewis lung cancer cells
(low or high metastatic sublines) were examined
about proliferation, migration, invasion and gaglioside
expression by MTT assay, trans-well assay and flow-
cytometry. Cells were inoculated into the mice subcu-
taneously or via tail vein, then tumour and metastatic
tissues were observed by H&E stain. Cells from tumour
sites were cultured then examined about proliferation
and invasion ability. Exosomes were isolated from cell
culture medium by differential centrifugation, and used
for Western blotting. Cells treated by exosomes were
analysed for malignant properties as described above.
Results: In proliferation, migration, and invasion assay,
low metastatic subline showed lower proliferation,
migration, invasion activity than high metastatic sub-
lines. In flow-cytometry, high metastatic sublines
showed decreased GM1 and GD1a expression levels
compared with low metastatic subline. To examine
metastatic ability, the cells were inoculated into mice.
After 2–4 weeks, invasive- and metastatic- foci to dis-
tant tissues such as thigh muscle and lung were
observed. To examine effects of exosomes on culture
cells, cells were treated with isolated exosomes. As a
result, low metastatic subline treated with high meta-
static cell-derived exosomes showed increased prolif-
eration, migration, and invasion activity, and increased
phosphorylation of intracellular signalling molecules
such as paxillin and Erk1/2. In turn, high metastatic
subline treated with low metastatic cell-derived exo-
somes showed reduced proliferation, migration, and
invasion activity, and phosphorylation of intracellular
signalling molecules.
Summary/Conclusion: High metastatic subline-
derived exosomes enhanced malignant properties in
low metastatic sublines.
PS10.04
Profiling of circulating exosomal content across epithelial ovarian
cancer and the role of exosomes in tumour progression
Shayna Sharmaa, Andrew Laia, Dominic Guanzonb, Terry Morganc, Lewis
Perrind, John Hooperd and Carlos Salomonb
aExosome Biology Laboratory, Centre for Clinical Diagnostics, University of
Queensland Centre for Clinical Research, Royal Brisbane and Women’s
Hospital, The University of Queensland, Brisbane, Australia; bExosome
Biology Laboratory, Centre for Clinical Diagnostics, University of
Queensland Centre for Clinical Research, Royal Brisbane and Women’s
Hospital, The University of Queensland, Brisbane, Australia; cDepartment
of Pathology and Obstetrics, Oregon Health and Science University, Portland,
OR, USA; dMater Health Services, Brisbane, Australia
Introduction: A significant proportion of patients with
epithelial ovarian cancer (EOC) often present with
advanced stage disease, when treatment options are
limited. Therefore, it is essential to gain a better under-
standing of the tumour microenvironment to identify
potential therapeutic targets. We profiled the exosomal
content (miRNAs and proteins) of patients with EOC
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and examined the effect of these exosomes on cells
within the tumour microenvironment.
Methods: A cohort of 127 patients were included in
this study. Exosomes were isolated and characterized
from plasma obtained at different stages of EOC. A
small RNA library was prepared, and the expression of
specific miRNAs was validated using RT-qPCR. The
protein profile was determined using Mass
Spectrometry (MS/MS) and SWATH Analysis.
Exosomal proteins and miRNAs were subjected to lin-
ear mixed modelling analysis using the lme4 package in
“R”. Fibroblast cells were incubated with patient-
derived exosomes and monitored using the IncuCyte
(TM), a live-cell imaging system. Cell proliferation and
migration was determined over the course of the
experiment and RNA and proteins were extracted
after 48 hours. The expression of nine specific
miRNAs was confirmed using RT-qPCR and the pro-
tein profile determined using MS/MS.
Results: Exosomal miRNAs and proteins demonstrated
differential expression with advancing cancer progres-
sion, following at least three distinct patterns of change:
increasing, constant or decreasing rate. Ingenuity
Pathway Analysis analysis revealed that the exosomal
content was associated mainly with cell–cell communica-
tion and cell migration. Functional analysis showed that
exosomes increase fibroblast migration and proliferation
in association with EOC progression (i.e. Stages I to IV).
MS/MS identified 115 proteins differentially expressed
between early stage and advanced stage-exosome treated
cells. A comparison between control cells (no treatment)
and treated cells showed a difference in the expression of
126 proteins, with tumour suppressor, Paired Box 1 and
lysosomal trafficking protein, VPS41 expression, signifi-
cantly lower in the treated cells (p < 0.05).
Summary/Conclusion: We propose that exosomes
present in the circulation of EOC patients transfer
oncogenic cargo to cells present in the tumour micro-
environment to promote cancer progression.
PS10.05
Extracellular vesicle-mediated transmission of bone morphogenic
proteins in Acute Myelogenous Leukaemia
John Butlera, Ben Doronb, Sherif Abdelhamedc, Peter Kurred and Daniel
Markse
aMedical Scientist Training Program, Oregon Health & Science University,
Portland, USA; bHuman Biology Division, Fred Hutch Center for Cancer
Research, Seattle, USA; cKnight Cancer Institute, Oregon Health & Science
University, Portland, USA; dChildren’s Hospital of Philadelphia, Philadelphia,
USA; eDepartment of Pediatrics, Oregon Health & Science University,
Portland, USA
Introduction: Acute Myelogenous Leukaemia (AML) is
an aggressive cancer originating from abnormal white
blood cells of the bone marrow (BM). AML modifies
the BM into a pro-leukaemic niche in part through the
release of extracellular vesicles (EVs). We previously
demonstrated that AML EVs decrease mature blood cell
production, and traffic to stromal cells to induce osteo-
genesis. We hypothesized that AML cells utilize EVs to
transmit regulatory factors to recipient BM cells to
change the cellular composition of the BM and support
cancer progression. Our studies confirmed that AML EVs
contain bone morphogenic protein (BMPs) – historically
though to be secreted growth factors – involved in for-
mation of bone and maintenance of stem cells.
Methods: To identify the association of BMPs with
AML EVs, we used both in vitro and in vivo xenograft
models, and a combination of ELISA, flow cytometry,
and super resolution microscopy.
Results: AML cells explanted from the BM display
marked ER-stress in comparison to in vitro cultured cell
types as an adaptive response to the tumour microenvir-
onment. In AML blasts, the expression of BMP-2,4,6,7
mRNA strongly correlated with the activation of the
unfolded protein response pathway (which acts to miti-
gate ER-stress). Inducing ER-stress in AML cells in vitro
resulted in both an increase in BMP protein as well as
total EVs produced. EVs released from these cells con-
tained ~3-fold more BMP-2,6 over non-stressed cells,
whereas the level of free-BMP-2,6 in supernatant
remained unchanged. Exposing these purified EVs to
BM stromal cells induced osteogenic differentiation and
apoptosis. Additionally, in ER-stressed AML cells, BMP-2
localizes into CD63+ intracytoplasmic vesicles – indica-
tive of pre-exosomal multivesicular bodies – further con-
firming the EV-BMP association. Thus far, AML cells
have been found to release EVs that contain BMP-2 and
−6, while additional BMP types remain to be tested.
Summary/Conclusion: Since we have shown that AML
EVs rapidly accumulate within stromal cells in vitro and
in vivo, altering cellular phenotypes, we propose that EVs
concentrate and target functional BMPs directly to these
cells to create a pro-leukaemic environment. EV traffick-
ing of BMPs is a novel signalling mechanism that may
explain phenotypic changes seen in leukaemic BM, and
their role in leukaemic progression merits further study.
PS10.06
Exosomes derived from differentially invasive ovarian cancer cells
modulate tumour growth and metastasis in vivo
Mona G. Alharbia, Carlos Salomona, Andrew Laib, Yaowu Hec, Felipe
Zunigad and John Hoopere
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Introduction: Exosomes have been likened to a
“fingerprint” of their originating cells, as they con-
tain several bioactive molecules which can be deliv-
ered to the target cells at either local or distant
locations. The delivery of these biomolecules can
cause changes in gene expression and signalling in
the target cells. Hence, in this study, we aimed to
explore the impact of exosomes on tumour growth/
metastasis in a xenograft model and assess the
changes in the proteomic content of tumour cells
and exosomes from mice.
Methods: Exosomes were isolated from highly invasive
SKOV-3 (exo-SKOV-3) and less invasive OVCAR-3
(exo-OVCAR-3) ovarian cancer cell lines. Exosomes
(10 ug/mL) were injected into a xenograft model
(n = 8/ group), twice a week for 6 weeks and the
tumour growth was monitored using In Vivo
Bioluminescence Imaging (IVIS). Tissue and circulat-
ing exosomes obtained from the mice were subjected to
a quantitative mass spectrometry approach SWATH
MS/MS, followed by ingenuity pathway analysis
(IPA). Finally, we compared between the protein
expressions profiles from the circulating exosomes
and metastatic nodes or tumour growth.
Results: IVIS imaging indicated that the tumour bur-
den in mice injected with exo-OVCAR-3 was higher
than in mice injected with exo-SKOV-3 (p = 0.004).
However, mice injected with exo-SKOV-3 had more
tumour nodules throughout the peritoneal cavity.
Proteomic analysis of the cancer tissue obtained from
mice injected with exo-SKOV-3 compared to exo-
OVCAR-3 identified the differential expression
(p < 0.05) of 105 proteins. Interestingly, the protein
profile in tumour tissue obtained from mice injected
with exo-SKOV-3 was associated with the Wnt cano-
nical pathway (β-catenin). Moreover, we found 36 pro-
teins with differential expression in exosomes from
mice treated with exo-SKOV-3, (p < 0.04). Finally, we
identified 29 exosomal proteins that are highly asso-
ciated with cancer metastasis and 21 proteins are asso-
ciated with tumour growth.
Summary/Conclusion: These observations suggest that
exosomal signalling plays an important role in ovarian
cancer metastasis.
PS10.07
Cancer-associated fibroblast accelerate cancer metastasis through
exosomes
Kim Kimina, Yeon Ju Hunb, Sohn Yeh Jooa, Ruri Leea, Yoo Hye Jua
aUniversity of brain education, Cheon-an, Republic of Korea; bUniversity of
British Columbia, Cheonan, Republic of Korea
Introduction: Exosomes are known to be important
mediators between the primary and secondary sites for
tumour progression and metastasis with their micro-
environment. Exosomes released by cancer cells induce
the cancer-associated fibroblasts, which create a niche
to development cancer progression, making it more
permissive cancer metastasis.
Methods: We have developed 3D tumour microenvir-
onment model mimicking the interactions between
cells and ECM by injecting of collagen gel for ECM
to, and then, the formation of monolayer of cells for
blood vessel. The exosomes were isolated from three
different malignant cancer cells (i.e. from A431,
B16BL6 and MDAMB231), and delivered into the
channel in microfluidic device, then created a unidir-
ectional flow by the difference in pressure gradient. We
profile mRNAs of normal cell, CAFs with and without
cancer cells in genetic analysis.
Results: We confirmed that various cancer-derived exo-
somes differentiated CAFs, facilitating metastasis in reca-
pitulating the 3D tumour microenvironment in real time.
The three difference CAFs have commonly enriched
genes related to extracellular region for cellular response,
and fibrinolysis to degrade ECM for biological process in
genetic analysis. The migrated cancer cells followed by
CAFs showed different specific molecular mechanisms,
suggesting that the melanoma cells had MAPK related
signalling, the squamous cancer cells had cell adhesion
related signalling, and the breast cancer cells had inflam-
mation, cytokine related signalling, whichmay contribute
to the invasive progression of cancer.
Summary/Conclusion: The cancer-derived exosomes
play an important role in modulating the tumour
microenvironment, and induce CAFs to promote
metastasis. The 3D microfluidic model showed the
relationship between the CAFs and cancer cells inva-
sion in real time in physiological manner and specific
mechanism in a genetic manner.
Funding: This work was supported by the Basic
Science Research Program through the National
Research Foundation of Korea (NRF) funded by the
ministry of Education, Science and Technology (NRF-
2016R1C1B2013345) and Samsung Research Funding
Center of Samsung Electronics under Project Number
SRFC-IT1701-00
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The miR-27b in breast cancer exosomes
Wen-Hung Kuo
National Taiwan University Hospital, Taipei, Taiwan (Republic of China)
Introduction: miR-27b has been shown to possess
anti-tumour growth and anti-drug resistance activities
in associated with breast cancer progression. Loss of
miR-27b existed in the cancer cells can lead to the
promotion of cancer cells. However, the precise
mechanism of miR-27b loss is unclear, in particular,
involving in tumour microenvironments and
metastasis.
Methods: Here, we attempted to elucidate tumour-
derived exosomes bearing miR-27b in regulating
tumour microenvironments via modulation of cancer
stem cell growth and migration.
Results: The expression level of miR-27b was decreased
in tumour-derived exosomes in coincidence with pro-
gression of breast cancer, suggesting its negative role in
tumour progression via modulating tumour microen-
vironments. Consistently, miR-27b showed a dimin-
ished trend in malignant breast cancer cell lines
compared with the control cell line. To further examine
the impact of miR27b in tumour microenviroments, we
found that the formation of tumour associated fibro-
blasts (TAFs) and tumour associated macrophages
(TAMs) were impacted by miR-27+ exosomes.
Moreover, the increases in tumour migration and inva-
sion were observed by miR-27b+ exosomes treated
fibroblasts.
Summary/Conclusion: Therefore, we illustrated a sim-
ple mechanism of miR-27b attending in the progres-
sion of breast cancer. In the future, the manipulating
the existence of miR-27b may be a novel strategy for
breast cancer therapeutic.
PS10.10=OWP1.01
Mir-1227 alters extracellular vesicle shedding
Andrew R. China, Minyung Kimb, Valentina R. Minciacchic, Tatyana
Vagnerb, Javier Mariscalb, Cristiana Spinellia, Mandana Zandianb, Paolo
Gandellinid, Nadia Zaffaronid, Shivani Sharmae, Sungyong Youb and
Dolores Di Vizioa
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Introduction: Extracellular vesicles (EV) play a key
role in cancer development and metastasis by influ-
encing the behaviour of the primary tumour and by
aiding the establishment of a pre-metastatic niche in
distant organs. This process is due to the EV-
mediated functional transfer of biologically active
molecules including microRNA (miRNA). miR-1227
is a poorly characterized miRNA that is enriched in
EV secreted by prostate cancer (PC) cells in compar-
ison to non-tumourigenic prostate epithelial cells.
However, the role of miR-1227 in cancer is poorly
understood. Our objective is to determine the role of
miR-1227 in PC.
Methods: RNA sequencing from miR-1227 stably
expressing PC cells, RISCTRAP
Immunoprecipitation of miR-1227 bound mRNA,
and five different in silico miRNA target prediction
methods were used to identify putative miR-1227
targets. Exosomes and large oncosomes (LO) were
isolated by differential ultracentrifugation followed
by density gradient purification. Atomic force micro-
scopy and TRPS were used to quantify exosomes and
LO secreted by PC cells stably expressing miR-1227
or vector control.
Results: A comparative analysis between different EV
subtypes indicates that miR-1227 is enriched in LO, a
class of EV that are secreted by highly invasive and
metastatic amoeboid-migrating cells. LO carry more
RNA than the more widely studied exosomes indicat-
ing that LO may be a more robust source of EV-
encapsulated miRNA. Gene ontology analysis from
miR-1227 targets identified by RNA sequencing from
miR-1227 stably expressing PC cells, RISCTRAP
Immunoprecipitation of miR-1227 bound mRNA, and
in silico miRNA target prediction highlighted several
genes related to EV secretion. miR-1227 alters the
localization of exosome and LO markers in multiple
cancer cell lines, and induces the shedding of LO while
inhibiting the shedding of exosomes. Furthermore,
miR-1227 induces the migration of poorly migratory
cancer cells and increases the expression of tumour
supportive cytokines.
Summary/conclusion: Together these data hint that
miR-1227 may promote prostate cancer progression
through several mechanisms including alteration of
EV shedding.
Funding: 2017–2022 R01CA218526 Chesapeake urol-
ogy associates Sanford J. Siegel, MD prostate cancer
research scholarship Luke wu-jei chang discovery fund
PI dod PCRP award PC150836
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Bacterial endotoxin-preconditioned periodontal ligament stem cells
induce M1 polarization of macrophage through extracellular vesicles
Hyejong Kanga, Myung-Ju Leeb, Sang Jung Parkb and Myung-Shin Leeb
aDankook University Sejong Dental Hospital, Sejong, Republic of Korea;
bEulji University School of Medicine, Daejeon, Republic of Korea
Introduction: Periodontitis is a common disease that
characterized by chronic inflammation and tissue
destruction of gums. To resist pathogenic microbes,
gingival epithelial cells and inflammatory cells produce
various pro-inflammatory cytokines, chemokines and
enzymes. Human periodontal ligament stem cells
(PDLSCs) derived from mature periodontal ligaments
have stem cell properties similar to mesenchymal stem
cells. PDLSCs possess not only differentiation potential
to other tissues but also immunomodulatory abilities.
Therefore, PDLSCs might be a vital role in the mod-
ulation of immune response. In this study, we investi-
gated the effect of PDLSCs on the polarization of
macrophages.
Methods: The polarization of macrophage cell line,
THP-1 cells, was investigated on the conditioned
media or extracellular vesicles (EVs) from PDLSCs
that were pretreated with or without lipopolysacchar-
ide. EVs were isolated from the conditioned media of
PDLSCs by differential centrifugation and character-
ized. The functions of EVs on macrophage polarization
and underlying mechanisms were analysed by RT-
qPCR and ELISA,
Results: While the conditioned media from PDLSCs in
normal culture condition did not affect the polarization
of macrophage, lipopolysaccharide (LPS)-precondi-
tioned PDLSCs induce significant changes in M1 polar-
ization of macrophages. Extracellular vesicles (EVs)
isolated from the conditioned media of LPS- precondi-
tioned PDLSCs by centrifugal filter device (MWCO
100 kD) or differential centrifugation methods showed
strong M1 polarization effect of macrophages.
Additionally, M1 polarization was abolished by
DNase I treatment on EVs.
Summary/Conclusion: Our results demonstrated that
LPS-stimulated PDLSCs induce M1 polarization of
macrophage through EVs, suggesting EVs from
PDLSCs might be a potential therapeutic target for
the inflammation in the periodontium.
Funding: This work was supported by the Basic Science
Research Program through the National Research
Foundation of Korea (NRF-2017R1A2B4002405).
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Hypoxia enhances the angiogenic properties of adipose stem cell-
derived extracellular vesicles in culture
Jolene Phelps, David Hart, Alim Mitha, Neil Duncan and Arindom Sen
University of Calgary, Calgary, Canada
Introduction: The widely recognized benefits of adi-
pose stem cells (ASCs) in regenerative medicine have at
least in part been attributed to the extracellular vesicles
(EVs) that they secrete, which are known to deliver
bioactive cargo to target cells. EVs can be isolated from
spent medium following ASC population expansion in
culture. It has been shown that manipulating the cul-
ture environment may impact the biological character-
istics of EVs. Here we examined if the angiogenic
properties of ASC-derived EVs are impacted by culture
oxygen level, and tested their effect on cerebral micro-
vascular endothelial cells (CMECs).
Methods: Ethically obtained human ASCs were cul-
tured for 3 days in PPRF-msc6 serum-free medium
under 3% (hypoxic) or 21% (normoxic) headspace O2
conditions. EVs were isolated from media via ultracen-
trifugation and evaluated for concentration (nanopar-
ticle tracking analysis), and angiogenic factor content
(Luminex technology). Functional assays (proliferation,
tube formation) were carried out by culturing human
CMECs in endothelial basal medium (EBM-2) supple-
mented with 2 different concentrations of ASC derived
EVs. CMEC proliferation in tissue culture flasks was
quantified using a Cyquant Proliferation Kit. Tube
formation on Matrigel coated plates was quantified
using ImageJ software. RT-qPCR was used to measure
angiogenic gene expression levels in ASCs and CMECs
for each test condition. All studies and analyses were
carried out in at least triplicate.
Results: Hypoxia upregulated VEGF expression in
ASCs 4.47 ± 0.24 fold (p < 0.0015) compared to nor-
moxia and induced higher EV secretion. EVs obtained
from hypoxic ASC cultures contained higher
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concentrations of angiogenic proteins VEGF, HGF,
PLGF and follistatin; and reduced concentrations of
bFGF, endoglin, IL-6 and IL-8. The presence of ASC-
derived EVs enhanced angiogenesis of CMEC cultures
in a dose dependent manner as measured via enhanced
proliferation, tube formation and upregulation of
ANG-1, ET-1, TGF-β and VEGF expression.
Summary/Conclusion: The angiogenic properties of
ASC-derived EVs may be enhanced through hypoxic
culture. These EVs are able to promote angiogenesis of
CMECs in vitro and may have utility in the treatment
of ischemic injury.
Funding: Natural Sciences and Engineering Research
Council of Canada
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Production and use of extracellular vesicles-depleted human platelet
lysate to improve large, clinical grade-compatible production of
therapeutic human cell-derived extracellular vesicles
Philippe Mauduita, Sylvie Goulinetb, Juliette Peltzerc, Bastien Rivalc, Sebastien
Banzetc, Jean-jacques Latailladec and Georges Uzanb
aInserm, Villejuif, France; bINSERM, villejuif, France; cCTSA, CLAMART,
France; dINSERM, Villejuif, France
Introduction: Human cells use multiple and sophisti-
cated modes of communication. These include direct
cellular communication, secretion of cytokines, chemo-
kines or growth factors and also production of extra-
cellular vesicles (EV) containing proteins, DNA,
mRNA, miRNA. On the other hand, cell therapy
using Mesenchymal Stromal Cells (MSCs) is getting a
growing interest in a wide range of indications in
human. In many cases, a substantial part of the ther-
apeutic effects relies on cell-secreted factors and the
extracellular vesicles (EV) are proposed as a cell-free
surrogate for MSCs therapy. However, culture media
commonly used for culturing cells requires serum or
platelet lysate that contains large amounts of EV that
cannot be distinguished and separated from the cell-
secreted EV. Purification and characterization of EV
therefore needs the prior elimination of contaminant
EV contained in serum or Human Platelet Lysate
(HPL). Serum-free media to produce EV may not be
fully satisfactory since they often limit cell survival.
Since regulatory authorities recommend avoiding ani-
mal components and xenobiotic-free culture condi-
tions have to be considered for EV production. HPL
offers such a possibility as it is useful substitute to FBS
to isolate, amplify and maintain human cells.
Therefore, we describe a new procedure for GMP-
compatible production of human cells-derived EV.
Methods: First, a Human Plasma Lysate (HPL) is pro-
duced from which the EV are removed by tangential-
flow-filtration resulting in an EV-FREE HPL (EV
depletion > 99%). Second, cells (grown in HPL-supple-
mented medium) are rinsed and placed in medium
added with EV-FREE HPL. After 72 h, the medium is
collected for EV quantification and replaced by fresh
EV-FREE HPL supplemented media for a new produc-
tion cycle.
Results: This method allows multiple production cycles
and improved cell survival, cellular morphology and
EV production. Following 3 × 72 h consecutive pro-
duction phase, MSCs amplification would produce 2.4
and 2.7 more EV when incubated in the presence of,
respectively, 5% and 8% EV-free HPL compared to
HPL-free medium.
Summary/Conclusion: This process, compatible with
the production of large volumes of conditioned media
including in bioreactors, will allow large-scale produc-
tion of therapeutic EV.
PS11.07
Synchronized cell differentiation via exosomes
Tomohiro Minakawa; Kae Nakamura and Jun K. Yamashita
aLaboratory of Stem Cell Differentiation, Center for iPS Cell Research and
Application (CiRA), Kyoto University, Kyoto, Japan
Introduction: Embryonic development proceeds in a
highly orchestrated manner. It is assumed that syn-
chronization of a timing of differentiation and cell
fate among neighbouring cells is necessary for proper
tissue development. However, the mechanism of syn-
chronization is still largely unknown.
Methods: A mouse embryonic stem cell (ESC) line
PKA-ESC, which can inducibly express constitutively
active protein kinase A (CA-PKA), rapidly differenti-
ates into mesoderm with PKA activation (depletion of
doxycycline (Dox-)). We established a cell-chimeric
culture system using two mouse ESC lines, PKA-ESC
and Control-ESC to artificially generate a gap of timing
in differentiation. We cocultured Control ESCs with
PKA-ESCs to observe how they synchronously differ-
entiate by overcoming the gap of timing in differentia-
tion. Exosomes were collected from PKA-ESCs and
added to Control-ESCs or mouse embryos. miRNA
sequencing was performed comparing contents in exo-
somes from PKA-ESCs under Dox+ condition: control
or Dox- condition: PKA activation, accelerated differ-
entiation. We also established several ESC lines that
encode miRNAs and performed coculture experiments
with control-ESCs.
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Results: After Dox-inducible activation of PKA, PKA-
ESCs differentiate faster than Control-ESCs. In the
coculture system, the timing of mesoderm differentia-
tion of Control-ESCs were synchronized with faster
differentiating PKA-ESCs (synchronized cell differen-
tiation). Furthermore, addition of exosomes purified
from PKA-ESCs promoted the differentiation of
Control-ESCs. The exosomes also promoted mesoderm
differentiation in postimplantation-stage mouse
embryos. We found several miRNAs as the functional
molecules in exosomes, and confirmed that miRNAs
overexpressing cells can promote the differentiation of
Control-ESCs in the coculture system.
Summary/Conclusion: We unveiled a novel cellular
synchrony phenomenon and its mechanisms regulated
by exosome-mediated cell communication, which
would be broadly involved in tissue development.
Funding: This work was supported by JST CREST
Grant Number [JPMJCR17H5 Japan].
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Effects of mesenchymal stromal cells licensing on profile of
extracellular vesicles
Giuliana Minani Bertolinoa, Tik Shing Cheungb, Chiara Giacominic, Martin
Bornhauserd and Francesco Dazzie
aKing’s College London, London, United Kingdom; bKing’s College London,
London, United Kingdom; cKing’s College London, London, United
Kingdom; dKing’s College London; Technische Universität Dresden,
Dresden, Germany; eKing’s College London, London, United Kingdom
Abstract: The roles of mesenchymal stromal cells
(MSC) in the immune system are subject of increasing
interest and of widening clinical applications. Recent
evidences has shown that extracellular vesicles (EV)
secreted by MSC can share some of the functional
roles of their parental cells, among them the immuno-
suppression ability. Prior to exert immunomodulation,
MSC effects rely on the presence of inflammatory
mediators in the microenvironment: (1) proinflamma-
tory cytokines such as IFN-γ and TNF-α, and (2) by
the action of inflammatory effector cells which culmi-
nates on MSC apoptosis without the loss of immuno-
modulatory property. Therefore, we propose that
different licensing of MSC can generate EV with dis-
tinct profiles and aspects on the immunomodulation.
Methods: To test this hypothesis, we characterized EV
population derived from untreated MSC, MSC licensed
by pro-inflammatory cytokines (IFNγ and TNFα) and
from MSC undergoing apoptosis (anti-Fas antibody).
We also isolated and characterized EV from plasma of
Graft-versus-Host Disease (GvHD) patients receiving
MSC as therapy (0, 4, 24, 48 h after MSC injection). EV
size, shape and concentration were accessed by NTA
and electron microscopy. MSC and EV surface markers
were identified by bead-based flow cytometry. To study
the EV contend, the presence of a panel of regulatory
molecules was verified by qPCR and Western blot.
Results: We found that both MSC treatment generate
population of EV heterogeneous in size, with main
range between 100 and 200 nm and bigger vesicles
(>500 nm) present in apoptotic MSC-EV samples.
Apoptosis induction significantly increased the particle
release. MSC-derived EV share mRNA and protein
with their parental cells, and the different environment
where the MSC is cultivated interfere in the EV con-
tent. Moreover, our preliminary data shown that
GvHD patients receiving MSC have increased EV con-
taining MSC-related suppressive molecules straight
after cell infusion.
Summary/conclusion: In summary, our results show
that the different environment where MSC is cultivated
interfere on their EV content, and can provide a sig-
nature of the “licensed” MSC. This was further tested
in patients undergoing MSC treatment with a view of
identifying biomarkers for pharmacokinetics studies.
Funding: This work was supported by the Bloodwise
Specialist Programme and by CAPES – Brazil.
PS11.09
Effects of mesenchymal stromal cells licensing on profile of
extracellular vesicles
Giuliana Minani Bertolinoa, Tik Shing Cheunga, Chiara Giacominia, Martin
Bornhauserb and Francesco Dazzia
aKing's College London, London, United Kingdom; bKing's College London;
Technische Universität Dresden, Dresden, Germany
Abstract: The roles of mesenchymal stromal cells
(MSC) in the immune system are subject of increasing
interest and of widening clinical applications. Recent
evidences has shown that extracellular vesicles (EV)
secreted by MSC can share some of the functional
roles of their parental cells, among them the immuno-
suppression ability. Prior to exert immunomodulation,
MSC effects rely on the presence of inflammatory
mediators in the microenvironment: (i) proinflamma-
tory cytokines such as IFN-γ and TNF-α, and (ii) by
the action of inflammatory effector cells which culmi-
nates on MSC apoptosis without the loss of immuno-
modulatory property. Therefore we propose that
different licensing of MSC can generate EV with dis-
tinct profiles and aspects on the immunomodulation.
Methods: To test this hypothesis, we characterized EV
population derived from untreated MSC, MSC licensed
by pro-inflammatory cytokines (IFNγ and TNFα) and
from MSC undergoing apoptosis (anti-Fas antibody).
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We also isolated and characterized EV from plasma of
Graft-versus-Host Disease (GvHD) patients receiving
MSC as therapy (0h, 4h, 24h, 48h after MSC injection).
EV size, shape and concentration was accessed by NTA
and electron microscopy. MSC and EV surface markers
were identified by bead-based flow cytometry. To study
the EV contend, the presence of a panel of regulatory
molecules was verified by qPCR and western blot.
Results: We found that both MSC treatment generate
population of EV heterogeneous in size, with main
range between 100 and 200 nm and bigger vesicles
(>500 nm) present in apoptotic MSC-EV samples.
Apoptosis induction significantly increased the particle
release. MSC-derived EV share mRNA and protein
with their parental cells, and the different environment
where the MSC is cultivated interfere in the EV con-
tent. Moreover, our preliminary data shown that
GvHD patients receiving MSC have increased EV con-
taining MSC-related suppressive molecules straight
after cell infusion.
Summary/Conclusion: In summary, our results show
that the different environment where MSC is cultivated
interfere on their EV content, and can provide a sig-
nature of the ‘licensed’ MSC. This was further tested in
patients undergoing MSC treatment with a view of
identifying biomarkers for pharmacokinetics studies.
Funding: This work was supported by the Bloodwise
Specialist Programme and by CAPES – Brazil.
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Mesenchymal stromal cells derived-extracellular vesicles effect on
microglia cells
Dorota Kaniowskaa, Kerstin Wenkb, Franziska Langea, Sebastian Greisera,
Ulf-Dietrich Braumanna and Yarua Jaimesc
aFraunhofer IZI, Leipzig, Germany; bInstitute for Clinical Immunology,
University of Leipzig, Leipzig, Germany; cISEV, Leipzig, Germany
Introduction: Mesenchymal stromal cells (MSCs) are a
heterogeneous population of cells with very high self-
renewal properties and the capacity to induce tissue
regeneration and reduce inflammation. Extracellular
vesicles (EVs) from MSCs have shown to have immune
modulatory properties and given their small size, are
good candidates as therapeutic agents for tissues of
difficult access, such as the central nervous system
(CNS). Microglia cells are the CNS immune cells and
are involved in the progression of the degeneration in
many neuroinflammatory diseases. We evaluated the
interaction of MSC-EVs with microglia cells and their
effect as regulators of activation.
Methods: We have used an in vitro model for stimula-
tion of the BV-2 microglia cell line and primary cells
with lipopolysaccharides (LPS) and amyloid β aggre-
gates. Real time PCR methods were used to assessed
the transcripts upregulation of tumour necrosis factor
(TNF)-α, Interleukin (IL)-1β, IL-6, nitric oxide
synthases (iNOS), Prostaglandinendoperoxide synthase
2 (PTGS2) and chemokine ligand (CCL)-22. Protein
levels of TNF-α, IL-1β and IL-6 were evaluated by
ELISA and cytometric bead arrays. Live cell imaging
approaches were used to evaluate the interaction of
MSC-EVs with microglia cells in vitro.
Results: We demonstrated that MSC-EVs are actively
internalized by microglia cells. Moreover, that presence
of MSC-EVs prevents transcription and protein expres-
sion of pro-inflammatory cytokines tumour necrosis
factor (TNF)-α, interleukin (IL)-1β, IL-6, inducible iso-
form of nitric oxide synthases (iNOS) and prostaglan-
dinendo peroxide synthase 2 (PTGS2) upregulation by
microglia cells towards LPS and amyloid β.
Furthermore, MSC-EVs suppressed the phosphoryla-
tion of the extracellular signal kinases 1/2 (ERK1/2),
c-Jun N-terminal kinases (JNK) and the p38 MAP
kinase (p38) molecules given in response to LPS
stimulation.
Summary/conclusion: MSC-EVs are strong modula-
tors of microglia activation. The modulatory activity
of MSC-EVs can be of major impact in the treatment
of neuroinflammatory diseases.
Funding: This project is co-financed with tax money
from the state of Saxony, Germany. High Performance
Center of Chemical and Biosystem Technology: Grant
100312141, Grant 100321061. YJ is financed by a
TALENTA Financing award from the Fraunhofer
Society.
LBS01.02
Porcine milk exosomes protect intestine against deoxynivalenol
damage
Mei-Ying Xiea, Ting Chena and Yong-Liang Zhangb
aSouth China Agricultural University, Guangzhou, USA; bcollege of animal
science, south china agricultural university, Guangzhou, China (People’s
Republic)
Introduction: Deoxynivalenol (DON) serious damage
intestinal vulnerable structures and intestinal integrity.
Our previous study showed that exosomes could facil-
itate intestinal cell proliferation and neonate intestinal
tract development, but the protection of milk exosomes
of damage caused by DON is unclear.
Methods: Neonatal Kunming mice were given 0.4 ml
porcine milk exosomes or saline for 3 weeks and then
given 2.5 mg/kg bw/day DON for 7 days. Intestinal
morphology was assessed using H&E. Cells viability
are tested by MTT, Edu and cell counting assay. WB,
qRT-PCR and immunofluorescence were used to show
the effects of porcine milk exosomes on the damages of
intestine and IPEC-J2 cells caused by DON. At last,
bioinformatics Analysis, luciferase reporter assay was
to verify the potential targeting relationship between
miRNAs and mRNAs.
Results: Porcine milk exosomes significantly alleviated
the negative effects of DON on body weight and the
damage degree of intestinal epithelial. In addition,
these exosomes significantly reversed the inhibition of
DON on cell proliferation and intercellular tight junc-
tion-associated proteins, such as levels of β-catenin, p-
Akt, cyclinD1 and claudin1, and decreased the
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apoptosis-related protein p53 and p21. In vitro, porcine
milk exosomes significantly attenuated the damage of
DON on cell viability, proliferation and tight junctions,
consistent with the results in vivo. Our results also
indicated that porcine milk exosomes up-regulate the
expression of miR-181a, miR-30c, miR-365-5p and
miR-769-3p in cells and downregulated their targeting
genes in p53 pathway, such as FAS, TP53, SERPINE1.
Summary/conclusion: Porcine milk exosomes pro-
tected intestine and IPEC-J2 cells against DON
damage, and encapsulated miRNAs play a role in reg-
ulating p53 pathway. Our study opened a new sight in
breast milk exosomes, which may contribute to intest-
inal health during the neonatal period
Funding: This work was supported by grants from the
National Natural Science Foundation of China [grant
numbers 31472163], and The Chinese National Key
Scientific Project (2016YFD0500503).
LBS01.03
Exosomal PD-L1 embedded with thermoresponsive gel promotes
wound healing
Dandan Sua, Zhanxue Xub, Hongbo Chenb, Fang Chengb and Xiangyi Caic
aSchool of pharmaceutical sciences(Shenzhen), Sun Yat-sen University,
Guanghzou, China (People‘s Republic); bSchool of pharmaceutical sciences
(Shenzhen), Sun Yat-sen University, Guangzhou, China (People‘s Republic);
cSchool of pharmaceutical sciences(Shenzhen), Sun Yat-sen University
Introduction: Wound healing is a complex process
involving multiple cell types with different roles,
which is divided into stages of haemostasis, inflamma-
tion, proliferation and remodelling. As many chronic
wounds are the result of excessive and chronic inflam-
mation, we hypothesized that effective wound repair
could be achieved by inhibiting overactive immune
cells to the injured skin. The PD-1/PD-L1 immune
checkpoint pathway prevents excessive tissue destruc-
tion during inflammatory states, and PD-L1 expression
is induced by pro-inflammatory factors in multiple cell
types throughout the body. Interestingly, recently PD-
L1 is found to exists in extracellular vesicles (EVs) as a
transmembrane protein. Thus we would like to test if
exosomal PD-L1 would regulate the immunity and
inflammatory response to promote proper wound
healing.
Methods: Exosomal PD-L1 were isolated from mela-
noma cells stimulated with IFN-γ by differential cen-
trifugation and were characterized by flow cytometry,
TEM, DLS, zeta potential, Western blot and confocal
microscopy. Exosomal PD-L1 were administered in a
mouse skin injury model through a thermoresponsive
hydrogel, which was gelatinized at body temperature to
preserve exosomal PD-L1 throughout the wound. Flow
cytometry analysis, qPCR, HE staining and immuno-
histochemical analysis were performed to further
explore the therapeutic effect of exosomal PD-L1 at
the tissue levels.
Results: Exosomal PD-L1 in thermoresponsive gel led
to a decreased T cell activation, indicated by CD4,
CD8, and IL-2 markers. In the presence of exosomal
PD-L1, there was also an increased expression of
growth factors, which significantly promoted wound
contraction and wound re-epithelialization.
Summary/conclusion: Collectively, our current find-
ings suggest that exosomal PD-L1 speeds up wound
healing when applying into a novel thermoresponsive
gel on top of the injured skin, which provides a new
perspective for using immunotherapy to promote tis-
sue repair and regeneration.
Funding: F. Cheng would like to thank Sigrid Jusélius
foundation, the National Natural Science Foundation
of China (Grant no. 81702750) and the Basic Research
Project of Shenzhen (Grant no.
JCY20170818164756460) for funding.
LBS01.05
Intranasal delivery of mesenchymal stem cell derived exosomes
loaded with PTEN siRNA repairs complete spinal cord injury
Shawei Goua, Nisim Peretsb, Oshra Betzerc, Shahar Ben-Shauld, Anton
Sheinine, Izhak MichaelevskiMichaelevskif, Rachela Popovtzerc, Daniel
Offeng and Shulamit Levenbergh
aDepartment of Biomedical Engineering, Technion-Israel Institute of
Technology, Israel; bSagol School of neuroscience, Tel Aviv University,
Israel, Tel aviv, Israel; cFaculty of Engineering and the Institute of
Nanotechnology & Advanced Materials, Bar-Ilan University, Israel, Ramat
Gan, USA; dDepartment of Biomedical Engineering, Technion-Israel Institute
of Technology, Haifa, 3200002, Israel, Haifa, Israel; eSagol School of
Neuroscience, Tel Aviv University, Israel., Haifa, Israel; fDepartment of
Molecular Biology, Ariel University, Israel.; gSagol School of neuroscience,
Tel Aviv University, Israel, Sacklar school of medicine, department of human
genetics and biochemistry Tel Aviv University, Israel., Tel Aviv, USA;
hDepartment of Biomedical Engineering, Technion-Israel Institute of
Technology, Israel, Haifa, Israel
Introduction: Complete spinal cord injury (SCI) is a
debilitating disease which usually leads to permanent
functional impairments, with various complications
and limited spontaneous recovery or efficient treat-
ment. Here, we report that in rats with complete SCI,
intranasal administrations of mesenchymal stem cells-
derived exosomes (MSC-Exo) could penetrate the
blood brain barrier, home selectively to the spinal
cord lesion, and show affinity to neurons within the
lesion. When these exosomes were loaded with phos-
phatase and tensin homolog small interfering RNA,
termed ExoPTEN, they migrated from the nose and
silenced PTEN expression in the lesion. Furthermore,
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the loaded exosomes promoted robust axonal regen-
eration and angiogenesis, accompanied with decreased
astrogliosis and microgliosis. Moreover, the intranasal
ExoPTEN treatment partially restored electrophysiolo-
gical and structural integrity, and most importantly,
enabled remarkable functional recovery. This rapid,
non-invasive approach, using cell-free nano-swimmers
carrying molecules to target pathophysiological
mechanisms, suggests novel strategy for clinical trans-
lation to SCI and beyond.
Methods: MSC-exo were extracted from Human bone
marrow mesenchymal stem cells. All rats had complete
transection of the spinal cord. MSC-exo were loaded
with co-incubation together with siRNA for PTEN
conjugated to cholesterol. The MSC-exo were given
by intranasal administration 1–4 h post SCI.
Results: Here we show that SCI rats that were intrana-
sally treated with MSC-exo present functional
improvement in motor and sensory output. The
MSC-exo were homed in the SCI area and led to
reduction in inflammatory markers, increased angio-
genesis and regrowth of transected axons. MRI and
electrophysiological measurements were done to show
the axonal recovery and signal transduction
Summary/conclusion: Exosomes derived from Human
bone marrow mesenchymal stem cells and loaded with
inhibitor molecule for PTEN pathway were found effi-
cient in ameliorating complete transection of the spinal
cord via intranasal administration, including remark-
able functional improvement.
LBS01.06
ASC-EXOSOME as a potential therapeutic for atopic dermatitis
Byong Seung Choa, Jin Ock Kimb, Dae Hyun Haa and Yong Weon Yia
aExocobio Inc., Seoul, Republic of Korea; bExocobio Inc, Seoul, Republic of
Korea
Introduction: Atopic dermatitis (AD) is an inflamma-
tory disease that has rapidly increased in the prevalence
in recent decades. Despite the high demand for AD
therapy, current treatment options are limited and have
potentially harmful side effects. Recently, several clin-
ical studies highlighted human mesenchymal stem cells
(MSCs) as novel potential therapeutics for suppressing
allergic progress in the AD, and the majority of their
therapeutic effects is mediated their secretome which
contains exosomes. There are, however, several draw-
backs for the therapeutic use of MSCs, such as poor
engraftment efficiency, non-specific differentiation,
and short half-life, etc. Otherwise, exosomes can be
off-the-shelf since they are not live, expecting to
overcome the limitations of MSC easily and become
powerful alternative therapeutics. Here, we investigated
the therapeutic effects of exosome from adipose tissue-
derived MSC (ASC-EXOSOME) on atopic dermatitis
in two in vivo models.
Methods: ASC originated from adipose tissue of a
healthy donor. ASC-EXOSOME was isolated from
ASC conditioned media through a sequential filtration
method. AD-like skin lesions were induced in mice by
applying house dust mite antigen or a chemical irritant.
After administration of ASC-EXOSOME either subcu-
taneously or intravenously the anti-inflammatory
effects were demonstrated by measuring serum IgE
level, immunostaining of immune cells, real-time
PCR, etc.
Results: Systemic administration of ASC-EXOSOME
dose-dependently lowered serum IgE level and the
number of eosinophils in AD mice blood, and reduced
mast cell infiltration and up-regulated mRNA levels of
IL-4, IL-31, IL-23 and TNF-α in the skin lesions com-
pared to AD control. Skin barrier function was also
improved by ASC-EXOSOME.
Summary/conclusion: Systemic administration of
ASC-EXOSOME dose-dependently lowered serum IgE
level and the number of eosinophils in AD mice blood,
and reduced mast cell infiltration and up-regulated
mRNA levels of IL-4, IL-31, IL-23, and TNF-α in the
skin lesions compared to AD control. Skin barrier
function was also improved by ASC-EXOSOME.
LBS01.07
Porcine milk exosome miRNAs attenuate lipopolysaccharide-induced
apoptosis by inhibiting TLR4/NF-κB and P53 pathways
Yong-Liang Zhanga, Mei-Ying Xieb and Ting Chenb
aCollege of Animal Science, South China Agricultural University, Guangzhou,
China (People‘s Republic); bSouth China agricultural university,
Guangzhou, USA
Introduction: Intestinal epithelial cells are important
for pathogen infection. LPS is an endotoxin and
induces intestine inflammation. Milk exosomes
improve the intestine development and immune sys-
tem of newborn. The objective of this study is to
investigate the protective mechanisms of porcine milk
exosomes in rescuing LPS-induced intestinal epithe-
lium injuries.
Methods: Both in vivo and in vitro tests were carried
out to confirm protection of porcine milk exosome on
LPS induced injury to intestine.
Results: In vivo, exosomes protected the jejunum integ-
rity and health from LPS damage through H&E results
and attenuated LPS-induced pro-inflammatory factors
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secretion through ELISA results. In vitro, we got simi-
lar results in the intestinal epithelial cell line IPEC-J2.
Bioinformatics analyses and cell experiments results
shown exosome miR-4334, miR-219 reduced pro-
inflammatory responses and miR-338 inhibited LPS-
induced apoptosis of intestinal epithelial cells via
TLR4/MyD88/NF-κB and P53 pathway, respectively.
Co-transfection of those three miRNAs had the best
effect on resisting LPS-induced IPEC-J2 apoptosis than
any one of these three miRNAs.
Summary/conclusion: In conclusion, porcine milk
exosomes protected the intestine against LPS-induced
injury through decreasing cell inflammatory and resist-
ing cell apoptosis by exosome miRNAs. This study
expands our understanding of bioactive molecules in
milk and provides new strategies for developing func-
tional foods in the future.
Funding: This work was supported by grants from the
National Natural Science Foundation of China [grant
numbers 31472163], and The Chinese National Key
Scientific Project (2016YFD0500503).
LBS01.08
Extracellular vesicles from mesenchymal stromal cells for the
treatment of radiological burns
Juliette Peltzera, Stephane Flamantb, Philippe Mauduitc, Sylvie Goulinetc,
Bastien Rivala, Jean-jacques Latailladed, Georges Uzanc, Sebastien Banzete
and Radia Tamaratb
aInstitut de Recherche Biomédicale des Armées, INSERM UMR-MD-1197,
Clamart, USA; bInstitut de Radioprotection et Sûreté Nucléaire (IRSN),
Fontenay aux Roses, France; cINSERM UMR-MD-1197, Villejuif, France;
dInstitut de Recherche Biomédicale des Armées, INSERM UMR-MD-1197,
Clamart, France; eInstitut de Recherche Biomédicale des Armées, INSERM
UMR-MD-1197, CLAMART, France
Introduction: High-dose acute radiation accidents of
industrial and medical origin and the risk of a terrorist
act (NRBC) have been taken into consideration for
some years. The work carried out by our teams led to
a new therapeutic approach for the management of
victims of accidental irradiation, consisting of autolo-
gous Mesenchymal Stromal Cells (MSCs) injection
associated with reparative surgery. Preclinical studies
showed that MSCs, mainly by their secretory activity,
contribute to control inflammation, promote angiogen-
esis and tissue regeneration. MSC-derived extracellular
vesicles (MSC-EVs) might be key mediators of MSC
function. This project aims to propose an innovative
therapy product based on the use of Extracellular
Vesicles (EVs) for the treatment of radiological burns
following accidental irradiation.
Methods: MSCs were grown until reaching 80% con-
fluence, then moved to EV collection medium for 72 h.
EVs were purified by tangential flow filtration followed
by size exclusion chromatography and characterized by
Nanoparticle tracking analysis. MSC-EVs were evalu-
ated in vitro in an inflammatory assay using human
monocytic THP-1 cells treated with lipopolysaccharide,
with or without co-culture with MSCs or EVs. The
level of pro-inflammatory TNFα in the culture super-
natant was measured by ELISA assay. EVs were also
evaluated in vivo using a mouse model of acute hind
limb radiation injury. Cell therapy products (1x106
MSCs or a range of 2.45E+10, 4.90E+10 or 9.80E+10
MSC-EVs/animal) were intramuscularly injected
14 days post-irradiation. Macroscopic analysis of injury
was performed at regular intervals.
Results: Preliminary results showed an immunomodu-
latory effect of MSCs-EVs, as shown by their ability to
reduce TNFα secretion by THP-1 cells in response to
LPS. Moreover, in vivo results showed a decrease of
injury score in animals injected with the highest EV
concentration at day 10 and 14 post-injection.
Summary/conclusion: These preliminary results sug-
gest a beneficial effect of MSC-EVs on the healing
process of cutaneous radiation syndrome and could
represent a valuable therapeutic alternative in the con-
text of radiological emergency. Further exploration of
the molecular mechanisms is now necessary.
Funding: French Direction Générale de l‘Armement,
under contract ANR-16-ASTR-0024
LBS01.09
Adipose-derived stem cells enhance chondrogenesis and
cartilaginous matrix synthesis of articular chondrocytes is mediated
by extracellular vesicles
Shun-Cheng Wu, Jhen-Wei Chen, Che-Wei Wu, Chung-Hwan Chen, Je-Ken
Chang and Mei-Ling Ho
Orthopaedic Research Center, College of Medicine, Kaohsiung Medical
University, Kaohsiung, Taiwan (Republic of China)
Introduction: To date, mesenchymal stem cells includ-
ing adipose-derived stem cells (ADSCs) have been
intensively investigated as a cell-based therapy to treat
articular cartilage damages in both animal and human
studies. However, the detailed mechanism of how
ADSCs regenerate the damaged articular cartilage
remains unclear. Increasingly, studies present evidence
that ADSCs mediate tissue repair via secretion of
trophic factors on damaged tissue. In this study, we
test the hypothesis that ADSCs-derived extracellular
vesicles (EVs) enhances chondrogenesis and matrix
synthesis of human articular chondrocytes.
Methods: Human ADSCs were labelled with CM-DiI
and then pre-cultured in DMEM supplemented with
2% FBS for 48 h to induce EVs release. After induce
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EVs release, the conditioned medium derived from
pre-cultured with ADSCs were isolated, and then was
used to treat articular chondrocytes. There were three
groups in the study: (1) Control: articular chondrocytes
treated with DMEM supplemented with 2% FBS with-
out pre-cultured with ADSCs, (2) Conditioned med-
ium: articular chondrocytes treated with DMEM
supplemented with 2% FBS, which is pre-cultured
with ADSCs, (3) Conditioned medium remove EVs:
articular chondrocytes treated with conditioned med-
ium, which the EVs were removed by ultracentrifuga-
tion. At the indicated time point, the chondrocytes
were harvested for further analysis including cell pro-
liferation, chondrogenic gene expressions (Collagen
type II), and cartilaginous matrix synthesis
(Glycosaminoglycan synthesis).
Results: Intercellular communication occurs through
EVs. EVs transferred into chondrocytes can be found
in the conditioned medium group. However, there is
no EVs transfer in the conditioned medium removed
EVs. There is no significant difference in cell prolifera-
tion of chondrocytes among three groups. The chon-
drogenic gene expression and cartilaginous matrix
synthesis of chondrocyte is significantly enhanced in
conditioned medium group when compared with con-
trol group. Moreover, there is no significant difference
between control and conditioned medium removed EV
groups.
Summary/conclusion: ADSCs enhances chondrogen-
esis and matrix synthesis of human articular chondro-
cytes is mediated by EVs
LBS01.10
Application of milk exosome for leaping cosmeceutical materials.
Gna Ahna, Yang-Hoon Kimb and Ji-Young Ahnb
aChungbuk National University, Cheong-ju, Republic of Korea; bSchool of
Biological Sciences, Chungbuk National University, Cheongju, Republic of
Korea
Introduction: Milk is one of the best exosome materi-
als widely used as an ingredient in various foods.
Although the antibacterial effect present in milk has
been long known, however studies related to the anti-
bacterial activity associated with milk exosomes are
fairly limited. The purpose of this study is to suggest
the possibility of using the antimicrobial effect of milk
exosomes in cosmeceutical field.
Methods: Commercially available non-fat milk-based
on Pasteur treatment was used. Milk was centrifuged at
210,000 g for 70 min at 4℃. TEM and cryo-EM was
used to determine the shape of milk exosomes and its
size was measured using qNano (iZon, Australia). For
antimicrobial activity test, Staphylococcus aureus (S.
aureus) was cultured in LB broth medium at 37℃, O/
N. The seed culture ratio (1/100, 1/1000) and different
exosome concentration were inoculated and growth
was confirmed by time.
Results: The average size of the MiExo obtained was
120 ~ 140 nm. Both TEM and cryo-EM image showed
a typical exosome shape morphology. The Western
blotting confirmed the detection of TSG101 marker,
which is a representative marker of MiExo. The anti-
microbial activity of S. aureus was determined at dif-
ferent conditions. It exhibited 2.5 times antimicrobial
effect when the MiExo and the bacteria were inoculated
together at an early stage in log phage (10^8 CFU/mL).
Based on the inoculation dilution factor(DF), very high
antimicrobial effect of approximately 19 times was
observed for 1/1000 DF as compared to the 1/100 DF.
S. aureus hardly grew in the experiment group with 1/
1000 DF. The antimicrobial efficacy based on the
amount of exosome was 13 times higher for 10^11
particles as compared to 10^6 particles.
Summary/conclusion: The extraction of MiExo and its
antimicrobial effect was determined. The antimicrobial
effect of MiExo performed in this study is considered
to be stable with low side effects and has great potential
as a superior natural material in the future cosmeceu-
tical market.
Funding: This work was carried out with the support
of “Cooperative Research Program for Agriculture
Science & Technology Development (Project No.
PJ012653)” Rural Development Administration
Republic of Korea.
LBS01.11
Control of neural stem cell differentiation to generate defined
exosome populations
Nicola Goddarda, Daniel Bracewellb, Randolph Cortelingc, Simon Youltonc
and Ivan Walld
aUniversity College London, Brentwood, United Kingdom; bUniversity
College London, London, United Kingdom; cReNeuron Limited, Pencoed
Business Park, Pencoed, Bridgend, Wales, CF35 5HY, United Kingdom,
Bridgend, United Kingdom; dUniversity College London, Birmingham,
United Kingdom
Introduction: Exosomes derived from the clinical
grade neural stem cell line CTX (ReNeuron) are the
basis of a new class of therapy for the treatment of
degenerative disorders. Since exosomes contain a sub-
set of molecules derived from their parent cell, pro-
genitor and differentiated CTX may generate exosomes
with diverse phenotypes. It is vital that these are well
characterized to allow robust manufacture and
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isolation of particular exosome populations and to
understand their implications in therapeutic
applications
Methods: Screening of support matrices (microcar-
riers) and substrates for growing CTX was performed
in a bespoke microfluidic device for 7 days. Cells were
then fixed and stained before applying automated ima-
ging and analysis to determine the differentiated state
of the cells. The process was repeated with a reduced
panel of matrix/substrate combinations to study differ-
entiation and exosome agonists for a period of 6 weeks
as a means to accelerate CTX differentiation and
increase exosome production. The conditions selected
for each cell type were validated in a model bioreactor
system at the 0.1L scale and the resultant exosomes
characterized in terms of particle number, size distri-
bution, miRNA content and CD markers
Results: The microfluidic screening approach allows
the study of a panel of 336 matrix, substrate, differ-
entiation agonist and exosome agonist/antagonist
combinations enabling the experimental space to be
reduced by >98% prior to any scale-up activities,
thereby minimising experimental time, cost and risk
of failure. Our validation successfully achieved our
target cell population of 60,000 cells/cm2 in 4 days
and found that the resultant exosomes had miRNA
and CD marker profiles dependent on stage of dif-
ferentiation of the culture
Summary/conclusion: CTX were successfully adapted
for growth on microcarriers in a suspension bioreactor
system to provide a scalable platform for progenitor
and differentiated CTX-derived exosome production.
The exosome characteristics change in terms of both
CD markers and miRNA profile according to the dif-
ferentiated state of their parent cell. This has implica-
tions on not only their therapeutic function and
potency but also the design of processes for their man-
ufacture and purification in order to deliver consistent
product profile
Funding: Innovate UK
LBS01.12
Engineered stem cell membrane-cloaked gold nanorods for efficient
cancer therapy
Won-Kyu Rhima, Kyungwon Koa, Soo-Hong Leeb, Wooram Parka and Dong
Keun Hanc
aBiomedical science, CHA university, seongnam, Republic of Korea;
bDongguk University, goyang, Republic of Korea; cBiomedical science, seong-
nam, Republic of Korea
Introduction: Faced with various limitations in how
functionalization of nanoparticles‘ surfaces with syn-
thetic organic materials, researchers have begun to
envision strategies for using bioinspired materials as
an alternative. In particular, nanoparticles require
many improvements in vivo to increase stability,
enhance circulation time and distribution and
improve dissolution. For this reason, directly trans-
ferring the cell membrane to the surface of the
nanoparticles, the complexity of the lipid, protein
and carbohydrate-containing cell membranes can be
faithfully maintained, allowing the coated nanoparti-
cles to have characteristics that appear to the source
cell. The behaviour of cells in vivo is usually deter-
mined by cell membrane proteins. This method of
directly coating the cell membrane also has the same
characteristics of nanoparticles depending on the
characteristics of the source cells.
Methods: First, in order to coat the cell membrane,
the capped CTAB for the surface stabilization of the
gold nanorod was replaced with a negatively charged
citrate. And, extracted stem cell membranes are engi-
neered using lipid-tethered peptide for enhancing
targeting specificity to cancer cell. Engineered cell
membrane was cloaked onto the surface of gold
nanorods using simple bath sonication. It can be
confirmed that the stem cell membrane is well-
coated on the surface of gold nanorod through var-
ious analysis including, zeta potential, TEM, PAGE
gel and Western blotting, etc.
Results: Citrate-capped gold nanorods are character-
ized using zeta potential and TEM. And, zeta potential
of well-established cell membrane-cloaked gold nanor-
ods is similar to that of cell membrane. Cell membrane
coating onto gold nanorods is also visualized using
TEM with negative staining. After cell membrane coat-
ing, the protein marker in the cell membrane is
detected identically to the cell membrane, but the
nuclear marker is not detected in Western blotting
analysis.
Summary/conclusion: Cell membrane coating is a
platform technology that provides an easy top-down
method for designing nanocarriers with surfaces that
replicate very complex and diverse functions needed
for effective bio-interfacing and give nanoparticles
more functional.
Funding: This study was supported by the National
Research Foundation of Korea (NRF) Grants funded
by MEST (NRF-2017R1A6A3A040123620)
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Annexin V binding modulates the response of macrophages to
mesenchymal stromal cell-derived extracellular vesicles
Michele Grassia, Michela Pozzobonb, Melania Scarpac, Damiana Incendid,
Alessia Giarraputoe, Anna Maria Tolomeoa, Marcin Jurgaf, Andrea
Porzionatog and Maurizio Muracah
aDepartment of Women’s and Children’s Health – University of Padova,
Padova, Italy; bUniversity of Padova, Padova, Italy; cIstituto Oncologico
Veneto IOV-IRCCS, Padova, Italy; dUniversity di Padova Department DNS,
Padova, Italy; eUniversity of Padova, Padova, Italy; fThe Cell Factory, Niel,
Belgium; gDepartment of Neuroscience, University of Padua, Padova, Italy,
Padova, Italy; hUniversity of Padova, Italy, Padova, Italy
Introduction: We have previously shown that Annexin
a5 (An5) binding to mesenchymal stromal cell-derived
extracellular vesicles (MSC-EVs) enhances the anti-
inflammatory properties of these nanoparticles in an
animal model of colitis. However, the mechanisms
underlying these effects are unknown. Here, we inves-
tigated the immunoregulatory effect of MSC-EVs with
and without An5 binding on activated macrophages in
vitro.
Methods: Macrophages were isolated from mouse bone
marrow and activated by INFgamma and LPS. Clinical
grade Wharton Jelly-derived MSC-EVs were obtained
from The Cell Factory (Esperite NV, Niel, Belgium)
and quantified by Resistive Pulse Sensing analysis. 5,0E
+05 macrophages were incubated with PBS (vehicle
only, control, group 1) 5,0E+08 MSC-EVs (group 2),
5,0E+08 MSC-EVs added with 2 ug An5 (group 3) or
with 2 ug free An5 (group 4). After 24 h, the cells were
analysed by flow cytometry and RNA was extracted for
RT-PCR analysis.
Results: Incubation with MSC-EVs significantly
increased only the expression of IL-10 in IFNgamma/
LPS-activated macrophages. Incubation with An5-
MSC-EVs resulted in a significant induction in the
expression of both pro- and anti-inflammatory cyto-
kines, including TNFalfa, IL-1Beta, IL-6, IL-10 and
TGFbeta1. Incubation with free An5 induced only
pro-inflammatory cytokines without affecting IL-10
and TGFbeta1 expression. The iNOS2/Arg1 ratio was
reduced in both EV-treated groups, indicating a shift
from M1 to M2 polarization.
Summary/conclusion: In conclusion, both MSC-EVs
and An5-MSC-EVs shift the macrophage phenotype
from M1 to M2. The combined induction of
TGFbeta1 and IL-10, observed only in An5-MSC-EV-
stimulated macrophages, might be related to the
immune-modulating characteristics of these modified
EVs that contribute to the therapeutic effects observed
in vivo.
Funding: The BROAD MEDICAL RESEARCH
PROGRAM AT CCFA supported this work
LBS02.02
PD-L1/CTLA-4 nanovesicles have an immunosuppressive effect on a
mouse skin graft model
Zhanxue Xua, Xiangyi Caib, Fang Chenga and Hongbo Chena
aSchool of pharmaceutical sciences(Shenzhen), Sun Yat-sen University,
Guangzhou, China (People‘s Republic); bSchool of pharmaceutical sciences
(Shenzhen), Sun Yat-sen University
Introduction: Skin transplantation has been employed
to serious injuries, but a potent inflammatory immune
response often leads to rejection of allogeneic skin
grafts. T-cell activation by immune allorecognition is
a major cause to trigger acute rejection. Immune
checkpoint pathways such as the programmed death-
1 (PD-1)/programmed death-ligand 1 (PD-L1) and
cytotoxic T-lymphocyte-associated protein 4 (CTLA-
4)/Cluster of differentiation 80 (CD80) provide an
immunosuppressive environment, preventing excessive
tissue destruction due to inflammatory immune
response. Thus we would like to see if bioengineering
cell membrane derived nanovesicles (NVs) to display
PD-L1 and CTLA-4 would reduce immunological
rejection through enhancing PD-1/PD-L1 and CTLA-
4/CD80 immune inhibitory axis.
Methods: We established HEK 293T cells that stably
express PD-L1/CTLA-4 on the cell membranes and
prepared cell membrane nanovesicles. Confocal micro-
scopy and immunoprecipitation analysis were used to
determine the interaction of PD-1/PD-L1 and CTLA-4/
CD80 on the cell membrane. After that, T-cell activa-
tion and proliferation were examined by flow cytome-
try analysis of a panel of markers. Finally, we tested the
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effect of PD-L1/CTLA-4 NVs on relieving skin grafting
in vivo.
Results: We successfully engineered cell membrane
derived nanovesicles to display PD-L1/CTLA-4, which
were characterized by transmission electron micro-
scopy and Western blotting In addition, confocal
microscopy showed that PD-L1/CTLA-4 NVs can
interact with PD-1 of and CD80 of target cells.
Furthermore, PD-L1/CTLA-4 NVs led to reduction of
T cells activation and proliferation. Finally, compared
to control mice, the skin-grafting mice had a high
response rate to relieve immunologic rejection when
treated with PD-L1/CTLA-4 NVs.
Summary/conclusion: As a summary, NVs containing
dual molecular targets PD-L1/CTLA-4 exhibit strong
immune inhibitory effect, promoting the healing of
grafting skin. Thus, PD-L1/CTLA-4 dual immune
blockade by nanovesicles provides a promising strategy
to inhibit skin graft rejection.
LBS02.03
Exosome-mediated horizontal gene transfer: a possible driving force
behind mammalian genome evolution & a new risk for genome
editing
Ryuichi Onoa, Yukuto Yasuhikob, Ken-ichi Aisakib, Satoshi Kitajimac, Jun
Kannod and Yoko Hirabayashib
aDivision of Cellular & Molecular Toxicology, Biological Safety Research
Center, National Institute of Health Sciences (NIHS), Kawasaki, Japan;
bNational Institute of Health Sciences (NIHS), Kawasaki, Japan; cNational
Institute of Health Sciences (NIHS), Kawasaki, USA; dJapan Bioassay
Research Center, Kawasaki, USA
Introduction: The CRISPR-Cas9 system has been suc-
cessfully applied in many organisms as a powerful
genome editing tool. We have previously reported
that unintentional DNA sequences derived from retro-
transposons, genomic DNA, mRNA and vectors are
captured at double-strand breaks (DSBs) sites when
DSBs are introduced by the CRISPR-Cas9 system.
Therefore, it is possible that unintentional insertions
associated with DSB repair represent a potential risk
for human genome editing gene therapies. To address
this possibility, comprehensive sequencing of DSB sites
was performed, and we found that bovine DNA frag-
ments were captured at DSB sites in fertilized mouse
eggs and cell lines.
Methods: We determined the lengths of the indels
introduced by the CRISPR-Cas9 system in vivo and in
vitro by deep sequencing of PCR products amplified
with two primers across the target DSB site.
All animal studies were conducted in accordance with
the guidelines approved by the animal care committee
of the National Institute of Health Sciences.
Results: To determine the origin of bovine DNA frag-
ments, we used goat serum, rabbit serum, and exo-
some-free FBS instead of FBS in the cell culture
medium. Goat BovB and rabbit LINE1 sequences
were horizontally transferred to DSB sites, however,
almost no bovine DNA sequences were captured, sug-
gesting that these horizontal gene transfers were
mediated by exosomes.
Summary/conclusion: We demonstrated that horizon-
tal gene transfer assisted by CRISPR-Cas9 occurs in
NIH-3T3 cells and mouse embryos. This phenomenon
might be the driving force behind mammalian genome
evolution. In fact, mice with fusions between the mur-
ine Peg10 gene and a bovine SINE were obtained. A
number of possible trans-species horizontal gene trans-
fer events have been reported in mammals. Exosomes
are present in all fluids from living animals, including
seawater and breathing mammals, suggesting that exo-
some-mediated horizontal gene transfer is the driving
force behind mammalian genome evolution. The find-
ings of this study also highlight an emerging new risk
for this leading-edge technology.
Funding: AMED (18mk0104073j0103
&18ak0101093j001), Health Sciences Research Grants
from the Ministry of Health, Labor, and Welfare, Japan
(H30-KAGAKU-IPPAN-002 & H30-KAGAKU-
SHITEI-001), and JSPS (26430183 and 18K19315)
LBS02.04
Comparative studies on in vitro and in vivo inflammatory activities of
extracellular vesicles and soluble factors derived from bacteria
Kim Sang sooa, Jaewook Leeb, Park Kyong-Suc and Yong Song Ghoa
aDepartment of Life Sciences, Pohang University of Science and Technology,
Pohang, Republic of Korea; bDepartment of Life Sciences, Pohang University
of Science and Technology (POSTECH), Pohang, Republic of Korea;
cDepartment of Life Sciences, Pohang University of Science and Technology
(POSTECH) (graduate), Pohang, Republic of Korea
Introduction: Soluble factors released by cells play
important roles in intercellular communication.
However, extracellular vesicles (EVs) have recently
attracted much attention as intercellular communica-
somes, complex extracellular organelles that mediate
intercellular communication. While it has been
reported that EV-associated molecules elicit greater
activities than soluble forms, no studies have compared
the activities of EVs as a whole with soluble factors. In
this study, EVs and soluble factors derived from bac-
teria were compared with regard to local and systemic
inflammatory activities.
Methods: Escherichia coli was cultured in a chemically
defined medium, and conditioned medium (CM) was
harvested from the culture. EVs and soluble factors
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(CM-EVs) were isolated from 3 kDa cut-off concen-
trated CM by ultracentrifugation. RAW264.7 cells were
treated with EVs and CM-EVs, then the release of
TNF-α and IL-6 were measured with ELISA. In addi-
tion, wild-type mice were intraperitoneally adminis-
tered with EVs and CM-EVs, and septic signs were
observed. Inflammatory indices including the concen-
trations of TNF-α and IL-6 as well as the numbers of
infiltrated immune cells were also assessed from the
peritoneal lavage fluid, serum and bronchoalveolar
lavage fluid.
Results: EVs mediated the release of IL-6 from
RAW264.7 cells in vitro, with greater extent than
CM-EVs. Unlike CM-EVs, EVs mediated systemic sep-
tic symptoms including hypothermia, eye exudate for-
mation and leukopenia. While both EVs and CM-EVs
mediated immune cell infiltration into the peritoneum,
EVs mediated the elevation of the concentrations of
TNF-α and IL-6 in the peritoneal lavage fluid, more
efficiently than CM-EVs. In addition, EVs mediated
the elevation of the concentrations of TNF-α and IL-6
in the serum, whereas, CM-EVs did not. More impor-
tantly, EVs mediated immune cell infiltration as well as
the elevation of the concentrations of TNF-α and IL-6
in the bronchoalveolar lavage fluid, whereas CM-EVs
did not.
Summary/conclusion: Although EVs and soluble fac-
tors mediated local inflammatory responses, only EVs
can act as long-range effectors in systemic inflamma-
tory responses, suggesting EVs as new therapeutic tar-
gets for infectious diseases.
LBS02.05
Gram-negative bacterial extracellular vesicles promote angiogenesis
by inducing interleukin-6
Jaemin Leea, Jaewook Leeb, Tae-Young Rohc and Yong Song Ghod
aPohang University of Science and Technology, Pohang, Republic of Korea;
bDepartment of Life Sciences, Pohang University of Science and Technology
(POSTECH), Pohang, Republic of Korea; cDiv. of IBB, Dept of Life Sciences,
Pohang University of Science and Technology (POSTECH), Pohang,
Republic of Korea; dDepartment of Life Sciences, Pohang University of
Science and Technology, Pohang, Republic of Korea
Introduction: Angiogenesis, the formation of blood
vessels from pre-existing vasculature, is an essential
complex process for multiple pathophysiological con-
ditions including bacterial infection, inflammatory dis-
eases and bacterial sepsis. Several pathological
functions of Gram-negative bacterial extracellular vesi-
cles (EVs), also known as outer membrane vesicles
have been shown to induce local inflammation, sys-
temic inflammation, and septic shock, and so on.
However, no studies have assessed the effects of
Gram-negative bacterial EVs on angiogenesis.
Methods: Escherichia coli EVs were subcutaneously
administered to wild-type mice, along with Matrigels.
The Matrigels were subjected to whole mount immu-
nostaining, and vascular area was measured. As macro-
phages are involved in angiogenesis, macrophage
infiltration was also assessed in the Matrigels.
Peritoneal macrophages from wild-type mice were
treated with E. coli EVs, and the conditioned media
were treated to endothelial cells to measure cell migra-
tion. Furthermore, to show the role of interleukin-6
(IL-6) on angiogenesis, E. coli EVs were subcutaneously
administered to wild-type and IL-6 knock-out mice,
along with Matrigels. Then, the Matrigels were sub-
jected to whole mount immunostaining, and vascular
area was measured. In addition, peritoneal macro-
phages from wild-type and IL-6 knock-out mice were
treated with E. coli EVs, and the conditioned media
from the macrophages were treated to endothelial cells
to measure cell migration.
Results: E. coli EVs promoted in vivo angiogenesis and
macrophage infiltration in wild-type mice. Peritoneal
macrophages from wild-type mice, treated with E. coli
EVs, mediated endothelial cell migration in vitro.
However, E. coli EVs did not promote angiogenesis
and macrophage infiltration in IL-6 knock-out mice.
Furthermore, peritoneal macrophages from IL-6
knock-out mice, treated with E. coli EVs, did not med-
iate endothelial cell migration.
Summary/conclusion: Gram-negative bacterial EVs
have potent angiogenic activities by promoting macro-
phage infiltration and inducing IL-6. These findings
provide insights into the effects of Gram-negative bac-
terial EVs on bacterial infection-related pathological
diseases including bacterial infection, inflammatory
diseases, and bacterial sepsis.
LBS02.06
Dendritic cell derived-exosomes activate immune systems by
transferring exosome involved factors to T cell
Masakatsu Takanashia, Shinobu Uedaa, Katsuko Sudob and Masahiko
Kurodaa
aDepartment of Molecular Pathology, Tokyo Medical University, Tokyo,
Japan; bAnimal Research Center, Tokyo Medical University, Tokyo, Japan
Introduction: Exosomes released from dendritic cells
(DCs) are responsible for the persistence of antigen
presentation. So, we considered that whether DCs-
derived exosomes could induce suppress cancer cells
and more effective response of an immune system and
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what factors in exosomes-involved DCs can activate T
cells.
Methods: Luciferase gene transferred-3LL cells (mur-
ine lung cancer cell line derived C57BL/6) were
injected into C57BL/6J mice by intraperitoneal admin-
istration. And then, DCs, DCs-exosomes or 3LL-exo-
somes were weekly administrated to lung cancer-
bearing mice. The exosomes derived from DCs
decreased lung cancer cell growth compared with
DCs, DCs-exosomes and non-treated. We evaluated
mRNA expressions differences in between LPS-treat-
ment DCs and none treatment DCs with DNA micro-
array analysis.
Results: DNA microarray analysis data showed that 44
genes increased as ratio LPS-treated DC mRNA vs
non-treatment DC one. Western blot analysis showed
one of the genes contained higher in exosomes derived
from LPS-treatment DCs than that derived from non-
treatments.
Summary/conclusion: This gene induces T cell prolif-
eration and signals for T cell maturation. We con-
cluded that DCs derived-exosomes activate anticancer
immune systems by transferring exosome-involved the
factor to T cells.
LBS02.07
Crosstalk between endoplasmic reticulum stress and autophagy in
kidney diseases
Yuh-Feng Lina and Hui-Wen Chiub
aTaipei Medical University, Taipei, Taiwan (Republic of China); bGraduate
Institute of Clinical Medicine, College of Medicine, Taipei Medical
University, Taipei, Taiwan (Republic of China)
Introduction: The endoplasmic reticulum (ER) regu-
lates several cellular functions, including the protein
biosynthesis, folding, trafficking and modification.
The accumulation of unfolded or misfolded proteins
causes a form of cellular stress that has been termed ER
stress. ER stress activates the unfolded protein response
(UPR) signalling network which serves as an adaptive
response. The potential benefit of maintaining ER
homeostasis modulates ER stress status to protect the
kidney against various pathogenic environments.
Furthermore, ER stress induces autophagy in mamma-
lian cells. The ER stress-induced autophagy offers pro-
tection from oxidative-induced cytotoxicity and
ameliorated kidney injury. In this study, we understand
the mechanism modulated the regulation of UPR and
autophagy in kidney cells.
Methods: We examined cytotoxicity of ER stress indu-
cers (tunicamycin (TM) or thapsigargin (TG)) in
human kidney cells HK-2. To analyse low doses TM
or TG induces autophagy using immunofluorescence
microscopy, transmission electron microscopy and
Western blot analysis. Also, to investigate TM or TG
inhibits oxidative stress through the induction of
autophagy. In addition, we established an adenine-
induced chronic kidney disease (CKD) mice model.
The effectiveness of TM or TG was investigated in
CKD mice model.
Results: Low concentrations of TM and TG did not
affect cell viability in HK-2 cells. TM and TG induced
UPR pathway and autophagy. Furthermore, TM and
TG inhibited oxidative stress-induced cell death. The
inhibition of autophagy can increase cytotoxicity in
HK-2 cells. Therefore, TM- and TG-induced autophagy
palys a protective role. The inflammasome and cyto-
kine synthesis were suppressed after treatment with
TM and TG. In addition, HK-2 stimulated with TM
or TG had increased production of exosomes. In the
model of adenine diet-induced CKD, TM and TG
ameliorated renal dysfunction and injury through the
induction of ER stress and autophagy.
Summary/conclusion: These results suggest that TM
and TG protected kidney cells against oxidative stress-
induced cell death and inhibited inflammatory effect.
ER stress-induced autophagy may be a pro-survival
role. However, the complete mechanism of how TM
and TG regulate exosomes is yet unknown and need
further investigation.
LBS02.08
Extracellular Vesicle-induced protein phosphorylation: Rapid
activation of epithelial-mesenchymal transition pathways in lung
epithelial cell
Ganesh Shelkea, Yin Yananb, Cecilia Lasserc, Hjalmar Brismard and Jan
Lötvalle
aSahlgrenska Cancer Center/Department of Surgery, Institute of Clinical
Sciences, University of Gothenburg, Gothenburg, Sweden., Gothenburg,
Sweden; bDepartment of Biochemistry and Molecular Cell Biology,
Shanghai Jiao Tong University, School of Medicine 80 South Chongqing
Road, Shanghai 200025 China, Shenghai, China (People‘s Republic);
cKrefting Research Centre/University of Gothenburg1 Krefting Research
Centre, Dept of Internal medicine and clinical nutrition, Institute of
Medicine, University of Gothenburg, Sweden, Gothenburg, Sweden;
dScience for Life Laboratory, Dept. of Applied Physics, Royal Institute of
Technology, PO Box 1031, 17121, Solna, Sweden, Solna, Stockholm, Sweden;
eKrefting Research Centre, Institute of Medicine at the Sahlgrenska Academy,
University of Gothenburg, Göteborg, Sweden, Gothenburg, Sweden
Introduction: Extracellular vesicles are important
mediators of cell-to-cell communication. With their
bioactive cargos including proteins, lipids and nucleic
acids, they can alter the fate of a recipient cell. Mast-
cells and lung epithelium exists in close physical proxi-
mity and activity in mast cells is reflected in epithelial
cells. In this study, we hypothesized that mast cell-
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derived EVs alter recipient epithelial cells by inducing
phosphorylation of multiple proteins.
Methods: Mast cells derived-EVs (HMC1.1) were
obtained by differential ultracentrifugation. We deter-
mined the early protein phosphorylation induced by
EVs, in recipient cell A549 cells using phospho-protein
microarray (Sciomics), and determined the longer-
term effects on RNA transcripts and protein changes
in epithelial cells.
Results: Prolonged exposure of EVs altered cellular
morphology of recipient epithelial A549 cells. This
was in line with changes in the transcript that are
known to activate epithelial-mesenchymal transition
(EMT), including increased levels of TWIST1, MMP9,
TGFB1, and BMP-7. This was also reflected at the
protein levels in recipient cells; e.g downregulation of
CDH1 and upregulation of MMP. By contrast, EMT
inducing transcription factor Slug-Snail was upregu-
lated. To determine any rapid responses 30 minutes
after EV treatment we performed phospho-protein
microarray of recipient cells. In-silico analysis of phos-
pho-proteome revealed proteins in signalling networks
that are part of the PI3K-Akt pathway or cytokine
receptor interactions. Interestingly, a protein involved
in regulating focal adhesion and tight junctions was
phosphorylated in these experiments; e.g. CLDN1,
OCLN, and ACTN1. Finally, we validated one of the
well-studied EMT-regulating pathway (TGFβ signal-
ling) in both A549 and BEAS-2B cell lines.
Summary/conclusion: Mast cell-derived EV facilitates
activation of EMT in lung epithelial cells, which is
closely associated to EMT-associated protein phos-
phorylation. This study highlights the component of
signalling pathways that are rapidly phosphorylated in
recipient cells with the contact of EVs.
Funding: VBG group Herman Krefting Foundation,
Swedish Cancer Foundation, Swedish Research
Council, and Heart and Lung Foundation, EAACI,
AG Foundation, Lundgren Foundation, Sahlgrenska
University Hospital, and Sahlgrenska Academy.
LBS02.09
Serum extracellular vesicular miR-21-5p is a predictor of the
prognosis in idiopathic pulmonary fibrosis
Mitsuhiro Yamadaa, Tomonori Makiguchia, Yusuke Yoshiokab, Takahiro
Ochiyac and Masakazu Ichinosea
aDepartment of Respiratory Medicine, Tohoku University Graduate School of
Medicine, Sendai, Japan; bTokyo Medical University, Tokyo, Japan;
cDepartment of Molecular and Cellular Medicine, Institute of Medical
Science, Tokyo Medical University, Tokyo, Japan
Introduction: Idiopathic pulmonary fibrosis (IPF) is
a chronic and progressive lung disease for which no
treatment is capable of providing a complete cure.
The median survival for IPF patients from the time
of diagnosis is approximately 3 years. IPF patients
differ in terms of the disease progression rate and
prognosis, complicating the prediction of survival.
The identification of prognostic predictors for IPF
is important for determining who requires the most
intensive therapies. In this study, we explored the
possibility that microRNAs of serum EVs changed
during lung fibrosis and could serve as prognostic
biomarkers of IPF.
Methods: To determine target microRNAs in IPF, we
measured serum EV microRNA expression profiles
using microRNA PCR arrays in a bleomycin mouse
lung fibrosis model. Secondly, we enrolled 41 IPF
patients and conducted a 60-month prospective cohort
study. Expression of serum EV miR-21-5p was normal-
ized by dividing by the EV amount. The relative
amount of EVs was measured using the ExoScreen
method. We calculated the correlations between base-
line serum EV miR-21-5p expression and other clinical
variables. Furthermore, we determined if serum EV
miR-21-5p can predict mortality during 60 months
using the Cox hazard model. According to the median
level, we divided the IPF patients into two groups.
Then we compared the survival rate during 60 months
between the two groups using the Kaplan-Meier
method.
Results: Serum EV miR-21-5p was elevated in both the
acute inflammatory phase (day 7) and the chronic
fibrotic phase (day 28) in the mouse model. In the
clinical setting, serum EV miR-21-5p was significantly
higher in IPF patients than in control subjects. The
baseline serum EV miR-21-5p was correlated with the
rate of decline in vital capacity over 6 months.
Furthermore, serum EV miR-21-5p was independently
associated with mortality during the following
60 months, even after adjustment for other variables.
In the survival analysis, IPF patients whose baseline
serum EV miR-21-5p was high had a significantly
poorer prognosis over 60 months.
Summary/conclusion: Our results may suggest that
serum EV miR-21-5p has potential as a prognostic
biomarker for IPF.
Funding: This work was supported by Grants-in-Aid
for Scientific Research (24591148 and 15K09206 to M
Yamada) from the Japan Society for the Promotion of
Science (JSPS).
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Extracellular vesicles subpopulations: who are the key players in
vascular inflammation?
Baharak Hosseinkhania, Sören Kuypersa, Nynke Van den Akkerb, Daniel
Molinb and Luc Michielsa
aHasselt University, Martelarenlaan 42, B-3500 Hasselt, Belgium, Diepenbeek,
Belgium; bMaastricht University, dept. Of Physiology, Cardiovascular
Research Institute Maastricht (CARIM), Universiteitssingel 50, 6200 MD
Maastricht, The Netherlands, Maastricht, Netherlands
Introduction: Current conceptual insights on the
mechanistic aspect of cell signalling by discovering
extracellular vesicles (EV) have shed light on the patho-
logical understanding of chronic inflammatory dis-
eases. The biological function of EV bulk in the
progression of inflammation-associated disorders has
become clear, the protein composition and function of
the disease-specific subsets are often hampered by
undesirable EV co-isolates. Thus, there is an urgent
need to isolate certain subpopulations to generate a
disease-relevant signature while retaining their func-
tional integrity. Therefore, we aimed to fractionate
the inflammation associated-EV subsets based on two
important characteristics (sedimentation and surface
markers) and subsequently profiling the immunomo-
dulatory protein content.
Methods: TEM, NTA and Western blot were used to
characterize the purified inflammation-associated EV
subsets from TNF-α treated HUVEC based on their
sedimentation speeds (10K and 110K) and surface
markers (CDs and ICAM-1). Protein arrays were used
to discover the immunomodulatory content of subsets.
In addition, functional integrity of the EV subpopula-
tions was assessed using migration cell based assays.
Results: We demonstrated that HUVEC upon inflam-
mation release two distinct populations of heteroge-
neous EV, differing in size and quantity. The
immunoaffinity of these two populations towards EV
classical markers (a cocktail of CD9, CD63 and CD81)
and an inflammatory-associated marker revealed that
the circulating form of ICAM-1 is abundantly docked
on the membrane of large EV, thus offering a poten-
tially promising biomarker for immunocapturing of EV
subsets. Moreover, protein profiling of EV size-based
populations and their inflammation-associated EV sub-
sets showed that the patterns of cytokines and adhesion
markers were significantly different. In cell-based
assays, EV of different sizes work synergistically in
accelerating the vascular inflammation.
Summary/conclusion: A procedure of two purification
steps resulted in purer inflammation-associated EV
isolates, allowing a better understanding of their biol-
ogy and functions at the onset of vascular
inflammation.
Funding: This work was co-financed by the EU
through the Interreg IV Flanders-the Netherlands pro-
ject Interreg V Flanders-the Netherlands project Trans
Tech Diagnostics (TTD).
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Membrane-radiolabelled exosomes for comparative biodistribution
analysis in immunocompetent and immunodeficient mice – A novel
and universal approach
Farid N. Faruqua, Julie Wanga, Lizhou Xub, Luke McNicklea, Ming-Yiu
Chonga, Mark Gurneyc, Aled Claytonc, Lesley A. Smythd, Robert Hidera,
Jane Sosabowskie and Khuloud Al-Jamala
aKing‘s College London, London, United Kingdom; bSchool of Cancer and
Pharmaceutical Sciences, King‘s College London, London, United Kingdom;
cCardiff University, Cardiff, United Kingdom; dUniversity of East London,
London, United Kingdom; eQueen Mary University of London, London,
United Kingdom
Introduction: Exosomes have gained interest as novel
drug nanocarriers due to their biological origin and
role in intercellular biomolecule delivery. In-depth
knowledge of their in vivo biodistribution is therefore
essential. This work aimed to develop a reliable and
universal method to radiolabel exosomes to study in
vivo biodistribution in mice.
Methods: Melanoma (B16F10 cells)-derived exosomes
(ExoB16) were isolated and characterized for size,
yield, purity, exosomal markers and morphology
using Nanoparticle Tracking Analysis (NTA), protein
measurements, flow cytometry and electron micro-
scopy. Two radiolabelling approaches were explored –
intraluminal labelling (111Indium entrapment via tro-
polone shuttling); and membrane labelling (111Indium
chelation by covalently attached bifunctional chelator).
Labelling efficiency and stability was assessed by gel
filtration and thin layer chromatography. Melanoma-
bearing immunocompetent (C57BL/6) and immunode-
ficient (NSG) mice were injected intravenously with
radiolabelled ExoB16 (1x1011 particles) followed by
metabolic cages study, whole body SPECT-CT imaging
and ex vivo gamma counting at 1, 4 and 24 h post-
injection.
Results: Membrane-labelled ExoB16 (ML-ExoB16)
showed superior radiolabelling efficiency and radioche-
mical stability compared to intraluminal-labelled
ExoB16 (IL-ExoB16). Both IL- and ML-ExoB16
showed prominent accumulation in liver and spleen.
IL-ExoB16 showed higher tumour accumulation than
ML- ExoB16 (6.7% and 0,6% ID/g tissue, respectively),
with the former showing similar value as its free tracer
([111]Trop). The superior stability of the membrane-
labelling approach rendered its result more reliable and
was used to compare ExoB16 biodistribution in mela-
noma-bearing immunocompromized (NSG) mice.
Similar biodistribution profile was observed in both
C57BL/6 and NSG mice, where prominent accumula-
tion was seen in liver and spleen, apart from the lower
tumour accumulation observed in the NSG mice.
Summary/conclusion: Membrane radiolabelling of
exosomes is a reliable approach that allows for both
live imaging and quantitative biodistribution studies to
be performed on potentially all exosome types without
engineering parent cells.
LBS03.02
Rala and ralb finely tune EVs biogenesis and promote metastasis
Vincent Hyennea, Shima Ghoroghib, Olivier Lefebvreb and Jacky G. Goetzb
aINSERM U1109/CNRS, Strasbourg, France; bINSERM U1109, Strasbourg,
France
Introduction: Tumour extracellular vesicles (EVs) pro-
mote tumour progression. However, their behaviour in
body fluids remains mysterious. In addition, further
understanding of molecular mechanisms driving their
biogenesis is needed to develop strategies aiming to
impair their tumorigenic potential. We recently
showed that the zebrafish embryo can be used to
track and assess the function of circulating tumour
EVs in vivo and provide a high-resolution description
of their dissemination and uptake (Hyenne et al., Dev
Cell, 19). We provided a first description of tumour
EVs’ hemodynamic behaviour and showed that they
are rapidly taken up by endothelial cells and blood
patrolling macrophages and subsequently stored in
degradative compartments.
Methods: In addition, we recently investigated the
molecular mechanisms of EV release in a tumorigenic
context, using a mouse model of breast cancer
carcinoma.
Results: We observed that depletion of either RalA or
RalB GTPases decreases levels of EVs’ secretion
(Hyenne et al. JCB 15) and modifies their protein and
RNA content. We further showed that RalA and B are
required to properly localize PLD1 on MVBs thereby
inducing EVs biogenesis. Interestingly, EVs secreted
from RalA and RalB depleted cells are less prone to
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endothelial permeabilization in vitro. Finally, RalA and
RalB depletion significantly impairs lung metastasis in
a syngeneic model of breast carcinoma suggesting that
RalA/B controls lung metastatis by tuning the levels
and contents of tEVs.
Summary/conclusion: Overall, our recent works
proves the usefulness and prospects of zebrafish
embryo to track tumour EVs and dissect their role in
metastatic niches formation in vivo. It further provides
new mechanistic information as to how RalA and RalB
control the biogenesis of potent tumour-promot-
ing EVs.
LBS03.03
In vivo visualization of extracellular vesicles released from mature
osteoblasts by intravital multiphoton microscopy
Hiroki Mizuno, Maki Uenaka and Masaru Ishii
Department of Immunology and Cell Biology, Graduate School of Medicine
and Frontier Biosciences, Osaka University, Osaka, Japan, Suita, Japan
Introduction: Bone remodelling is essential for main-
taining bone architecture and systemic mineral home-
ostasis throughout life. In the process, the formation of
bone matrix by osteoblasts follows the removal of
mineralized bone by osteoclasts. Despite intensive
investigations on understanding their functions, the
detailed mechanisms on their dynamic nature in vivo
remain unknown. In this study we especially focus on
the dynamics of mature osteoblasts which replenish
bone matrices during homeostasis.
Methods: To understand the cellular dynamics of
mature osteoblasts in vivo, here we established a repor-
ter system where mature osteoblasts express enhanced
cyan fluorescent protein (ECFP). We could visualize
their dynamic nature in vivo by using intravital multi-
photon microscopy for live bone tissues which we have
originally developed so far.
Results: We detected that mature osteoblasts sponta-
neously release large extracellular vesicles (EVs), whose
sizes are from 0.2 to 1 µm, and those are also taken up
by mature osteoblasts. Such phenomenon could also be
reconstituted in mature osteoblasts cultured ex vivo.
Further analyses are currently ongoing in order to
analyse the physiological and pathophysiological func-
tions of these vesicles.
Summary/conclusion: This is the first study detecting
the real dynamic nature of microvesicles in vivo, which
are actively released from mature osteoblasts in the
bone cavity. We think these microvesicles are impor-
tant regulators for normal bone homeostasis as well as
pathological remodelling.
LBS03.04
New products from donated blood – unravelling the potential of
blood cell derived EVs
Ulla Impolaa, Sami Valkonenb and Saara Laitinenb
aBlood Service, Finnish Red Cross, Helsinki, Finland; bBlood Service Finnish
Red Cross, Helsinki, Finland
Introduction: Extracellular vesicles (EV) originated
from different cell types have recently been under
intense investigation. Platelet EVs constitute the
major fraction of EVs in the circulating plasma, how-
ever, there are only a few studies characterizing the
populations of platelet concentrate derived EVs in
more detail. Few recent publications show that plasma
EVs can target specifically into certain mononuclear
cell populations but little is known about their biologi-
cal function, signalling and communication. As just
recently addressed by Onodi et al., EV purification
has major challenges as majority of EVs from plasma
has lipoprotein particles and the abundant plasma pro-
teins as impurities complicating the study of the role of
pure EVs. We have previously shown that platelet
concentrates used for transfusions contain increasing
amount of EVs after longer storage period. It is impor-
tant to study these platelet-EVs in more detail in order
to understand their role in product functionality.
Methods: Excess platelet concentrates not needed for
the clinical use were obtained from the Finnish Red
Cross Blood Service. All donated blood products used
for research were obtained from healthy volunteers
who had given their informed consent. In our ongoing
work we compared ultracentrifugation based isolation
methods and size exclusion chromatography in order
to collect differing populations of platelet concentrate
derived EVs. EVs are further labelled with fluorescent
surface protein, lipid and RNA markers and studied
using Amnis ImageStream®X Mark II Imaging Flow
Cytometer. Purity and characteristics of these isolated
EVs are compared and their targeting into different
mononuclear cells as well as their immunological rele-
vance are investigated.
Results: Based on our results we are able to say that we
get a pure population of EVs with low contamination
of lipid or plasma protein impurities. The main popu-
lation of the platelet concentrate derived EVs are plate-
let derived and thus CD41 positive, however, the origin
of EVs differ as well as their cargo indicating differ-
ences in their immunological functions.
Summary/conclusion: Our aim is to find previously
ignored, new applications for donated blood compo-
nents and to identify the potential EV population to be
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utilized either as therapeutic components in tissue
repair or as drug delivery vehicles.
LBS03.05
The effect of rhinovirus type 16 derived microvesicles on the growth
of hela cells
Roberta Cordeiro Freezora, Gary McLeanb and Sheelagh Heughc
aLondon Metropolitan University, London, United Kingdom; bSupporting
PhD supervisor, London, United Kingdom; cPhD supervisor, London,
United Kingdom
Introduction: Belonging to group A, Rhinovirus Type
16 (HRV16) uses the receptor Intercellular Adhesion
Molecule (ICAM) 1 to enter cells. Studies demon-
strated Extracellular Vesicles (EV) discharge from
viral infected cells harbour and distribute regulatory
factors to recipient cells. These include viral RNA and
proteins, viral and cellular miRNA, as well as host
functional genetic elements to nearby cells, leading to
the production of infections particles and modulating
cellular responses including the spread or limitation of
infection conditional on the type of pathogen and
target cells. Here, we demostrate that HRV16 derived
microvesicles (HRV16MV) infect HeLa cells at a higher
rate than HRV16 particles.
Methods: HRV16MV were extracted from HeLa cells
after 24 h of HRV16 infection (MOI 0.2) via ultracen-
trifugation. Quantified by Flow cytometry, HeLaMV
control (HelaMVc) and HRV16MV were added to
each well containing the HeLa cells treated with CGM
(exosome free). The plates were incubated at 37°C in a
5% CO2 and left untreated for 24 h. HeLa cells control
samples were observed against MV treated cells and the
concentration/mL and % viability were determined
every 4 h after 12 h incubation period to determine
the effect of MV on the growth of the cell line.
Results: HRV16MV treated cells showed a growth
decline after 16 h into the experiment, which suggests
a faster infection rate (P**) when compared to HRV16
infection. Both, HRV16 and HRV16MV treated cells
demonstrated a decline in % viability (P>**) after 16 h
of infection in comparison to HeLaMVc. However,
despite a slight decrease in in the growth rate of
HRV16MV treated cells no statistical significance was
observed in % viability between samples.
Summary/conclusion: HRV16MV treated cells showed
an advanced infection rate of treated HeLa cells.
HRV16 genome encodes two proteases specifically,
2A and 3C as well as a precursor protease, 3CD.
These proteases are necessary for adequate virus repli-
cation, for the precise localisation of proteins during
infection and for the temporal regulation of 2A and
3CD/3C protease activities during HRV16 infection.
Therefore, these proteases may be hypothesized to be
embedded in HRV16MV suggesting that they could
potentially be hijacked by the virus to spread infection.
LBS03.06
A highly efficient cell-free protein synthesis system from
plasmid DNA.
Hyangsu Nam
University of Seoul, Seoul, Republic of Korea
Introduction: Protein is essential molecules that play
many critical roles in the body. Activity and interaction
of gene encoding proteins are recognized as a key
element of pharmaceutical and biomaterials. However,
since the general protein production method is per-
formed through microorganisms and cell culture pro-
cesses that require a lot of time and labour, it is not
only decomposed and deformed by enzymes produced
by cell growth but also has a limit to producing a large
amount of protein. This study reports a DNA hydrogel
that can induce excessive protein without lives cells
using denatured DNA plasmid. This novel synthesis
method improved the efficiency of protein expression
through Rolling circle amplification that repetitive
sequencing of nucleotides for protein expression in
plasmid DNA that codes a specific gene. Notably, our
synthesized DNA plasmid gel expressed large scale
green fluorescence protein (GFP) than wild type. In
addition, DNA gel has the strength of having a physical
characteristic and being able to express the specific
protein in a specific area. Novel large-scale protein
expression method using cell-free DNA gel has great
potential as a biomaterial for therapeutic protein deliv-
ery. In addition, this method can be applied mRNA
manipulation, which plays a major role in transmitting
proteins, can be used to transfer particles using RCA
method and to produce vesicles containing proteins by
putting them in vesicles.
Methods: The plasmid pT7CEF1-Chis was prepared
Thermofisher. Linear single stranded circular DNA
oligonucleotides from denatured DNA plasmid were
incubated with T4 polymerase at 30℃ 72 h with
dNTPs.
Results: We developed the periodically repeated
nucleotides through RCA process band its cell-free
largescale protein expression system. The synthesized
plasmid DNA hydrogel has stable formation and hav-
ing a high efficiency to express specific protein.
Summary/conclusion: In this study, we developed cell-
free protein expression method, which were
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synthesized by a uniquely designed RCA method, as a
protein therapeutics platform technology. The cell-free
protein producing DNA plasmid gel can be considered
as a potential candidate for protein delivery.
LBS03.07
Targeting mevalonate pathway with low doses of valproic acid
reduces large EVs shedding in different solid tumours
Chiara Ciardielloa, Rossella Migliorinoa, Federica Iannellia, Maria S. Rocaa,
Francesca Bruzzesea, Biagio Puccia, Susan Costantinia, Elena Di Gennaroa,
Alessandra Leonea and Alfredo Budillonb
aExperimental Pharmacology Unit, Istituto Nazionale Tumori – IRCCS-
Fondazione G. Pascale, Napoli, Italy; bIstituto Nazionale Tumori – IRCCS-
Fondazione G. Pascale, Napoli, Italy
Introduction: Epithelial to mesenchymal transition
(EMT) as well as mesenchymal to amoeboid transition
(MAT) are linked with increased cancer cell motility
and stemness, MAT being also described to favour
large extracellular vesicles (EVs) shedding. Recently,
both these phenotypic changes were associated to
metabolic control involving the mevalonate pathway
(MVP), a key controller of lipid metabolism but also
a regulator of cell structure and signalling. valproic acid
(VPA), an antiepileptic and a well-known histone dea-
cetylase inhibitor, showed antitumor activity and cap-
ability to augment anticancer efficacies of other
therapeutic approaches (i.e. ionizing radiation, che-
motherapy, immunotherapy).
Methods: Two different isogenic models developed by
our group were used: prostate cancer DU145 cells and
their derived more aggressive subline DU145R80
selected as resistant to MVP-pathway inhibitors and
enriched in stem markers; the colorectal cancer
CO147 primary cell line, cultured either as differen-
tiated cells or as cancer stem cells enriched spheres.
Western blotting and metabolomics were performed to
monitor MVP modulation upon VPA treatment (0.5-
1 mM). Large EVs were isolated from cell media by
discontinuous density gradient ultra-centrifugations
and measured by Tunable resistive pulse sensing or
flow cytometry VPA-treated or untreated cells.
Results: Both DU145R80 cells and CO147 cultured as
spheres showed enriched stem like features and higher
large EVs shedding, compared to parental DU145 and
differentiated CO147 cells, respectively. At very low
doses, VPA reduced large EVs shedding in both
DU145R80 and CO147 sphere cultures, compared to
the untreated cells, without affecting cells viability.
Mechanistically, preliminary data suggest that VPA-
induced effect is mediated by MVP pathway
modulation.
Summary/conclusion: Our results describe for the first
time a novel anticancer potential of VPA, being able to
impact cancer cell to cell communication by reducing
the shedding of large EVs.
Funding: AIRC FIRC
LBS03.08
The role of glycogen synthase kinase 3 beta in the biogenesis of
extracellular vesicles by modulating microtubule dynamics
Seoyoon Baea, Eun-Jeong Choia, Kwan Soo Hongb and Yong Song Ghoa
aDepartment of Life Sciences, Pohang University of Science and Technology,
Pohang, Republic of Korea; bBioimaging Research Team, Korea Basic Science
Institute, Cheongju, Republic of Korea
Introduction: Extracellular vesicles (EVs) are spherical,
bilayered membranous vesicles secreted by all living
cells. EVs harbour various bioactive materials, and
play diverse roles in biological processes such as
tumour progression. There are several reports studied
on the proteins involved in EV biogenesis mainly
focused on the proteins involved in vesicle trafficking.
However, proteins regulating EV biogenesis are still
unclear. As most cellular processes are regulated by
protein phosphorylation, which is regulated by kinases
and phosphatases, identifying kinases and phospha-
tases involved in EV biogenesis helps to understand
EV-mediated pathophysiological functions.
Methods: To identify kinases and phosphatases
involved in EV biogenesis, a total of 76 kinase inhibi-
tors and 33 phosphatase inhibitors were treated to
A549 cells. The amounts of CD81, an EV-enriched
protein, were quantified from the conditioned media
to show alterations in EV biogenesis. To further verify
the role of glycogen synthase kinase 3 beta (GSK3β) in
EV biogenesis, stable cell lines expressing wild-type,
constitutively active mutant, and dominant-negative
mutant GSK3β were established, and alterations in
EV biogenesis were measured in these cell lines. As
microtubule dynamics affects EV biogenesis, changes
in microtubule dynamics were also assessed in these
cell lines.
Results: Among the kinase and phosphatase inhibitors,
an inhibitor of GSK3β and calcineurin decreased and
increased EV biogenesis, respectively. EV biogenesis
was increased in the conditioned media from cells
expressing constitutively active mutant GSK3β, and
decreased in the conditioned media from cells expres-
sing dominant-negative mutant GSK3β, when com-
pared with cells expressing wild-type GSK3β.
Microtubules were more disorganized in cells expres-
sing constitutively active mutant GSK3β, and more
aligned in cells expressing dominant-negative mutant
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GSK3β, when compared with cells expressing wild-type
GSK3β.
Summary/conclusion: By high-throughput screening
of kinase/phosphatase inhibitors, we identified GSK3β
as a positive regulator of EV biogenesis by modulating
microtubule dynamics. These observations suggest that
GSK3β as a novel therapeutic target against several
diseases by modulating EV biogenesis.
LBS03.09
Post-translational modifications affects trafficking of hyaluronan
synthase 2 and the release of extracellular vesicles
Raquel Maria. Meleroa, Uma Thanigai Arasub, Riikka Kärnäb, Sanna Oikarib,
Kirsi Rillab, Davide Vigettic, Alberto G. Passic, Heldin Paraskevid, Tammi
Markkue and Ashik Jawahar Deene
aCEU-San Pablo, Boadilla, Spain; bInstitute of Biomedicine, University of
Eastern Finland, Kuopio, Finland., Kuopio, Finland; cDepartment of
Medicine and Surgery, University of Insubria, Varese, Italy., Varese, Italy;
dDepartment of Medical Biochemistry and Microbiology, Uppsala University,
Uppsala, Sweden, Uppsala, Sweden; eInstitute of Biomedicine, University of
Eastern Finland, Kuopio, Finland, Kuopio, Finland
Introduction: Hyaluronan synthase 2 (HAS2) is the
major producer of Hyaluronan (HA) in adult verte-
brates. Its enhanced expression has been lately related
within the apical filopodia growth and the budding of
extracellular vesicles (EVs). Moreover, a fraction of
HAS enzymes are secreted from PM into extracellular
vesicles (EVs), often covered by HA. We studied
whether the mutations blocking post-translational
modifications on HAS2 also affected the EVs released.
Methods: Site-directed mutagenesis was used to block
ubiquitination (K190R), and phosphorylation (T110A)
HA was measured using ELSA
Isolation of EV secreted by HAS2-transfected cells was
performed using ultracentrifugation
Analysis of extracellular vesicles (EV) was performed
with a Nanoparticle Tracking Analyzer and 3D culture
Results: Cell cultures transfected with HAS2 wt
secreted ~50% more EVs as compared to mock con-
trols. Similar stimulation of EV secretion was found
with K190R, while non-increase of EVs occurred with
T110A. These results lead us to two conclusions. First,
PM residence of HAS2 is likely required for the stimu-
lation of EV secretion. And second, HA synthesis is not
strictly necessary for EV secretion, since K190R is
enzymatically inactive. Cells were grown in a 3D
matrix to check if K190R was entering itself in the
vesicles. The data show that HAS2 wt and K190R, but
not T110A were present in the EVs. This indicates that
the mechanism of HAS2 stimulation of EVs involves
HAS2 incorporation in them, and without the involve-
ment of HA. Unexpectedly, 4-MU (HA synthesis
inhibitor 4-MU) blocked the shedding of all transfected
HAS2 and its mutants.
Summary/conclusion: Our data show that an enzyma-
tically inactive HAS2 residing in PM (K190R)
enhanced EV secretion to the same extent as
HAS2 wt, while it did not induce the PM protrusions.
Just the insertion of HAS2 in PM must, therefore,
trigger a signal or structural alteration in the mem-
brane that facilitates its inclusion in, and shedding of
the EVs.
Another interesting finding was that while HA was not
necessary for EV formation, the HA synthesis inhibitor
4-MU blocked HAS2 insertion in the EVs. This may
represent yet another mechanism of HA synthesis inhi-
bition by 4-MU. Exploring the mechanism of the block
and its importance in HA synthesis and EV shedding
will be interesting targets of future studies, especially in
cancer epidemiology.
LBS03.10
Improving the stability of the large extracellular loop of human
tetraspanin CD81
Stefan Vogta, Gordana Wozniak-Knoppb, Gerhard Stadlmayrb, Katharina
Stadlbauerb, Florian Rükerc and Johannes Grillarid
aDepartment of Biotechnology, University of Natural Resources and Life
Sciences (BOKU), Vienna, Muthgasse 18, 1190 Vienna, Austria, Vienna,
Austria; bChristian Doppler Laboratory for Innovative Immunotherapeutics,
Department of Biotechnology, University of Natural Resources and Life
Sciences, Vienna (BOKU),Muthgasse 18, A-1190 Vienna, Austria, Wien,
Austria; cChristian Doppler Laboratory for Innovative Immunotherapeutics,
Department of Biotechnology, University of Natural Resources and Life
Sciences, Vienna (BOKU), Muthgasse 18, A-1190 Vienna, Austria, Wien,
Austria; dEvercyte GmbH, Muthgasse 18, A-1190 Vienna, Austria, Wien,
Austria
Introduction: Members of tetraspanin protein family
are abundant on the surface of nearly every type of
extracellular vesicles (EVs) and are therefore attractive
targets for modification, leading to transformation of
the EVs into a targeted drug delivery system. The
engineering of tetraspanin extracellular domains as
independent folding units towards specific antigen
recognition is therefore of particular interest.
Methods: We have applied rigid body protein model-
ling approach to design more stable mutants of large
extracellular loop (LEL) of human tetraspanin protein
CD81. Proteins were expressed in ExpiCHO expression
system and IMAC-purified. Their stability was exam-
ined using DSC and the protein fold integrity assessed
with HPLC-SEC in native conditions and reactivity
with structurally dependent binding anti-CD81 anti-
body. Mutants based on such stabilized scaffolds were
engrafted with human transferrin receptor (hTfr) spe-
cific peptide at different positions, tested for their bio-
physical properties and internalization in vitro.
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Results: In order to enhance the tolerance for modifi-
cation we successfully identified positions that could
accommodate pairs of point mutations to cysteine resi-
dues, leading to de novo disulphide bridges in the
human CD81 LEL. We achieved an increased thermal
stability with a shift in melting temperature (Tm) of up
to 25°C in mutants with one additional disulphide
bridge. Mutants harbouring a combination of 2 engi-
neered disulphide bonds showed an increased Tm of
up to 43°C.
The graft of a hTFR-binding peptide into the D-Helix
of the wild-type LEL resulted in a protein that still
exhibited a compact fold. When the same peptide
sequence was inserted between the helices A and B,
the mutant showed an aberrant profile in SEC, which
could be cured by using a scaffold variant with a
stabilized LEL backbone. Additionally, both peptide-
grafted proteins revealed increased internalization
into hTFR-overexpressing SK-BR-3 breast cancer cells
compared to the respective wild-type proteins.
Summary/conclusion: These results define important
requirements for improving the amenability of tetra-
spanins, in particular CD81 LEL, for their engineering
into a more versatile protein scaffold, which should
empower the design of antigen-binding tetraspanins
as targeting moieties of EVs and functionalize them
as a drug delivery vehicle.
LBS03.11
Comparison of exosomes and ferritin protein nanocages for the
delivery of membrane protein theraqeutics
Eunji Cho, Gi-Hoon Nam, Jiyoung Goo, Cherlhyun Jeong, Yoosoo Yang and
In-San Kim
Center for Theragnosis, Korea Institute of Science and Technology, Seoul,
Republic of Korea
Introduction: Exosomes are small membrane vesicles
secreted by most cell types that plays an important role
in intercellular communication. Due to the character-
istic of transferring their biomacromolecules, exosomes
have potential as a new alternative for delivering pro-
tein therapeutics. Here, we investigate whether exo-
somes provide crucial advantages over other
nanoparticles, in particular protein nanocage formula-
tions, as a delivery system for membrane protein ther-
apeutics. We characterized membrane-scaffold–based
exosomes and protein-scaffold–based ferritin nano-
cages, both harbouring SIRPα (signal regulatory pro-
tein α), an antagonist of CD47 on tumour cells.
Methods: For preparing exo-SIRPα, HEK293T cells
were transiently transfected with desirable plasmid
DNA. Following a further incubation for 48 h, the
supernatants of transfected HEK293T cells were har-
vested and subjected to a serial centrifugation protocol
(300 × g for 10 min, 2000 × g for 10 min and 10,000 × g
for 30 min) to remove debris. Then, exosomes were
isolated from the cell culture medium by ultracentrifu-
gation (150,000×g for 2 h). Ferritin-SIRPα and mono-
mer SIRPα proteins were purified through an Ni-NTA
chromatography step. For the impartial comparison,
we adjusted the same amount of SIRPα proteins of 2
nanocages in all experiments.
Results: Exo-SIRPα exceeds Ferritin-SIRPα in all
experiments, cell binding ability, enhancing phagocytic
function of bone marrow derived macrophage, in vivo
anti-tumour effect and tumour specific immune
response. Exosome-SIRPα shows better feasibility com-
pared to ferritin-SIRPα; five-folds higher in the aspect
of cell binding ability, three folds higher of phagocyto-
sic activity and 4 folds higher in the case of tumour
growth inhibition.
Summary/conclusion: We compared the efficacy of
two nanoparticles and concluded that exosome has
more advantages in delivering membrane proteins for
therapeutic purpose. Our findings highlight the ability
of exosomes to display native membrane proteins on
their surface – a significant advantage of this delivery
system – and suggest that CD47 blockade by exosome-
mediated SIRPα delivery is superior to that mediated
by a protein scaffold.
LBS03.12
Cell-specific growth surface topography optimization for extracellular
vesicle studies
Colin L. Hiseya, Cherie Blenkironb and Larry Chamleyc
aUniversity of Auckland, Grafton, New Zealand; bThe University of
Auckland, Auckland, New Zealand; cThe University of Auckland
Introduction: While patient fluid samples provide
valuable insight into the role of EVs in human health,
their limited supply and heterogeneous nature make
them impractical for basic studies. Conditioned media
provides a consistent and limitless supply of EVs from
a known cell type, but large volumes are required to
generate adequate numbers of EVs. Also, little is
known about how factors in the cellular microenviron-
ment, like surface topography, affect the EVs due to a
lack of accessible biomimetic cell culture systems. We
present a unique cell culture dish covered in micro-
track patterns and demonstrate that this biomimicry
affects the EVs produced by cancer cells.
Methods: Microtrack patterns were fabricated using
photolithography. Soft lithography was used to create
microtrack moulds, which were spincoated with
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polystyrene and stamped onto 150 mm petri dishes.
Oxygen plasma and UV sterilisation were used to pre-
pare the surfaces for cell growth. MCF7 breast cancer
cells were seeded and cell viability and morphology
were quantified. Live cells stained with Calcein-AM
were imaged and their morphology was quantified
using FIJI. Cytoskeletal structure was imaged using
DAPI, TRITC-phalloidin and anti-vinculin/FITC-IgG.
Cells were cultured in EV-depleted media for the last
48h and EVs from smooth (control) and patterned
dishes were isolated using Vivaspin ultrafiltration and
sequential ultracentrifugation. Finally, EV structural
integrity, concentration and size distribution were
characterized using TEM and nanoparticle tracking
analysis.
Results: MCF7 cells cultured on microtrack dishes
demonstrated similar viability to smooth surfaces.
Cell morphologies on microtracks had higher average
aspect ratios and less circularity (p < .05), as well as
greater actin cytoskeletal alignment. Early nanoparticle
tracking analysis results indicate that cells cultured on
fibrous surfaces release more EVs than EVs from
smooth surfaces and these results are currently being
further corroborated.
Summary/conclusion: This type of patterned growth
surface could have implications in both EV biomimicry
and biomanufacturing. While it appears that simple
surface patterning with microtracks could simply and
inexpensively improve EV-yield from cell cultures, we
are now exploring whether it also affects their
biomimicry.
LBS03.13
Development of engineered extracellular vesicles expressing immune
checkpoint protein PD-1 by fusion with liposomes
Raga Ishikawaa, Shosuke Yoshidab, Shin-ichi Sawadaa, Sada-atsu Mukaia,
Yoshihiro Sasakia and Kazunari Akiyoshia
aKyoto University, Kyoto, Japan; bNara Institute of Science and Technology,
Ikoma, Japan
Introduction: Extracellular vesicles (EVs) can poten-
tially be used in biomedical applications in drug deliv-
ery system. However, many problems still remain, such
as equipping EVs with active targeting ability and con-
trolling the encapsulation of therapeutic drugs in EVs.
We have developed a new method for the preparation
of the functional EVs that display exogeneous mem-
brane proteins using the baculovirus-expression sys-
tem. In addition, we have proposed that EV –
liposome hybrids were prepared by membrane fusion
between liposomes and EVs containing fusogenic viral
glycoprotein 64 (gp64). Here, we report preparation of
new hybrid EVs expressing immune checkpoint pro-
tein PD-1 by this method and evaluation of the func-
tions such as the specific interaction with cancer cells
Methods: The cDNA of PD-1 on a baculovirus vector
was transfected into Sf9 insect cells, and EVs that were
expressed PD-1 on the surface were collected by ultra-
centrifugation. The hybrid EVs were prepared by
membrane fusion between PD-1 EVs and FITC-
Dextran loaded-liposomes at the acidic condition.
PD-1 and gp64 expression on PD-1 EVs and PD-1
hybrid EVs were detected by Western blotting. PD-1
hybrid EVs were incubated with Hela cells, and cellular
uptake of PD-1 hybrid EVs was observed by confocal
laser scanning microscopy (CLSM).
Results: As results of Western blotting, PD-1 and gp64
were detected on EVs and also hybrid EVs prepared at
acidic pH. Membrane fusion between EVs containing
gp64 and liposomes proceeded only under the acidic
pH. Interaction between PD-1 hybrid EVs and PD-L1-
expressing cancer cells was investigated by CLSM. The
PD-1 hybrid EVs effectively internalized into the cells
via interaction with PD-L1, and FITC-dextran (as a
model of drug) loaded into PD-1 hybrid EVs was
efficiently delivered into the cells.
Summary/conclusion: In summary, we prepared PD-1
hybrid EVs by using baculovirus-expression system
and membrane fusion with functional liposomes. This
method provides a new strategy for engineering EVs.
LBS03.14
Carcinogenesis and exosome packaging
Parul Katocha, Jessica Rodrigueza, Mark Floryb, Randall Armstrongb and
Thuy Ngob
aOregon Health and Science University, Portland, USA; bOHSU, port-
land, USA
Introduction: Identification of cancer-specific biomar-
kers on exosomes has evaded researchers for years and
poses an enormous roadblock towards developing
effective diagnostic tools for early cancer detection.
This is mainly due to the lack of a unique exosome
marker. Therefore, if we intend to use exosomes as
cancer biomarkers in liquid biopy we need to identify
unique markers present on the exosomes or associated
with them in cancer. Thus, we aim to delineate mole-
cular mechanisms employed during exosome packa-
ging and cargo-loading. We hypothesize that cancer
cell employ distinct molecular machineries to package
protein-cargo vs RNA-cargo into exosomes. We further
postulate that understanding the packaging proteins
involved in this cargo-specific packaging will reveal
key stages of biogenesis and will aid in identifying
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unique markers associated with exosomes during
carcinogenesis.
Methods: Recombinant DNA technology, confocal,
super-resolution imaging, ultracentrifugation, ultrafil-
tration and size exclusion columns, nanoparticle-track-
ing analysis electron microscopy, high-resolution flow
cytometry and Western blotting
Results: We have generated an in-vitro cell culture
system comprised of lung-cancer cell lines BEAS2-B
and A549. The former represents early stage indolent
disease while the latter represents late stage aggressive
disease. The culture system is genetically engineered to
stably express tagged components of an exosome,
namely- lipid bilayer (Td-Tomato-tagged
myristoylation sequence), transmembrane cargo pro-
tein (EGFP-tagged α5β6 integrin) and an RNA mole-
cule (metabolically labelled). Exosomes generated by
the system are isolated and characterized.
Summary/conclusion: Thus, we have generated a
unique tool, with which we aim to identify – a) unique
patterns of cargo packaging within these exosomes and
b) to elucidate the proteins involved in this directed
packaging. Research undertaken in this project will
provide new and exciting avenues to detect signs of
early cancer progression holds immense potential for
identifying cancer biomarkers.
Funding: CEDAR (Cancer Early Detection Advanced
Research Center), Knight Cancer Institute)
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OS26.01
Influence of lipoprotein particles in extracellular vesicle analysis by
single particle flow cytometry
Estefanía Lozano-Andrésa, Sten F. Libregtsb, Ger Arkesteijnb and Marca H.
M. Waubenc
aDeaprtment of Biochemistry & Cell Biology, Faculty of Veterinary Medicine,
Utrecht University, Utrecht, Netherlands; bFaculty of Veterinary Medicine,
Utrecht University, Utrecht, Netherlands; cDepartment of Biochemistry &
Cell Biology, Faculty of Veterinary Medicine, Utrecht University, Utrecht,
Netherlands
Introduction: High-resolution flow cytometry (FC)
allows for the detection of single extracellular vesicles
(EV) and enables quantitative and qualitative charac-
terization. EV in plasma has been associated with dis-
eases, making them attractive for diagnosis and
prognosis of patients. However, the presence of lipo-
protein particles (LPP) in plasma may hamper robust
flow cytometric analysis of EV. We here investigated
the interference of these particles when generic fluor-
escent dyes are used for labelling and detection of EV
by FC.
Methods: To define the impact of LPP on fluorescence-
based FC–detection of EV, commercially available LPP
preparations, EV isolated from conditioned media of
the mouse 4T1 mammary carcinoma cell line, and
platelet-poor plasma samples from healthy fastened
human donors were stained with PKH67 and CFSE.
EV was isolated from samples by differential ultracen-
trifugation or size-exclusion chromatography (SEC).
Stained LPP, plasma EV and 4T1 EV were succumbed
to density gradient floatation, after which FC-analysis
was performed using a BD Influx that was optimized
for detection of submicron-sized particles.
Results: We found that both PKH67 and CFSE have
the capacity to label various types of LPP. When ana-
lysed by FC, fluorescently labelled LPP and EV are
hard to discriminate based on fluorescent and light
scatter signals. Interestingly however, both dyes show
a different staining pattern for LPP and are indicative
for the type of LPP analysed. In addition, we demon-
strated that LPP show different sensitivity to detergent
lysis when compared to EV. Finally, using spike-in
experiments we found that the presence of LPP can
obscure generic fluorescent labelling of EV, highlight-
ing the need for proper EV isolation and purification
when human plasma is used in generic fluorescent-
based FC-detection of EV.
Summary/Conclusion: In order to perform reliable
and reproducible fluorescent-based FC-analysis of sin-
gle EV from human plasma, either EV-specific fluor-
escent dyes or labels should be used or plasma samples
should be carefully cleared from particles prone to
incorporate the generic dye.
Funding: European Union’s Horizon 2020 research
and innovation programme under the Marie
Skłodowska-Curie grant agreement No [722148] and
STW-Perspectief Cancer-ID grant [14,191].
OS26.02
Single-particle analysis of exosome DNA/RNA abundance, identity
and location via a laboratory-built nano-flow cytometer
Xiaomei Yana, Haisheng Liua, Ye Tianb and Shaobin Zhuc
aDepartment of Chemical Biology, College of Chemistry and Chemical
Engineering, Xiamen University, Xiamen, China (People’s Republic);
bDepartment of Chemical Biology, College of Chemistry and Chemical
Engineering, Xiamen University, Xiamen, China; cNanoFCM Inc., Xiamen,
China (People’s Republic)
Introduction: Through packing and transferring nucleic
acids including genomic DNA, mitochondrial DNA,
microRNA, mRNA and long noncoding RNA, exosomes
play important roles in maintaining cellular homeostasis,
priming immune system and regulating tumour progres-
sion. However, the abundance, identity (single stranded or
double stranded) and location (surface-bound or inside) of
nucleic acids in single exosomes is still a conundrum.
Herein, a laboratory-built nano-flow cytometer (nFCM)
that enables multiparameter analysis of single exosomes as
small as 40 nm is used to investigate the features of exoso-
mal nucleic acids.
Methods: Exosomes derived from a colorectal cancer
cell line (HCT15) and a normal colon fibroblast cell
line (CCD-18Co) were isolated by differential ultracen-
trifugation. The location and identity of DNA/RNA
was examined by measuring the fluorescence signals
of single exosomes upon nucleic acid labelling with
SYTO 16 or SYTO RNASelect dye before and after
enzymatic digestion with DNase I, dsDNase, S1 nucle-
ase and RNase A, respectively. To achieve a selective
labelling for DNA/RNA, ethynyl-modified dUTP
(EdU)/ethynyl-modified UTP (EU) were incorporated
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into the newly synthesized DNA/RNA by metabolic
biosynthetic pathway followed by chemoselective cou-
pling with azide-AF488 via click chemistry.
Results: We found that the majority of exosomal DNA
reside on the outer surface of exosomes via bound with
membrane proteins and most of DNA are dsDNA.
Meanwhile, almost all the RNA are encapsulated inside
exosomes. Through correlation analysis with side scat-
tering signals of single exosomes, it was identified that
most of the luminal DNA are associated with large size
exosomes and surface-adhering DNA mainly exist on
small size exosomes; yet the particle size of RNA con-
taining exosomes ranges from small to large sizes.
Because exosomes maintain cellular homeostasis by
excreting harmful cytoplasmic DNA from cells, the
effect of anti-tumour agents such as etoposide, topote-
can, SN-38 and cisplatin on the abundance and loca-
tion change of exosomal DNA will be reported.
Summary/Conclusion: nFCM provides a straightfor-
ward and practical approach for the location and iden-
tity studies of nucleic acids in individual exosomes,
which will be very helpful in the illustration of exo-
some-mediated, nucleic acids-based intercellular
communication.
OS26.03
Using a combination of bead-based flow cytometry and imaging flow
cytometry to understand Extracellular Vesicle heterogeneity
André Görgensa, Beklem Bostancioglub, Daniel Hageyb, Joshua Welshc,
Maximilian Kordesd, Björn Evertssone, Manuela Gustafssonb, Jennifer C.
Jonesc, Oscar Wiklanderb and Samir El Andaloussif
aKarolinska Institutet, Department of Laboratory Medicine, Stockholm,
Sweden; bClinical Research Center, Department for Laboratory Medicine,
Karolinska Institutet, Stockholm, Sweden; cTranslational Nanobiology
Section, Laboratory of Pathology, National Cancer Institute, National
Institutes of Health, Bethesda, MD, USA; dDepartment of Clinical Sciences,
Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm,
Sweden; eDepartment of Clinical Neuroscience, Karolinska Institutet,
Karolinska University Hospital, Stockholm, Sweden; fDepartment of
Laboratory Medicine, Clinical Research Center, Karolinska Institutet,
Sweden, Stockholm
Introduction: Extracellular vesicles (EVs) are secreted
by all cell types and can be found in all body fluids.
They can be roughly classified based on their size and
origin as exosomes (70–150 nm) and microvesicles
(100 nm to 1 µm). However, it is nowadays commonly
accepted in the field that there is a much higher degree
of EV heterogeneity within these two subgroups. Also,
their content, protein composition and surface signa-
ture likely is dependent on multiple parameters like the
cell’s metabolic or immunological status. Moreover, the
protein composition and surface marker signature of
EVs is further dependent on the cell type releasing
them. Accordingly, EVs secreted by different normal
cell types or malignant cells also will display distinct
surface profiles. Until today, only few EV surface mar-
kers have been related to specific cell sources.
Methods: We have recently optimized two flow cyto-
metry based methods for EV surface marker analysis, a
multiplex bead-based approach which allows robust
identification of co-expressed surface marker combina-
tions (Wiklander et al, 2018) and a method using
imaging flow cytometry to quantify EV subsets at the
single vesicle level (Görgens et al, in revision).
Results: Here, we combined both flow cytometric
approaches aiming to identify EV surface marker com-
binations being specific for EVs from specific cell types
and/or disease-related cells such as cancer cells. We
first used the multiplex bead-based assay to screen
EVs isolated from 40+ different immortalized human
cell lines from different tissues. Next, we have applied
the same screening technology to assess surface signa-
tures of EVs derived from diverse biological fluids of
human healthy donors in order to identify differential
surface marker combinations between different body
fluids and estimate general donor-to-donor variation
within respective sample groups. Validation of identi-
fied EV surface signatures by high resolution single
vesicle imaging flow cytometry and other methods is
currently ongoing.
Summary/Conclusion: We will show preliminary data
resulting from this approach and propose that the
identification of specific EV surface marker combina-
tions will be highly relevant to further understand the
molecular content and related functions of subsets of
EVs in health and disease.
OS26.04
A single extracellular vesicle (EV) flow cytometry approach to reveal
EV heterogeneity
Wenwan Zhong and Kaizhu Guo
University of California, Riverside, CA, USA
Introduction: To reveal the clear correlation between
extracellular vesicle (EV) functions and molecular sig-
natures, the only effective approach is to analyse the
molecular profile of individual EVs. Flow cytometry
(FC) has been widely employed to distinguish different
cell types in mixed populations, but the sizes of EVs fall
well below the detection limit of conventional flow
cytometers, making it impossible to do single-EV ana-
lysis without significant instrumentation development.
Methods: We innovatively solve this difficulty by
amplifying the size of each EV by DNA nanostructures
so that they can be analysed in conventional flow
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cytometers. In this approach, either an aptamer or an
antibody is employed to recognize the specific surface
marker on each EV, and initiate construction of a large
DNA nanostructure by hybridization chain reaction.
The resultant structure not only enlarges the overall
size of the single EV, but also can bind to multiple
fluorophores to amplify the signal from the few num-
ber of molecules on the EV surface, enabling visualiza-
tion of single EVs in a conventional flow cytometer.
Results: We have successfully demonstrated counting
single EVs in the FACSCanto after a one-pot reaction,
and multiple surface markers can be simultaneously
targeted to differentiate EV sub-groups based on their
surface protein signature. While aptamers provide a
cleaner background for detection, the large selection
of antibodies makes it applicable for diverse surface
markers on the EVs for sub-grouping. We have been
applying this technique to analyse EVs produced from
different breast cancer cell lines, as well as the EVs in
patients’ sera.
Summary/Conclusion: In summary, we have devel-
oped a single-EV FC analysis technique to visualize
single EV in a conventional flow cytometer. Our
technique enables study of single EVs using this
widely available instrument to gain in-depth insights
into the molecular signatures of EV sub-populations
at the single EV level. Targeting multiple markers
greatly improves differentiation of EV sub-popula-
tions. The high simplicity of our method and its
good adaptivity to clinical labs will be highly bene-
ficial for screening for effective EV markers for
liquid biopsy applications.
Funding: NIH-NCI
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OS27.01
Extracellular vesicles released by commensal Lactobacillus suppress
HIV-1 infection
Rogers A. Nahui Palominoa, Christophe Vanpouillea, Peter Backlundb, Carola
Parolinc, Luca Laghid, Beatrice Vitalic and Leonid Margolisa
aSection of Intercellular Interaction, Eunice Kennedy Shriver National
Institute of Child Health and Human Development, National Institutes of
Health, Bethesda, MD, USA; bBiomedical Mass Spectrometry Facility, Eunice
Kennedy Shriver National Institute of Child Health and Human
Development, National Institutes of Health, Bethesda, MD, USA;
cDepartment of Pharmacy and Biotechnology, University of Bologna,
Bologna, Italy; dCentre of Foodomics, Department of Agro-Food Science
and Technology, University of Bologna, Bologna, Italy
Introduction: The vaginal microbiota, mostly domi-
nated by Lactobacillus spp. plays a key role in prevent-
ing from numerous uro-pathogens’ infections, in
particular from HIV-1. Recently, we demonstrated
that Lactobacillus of various strains inhibit HIV-1
replication in human cervico-vaginal and tonsillar tis-
sues ex vivo providing an experimental system to study
mechanisms of this phenomenon. A growing body of
evidences suggest that any kind of cells, including
bacteria communicate to each other through extracel-
lular vesicles (EVs). Here, we investigated whether the
protective anti-HIV effect of lactobacilli is mediated by
EVs released by these bacteria.
Methods: EVs were isolated from four strains of
Lactobacillus cultures, previously isolated from vaginas
of healthy women, by ultracentrifugation. Vesicles’
sizes and concentrations were evaluated using
NanoSight. Human cervico-vaginal and tonsillar tissues
ex vivo, as well as cell lines were treated with
Lactobacillus-derived EVs, infected with HIV-1 and
virus replication was assessed by measuring the
released capsidic protein p24 using Luminex. Protein
and metabolite cargo of bacterial EVs were detected by
LC/MS/MS and 1H-NMR analysis, respectively.
Results: EVs released by L. crispatus BC3 and L. gasseri
BC12 protected human cervico-vaginal and tonsillar
tissues ex vivo as well as isolated mammalian cells
from HIV-1 infection by at least 50%. This protection
was not due to cytostatic or cytotoxic EV-effects but
rather was associated with the decrease of viral attach-
ment to the target cell and viral entry as demonstrated
in TZM-bl and MT-4 cell assays. Metabolomic analysis
showed 42 molecules associated with EVs including
amino acids, alcohols, ketones and monosaccharides.
Proteomic analysis showed the presence of several bac-
terial proteins in EVs that may be associated with the
anti-HIV effect.
Summary/Conclusion: Our findings demonstrate that
the protective effect of Lactobacillus against HIV trans-
mission is, in part, mediated by EVs released by these
commensal bacteria. This finding may lead to new
strategies to prevent male-to-female sexual HIV
transmission.
OS27.02
Extracellular vesicles of the human gut microbiota: do you hear me
host?
Anna Kaisanlahtia, Anatoliy Samoylenkob, Genevieve Bartb, Johanna
Korvalaa, Annastiina Rytkönenc, Artem Zhyvolozhnyic, Ilkka Miinalainenc,
Leo Lahtid, Seppo Vainioe and Justus Reunanenf
aBiocenter Oulu/Cancer and Translational Medicine Research Unit,
University of Oulu, Oulu, Finland; bUniversity of Oulu, Biocenter Oulu,
Laboratory of developmental Biology, Oulu, Finland; cBiocenter Oulu,
University of Oulu, Oulu, Finland; dDepartment of Mathematics and
Statistics, University of Turku, Turku, Finland; eUniversity of Oulu,
Biocenter Oulu, Laboratory of Developmental Biology, Oulu, Finland;
fUniversity of Oulu, Biocenter Oulu, Cancer and Translational Medicine
Research Unit, Oulu, Finland
Introduction: Microbial populations colonize the
whole length of the human gastrointestinal track.
Changes in composition and function of the gut micro-
biota have been linked with numerous pathologies,
underlining the importance of the host-microbiota
co-operation, although quite little is known of the
mechanism of communication between microbiota
and distal organs. Our aim was to describe EV secre-
tion in healthy human gut, explore the contribution of
different bacteria to EV secretion and characterize the
cargo of gut microbiota EVs, our hypothesis being that
EVs are one of the major communication systems
between human gut microbiota and the host.
Methods: Gut microbiota EVs were isolated with a
combination of commercial kits and centrifugation
methods from 20 faecal samples from healthy donors.
Presence of EVs was assessed with transmission elec-
tron microscopy (TEM). Proteins and RNA were iso-
lated from the obtained vesicles and analysed with LC-
ESI-MS/MS (Turku Proteomics Facility) and
Illumina550 sequencing (Biocenter Oulu Sequencing
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Centre). DNA was isolated from the faecal samples and
analysed with 16S rRNA sequencing (Institute of
Biotechnology, University of Helsinki) along with
intact faeces-derived vesicles to allow comparison of
taxonomic profiles.
Results: Populations of faecal EVs were detected with
TEM, with a size ranging from 50 to 200 nm. On
average, 184 bacterial proteins and 56 human proteins
were identified per sample. Taken together, the data
describes presence of 1194 distinct bacterial proteins
and 264 human proteins in faecal EVs. On functional
level, the majority of bacterial EV proteins of the gut
seem to consist of outer membrane proteins relating to
metabolism, bacterial invasion and transport. Data for
RNA cargo analysis is pending. In terms of bacterial
EV proteins, the data suggests the most diverse secre-
tion from phyla bacteroidetes and firmicutes.
Taxonomic profiles analysed by 16S rRNA sequencing
demonstrated differences in the bacterial composition
of the faecal samples and faeces-derived EVs: proteo-
bacteria, while present in small abundancies in faeces,
was one of the most predominant phyla found in
faeces-derived EVs.
Summary/Conclusion: Human gut microbiota actively
secretes EVs with range of protein and RNA cargo
which biological significance in human health and dis-
ease needs to be studied further.
Funding: Academy of Finland
OS27.03
Preparation, characterization and cellular interaction of edible plant-
derived nanoparticles
Daisuke Sasakia, Kosuke Kusamorib and Makiya Nishikawab
aFaculty of Pharmaceutical Sciences, Tokyo University of Science, Noda,
Japan; bTokyo University of Science, Noda, Japan
Introduction: Nanoparticles, including liposomes,
polymeric micelles and animal cell-derived extracellu-
lar vesicles (EVs), are promising carriers for bioactive
molecules. Recently, edible plant-derived nanoparticles
are expected to be a novel class of nanoparticles,
because they have advantages in terms of mass produc-
tion and cost-effectiveness. However, their pharmaceu-
tical and biological characteristics need to be evaluated
prior to their application and use in clinical practice. In
this study, we selected corn as an edible plant, and
prepared corn-derived nanoparticles (cNPs). Then, we
evaluated their property and interaction with cells.
Methods: Corn was put in a blender with distilled
water to obtain juice. The juice was separated by cen-
trifugation and ultra-centrifugation (UC), and the pel-
let after UC at 100,000 g was collected as cNPs. The
yield of the cNPs was evaluated by the protein amount
measured using Bradford assay. The size and zeta
potential of the cNPs were measured by a zeta sizer.
To evaluate the effect of the cNPs on cells, three types
of cell lines, i.e. murine fibroblast NIH3T3 cells, mur-
ine macrophage-like RAW264.7 cells, and murine
colon adenocarcinoma colon26 cells, were selected.
Cells were added with cNPs and incubated at 37°C
for 24 h. The cell viability was evaluated by using
CCK8 assay. Separately, the cNPs were labelled with
DiI and labelled cNPs were added to cells. After incu-
bation, we observed the cells by confocal microscopy.
Results: About 10 mg cNPs were obtained from 100 g
plants, indicating that cNPs can be obtained with high
yield compared with EVs. The size of the cNPs was
about 200 nm. In addition, the zeta potential was a
negative charge (about −15 mV), which is comparable
to that of EVs. Low concentrations of cNPs hardly
affected the viability of the cells. Confocal microscopy
showed that DiI-labelled cNPs were taken up by
RAW264.7 cells. The results of onion- or orange-
derived NPs will also be presented.
Summary/Conclusion: We succeeded in preparing
cNPs in large scale and revealed that the particulate
properties of the cNPs are comparable to those of EVs.
We also demonstrated that cNPs can be efficiently
taken up by RAW264.7 cells. These results raise a
possibility that cNPs can be used as carriers for bioac-
tive molecules to such cells.
OS27.04
Biophysical and electrochemical characterization of redox-active
extracellular vesicles from Shewanella oneidensis
Lori Zacharoffa,Shuai Xua, Grace Chonga, Lauren Ann Metskasb, Poorna
Subramanianb, Grant Jensenb and Moh El-Naggara
aUniversity of Southern California, Los Angeles, CA, USA; 2California
Institute of Technology, Pasadena, CA, USA
Introduction: Production of bacterial extracellular
vesicles has been observed in marine and freshwater
systems and in laboratory cultures. However, little is
known about the function and mechanism of vesicula-
tion in these nonpathogenic contexts. In addition to
vesicles, the Gram-negative bacterium, Shewanella
oneidensis also produces chains of outer-membrane
vesicles that are proposed to function as bacterial nano-
wires for electron transport to solid-phase electron
acceptors ranging from minerals to electrodes. A pre-
vious report demonstrated mineral reduction by iso-
lated S. oneidensis vesicles. Many basic questions
remain about the function and biogenesis of these
JOURNAL OF EXTRACELLULAR VESICLES 375
structures, particularly during metal and electrode
respiration.
Methods: Here we report the purification and charac-
terization of outer membrane vesicles from S. oneiden-
sis. Preliminary analyses using dynamic light scattering,
fluorescence microscopy, cryoelectron microscopy, and
proteomics, confirm the size, content and reproduci-
bility of purified vesicles.
Results: Proteomic data suggest that some proteins
are selectively loaded into vesicles with the assis-
tance of a novel BAR domain protein.
Electrochemical analysis of surface deposited
vesicles reveals the signatures of known outer-mem-
brane multiheme cytochromes.
Summary/Conclusion: These results have implica-
tions for the role of vesicles and vesicle chains
during respiration of iron oxides and anodes.
Excitingly, this research suggest that a BAR domain
protein provides the mechanistic relationship
between vesicles and the outer membrane exten-
sions known as nanowires
Funding: US DOE Division of Chemical Sciences,
Geociences and Biosciences, Office of Basic Energy
Science DE-FG02-13ER16415 National Science
Foundation grant DEB-1542527
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Single MSC EV analysis for characterizing a subpopulation having
therapeutic effects in AKI model
Hyejin Kanga, Chungmin Hanb, Jongok Pyoc and Jaesung Parkd
aPohang University of Science and Technology, Pohang, Republic of Korea;
bPohang University of Science and Technology, Pohang, Republic of Korea;
cEXOSOMEplus, Seoul, Republic of Korea; dDepartment of Mechanical
Engineering, POSTECH, Pohang, Republic of Korea
Introduction: Therapeutic applications of MSCEVs
have been extensively studied. Previous MSCEV studies
demonstrated that MSCEVs showed various effects
depending on how they were prepared. Recent studies
suggested that this diversity might result from the
heterogeneity of isolated EV populations. However,
because of the absent of a proper EV subpopulation
analysis method, no studies have succeeded to charac-
terize an effective subpopulation from whole EV popu-
lations. We analysed the subpopulations of MSCEVs
prepared by different isolation methods using a single
EV analysis method. We assessed the correlation
between the therapeutic effectiveness and MSC EV
subpopulations using mouse acute kidney injury
(AKI) model
Methods: EVs were prepared from hMSC conditioned
media using different isolation methods: differential
centrifugation, density gradient centrifugation and
polymeric methods. A part of EVs were analysed
using a TIRF microscopy based single EV analysis
method, which can provide quantitative subpopulation
information characterized by up to four different mar-
ker expressions. EVs were applied to an AKI model to
assess their therapeutic effectiveness.
Results: EVs prepared by different isolation methods
showed different subpopulation characteristics. The
numbers of lipid marker positive EVs were different
depending on their isolation method. Overall expres-
sion profile of three representative EV specific marker
(CD9, 63 and 81) were also different depending on
their isolation methods. EVs expressing more EV-spe-
cific markers were found to be more effective in mouse
AKI models.
Summary/Conclusion: We demonstrated that the sub-
population composition of EVs prepared by different
isolation methods were different. The numbers of EVs
positive for multiple markers varied depending on the
isolation methods. The relationship between therapeu-
tic effectiveness and EV subpopulation marker expres-
sion were tested using an AKI model. EV
subpopulation using four different EV-specific markers
might be a useful tool for assessing the quality of
isolated EVs in terms of their therapeutic effectiveness.
Funding: This work was supported by the KHIDI grant
[HI16C2221] and supported by NRF grant [NRF-
2018R1A2B3006280] funded by the Korean government.
OS28.02
Urinary microvesicular biomarkers for delayed graft function and
overall outcome after living donor kidney transplantation
Fabian Brauna, Markus Rinschenb, Ingo Plagmannb, Corinna Kleinc, Denise
Buchnerd, Roger Wahbad, Dirk Stippeld, Christine Kurschatb, Bernhard
Schermerb, Andreas Beyerc, Thomas Benzingb and Roman-Ulrich Müllerb
aIII. Department of Medicine, University Medical Center Hamburg-
Eppendorf, Hamburg, Germany; bDepartment II of Internal Medicine and
Center for Molecular Medicine Cologne, University of Cologne, Germany,
Cologne, Germany; cCologne Excellence Cluster on Cellular Stress Responses
in Aging-Associated Diseases, University of Cologne, Germany, Cologne,
Germany; dDepartment of General, Visceral and Cancer Surgery, Division
of Transplantation Surgery, Transplant Center Cologne, University of
Cologne, Cologne, Germany
Introduction: With a cargo of specific proteins and
nucleic acids, urinary microvesicles represent a poten-
tial source for cellular material, that can be isolated
easily and non-invasively. Yet, their clinical implemen-
tation in nephrology remains scarce with kidney biop-
sies still being the gold standard procedure in most
diagnoses. We hypothesize that the addition of non-
invasive biomarkers could benefit this invasive method
with the potential risk of a sampling error.
Methods: With differential (ultra-)centrifugation, we
isolated urinary microvesicles from living kidney trans-
plant recipients and their donors over the course of 40
kidney transplantations. Whole urine samples were
collected on day −1 (donor sample), 0, 1 and 3 months
after transplantation (recipient sample). Microvesicular
protein content was measured using quantitative mass
spectrometry. We detected proteins, which linearly
change their abundance in correspondence to clinical
parameters, e.g. glomerular filtration rate (GFR) at 6
and 12 Months after transplantation in a set of 20
transplantations, by linear regression models. These
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results were validated in a targeted proteomic screen in
a cohort of 20 additional transplantations.
Results: We identified >1500 proteins present in at
least 50% of the first sample set. Hierarchical clustering
analysis depicted a clear clustering by time point of
urine collection. Microvesicular proteins of glomerular
(e.g. nephrin, podocin) or tubular origin (e.g. V-
ATPase and Slc transporters) were regulated distinctly
over the course of transplantation. Overall, specific
proteomic time course patterns were apparent over
the course of transplantation. Depending on low sta-
tistical error and high stability in a leave-one-out cross-
validation of the linear models correlating to GFR
values after transplantation, we created a list of 64
candidate proteins. Validation of these revealed
PEPCK as a urinary microvesicular protein associated
with GFR 12 months after transplantation.
Summary/Conclusion: With this study, we present the
first analysis of the changes in the human urinary
microvesicular proteome over the course of kidney
transplantation. We believe, the validated biomarkers
of all 40 Transplantations to hold the potential to
further aid the diagnosis of graft survival.
Funding: MIWF Nachwuchsgruppen.NRW
OS28.03
Exosomal miRNA-19b-3p of tubular epithelial cell promotes M1
macrophage activation in kidney injury
Ye Fenga, Linli Lvb, Taotao Tangc and Bi-Cheng Liua
aInstitute of Nephrology, Southeast University, Nanjing, China (People’s
Republic); bInstitute of Nephrology, Zhongda Hospitial, Southeast
University, Nanjing, China (People’s Republic); cInstitute of Nephrology,
Zhongda Hospital, Southeast University School of Medicine, Nanjing,
China (People’s Republic)
Introduction: Tubulointerstitial inflammation is a
common characteristic for acute and chronic kidney
injury. However, the mechanism by which the initial
injury on tubular epithelial cells (TECs) drives inter-
stitial inflammation remains unclear. Here we set out
to characterize the miRNA profile of kidney exosomes
and aim to explore the role of exosomal miRNAs
derived from TECs in the development of tubulointer-
stitial inflammation.
Methods: Exosomes were isolated from kidney and
characterized via electron microscopy and nanoparticle
analysis. We examined expression profiles of miRNAs
in kidney exosomes from LPS-induced kidney injury
model by Exiqon microarray. Putative targets of
miRNA were predicted by TargetScan. Chronic protei-
nuric kidney disease model was induced by adriamycin
(ADR) administration. Exosomes purified from TECs
were added to macrophages or intrarenal injected to
mice to determine its effects both in vitro and in vivo.
Results: Global miRNA expression profiling on renal
exosomes was examined in LPS-induced AKI model
and miR-19b-3p was identified as the most remarkable
miRNA increased in TEC-derived exosomes compared
with controls. Similar results were found in ADR-
induced chronic proteinuric kidney disease model in
which exosomal miR-19b-3p was markedly released.
Interestingly, once released, TEC-derived exosomal
miR-19b-3p was internalized by macrophages, leading
to M1 phenotype polarization through targeting NF-
κB/SOCS-1. Importantly, the pathogenic role of exoso-
mal miR-19b-3p in initiating renal inflammation was
revealed by the ability of adoptive transfer of purified
TEC-derived exosomes to cause tubulointerstitial
inflammation in mice, which was reversed by inhibi-
tion of miR-19b-3p. Clinically, high levels of miR-19b-
3p were found in urinary exosomes and correlated with
the severity of tubulointerstitial inflammation in
patients with diabetic nephropathy. Thus, our studies
demonstrated exosomal miR-19b-3p mediated the
communication between injured TECs and macro-
phages, leading to M1 macrophage activation.
Summary/Conclusion: Exosome/miR-19b-3p/SOCS1
axis played a critical pathologic role in tubulointersti-
tial inflammation that might represent a new therapeu-
tic target for kidney disease.
OS28.04
A urine exosome RNA signature for prediction of high-grade prostate
cancer: clinical validation in over 1,000 biopsy naïve patients
Robert Kitchena, Phillipp Torklerb, James McKiernanc, Michael Donovand,
Mikkel Noerholmb, Peter Carrolle and Johan Skogf
aExosome Diagnostics, Inc, Waltham, MA, USA; bExosome Diagnostics,
GmbH, Martinsried, Germany; cColumbia University, Department of
Urology, New York, NY, USA; dDepartment of Pathology, Mount Sinai,
New York, NY, USA; eUniversity of California San Francisco, San
Francisco, CA, USA; fExosome Diagnostics, Inc., Waltham, MA, USA
Introduction: Discriminating indolent from clinically
significant prostate cancer (PCa) prior to initial biopsy
remains an important clinical and health economic
issue. We have previously described the ExoDx
Prostate(IntelliScore) (EPI) assay for discriminating
high- vs low-grade prostate cancers using RNA
extracted from urine exosomes. However proving effi-
cacy and facilitating clinical adoption of a diagnostic
assay requires extensive validation in prospectively col-
lected patient cohorts. Here we compare performance
of the EPI urine exosome assay vs. the Prostate Cancer
Prevention Trial-Risk Calculator 2.0 (PCPT-RC) for
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discriminating high-grade from low-grade PCa and
benign disease on initial biopsy.
Methods: We collected data from two distinct valida-
tion cohorts (N = 519 and 503, respectively) repre-
senting 1022 subjects and compared EPI test results
with biopsy outcomes. Eligible subjects were selected
by age (>50-years) and PSA concentration (2–10 ng/
mL), and were scheduled for initial prostate needle
biopsy. Test performance was reported using the area
under the receiver operating characteristic curve
(AUC), negative and positive predictive value (NPV;
PPV), sensitivity, and specificity. Outcome was based
on Gleason Score (GS) for discriminating high-
(GS≥7) from low-grade (GS = 6) and benign disease
on initial biopsy.
Results: In this diverse cohort of 1022 biopsy naïve
patients (mean age: 64 years, mean PSA: 5.6 ng/mL,
ethnicity: 16% African, 71% Caucasian) we observed a
51% positive biopsy rate (30% GS≥7, 13% GS≥4 + 3).
Performance of the EPI test (AUC = 0.70) was superior
to PSA (AUC = 0.56), and PCPT-RC (AUC = 0.6; all p-
values<0.001) for discriminating high- from low-grade
PCa and benign disease. Using the previously validated
cut-point of 15.6 (or alternative 20) would avoid 30%
(or 43%) of unnecessary biopsies, with an NPV of 90%
for both cut-points and miss only 7.5% (or 12%) of
high-grade PCa patients.
Summary/Conclusion: EPI is a non-invasive 3-gene
urine exosome RNA expression assay that we have
now successfully validated in over 1000 patients to
discriminate high- from low-grade PCa and benign
disease. EPI identifies high-risk patients better than
any current standard of care and provides a valuable
tool for shared decision making so the right patients
are sent for biopsy.
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First-in-human application of umbilical cord mesenchymal stromal
cell-derived exosomes for the prevention of fibrosis following
cochlear implant surgery
Athanasia Warneckea, Jennifer Schulzea, Julia Hollerwegerb, Teresa
Lassacherb, Karin Pachlerb, Heide-Marie Binderb, Alexandre Desgeorgesb,
Gerhard Weidlerb, Magdalena Mayrb, Pasquale Romanellic, Sebastien
Couillard-despresc, Hinrich Staeckerd, Jennifer Nelson-Brantleyd, Andreas
Trawegere, Eva Rohdeb and Mario Gimonaf
aKlinik für Hals-, Nasen-, Ohrenheilkunde, Hannover Medical School,
Hannover, GERMANY, Hannover, Germany; bSCI-TReCS GMP Unit at
Paracelsus Medical University, Salzburg, AUSTRIA, Salzburg, Austria;
cInstitute of Experimental Neuroregeneration, Paracelsus Medical
University, Salzburg,, Salzburg, Austria; dAuditory & Vestibular
Neuroscience Laboratory, University of Kansas Medical Center, Kansas
City,, Kansas City, USA; eInstitute of Tendon and Bone Regeneration,
Paracelsus Medical University, Salzburg, AUSTRIA, Salzburg, Austria;
fGMP Unit at Paracelsus Medical University, Salzburg, AUSTRIA, Salzburg,
Austria
Introduction: Cochlear implantation (CI) can restore
hearing perception by bypassing the auditory hair cells
(HC) and directly stimulating the spiral ganglion neu-
rons (SGN). Insertion of an electrode array into the
cochlea is associated with robust early and chronic
inflammatory responses that promote intra-cochlear
fibrosis and loss of HC and SGN. Conservation of
residual hearing and prevention of fibrous tissue
deposition around the electrode are thus major chal-
lenges in CI surgery.
Methods: We have manufactured GMP-compliant
umbilical cord (UC)-MSC- derived extracellular vesi-
cles/exosomes (EVs) and subjected such preparations
to a series of in vivo and in vitro assays. Animal studies
included both systemic and local injection for the
improvement of seemingly unrelated indications such
as critical size bone defects, partial tendon rupture and
spinal cord injury in a rat contusion-model.
Results: In all cases EV application resulted in a sig-
nificant modulation of immune reaction, overall
reduced inflammation and scar reduction as evidenced
by a reduction in ECM deposition. In an in vitro spiral
ganglion neuron protection assay UC-MSC-EVs out-
performed the current best-in-class soluble neuropro-
tective factor, BDNF. In vivo application of EVs in mice
challenged by noise trauma resulted in significant pro-
tection of hearing when compared to untreated con-
trols. Reduction of impedance as a measure for current
resistance and fibrotic tissue formation around the
electrode array were observed in a model of implanta-
tion trauma in guinea pigs implanted with an electrode
array. After careful consideration of the medical history
of a patient requiring CI surgery an experimental heal-
ing attempt was performed and the patient received a
single intra-cochlear injection of 5 × 109 EVs (total)
prior to electrode insertion. The application was toler-
ated well, no adverse reactions were recorded and
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robust auditory sensation was detected 6 weeks post
surgery.
Summary/conclusion: Based on these initial safety
data on the local application of EVs in the inner ear,
a phase 1/2a clinical trial is currently in preparation to
further evaluate the neuroprotective, immunomodula-
tory and anti-fibrotic potential of UC-MSC-EVs.
Funding: “Exothera” IT-AT 1036 (EU), Project
“ExtraNeu” (Land Salzburg)
LB01.03
Engineering of ARMMs for efficient delivery of Cas9 genome editors
Qiyu Wanga and Quan Lub
aQilu Pharma, Boston, USA; bHarvard University, Boston, USA
Introduction: Our previous studies have shown that
the arrestin domain containing protein 1 (ARRDC1)
drives the formation of extracellular vesicles known as
ARMMs (ARRDC1-mediated microvesicles) (Nabhan J
et al., PNAS 2012) and that these vesicles can be har-
nessed to package and deliver a variety of molecular
cargos such as protein, RNA and the genome editor
Cas9 (Wang Q and Lu Q, Nat Commun 2018). In the
published packaging and delivery study, we used the
full-length ARRDC1 protein (433 amino acids at ~46
kD) to recruit the molecular cargos into the vesicles,
either through a direct fusion or via a protein-protein
interaction module. Because ARRDC1 protein itself is
packaged into ARMMs and because the size of the
vesicles is limited (~80–100 nm), a smaller ARRDC1
protein that can still function in driving budding would
potentially increase the number of cargos that can be
packaged into the vesicles. Moreover, a smaller
ARRDC1 may allow the recruitment of a relatively
large cargo molecule.
Methods: We used protein engineering to identify a
minimal ARRDC1 protein that can drive the formation
of ARMMs. We then fused the minimal ARRDC1 to
multiple proteins including the genome-editor Cas9
and tested the packaging and delivery efficiency of
the fusion protein.
Results: Here we will present new data that identified a
minimal ARRDC1 protein that contains an arrestin
domain, PSAP and PPXY motifs. The minimal
ARRDC1 is able to drive ARMM budding as efficiently
as the full-length ARRDC1. We further present evi-
dence that the minimal ARRDC1 protein can effi-
ciently package cargos such as the relatively large
Cas9/gRNA complex. In particular, we showed that
the minimal ARRDC1 can package Cas9/gRNA into
ARMMs through direction fusion whereas the full
length ARRDC1 failed to.
Summary/conclusion: These results indicate that
ARMMs formed by the minimal ARRDC1 may be
used as a novel efficient therapeutic delivery platform
for the Cas9-based gene editors.
LB01.04
Microvesicle-mediated delivery of minicircle DNA results in effective
gene-directed enzyme prodrug cancer therapy
Masamitsu Kanadaa, Bryan Kimb, Jonathan Hardyc, John Ronaldd, Michael
Bachmanne, Matthew Bernardf, Gloria Perezg, Ahmed Zareag, Jessie Geh,
Alicia Withrowi, Sherif Ibrahimg, Victoria Toomajianj, Sanjiv Gambhirk,
Ramasamy Paulmuruganl and Christopher Contagm
aInstitute for Quantitative Health Science and Engineering (IQ), Dept. of
Pharmacology & Toxicology, Michigan State University, East Lansing, USA;
bDept. of Chemistry, UC Santa Cruz, Santa Cruz, USA; cInstitute for
Quantitative Health Science and Engineering (IQ), Dept. of Microbiology &
Molecular Genetics, Michigan State University, East Lansing, USA; dRobarts
Research Institute, Western University, Lawson Health Research Institute,
London, Canada; eAssociate Professor, Institute for Quantitative Health
Science and Engineering (IQ), Dept. of Microbiology & Molecular Genetics,
Michigan State University, East Lansing, USA; fAssistant Professor, Institute
for Quantitative Health Science and Engineering (IQ), Dept. of Pharmacology
& Toxicology, Michigan State University, East Lansing, USA; gInstitute for
Quantitative Health Science and Engineering (IQ), Michigan State University,
East Lansing, USA; hDept. of Radiology, Stanford University, Palo Alto, USA;
iCenter for Advanced Microscopy, Michigan State University, East Lansing,
USA; jInstitute for Quantitative Health Science and Engineering (IQ), Dept of
Biomedical Engineering, Michigan State University, East Lansing, USA;
kDepts. of Radiology, Bioengineering, and Materials Science, and Molecular
Imaging Program at Stanford (MIPS), Stanford University, East Lansing,
USA; lDept. of Radiology, Molecular Imaging Program at Stanford (MIPS),
Stanford University, Palo Alto, USA; mInstitute for Quantitative Health
Science and Engineering (IQ), Depts of Microbiology & Molecular
Genetics, Biomedical Engineering, Michigan State UniversityMichigan State
University, East Lansing, USA
Introduction: An emerging approach for cancer treat-
ment employs the use of extracellular vesicles (EVs),
specifically exosomes and microvesicles, as delivery
vehicles.
Methods: We previously demonstrated that microvesi-
cles can functionally deliver plasmid DNA to cells and
showed that plasmid size and sequence determine, in
part, the efficiency of delivery. Delivery vehicles com-
prised of microvesicles loaded with engineered mini-
circle DNA (MC) encoding prodrug converting
enzymes were developed here as a cancer therapy in
mammary carcinoma models.
Results: We demonstrated that MCs were loaded into
shed microvesicles with greater efficiency than their
parental plasmid counterparts and that microvesicle-
mediated MC delivery led to significantly higher and
more prolonged transgene expression in recipient cells
than did microvesicles loaded with the parental plas-
mid. Microvesicles loaded with MCs encoding a thy-
midine kinase (TK)/nitroreductase (NTR) fusion
protein produced TK-NTR expression in mammary
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carcinoma cells. In vivo delivery of TK-NTR and
administration of prodrugs led to the effective killing
of both targeted cells and surrounding tumour cells via
TK-NTR-mediated conversion of prodrugs to active
cytotoxic agents. The efficiency of killing non-trans-
fected bystander/neighbouring cells was assessed in
mouse models and determined to require one in 100
cancer cells to be targeted.
Summary/conclusion: These results suggest that MC
delivery via microvesicles can mediate gene transfer to
an extent that enables effective prodrug conversion and
tumour cell death such that it comprises a promising
approach to cancer therapy. To understand the
mechanism of this microvesicle-mediated enzyme pro-
drug therapy, we are currently assessing recipient cells
in the tumour microenvironment.
Funding: This work was funded in part through a
generous gift from the Chambers Family Foundation
for Excellence in Pediatrics Research (to C.H.C.), Grant
1UH2TR000902-01 from the National Institutes of
Health (to C.H.C.), and the Child Health Research
Institute at Stanford University (to C.H.C.). Start-up
fund from Michigan State University (to M.K.)
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Extremely-large extracellular vesicles (elevs) aid invasiveness of
rasv12 tumour cell dissemination
Jiae Lee and Young Kwon
University of Washington, Seattle, USA
Introduction: Cancer cell dissemination has been
recognized for the association with cancer recurrence,
invasion and metastasis, however, the exact molecular
mechanism is not fully understood. Most of the pre-
vious studies were conducted in cell culture, which is
difficult to track the consequence of disseminated cells.
Moreover, the lack of a simple yet conserved model
system deferred genome-wide screening. Therefore, we
established an in vivo cell dissemination model in
Drosophila.
Methods: We express mutant Ras (RasV12) in adult
Drosophila midgut intestinal stem cells (ISCs) and
enteroblasts (EBs) using the conditional GAL4 driver
esgts (esg-GAL4, tub-GAL80ts, UAS-GFP).
Results: When RasV12 is expressed in ISCs and EBs,
tumour rapidly proliferates, then become eliminated.
Cellular processes protrude while damaging and invad-
ing the surrounding visceral muscle fibres, and intact
cells can completely disseminate. Interestingly, we
observed with ex vivo live imaging that RasV12 cells
produce large blebs and release extracellular vesicles.
The average size of these vesicles was bigger than exo-
somes (<100 nm) and microvesicles (100–1000 nm), so
we refer them as extremely-large extracellular vesicles
(ELEVs). Additionally, GFP-positive particles were
detected in haemolymph prepared from RasV12 flies
but not from controls assuring that ELEVs were also
produced in vivo. Of note, we found that metastatic
RasV12, scrib-/- disc tumours also produced ELEVs.
Thus, we propose that the generation of ELEVs is a
characteristic of invasive tumours in Drosophila.
Interestingly, these ELEVs are reminiscent of large
oncosomes or cytoplasts, which have been implicated
in the invasive behaviour of cancer cells.
Summary/conclusion: This model shares many known
aspects of tumour cell dissemination implied from the
studies in mammalian systems. We plan to utilize this
unique system to elucidate the molecular mechanism
for cell dissemination and ELEVs production using
vast genetic tools available in Drosophila.
LB02.02
House dust extracellular vesicles promote tumour metastasis to the
lungs by inducing tumour necrosis factor-α
Nhung Thi Hong. Dinha, Jaewook Leeb, Jaemin Leec, Gyeongyun God, Kim
Sang sood, Seoyoon Baed, Yein June, Tae Young Rohf and Yong Song Ghod
aPostech, Pohang, Republic of Korea; bDepartment of Life Sciences, Pohang
University of Science and Technology (POSTECH), Pohang, Republic of
Korea; cPohang University of Science and Technology, Pohang, Republic of
Korea; dDepartment of Life Sciences, Pohang University of Science and
Technology, Pohang, Republic of Korea; ePohang University of Science and
Technology (POSTECH), Pohang, Republic of Korea; fDepartment of Life
Sciences, Pohang University of Science and Technology (POSTECH), 77
Cheongam-ro, Nam-gu, Pohang 37673, Republic of Korea, Pohang,
Republic of Korea
Introduction: Air pollution is associated with multiple
pulmonary disorders. As a part of pollutant air, house
dust harbours several biological contaminants includ-
ing extracellular vesicles (EVs). House dust EVs have
been shown to induce pulmonary inflammation, but no
studies have assessed the effect of dust EVs on tumour
metastasis to the lungs.
Methods: EVs were isolated from house dust using
buoyant density gradient ultracentrifugation. Isolated
dust EVs were characterized with transmission electron
microscopy and dynamic light scattering. To assess the
role of dust EVs in tumour metastasis, dust EVs were
intranasally administered to mice, followed by intrave-
nous injection of tumour cells after 1 day. At 2 weeks
after tumour introduction, lungs were harvested from
mice to measure metastasis by counting metastatic
colonies. To investigate the mechanism, the lungs
were collected at 12 h or 24 h after tumour cell intro-
duction to access tumour cell infiltration into the lungs
by immunohistochemistry. Furthermore, lung lysates
were prepared from mice intranasally administered
with dust EVs to examine tumour necrosis factor-α
(TNF-α) production and their effect on tumour cell
migration. Finally, TNF-α knock-out mice were used
to show the importance of TNF-α in dust EV-induced
tumour metastasis.
Results: House dust EVs had membrane-enclosed
structures with an average diameter of
129.6 ± 4.5 nm, as observed by transmission electron
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microscopy and dynamic light scattering. Dust EVs
significantly promoted tumour metastasis to the
lungs. The mechanism study showed that these EVs
enhanced tumour cell infiltration into the lungs.
Although dust EVs did not directly mediate tumour
cell migration, lung lysates from dust EV-treated mice
could promote this migratory effect. In addition, the
concentration of TNF-α was increased in lung lysates
by treating dust EVs. Finally, TNF-α knock-out mice
treated with dust EVs could not promote tumour
metastasis to the lungs.
Summary/conclusion: House dust harboured signifi-
cant amounts of EVs which could promote tumour
metastasis by inducing TNF-α. These findings provide
mechanistic insights into the effect of house dust on
tumour metastasis to the lungs.
LB02.03
Modeling tumour: key issues of cell communication by mean of EVs in
a three-dimensional environment and the impact on biomarker
discovery
Richa Khandurya, Liliia Paniushkinaa, Andreas Kellerb, Tanja Gajney-
Schleichera and Irina Nazarenkoc
aMedical Center Univeristy of Freiburg, Freiburg, Germany; bSaarland
University, Saabruecken, Germany; cMedical Center University of Freiburg,
Freiburg, Germany
Introduction: The impact of growth architecture on
intercellular communication, including EV release,
cargo, and function was not examined in many details.
In our recent work, we described a new model for
efficient EV production in a three-dimensional envir-
onment. Cells growing in 3D produced an increased
number of small EVs, which differed in their miRNA
and protein profiles from the EVs, released by the cells
grown under conventional conditions. In the current
work, we describe the impact of growth architecture on
EV heterogeneity and their content respecting recruit-
ment of activated oncogenes and mutated products
on EVs.
Methods: EVs of different size were isolated by subse-
quent sedimentation by 5000 ×g (EV5), 12000 ×g
(EV12) and small EVs, purified by size exclusion chro-
matography (SEC). Subsequently, iodixanol gradient
centrifugation was performed. These EV populations
were separated from 2D and 3D cell cultures and
characterized respecting their size using NTA, DLS,
and TRPS. Surface proteins were examined using
beads-assisted flow cytometry. Subsequently, DNA
and RNA were isolated, and the number of mutated
oncogenes to different EV populations was assessed
using ddPCR.
Results: In all models, including prostate, breast, color-
ectal and gastric cancer, 3D environment caused a
considerable shift in EV size distribution. Specific
changes in EV surface protein profiles and distribution
of oncogenic DNA and RNA among EV populations
was observed. These changes varied between different
tumour types. Comparison with the delivery of
mutated oncogenes among EV populations in the
blood of patients revealed that EVs released from in
3D resemble closer the content of EVs isolated from
the blood of tumour patients.
Summary/conclusion: Here, we present a unique
model applicable to study the EV heterogeneity under
conditions mimicking physiological tumour microen-
vironment. It can serve as a new tool for drug screen-
ing and biomarker search, representing a new reliable
model for EV-based liquid biopsy.
Funding: H2020 MSCA-ITN „Train-EV“, Project
722148; BMBF “EXONANSENS”, Project 01DJ51206.
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Secretion mechanisms of wnt proteins
Alena Ivanovaa, Jan Wintera, Oksana Voloshanenkoa, Kathrin Glaesera,
Steffen Scholppb, Ulrike Engelc, Clotilde Theryd and Michael Boutrose
aGerman Cancer Research Center, Division of Signaling and Functional
Genomics, Heidelberg, Germany, Heidelberg, Germany; bLiving Systems
Institute, School of Biosciences, College of Life and Environmental Sciences,
University of Exeter, Exeter, United Kingdom, Exeter, United Kingdom;
cNikon Imaging Center at Heidelberg University and Centre for
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U932, Immunity and Cancer, Paris, France, Paris, France; eDepartment of
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Introduction: Wnt signalling pathways play important
roles in development and diseases of multicellular
organisms. Key players in intercellular signalling –
Wnt proteins – travel through extracellular space, but
since lipid modifications renders them insoluble, they
use special carriers. According to the current under-
standing of Wnt secretion, to contact neighbouring
cells Wnt proteins can diffuse using heparan sulphate
proteoglycan chains on the cell surface or they can be
transported on filopodia. Additionally, Wnt ligands can
be solubilized and travel in the intracellular space by
creating lipoprotein particles. Wnts can be recycled
through the endosomal compartment and secreted on
exosomes. It is been a long debate which secretory
mechanism is preferred by Wnt ligands and which
forms of secreted Wnt proteins maintain signalling
activity. We aimed to dissect the very complex Wnt
secretion network to identify new regulators specific
for the certain secretion roots.
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Methods: We first, performed focused RNAi screen to
identify new components of Wnt secretory pathway. By
activating Wnt pathway either in the secreting cell or at
the receptor level we manage to distinguish between
proteins that involved only in the secretory part of the
pathway or play role in the receiving cells. At the next
step, we used array CRISPR/Cas9 screening approach
for targeted disruption of genes together with canonical
Wnt activity assay to confirm that identified genes are
required for the secretion of functional Wnt proteins.
Results: With the described approach, a panel of 83
possible secretory factors have been tested. Among the
others we found a protein that involved in the filopodia
formation process. Identified protein regulates number
and length of cell filopodia. Beyond this, only a few
other proteins have been described so far to regulate
specialized filopodia like cytonemes. Additionally, we
observed that Wnt proteins travel across filopodia
being packed on vesicle-like structures.
Summary/conclusion: For the first time a forward
genetic screen allowed to identify new components
that are important for filopodia associated Wnt signal-
ling. Surprisingly, Wnt ligands use vesicles as carries
for transport across cell protrusions. These findings
add another piece of evidence that microvesicles and
filopodia plays a significant role in the distribution of
Wnt ligands.
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Assessing the value of extracellular vesicles‘ DNA and proteins as
biomarkers in metastatic breast cancer
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Introduction: Analysis of cell-free circulating tumour
DNA (ctDNA) and cancer-specific extracellular vesicles
(EVs) in patients’ blood have been widely explored as
biomarkers for cancer detection and disease follow up.
These non-invasive biomarkers represent a promising
tool for real-time monitoring of treatment efficacy.
Particularly, tumour-derived EVs contain specific pro-
tein cargo and nucleic acids, which are protected from
degradation. However, most of the protocols used to
isolate EVs co-isolate other nucleic acids carriers and
the actual value of EV-associated nucleic acids as
robust biomarkers remain unclear. Here, we assessed
the clinical validity of nucleic acids specifically derived
from EV-enriched fractions in comparison to non-EV
fractions and total plasma as a source of specific and
sensitive biomarkers in breast cancer.
Methods: Healthy donors or metastatic breast cancer
patient’s plasma (collected under patient written con-
sent) was subjected to size exclusion chromatography
to separate EVs (EV fraction) from other circulating
components (soluble fraction). We quantified different
DNA species present in these fractions as compared to
total plasma. Nuclear and mitochondrial DNA (gDNA
and mtDNA) were quantified by qPCR. Tumour spe-
cific nuclear alleles were detected by droplet digital
PCR targeting known point mutations (previously
identified from the tumour of each patient). Finally,
37 EV proteins were analysed using the MACSPlex
Exosome Kit (Miltenyi).
Results: gDNA and mtDNA were both detected in EV
fractions. However, gDNA content (total or mutant
alleles) detected in the EV fractions was lower than in
the soluble fractions and total plasma. In contrast,
mtDNA was preferentially enriched in EV fractions.
We observed similar levels of mtDNA or gDNA in
cancer patients and healthy donors in the EV fractions,
whereas in total plasma, gDNA was increased in cancer
patients. In addition, several membrane proteins were
significantly enriched or exclusively present in cancer
patients EVs compared to healthy donors.
Summary/conclusion: Our findings provide evidence
that the detection of DNA within total circulating EV
does not provide added value as compared to the whole
plasma. However, analysis of a subtype of EV-asso-
ciated proteins may reliably identify cancer patients.
Funding: INCa-11548, ARC PGA1 RF20180206962
LB03.03
A novel strategy for early detection of clinically significant prostate
cancer by high-throughput palmitoyl-proteomics of extracellular
vesicles
Dolores Di Vizioa, Javier Mariscalb, Tatyana Vagnerb, Minyung Kimb, Bo
Zhouc, Desmond PINKd, Andrew Chinb, Mandana Zandianb, John Lewise,
Michael Freemanb, Stephen Freedlandb, Sungyong Youb, Wei Yangb and
Andries Zijlstraf
aCedars Sinai Medical Center, West Hollywood, USA; bCedars Sinai Medical
Center, Los Angeles, USA; c1Cedars Sinai Medical Center, Los Angeles, USA;
dNanostics and University of Alberta, Nashville, USA; eNanostics, Nashville,
USA; fVanderbilt University Medical Center, Nashville, USA
Introduction: Early diagnosis of lethal prostate cancer
(PC) is critical for treatment stratification. Extracellular
Vesicles (EVs) are an appealing source of circulating
biomarkers. We sought to perform a state-of-the-art
palmitoyl proteome to identify markers of aggressive
PC because we noticed an enrichment for putative
palmitoylated proteins in EVs in comparison with
cells, and because most of the plasma proteins that
contaminate the EV preps are not palmitoylated.
Palmitoylation is a post-translational modification
that anchors proteins transiently to the membrane.
We reasoned that this could be a mechanism to anchor
proteins temporary to the membrane and shed them
in EVs.
Methods: Discontinuous centrifugation gradient, tun-
able resistive pulse sensing (QNano), next-generation
PalmPISC for highly selective enrichment of palmitoyl-
proteins, 2D LC-MS/MS for deep proteomics profiling,
Nano-Flow Cytometry (Apogee), Western blotting.
Results: We isolated large and small EVs from PC3
cells and confirmed their biochemical and biophysical
identity. We observed enrichment of distinct palmi-
toyl-proteins in both populations of EVs versus the
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cells of origin. Pathway analysis demonstrated a strong
association between large EV cargo and protein locali-
zation and small EV cargo and metabolic activity.
Interestingly, palmitoyl-CD63 was enriched in large
EVs while the total protein is enriched in small EVs.
Similarly, palmitoyl-HSPA5 was enriched in small EVs,
while the total protein is enriched in large EVs. This
result suggests that the palmitoyl proteome might
reveal a pool of markers that would not be identified
otherwise. The Six Transmembrane Epithelial Antigen
Prostate 1 (STEAP1) was enriched in EVs from aggres-
sive cancer cells but not in the cell themselves, suggest-
ing that it might be shed and thus identified in plasma
of patients with aggressive disease even if it is not
enriched in the tumour tissue. We interrogated a
cohort of benign (n = 30), low Gleason Score (GS)
(n = 30) and high GS (n = 30) patients. The number
of samples with detectable STEAP1 expression was
negligible in men with benign disease, and a signifi-
cantly more frequent event in patients with high vs
low GS.
Summary/conclusion: This study suggests that identi-
fication of bonafide palmitoylated proteins in EVs
represents a viable liquid biopsy to identify lethal pros-
tate cancer.
LB03.04
Circulating exosomal PD-L1 as a marker for the follow up of
melanoma patients
Jessica Gobboa, Marine Cordonnierb, Charlée Nardinc, Gaetan Chanteloupb,
Valentin Derangéred, Marie-Paule Algrose, Aurelie Bertautd, Laurent
Arnouldd, Carmen Garridob and François Aubinc
aCentre Georges-Francois Leclerc, dijon, France; binserm1231, dijon, France;
cCHU Besançon, besançon, France; dCGFL, dijon, France; eCHU Besançon,
besancon, France
Introduction: In the era of effective molecular targeted
treatments and immunotherapies, there is an urgent
need to implement the use of circulating biomarkers
in the clinic to facilitate personalized therapy and pre-
dict treatment response. We conducted a prospective
study to demonstrate the involvement of circulating
PD-L1 exosomes in melanoma patients.
Methods: One hundred melanoma patients were
included. Exosomes were isolated by ultracentrifuga-
tion and evaluated by nanoparticle tracking analysis
using a NTA technology. Isolated exosomes were tested
for the expression of exosomal markers such as
TSG101. PD-L1 expression in plasma and in melanoma
plasma-derived exosomes (ExoPD-L1) was measured
using an enzyme-linked immunosorbent assay.
Results: First, ExoPD-L1 was assessed in melanoma
cell lines. ExoPD-L1 have a role in cancer immunosup-
pression mediated by T-cells since they were as effi-
cient as cancer cells to inhibit T-cells activation. In
melanoma patients, ExoPD-L1 (median 64,26 pg/mL)
was significantly higher than free PD-L1 in the plasma
which was barely detectable (0,1 pg/mL). Furthermore,
ExoPD-L1 was detected in all patients whereas only
67% of the tumours were positive for PD-L1.
Although baseline ExoPD-L1 levels were not associated
with clinicopathologic characteristics and tumour bur-
den, ExoPD-L1 variations (ΔExoPD-L1) after treat-
ment correlated with tumour response and survival. A
ΔExoPD-L1 cut-off of > 100 was defined, yielding a
83% sensitivity, a 70% specificity, a 91% positive pre-
dictive value and a 54% negative predictive values for
disease progression. The use of this cut-off allowed
stratification in two groups of patients statistically dif-
ferent in terms of overall survival and progression free
survival.
Summary/conclusion: PD-L1 level in circulating exo-
somes may be a more reliable marker than PD-L1
expression in tumour tissue. Circulating exosomal
PD-L1 monitoring may be a promising biomarker to
predict tumour response and the clinical outcome.
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LB04.01
A microfluidic device with nanoscale surface topology and
functionalized with lipid nanoprobes for extracellular vesicle isolation
and clinical cancer diagnosis
Yuan Wana, Mackenzie Maurerb, Hong-Zhang Heb, Yi-Qiu Xiab, Wen-Long
Zhangb, Si-Jie Haob, Nelson Yeec and Siyang Zhengb
aBinghamton University, State University of New York, Binghamton, USA;
bThe Pennsylvania State University, University Park, USA; cPenn State
College of Medicine, Hershey, USA
Introduction: Extracellular vesicles (EVs) are cell-
derived, lipid membrane enclosed particles. Tumour
cell-derived are increasingly recognized for their patho-
physiological contributions and potential towards can-
cer diagnosis and treatment monitoring. However,
clinical translation of EVs has been limited by techno-
logical challenges for EV isolation. A rapid, high-
throughput, and on-chip EV isolation technology is
critical for EV-based cancer diagnosis.
Methods: We report a lipid nanoprobe-functionalized
nanostructured silica microfluidic device that can be
used in combination with nucleic acid extraction, and
digital droplet polymerase chain reaction (ddPCR) for
EV isolation, enrichment, and DNA mutation detec-
tion from clinical plasma samples for cancer diagnosis.
The device consists of EV-size-matched silica nanos-
tructures, surface-grafted lipid nanoprobes and a poly-
dimethylsiloxane (PDMS) herringbone micromixer
chamber. Plasma samples are collected from either
cell lines or clinical samples (IRB approved and
patients consented). As plasma flows through the
microfluidic device, the EVs are isolated. EV DNA is
then extracted and pathological mutations are detected
with ddPCR.
Results: The microfluidic device removes 96.5%
plasma proteins. The limit of detection of a KRAS
mutation from plasma EV by ddPCR is 0.01% mutant
allele fraction (MAF). The device is validated in a pilot
clinical study for pancreatic cancer diagnosis. Clinical
samples with known KRAS mutations in the tissue
were validated with the device. ddPCR indicated MAF
of 1.8%, 10.1%, and 22.3%, respectively, from DNA
extracted from plasma EV, while none were detected
in healthy controls.
Summary/conclusion: This new platform suggests that
MAF of EV-derived DNA can have large patient varia-
bility that may depend on cancer type, stage, progres-
sion, or other pathophysiological factors. These results
support the need for a rapid and reliable EV isolation
technique, such as this reported device.
Funding: This work was supported by the National
Cancer Institute of the US National Institutes of
Health under grant number 1R01CA230339 to S. Y.
Zheng.
LB04.02
Asparagine-linked glycosylation amplifies the heterogeneity of
tumour extracellular vesicles
Yoichiro Haradaa, Kazuki Nakajimab, Nobuyoshi Kosakac, Tomoko
Fukushiged, Kiyotaka Kondoa, Junichi Seinoe, Tadashi Suzukie, Hiromasa
Inouea, Takuro Kanekuraf, Takahiro Ochiyac and Ikuro Maruyamaa
aKagoshima University Medical and Dental Sciences, Kagoshima, Japan;
bFujita Health University, Aichi, Japan; cDepartment of Molecular and
Cellular Medicine, Institute of Medical Science, Tokyo Medical University,
Tokyo, Japan; dKagoshima Univeristy Medical and Dental Sciences,
Kagoshima, Japan; eRIKEN, Saitama, Japan
Introduction: Tumour cells secrete heterogeneous
populations of extracellular vesicles (EVs) carrying dis-
tinct proteins. However, the molecular underpinnings
that regulate such EV heterogeneity remain largely
elusive. Tumours consume a large quantity of glucose
through glycolysis for the synthesis of various bioactive
metabolites.
Methods: EVs were prepared from conditioned med-
ium of mouse B16-F10 melanoma cells by differential
centrifugation. The number of EVs secreted, their
cargo proteins and intracellular carbohydrate metabo-
lism were analysed.
Results: Here, we show that 2-DG, a glycolysis inhibi-
tor, suppressed secretion of melanoma EVs indepen-
dently of its glycolysis blockade action. 2-DG-sensitive
EVs were enriched with asparagine (N)-linked glycosy-
lated proteins, while 2-DG-resistant EVs contained
intrinsically non-glycosylated proteins. Metabolic con-
version of 2-DG to artificial nucleotide sugars via gly-
colysis branches induced degradation of N-linked
glycan precursors and hypoglycosylation of multiple
glycoproteins. Mutagenesis at N-linked glycosylation
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sites of an EV cargo protein or pharmacological inhibi-
tion of N-glycosylation reaction by oligosaccharyltrans-
ferase was sufficient to suppress secretion of N-linked
glycosylated proteins by EVs.
Summary/conclusion: This study establishes N-linked
glycosylation as a key posttranslational modification
that influences the heterogeneity of tumour-
derived EVs.
LB04.03
Characterization of fluorescent plasma evs following 5-ALA use in
malignant gliomas.
Leonora Balaja, Pamela Jonesb, Anudeep Yekulab and Bob Carterb
aMassachusetts General Hospital, Boston, USA; bMGH, Boston, USA
Introduction: Malignant gliomas are rapidly progres-
sive brain tumours with very high morbidity and mor-
tality. The recent FDA approval of 5-aminolevulinic
acid (5-ALA, Gliolan) provides the neurosurgeon with
real-time fluorescent delineation of malignant tissue
which allows a significantly higher rate of complete
resections of malignant gliomas and longer progres-
sion-free survival compared to conventional white-
light resections. We sought to determine whether fluor-
escent EVs would be released in the plasma of these
patients.
Methods: Here, we characterize EVs isolated from
glioma cell lines treated with 5-ALA for 24 h. We
also evaluated plasma-derived EVs from glioma
patients following preoperative oral administration of
5-ALA. We used a highly sensitive fluorescence-based
analysis known as Amnis ISX mkII imaging flow cyt-
ometer to measure fluorescent signals from individual
nanoparticles with the added value of being able to
individually visualize particles being measured.
Results: We first compared the rate of EVs released
from glioma cells treated with 5-ALA and determined a
significant number of fluorescent EVs released within
hours of exposure to 5-ALA, while the healthy human
brain microvascular endothelial cells (HBMVEC) did
not release any fluorescent EVs. We also compared the
direct analysis of conditioned media to that of EVs
purified by a commercial kit and determined that the
extra exposure to light of EVs with the commercial kit
leads to a significant loss of fluorescent EVs. To con-
firm our findings we exposed 5-ALA EVs to white light
for 20 min and compared the number of fluorescent
events before and after exposure to light, and deter-
mined a > 98% loss of fluorescent EVs. Finally, a
comparison of the plasma samples from glioma
patients collected upon administration of 5-ALA
revealed that we can reliably detect fluorescent EVs in
the plasma of these patients when the primary tumour
fluoresces, while these events were undetectable in the
cases where the primary tumour did not fluoresce.
Furthermore, these events were undetectable upon
tumour resection.
Summary/conclusion: This study is as a proof of con-
cept to determine our ability to utilize fluorescent
based tumour-specific EV characterization to aid in
the diagnostics and prognostics of gliomas.
Funding: CA069246 CA230697 TR000931
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LB05.01
Reassessment of exosome composition
Dennis Jeppesena, Aidan Fenixb, Jeffrey Franklina, James Higginbothama, Qin
Zhanga, Leonard Romec, Dylan Burnetteb and Robert Coffeya
aVanderbilt University Medical Center, Nashville, USA; bVanderbilt
University School of Medicine, Nashville, USA; cDavid Geffen School of
Medicine, University of California, Los Angeles, USA
Introduction: The heterogeneity of extracellular vesi-
cles (EVs) and presence of non-vesicular extracellular
nanoparticles pose major obstacles to our understand-
ing of the composition and functional properties of
distinct secreted components. Greater precision in
assigning RNA, DNA and protein to their correct
extracellular compartments and identifying their
mechanisms of secretion is crucial for identification
of biomarkers and design of future drug interventions.
Methods: We have employed high-resolution density
gradient fractionation and direct immunoaffinity cap-
ture (DIC) to precisely characterize the RNA, DNA,
and protein constituents of exosomes and other non-
vesicle material. Proteomics and RNA-Seq analyses
were performed on purified small EVs and extracellular
non-vesicular material. DIC was used to specifically
isolate exosomes from other types of small EVs and
was performed without ultracentrifugation and with
capture beads targeting the classical exosomal tetraspa-
nins CD63, CD81 and CD9. Biochemical analysis and
structured illumination microscopy were used to exam-
ine secretion and presence of extracellular DNA.
Results: Extracellular RNA, RNA-binding proteins and
other cellular proteins are differentially expressed in
exosomes and non-vesicle compartments. Argonaute
1–4, glycolytic enzymes and cytoskeletal proteins were
not detected in exosomes. We further demonstrate that
small EVs are not vehicles of active DNA release.
Instead, we propose a new model for active secretion
of extracellular DNA through an autophagy- and mul-
tivesicular endosome-dependent but exosome-indepen-
dent mechanism.
Summary/conclusion: This study demonstrates the
need for a reassessment of exosome composition and
offers a framework for a clearer understanding of EV
and extracellular nanoparticle heterogeneity.
Funding: This study was part of the NIH Extracellular
RNA Communication Consortium paper package and
was supported by the NIH Common Fund’s exRNA
Communication Program. The work was funded by
NIH grants The work was funded by NIH grants F31
HL136081 to Aidan M. Fenix, R35 GM125028 to Dylan
T. Burnette, and R35 CA197570 and U19 CA179514 to
Robert J. Coffey
LB05.02
Biofunctional peptide-modified extracellular vesicles for targeted
intracellular delivery
Ikuhiko Nakase
Graduate School of Science, Osaka Prefecture University, Sakai-Shi, Japan
Introduction: Our research group is developing ther-
apeutic techniques based on extracellular vesicles (exo-
somes, EVs) and peptide chemistry to deliver
therapeutic/diagnostic molecules into targeted cells.
Because of pharmaceutical advantages of the EVs as
carriers for intracellular delivery of therapeutic mole-
cules, we are trying to develop methodology to easily
modify biofunctional peptides on exosomal mem-
branes for receptor target and enhanced cellular uptake
of the EVs. In this presentation, modification techni-
ques using biofunctional peptides such as arginine-rich
cell-penetrating peptides (CPPs, macropinocytosis
induction) [1], artificial coiled-coil peptides (receptor
target) [2], membrane fusion peptides (cytosolic
release) will be introduced [3, 4]. And newly developed
exosomes decorated with cell-penetrating sC18 pep-
tides [5], which are derived from cationic antimicrobial
protein, CAP18, will be also presented and discussed
for cancer targeting.
Methods: For cellular uptake assessments of EVs, we
used CD63 (EV marker protein)-GFP-fusion protein
expressed EVs. All biofunctional peptides were synthe-
sized by Fmoc solid-phase methods.
Results: Macropinocytosis has been shown to be very
important for cellular EV uptake [1]. Therefore, our
research group developed the methods for modification
of arginine-rich CPPs on EV membranes using chemi-
cal linkers or acylation technique, which can induce
clustering of proteoglycans (e.g. syndecan-4) and
macropinocytosis signal transduction [1]. In the
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research of artificial coiled-coil peptides, the artificial
leucine zipper peptide-modified EVs recognize the
peptide-tagged receptor expression on targeted cells
[2]. Stearylation of branched sC18 peptides were easily
modified on the EVs by their insertion of hydrophobic
moiety in EV membranes, resulted in effective induc-
tion of macropinocytosis and cancer cellular uptake.
Summary/conclusion: These experimental techniques
will contribute to development for the EV-based tar-
geted intracellular delivery systems.
Reference: [1] I. Nakase, et al. Sci. Rep. 6, 34937 (2016),
[2] I. Nakase, et al. Chem. Commun. 53, 317 (2017), [3]
I. Nakase, et al. Sci. Rep. 5, 10112 (2015), [4] M.
Akishiba, et al. Nat. Chem. 9, 751 (2017), [5] A.
Gronewold, et al. ChrmMedChem. 12, 42 (2017)
LB05.03
Virus protein pX facilitates naked particles of hepatitis A virus to
acquire an exosome-derived membrane by interacting with ESCRT-
associated protein ALIX
Wang Jianga, Pengjuan Mab, Libin Dengb and Gang Longb
aInstititut Pasteur of Shanghai, Shanghai, USA; bInstitut Pasteur of Shanghai,
Shanghai, China (People‘s Republic)
Introduction: Hepatitis A virus (HAV), a classically-
thought non-enveloped virus, has recently been found
to release majorly in the form of quasi-enveloped HAV
(eHAV) by hijacking the host’s endosomal sorting
complexes required for transport (ESCRT) complexes.
Compared to the non-enveloped virion, eHAV exclu-
sively contains a viral protein pX.
Methods: Differential centrifugation and iodixanol-
based gradient centrifugation were used to isolate dif-
ferent types of EVs. Western-blot, Nanoparticle track-
ing analysis, and immune-electron microscopy were
used to analyse EVs and HAV virus particles.
Fluorescence microscopy in live-cell and immune-elec-
tron microscopy was used to identify the exosome-like
biogenesis of eGFP-pX. Co-IP was performed in 293T
cells. Amino-acids truncation and mutation in pX were
performed in order to find the novel functional domain
of pX.
Results: Fusing pX to eGFP could guide eGFP into
exosomes through directing eGFP into multivesicular
bodies (MVBs). Simultaneously, the release of ALIX, an
MVBs maker protein, is enhanced and co-IP assay
confirms the direct interaction between pX and V
domain of ALIX. Furthermore, deleting C-terminal
half of pX abolishes eHAV release and the interaction
between HAV virion and ALIX. Consistently, the C-
terminal half of pX alone is sufficient to load eGFP into
exosomes by interacting with ALIX. On the other side,
we find there is a novel nucleus export signal (NES)
motif MMSRIAAGD in its N-terminal 12 amino-acids,
which was previously reported essential for virion
assembly
Summary/conclusion: Here, we find that pX is
required for eHAV release and contains a novel
nucleus export signal (NES) in its N-terminal. To con-
clude, pX plays important roles in HAV assembly and
release through two independent domains: the N-term-
inal domain containing a novel NES, and the C-term-
inal half domain associated with the membrane
envelopment via the interaction with ALIX. Thus, pX
may have the potential for protein loading into exo-
somes in the future.
Funding: This work was supported by the national
natural Science Foundation of China (81772200).
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Proteomic and miRNA transcriptome analysis revealed an association
between circulating exosomal miRNAs and insulin sensitivity in
gestational diabetes mellitus during gestation
Soumyalekshmi Naira, Dominic Guanzonb, Andrew Laic, Katherin Scholz-
Romeroc, Carlos Palmac, Jezid Mirandad, Fatima Crispie, David McIntyref,
Martha Lappasg and Carlos Salomonb
aExosome Biology Laboratory, Centre for Clinical Diagnostics, UQ centre for
Clinical Research, Royal Brisbane and Women‘s Hospital, Faculty of
Medicine + Biomedical Sciences, The University of Queensland, Brisbane,
Australia; bExosome Biology Laboratory, Centre for Clinical Diagnostics,
University of Queensland Centre for Clinical Research, Royal Brisbane and
Women’s Hospital, The University of Queensland, Brisbane QLD 4029,
Australia., Brisbane, Australia; cExosome Biology Laboratory, Centre for
Clinical Diagnostics, University of Queensland Centre for Clinical Research,
Royal Brisbane and Women’s Hospital, The University of Queensland,
Brisbane QLD 4029, Australia, Brisbane, Australia; dFetal i + D Fetal
Medicine Research Center, BCNatal – Barcelona Center for Maternal-Fetal
and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Deu),
ICGON, IDIBAPS, Universitat de Barcelona, Spain, Barcelona, Spain; eFetal
i + D Fetal Medicine Research Center, BCNatal – Barcelona Center for
Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant
Joan de Deu), ICGON, IDIBAPS, Universitat de Barcelona, Spain., Barcelona,
Spain; fMater Research, Faculty of Medicine, University of Queensland,
Mater Health, South Brisbane, Australia., Brisbane, Australia; gUniversity of
Melbourne, Department of Obstetrics and Gynaecology, Australia. Mercy
Hospital for Women, 163 Studley Road, Heidelberg, Victoria 3084,
Australia., Brisbane, Australia
Introduction: Gestational Diabetes Mellitus (GDM) is
the most common medical complication in pregnancy,
with short and long term metabolic effects in mothers
and offsprings. We comprehensively analysed the exo-
somal miRNA profile across gestation in normal glu-
cose tolerant (NGT) and women with GDM and
determined the signalling pathways associated with
changes in miRNA profile.
Methods: Exosomes were isolated from plasma sam-
ples collected at three time points during pregnancy
from NGT and GDM women. Using a small RNA
library and linear mixed modelling analysis, the
miRNA profiles across gestation in NGT, GDM and
NGT vs GDM were identified in a discovery cohort
and the expression of candidate miRNAs were mea-
sured using qRT-PCR in a validation cohort. Further,
we characterized the changes in the proteomic profile
in skeletal muscles obtained from GDM patients com-
pared to NGT controls, using a quantitative, data-inde-
pendent acquisition mass spectrometric approach and
finally integrated the exosomal miRNA and skeletal
muscle protein expression profiles to identify miRNA-
targeted networks.
Results: A total of 279 (NGT), 308 (GDM) and 175
(NGT vs GDM) miRNAs were significantly changing
in expression across gestation. 6 miRNAs (hsa-miR-
92a-3p, hsa-miR-10a-5p, hsa-miR-151b, hsa-miR-16–
2-3p, hsa-miR-1910-5p and hsa-miR-423-5p) were
confirmed to be differentially expressed in GDM.
Proteomic characterization revealed 55 proteins to be
differentially expressed in GDM skeletal muscles com-
pared to NGT. The exosomal miRNAs upregulated in
GDM target some of these differentially expressed pro-
teins (Serine/Threonine Protein Phosphatase 6 (PPP6),
Chloride Intracellular Channel Protein 4 (CLIC4) and
Actin Related Protein Complex 2 (ARPC2)) in skeletal
muscles in GDM and associated with pathways regu-
lating glucose metabolism and insulin signalling (such
as STAT 3 pathway).
Summary/conclusion: The miRNA content in mater-
nal circulating exosomes differs across gestation in
GDM patients compared to NGT and target specific
proteins and pathways in skeletal muscle. This suggests
that exosomes may be involved in maternal metabolic
adaptation to pregnancy through the delivery of bioac-
tive miRNAs.
Funding: Diabetes Australia, Lions Medical Research
Foundation, NHMRC; 1114013, and FONDECYT
1170809.
LB06.02
Extracellular vesicles from induced neurons trigger epigenetic
silencing of a brain neurotransmitter
Glenn McConkeya, Isra Alsaadyb, Ellie Tedfordc and Norhidayah Badyad
aUniversity of Leeds, Leeds, United Kingdom; bUniversity of King Abdulaziz,
Leeds, United Kingdom; cUniversity of Cambridge, Cambridge, United
Kingdom; dUniversity of Leeds, Leeds, United Kingdom
Introduction: Our new breakthrough finding is that
extracellular vesicles (EVs) injected into the brain spe-
cifically down-regulated production of the neurotrans-
mitter norepinephrine suppressing transcription of the
DBH gene and hypermethylation of the gene’s promo-
ter. DBH produces norepinephrine from dopamine in
neurons. Previous studies found EVs regulate immune
responses via PTGS but regulating neurons and
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epigenetic changes have not been described. DNA
methylation in neurons is involved in memory and
neurological disorders (Science 2018 361 (6409)).
These observations concur with our recent study that
found central noradrenergic signalling is suppressed in
the brains of infected rodents and in neurons (Infect
Immun 2019 87(2)) for this parasite that causes move-
ment disorders and is associated with neurological
disorders.
Methods: Neuronal cells were induced by infection with
the neurotropic protozoan Toxoplasma gondii and EVs
purified on sucrose gradients. EVs, characterized by
TEM, were used to treat rat and human neuronal cells
and DBH mRNA and nascent DBH gene transcription
were measured. DNA methylation was measured by
MSRE-qPCR. Induced EVs were injected into the locus
co-eruleus of rats and DBH gene expression was
monitored.
Results: We found that EVs purified from infected neu-
ronal cultures (43 ± 5 nm) specifically caused transcrip-
tional gene silencing (TGS) and DNA methylation in
noradrenergic neurons. The induced EVs down-regu-
lated DBH gene expression >200-fold and, surprisingly,
the down-regulation was at transcriptional level. The EVs
also caused an epigenetic change; specifically inducing
DNA hypermethylation of the DBH gene. Intracerebral
injection of induced EVs into rats down-regulated DBH
expression. We are currently identifying the RNA
responsible as the down-regulation was disabled by
degradation of the small RNAs in the EVs.
Summary/conclusion: This is the first study to find
transcriptional gene silencing of a neurotransmitter in
the brain by EVs and DNA hypermethylation in the
neurons. This research will enhance our understanding
of neurological disorders (ie. schizophrenia, epilepsy,
drug addiction) and how memory works. The role of
EVs in regulating neurotransmission in the brain will
be presented.
LB06.03
Extracellular vesicles from human iPS-derived cardiovascular
progenitors do not trigger an immune response in the infarcted heart
Bruna Lima Correaa, Nadia EL-Haraneb, Ingrid Gomezb, Hocine Rachidc,
José Vilard, Manon Desgrese, Valérie Bellamye, Laetitia Pidiale, Paul Alayrace,
Dominique Charronf, Nisa Renaultg, Reem Al-Daccakh, Jean-Sebastien
Silvestree and Philippe Menaschéi
aINSERM U970 – PARCC, Paris, France; bINSERM U970 – PARCC, PARIS,
France; cINSTITUT CURIE, Paris, France; dINSERM U970 – PARCC, Paris,
French Guiana; eINSERM U970 – PARCC, paris, France; fAssistance
Publique – HÔPITAL SAINT-LOUIS -Immunology, Paris, France;
gFUJIFILM Cellular Dynamics, Inc., Madison, USA; hINSERM· UMRS 976,
Paris, France; iAssistance Publique – Hôpital Européen Georges Pompidou-
Cardiology and INSERM U970 – PARCC, Paris, France
Introduction: Extracellular vesicles (EV) recapitulate
most of the cardioprotective effects of stem cells but
their immunological impact remains poorly
understood.
Hypothesis: Immune response to EV may be beneficial
rather than deleterious for the infarcted heart.
Methods: EV secreted from human-induced pluripo-
tent stem cells [EV-hPg-iPS] were first assessed in vitro
for the expression of immune and stem cell markers by
flow cytometry and their cross-talk with allogeneic T
and NK cells, was determined by mixed lymphocyte
reactions (MLR). Then, 70 immunocompetent mice
underwent a myocardial infarction and surviving
mice were injected intramyocardially (under echo gui-
dance) with EV-hPg-iPS, hPg-iPS or PBS either acutely
(n = 6) or chronically (n = 6), i.e., 3 days and 3 weeks
after infarction, respectively. Immune responses were
monitored 3 days after treatment in all mice. Eighteen
additional animals were sham-operated and also
injected after 3 weeks with EV-hPg-iPS, hPg-iPS or
PBS. Pro- and anti-inflammatory cytokines were mea-
sured in heart tissue and plasma by a bead-based multi-
plex immunoassay (n = 6/group).
Results: EV-hPg-iPS expressed stem cell markers
(SSEA-1, CD15, CD133) and low levels of HLA class
I and PD-L1. MLR and in vivo studies demonstrated
that EV do not activate an adaptive allogeneic immune
response since they failed to induce proliferation of
allogeneic CD8+ or CD4 + T cells. In contrast to
their parental cells, EV did not induce NK cell degra-
nulation either. While injection of hPg-iPS or their EV
at the chronic post infarction stage did not affect the
number of T cells, B cells, and macrophages in cardiac
tissue, spleen, bone marrow and blood, they signifi-
cantly decreased the circulating levels of the pro-
inflammatory cytokines IL-1α and IFN-γ compared to
the control group (PBS). However, at the acute stage,
and in contrast to PBS, EV significantly reduced the
number of monocytes High (M1 macrophage precur-
sor), M1 macrophages, and neutrophils as well as the
circulating levels of the pro-inflammatory cytokines IL-
1α, IL-2 and IL-8 while it significantly increased those
of IL-10.
Summary/conclusion: EV-hPg-iPS look immunologi-
cally neutral in vitro and in vivo and seem even able to
mitigate the infarct-related inflammatory response.
Funding: INSERM, LabexRevive, APHP, University
Paris Descartes, Fondation de France, FRM
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